data_2mh9_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mh9 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.432 ' NH2' ' HB2' ' A' ' 14' ' ' ASP . 60.2 ttt180 . . . . . 0 N--CA 1.408 -2.54 0 CA-C-O 122.107 0.956 . . . . 0.0 112.446 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -81.09 111.68 17.76 Favored 'General case' 0 N--CA 1.394 -3.272 0 N-CA-C 104.633 -2.358 . . . . 0.0 104.633 170.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.4 m -84.58 76.15 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.279 -2.47 0 C-N-CA 118.281 -1.368 . . . . 0.0 109.721 178.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.483 ' CG2' ' HA ' ' A' ' 120' ' ' LYS . 26.1 p -110.07 -37.34 5.61 Favored 'General case' 0 C--N 1.259 -3.356 0 CA-C-N 114.849 -1.069 . . . . 0.0 109.391 178.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -69.67 -37.7 76.78 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 176.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.432 ' HB2' ' NH2' ' A' ' 9' ' ' ARG . 11.4 t70 -69.21 -54.93 12.26 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.73 -1.123 . . . . 0.0 108.176 -178.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.404 ' O ' HG21 ' A' ' 19' ' ' VAL . 77.2 t -63.27 -40.38 88.84 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.179 0 CA-C-N 113.76 -1.564 . . . . 0.0 112.966 -177.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 9.6 ttmm -67.08 -35.22 79.35 Favored 'General case' 0 C--N 1.323 -0.586 0 O-C-N 121.907 -0.496 . . . . 0.0 111.586 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 50.1 m -62.97 -45.42 92.52 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 174.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 66.6 mt -55.79 -53.3 39.04 Favored 'Isoleucine or valine' 0 C--O 1.243 0.723 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.134 175.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.404 HG21 ' O ' ' A' ' 15' ' ' VAL . 75.3 t -56.86 -43.99 81.2 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.011 0 CA-C-N 114.985 -1.007 . . . . 0.0 112.162 -178.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.462 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 32.9 ttt180 -53.04 -54.12 40.0 Favored 'General case' 0 N--CA 1.45 -0.453 0 O-C-N 123.765 0.666 . . . . 0.0 110.198 179.257 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.427 ' CD2' HG22 ' A' ' 64' ' ' ILE . 66.0 m-85 -64.91 -43.05 94.08 Favored 'General case' 0 CA--C 1.494 -1.193 0 N-CA-C 113.183 0.809 . . . . 0.0 113.183 -175.045 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 35.9 m -70.84 -35.96 62.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 C-N-CA 119.367 -0.933 . . . . 0.0 111.345 -178.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -65.13 -47.09 78.33 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 123.402 0.439 . . . . 0.0 110.782 177.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.462 ' HG2' ' O ' ' A' ' 20' ' ' ARG . 12.5 pt-20 . . . . . 0 C--O 1.238 0.457 0 C-N-CA 120.113 -0.635 . . . . 0.0 111.878 -179.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 . . . . . 0 CA--C 1.494 -1.182 0 CA-C-O 121.942 0.877 . . . . 0.0 110.226 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 70.1 p -118.79 162.27 18.75 Favored 'General case' 0 N--CA 1.413 -2.305 0 CA-C-N 114.193 -1.367 . . . . 0.0 107.762 178.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.529 ' O ' HG23 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -55.11 -44.27 74.81 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -176.5 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.419 ' O ' ' HB ' ' A' ' 49' ' ' VAL . 3.5 m-20 -71.22 -23.36 62.0 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -177.24 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 26.0 mmt -71.66 -39.7 70.14 Favored 'General case' 0 CA--C 1.508 -0.673 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 176.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 78.4 mt -66.95 -30.89 71.15 Favored 'General case' 0 C--O 1.216 -0.676 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.301 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 45' ' ' MET . 27.3 t -62.8 -52.7 56.28 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.944 0 C-N-CA 124.806 1.242 . . . . 0.0 110.98 178.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.449 ' CG ' ' HB3' ' A' ' 55' ' ' SER . 10.7 t70 -63.02 -38.2 90.24 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 114.848 -1.069 . . . . 0.0 109.287 -178.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.534 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 71.2 mt -63.91 -47.98 88.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.252 -0.885 . . . . 0.0 111.513 176.121 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.484 ' CE2' ' HA3' ' A' ' 68' ' ' GLY . 49.1 t80 -52.65 -43.34 65.43 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 124.778 1.231 . . . . 0.0 111.618 -177.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.9 mp -76.96 -22.54 53.09 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 179.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.77 31.48 18.04 Favored Glycine 0 C--O 1.267 2.2 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -174.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.449 ' HB3' ' CG ' ' A' ' 50' ' ' ASP . 22.8 t -75.69 -179.42 4.71 Favored 'General case' 0 N--CA 1.415 -2.187 0 CA-C-N 113.7 -1.25 . . . . 0.0 108.541 -178.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 43.7 mttm -123.51 17.36 9.67 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 118.76 -1.176 . . . . 0.0 113.297 -169.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.4 m -88.85 -38.31 14.68 Favored 'General case' 0 C--O 1.247 0.971 0 N-CA-C 105.06 -2.2 . . . . 0.0 105.06 173.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -45.85 137.37 5.61 Favored 'General case' 0 N--CA 1.429 -1.494 0 C-N-CA 128.213 2.605 . . . . 0.0 111.59 178.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -120.01 18.22 12.45 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.971 -178.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . 0.251 67.6 mt -104.03 -50.4 9.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 C-N-CA 117.496 -1.682 . . . . 0.0 114.19 -177.276 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.632 ' HA ' ' CD2' ' A' ' 65' ' ' PHE . 25.7 mp0 60.91 26.59 16.48 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 176.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.9 t -139.41 129.65 25.34 Favored 'General case' 0 N--CA 1.421 -1.898 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 106.38 -134.8 12.33 Favored Glycine 0 N--CA 1.435 -1.383 0 N-CA-C 111.61 -0.596 . . . . 0.0 111.61 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.427 HG22 ' CD2' ' A' ' 21' ' ' PHE . 1.4 pt -70.95 29.06 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 124.708 1.203 . . . . 0.0 113.694 179.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.632 ' CD2' ' HA ' ' A' ' 61' ' ' GLN . 9.0 t80 -71.69 112.31 7.7 Favored 'General case' 0 N--CA 1.425 -1.689 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -177.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.34 48.18 46.91 Favored Glycine 0 N--CA 1.441 -0.968 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.505 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 32.5 mmtm -119.25 -21.0 7.73 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 120.941 0.4 . . . . 0.0 111.34 177.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.484 ' HA3' ' CE2' ' A' ' 52' ' ' PHE . . . -121.58 45.13 1.25 Allowed Glycine 0 N--CA 1.437 -1.299 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 178.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.7 m -73.99 6.69 3.17 Favored 'General case' 0 C--N 1.306 -1.292 0 C-N-CA 124.614 1.166 . . . . 0.0 112.173 -175.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -101.71 3.87 40.06 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-O 121.527 0.679 . . . . 0.0 109.883 178.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -101.36 168.8 9.3 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.884 176.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 36.1 t -104.07 155.77 18.42 Favored 'General case' 0 N--CA 1.417 -2.117 0 N-CA-C 104.548 -2.39 . . . . 0.0 104.548 168.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 69.7 mtm180 -57.7 -39.66 77.69 Favored 'General case' 0 C--O 1.209 -1.035 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -175.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 69.7 t60 -77.49 -17.0 58.41 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-O 121.519 0.676 . . . . 0.0 110.886 -176.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -80.53 -43.61 20.44 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 177.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.422 ' HB1' HG11 ' A' ' 49' ' ' VAL . . . -61.81 -41.55 97.91 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.009 -0.996 . . . . 0.0 108.842 175.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -54.16 -43.61 70.76 Favored 'General case' 0 CA--C 1.501 -0.929 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.327 174.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 20.2 ttm180 -64.93 -28.81 69.78 Favored 'General case' 0 C--O 1.217 -0.647 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.228 -172.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.3 tt -80.63 -47.25 14.37 Favored 'General case' 0 N--CA 1.429 -1.523 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.26 -177.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -62.09 -20.04 63.6 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 121.861 0.839 . . . . 0.0 109.471 177.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.402 ' HA ' HG13 ' A' ' 84' ' ' ILE . 94.4 mttt -91.26 -22.34 20.63 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 114.471 -1.241 . . . . 0.0 110.394 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 29.6 tptp -70.93 -47.08 61.03 Favored 'General case' 0 C--O 1.219 -0.531 0 N-CA-C 106.133 -1.802 . . . . 0.0 106.133 171.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 94.3 mt -56.8 -39.65 74.52 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 114.35 -1.295 . . . . 0.0 113.941 177.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.476 ' O ' ' HD2' ' A' ' 87' ' ' LYS . 2.7 pp -69.61 -33.02 54.81 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.785 0 C-N-CA 120.261 -0.576 . . . . 0.0 110.908 178.453 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 53.4 mt -70.36 -44.1 68.81 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 121.087 0.47 . . . . 0.0 111.558 176.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -66.96 -27.28 67.33 Favored 'General case' 0 C--O 1.259 1.575 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.199 179.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.476 ' HD2' ' O ' ' A' ' 84' ' ' ILE . 2.2 mptp? 84.89 18.73 0.13 Allowed 'General case' 0 CA--C 1.476 -1.902 0 C-N-CA 125.781 1.632 . . . . 0.0 112.846 176.215 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.462 ' HA ' ' HB2' ' A' ' 110' ' ' LYS . 1.9 mp -69.77 -40.64 79.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 105.391 -2.077 . . . . 0.0 105.391 166.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.474 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 3.1 mm? -103.6 144.31 31.61 Favored 'General case' 0 N--CA 1.411 -2.405 0 CA-C-N 113.419 -1.719 . . . . 0.0 109.04 173.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -124.72 131.57 53.45 Favored 'General case' 0 N--CA 1.408 -2.538 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 176.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.433 ' OE2' ' HB ' ' A' ' 84' ' ' ILE . 0.1 OUTLIER -95.27 129.67 42.31 Favored 'General case' 0 C--N 1.27 -2.86 0 CA-C-N 114.271 -1.331 . . . . 0.0 111.708 -173.838 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.493 ' O ' ' HA ' ' A' ' 103' ' ' ALA . 7.9 m-20 -96.48 95.84 8.29 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 179.092 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 97.5 mt -76.28 114.54 15.08 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.461 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -130.86 130.86 44.12 Favored 'General case' 0 N--CA 1.42 -1.968 0 CA-C-N 115.344 -0.844 . . . . 0.0 108.837 -177.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.483 HG13 ' C ' ' A' ' 100' ' ' GLN . 16.8 tt -128.81 141.15 47.35 Favored 'Isoleucine or valine' 0 N--CA 1.399 -3.005 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 176.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.456 ' C ' ' H ' ' A' ' 98' ' ' ASN . 3.5 p-10 -95.72 170.85 9.04 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 176.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -67.9 21.72 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -173.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.456 ' H ' ' C ' ' A' ' 96' ' ' ASN . 16.8 m120 -119.32 7.49 11.26 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 177.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 62.14 30.76 17.82 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 124.787 1.305 . . . . 0.0 110.99 -177.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.483 ' C ' HG13 ' A' ' 95' ' ' ILE . 83.6 mm-40 -101.71 107.42 18.64 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 177.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -96.27 139.25 32.68 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 115.663 -0.699 . . . . 0.0 112.081 -175.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 18.4 tt -142.21 146.16 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.723 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 176.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.493 ' HA ' ' O ' ' A' ' 92' ' ' ASP . . . -114.19 132.86 55.95 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 -178.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.442 ' HB2' ' HB2' ' A' ' 92' ' ' ASP . 68.1 m-85 -97.23 175.4 6.29 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 177.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.448 HG11 ' CD1' ' A' ' 89' ' ' LEU . 14.6 t -116.4 121.01 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.803 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 -178.233 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 58.4 mtp -141.76 168.48 19.65 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 113.436 -1.711 . . . . 0.0 108.764 173.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 7.5 mp -116.86 130.27 56.61 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 177.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -131.8 -80.24 0.19 Allowed Glycine 0 N--CA 1.422 -2.257 0 C-N-CA 118.897 -1.62 . . . . 0.0 115.716 -175.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -65.96 -54.9 20.31 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 115.25 1.574 . . . . 0.0 115.25 -168.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.462 ' HB2' ' HA ' ' A' ' 88' ' ' ILE . 41.9 mmtm -97.55 6.15 48.51 Favored 'General case' 0 C--N 1.313 -0.979 0 O-C-N 121.455 -0.778 . . . . 0.0 109.995 -179.222 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.445 ' O ' ' HG ' ' A' ' 115' ' ' LEU . . . -58.03 -32.82 68.34 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -175.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -69.5 -29.13 66.7 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.469 0.652 . . . . 0.0 110.029 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 13.1 m -75.95 -25.16 55.66 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.405 HG21 HG21 ' A' ' 88' ' ' ILE . 40.0 t -70.19 -39.69 77.23 Favored 'Isoleucine or valine' 0 C--O 1.25 1.083 0 CA-C-N 115.246 -0.888 . . . . 0.0 108.942 175.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.445 ' HG ' ' O ' ' A' ' 111' ' ' ALA . 76.1 mt -69.54 -39.2 77.6 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.981 178.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -71.58 -20.07 62.05 Favored 'General case' 0 C--O 1.217 -0.635 0 CA-C-O 121.735 0.778 . . . . 0.0 109.529 176.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 85.04 6.52 84.78 Favored Glycine 0 CA--C 1.503 -0.718 0 CA-C-N 115.396 -0.82 . . . . 0.0 113.173 176.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -93.81 18.9 9.54 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 121.584 0.707 . . . . 0.0 109.644 -175.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.591 ' O ' HD13 ' A' ' 119' ' ' LEU . 0.0 OUTLIER -90.06 112.53 24.01 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-O 123.277 1.513 . . . . 0.0 108.442 -176.898 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.483 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 4.9 ptpp? -130.13 105.72 8.13 Favored 'General case' 1 C--N 1.228 -4.697 0 CA-C-N 113.309 -1.769 . . . . 0.0 112.229 179.551 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.4 m -119.07 171.01 7.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 177.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -105.56 158.39 16.71 Favored 'General case' 0 C--N 1.262 -3.223 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.291 -177.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -158.08 151.7 23.6 Favored 'General case' 0 N--CA 1.426 -1.636 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 172.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 49.8 ttm . . . . . 0 C--N 1.303 -1.415 0 C-N-CA 120.501 -0.48 . . . . 0.0 112.037 -173.384 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.493 ' O ' ' HA ' ' A' ' 122' ' ' ASP . 8.8 mpt_? . . . . . 0 N--CA 1.438 -1.027 0 N-CA-C 111.342 0.127 . . . . 0.0 111.342 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -84.97 90.86 7.92 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 177.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.2 m -85.72 64.96 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 CA-C-O 121.705 0.764 . . . . 0.0 110.498 -179.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.484 HG21 ' CB ' ' A' ' 120' ' ' LYS . 42.8 p -102.92 -16.84 15.74 Favored 'General case' 0 C--N 1.26 -3.3 0 C-N-CA 116.15 -2.22 . . . . 0.0 113.187 -176.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 17.9 p-10 -82.14 -35.88 28.01 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 174.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -68.65 -58.98 3.47 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.3 179.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.407 ' O ' HG22 ' A' ' 19' ' ' VAL . 88.6 t -59.51 -35.72 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 CA-C-N 114.675 -1.148 . . . . 0.0 112.04 -179.028 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -66.07 -40.01 90.52 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.294 178.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.46 ' O ' ' HD2' ' A' ' 21' ' ' PHE . 49.6 m -65.14 -42.03 94.19 Favored 'General case' 0 N--CA 1.442 -0.853 0 O-C-N 123.362 0.414 . . . . 0.0 110.246 178.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 59.0 mt -57.13 -51.89 63.35 Favored 'Isoleucine or valine' 0 C--O 1.244 0.807 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.266 176.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.407 HG11 HG11 ' A' ' 114' ' ' VAL . 70.6 t -65.6 -37.33 79.75 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.621 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.929 -178.001 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 16.2 ttp180 -55.11 -52.24 63.86 Favored 'General case' 0 C--O 1.222 -0.386 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.466 ' CD2' HG22 ' A' ' 64' ' ' ILE . 55.5 m-85 -63.16 -43.81 97.24 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-N 115.103 -0.953 . . . . 0.0 113.006 -177.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 27.3 m -72.87 -33.79 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.055 0 C-N-CA 119.365 -0.934 . . . . 0.0 111.742 -178.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 58.9 tp60 -65.59 -48.88 70.82 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 123.141 0.276 . . . . 0.0 110.737 176.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 . . . . . 0 N--CA 1.474 0.767 0 CA-C-O 121.69 0.757 . . . . 0.0 110.461 179.687 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 . . . . . 0 N--CA 1.433 -1.301 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.503 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 80.9 p -130.69 156.34 45.09 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 104.497 -2.409 . . . . 0.0 104.497 174.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.551 ' O ' HG23 ' A' ' 49' ' ' VAL . 11.9 ptp -59.91 -35.03 74.01 Favored 'General case' 0 C--O 1.215 -0.712 0 CA-C-N 119.701 1.137 . . . . 0.0 110.986 -179.382 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -72.72 -32.74 65.95 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.896 -175.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' MET . . . . . 0.662 ' SD ' ' HA ' ' A' ' 58' ' ' ALA . 48.2 tpp -67.17 -39.45 86.47 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 176.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.503 ' HG ' ' O ' ' A' ' 44' ' ' THR . 77.9 mt -64.26 -40.76 96.66 Favored 'General case' 0 C--O 1.207 -1.152 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.544 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 45' ' ' MET . 68.7 t -64.19 -46.3 93.87 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.687 0 C-N-CA 124.037 0.935 . . . . 0.0 110.245 177.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.609 ' OD1' ' HB3' ' A' ' 55' ' ' SER . 7.9 t70 -60.7 -44.32 96.7 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 114.731 -1.122 . . . . 0.0 109.507 -178.332 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.494 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 54.9 mt -65.18 -47.12 88.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.044 175.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.411 ' CZ ' ' HA3' ' A' ' 68' ' ' GLY . 25.7 t80 -57.18 -44.12 83.28 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 124.353 1.061 . . . . 0.0 110.757 -177.313 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 11.0 mp -77.21 -28.66 53.91 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 177.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 100.74 29.14 6.68 Favored Glycine 0 C--O 1.244 0.722 0 C-N-CA 120.525 -0.845 . . . . 0.0 113.162 177.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.609 ' HB3' ' OD1' ' A' ' 50' ' ' ASP . 23.1 t -80.28 -170.51 2.56 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 123.388 0.675 . . . . 0.0 110.836 -176.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.465 ' HD2' ' C ' ' A' ' 55' ' ' SER . 1.6 mptp? -121.14 7.84 10.31 Favored 'General case' 0 C--O 1.25 1.1 0 N-CA-C 114.271 1.212 . . . . 0.0 114.271 -177.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.5 m -78.36 -30.08 47.85 Favored 'General case' 0 C--O 1.245 0.823 0 N-CA-C 104.837 -2.283 . . . . 0.0 104.837 173.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.662 ' HA ' ' SD ' ' A' ' 47' ' ' MET . . . -50.2 120.97 4.93 Favored 'General case' 0 N--CA 1.417 -2.113 0 C-N-CA 127.34 2.256 . . . . 0.0 109.825 172.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.497 ' HA ' ' HE3' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -100.64 9.69 42.14 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-O 121.067 0.46 . . . . 0.0 111.297 -179.482 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 61.8 mt -128.23 120.88 54.4 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 176.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -105.39 32.43 4.27 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.192 0.52 . . . . 0.0 110.144 -177.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 24.5 m -141.65 126.76 18.43 Favored 'General case' 0 C--N 1.311 -1.077 0 O-C-N 122.057 -0.402 . . . . 0.0 110.84 -177.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.411 ' C ' ' H ' ' A' ' 65' ' ' PHE . . . 131.16 -132.57 6.87 Favored Glycine 0 N--CA 1.442 -0.91 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.466 HG22 ' CD2' ' A' ' 21' ' ' PHE . 1.7 pt -75.9 31.02 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 123.32 0.648 . . . . 0.0 112.054 177.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.494 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 11.5 t80 -66.87 112.8 4.47 Favored 'General case' 0 N--CA 1.42 -1.974 0 CA-C-O 120.992 0.425 . . . . 0.0 110.443 -174.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 63.79 36.8 93.78 Favored Glycine 0 N--CA 1.436 -1.303 0 CA-C-N 115.045 -0.98 . . . . 0.0 112.156 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.505 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -100.8 -25.04 14.25 Favored 'General case' 0 C--N 1.32 -0.701 0 O-C-N 122.153 -0.616 . . . . 0.0 110.247 177.672 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.411 ' HA3' ' CZ ' ' A' ' 52' ' ' PHE . . . -120.13 51.59 0.76 Allowed Glycine 0 N--CA 1.436 -1.351 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.7 t -82.84 9.3 10.16 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 122.017 0.913 . . . . 0.0 109.86 -174.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -102.0 6.8 41.33 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-O 121.709 0.766 . . . . 0.0 109.82 178.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -100.91 154.45 18.66 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 115.019 -0.991 . . . . 0.0 108.852 176.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.643 ' HB3' ' OD1' ' A' ' 75' ' ' ASN . 43.5 t -97.09 164.85 12.34 Favored 'General case' 0 N--CA 1.416 -2.141 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 171.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 10.6 mmm180 -54.16 -40.35 67.39 Favored 'General case' 0 CA--C 1.509 -0.624 0 C-N-CA 122.981 0.512 . . . . 0.0 112.289 -174.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 16.0 t-80 -86.87 -21.73 26.18 Favored 'General case' 0 C--O 1.2 -1.524 0 C-N-CA 119.015 -1.074 . . . . 0.0 111.372 -172.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.643 ' OD1' ' HB3' ' A' ' 72' ' ' SER . 13.4 m120 -79.78 -38.87 32.17 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 -178.403 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.09 -46.29 84.93 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.752 176.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.74 -20.56 61.18 Favored 'General case' 0 C--O 1.214 -0.808 0 C-N-CA 120.544 -0.463 . . . . 0.0 111.231 -178.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.404 ' HB3' ' O ' ' A' ' 75' ' ' ASN . 21.7 tpp180 -65.94 -35.63 81.14 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 176.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.42 ' HG ' ' CD1' ' A' ' 123' ' ' PHE . 2.2 tt -76.83 -45.27 29.22 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 114.761 -1.108 . . . . 0.0 110.175 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -62.99 -17.19 61.87 Favored 'General case' 0 C--O 1.216 -0.693 0 C-N-CA 120.108 -0.637 . . . . 0.0 109.706 176.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.447 ' HA ' HG13 ' A' ' 84' ' ' ILE . 53.1 mttp -86.52 -26.18 24.71 Favored 'General case' 0 CA--C 1.496 -1.099 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.399 177.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.418 ' HG3' ' OD2' ' A' ' 86' ' ' ASP . 29.2 tptp -72.09 -47.24 52.82 Favored 'General case' 0 N--CA 1.427 -1.599 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 176.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.432 ' HB3' HD22 ' A' ' 89' ' ' LEU . 95.8 mt -58.7 -38.08 77.51 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 179.015 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.556 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 2.6 pp -77.7 -23.13 14.08 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 C-N-CA 120.048 -0.661 . . . . 0.0 111.747 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.9 tt -77.76 -47.24 19.49 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 176.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.418 ' OD2' ' HG3' ' A' ' 82' ' ' LYS . 68.3 m-20 -69.64 -20.95 63.59 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.567 -179.58 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.43 ' HB3' ' HB2' ' A' ' 109' ' ' ASN . 3.7 mptp? 84.75 15.61 0.19 Allowed 'General case' 0 CA--C 1.479 -1.765 0 C-N-CA 124.747 1.219 . . . . 0.0 113.679 173.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.411 HG21 HD23 ' A' ' 89' ' ' LEU . 1.8 mp -67.92 -39.92 82.53 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.847 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 169.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.556 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 4.4 mm? -112.08 147.74 35.41 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.682 170.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -133.32 100.53 4.87 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 120.838 0.351 . . . . 0.0 110.061 178.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -100.26 156.76 17.05 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.458 175.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -133.3 179.9 5.91 Favored 'General case' 0 C--O 1.248 0.987 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 179.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 99.1 mt -104.14 150.18 24.57 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 122.511 1.148 . . . . 0.0 113.727 -170.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -141.57 121.01 13.2 Favored 'General case' 0 N--CA 1.422 -1.85 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 176.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 14.7 tt -118.1 149.98 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.444 0 C-N-CA 119.687 -0.805 . . . . 0.0 108.94 -179.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 39.1 p30 -102.1 -176.7 3.19 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.201 178.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -74.05 11.51 0.9 Allowed 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 123.493 0.717 . . . . 0.0 112.315 -178.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -110.79 -2.89 15.99 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 -179.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 29.5 t70 69.11 24.48 6.1 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-O 123.462 1.601 . . . . 0.0 109.189 -176.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -97.52 107.12 19.56 Favored 'General case' 0 C--O 1.245 0.859 0 CA-C-N 114.998 -1.001 . . . . 0.0 108.749 176.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -88.68 129.53 35.5 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.833 -177.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 15.0 tt -124.5 150.14 29.14 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 175.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -108.92 134.54 51.46 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 122.315 -0.241 . . . . 0.0 110.681 -177.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -106.36 143.33 34.63 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 19.0 t -96.61 133.98 35.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 CA-C-O 122.094 0.949 . . . . 0.0 113.168 -171.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 62.6 mtt -134.62 175.95 9.08 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 113.365 -1.743 . . . . 0.0 106.876 176.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -121.61 132.24 54.56 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 -179.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -140.21 -104.99 0.6 Allowed Glycine 0 N--CA 1.429 -1.808 0 C-N-CA 118.484 -1.817 . . . . 0.0 115.525 -174.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.43 ' HB2' ' HB3' ' A' ' 87' ' ' LYS . 37.1 m-80 -49.99 -55.33 15.05 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 115.312 1.597 . . . . 0.0 115.312 -167.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.472 ' O ' HG22 ' A' ' 114' ' ' VAL . 74.8 mmtt -110.89 19.79 18.18 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.833 -0.542 . . . . 0.0 111.119 -176.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -76.3 -33.36 59.07 Favored 'General case' 0 CA--C 1.495 -1.167 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 35.5 tp60 -62.87 -36.48 83.44 Favored 'General case' 0 N--CA 1.423 -1.821 0 CA-C-N 113.025 -1.898 . . . . 0.0 110.023 173.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 19.8 m -69.31 -28.53 66.35 Favored 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 179.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.472 HG22 ' O ' ' A' ' 110' ' ' LYS . 38.9 t -66.76 -43.81 89.71 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.758 176.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 65.3 mt -67.6 -33.05 74.22 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.314 -179.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -72.71 -23.5 60.87 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 177.21 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 98.12 -19.32 54.98 Favored Glycine 0 N--CA 1.44 -1.063 0 CA-C-N 115.597 -0.729 . . . . 0.0 113.075 177.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -79.17 24.22 0.34 Allowed 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.534 1.134 . . . . 0.0 113.56 -172.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.625 HD11 ' O ' ' A' ' 119' ' ' LEU . 0.0 OUTLIER -94.13 109.53 21.3 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 122.914 1.34 . . . . 0.0 109.73 -178.892 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.5 ' HB3' ' HZ3' ' A' ' 120' ' ' LYS 0.341 0.1 OUTLIER -129.54 114.65 16.35 Favored 'General case' 1 C--N 1.225 -4.831 0 N-CA-C 114.449 1.277 . . . . 0.0 114.449 172.651 . . . . . . . . 5 4 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 5.4 m -126.83 173.68 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.796 0 CA-C-N 114.758 -1.11 . . . . 0.0 108.147 177.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.493 ' HA ' ' O ' ' A' ' 9' ' ' ARG . 8.5 p-10 -107.77 173.07 6.48 Favored 'General case' 0 C--N 1.269 -2.919 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.702 -177.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . 0.42 ' CD1' ' HG ' ' A' ' 79' ' ' LEU . 51.1 t80 -157.81 166.78 31.82 Favored 'General case' 0 C--O 1.251 1.166 0 C-N-CA 123.93 0.892 . . . . 0.0 108.95 178.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 42.8 tpp . . . . . 0 N--CA 1.442 -0.827 0 C-N-CA 125.827 1.651 . . . . 0.0 106.595 -178.737 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.529 ' HB2' ' O ' ' A' ' 123' ' ' PHE . 6.9 mpt_? . . . . . 0 N--CA 1.432 -1.355 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -90.76 94.18 9.56 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 -174.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.602 ' HB ' ' OD1' ' A' ' 14' ' ' ASP . 21.6 m -89.64 104.35 15.0 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 CA-C-O 122.658 1.218 . . . . 0.0 110.648 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -122.28 -42.61 2.35 Favored 'General case' 0 C--N 1.267 -3.018 0 C-N-CA 119.285 -0.966 . . . . 0.0 112.545 174.047 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.47 ' HA ' ' HB2' ' A' ' 16' ' ' LYS 0.367 7.3 m-20 -87.62 -9.84 53.13 Favored 'General case' 0 N--CA 1.419 -1.99 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 -171.639 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.602 ' OD1' ' HB ' ' A' ' 11' ' ' VAL . 20.2 p-10 -84.32 -39.92 18.55 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 105.545 -2.021 . . . . 0.0 105.545 171.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.436 ' O ' ' HB ' ' A' ' 18' ' ' ILE . 65.0 t -65.39 -37.32 79.79 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.378 0 CA-C-N 113.847 -1.524 . . . . 0.0 109.448 174.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.47 ' HB2' ' HA ' ' A' ' 13' ' ' ASP . 1.4 tppp? -61.6 -42.7 99.24 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 124.941 1.296 . . . . 0.0 109.776 178.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.9 t -61.66 -45.24 94.89 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.436 ' HB ' ' O ' ' A' ' 15' ' ' VAL . 87.6 mt -54.28 -54.28 22.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.168 175.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 77.2 t -56.5 -47.06 82.39 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.773 0 CA-C-N 115.144 -0.934 . . . . 0.0 111.562 -179.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 7.3 tpt180 -51.25 -51.6 52.57 Favored 'General case' 0 C--N 1.321 -0.644 0 O-C-N 123.421 0.451 . . . . 0.0 111.282 177.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.507 ' CE1' ' HA3' ' A' ' 63' ' ' GLY . 69.0 m-85 -72.58 -35.9 68.05 Favored 'General case' 0 CA--C 1.492 -1.287 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -174.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 27.0 m -73.96 -37.13 46.96 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.533 0 C-N-CA 118.963 -1.095 . . . . 0.0 110.222 178.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -61.02 -50.85 71.67 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 176.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 . . . . . 0 C--N 1.324 -0.511 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.922 -177.796 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 . . . . . 0 N--CA 1.432 -1.327 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.455 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 68.4 p -114.73 163.44 15.46 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 179.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.572 ' O ' HG21 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -58.11 -39.85 79.69 Favored 'General case' 0 C--O 1.214 -0.775 0 CA-C-O 121.028 0.442 . . . . 0.0 109.885 -179.138 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.41 ' CG ' HH22 ' A' ' 73' ' ' ARG . 18.7 t-20 -60.78 -45.42 94.43 Favored 'General case' 0 C--N 1.31 -1.124 0 C-N-CA 124.967 1.307 . . . . 0.0 111.157 -175.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' MET . . . . . 0.473 ' SD ' ' HA ' ' A' ' 58' ' ' ALA . 35.6 tpp -67.48 -36.4 81.04 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.584 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.455 ' HG ' ' O ' ' A' ' 44' ' ' THR . 73.1 mt -69.75 -29.54 66.92 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.271 -178.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.572 HG21 ' O ' ' A' ' 45' ' ' MET . 44.2 t -67.07 -48.67 78.39 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.24 0 C-N-CA 123.679 0.792 . . . . 0.0 110.37 178.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -58.91 -41.16 86.6 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.955 177.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.706 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 49.9 mt -63.94 -46.05 95.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.629 176.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.512 ' CE2' ' HA3' ' A' ' 68' ' ' GLY . 49.0 t80 -63.0 -40.08 96.69 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 123.208 0.603 . . . . 0.0 111.361 -178.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.0 mp -75.78 -35.12 60.21 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 111.46 8.18 23.4 Favored Glycine 0 C--O 1.244 0.734 0 C-N-CA 119.822 -1.18 . . . . 0.0 112.184 -177.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 63.2 m -65.63 124.19 21.72 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 123.47 0.708 . . . . 0.0 109.872 177.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -82.88 20.26 1.21 Allowed 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 -178.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.1 m -77.55 -24.55 49.84 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 106.163 -1.791 . . . . 0.0 106.163 172.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.473 ' HA ' ' SD ' ' A' ' 47' ' ' MET . . . -52.85 151.06 4.8 Favored 'General case' 0 C--O 1.247 0.947 0 CA-C-N 113.529 -1.669 . . . . 0.0 112.042 178.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -93.92 -16.82 23.63 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.889 178.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 71.1 mt -132.03 143.5 39.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.392 -175.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 20.2 mm-40 -106.23 80.91 1.55 Allowed 'General case' 0 C--O 1.245 0.834 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 176.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 42.0 m -79.59 173.82 12.2 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 110.121 -0.325 . . . . 0.0 110.121 179.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.507 ' HA3' ' CE1' ' A' ' 21' ' ' PHE . . . -60.93 -31.15 75.2 Favored Glycine 0 N--CA 1.467 0.735 0 C-N-CA 121.096 -0.573 . . . . 0.0 112.513 -179.203 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.433 HG21 ' CD2' ' A' ' 21' ' ' PHE . 5.8 pt -73.74 2.77 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.73 0 N-CA-C 113.515 0.931 . . . . 0.0 113.515 177.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.706 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 6.4 t80 -65.56 106.54 1.46 Allowed 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -178.073 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 83.41 18.69 63.76 Favored Glycine 0 N--CA 1.429 -1.776 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.493 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.425 ' CG ' ' HA ' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -86.72 -35.27 19.34 Favored 'General case' 0 CA--C 1.51 -0.576 0 C-N-CA 119.022 -1.071 . . . . 0.0 109.956 177.197 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.512 ' HA3' ' CE2' ' A' ' 52' ' ' PHE . . . -105.25 44.37 1.49 Allowed Glycine 0 N--CA 1.426 -1.982 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 44.0 t -72.49 -0.21 12.07 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 123.402 0.681 . . . . 0.0 111.002 -177.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -97.74 1.94 49.03 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-O 121.207 0.527 . . . . 0.0 110.64 178.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -99.55 148.41 24.32 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 115.454 -0.794 . . . . 0.0 108.955 175.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 39.1 t -90.83 161.78 15.11 Favored 'General case' 0 C--N 1.281 -2.382 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 168.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.447 ' HB3' ' NH1' ' A' ' 73' ' ' ARG . 13.5 mtp-105 -60.29 -36.19 77.3 Favored 'General case' 0 C--O 1.219 -0.522 0 CA-C-O 121.053 0.454 . . . . 0.0 110.293 -177.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 19.4 t-160 -62.67 -41.64 99.19 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.113 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -65.93 -52.58 48.59 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -176.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.7 -44.12 96.94 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.473 -0.785 . . . . 0.0 112.441 -177.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.436 ' CG ' HG23 ' A' ' 49' ' ' VAL . 42.9 mt-10 -64.33 -33.81 76.71 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 121.585 0.707 . . . . 0.0 111.009 178.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 17.7 mmm180 -78.04 -17.0 57.57 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.913 -179.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.3 tt -79.84 -42.69 23.8 Favored 'General case' 0 N--CA 1.426 -1.635 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 176.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -60.53 -19.98 58.86 Favored 'General case' 0 C--O 1.216 -0.705 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 172.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.404 ' HA ' HG13 ' A' ' 84' ' ' ILE . 73.0 mmtt -82.75 -28.58 30.31 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.463 176.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 29.1 tptp -70.43 -45.42 65.9 Favored 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 174.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.477 ' HB3' HD23 ' A' ' 89' ' ' LEU . 97.8 mt -58.83 -37.1 75.67 Favored 'General case' 0 N--CA 1.428 -1.563 0 CA-C-N 113.958 -1.474 . . . . 0.0 113.834 178.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.511 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 2.7 pp -74.02 -26.94 21.58 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.592 0 C-N-CA 119.884 -0.726 . . . . 0.0 111.627 178.392 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 49.0 mt -73.42 -47.65 40.12 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 123.49 0.494 . . . . 0.0 110.507 175.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -67.1 -25.31 66.15 Favored 'General case' 0 C--O 1.254 1.312 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.054 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? 85.51 23.52 0.08 Allowed 'General case' 0 CA--C 1.478 -1.797 0 C-N-CA 125.951 1.7 . . . . 0.0 113.475 175.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.421 HG21 HG23 ' A' ' 114' ' ' VAL . 2.0 mp -74.58 -41.47 48.67 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.224 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 169.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.511 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 3.7 mm? -103.68 140.39 37.65 Favored 'General case' 0 N--CA 1.424 -1.769 0 CA-C-N 114.153 -1.385 . . . . 0.0 109.748 175.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -131.35 109.75 10.57 Favored 'General case' 0 C--N 1.285 -2.216 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 176.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -94.96 149.21 21.5 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 121.051 0.453 . . . . 0.0 112.16 -172.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.456 ' O ' ' HA ' ' A' ' 103' ' ' ALA . 8.1 m-20 -97.78 108.37 21.07 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 94.5 mt -81.68 108.82 15.55 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.716 0.77 . . . . 0.0 109.661 176.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -120.69 125.57 48.01 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-N 114.802 -1.09 . . . . 0.0 108.402 -175.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.462 HG13 ' C ' ' A' ' 100' ' ' GLN . 16.9 tt -130.3 141.78 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.753 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 178.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -97.13 173.15 7.39 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 176.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -66.44 18.21 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 -173.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -118.61 10.24 12.46 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 177.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.407 ' HA ' HD13 ' A' ' 95' ' ' ILE . 6.1 m-20 60.13 29.32 18.9 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 122.644 1.212 . . . . 0.0 111.023 -174.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.462 ' C ' HG13 ' A' ' 95' ' ' ILE . 94.0 mt-30 -95.92 106.04 18.14 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 114.426 -1.261 . . . . 0.0 107.998 176.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -101.36 144.33 30.31 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.626 -0.715 . . . . 0.0 112.437 -175.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 9.6 tp -141.6 146.86 22.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 174.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.456 ' HA ' ' O ' ' A' ' 92' ' ' ASP . . . -112.0 129.04 56.33 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 110.156 -0.312 . . . . 0.0 110.156 -178.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -97.49 162.78 13.15 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 177.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.42 HG13 ' CD1' ' A' ' 89' ' ' LEU . 8.4 t -105.16 123.71 59.5 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.862 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 -177.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 26.2 mmt -137.83 162.68 33.32 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 113.178 -1.828 . . . . 0.0 106.743 173.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -127.71 123.29 35.06 Favored 'General case' 0 C--N 1.285 -2.226 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 177.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -125.49 -86.27 0.63 Allowed Glycine 0 N--CA 1.422 -2.237 0 C-N-CA 119.099 -1.524 . . . . 0.0 115.705 -171.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -57.32 -46.49 83.18 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 115.86 1.8 . . . . 0.0 115.86 -167.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.455 ' O ' HG21 ' A' ' 114' ' ' VAL . 41.9 mmtm -106.2 8.8 32.2 Favored 'General case' 0 C--N 1.308 -1.199 0 O-C-N 121.507 -0.746 . . . . 0.0 111.321 -179.095 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -54.64 -45.7 73.83 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -172.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -72.9 -24.28 60.82 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.213 0.53 . . . . 0.0 110.946 -176.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 7.2 m -75.51 -24.9 56.87 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 -178.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.455 HG21 ' O ' ' A' ' 110' ' ' LYS . 21.9 t -74.97 -37.52 41.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 176.004 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 81.4 mt -66.44 -38.59 87.73 Favored 'General case' 0 C--O 1.219 -0.507 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.621 177.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -72.57 -24.99 61.18 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 174.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 70.64 24.7 76.68 Favored Glycine 0 C--O 1.218 -0.852 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.402 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -95.98 32.64 1.86 Allowed 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 105.788 -1.93 . . . . 0.0 105.788 176.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.428 HD22 ' N ' ' A' ' 120' ' ' LYS . 0.3 OUTLIER -142.71 127.16 17.8 Favored 'General case' 0 N--CA 1.384 -3.772 0 CA-C-N 113.012 -1.904 . . . . 0.0 108.018 -174.531 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.46 ' HD3' ' O ' ' A' ' 120' ' ' LYS . 0.0 OUTLIER -130.25 137.99 50.3 Favored 'General case' 0 N--CA 1.414 -2.268 0 N-CA-C 107.896 -1.149 . . . . 0.0 107.896 172.362 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.547 HG21 ' O ' ' A' ' 11' ' ' VAL . 4.8 m -114.35 -174.79 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 C-N-CA 119.363 -0.935 . . . . 0.0 108.51 176.212 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -133.83 140.85 47.15 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -171.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . 0.529 ' O ' ' HB2' ' A' ' 9' ' ' ARG . 11.2 t80 -158.17 -175.5 5.38 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 175.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 26.1 ptt? . . . . . 0 C--N 1.314 -0.97 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 177.679 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 72.1 mtm180 . . . . . 0 CA--C 1.499 -0.982 0 N-CA-C 114.621 1.341 . . . . 0.0 114.621 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -98.16 90.26 4.79 Favored 'General case' 0 CA--C 1.48 -1.727 0 N-CA-C 102.146 -3.279 . . . . 0.0 102.146 170.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.448 ' O ' HG21 ' A' ' 11' ' ' VAL . 19.0 m -71.95 84.53 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.317 0 CA-C-O 122.85 1.31 . . . . 0.0 112.652 -172.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.486 HG21 ' HA ' ' A' ' 120' ' ' LYS . 37.8 p -100.88 -54.79 2.73 Favored 'General case' 0 C--N 1.26 -3.301 0 C-N-CA 117.869 -1.532 . . . . 0.0 112.831 174.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -86.96 -11.56 50.18 Favored 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 119.405 -0.918 . . . . 0.0 110.142 -178.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.429 ' OD1' ' HA ' ' A' ' 11' ' ' VAL . 1.6 m-20 -69.41 -41.77 75.96 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 104.864 -2.272 . . . . 0.0 104.864 173.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 51.5 t -70.07 -45.37 76.49 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.828 0 CA-C-N 112.946 -1.934 . . . . 0.0 109.847 176.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 30.9 ttmt -65.56 -35.54 81.13 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.6 p -62.72 -44.56 95.89 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 120.628 -0.429 . . . . 0.0 109.937 176.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 56.9 mt -53.9 -50.24 54.12 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 O-C-N 123.745 0.653 . . . . 0.0 109.725 172.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.418 ' O ' ' HG3' ' A' ' 23' ' ' GLN . 76.5 t -58.05 -46.36 88.08 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.867 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.27 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 58.7 mtm-85 -58.33 -32.43 68.49 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.666 ' CD2' HG23 ' A' ' 64' ' ' ILE . 70.7 m-85 -83.48 -37.75 22.71 Favored 'General case' 0 N--CA 1.427 -1.58 0 C-N-CA 119.514 -0.875 . . . . 0.0 112.747 179.067 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.403 HG21 ' HA ' ' A' ' 19' ' ' VAL . 27.7 m -69.01 -29.73 44.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 C-N-CA 117.629 -1.629 . . . . 0.0 109.668 176.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.418 ' HG3' ' O ' ' A' ' 19' ' ' VAL . 54.9 mt-30 -62.61 -38.35 89.82 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.471 170.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.632 ' HG3' ' O ' ' A' ' 21' ' ' PHE . 0.3 OUTLIER . . . . . 0 CA--C 1.493 -1.245 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.466 -179.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 . . . . . 0 N--CA 1.444 -0.727 0 CA-C-O 120.887 0.375 . . . . 0.0 110.744 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 41.6 p -116.63 155.98 27.84 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 106.306 -1.738 . . . . 0.0 106.306 172.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.468 ' O ' HG23 ' A' ' 49' ' ' VAL . 16.2 ptp -62.45 -36.08 81.3 Favored 'General case' 0 C--O 1.217 -0.637 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -175.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -66.13 -30.94 71.52 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.936 0.398 . . . . 0.0 110.133 -178.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 22.7 mmt -73.88 -41.32 62.35 Favored 'General case' 0 C--O 1.202 -1.409 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.845 177.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 80.4 mt -56.43 -37.21 69.91 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.979 0.418 . . . . 0.0 110.908 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 45' ' ' MET . 74.2 t -66.11 -44.51 91.77 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.317 0 C-N-CA 124.268 1.027 . . . . 0.0 110.601 177.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -59.72 -43.17 94.29 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.45 -178.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.414 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 1.9 mp -64.29 -47.93 87.61 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.959 174.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -54.81 -42.37 71.76 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.441 1.096 . . . . 0.0 111.16 -177.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.7 mp -83.04 -15.14 52.2 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 178.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.58 39.09 12.69 Favored Glycine 0 C--O 1.253 1.327 0 C-N-CA 120.417 -0.897 . . . . 0.0 111.079 -178.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 65.2 m -86.89 -172.52 4.03 Favored 'General case' 0 N--CA 1.418 -2.055 0 CA-C-N 115.294 -0.453 . . . . 0.0 111.886 -178.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -109.79 -4.72 15.88 Favored 'General case' 0 C--O 1.261 1.703 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 -170.213 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.3 m -78.07 -28.07 48.74 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 105.565 -2.013 . . . . 0.0 105.565 176.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -51.59 107.19 0.17 Allowed 'General case' 0 N--CA 1.419 -1.998 0 C-N-CA 126.56 1.944 . . . . 0.0 112.428 175.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.67 -7.27 28.18 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 174.212 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 28.1 mm -95.65 110.84 24.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 114.511 -1.222 . . . . 0.0 108.866 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -122.2 97.13 5.33 Favored 'General case' 0 C--N 1.293 -1.859 0 O-C-N 121.781 -0.575 . . . . 0.0 110.283 172.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.9 m -145.97 -80.13 0.16 Allowed 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 173.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -100.98 165.16 18.59 Favored Glycine 0 N--CA 1.433 -1.551 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.243 178.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.666 HG23 ' CD2' ' A' ' 21' ' ' PHE 0.26 16.6 pt 48.55 9.71 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.443 0 N-CA-C 117.573 2.434 . . . . 0.0 117.573 178.4 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.414 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 23.0 t80 -64.74 105.07 0.92 Allowed 'General case' 0 C--O 1.243 0.762 0 CA-C-N 118.442 0.565 . . . . 0.0 111.292 -177.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 74.56 29.63 61.34 Favored Glycine 0 C--N 1.312 -0.762 0 CA-C-N 115.628 -0.714 . . . . 0.0 112.241 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.433 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.7 OUTLIER -94.2 -19.31 20.86 Favored 'General case' 0 C--N 1.322 -0.611 0 O-C-N 122.409 -0.465 . . . . 0.0 111.565 176.83 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -126.53 39.09 2.05 Favored Glycine 0 N--CA 1.433 -1.538 0 C-N-CA 120.465 -0.874 . . . . 0.0 111.433 -178.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 15.5 m -71.3 1.76 5.72 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 123.944 0.898 . . . . 0.0 112.064 -177.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -98.99 4.27 47.18 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-O 121.422 0.629 . . . . 0.0 110.099 178.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -95.35 147.19 23.76 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 115.291 -0.868 . . . . 0.0 108.779 175.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.445 ' HB3' ' CG ' ' A' ' 75' ' ' ASN . 30.5 t -75.95 149.31 37.69 Favored 'General case' 0 N--CA 1.416 -2.171 0 N-CA-C 105.299 -2.112 . . . . 0.0 105.299 169.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.439 ' O ' ' HG3' ' A' ' 77' ' ' GLU . 0.2 OUTLIER -50.33 -44.92 54.54 Favored 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 123.946 0.898 . . . . 0.0 110.339 -173.356 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.419 ' HA ' ' OE1' ' A' ' 77' ' ' GLU . 17.5 t-80 -84.87 -12.55 53.25 Favored 'General case' 0 N--CA 1.428 -1.568 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.936 -173.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.445 ' CG ' ' HB3' ' A' ' 72' ' ' SER . 6.5 m120 -71.58 -45.41 62.29 Favored 'General case' 0 CA--C 1.48 -1.718 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 179.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.412 ' HB1' HG11 ' A' ' 49' ' ' VAL . . . -63.88 -41.52 97.71 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 114.477 -1.238 . . . . 0.0 109.44 179.177 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.439 ' HG3' ' O ' ' A' ' 73' ' ' ARG . 47.9 mt-10 -61.26 -36.09 79.04 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-O 121.53 0.681 . . . . 0.0 110.508 176.136 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 62.7 ttp180 -72.75 -23.79 60.87 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.63 -177.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.3 tt -79.8 -44.36 20.76 Favored 'General case' 0 N--CA 1.419 -1.98 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.175 -178.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -63.13 -21.47 66.21 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 175.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.415 ' O ' HG13 ' A' ' 84' ' ' ILE . 22.6 mmtm -82.49 -28.19 31.32 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.814 176.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 45.8 tptt -70.29 -44.0 69.24 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 175.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.429 ' HB3' HD21 ' A' ' 89' ' ' LEU . 94.3 mt -62.24 -33.63 74.95 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 114.782 -1.099 . . . . 0.0 113.533 178.138 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.415 HG13 ' O ' ' A' ' 81' ' ' LYS . 2.5 pp -75.56 -25.77 17.85 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.643 0 C-N-CA 119.716 -0.794 . . . . 0.0 111.506 178.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 52.4 mt -72.12 -49.06 39.15 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 121.034 0.445 . . . . 0.0 110.693 176.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.52 -14.2 61.17 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.267 -179.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.407 ' HA ' ' HZ2' ' A' ' 87' ' ' LYS . 0.0 OUTLIER 83.96 13.45 0.32 Allowed 'General case' 0 CA--C 1.501 -0.915 0 C-N-CA 125.432 1.493 . . . . 0.0 112.153 167.761 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 1.8 mp -65.38 -41.65 91.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 169.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.429 HD21 ' HB3' ' A' ' 83' ' ' LEU . 3.3 mm? -103.88 148.01 26.65 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 114.107 -1.406 . . . . 0.0 110.466 174.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -132.76 127.84 35.53 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.386 177.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -94.53 137.16 33.98 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-O 121.264 0.554 . . . . 0.0 110.978 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -98.36 144.47 27.71 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 114.585 -1.189 . . . . 0.0 108.924 -179.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 91.1 mt -104.59 97.88 7.73 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 121.881 0.848 . . . . 0.0 110.528 -178.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -100.14 111.68 23.97 Favored 'General case' 0 C--N 1.282 -2.357 0 CA-C-N 114.443 -1.253 . . . . 0.0 108.09 -177.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.638 ' HA ' ' CB ' ' A' ' 101' ' ' ALA . 1.8 tt -132.3 141.88 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.844 0 O-C-N 123.597 0.56 . . . . 0.0 111.162 174.325 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.446 ' C ' ' H ' ' A' ' 98' ' ' ASN . 2.2 p-10 -99.32 171.38 8.01 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 177.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -67.8 26.4 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -172.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.446 ' H ' ' C ' ' A' ' 96' ' ' ASN . 15.3 m120 -119.0 -4.95 10.57 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 177.114 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 57.38 33.03 22.71 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 122.802 1.287 . . . . 0.0 110.718 -174.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.44 ' HG3' ' O ' ' A' ' 98' ' ' ASN . 27.3 mt-30 -128.53 87.19 2.55 Favored 'General case' 0 CA--C 1.495 -1.151 0 CA-C-N 114.023 -1.444 . . . . 0.0 108.744 -177.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.638 ' CB ' ' HA ' ' A' ' 95' ' ' ILE . . . -159.39 -177.86 6.73 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -175.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 10.6 tp -139.42 167.75 19.45 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.332 0 O-C-N 123.366 0.416 . . . . 0.0 110.436 -170.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -84.74 141.18 30.73 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 122.945 0.498 . . . . 0.0 110.556 179.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -111.8 167.72 10.14 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.21 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 14.7 t -98.27 129.65 48.21 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -177.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 26.3 mmt -136.33 163.45 30.41 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 113.774 -1.557 . . . . 0.0 107.943 176.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.475 ' HB3' ' CB ' ' A' ' 111' ' ' ALA . 7.7 mp -115.19 124.35 51.19 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 176.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -131.8 -102.86 0.89 Allowed Glycine 0 N--CA 1.434 -1.481 0 C-N-CA 118.592 -1.765 . . . . 0.0 116.316 -173.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 45.1 t-20 -58.24 -45.71 87.27 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.554 1.142 . . . . 0.0 113.693 -165.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.505 ' HD3' ' OG1' ' A' ' 113' ' ' THR . 19.8 mmtm -111.16 13.81 21.82 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -178.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.475 ' CB ' ' HB3' ' A' ' 107' ' ' LEU . . . -70.6 -38.5 74.01 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.693 0.758 . . . . 0.0 109.681 177.132 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.19 -30.64 71.69 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.882 0.848 . . . . 0.0 109.246 176.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' THR . . . . . 0.505 ' OG1' ' HD3' ' A' ' 110' ' ' LYS . 17.2 m -74.53 -25.65 59.47 Favored 'General case' 0 N--CA 1.424 -1.772 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.329 -178.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.48 ' HA ' ' HG ' ' A' ' 119' ' ' LEU . 63.4 t -66.15 -44.83 91.49 Favored 'Isoleucine or valine' 0 C--O 1.248 0.998 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 174.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 59.3 mt -63.74 -42.05 97.94 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.919 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -72.3 -14.3 61.71 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.618 177.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 83.43 11.6 79.98 Favored Glycine 0 C--O 1.213 -1.161 0 C-N-CA 120.685 -0.769 . . . . 0.0 113.65 176.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -95.92 23.27 6.5 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 122.562 1.172 . . . . 0.0 109.481 -176.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.573 HD11 ' O ' ' A' ' 119' ' ' LEU . 0.0 OUTLIER -103.39 101.33 11.23 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-O 122.926 1.346 . . . . 0.0 108.647 -178.474 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.486 ' HA ' HG21 ' A' ' 12' ' ' THR . 0.0 OUTLIER -128.94 96.55 4.38 Favored 'General case' 1 C--N 1.229 -4.668 0 CA-C-N 115.021 -0.99 . . . . 0.0 112.957 175.512 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 5.8 m -114.13 173.45 3.16 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.777 -178.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -104.94 160.62 14.88 Favored 'General case' 0 C--N 1.277 -2.545 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.967 -179.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -158.06 135.12 10.0 Favored 'General case' 0 C--O 1.25 1.095 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.788 172.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 17.6 tmm? . . . . . 0 N--CA 1.434 -1.26 0 CA-C-N 115.132 -0.94 . . . . 0.0 108.651 -179.285 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 28.9 mmt180 . . . . . 0 CA--C 1.501 -0.924 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -118.68 108.51 15.0 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 12.8 m -101.61 101.3 11.91 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.167 0 CA-C-O 122.271 1.034 . . . . 0.0 110.002 177.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.489 HG22 ' HA ' ' A' ' 120' ' ' LYS . 42.9 p -120.17 -40.2 2.73 Favored 'General case' 0 C--N 1.264 -3.134 0 C-N-CA 119.494 -0.882 . . . . 0.0 109.8 177.154 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -69.35 -40.62 77.41 Favored 'General case' 0 C--N 1.29 -1.982 0 C-N-CA 125.867 1.667 . . . . 0.0 109.643 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.403 ' CG ' ' HZ2' ' A' ' 67' ' ' LYS . 9.9 t0 -68.78 -45.29 71.72 Favored 'General case' 0 C--O 1.244 0.776 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 87.2 t -67.38 -40.83 85.48 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 CA-C-N 114.063 -1.426 . . . . 0.0 111.765 -177.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -65.31 -36.93 85.56 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 43.4 t -61.27 -46.76 89.02 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 175.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.404 ' O ' HG21 ' A' ' 22' ' ' VAL . 68.6 mt -56.0 -54.11 30.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 C-N-CA 123.072 0.549 . . . . 0.0 110.399 177.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 71.7 t -59.4 -44.03 91.68 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.789 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.859 -178.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 19.6 ttt180 -61.51 -45.86 92.44 Favored 'General case' 0 N--CA 1.436 -1.13 0 C-N-CA 120.0 -0.68 . . . . 0.0 110.847 179.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -63.15 -42.83 99.53 Favored 'General case' 0 CA--C 1.5 -0.943 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.404 HG21 ' O ' ' A' ' 18' ' ' ILE . 28.2 m -72.89 -33.47 43.62 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 C-N-CA 119.909 -0.716 . . . . 0.0 111.006 179.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -65.98 -54.86 20.72 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 121.164 -0.214 . . . . 0.0 110.796 173.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 . . . . . 0 N--CA 1.467 0.392 0 CA-C-O 121.365 0.602 . . . . 0.0 111.114 -177.278 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 . . . . . 0 N--CA 1.436 -1.144 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.409 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 57.6 p -116.37 158.02 24.14 Favored 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 171.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.432 ' O ' HG21 ' A' ' 49' ' ' VAL . 21.2 ptm -54.91 -37.85 66.88 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 120.283 -0.567 . . . . 0.0 111.634 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -66.05 -36.02 82.12 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 46.0 mtt -66.94 -42.97 84.37 Favored 'General case' 0 CA--C 1.497 -1.09 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 44' ' ' THR . 80.8 mt -59.34 -45.58 90.98 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.111 -178.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.432 HG21 ' O ' ' A' ' 45' ' ' MET . 82.2 t -66.43 -52.78 42.95 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.137 0 C-N-CA 123.908 0.883 . . . . 0.0 111.311 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.16 -39.79 87.65 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.182 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.466 ' CD1' ' HA ' ' A' ' 58' ' ' ALA . 1.8 mp -71.6 -38.73 68.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 O-C-N 121.984 -0.447 . . . . 0.0 111.402 177.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.481 ' CE2' ' HA3' ' A' ' 68' ' ' GLY . 60.2 t80 -55.47 -37.71 68.16 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 124.111 0.964 . . . . 0.0 111.293 -178.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.5 mp -92.7 -25.85 18.04 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 177.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.33 50.23 4.61 Favored Glycine 0 C--O 1.22 -0.731 0 N-CA-C 108.694 -1.762 . . . . 0.0 108.694 -172.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 47.6 t -97.56 -170.24 1.97 Allowed 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 124.535 1.134 . . . . 0.0 112.92 -171.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.507 ' NZ ' ' HB2' ' A' ' 56' ' ' LYS . 6.2 mtmp? -43.55 -53.69 5.42 Favored 'General case' 0 C--O 1.247 0.925 0 C-N-CA 128.137 2.575 . . . . 0.0 112.282 -178.24 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.5 m -94.46 9.05 39.95 Favored 'General case' 0 N--CA 1.417 -2.087 0 CA-C-N 114.54 -1.209 . . . . 0.0 111.406 -171.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.466 ' HA ' ' CD1' ' A' ' 51' ' ' ILE . . . -82.41 91.12 6.78 Favored 'General case' 0 N--CA 1.399 -2.998 0 CA-C-O 121.918 0.866 . . . . 0.0 110.21 178.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.511 ' HA ' HE22 ' A' ' 61' ' ' GLN . 62.7 mttp -119.96 24.11 10.68 Favored 'General case' 0 C--N 1.287 -2.148 0 CA-C-N 114.622 -1.172 . . . . 0.0 109.519 179.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.407 ' HB ' HG12 ' A' ' 51' ' ' ILE . 1.9 mp -105.39 -55.4 5.66 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 CA-C-N 115.356 -0.838 . . . . 0.0 113.028 -178.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.52 ' HA ' ' CD2' ' A' ' 65' ' ' PHE . 26.2 mp0 67.22 -7.73 0.5 Allowed 'General case' 0 N--CA 1.507 2.376 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 175.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 12.6 m -94.59 84.71 4.33 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-O 120.765 0.317 . . . . 0.0 110.449 -179.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 101.67 138.74 10.29 Favored Glycine 0 N--CA 1.437 -1.246 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.024 178.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . 0.258 10.8 pt 49.45 14.92 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 N-CA-C 116.217 1.932 . . . . 0.0 116.217 177.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.52 ' CD2' ' HA ' ' A' ' 61' ' ' GLN . 27.9 t80 -75.5 104.88 6.25 Favored 'General case' 0 N--CA 1.419 -1.987 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -177.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 88.48 12.62 64.6 Favored Glycine 0 N--CA 1.437 -1.264 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.186 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.403 ' HZ2' ' CG ' ' A' ' 14' ' ' ASP . 0.1 OUTLIER -67.61 -34.53 77.19 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 -179.211 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.481 ' HA3' ' CE2' ' A' ' 52' ' ' PHE . . . -134.27 48.92 0.92 Allowed Glycine 0 N--CA 1.421 -2.324 0 C-N-CA 119.628 -1.272 . . . . 0.0 112.536 -175.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 19.9 m -71.36 4.27 3.06 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 120.975 0.417 . . . . 0.0 111.804 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -102.97 1.35 33.53 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-O 121.325 0.584 . . . . 0.0 109.99 177.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -95.26 160.11 14.69 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 174.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 41.2 t -88.75 169.98 11.17 Favored 'General case' 0 N--CA 1.411 -2.417 0 N-CA-C 103.901 -2.629 . . . . 0.0 103.901 165.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.528 ' O ' ' HG3' ' A' ' 77' ' ' GLU . 10.9 ptm180 -64.96 -27.37 68.79 Favored 'General case' 0 C--O 1.2 -1.536 0 C-N-CA 118.462 -1.295 . . . . 0.0 110.166 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.663 ' O ' ' HG2' ' A' ' 78' ' ' ARG . 34.2 m170 -57.34 -59.74 4.68 Favored 'General case' 0 C--O 1.209 -1.065 0 O-C-N 124.169 0.918 . . . . 0.0 112.439 -177.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.626 ' HA ' ' CG ' ' A' ' 78' ' ' ARG 0.398 12.9 m-80 -64.18 -28.0 69.46 Favored 'General case' 0 CA--C 1.485 -1.529 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 177.715 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.4 -50.59 72.24 Favored 'General case' 0 N--CA 1.439 -1.001 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 171.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.643 ' O ' ' HG2' ' A' ' 81' ' ' LYS . 42.9 mt-10 -56.83 -42.81 80.3 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.599 0.759 . . . . 0.0 111.078 177.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.663 ' HG2' ' O ' ' A' ' 74' ' ' HIS . 13.1 mmt85 -59.13 -36.41 75.18 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -175.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -77.57 -47.45 19.4 Favored 'General case' 0 CA--C 1.47 -2.125 0 CA-C-N 114.675 -1.148 . . . . 0.0 111.84 -172.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -62.91 -20.75 65.48 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 121.594 0.711 . . . . 0.0 109.207 178.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.643 ' HG2' ' O ' ' A' ' 77' ' ' GLU . 30.6 mmmt -88.87 -26.13 21.78 Favored 'General case' 0 N--CA 1.436 -1.133 0 C-N-CA 118.938 -1.105 . . . . 0.0 109.669 179.328 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 29.8 tptp -69.74 -45.69 67.58 Favored 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 177.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 95.8 mt -56.71 -40.77 76.23 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-N 114.086 -1.415 . . . . 0.0 113.581 177.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.598 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 2.5 pp -78.11 -18.12 13.77 Favored 'Isoleucine or valine' 0 C--O 1.254 1.342 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 179.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 46.9 mt -81.59 -48.66 11.48 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.49 175.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -66.49 -33.84 76.6 Favored 'General case' 0 C--O 1.249 1.042 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.525 ' HB3' ' HB2' ' A' ' 109' ' ' ASN 0.274 57.8 mttm 84.78 27.71 0.07 Allowed 'General case' 0 CA--C 1.454 -2.712 0 C-N-CA 126.524 1.93 . . . . 0.0 115.181 174.792 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.423 HG23 HG22 ' A' ' 114' ' ' VAL . 1.8 mp -67.75 -36.37 75.7 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.274 0 N-CA-C 105.111 -2.181 . . . . 0.0 105.111 164.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.598 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 4.4 mm? -110.94 151.68 27.64 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 114.005 -1.452 . . . . 0.0 108.318 171.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -141.43 111.95 7.01 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 177.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -92.46 143.23 26.57 Favored 'General case' 0 C--N 1.278 -2.518 0 CA-C-O 121.676 0.751 . . . . 0.0 111.439 -176.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -98.51 113.07 24.94 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 114.726 -1.125 . . . . 0.0 109.496 -178.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 72.1 mt -78.0 113.93 16.38 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 114.673 -1.149 . . . . 0.0 109.745 -178.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 92.0 t80 -119.46 100.04 7.05 Favored 'General case' 0 N--CA 1.417 -2.076 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 178.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.495 ' HA ' ' HB1' ' A' ' 101' ' ' ALA . 0.3 OUTLIER -130.89 144.05 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.388 -3.537 0 C-N-CA 119.409 -0.917 . . . . 0.0 109.467 -178.672 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 40.3 p30 -100.84 -178.92 3.91 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 120.306 -0.558 . . . . 0.0 111.453 -176.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -80.32 15.5 1.57 Allowed 'General case' 0 C--N 1.316 -0.874 0 C-N-CA 123.841 0.856 . . . . 0.0 111.275 -178.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.475 ' HB3' ' NE2' ' A' ' 100' ' ' GLN . 2.6 m-20 -117.54 -0.4 11.91 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 58.92 27.22 15.93 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 124.548 1.155 . . . . 0.0 110.17 -174.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.475 ' NE2' ' HB3' ' A' ' 98' ' ' ASN . 42.0 mt-30 -128.94 68.63 1.4 Allowed 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.756 -1.111 . . . . 0.0 111.933 -174.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.495 ' HB1' ' HA ' ' A' ' 95' ' ' ILE . . . -158.43 178.85 9.7 Favored 'General case' 0 C--N 1.273 -2.723 0 CA-C-N 114.577 -1.192 . . . . 0.0 108.42 178.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 14.7 tt -140.57 157.15 23.94 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.973 0 CA-C-N 118.708 0.685 . . . . 0.0 112.196 -170.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -85.64 135.02 33.96 Favored 'General case' 0 C--O 1.255 1.38 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.758 176.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -103.65 165.76 10.84 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 54.0 t -111.92 135.23 51.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -176.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 14.6 mmt -138.61 -173.59 3.59 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 113.463 -1.699 . . . . 0.0 107.775 176.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -137.26 138.21 39.84 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 177.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -145.52 -84.6 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.893 0 C-N-CA 118.313 -1.899 . . . . 0.0 116.456 -174.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.525 ' HB2' ' HB3' ' A' ' 87' ' ' LYS . 29.4 m-80 -56.57 -50.46 71.86 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 -166.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 40.0 mmtm -104.06 3.89 33.73 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.615 -0.678 . . . . 0.0 110.554 -176.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -58.31 -31.68 67.74 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 123.022 0.529 . . . . 0.0 112.29 -178.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -70.59 -26.22 63.42 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-O 121.57 0.7 . . . . 0.0 110.112 179.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 4.8 m -80.0 -23.88 41.23 Favored 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.423 HG22 HG23 ' A' ' 88' ' ' ILE . 54.5 t -67.9 -36.13 74.61 Favored 'Isoleucine or valine' 0 C--O 1.246 0.918 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 174.211 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 75.2 mt -73.22 -34.92 66.18 Favored 'General case' 0 C--O 1.216 -0.696 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.661 177.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -72.32 -14.51 61.76 Favored 'General case' 0 C--O 1.217 -0.629 0 CA-C-O 122.211 1.005 . . . . 0.0 108.709 175.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 94.18 -19.02 55.6 Favored Glycine 0 N--CA 1.44 -1.092 0 CA-C-N 115.186 -0.915 . . . . 0.0 113.163 176.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -87.63 66.57 8.97 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.738 0.78 . . . . 0.0 111.738 -173.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.464 ' O ' HD22 ' A' ' 119' ' ' LEU . 0.0 OUTLIER -126.75 79.44 1.87 Allowed 'General case' 0 C--N 1.288 -2.096 0 CA-C-O 123.636 1.684 . . . . 0.0 110.628 175.675 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.489 ' HA ' HG22 ' A' ' 12' ' ' THR . 0.0 OUTLIER -101.14 96.32 7.13 Favored 'General case' 0 C--N 1.264 -3.136 0 CA-C-N 114.587 -1.188 . . . . 0.0 112.136 174.877 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 5.9 m -93.25 172.34 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.138 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 177.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -110.98 163.87 13.38 Favored 'General case' 0 C--N 1.263 -3.161 0 CA-C-N 115.178 -0.919 . . . . 0.0 108.77 178.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -153.64 174.97 13.79 Favored 'General case' 0 N--CA 1.424 -1.769 0 CA-C-O 121.69 0.757 . . . . 0.0 111.287 -179.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 60.2 mtt . . . . . 0 N--CA 1.426 -1.632 0 C-N-CA 126.152 1.781 . . . . 0.0 108.137 -179.25 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 74.0 mtt180 . . . . . 0 N--CA 1.428 -1.555 0 CA-C-O 121.237 0.542 . . . . 0.0 111.334 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -78.26 89.62 4.32 Favored 'General case' 0 CA--C 1.491 -1.303 0 CA-C-O 122.408 1.099 . . . . 0.0 109.854 -178.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.511 ' O ' HG21 ' A' ' 121' ' ' VAL . 21.3 t -84.88 103.99 12.59 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.689 0 CA-C-N 113.395 -1.73 . . . . 0.0 109.772 -177.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.44 HG22 ' HA ' ' A' ' 120' ' ' LYS . 21.5 p -121.01 -50.41 2.16 Favored 'General case' 0 N--CA 1.413 -2.31 0 C-N-CA 117.758 -1.577 . . . . 0.0 112.482 175.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.409 ' HA ' ' CB ' ' A' ' 16' ' ' LYS . 0.3 OUTLIER -87.37 -11.91 47.92 Favored 'General case' 0 N--CA 1.426 -1.675 0 C-N-CA 119.126 -1.03 . . . . 0.0 112.304 -173.843 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.469 ' HB2' HG11 ' A' ' 11' ' ' VAL . 0.7 OUTLIER -65.85 -52.35 51.16 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 103.978 -2.601 . . . . 0.0 103.978 169.195 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.443 ' O ' ' HB ' ' A' ' 18' ' ' ILE . 31.3 t -56.77 -44.2 81.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 113.581 -1.645 . . . . 0.0 111.337 174.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.449 ' HE2' ' O ' ' A' ' 114' ' ' VAL . 2.0 tppp? -57.78 -45.28 86.21 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.788 177.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 53.4 m -61.78 -41.58 97.89 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.5 178.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.443 ' HB ' ' O ' ' A' ' 15' ' ' VAL . 66.2 mt -53.63 -52.64 31.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 O-C-N 123.748 0.655 . . . . 0.0 109.459 173.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 93.0 t -57.78 -45.05 87.13 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.576 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.74 179.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.441 ' HG3' ' O ' ' A' ' 16' ' ' LYS . 64.3 mtt85 -53.52 -45.72 69.87 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.151 0.501 . . . . 0.0 110.728 178.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.437 ' HA ' ' HG3' ' A' ' 24' ' ' GLU . 77.1 m-85 -83.18 -33.88 26.1 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 -174.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 18' ' ' ILE . 27.0 m -73.25 -31.77 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.521 0 C-N-CA 118.376 -1.329 . . . . 0.0 110.107 177.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -59.97 -48.73 80.5 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.194 174.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.437 ' HG3' ' HA ' ' A' ' 21' ' ' PHE . 1.5 pp20? . . . . . 0 C--O 1.238 0.453 0 C-N-CA 120.292 -0.563 . . . . 0.0 112.111 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 . . . . . 0 CA--C 1.485 -1.532 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.575 ' HA ' ' HA ' ' A' ' 104' ' ' TYR . 55.4 p -82.13 155.55 24.96 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 175.328 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.547 ' O ' HG22 ' A' ' 49' ' ' VAL . 5.8 ptm -52.34 -35.67 51.59 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-O 121.427 0.632 . . . . 0.0 110.124 177.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.537 ' N ' ' HG3' ' A' ' 45' ' ' MET . 22.7 t-20 -63.22 -40.09 96.49 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.439 -1.255 . . . . 0.0 110.839 -175.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' MET . . . . . 0.539 ' HG3' ' OG1' ' A' ' 44' ' ' THR . 64.5 mtt -69.27 -36.44 77.1 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-O 121.554 0.692 . . . . 0.0 109.928 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 82.3 mt -67.91 -33.74 75.28 Favored 'General case' 0 C--O 1.206 -1.186 0 CA-C-N 114.992 -1.004 . . . . 0.0 111.227 -178.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.547 HG22 ' O ' ' A' ' 45' ' ' MET . 88.1 t -67.96 -38.88 80.69 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.016 0 C-N-CA 123.355 0.662 . . . . 0.0 110.303 178.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -53.69 -47.5 70.41 Favored 'General case' 0 CA--C 1.506 -0.732 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.128 175.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.438 HG13 ' O ' ' A' ' 47' ' ' MET . 4.9 mt -76.83 -38.58 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.524 0 CA-C-N 114.717 -1.129 . . . . 0.0 111.738 -176.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.45 ' CE2' ' HA3' ' A' ' 68' ' ' GLY . 60.5 t80 -53.1 -48.08 68.09 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 125.019 1.328 . . . . 0.0 110.733 179.142 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.9 mp -77.52 -12.12 59.93 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.085 -0.507 . . . . 0.0 112.302 178.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.95 26.97 54.68 Favored Glycine 0 C--O 1.249 1.066 0 C-N-CA 120.915 -0.659 . . . . 0.0 111.702 -179.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 40.2 t -67.29 176.4 2.27 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-O 121.797 0.808 . . . . 0.0 111.048 -176.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.474 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 0.7 OUTLIER -106.8 6.63 29.69 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 122.055 0.931 . . . . 0.0 110.117 176.592 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 27.8 p -90.89 1.21 57.17 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 169.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.74 117.41 8.85 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-N 113.69 -1.596 . . . . 0.0 108.893 178.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 43.0 mttp -81.52 -11.83 59.04 Favored 'General case' 0 C--N 1.29 -2.02 0 CA-C-N 114.801 -1.09 . . . . 0.0 111.862 -172.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.429 ' O ' HD11 ' A' ' 51' ' ' ILE . 66.7 mt -143.42 138.3 26.04 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.94 0 N-CA-C 105.953 -1.869 . . . . 0.0 105.953 175.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.583 ' HA ' ' CE2' ' A' ' 65' ' ' PHE . 25.6 mm-40 -93.6 44.78 1.14 Allowed 'General case' 0 C--N 1.3 -1.584 0 CA-C-O 120.993 0.425 . . . . 0.0 110.5 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 42.2 m -153.95 153.03 31.28 Favored 'General case' 0 C--O 1.245 0.844 0 O-C-N 122.026 -0.421 . . . . 0.0 110.203 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 80.92 109.29 0.31 Allowed Glycine 0 C--O 1.2 -2.014 0 CA-C-O 119.393 -0.671 . . . . 0.0 111.599 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . 0.275 3.7 pt 51.94 17.59 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 C-N-CA 125.007 1.323 . . . . 0.0 114.494 -176.255 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.583 ' CE2' ' HA ' ' A' ' 61' ' ' GLN . 18.3 t80 -62.68 107.53 0.98 Allowed 'General case' 0 C--O 1.252 1.222 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.515 -176.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 64.29 41.65 98.13 Favored Glycine 0 N--CA 1.434 -1.452 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.408 178.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 28.3 mmtm -114.86 -3.98 12.68 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.22 0.533 . . . . 0.0 111.017 177.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.45 ' HA3' ' CE2' ' A' ' 52' ' ' PHE . . . -133.51 30.32 3.02 Favored Glycine 0 N--CA 1.425 -2.055 0 N-CA-C 110.19 -1.164 . . . . 0.0 110.19 176.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 16.5 m -70.35 2.16 4.15 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 123.91 0.884 . . . . 0.0 112.417 -176.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -98.74 7.19 46.36 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-O 122.081 0.944 . . . . 0.0 109.199 176.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -108.28 146.65 32.59 Favored 'General case' 0 N--CA 1.418 -2.04 0 CA-C-N 114.675 -1.148 . . . . 0.0 108.825 177.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 44.6 t -86.15 169.21 13.3 Favored 'General case' 0 C--N 1.288 -2.081 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 171.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.425 HH21 ' ND2' ' A' ' 46' ' ' ASN . 11.3 tpt180 -58.77 -35.18 72.36 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 177.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 23.2 t-80 -61.61 -40.17 93.88 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 113.487 -1.688 . . . . 0.0 110.26 178.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -80.97 -49.89 10.39 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.522 -172.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.405 ' O ' ' HD2' ' A' ' 80' ' ' PHE . . . -59.31 -48.99 79.55 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.136 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.628 ' O ' ' HG3' ' A' ' 81' ' ' LYS . 18.3 mt-10 -65.16 -34.31 78.09 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 70.2 ttt180 -69.32 -28.61 66.39 Favored 'General case' 0 CA--C 1.521 -0.149 0 C-N-CA 119.432 -0.907 . . . . 0.0 109.476 -177.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.0 tt -78.77 -48.55 14.62 Favored 'General case' 0 N--CA 1.422 -1.832 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.569 -178.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.425 ' HA ' HD12 ' A' ' 83' ' ' LEU . 58.1 m-85 -59.54 -21.27 60.01 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-O 121.397 0.617 . . . . 0.0 110.235 177.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.628 ' HG3' ' O ' ' A' ' 77' ' ' GLU . 46.2 mttm -85.35 -26.29 26.59 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 119.208 -0.997 . . . . 0.0 109.097 179.116 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 58.9 tttp -73.34 -38.55 65.72 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 175.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.425 HD12 ' HA ' ' A' ' 80' ' ' PHE . 95.7 mt -58.05 -37.36 74.25 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 177.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.506 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 2.4 pp -75.86 -26.21 17.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 120.232 -0.587 . . . . 0.0 111.626 177.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 51.4 mt -74.97 -49.38 20.19 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.555 175.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -70.49 -24.11 62.79 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.578 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.4 ' HZ1' ' CG ' ' A' ' 90' ' ' ASP 0.288 50.6 mttm 83.23 24.07 0.14 Allowed 'General case' 0 CA--C 1.469 -2.171 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 172.545 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.0 mp -69.74 -39.95 78.6 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.273 0 N-CA-C 105.117 -2.179 . . . . 0.0 105.117 165.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.506 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 4.3 mm? -111.6 150.04 30.63 Favored 'General case' 0 CA--C 1.498 -1.041 0 CA-C-N 114.067 -1.424 . . . . 0.0 108.271 173.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.4 ' CG ' ' HZ1' ' A' ' 87' ' ' LYS . 0.7 OUTLIER -137.77 110.61 7.66 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.595 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.481 ' HA ' ' O ' ' A' ' 104' ' ' TYR . 38.8 mt-10 -95.35 147.52 23.42 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 177.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.548 ' O ' ' HA ' ' A' ' 103' ' ' ALA . 16.8 t70 -97.48 142.8 28.88 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.729 -1.123 . . . . 0.0 108.825 178.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 94.7 mt -103.75 101.72 11.55 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-O 121.971 0.891 . . . . 0.0 110.144 -178.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 72.0 t80 -107.74 115.65 30.54 Favored 'General case' 0 C--N 1.275 -2.658 0 CA-C-N 114.252 -1.34 . . . . 0.0 108.331 -175.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 17.1 tt -121.23 141.69 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.657 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.51 ' C ' ' H ' ' A' ' 98' ' ' ASN . 13.1 m-80 -97.44 -171.79 2.27 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -179.016 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -73.5 21.66 0.08 Allowed 'General case' 0 C--N 1.311 -1.094 0 C-N-CA 125.337 1.455 . . . . 0.0 111.203 178.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.51 ' H ' ' C ' ' A' ' 96' ' ' ASN . 14.8 m120 -119.29 -2.64 10.61 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 108.866 -0.791 . . . . 0.0 108.866 -178.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 59.42 25.45 14.2 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-O 122.832 1.301 . . . . 0.0 110.257 -172.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -100.05 108.65 20.88 Favored 'General case' 0 C--O 1.251 1.132 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 177.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -96.52 142.48 28.54 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 124.051 0.845 . . . . 0.0 111.567 -176.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 10.5 tp -131.44 145.21 35.56 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 174.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.548 ' HA ' ' O ' ' A' ' 92' ' ' ASP . . . -113.5 138.76 49.66 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.575 ' HA ' ' HA ' ' A' ' 44' ' ' THR . 24.8 p90 -134.74 163.47 29.71 Favored 'General case' 0 CA--C 1.496 -1.108 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 176.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 6.7 t -94.83 134.06 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.636 0 N-CA-C 115.112 1.523 . . . . 0.0 115.112 -163.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 68.9 mtm -140.69 168.92 18.65 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 111.422 -2.626 . . . . 0.0 105.14 173.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 7.0 mp -90.77 136.69 32.9 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 -179.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -91.57 -178.58 42.49 Favored Glycine 0 N--CA 1.438 -1.232 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.506 -176.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -70.23 -13.3 62.11 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -176.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.43 ' O ' HG21 ' A' ' 114' ' ' VAL . 46.9 mmtt -93.73 -3.65 51.85 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 178.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -62.01 -29.39 70.23 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.969 0.414 . . . . 0.0 111.223 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.431 ' HA ' ' HG ' ' A' ' 115' ' ' LEU . 0.0 OUTLIER -72.35 -31.96 66.07 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 120.218 -0.593 . . . . 0.0 110.247 179.673 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 9.9 m -72.87 -25.72 61.2 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -178.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.449 ' O ' ' HE2' ' A' ' 16' ' ' LYS . 22.0 t -72.1 -42.91 67.38 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.244 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.681 177.051 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.431 ' HG ' ' HA ' ' A' ' 112' ' ' GLN . 4.6 pp -67.87 -33.73 75.31 Favored 'General case' 0 CA--C 1.51 -0.57 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.969 178.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -71.41 -27.8 63.56 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 172.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 73.49 21.76 79.21 Favored Glycine 0 CA--C 1.495 -1.179 0 CA-C-N 115.333 -0.849 . . . . 0.0 112.36 177.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -97.33 35.51 1.61 Allowed 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 104.95 -2.241 . . . . 0.0 104.95 177.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.425 ' CD1' HG22 ' A' ' 114' ' ' VAL . 0.4 OUTLIER -142.42 124.91 15.7 Favored 'General case' 0 N--CA 1.381 -3.906 0 CA-C-N 113.037 -1.892 . . . . 0.0 107.165 -174.241 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.44 ' HA ' HG22 ' A' ' 12' ' ' THR . 0.2 OUTLIER -129.87 132.84 46.56 Favored 'General case' 0 N--CA 1.393 -3.295 0 N-CA-C 106.795 -1.558 . . . . 0.0 106.795 172.089 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.511 HG21 ' O ' ' A' ' 11' ' ' VAL . 14.0 m -106.51 -178.81 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 C-N-CA 118.528 -1.269 . . . . 0.0 107.924 174.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -129.28 134.07 47.77 Favored 'General case' 0 C--N 1.254 -3.573 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 178.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -107.32 113.54 26.99 Favored 'General case' 0 C--N 1.273 -2.719 0 C-N-CA 118.95 -1.1 . . . . 0.0 110.545 171.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 17.3 ptp . . . . . 0 C--N 1.295 -1.795 0 CA-C-N 113.453 -1.703 . . . . 0.0 108.847 176.496 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 54.6 ttt180 . . . . . 0 N--CA 1.394 -3.253 0 N-CA-C 104.037 -2.579 . . . . 0.0 104.037 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -77.57 98.78 5.5 Favored 'General case' 0 CA--C 1.488 -1.434 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -174.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 30.4 m -99.94 65.58 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.275 -2.648 0 CA-C-O 122.417 1.103 . . . . 0.0 112.964 -173.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.479 ' O ' ' HB2' ' A' ' 16' ' ' LYS . 2.1 t -111.53 -37.74 5.13 Favored 'General case' 0 C--N 1.263 -3.188 0 C-N-CA 119.495 -0.882 . . . . 0.0 109.001 169.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -84.83 -20.64 30.6 Favored 'General case' 0 CA--C 1.496 -1.1 0 CA-C-O 120.989 0.423 . . . . 0.0 111.221 174.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.447 ' CG ' ' HZ2' ' A' ' 67' ' ' LYS . 8.0 t70 -76.24 -44.49 37.26 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 105.425 -2.065 . . . . 0.0 105.425 175.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.558 ' O ' ' HB ' ' A' ' 18' ' ' ILE . 4.9 t -64.35 -21.88 30.01 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.48 0 CA-C-N 112.938 -1.937 . . . . 0.0 111.167 174.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.614 ' HE2' ' O ' ' A' ' 114' ' ' VAL . 34.2 ttmt -75.09 -35.55 61.77 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 122.016 -0.427 . . . . 0.0 110.568 179.112 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 68.9 p -67.39 -31.25 71.34 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 119.358 -0.937 . . . . 0.0 108.883 173.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.558 ' HB ' ' O ' ' A' ' 15' ' ' VAL . 36.0 mt -63.62 -48.13 88.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.757 173.219 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.531 HG21 ' O ' ' A' ' 15' ' ' VAL . 97.2 t -56.96 -47.77 82.76 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.774 0 C-N-CA 123.289 0.636 . . . . 0.0 109.868 176.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.636 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 0.9 OUTLIER -52.61 -53.71 43.07 Favored 'General case' 0 C--O 1.22 -0.49 0 O-C-N 123.898 0.749 . . . . 0.0 109.332 176.838 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -52.94 -57.14 11.31 Favored 'General case' 0 N--CA 1.448 -0.545 0 O-C-N 124.424 1.078 . . . . 0.0 112.223 -178.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 27.1 m -67.78 -38.78 80.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.779 -177.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -60.33 -50.28 74.23 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 176.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.636 ' HG2' ' O ' ' A' ' 20' ' ' ARG . 10.3 pt-20 . . . . . 0 C--N 1.327 -0.41 0 C-N-CA 120.208 -0.597 . . . . 0.0 112.083 -178.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 . . . . . 0 CA--C 1.481 -1.699 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 80.2 p -120.94 157.13 30.57 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -177.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.413 ' O ' HG23 ' A' ' 49' ' ' VAL . 22.0 ptm -50.13 -39.59 43.63 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.353 0.661 . . . . 0.0 112.63 -178.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -68.71 -39.29 80.52 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.156 -172.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 23.4 mmt -67.34 -38.6 85.11 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.467 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 78.7 mt -63.35 -41.95 98.89 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.247 -178.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 45' ' ' MET . 69.6 t -66.01 -45.16 91.55 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.058 0 C-N-CA 123.68 0.792 . . . . 0.0 110.679 179.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.598 ' OD2' ' HB3' ' A' ' 55' ' ' SER . 4.4 t70 -61.92 -36.78 82.39 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 114.678 -1.146 . . . . 0.0 109.626 -177.148 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.659 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 75.4 mt -69.54 -50.21 52.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.568 174.432 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.499 ' CE2' ' HA3' ' A' ' 68' ' ' GLY . 50.4 t80 -50.86 -41.21 57.74 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.446 1.098 . . . . 0.0 111.775 179.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.9 mp -80.17 -30.51 38.83 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 177.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 99.2 33.06 5.57 Favored Glycine 0 C--O 1.248 1.002 0 C-N-CA 120.166 -1.016 . . . . 0.0 112.725 -179.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.598 ' HB3' ' OD2' ' A' ' 50' ' ' ASP . 32.0 t -86.8 -176.45 5.78 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 123.291 0.636 . . . . 0.0 111.15 -176.06 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.14 9.17 17.12 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -176.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 16.9 m -89.44 -17.66 28.29 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 175.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.404 ' HB1' ' CG1' ' A' ' 51' ' ' ILE . . . -50.85 173.8 0.02 OUTLIER 'General case' 0 N--CA 1.432 -1.329 0 C-N-CA 128.861 2.865 . . . . 0.0 113.476 176.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.418 ' HZ2' ' HB3' ' A' ' 59' ' ' LYS . 4.0 mmmp? -116.87 11.02 14.31 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 -179.138 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.5 tt -158.65 164.82 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 N-CA-C 104.795 -2.298 . . . . 0.0 104.795 175.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -125.74 21.96 7.58 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 119.021 0.828 . . . . 0.0 110.42 177.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 43.8 m -152.24 146.95 25.83 Favored 'General case' 0 C--N 1.322 -0.63 0 O-C-N 122.002 -0.436 . . . . 0.0 110.037 -178.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.585 ' C ' ' H ' ' A' ' 65' ' ' PHE . . . 82.15 111.37 0.42 Allowed Glycine 0 C--O 1.212 -1.28 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.498 HD11 ' HG3' ' A' ' 67' ' ' LYS . 3.4 mm 70.25 -18.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 CA-C-O 121.971 0.891 . . . . 0.0 111.64 -176.269 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.659 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 3.5 t80 -65.46 104.45 0.99 Allowed 'General case' 0 N--CA 1.399 -2.986 0 C-N-CA 125.318 1.447 . . . . 0.0 109.202 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 102.93 0.36 48.52 Favored Glycine 0 N--CA 1.434 -1.46 0 C-N-CA 120.814 -0.707 . . . . 0.0 111.713 -178.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.498 ' HG3' HD11 ' A' ' 64' ' ' ILE . 2.9 mmmp? -67.35 -19.48 65.44 Favored 'General case' 0 C--O 1.252 1.189 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.499 ' HA3' ' CE2' ' A' ' 52' ' ' PHE . . . -148.81 49.76 0.58 Allowed Glycine 0 C--O 1.207 -1.544 0 C-N-CA 120.462 -0.875 . . . . 0.0 111.644 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 16.0 m -70.6 0.78 6.18 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -178.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -100.37 -5.34 27.44 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-O 121.094 0.473 . . . . 0.0 110.303 178.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -80.41 144.11 32.92 Favored 'General case' 0 N--CA 1.428 -1.547 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.49 177.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 34.5 t -77.33 134.68 38.44 Favored 'General case' 0 N--CA 1.398 -3.029 0 N-CA-C 102.928 -2.989 . . . . 0.0 102.928 167.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.531 ' O ' ' HG3' ' A' ' 77' ' ' GLU . 10.6 ptm180 -52.12 -38.64 58.1 Favored 'General case' 0 C--O 1.202 -1.43 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -173.01 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.563 ' HA ' ' OE1' ' A' ' 77' ' ' GLU . 32.4 t-80 -70.86 -24.31 62.49 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 120.978 0.418 . . . . 0.0 111.475 -175.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -81.69 -38.2 26.21 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.29 -40.21 96.73 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 174.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.656 ' O ' ' HG2' ' A' ' 81' ' ' LYS . 80.0 mt-10 -58.15 -37.8 75.37 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.235 -0.439 . . . . 0.0 109.902 174.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 18.4 mmm180 -71.68 -23.13 61.6 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.372 -178.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.4 tt -76.38 -45.36 32.2 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 179.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -63.87 -19.53 65.13 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.432 0.634 . . . . 0.0 109.406 176.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.656 ' HG2' ' O ' ' A' ' 77' ' ' GLU . 31.3 mmmt -81.12 -28.43 35.14 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.379 176.154 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.428 ' HG2' ' OD2' ' A' ' 86' ' ' ASP . 58.3 tttm -74.48 -43.04 57.88 Favored 'General case' 0 C--O 1.193 -1.878 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 179.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.3 mt -58.64 -35.2 72.13 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 178.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.47 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 2.5 pp -74.67 -26.3 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.061 177.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.9 tt -76.85 -45.19 29.33 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 175.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.491 ' O ' ' HB2' ' A' ' 87' ' ' LYS . 70.9 m-20 -66.1 -29.62 69.98 Favored 'General case' 0 C--O 1.259 1.587 0 C-N-CA 123.491 0.716 . . . . 0.0 109.944 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.491 ' HB2' ' O ' ' A' ' 86' ' ' ASP . 4.4 mptp? 85.6 21.65 0.09 Allowed 'General case' 0 CA--C 1.478 -1.821 0 C-N-CA 125.252 1.421 . . . . 0.0 113.378 179.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 1.8 mp -68.62 -42.22 83.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 N-CA-C 104.8 -2.296 . . . . 0.0 104.8 164.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.47 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 90.7 mt -114.3 164.22 14.21 Favored 'General case' 0 N--CA 1.418 -2.068 0 CA-C-N 113.829 -1.532 . . . . 0.0 109.141 174.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.467 ' CG ' ' HZ2' ' A' ' 87' ' ' LYS . 0.2 OUTLIER -144.44 117.79 9.04 Favored 'General case' 0 C--N 1.283 -2.305 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 172.762 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -95.02 144.38 25.74 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-O 121.598 0.713 . . . . 0.0 112.463 -178.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.464 ' O ' ' HA ' ' A' ' 103' ' ' ALA . 16.6 t70 -100.0 133.24 44.68 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 114.195 -1.366 . . . . 0.0 109.055 178.422 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 98.3 mt -105.64 105.62 15.75 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 121.579 0.704 . . . . 0.0 109.429 -179.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -122.36 135.42 54.7 Favored 'General case' 0 C--N 1.28 -2.427 0 CA-C-N 114.561 -1.2 . . . . 0.0 109.06 -172.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.477 HG13 ' C ' ' A' ' 100' ' ' GLN . 16.6 tt -131.23 141.34 46.24 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.296 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 174.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.472 ' C ' ' H ' ' A' ' 98' ' ' ASN . 3.4 p-10 -96.11 172.81 7.75 Favored 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 176.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -66.67 17.97 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 -173.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.472 ' H ' ' C ' ' A' ' 96' ' ' ASN . 15.7 m120 -118.15 5.57 11.99 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.427 ' HA ' HD12 ' A' ' 95' ' ' ILE . 26.7 t70 65.97 26.47 10.93 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-O 123.531 1.634 . . . . 0.0 109.353 -177.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.477 ' C ' HG13 ' A' ' 95' ' ' ILE . 27.1 mt-30 -90.29 99.57 12.57 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.918 -1.037 . . . . 0.0 108.548 176.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -86.2 133.87 33.82 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.627 -178.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 16.4 tt -141.99 143.79 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.822 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 178.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.464 ' HA ' ' O ' ' A' ' 92' ' ' ASP . . . -112.08 119.96 40.22 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 -178.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -97.38 150.58 20.84 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 52.4 t -103.74 128.86 56.62 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 CA-C-O 121.759 0.79 . . . . 0.0 112.143 -178.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 58.3 mtt -128.28 178.82 5.99 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-N 113.908 -1.496 . . . . 0.0 107.792 177.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -99.52 137.49 37.94 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -178.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -98.21 -166.51 31.37 Favored Glycine 0 N--CA 1.439 -1.118 0 C-N-CA 120.799 -0.715 . . . . 0.0 113.158 -175.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 32.7 p30 -75.28 -2.85 30.06 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 114.147 1.165 . . . . 0.0 114.147 -175.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.502 ' O ' HG22 ' A' ' 114' ' ' VAL . 41.4 mmtm -101.98 -6.34 23.56 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 120.113 -0.635 . . . . 0.0 110.357 177.132 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -54.31 -43.77 71.42 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 113.623 0.972 . . . . 0.0 113.623 -172.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -73.44 -29.48 62.58 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.626 0.727 . . . . 0.0 109.701 -178.145 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 4.4 m -73.05 -26.19 61.2 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.585 -179.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.614 ' O ' ' HE2' ' A' ' 16' ' ' LYS . 24.9 t -68.41 -44.05 83.67 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.783 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 174.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 84.7 mt -62.39 -39.79 94.35 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.113 178.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -72.84 -19.37 61.33 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.059 175.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.456 ' C ' ' H ' ' A' ' 119' ' ' LEU . . . 60.87 30.42 72.98 Favored Glycine 0 C--O 1.212 -1.226 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.127 -177.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -95.99 22.58 7.3 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 105.862 -1.903 . . . . 0.0 105.862 174.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.456 ' H ' ' C ' ' A' ' 117' ' ' GLY . 0.8 OUTLIER -141.99 122.65 14.24 Favored 'General case' 0 N--CA 1.385 -3.676 0 CA-C-N 112.229 -2.26 . . . . 0.0 105.96 -175.869 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.533 ' HB2' ' HZ2' ' A' ' 120' ' ' LYS . 0.1 OUTLIER -131.08 127.6 38.5 Favored 'General case' 0 C--N 1.283 -2.308 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 171.549 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 5.1 m -119.07 173.28 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.261 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 177.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -123.31 161.36 24.79 Favored 'General case' 0 C--N 1.265 -3.076 0 CA-C-N 114.971 -1.013 . . . . 0.0 112.258 -171.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -141.51 130.83 23.61 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 104.93 -2.248 . . . . 0.0 104.93 164.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 25.3 mmt . . . . . 0 C--N 1.298 -1.636 0 N-CA-C 116.229 1.937 . . . . 0.0 116.229 -163.207 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.535 ' HB2' ' O ' ' A' ' 123' ' ' PHE . 41.9 mtt85 . . . . . 0 N--CA 1.422 -1.86 0 N-CA-C 106.239 -1.764 . . . . 0.0 106.239 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -78.03 89.4 4.17 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 10.6 m -79.67 89.47 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 CA-C-O 122.69 1.233 . . . . 0.0 110.36 -178.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.435 ' CG2' ' HA ' ' A' ' 120' ' ' LYS . 34.3 p -115.3 -33.58 5.26 Favored 'General case' 0 C--N 1.261 -3.262 0 CA-C-O 122.092 0.949 . . . . 0.0 109.378 177.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -75.62 -40.64 56.0 Favored 'General case' 0 N--CA 1.413 -2.285 0 C-N-CA 125.967 1.707 . . . . 0.0 107.894 178.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.48 ' O ' ' HB3' ' A' ' 17' ' ' SER . 16.5 t70 -74.0 -39.78 63.39 Favored 'General case' 0 CA--C 1.495 -1.164 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 74.4 t -67.6 -32.99 59.32 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.691 177.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.557 ' HE2' ' O ' ' A' ' 114' ' ' VAL . 3.3 tppp? -66.85 -43.49 83.51 Favored 'General case' 0 C--O 1.245 0.833 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 174.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.48 ' HB3' ' O ' ' A' ' 14' ' ' ASP . 32.6 t -57.09 -47.95 79.78 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 114.092 -1.413 . . . . 0.0 108.718 174.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 28.2 mt -51.36 -42.86 28.47 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.736 0 C-N-CA 124.094 0.958 . . . . 0.0 111.746 177.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.425 ' HA ' HG21 ' A' ' 22' ' ' VAL . 72.9 t -59.62 -45.56 94.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 179.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 31.5 ttt180 -56.72 -45.33 81.98 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.788 0.804 . . . . 0.0 109.401 173.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.751 ' CG ' ' HB ' ' A' ' 64' ' ' ILE . 47.4 m-85 -68.63 -38.25 80.36 Favored 'General case' 0 N--CA 1.422 -1.835 0 N-CA-C 115.186 1.55 . . . . 0.0 115.186 -175.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.425 HG21 ' HA ' ' A' ' 19' ' ' VAL . 20.1 m -69.69 -36.62 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.859 0 C-N-CA 119.99 -0.684 . . . . 0.0 109.892 176.322 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.409 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 14.8 mm100 -60.63 -46.79 88.95 Favored 'General case' 0 CA--C 1.55 0.956 0 O-C-N 123.83 0.706 . . . . 0.0 111.318 172.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.476 ' OE2' ' HB3' ' A' ' 62' ' ' SER . 7.6 pt-20 . . . . . 0 C--O 1.247 0.955 0 O-C-N 121.707 -0.621 . . . . 0.0 112.473 178.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.483 ' CD1' HD23 ' A' ' 48' ' ' LEU . 2.9 p90 . . . . . 0 CA--C 1.493 -1.217 0 CA-C-O 120.501 0.191 . . . . 0.0 111.03 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 63.2 p -86.33 155.99 20.4 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 178.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.507 ' O ' HG21 ' A' ' 49' ' ' VAL . 19.2 ptt? -48.64 -41.81 32.37 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 123.483 0.49 . . . . 0.0 111.905 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.443 ' N ' ' HG3' ' A' ' 45' ' ' MET . 14.8 m120 -67.45 -31.96 72.49 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.584 -175.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' MET . . . . . 0.496 ' O ' HD11 ' A' ' 51' ' ' ILE . 26.3 mmt -74.88 -36.33 62.27 Favored 'General case' 0 C--O 1.203 -1.344 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.483 HD23 ' CD1' ' A' ' 43' ' ' PHE . 87.1 mt -60.75 -38.4 85.05 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.373 179.221 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.507 HG21 ' O ' ' A' ' 45' ' ' MET . 94.1 t -65.19 -41.59 92.03 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.203 0 C-N-CA 124.395 1.078 . . . . 0.0 110.861 178.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -55.38 -46.26 76.55 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.309 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.496 HD11 ' O ' ' A' ' 47' ' ' MET . 1.3 mp -70.07 -40.36 78.32 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.103 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.227 177.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -57.84 -42.29 84.13 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.735 0.814 . . . . 0.0 111.808 -175.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.9 mp -82.32 -20.17 37.9 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 178.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 96.14 32.63 6.65 Favored Glycine 0 C--N 1.313 -0.731 0 C-N-CA 120.126 -1.035 . . . . 0.0 112.257 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 31.1 t -76.55 137.41 39.55 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 177.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.509 ' HD3' ' O ' ' A' ' 56' ' ' LYS . 2.4 tmtm? -84.31 -0.87 54.14 Favored 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 119.264 -0.974 . . . . 0.0 109.537 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.0 m -77.86 -5.95 52.6 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 176.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.03 145.45 53.08 Favored 'General case' 0 N--CA 1.425 -1.721 0 C-N-CA 125.787 1.635 . . . . 0.0 111.173 175.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.515 ' N ' ' HD2' ' A' ' 59' ' ' LYS . 9.1 mptt -105.23 -1.57 25.17 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.447 -177.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.433 ' O ' HG13 ' A' ' 51' ' ' ILE . 60.6 mt -132.28 122.0 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.108 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -177.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.01 94.37 4.98 Favored 'General case' 0 C--N 1.277 -2.585 0 C-N-CA 118.313 -1.355 . . . . 0.0 108.707 176.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.476 ' HB3' ' OE2' ' A' ' 24' ' ' GLU . 73.5 m -104.25 177.79 4.74 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.843 176.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -75.32 7.63 22.89 Favored Glycine 0 N--CA 1.482 1.712 0 C-N-CA 121.068 -0.587 . . . . 0.0 113.979 -176.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.751 ' HB ' ' CG ' ' A' ' 21' ' ' PHE . 6.4 tt -100.74 3.1 10.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -69.52 95.97 0.88 Allowed 'General case' 0 N--CA 1.42 -1.945 0 CA-C-N 114.01 -1.45 . . . . 0.0 110.01 -173.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 102.35 17.22 20.54 Favored Glycine 0 N--CA 1.419 -2.438 0 CA-C-N 114.93 -1.032 . . . . 0.0 112.638 -179.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.493 ' HE2' HG13 ' A' ' 64' ' ' ILE . 33.5 mtmt -67.97 -58.1 5.1 Favored 'General case' 0 C--N 1.353 0.751 0 C-N-CA 117.891 -1.523 . . . . 0.0 110.51 175.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -95.41 47.82 1.92 Allowed Glycine 0 N--CA 1.436 -1.353 0 CA-C-N 115.154 -0.93 . . . . 0.0 113.356 -170.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 19.6 m -71.84 -4.31 27.26 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -178.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -100.91 2.93 41.33 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 121.682 0.753 . . . . 0.0 111.036 178.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -88.44 142.57 27.61 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 174.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 42.5 t -71.08 148.5 47.44 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 105.331 -2.1 . . . . 0.0 105.331 168.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 35.1 ttt-85 -56.46 -42.92 79.0 Favored 'General case' 0 C--O 1.217 -0.637 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.945 -174.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.581 ' O ' ' HG2' ' A' ' 78' ' ' ARG . 90.8 m-70 -75.97 -20.3 58.02 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.476 -0.489 . . . . 0.0 111.274 -177.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -73.17 -44.14 60.37 Favored 'General case' 0 CA--C 1.501 -0.913 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 176.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.447 ' O ' ' HB3' ' A' ' 79' ' ' LEU . . . -61.69 -36.51 81.11 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 175.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -61.13 -32.93 72.62 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.639 174.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.581 ' HG2' ' O ' ' A' ' 74' ' ' HIS . 31.7 mmt180 -79.36 -25.93 42.13 Favored 'General case' 0 CA--C 1.496 -1.114 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -176.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.447 ' HB3' ' O ' ' A' ' 76' ' ' ALA . 14.5 tp -60.22 -61.24 2.74 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 124.154 0.909 . . . . 0.0 108.928 177.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -60.6 -27.72 67.95 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.452 -178.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.502 ' O ' HG13 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -69.18 -30.07 68.19 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.061 175.476 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 20.2 ttpp -80.88 -34.93 33.24 Favored 'General case' 0 C--O 1.203 -1.394 0 C-N-CA 117.294 -1.762 . . . . 0.0 107.713 -178.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.487 ' HB3' ' HG ' ' A' ' 89' ' ' LEU . 9.7 mp -60.11 -29.04 68.34 Favored 'General case' 0 C--O 1.211 -0.95 0 CA-C-N 116.24 -0.436 . . . . 0.0 112.015 176.235 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.502 HG13 ' O ' ' A' ' 81' ' ' LYS . 2.1 pp -82.93 -22.14 8.89 Favored 'Isoleucine or valine' 0 C--O 1.244 0.813 0 C-N-CA 120.028 -0.669 . . . . 0.0 111.278 178.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.5 tt -75.97 -49.83 16.58 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 174.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -65.38 -36.1 82.95 Favored 'General case' 0 C--O 1.253 1.281 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 178.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.481 ' HD3' HD22 ' A' ' 109' ' ' ASN 0.31 59.4 mttm 85.0 29.69 0.05 Allowed 'General case' 0 CA--C 1.464 -2.328 0 C-N-CA 125.954 1.702 . . . . 0.0 114.952 176.822 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 1.8 mp -69.04 -31.48 50.49 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 105.012 -2.218 . . . . 0.0 105.012 163.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.487 ' HG ' ' HB3' ' A' ' 83' ' ' LEU . 44.7 mt -116.01 154.4 29.94 Favored 'General case' 0 N--CA 1.425 -1.676 0 CA-C-N 113.966 -1.47 . . . . 0.0 108.896 173.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -139.81 117.68 11.71 Favored 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 174.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -94.54 145.32 24.89 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.471 0.653 . . . . 0.0 112.133 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -111.08 159.36 17.87 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-N 114.523 -1.217 . . . . 0.0 108.712 176.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 87.6 mt -117.92 145.37 44.71 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -170.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -141.51 163.06 33.94 Favored 'General case' 0 CA--C 1.479 -1.775 0 N-CA-C 105.412 -2.07 . . . . 0.0 105.412 173.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 19.0 tt -132.68 147.07 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.268 0 N-CA-C 106.811 -1.552 . . . . 0.0 106.811 171.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 47.0 p30 -92.41 -174.32 3.66 Favored 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 120.22 -0.592 . . . . 0.0 110.515 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -75.97 5.53 6.43 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 123.009 0.524 . . . . 0.0 111.973 -177.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -108.19 3.01 23.24 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 29.3 t70 66.84 26.73 9.27 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-O 123.547 1.641 . . . . 0.0 108.9 -176.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -101.13 110.62 22.66 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 114.8 -1.091 . . . . 0.0 108.507 177.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.7 140.78 51.53 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.513 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 10.5 tp -134.52 143.44 37.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -117.65 132.69 56.46 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.675 -178.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -108.47 153.0 23.96 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 55.5 t -97.6 137.87 24.02 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 CA-C-O 122.103 0.954 . . . . 0.0 112.964 -174.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 16.5 mmt -134.55 177.98 7.35 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 112.798 -2.001 . . . . 0.0 107.427 174.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 7.3 mp -92.03 142.32 27.66 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -94.97 -176.89 38.0 Favored Glycine 0 N--CA 1.414 -2.809 0 C-N-CA 119.991 -1.099 . . . . 0.0 114.778 -172.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.481 HD22 ' HD3' ' A' ' 87' ' ' LYS . 6.1 p30 -71.13 -11.37 60.91 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 114.075 -1.062 . . . . 0.0 112.404 -178.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.548 ' O ' HG22 ' A' ' 114' ' ' VAL . 40.2 mmtm -103.58 13.3 33.62 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 177.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.515 ' O ' ' HG ' ' A' ' 115' ' ' LEU . . . -75.94 -28.77 58.09 Favored 'General case' 0 CA--C 1.494 -1.201 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 -177.128 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 15.8 tp60 -66.16 -39.84 90.08 Favored 'General case' 0 N--CA 1.416 -2.141 0 CA-C-N 112.891 -1.959 . . . . 0.0 109.262 174.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 6.6 m -64.98 -32.7 74.56 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 177.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.557 ' O ' ' HE2' ' A' ' 16' ' ' LYS . 46.2 t -65.69 -46.41 89.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.103 177.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.515 ' HG ' ' O ' ' A' ' 111' ' ' ALA . 68.7 mt -62.59 -37.59 86.81 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.41 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -72.63 -21.35 61.12 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 86.54 12.21 70.02 Favored Glycine 0 C--O 1.215 -1.05 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.627 178.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -96.39 36.86 1.3 Allowed 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 122.299 1.047 . . . . 0.0 109.072 -176.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.704 ' O ' HD12 ' A' ' 119' ' ' LEU . 0.0 OUTLIER -124.7 121.0 33.43 Favored 'General case' 0 N--CA 1.422 -1.857 0 CA-C-O 122.264 1.031 . . . . 0.0 108.34 -176.42 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.435 ' HA ' ' CG2' ' A' ' 12' ' ' THR 0.265 7.7 ptmm? -131.1 85.5 2.27 Favored 'General case' 1 C--N 1.225 -4.805 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 172.676 . . . . . . . . 4 3 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 14.4 m -91.43 170.52 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.053 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 177.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -142.62 153.3 43.35 Favored 'General case' 0 C--N 1.266 -3.025 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 -176.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . 0.535 ' O ' ' HB2' ' A' ' 9' ' ' ARG . 56.2 t80 -158.3 143.21 16.35 Favored 'General case' 0 N--CA 1.432 -1.353 0 C-N-CA 120.869 -0.332 . . . . 0.0 111.118 175.059 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.439 -1.019 0 CA-C-O 121.368 0.604 . . . . 0.0 109.455 176.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 . . . . . 0 N--CA 1.429 -1.524 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.472 ' OD2' ' HB2' ' A' ' 120' ' ' LYS . 0.2 OUTLIER -78.15 90.09 4.26 Favored 'General case' 0 CA--C 1.489 -1.371 0 O-C-N 124.016 0.823 . . . . 0.0 108.829 -179.725 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.6 m -74.58 85.58 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.216 0 CA-C-O 122.713 1.244 . . . . 0.0 109.759 178.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.597 ' O ' ' HE2' ' A' ' 16' ' ' LYS . 29.8 p -107.6 -30.33 8.66 Favored 'General case' 0 C--N 1.258 -3.409 0 C-N-CA 118.459 -1.297 . . . . 0.0 110.933 176.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -76.64 -38.95 53.79 Favored 'General case' 0 C--N 1.29 -1.992 0 C-N-CA 124.69 1.196 . . . . 0.0 108.81 -179.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.526 ' O ' ' HB3' ' A' ' 17' ' ' SER . 23.3 t70 -76.62 -36.92 57.15 Favored 'General case' 0 CA--C 1.491 -1.293 0 CA-C-O 122.178 0.989 . . . . 0.0 109.051 -179.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.503 ' O ' HG22 ' A' ' 19' ' ' VAL . 99.5 t -72.97 -21.46 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.803 0 CA-C-N 114.649 -1.16 . . . . 0.0 110.185 177.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.597 ' HE2' ' O ' ' A' ' 12' ' ' THR . 1.3 tppt? -72.25 -31.81 66.12 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 173.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.526 ' HB3' ' O ' ' A' ' 14' ' ' ASP . 29.0 t -63.84 -38.37 90.83 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 173.108 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.488 ' HB ' ' O ' ' A' ' 15' ' ' VAL . 41.4 mt -62.4 -42.89 97.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.005 173.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.503 HG22 ' O ' ' A' ' 15' ' ' VAL . 82.4 t -57.36 -42.8 81.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.137 177.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 43.7 ttt180 -54.05 -48.07 70.96 Favored 'General case' 0 C--N 1.332 -0.174 0 O-C-N 123.364 0.415 . . . . 0.0 109.892 174.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -65.4 -45.96 81.91 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 115.751 -0.658 . . . . 0.0 112.582 -177.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.436 HG21 ' HA ' ' A' ' 19' ' ' VAL . 29.4 m -65.63 -33.4 63.34 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 C-N-CA 119.907 -0.717 . . . . 0.0 111.045 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 14.7 mm-40 -60.22 -55.6 31.8 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 120.819 0.343 . . . . 0.0 110.806 170.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 . . . . . 0 CA--C 1.534 0.364 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -177.154 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 . . . . . 0 CA--C 1.481 -1.703 0 CA-C-O 121.64 0.733 . . . . 0.0 109.038 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.545 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 47.1 p -109.98 144.63 38.25 Favored 'General case' 0 N--CA 1.414 -2.266 0 CA-C-N 114.347 -1.297 . . . . 0.0 107.852 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.523 ' O ' HG23 ' A' ' 49' ' ' VAL . 18.7 ptm -44.52 -44.34 8.59 Favored 'General case' 0 C--O 1.206 -1.19 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -176.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.469 ' N ' ' HG3' ' A' ' 45' ' ' MET . 16.7 t-20 -68.5 -37.97 80.56 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 121.049 -0.26 . . . . 0.0 111.595 -172.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 49.6 ttm -72.54 -36.56 68.32 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.597 ' O ' ' HB2' ' A' ' 52' ' ' PHE . 47.9 mt -67.88 -30.24 69.55 Favored 'General case' 0 C--O 1.192 -1.972 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.846 -178.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 45' ' ' MET . 43.0 t -74.19 -44.65 49.26 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.609 0 C-N-CA 123.327 0.651 . . . . 0.0 110.695 179.258 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -54.42 -51.41 65.0 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.728 HD13 ' CD1' ' A' ' 65' ' ' PHE . 6.2 tt -75.97 -24.79 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.28 0 N-CA-C 114.232 1.197 . . . . 0.0 114.232 -178.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.597 ' HB2' ' O ' ' A' ' 48' ' ' LEU . 59.8 t80 -55.44 -43.59 75.55 Favored 'General case' 0 C--N 1.277 -2.579 0 CA-C-N 114.842 -1.072 . . . . 0.0 108.754 175.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.485 ' HA ' ' O ' ' A' ' 68' ' ' GLY . 9.5 mp -77.73 -35.79 51.54 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.892 -1.049 . . . . 0.0 111.551 177.176 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 98.61 53.3 1.23 Allowed Glycine 0 C--N 1.305 -1.185 0 N-CA-C 108.496 -1.841 . . . . 0.0 108.496 -173.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 52.6 p -64.81 -178.89 0.46 Allowed 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 115.564 1.69 . . . . 0.0 115.564 -175.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -81.88 -27.75 33.3 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 113.117 -1.856 . . . . 0.0 110.811 176.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.8 m -88.72 -45.29 9.92 Favored 'General case' 0 C--O 1.252 1.219 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -175.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.623 ' HB3' ' CG1' ' A' ' 51' ' ' ILE . . . -97.91 90.58 4.98 Favored 'General case' 0 N--CA 1.403 -2.781 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 178.274 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 50.2 mttp -72.95 26.57 0.06 Allowed 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 126.285 1.834 . . . . 0.0 114.423 -174.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 81.3 mt 71.0 116.71 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 C-N-CA 125.391 1.476 . . . . 0.0 112.713 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.514 ' H ' ' CB ' ' A' ' 65' ' ' PHE . 17.4 mm-40 -113.34 17.52 18.46 Favored 'General case' 0 N--CA 1.439 -1.005 0 C-N-CA 119.782 -0.767 . . . . 0.0 112.372 -176.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 21.1 m 70.31 107.04 0.06 Allowed 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 124.111 0.964 . . . . 0.0 112.513 -178.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 153.6 -111.06 0.47 Allowed Glycine 0 CA--C 1.498 -0.973 0 N-CA-C 109.056 -1.618 . . . . 0.0 109.056 -179.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.555 ' O ' ' HG3' ' A' ' 67' ' ' LYS . 5.8 tt -91.12 -5.36 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 172.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.728 ' CD1' HD13 ' A' ' 51' ' ' ILE . 9.4 m-85 -70.85 102.04 2.27 Favored 'General case' 0 N--CA 1.41 -2.468 0 CA-C-N 113.353 -1.749 . . . . 0.0 108.959 -174.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.19 9.7 55.36 Favored Glycine 0 N--CA 1.42 -2.423 0 O-C-N 124.338 1.024 . . . . 0.0 112.829 -179.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.603 ' HD3' ' N ' ' A' ' 68' ' ' GLY . 0.1 OUTLIER -65.29 -31.81 73.15 Favored 'General case' 0 C--N 1.357 0.901 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 -178.439 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.603 ' N ' ' HD3' ' A' ' 67' ' ' LYS . . . -160.04 107.71 0.33 Allowed Glycine 0 CA--C 1.498 -1.018 0 C-N-CA 117.808 -2.139 . . . . 0.0 114.991 -175.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.45 ' HB3' ' O ' ' A' ' 53' ' ' LEU . 2.8 p -94.16 10.33 34.26 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 124.406 1.082 . . . . 0.0 110.29 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -91.56 6.31 46.15 Favored 'General case' 0 CA--C 1.506 -0.747 0 CA-C-O 121.965 0.888 . . . . 0.0 110.693 -178.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -99.45 143.12 30.06 Favored 'General case' 0 C--N 1.283 -2.31 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.269 175.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 30.0 t -78.24 139.73 38.9 Favored 'General case' 0 N--CA 1.414 -2.257 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 170.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.442 HH12 ' ND2' ' A' ' 46' ' ' ASN . 32.8 tpt85 -43.52 -56.46 3.64 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.385 1.074 . . . . 0.0 112.223 -175.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -81.32 -12.26 59.08 Favored 'General case' 0 C--N 1.309 -1.169 0 C-N-CA 120.132 -0.627 . . . . 0.0 112.407 -175.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -86.57 -29.72 22.42 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.423 ' HB2' HG13 ' A' ' 49' ' ' VAL . . . -65.35 -40.04 93.09 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 171.154 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.492 ' HG3' HG12 ' A' ' 49' ' ' VAL . 38.7 mt-10 -60.44 -32.81 71.73 Favored 'General case' 0 C--O 1.246 0.874 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.43 173.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 15.3 tpp180 -68.9 -31.25 70.04 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 -176.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.661 ' HG ' ' CD1' ' A' ' 123' ' ' PHE . 0.4 OUTLIER -73.84 -47.99 34.48 Favored 'General case' 0 CA--C 1.469 -2.165 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.303 -178.571 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -59.2 -21.24 59.17 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-O 121.667 0.746 . . . . 0.0 109.125 176.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.406 ' NZ ' ' SD ' ' A' ' 45' ' ' MET . 30.7 mmtm -87.22 -31.61 20.22 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.78 178.107 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.644 ' HE2' ' O ' ' A' ' 122' ' ' ASP . 19.1 ttpp -71.91 -39.04 69.8 Favored 'General case' 0 C--O 1.194 -1.861 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 175.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.472 ' HB3' ' HG ' ' A' ' 89' ' ' LEU . 0.6 OUTLIER -57.19 -38.7 74.05 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 125.186 1.395 . . . . 0.0 112.16 178.484 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.5 pp -75.68 -23.23 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 119.76 -0.776 . . . . 0.0 111.525 177.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 50.2 mt -77.93 -41.83 35.06 Favored 'General case' 0 N--CA 1.45 -0.434 0 O-C-N 123.425 0.453 . . . . 0.0 110.597 173.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -65.2 -29.12 69.91 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? 84.9 15.71 0.18 Allowed 'General case' 0 CA--C 1.477 -1.859 0 C-N-CA 125.154 1.382 . . . . 0.0 112.77 175.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.431 HG23 HG21 ' A' ' 114' ' ' VAL . 1.8 mp -67.96 -38.44 79.98 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.794 0 N-CA-C 106.349 -1.722 . . . . 0.0 106.349 167.351 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.472 ' HG ' ' HB3' ' A' ' 83' ' ' LEU . 30.3 mt -109.03 151.01 26.93 Favored 'General case' 0 N--CA 1.414 -2.261 0 CA-C-N 114.4 -1.273 . . . . 0.0 111.003 177.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.409 ' O ' ' HB2' ' A' ' 106' ' ' MET . 15.6 m-20 -143.85 118.24 9.65 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 175.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -94.03 155.21 17.24 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 121.052 0.454 . . . . 0.0 112.187 -176.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.579 ' O ' ' HA ' ' A' ' 103' ' ' ALA . 13.4 m-20 -97.77 138.08 35.68 Favored 'General case' 0 CA--C 1.497 -1.059 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 91.5 mt -106.94 116.76 32.49 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 121.482 0.658 . . . . 0.0 111.168 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -125.83 108.9 11.92 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.415 HG13 ' C ' ' A' ' 100' ' ' GLN . 14.6 tt -112.04 148.94 14.83 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.381 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -177.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -103.69 -175.54 2.83 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -74.53 17.9 0.18 Allowed 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -177.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -118.45 6.01 11.77 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 177.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.408 ' HA ' HD12 ' A' ' 95' ' ' ILE . 6.1 m-20 62.18 28.28 16.98 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 122.299 1.047 . . . . 0.0 111.264 -176.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.415 ' C ' HG13 ' A' ' 95' ' ' ILE . 22.7 mt-30 -93.36 103.03 15.29 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 176.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -83.95 116.05 22.61 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.602 -177.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 4.3 mm -100.01 131.99 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.388 -3.535 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 176.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.579 ' HA ' ' O ' ' A' ' 92' ' ' ASP . . . -113.66 124.51 52.49 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.682 -178.261 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -97.06 155.65 16.71 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 42.2 t -100.55 120.89 50.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -175.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.409 ' HB2' ' O ' ' A' ' 90' ' ' ASP . 25.9 mmt -133.05 -173.04 3.09 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 113.369 -1.741 . . . . 0.0 108.307 177.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -143.67 134.24 24.92 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -138.01 -78.1 0.07 OUTLIER Glycine 0 N--CA 1.44 -1.098 0 C-N-CA 118.515 -1.802 . . . . 0.0 116.075 -174.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -63.78 -51.62 63.97 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 115.243 1.571 . . . . 0.0 115.243 -167.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.467 ' O ' HG22 ' A' ' 114' ' ' VAL . 65.1 mmtt -98.24 -1.64 41.49 Favored 'General case' 0 C--N 1.321 -0.645 0 O-C-N 121.474 -0.766 . . . . 0.0 109.802 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.598 ' O ' ' HG ' ' A' ' 115' ' ' LEU . . . -51.92 -33.18 36.04 Favored 'General case' 0 C--O 1.217 -0.608 0 CA-C-N 114.798 -1.092 . . . . 0.0 113.706 -174.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.406 HE21 ' N ' ' A' ' 113' ' ' THR . 0.0 OUTLIER -64.54 -37.42 87.5 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.474 -177.43 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' THR . . . . . 0.406 ' N ' HE21 ' A' ' 112' ' ' GLN . 5.4 m -78.19 -25.16 47.0 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 121.617 0.722 . . . . 0.0 109.238 -179.132 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.467 HG22 ' O ' ' A' ' 110' ' ' LYS . 62.0 t -67.64 -40.35 83.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-N 114.703 -1.135 . . . . 0.0 108.272 175.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.598 ' HG ' ' O ' ' A' ' 111' ' ' ALA . 73.1 mt -72.39 -29.09 63.43 Favored 'General case' 0 C--O 1.222 -0.388 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.92 177.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -73.19 -11.37 60.5 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-O 121.165 0.507 . . . . 0.0 110.111 173.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 86.47 -12.62 60.44 Favored Glycine 0 N--CA 1.438 -1.208 0 CA-C-N 115.621 -0.718 . . . . 0.0 113.05 177.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -91.33 62.85 4.78 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 122.253 1.025 . . . . 0.0 111.177 -173.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.555 ' O ' HD12 ' A' ' 119' ' ' LEU . 0.0 OUTLIER -132.04 131.53 42.54 Favored 'General case' 0 N--CA 1.409 -2.517 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 175.201 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.474 ' HA ' HG22 ' A' ' 12' ' ' THR . 0.0 OUTLIER -130.62 128.03 40.16 Favored 'General case' 1 C--N 1.241 -4.124 0 CA-C-N 113.311 -1.768 . . . . 0.0 109.66 179.486 . . . . . . . . 4 4 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 14.3 m -133.71 170.66 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 176.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.644 ' O ' ' HE2' ' A' ' 82' ' ' LYS . 8.0 p-10 -108.68 161.01 15.48 Favored 'General case' 0 C--N 1.274 -2.7 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.756 -178.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . 0.661 ' CD1' ' HG ' ' A' ' 79' ' ' LEU . 37.8 t80 -159.08 156.53 29.35 Favored 'General case' 0 C--O 1.256 1.4 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 171.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.314 -0.974 0 N-CA-C 104.53 -2.396 . . . . 0.0 104.53 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 47.0 mmt-85 . . . . . 0 N--CA 1.438 -1.051 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -118.71 93.8 4.23 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 104.949 -2.241 . . . . 0.0 104.949 178.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.404 ' O ' HG22 ' A' ' 11' ' ' VAL . 11.8 m -82.07 87.59 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.272 -2.782 0 CA-C-O 122.64 1.209 . . . . 0.0 111.322 -175.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.497 HG22 ' HA ' ' A' ' 120' ' ' LYS . 44.7 p -98.47 -58.43 1.96 Allowed 'General case' 0 C--N 1.262 -3.208 0 C-N-CA 117.564 -1.654 . . . . 0.0 113.13 174.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.434 ' HA ' ' HB3' ' A' ' 16' ' ' LYS . 12.3 t70 -83.49 -10.9 58.05 Favored 'General case' 0 C--O 1.205 -1.281 0 C-N-CA 118.797 -1.161 . . . . 0.0 111.139 -176.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -66.59 -46.85 74.6 Favored 'General case' 0 CA--C 1.5 -0.977 0 N-CA-C 105.279 -2.119 . . . . 0.0 105.279 171.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 77.1 t -65.85 -43.28 93.21 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.404 0 CA-C-N 112.944 -1.935 . . . . 0.0 110.074 177.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.434 ' HB3' ' HA ' ' A' ' 13' ' ' ASP . 17.2 ttmt -64.95 -40.26 94.74 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.628 178.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.516 ' O ' ' HD2' ' A' ' 21' ' ' PHE . 72.2 m -55.13 -45.86 75.61 Favored 'General case' 0 CA--C 1.509 -0.608 0 O-C-N 123.33 0.394 . . . . 0.0 109.955 175.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.427 ' O ' HG21 ' A' ' 22' ' ' VAL . 88.1 mt -55.43 -56.62 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.486 177.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.406 HG23 HG11 ' A' ' 114' ' ' VAL . 97.9 t -60.19 -44.44 95.38 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.101 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.41 -179.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.488 ' O ' ' HG3' ' A' ' 24' ' ' GLU . 35.8 ttp180 -58.72 -36.32 74.09 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 124.036 0.934 . . . . 0.0 111.069 -178.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.516 ' HD2' ' O ' ' A' ' 17' ' ' SER . 64.8 m-85 -90.86 -25.36 19.9 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -178.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.427 HG21 ' O ' ' A' ' 18' ' ' ILE . 30.5 m -79.38 -30.8 14.0 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.377 0 C-N-CA 117.307 -1.757 . . . . 0.0 108.54 173.378 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -63.05 -52.4 62.95 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.251 174.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.488 ' HG3' ' O ' ' A' ' 20' ' ' ARG 0.322 0.0 OUTLIER . . . . . 0 C--N 1.347 0.468 0 C-N-CA 119.366 -0.934 . . . . 0.0 112.849 -179.447 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 . . . . . 0 CA--C 1.488 -1.41 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 51.2 p -122.56 156.34 34.4 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 176.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.442 ' HG3' ' N ' ' A' ' 46' ' ' ASN . 13.2 ptp -50.71 -42.27 56.91 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-O 121.221 0.534 . . . . 0.0 110.799 178.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.442 ' N ' ' HG3' ' A' ' 45' ' ' MET . 44.2 m-80 -64.1 -34.19 77.49 Favored 'General case' 0 CA--C 1.505 -0.77 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.348 -177.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' MET . . . . . 0.425 ' O ' ' HB ' ' A' ' 51' ' ' ILE . 49.2 ttm -71.2 -43.22 67.82 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.437 ' O ' HG23 ' A' ' 51' ' ' ILE . 82.9 mt -67.77 -42.8 81.16 Favored 'General case' 0 C--O 1.208 -1.101 0 CA-C-N 115.224 -0.898 . . . . 0.0 112.469 -176.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 45' ' ' MET . 69.2 t -64.57 -46.38 92.75 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.727 0 CA-C-O 121.622 0.725 . . . . 0.0 110.436 179.321 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -63.52 -37.85 88.88 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 114.712 -1.131 . . . . 0.0 108.927 -178.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.684 ' CG1' ' HB1' ' A' ' 58' ' ' ALA . 0.4 OUTLIER -76.33 -37.85 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.407 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 179.62 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.409 ' CZ ' ' HA3' ' A' ' 68' ' ' GLY . 37.8 t80 -55.81 -39.23 71.05 Favored 'General case' 0 C--N 1.296 -1.745 0 O-C-N 123.877 0.736 . . . . 0.0 110.036 176.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.5 mp -82.13 -28.77 32.01 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.137 -0.938 . . . . 0.0 112.116 177.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.15 35.43 15.1 Favored Glycine 0 C--O 1.251 1.159 0 N-CA-C 109.841 -1.303 . . . . 0.0 109.841 -176.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.525 ' OG ' ' HD3' ' A' ' 56' ' ' LYS . 34.9 t -70.47 -168.96 0.27 Allowed 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 126.619 1.968 . . . . 0.0 112.858 -172.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.535 ' HZ3' ' HB2' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -50.27 -66.75 0.34 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.205 1.402 . . . . 0.0 112.902 -174.236 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.05 -42.83 22.97 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 114.771 -1.104 . . . . 0.0 111.545 -170.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.684 ' HB1' ' CG1' ' A' ' 51' ' ' ILE . . . -91.78 81.1 5.23 Favored 'General case' 0 N--CA 1.398 -3.048 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 174.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.601 ' O ' ' HB ' ' A' ' 60' ' ' ILE . 0.1 OUTLIER -73.13 25.21 0.06 Allowed 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 114.612 -1.176 . . . . 0.0 111.99 -175.484 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.601 ' HB ' ' O ' ' A' ' 59' ' ' LYS . 88.3 mt 83.34 127.91 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 C-N-CA 126.831 2.053 . . . . 0.0 111.057 -175.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.457 ' HG3' ' O ' ' A' ' 60' ' ' ILE 0.297 14.8 mt-30 -135.82 58.86 1.73 Allowed 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 178.609 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 15.2 t 71.44 137.14 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 125.91 1.684 . . . . 0.0 112.729 177.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.422 ' C ' ' H ' ' A' ' 65' ' ' PHE . . . 97.28 -141.65 15.73 Favored Glycine 0 C--O 1.241 0.581 0 C-N-CA 121.288 -0.482 . . . . 0.0 112.728 177.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 6.3 pt -73.39 7.19 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 C-N-CA 123.331 0.652 . . . . 0.0 112.427 178.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.674 ' CD2' HG12 ' A' ' 51' ' ' ILE . 0.3 OUTLIER -70.96 113.32 7.88 Favored 'General case' 0 N--CA 1.389 -3.504 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 -178.784 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.68 33.67 46.34 Favored Glycine 0 N--CA 1.424 -2.116 0 CA-C-N 114.849 -1.068 . . . . 0.0 111.305 -174.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 32.9 mmtm -121.32 -15.08 8.19 Favored 'General case' 0 C--O 1.22 -0.452 0 CA-C-O 121.2 0.524 . . . . 0.0 109.72 174.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.409 ' HA3' ' CZ ' ' A' ' 52' ' ' PHE . . . -107.78 35.03 5.25 Favored Glycine 0 N--CA 1.432 -1.579 0 N-CA-C 109.771 -1.331 . . . . 0.0 109.771 178.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 9.2 m -72.62 6.23 2.58 Favored 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 124.932 1.293 . . . . 0.0 111.953 -176.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -93.52 -1.53 55.46 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-O 121.923 0.868 . . . . 0.0 109.337 176.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -103.41 153.62 20.28 Favored 'General case' 0 N--CA 1.422 -1.828 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 175.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 37.5 t -105.35 171.86 7.1 Favored 'General case' 0 C--N 1.28 -2.43 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 170.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.3 mmm180 -52.78 -37.95 60.37 Favored 'General case' 0 C--O 1.205 -1.277 0 CA-C-O 121.215 0.531 . . . . 0.0 110.869 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.453 ' O ' ' HG2' ' A' ' 78' ' ' ARG . 6.5 t-160 -67.6 -43.98 79.18 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.577 -172.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -68.78 -55.7 10.4 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.319 -178.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.433 ' O ' ' HD1' ' A' ' 80' ' ' PHE . . . -57.41 -44.82 84.88 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.929 -177.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -62.62 -33.92 75.99 Favored 'General case' 0 C--O 1.208 -1.096 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 178.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.453 ' HG2' ' O ' ' A' ' 74' ' ' HIS . 9.7 mmm180 -67.14 -30.31 70.26 Favored 'General case' 0 CA--C 1.495 -1.144 0 C-N-CA 119.08 -1.048 . . . . 0.0 110.296 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.527 ' O ' ' HG ' ' A' ' 83' ' ' LEU . 2.5 tt -79.46 -50.99 9.94 Favored 'General case' 0 N--CA 1.42 -1.926 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.261 -177.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.452 ' HA ' HD13 ' A' ' 83' ' ' LEU . 60.6 m-85 -58.45 -23.18 56.89 Favored 'General case' 0 CA--C 1.506 -0.747 0 CA-C-O 121.855 0.836 . . . . 0.0 110.326 179.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -89.2 -23.57 22.36 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 114.473 -1.239 . . . . 0.0 110.118 -179.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.406 ' HE2' ' O ' ' A' ' 122' ' ' ASP . 48.5 tttp -73.36 -40.27 64.51 Favored 'General case' 0 C--O 1.209 -1.053 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 174.127 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.527 ' HG ' ' O ' ' A' ' 79' ' ' LEU . 94.6 mt -53.62 -50.19 66.21 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 114.905 -1.043 . . . . 0.0 112.864 178.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.608 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 2.6 pp -73.82 -24.65 19.83 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -178.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 41.0 mt -79.83 -40.2 29.03 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 176.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.629 ' O ' ' HE2' ' A' ' 110' ' ' LYS . 35.1 t70 -82.96 -13.07 56.72 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.675 -177.268 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 86' ' ' ASP . 2.8 mptp? 85.61 16.77 0.13 Allowed 'General case' 0 CA--C 1.462 -2.418 0 N-CA-C 114.355 1.243 . . . . 0.0 114.355 171.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 11.6 mt -70.02 -45.32 76.87 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.092 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 168.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.608 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 4.3 mm? -114.95 158.57 21.83 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 113.953 -1.476 . . . . 0.0 108.416 174.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.45 ' O ' ' HB2' ' A' ' 106' ' ' MET . 0.3 OUTLIER -149.12 109.97 4.3 Favored 'General case' 0 CA--C 1.476 -1.902 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 176.452 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.434 ' HB2' ' O ' ' A' ' 104' ' ' TYR 0.28 11.8 pt-20 -95.53 159.11 15.15 Favored 'General case' 0 C--N 1.282 -2.36 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 178.56 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.438 ' O ' ' HA ' ' A' ' 103' ' ' ALA . 9.8 t70 -97.98 118.14 33.89 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 126.042 1.737 . . . . 0.0 109.287 -170.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -85.5 103.64 14.55 Favored 'General case' 0 N--CA 1.419 -1.997 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.993 179.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -100.54 113.48 26.32 Favored 'General case' 0 C--N 1.279 -2.479 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.438 HD12 HG23 ' A' ' 95' ' ' ILE . 16.3 tt -128.47 147.01 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.197 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -178.075 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 30.5 p-10 -98.16 -175.12 3.04 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -76.43 18.69 0.29 Allowed 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -177.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -117.89 3.92 12.18 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 178.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 62.91 28.41 16.33 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 122.29 1.043 . . . . 0.0 111.123 -175.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -97.92 106.09 18.34 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 176.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -104.64 146.88 28.29 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 -174.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 14.4 tt -135.19 143.24 37.65 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 N-CA-C 105.855 -1.906 . . . . 0.0 105.855 170.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.438 ' HA ' ' O ' ' A' ' 92' ' ' ASP . . . -112.11 131.5 55.41 Favored 'General case' 0 C--N 1.29 -2.005 0 C-N-CA 120.107 -0.637 . . . . 0.0 111.728 -176.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.434 ' O ' ' HB2' ' A' ' 91' ' ' GLU . 94.6 m-85 -105.21 143.61 33.15 Favored 'General case' 0 C--O 1.196 -1.73 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 177.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 49.8 t -95.3 131.18 42.79 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 CA-C-O 121.999 0.904 . . . . 0.0 113.177 -169.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.45 ' HB2' ' O ' ' A' ' 90' ' ' ASP . 84.8 mmm -130.51 -172.43 2.8 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 112.91 -1.95 . . . . 0.0 106.834 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -102.81 150.17 23.76 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -178.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.402 ' HA2' ' HB2' ' A' ' 90' ' ' ASP . . . -104.96 -175.42 24.56 Favored Glycine 0 N--CA 1.437 -1.248 0 C-N-CA 120.063 -1.065 . . . . 0.0 113.777 -176.044 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -58.67 -40.47 83.63 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 123.968 0.907 . . . . 0.0 112.256 -177.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.629 ' HE2' ' O ' ' A' ' 86' ' ' ASP . 37.5 mtmt -92.21 19.85 6.56 Favored 'General case' 0 C--N 1.314 -0.963 0 O-C-N 122.037 -0.415 . . . . 0.0 111.831 -176.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.449 ' O ' ' HB ' ' A' ' 114' ' ' VAL . . . -78.09 -30.25 49.48 Favored 'General case' 0 CA--C 1.497 -1.082 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 177.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 34.8 tp60 -63.76 -39.55 94.54 Favored 'General case' 0 N--CA 1.421 -1.921 0 CA-C-N 112.93 -1.941 . . . . 0.0 109.4 173.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 5.2 m -66.2 -30.14 70.55 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.522 ' HA ' ' HG ' ' A' ' 119' ' ' LEU . 94.5 t -64.64 -43.77 96.67 Favored 'Isoleucine or valine' 0 C--O 1.25 1.108 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.105 176.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 54.0 mt -69.05 -32.91 72.74 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.775 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -72.11 -24.43 61.48 Favored 'General case' 0 C--O 1.216 -0.659 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.213 177.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 103.18 -13.63 55.37 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.723 -0.751 . . . . 0.0 113.336 176.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -83.72 47.59 1.31 Allowed 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 121.531 0.682 . . . . 0.0 112.197 -175.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.522 ' HG ' ' HA ' ' A' ' 114' ' ' VAL . 0.0 OUTLIER -122.41 80.35 1.72 Allowed 'General case' 0 N--CA 1.434 -1.265 0 CA-C-O 123.263 1.506 . . . . 0.0 110.214 179.891 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.497 ' HA ' HG22 ' A' ' 12' ' ' THR . 5.8 ptmm? -114.31 93.13 4.21 Favored 'General case' 0 C--N 1.246 -3.902 0 C-N-CA 118.733 -1.187 . . . . 0.0 110.935 172.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 8.5 m -111.25 170.43 3.58 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.329 -176.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.406 ' O ' ' HE2' ' A' ' 82' ' ' LYS . 6.8 p-10 -95.52 168.43 10.7 Favored 'General case' 0 C--N 1.271 -2.816 0 CA-C-N 114.655 -1.157 . . . . 0.0 111.967 -178.117 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -158.36 142.34 15.59 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 114.627 -1.169 . . . . 0.0 108.028 172.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 26.5 ptt? . . . . . 0 C--N 1.295 -1.8 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 177.305 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 49.5 m . . . . . 0 N--CA 1.441 -0.91 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.558 ' HA ' ' O ' ' A' ' 5' ' ' ASP . 0.0 OUTLIER -62.46 95.1 0.07 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.8 -1.091 . . . . 0.0 112.197 -177.834 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.6 t 163.19 -27.72 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 -177.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 27.2 ttpp -121.2 -40.92 2.55 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 114.159 -1.382 . . . . 0.0 107.896 175.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.558 ' O ' ' HA ' ' A' ' 2' ' ' LYS . 7.4 m-20 -113.02 165.05 12.72 Favored 'General case' 0 CA--C 1.491 -1.317 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -178.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 47.5 p90 -97.35 3.93 50.92 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 121.979 0.895 . . . . 0.0 108.586 174.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.415 ' HE2' ' O ' ' A' ' 8' ' ' THR . 26.4 tttt -70.7 145.5 50.5 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 114.664 -1.153 . . . . 0.0 110.665 -177.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.487 ' HA ' ' NZ ' ' A' ' 2' ' ' LYS . 89.2 m -114.25 163.51 15.16 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 104.882 -2.266 . . . . 0.0 104.882 169.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.48 ' HB2' ' HB3' ' A' ' 127' ' ' GLU . 60.2 ttt180 -92.65 127.01 37.99 Favored 'General case' 0 N--CA 1.408 -2.54 0 C-N-CA 118.315 -1.354 . . . . 0.0 112.446 -165.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -81.09 111.68 17.76 Favored 'General case' 0 N--CA 1.394 -3.272 0 N-CA-C 104.633 -2.358 . . . . 0.0 104.633 170.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.4 m -84.58 76.15 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.279 -2.47 0 C-N-CA 118.281 -1.368 . . . . 0.0 109.721 178.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.483 ' CG2' ' HA ' ' A' ' 120' ' ' LYS . 26.1 p -110.07 -37.34 5.61 Favored 'General case' 0 C--N 1.259 -3.356 0 CA-C-N 114.849 -1.069 . . . . 0.0 109.391 178.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -69.67 -37.7 76.78 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 176.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.432 ' HB2' ' NH2' ' A' ' 9' ' ' ARG . 11.4 t70 -69.21 -54.93 12.26 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.73 -1.123 . . . . 0.0 108.176 -178.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.404 ' O ' HG21 ' A' ' 19' ' ' VAL . 77.2 t -63.27 -40.38 88.84 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.179 0 CA-C-N 113.76 -1.564 . . . . 0.0 112.966 -177.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 9.6 ttmm -67.08 -35.22 79.35 Favored 'General case' 0 C--N 1.323 -0.586 0 O-C-N 121.907 -0.496 . . . . 0.0 111.586 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 50.1 m -62.97 -45.42 92.52 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 174.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 66.6 mt -55.79 -53.3 39.04 Favored 'Isoleucine or valine' 0 C--O 1.243 0.723 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.134 175.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.404 HG21 ' O ' ' A' ' 15' ' ' VAL . 75.3 t -56.86 -43.99 81.2 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.011 0 CA-C-N 114.985 -1.007 . . . . 0.0 112.162 -178.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.462 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 32.9 ttt180 -53.04 -54.12 40.0 Favored 'General case' 0 N--CA 1.45 -0.453 0 O-C-N 123.765 0.666 . . . . 0.0 110.198 179.257 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.456 ' O ' ' HB2' ' A' ' 25' ' ' HIS . 66.0 m-85 -64.91 -43.05 94.08 Favored 'General case' 0 CA--C 1.494 -1.193 0 N-CA-C 113.183 0.809 . . . . 0.0 113.183 -175.045 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 35.9 m -70.84 -35.96 62.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 C-N-CA 119.367 -0.933 . . . . 0.0 111.345 -178.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -65.13 -47.09 78.33 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 123.402 0.439 . . . . 0.0 110.782 177.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.462 ' HG2' ' O ' ' A' ' 20' ' ' ARG . 12.5 pt-20 -79.98 -5.0 54.89 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 120.113 -0.635 . . . . 0.0 111.878 -179.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.456 ' HB2' ' O ' ' A' ' 21' ' ' PHE . 30.1 t-80 -78.73 34.91 0.23 Allowed 'General case' 0 CA--C 1.553 1.075 0 CA-C-O 121.673 0.749 . . . . 0.0 111.587 178.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.421 ' H ' ' C ' ' A' ' 24' ' ' GLU . 44.8 t -72.13 -16.97 62.0 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 171.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 24.9 t -134.21 -177.25 4.5 Favored 'General case' 0 N--CA 1.419 -1.995 0 N-CA-C 105.385 -2.08 . . . . 0.0 105.385 174.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 62.1 m -133.57 151.19 51.67 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 118.619 0.645 . . . . 0.0 110.995 -178.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -71.68 120.0 16.65 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.134 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -65.35 -22.95 69.77 Favored Glycine 0 C--O 1.223 -0.576 0 C-N-CA 121.345 -0.455 . . . . 0.0 112.508 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -76.57 6.02 6.51 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 123.196 0.598 . . . . 0.0 111.799 -178.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.8 ptm180 -57.54 -42.42 82.91 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 122.789 0.435 . . . . 0.0 110.657 178.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 40.7 t30 54.91 -70.05 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 115.861 1.8 . . . . 0.0 115.861 176.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 53.6 mt -31.77 -78.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 C-N-CA 126.843 2.057 . . . . 0.0 114.654 -167.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.412 ' HD2' ' HA ' ' A' ' 59' ' ' LYS . 99.2 mttt -90.27 76.59 6.79 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-O 122.449 1.119 . . . . 0.0 112.345 -176.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 32.9 p80 -101.6 23.01 11.81 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 114.12 -1.4 . . . . 0.0 109.301 177.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 18.1 m -140.97 145.75 24.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 C-N-CA 124.261 1.024 . . . . 0.0 108.519 179.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 110.36 173.42 20.29 Favored Glycine 0 N--CA 1.438 -1.202 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.711 178.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -76.16 170.24 20.45 Favored 'Trans proline' 0 C--O 1.251 1.159 0 C-N-CA 122.214 1.943 . . . . 0.0 111.698 178.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.3 p -73.3 -173.84 1.46 Allowed 'General case' 0 C--O 1.256 1.424 0 C-N-CA 123.927 0.891 . . . . 0.0 112.579 -177.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -142.3 -174.64 15.0 Favored Glycine 0 N--CA 1.433 -1.503 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 -178.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 85.7 mtm180 -132.89 163.47 29.06 Favored 'General case' 0 N--CA 1.422 -1.836 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -107.82 92.15 3.95 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-O 121.942 0.877 . . . . 0.0 110.226 -174.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 70.1 p -118.79 162.27 18.75 Favored 'General case' 0 N--CA 1.413 -2.305 0 CA-C-N 114.193 -1.367 . . . . 0.0 107.762 178.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.529 ' O ' HG23 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -55.11 -44.27 74.81 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -176.5 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.419 ' O ' ' HB ' ' A' ' 49' ' ' VAL . 3.5 m-20 -71.22 -23.36 62.0 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -177.24 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 26.0 mmt -71.66 -39.7 70.14 Favored 'General case' 0 CA--C 1.508 -0.673 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 176.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 78.4 mt -66.95 -30.89 71.15 Favored 'General case' 0 C--O 1.216 -0.676 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.301 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 45' ' ' MET . 27.3 t -62.8 -52.7 56.28 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.944 0 C-N-CA 124.806 1.242 . . . . 0.0 110.98 178.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.449 ' CG ' ' HB3' ' A' ' 55' ' ' SER . 10.7 t70 -63.02 -38.2 90.24 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 114.848 -1.069 . . . . 0.0 109.287 -178.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.534 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 71.2 mt -63.91 -47.98 88.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.252 -0.885 . . . . 0.0 111.513 176.121 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.484 ' CE2' ' HA3' ' A' ' 68' ' ' GLY . 49.1 t80 -52.65 -43.34 65.43 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 124.778 1.231 . . . . 0.0 111.618 -177.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.9 mp -76.96 -22.54 53.09 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 179.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.77 31.48 18.04 Favored Glycine 0 C--O 1.267 2.2 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -174.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.449 ' HB3' ' CG ' ' A' ' 50' ' ' ASP . 22.8 t -75.69 -179.42 4.71 Favored 'General case' 0 N--CA 1.415 -2.187 0 CA-C-N 113.7 -1.25 . . . . 0.0 108.541 -178.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 43.7 mttm -123.51 17.36 9.67 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 118.76 -1.176 . . . . 0.0 113.297 -169.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.4 m -88.85 -38.31 14.68 Favored 'General case' 0 C--O 1.247 0.971 0 N-CA-C 105.06 -2.2 . . . . 0.0 105.06 173.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -45.85 137.37 5.61 Favored 'General case' 0 N--CA 1.429 -1.494 0 C-N-CA 128.213 2.605 . . . . 0.0 111.59 178.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.412 ' HA ' ' HD2' ' A' ' 35' ' ' LYS . 50.4 mtmt -120.01 18.22 12.45 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.971 -178.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . 0.251 67.6 mt -104.03 -50.4 9.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 C-N-CA 117.496 -1.682 . . . . 0.0 114.19 -177.276 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.632 ' HA ' ' CD2' ' A' ' 65' ' ' PHE . 25.7 mp0 60.91 26.59 16.48 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 176.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.9 t -139.41 129.65 25.34 Favored 'General case' 0 N--CA 1.421 -1.898 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 106.38 -134.8 12.33 Favored Glycine 0 N--CA 1.435 -1.383 0 N-CA-C 111.61 -0.596 . . . . 0.0 111.61 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.427 HG22 ' CD2' ' A' ' 21' ' ' PHE . 1.4 pt -70.95 29.06 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 124.708 1.203 . . . . 0.0 113.694 179.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.632 ' CD2' ' HA ' ' A' ' 61' ' ' GLN . 9.0 t80 -71.69 112.31 7.7 Favored 'General case' 0 N--CA 1.425 -1.689 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -177.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.34 48.18 46.91 Favored Glycine 0 N--CA 1.441 -0.968 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.505 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 32.5 mmtm -119.25 -21.0 7.73 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 120.941 0.4 . . . . 0.0 111.34 177.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.484 ' HA3' ' CE2' ' A' ' 52' ' ' PHE . . . -121.58 45.13 1.25 Allowed Glycine 0 N--CA 1.437 -1.299 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 178.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.7 m -73.99 6.69 3.17 Favored 'General case' 0 C--N 1.306 -1.292 0 C-N-CA 124.614 1.166 . . . . 0.0 112.173 -175.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -101.71 3.87 40.06 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-O 121.527 0.679 . . . . 0.0 109.883 178.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -101.36 168.8 9.3 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.884 176.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 36.1 t -104.07 155.77 18.42 Favored 'General case' 0 N--CA 1.417 -2.117 0 N-CA-C 104.548 -2.39 . . . . 0.0 104.548 168.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 69.7 mtm180 -57.7 -39.66 77.69 Favored 'General case' 0 C--O 1.209 -1.035 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -175.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 69.7 t60 -77.49 -17.0 58.41 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-O 121.519 0.676 . . . . 0.0 110.886 -176.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -80.53 -43.61 20.44 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 177.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.422 ' HB1' HG11 ' A' ' 49' ' ' VAL . . . -61.81 -41.55 97.91 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.009 -0.996 . . . . 0.0 108.842 175.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -54.16 -43.61 70.76 Favored 'General case' 0 CA--C 1.501 -0.929 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.327 174.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 20.2 ttm180 -64.93 -28.81 69.78 Favored 'General case' 0 C--O 1.217 -0.647 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.228 -172.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.3 tt -80.63 -47.25 14.37 Favored 'General case' 0 N--CA 1.429 -1.523 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.26 -177.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -62.09 -20.04 63.6 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 121.861 0.839 . . . . 0.0 109.471 177.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.402 ' HA ' HG13 ' A' ' 84' ' ' ILE . 94.4 mttt -91.26 -22.34 20.63 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 114.471 -1.241 . . . . 0.0 110.394 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 29.6 tptp -70.93 -47.08 61.03 Favored 'General case' 0 C--O 1.219 -0.531 0 N-CA-C 106.133 -1.802 . . . . 0.0 106.133 171.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 94.3 mt -56.8 -39.65 74.52 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 114.35 -1.295 . . . . 0.0 113.941 177.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.476 ' O ' ' HD2' ' A' ' 87' ' ' LYS . 2.7 pp -69.61 -33.02 54.81 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.785 0 C-N-CA 120.261 -0.576 . . . . 0.0 110.908 178.453 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 53.4 mt -70.36 -44.1 68.81 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 121.087 0.47 . . . . 0.0 111.558 176.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -66.96 -27.28 67.33 Favored 'General case' 0 C--O 1.259 1.575 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.199 179.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.476 ' HD2' ' O ' ' A' ' 84' ' ' ILE . 2.2 mptp? 84.89 18.73 0.13 Allowed 'General case' 0 CA--C 1.476 -1.902 0 C-N-CA 125.781 1.632 . . . . 0.0 112.846 176.215 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.462 ' HA ' ' HB2' ' A' ' 110' ' ' LYS . 1.9 mp -69.77 -40.64 79.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 105.391 -2.077 . . . . 0.0 105.391 166.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.474 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 3.1 mm? -103.6 144.31 31.61 Favored 'General case' 0 N--CA 1.411 -2.405 0 CA-C-N 113.419 -1.719 . . . . 0.0 109.04 173.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -124.72 131.57 53.45 Favored 'General case' 0 N--CA 1.408 -2.538 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 176.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.433 ' OE2' ' HB ' ' A' ' 84' ' ' ILE . 0.1 OUTLIER -95.27 129.67 42.31 Favored 'General case' 0 C--N 1.27 -2.86 0 CA-C-N 114.271 -1.331 . . . . 0.0 111.708 -173.838 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.493 ' O ' ' HA ' ' A' ' 103' ' ' ALA . 7.9 m-20 -96.48 95.84 8.29 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 179.092 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 97.5 mt -76.28 114.54 15.08 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.461 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -130.86 130.86 44.12 Favored 'General case' 0 N--CA 1.42 -1.968 0 CA-C-N 115.344 -0.844 . . . . 0.0 108.837 -177.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.483 HG13 ' C ' ' A' ' 100' ' ' GLN . 16.8 tt -128.81 141.15 47.35 Favored 'Isoleucine or valine' 0 N--CA 1.399 -3.005 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 176.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.456 ' C ' ' H ' ' A' ' 98' ' ' ASN . 3.5 p-10 -95.72 170.85 9.04 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 176.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -67.9 21.72 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -173.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.456 ' H ' ' C ' ' A' ' 96' ' ' ASN . 16.8 m120 -119.32 7.49 11.26 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 177.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 62.14 30.76 17.82 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 124.787 1.305 . . . . 0.0 110.99 -177.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.483 ' C ' HG13 ' A' ' 95' ' ' ILE . 83.6 mm-40 -101.71 107.42 18.64 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 177.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -96.27 139.25 32.68 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 115.663 -0.699 . . . . 0.0 112.081 -175.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 18.4 tt -142.21 146.16 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.723 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 176.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.493 ' HA ' ' O ' ' A' ' 92' ' ' ASP . . . -114.19 132.86 55.95 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 -178.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.442 ' HB2' ' HB2' ' A' ' 92' ' ' ASP . 68.1 m-85 -97.23 175.4 6.29 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 177.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.448 HG11 ' CD1' ' A' ' 89' ' ' LEU . 14.6 t -116.4 121.01 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.803 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 -178.233 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 58.4 mtp -141.76 168.48 19.65 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 113.436 -1.711 . . . . 0.0 108.764 173.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 7.5 mp -116.86 130.27 56.61 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 177.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -131.8 -80.24 0.19 Allowed Glycine 0 N--CA 1.422 -2.257 0 C-N-CA 118.897 -1.62 . . . . 0.0 115.716 -175.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -65.96 -54.9 20.31 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 115.25 1.574 . . . . 0.0 115.25 -168.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.462 ' HB2' ' HA ' ' A' ' 88' ' ' ILE . 41.9 mmtm -97.55 6.15 48.51 Favored 'General case' 0 C--N 1.313 -0.979 0 O-C-N 121.455 -0.778 . . . . 0.0 109.995 -179.222 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.445 ' O ' ' HG ' ' A' ' 115' ' ' LEU . . . -58.03 -32.82 68.34 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -175.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -69.5 -29.13 66.7 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.469 0.652 . . . . 0.0 110.029 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 13.1 m -75.95 -25.16 55.66 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.405 HG21 HG21 ' A' ' 88' ' ' ILE . 40.0 t -70.19 -39.69 77.23 Favored 'Isoleucine or valine' 0 C--O 1.25 1.083 0 CA-C-N 115.246 -0.888 . . . . 0.0 108.942 175.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.445 ' HG ' ' O ' ' A' ' 111' ' ' ALA . 76.1 mt -69.54 -39.2 77.6 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.981 178.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -71.58 -20.07 62.05 Favored 'General case' 0 C--O 1.217 -0.635 0 CA-C-O 121.735 0.778 . . . . 0.0 109.529 176.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 85.04 6.52 84.78 Favored Glycine 0 CA--C 1.503 -0.718 0 CA-C-N 115.396 -0.82 . . . . 0.0 113.173 176.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -93.81 18.9 9.54 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 121.584 0.707 . . . . 0.0 109.644 -175.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.591 ' O ' HD13 ' A' ' 119' ' ' LEU . 0.0 OUTLIER -90.06 112.53 24.01 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-O 123.277 1.513 . . . . 0.0 108.442 -176.898 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.483 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 4.9 ptpp? -130.13 105.72 8.13 Favored 'General case' 1 C--N 1.228 -4.697 0 CA-C-N 113.309 -1.769 . . . . 0.0 112.229 179.551 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.4 m -119.07 171.01 7.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 177.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -105.56 158.39 16.71 Favored 'General case' 0 C--N 1.262 -3.223 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.291 -177.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -158.08 151.7 23.6 Favored 'General case' 0 N--CA 1.426 -1.636 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 172.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 49.8 ttm -122.05 107.85 12.69 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 120.501 -0.48 . . . . 0.0 112.037 -173.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -133.91 -146.25 0.26 Allowed 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 174.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 18.8 m -97.89 71.9 2.21 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-O 122.6 1.191 . . . . 0.0 108.444 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.48 ' HB3' ' HB2' ' A' ' 9' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.428 -1.532 0 N-CA-C 102.401 -3.185 . . . . 0.0 102.401 177.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 74.1 m . . . . . 0 N--CA 1.464 0.236 0 N-CA-C 110.353 -0.24 . . . . 0.0 110.353 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.413 ' HB2' ' HZ3' ' A' ' 2' ' ' LYS . 4.8 ttmp? -94.6 158.9 15.32 Favored 'General case' 0 C--O 1.225 -0.2 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 177.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 28.1 m 67.87 85.58 0.14 Allowed 'General case' 0 CA--C 1.535 0.366 0 O-C-N 124.298 0.999 . . . . 0.0 109.718 -178.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -135.04 -42.45 0.73 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.113 -173.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -93.48 97.75 10.74 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -173.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -75.29 -47.45 27.85 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 103.614 -2.736 . . . . 0.0 103.614 167.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.637 ' NZ ' ' HA ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -165.55 152.54 10.27 Favored 'General case' 0 N--CA 1.412 -2.362 0 N-CA-C 105.482 -2.044 . . . . 0.0 105.482 169.512 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.96 155.95 30.51 Favored 'General case' 0 N--CA 1.419 -2.001 0 CA-C-O 121.133 0.492 . . . . 0.0 111.415 -171.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.493 ' O ' ' HA ' ' A' ' 122' ' ' ASP . 8.8 mpt_? -97.4 119.81 36.63 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.342 -170.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -84.97 90.86 7.92 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 177.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.2 m -85.72 64.96 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 CA-C-O 121.705 0.764 . . . . 0.0 110.498 -179.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.484 HG21 ' CB ' ' A' ' 120' ' ' LYS . 42.8 p -102.92 -16.84 15.74 Favored 'General case' 0 C--N 1.26 -3.3 0 C-N-CA 116.15 -2.22 . . . . 0.0 113.187 -176.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 17.9 p-10 -82.14 -35.88 28.01 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 174.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -68.65 -58.98 3.47 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.3 179.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.407 ' O ' HG22 ' A' ' 19' ' ' VAL . 88.6 t -59.51 -35.72 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 CA-C-N 114.675 -1.148 . . . . 0.0 112.04 -179.028 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -66.07 -40.01 90.52 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.294 178.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.46 ' O ' ' HD2' ' A' ' 21' ' ' PHE . 49.6 m -65.14 -42.03 94.19 Favored 'General case' 0 N--CA 1.442 -0.853 0 O-C-N 123.362 0.414 . . . . 0.0 110.246 178.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 59.0 mt -57.13 -51.89 63.35 Favored 'Isoleucine or valine' 0 C--O 1.244 0.807 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.266 176.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.407 HG11 HG11 ' A' ' 114' ' ' VAL . 70.6 t -65.6 -37.33 79.75 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.621 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.929 -178.001 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 16.2 ttp180 -55.11 -52.24 63.86 Favored 'General case' 0 C--O 1.222 -0.386 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.466 ' CD2' HG22 ' A' ' 64' ' ' ILE . 55.5 m-85 -63.16 -43.81 97.24 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-N 115.103 -0.953 . . . . 0.0 113.006 -177.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 27.3 m -72.87 -33.79 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.055 0 C-N-CA 119.365 -0.934 . . . . 0.0 111.742 -178.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 58.9 tp60 -65.59 -48.88 70.82 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 123.141 0.276 . . . . 0.0 110.737 176.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -69.03 -16.47 63.71 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 121.69 0.757 . . . . 0.0 110.461 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 46.7 t-80 -81.82 35.93 0.43 Allowed 'General case' 0 CA--C 1.551 0.984 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.514 177.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 20.0 m -60.54 -33.88 73.3 Favored 'General case' 0 CA--C 1.55 0.965 0 CA-C-O 122.008 0.909 . . . . 0.0 108.591 174.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 20.2 m -89.75 147.02 24.08 Favored 'General case' 0 N--CA 1.432 -1.368 0 CA-C-N 115.135 -0.939 . . . . 0.0 108.797 175.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 40.6 t -56.72 -49.05 76.32 Favored 'General case' 0 C--O 1.249 1.072 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 178.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 53.2 tp60 70.4 -43.23 0.54 Allowed 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 125.556 1.542 . . . . 0.0 113.185 174.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -78.3 56.86 4.07 Favored Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 112.181 -0.367 . . . . 0.0 112.181 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 90.1 mmm -83.33 5.52 23.02 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 123.68 0.792 . . . . 0.0 110.396 -178.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 18.8 mmm180 -78.15 -16.69 57.69 Favored 'General case' 0 C--O 1.214 -0.771 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.599 175.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 59.76 97.78 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 125.372 1.469 . . . . 0.0 113.213 176.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.607 HD11 ' CD ' ' A' ' 61' ' ' GLN . 2.2 tt -79.85 74.74 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 N-CA-C 109.055 -0.721 . . . . 0.0 109.055 174.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 97.9 mttt 40.66 80.1 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 126.726 2.01 . . . . 0.0 115.047 176.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 42.5 p-80 -165.28 146.21 7.28 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.809 177.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 16.5 m -94.08 110.29 23.33 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 CA-C-O 121.442 0.639 . . . . 0.0 109.422 175.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 136.48 171.27 12.21 Favored Glycine 0 N--CA 1.429 -1.816 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -72.56 145.74 42.65 Favored 'Trans proline' 0 C--O 1.248 0.986 0 C-N-CA 122.469 2.112 . . . . 0.0 112.354 -179.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 12.9 m -85.0 78.73 9.86 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -159.75 76.89 0.19 Allowed Glycine 0 N--CA 1.438 -1.224 0 C-N-CA 120.043 -1.075 . . . . 0.0 113.275 -178.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 63.0 mtt180 -135.2 115.94 13.91 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 174.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -109.09 109.79 20.88 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.15 -177.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.503 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 80.9 p -130.69 156.34 45.09 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 104.497 -2.409 . . . . 0.0 104.497 174.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.551 ' O ' HG23 ' A' ' 49' ' ' VAL . 11.9 ptp -59.91 -35.03 74.01 Favored 'General case' 0 C--O 1.215 -0.712 0 CA-C-N 119.701 1.137 . . . . 0.0 110.986 -179.382 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -72.72 -32.74 65.95 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.896 -175.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' MET . . . . . 0.662 ' SD ' ' HA ' ' A' ' 58' ' ' ALA . 48.2 tpp -67.17 -39.45 86.47 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 176.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.503 ' HG ' ' O ' ' A' ' 44' ' ' THR . 77.9 mt -64.26 -40.76 96.66 Favored 'General case' 0 C--O 1.207 -1.152 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.544 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 45' ' ' MET . 68.7 t -64.19 -46.3 93.87 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.687 0 C-N-CA 124.037 0.935 . . . . 0.0 110.245 177.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.609 ' OD1' ' HB3' ' A' ' 55' ' ' SER . 7.9 t70 -60.7 -44.32 96.7 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 114.731 -1.122 . . . . 0.0 109.507 -178.332 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.494 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 54.9 mt -65.18 -47.12 88.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.044 175.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.411 ' CZ ' ' HA3' ' A' ' 68' ' ' GLY . 25.7 t80 -57.18 -44.12 83.28 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 124.353 1.061 . . . . 0.0 110.757 -177.313 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 11.0 mp -77.21 -28.66 53.91 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 177.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 100.74 29.14 6.68 Favored Glycine 0 C--O 1.244 0.722 0 C-N-CA 120.525 -0.845 . . . . 0.0 113.162 177.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.609 ' HB3' ' OD1' ' A' ' 50' ' ' ASP . 23.1 t -80.28 -170.51 2.56 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 123.388 0.675 . . . . 0.0 110.836 -176.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.465 ' HD2' ' C ' ' A' ' 55' ' ' SER . 1.6 mptp? -121.14 7.84 10.31 Favored 'General case' 0 C--O 1.25 1.1 0 N-CA-C 114.271 1.212 . . . . 0.0 114.271 -177.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.5 m -78.36 -30.08 47.85 Favored 'General case' 0 C--O 1.245 0.823 0 N-CA-C 104.837 -2.283 . . . . 0.0 104.837 173.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.662 ' HA ' ' SD ' ' A' ' 47' ' ' MET . . . -50.2 120.97 4.93 Favored 'General case' 0 N--CA 1.417 -2.113 0 C-N-CA 127.34 2.256 . . . . 0.0 109.825 172.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.497 ' HA ' ' HE3' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -100.64 9.69 42.14 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-O 121.067 0.46 . . . . 0.0 111.297 -179.482 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 61.8 mt -128.23 120.88 54.4 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 176.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.607 ' CD ' HD11 ' A' ' 34' ' ' ILE . 29.9 mm-40 -105.39 32.43 4.27 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.192 0.52 . . . . 0.0 110.144 -177.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 24.5 m -141.65 126.76 18.43 Favored 'General case' 0 C--N 1.311 -1.077 0 O-C-N 122.057 -0.402 . . . . 0.0 110.84 -177.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.411 ' C ' ' H ' ' A' ' 65' ' ' PHE . . . 131.16 -132.57 6.87 Favored Glycine 0 N--CA 1.442 -0.91 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.466 HG22 ' CD2' ' A' ' 21' ' ' PHE . 1.7 pt -75.9 31.02 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 123.32 0.648 . . . . 0.0 112.054 177.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.494 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 11.5 t80 -66.87 112.8 4.47 Favored 'General case' 0 N--CA 1.42 -1.974 0 CA-C-O 120.992 0.425 . . . . 0.0 110.443 -174.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 63.79 36.8 93.78 Favored Glycine 0 N--CA 1.436 -1.303 0 CA-C-N 115.045 -0.98 . . . . 0.0 112.156 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.505 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -100.8 -25.04 14.25 Favored 'General case' 0 C--N 1.32 -0.701 0 O-C-N 122.153 -0.616 . . . . 0.0 110.247 177.672 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.411 ' HA3' ' CZ ' ' A' ' 52' ' ' PHE . . . -120.13 51.59 0.76 Allowed Glycine 0 N--CA 1.436 -1.351 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.7 t -82.84 9.3 10.16 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 122.017 0.913 . . . . 0.0 109.86 -174.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -102.0 6.8 41.33 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-O 121.709 0.766 . . . . 0.0 109.82 178.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -100.91 154.45 18.66 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 115.019 -0.991 . . . . 0.0 108.852 176.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.643 ' HB3' ' OD1' ' A' ' 75' ' ' ASN . 43.5 t -97.09 164.85 12.34 Favored 'General case' 0 N--CA 1.416 -2.141 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 171.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 10.6 mmm180 -54.16 -40.35 67.39 Favored 'General case' 0 CA--C 1.509 -0.624 0 C-N-CA 122.981 0.512 . . . . 0.0 112.289 -174.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 16.0 t-80 -86.87 -21.73 26.18 Favored 'General case' 0 C--O 1.2 -1.524 0 C-N-CA 119.015 -1.074 . . . . 0.0 111.372 -172.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.643 ' OD1' ' HB3' ' A' ' 72' ' ' SER . 13.4 m120 -79.78 -38.87 32.17 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 -178.403 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.09 -46.29 84.93 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.752 176.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.74 -20.56 61.18 Favored 'General case' 0 C--O 1.214 -0.808 0 C-N-CA 120.544 -0.463 . . . . 0.0 111.231 -178.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.412 HH21 ' CD ' ' A' ' 127' ' ' GLU . 21.7 tpp180 -65.94 -35.63 81.14 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 176.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.42 ' HG ' ' CD1' ' A' ' 123' ' ' PHE . 2.2 tt -76.83 -45.27 29.22 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 114.761 -1.108 . . . . 0.0 110.175 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -62.99 -17.19 61.87 Favored 'General case' 0 C--O 1.216 -0.693 0 C-N-CA 120.108 -0.637 . . . . 0.0 109.706 176.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.447 ' HA ' HG13 ' A' ' 84' ' ' ILE . 53.1 mttp -86.52 -26.18 24.71 Favored 'General case' 0 CA--C 1.496 -1.099 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.399 177.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.418 ' HG3' ' OD2' ' A' ' 86' ' ' ASP . 29.2 tptp -72.09 -47.24 52.82 Favored 'General case' 0 N--CA 1.427 -1.599 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 176.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.432 ' HB3' HD22 ' A' ' 89' ' ' LEU . 95.8 mt -58.7 -38.08 77.51 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 179.015 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.556 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 2.6 pp -77.7 -23.13 14.08 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 C-N-CA 120.048 -0.661 . . . . 0.0 111.747 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.9 tt -77.76 -47.24 19.49 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 176.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.418 ' OD2' ' HG3' ' A' ' 82' ' ' LYS . 68.3 m-20 -69.64 -20.95 63.59 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.567 -179.58 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.43 ' HB3' ' HB2' ' A' ' 109' ' ' ASN . 3.7 mptp? 84.75 15.61 0.19 Allowed 'General case' 0 CA--C 1.479 -1.765 0 C-N-CA 124.747 1.219 . . . . 0.0 113.679 173.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.411 HG21 HD23 ' A' ' 89' ' ' LEU . 1.8 mp -67.92 -39.92 82.53 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.847 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 169.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.556 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 4.4 mm? -112.08 147.74 35.41 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.682 170.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -133.32 100.53 4.87 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 120.838 0.351 . . . . 0.0 110.061 178.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -100.26 156.76 17.05 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.458 175.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -133.3 179.9 5.91 Favored 'General case' 0 C--O 1.248 0.987 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 179.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 99.1 mt -104.14 150.18 24.57 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 122.511 1.148 . . . . 0.0 113.727 -170.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -141.57 121.01 13.2 Favored 'General case' 0 N--CA 1.422 -1.85 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 176.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 14.7 tt -118.1 149.98 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.444 0 C-N-CA 119.687 -0.805 . . . . 0.0 108.94 -179.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 39.1 p30 -102.1 -176.7 3.19 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.201 178.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -74.05 11.51 0.9 Allowed 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 123.493 0.717 . . . . 0.0 112.315 -178.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -110.79 -2.89 15.99 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 -179.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 29.5 t70 69.11 24.48 6.1 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-O 123.462 1.601 . . . . 0.0 109.189 -176.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -97.52 107.12 19.56 Favored 'General case' 0 C--O 1.245 0.859 0 CA-C-N 114.998 -1.001 . . . . 0.0 108.749 176.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -88.68 129.53 35.5 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.833 -177.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 15.0 tt -124.5 150.14 29.14 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 175.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -108.92 134.54 51.46 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 122.315 -0.241 . . . . 0.0 110.681 -177.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -106.36 143.33 34.63 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 19.0 t -96.61 133.98 35.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 CA-C-O 122.094 0.949 . . . . 0.0 113.168 -171.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 62.6 mtt -134.62 175.95 9.08 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 113.365 -1.743 . . . . 0.0 106.876 176.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -121.61 132.24 54.56 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 -179.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -140.21 -104.99 0.6 Allowed Glycine 0 N--CA 1.429 -1.808 0 C-N-CA 118.484 -1.817 . . . . 0.0 115.525 -174.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.43 ' HB2' ' HB3' ' A' ' 87' ' ' LYS . 37.1 m-80 -49.99 -55.33 15.05 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 115.312 1.597 . . . . 0.0 115.312 -167.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.472 ' O ' HG22 ' A' ' 114' ' ' VAL . 74.8 mmtt -110.89 19.79 18.18 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.833 -0.542 . . . . 0.0 111.119 -176.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -76.3 -33.36 59.07 Favored 'General case' 0 CA--C 1.495 -1.167 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 35.5 tp60 -62.87 -36.48 83.44 Favored 'General case' 0 N--CA 1.423 -1.821 0 CA-C-N 113.025 -1.898 . . . . 0.0 110.023 173.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 19.8 m -69.31 -28.53 66.35 Favored 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 179.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.472 HG22 ' O ' ' A' ' 110' ' ' LYS . 38.9 t -66.76 -43.81 89.71 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.758 176.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 65.3 mt -67.6 -33.05 74.22 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.314 -179.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -72.71 -23.5 60.87 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 177.21 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 98.12 -19.32 54.98 Favored Glycine 0 N--CA 1.44 -1.063 0 CA-C-N 115.597 -0.729 . . . . 0.0 113.075 177.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -79.17 24.22 0.34 Allowed 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.534 1.134 . . . . 0.0 113.56 -172.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.625 HD11 ' O ' ' A' ' 119' ' ' LEU . 0.0 OUTLIER -94.13 109.53 21.3 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 122.914 1.34 . . . . 0.0 109.73 -178.892 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.5 ' HB3' ' HZ3' ' A' ' 120' ' ' LYS 0.341 0.1 OUTLIER -129.54 114.65 16.35 Favored 'General case' 1 C--N 1.225 -4.831 0 N-CA-C 114.449 1.277 . . . . 0.0 114.449 172.651 . . . . . . . . 5 4 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 5.4 m -126.83 173.68 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.796 0 CA-C-N 114.758 -1.11 . . . . 0.0 108.147 177.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.493 ' HA ' ' O ' ' A' ' 9' ' ' ARG . 8.5 p-10 -107.77 173.07 6.48 Favored 'General case' 0 C--N 1.269 -2.919 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.702 -177.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . 0.42 ' CD1' ' HG ' ' A' ' 79' ' ' LEU . 51.1 t80 -157.81 166.78 31.82 Favored 'General case' 0 C--O 1.251 1.166 0 C-N-CA 123.93 0.892 . . . . 0.0 108.95 178.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 42.8 tpp -141.19 118.85 11.64 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 125.827 1.651 . . . . 0.0 106.595 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -43.56 -72.8 0.05 Allowed 'General case' 0 N--CA 1.501 2.105 0 C-N-CA 124.477 1.111 . . . . 0.0 113.144 -176.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.467 ' HA ' ' ND2' ' A' ' 75' ' ' ASN . 14.9 t -114.32 -177.63 3.18 Favored 'General case' 0 N--CA 1.428 -1.568 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.739 -173.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.412 ' CD ' HH21 ' A' ' 78' ' ' ARG . 4.2 mm-40 . . . . . 0 C--N 1.305 -1.367 0 C-N-CA 125.304 1.442 . . . . 0.0 109.67 -174.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 7.3 p . . . . . 0 N--CA 1.441 -0.884 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.466 ' HG2' ' OD1' ' A' ' 5' ' ' ASP . 44.9 mmtm -163.26 -171.68 2.7 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 102.57 -3.122 . . . . 0.0 102.57 176.209 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 6.7 m -72.52 -30.68 64.7 Favored 'General case' 0 CA--C 1.552 1.043 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 169.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -141.76 104.29 4.5 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 175.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.466 ' OD1' ' HG2' ' A' ' 2' ' ' LYS . 26.9 t70 -118.92 102.47 8.8 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 -175.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 28.9 p90 -75.1 78.19 2.26 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 -174.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 6.3 ptmm? -175.43 -160.13 0.08 Allowed 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 126.658 1.983 . . . . 0.0 105.846 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.2 m -76.67 157.29 31.92 Favored 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 176.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.529 ' HB2' ' O ' ' A' ' 123' ' ' PHE . 6.9 mpt_? -93.83 130.14 39.97 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 -174.164 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -90.76 94.18 9.56 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 -174.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.602 ' HB ' ' OD1' ' A' ' 14' ' ' ASP . 21.6 m -89.64 104.35 15.0 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 CA-C-O 122.658 1.218 . . . . 0.0 110.648 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -122.28 -42.61 2.35 Favored 'General case' 0 C--N 1.267 -3.018 0 C-N-CA 119.285 -0.966 . . . . 0.0 112.545 174.047 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.47 ' HA ' ' HB2' ' A' ' 16' ' ' LYS 0.367 7.3 m-20 -87.62 -9.84 53.13 Favored 'General case' 0 N--CA 1.419 -1.99 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 -171.639 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.602 ' OD1' ' HB ' ' A' ' 11' ' ' VAL . 20.2 p-10 -84.32 -39.92 18.55 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 105.545 -2.021 . . . . 0.0 105.545 171.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.436 ' O ' ' HB ' ' A' ' 18' ' ' ILE . 65.0 t -65.39 -37.32 79.79 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.378 0 CA-C-N 113.847 -1.524 . . . . 0.0 109.448 174.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.47 ' HB2' ' HA ' ' A' ' 13' ' ' ASP . 1.4 tppp? -61.6 -42.7 99.24 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 124.941 1.296 . . . . 0.0 109.776 178.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.9 t -61.66 -45.24 94.89 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.436 ' HB ' ' O ' ' A' ' 15' ' ' VAL . 87.6 mt -54.28 -54.28 22.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.168 175.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 77.2 t -56.5 -47.06 82.39 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.773 0 CA-C-N 115.144 -0.934 . . . . 0.0 111.562 -179.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 7.3 tpt180 -51.25 -51.6 52.57 Favored 'General case' 0 C--N 1.321 -0.644 0 O-C-N 123.421 0.451 . . . . 0.0 111.282 177.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.507 ' CE1' ' HA3' ' A' ' 63' ' ' GLY . 69.0 m-85 -72.58 -35.9 68.05 Favored 'General case' 0 CA--C 1.492 -1.287 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -174.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 27.0 m -73.96 -37.13 46.96 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.533 0 C-N-CA 118.963 -1.095 . . . . 0.0 110.222 178.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -61.02 -50.85 71.67 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 176.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -71.46 -25.8 62.45 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.922 -177.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 14.6 t60 -69.68 -32.44 71.07 Favored 'General case' 0 C--O 1.211 -0.952 0 C-N-CA 120.156 -0.618 . . . . 0.0 109.764 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 20.3 m -82.29 6.26 17.43 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 121.184 0.516 . . . . 0.0 112.017 -175.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 33.1 t -95.51 7.67 45.56 Favored 'General case' 0 N--CA 1.44 -0.936 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 177.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 29.4 t -171.35 -166.76 0.48 Allowed 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 -178.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -83.8 -34.04 24.83 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 175.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.452 ' C ' ' H ' ' A' ' 32' ' ' ARG . . . 74.79 77.59 0.67 Allowed Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.106 179.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 66.7 mtt -61.72 18.47 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.425 0 C-N-CA 126.91 2.084 . . . . 0.0 115.281 -175.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.452 ' H ' ' C ' ' A' ' 30' ' ' GLY . 27.2 mmm180 -79.08 18.65 0.62 Allowed 'General case' 0 C--N 1.299 -1.587 0 C-N-CA 124.095 0.958 . . . . 0.0 112.315 -178.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -64.48 136.52 57.15 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 121.163 0.506 . . . . 0.0 112.325 -177.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.481 ' HB ' ' HG2' ' A' ' 61' ' ' GLN . 7.1 tt -101.7 -6.63 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-O 123.033 1.397 . . . . 0.0 107.639 176.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 48.7 mmtm -118.15 135.86 53.97 Favored 'General case' 0 N--CA 1.42 -1.95 0 N-CA-C 105.664 -1.976 . . . . 0.0 105.664 178.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 14.7 p-80 -56.64 153.18 10.79 Favored 'General case' 0 C--O 1.244 0.797 0 O-C-N 123.749 0.656 . . . . 0.0 110.745 -179.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 56.2 t -50.34 123.47 2.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 O-C-N 124.413 1.07 . . . . 0.0 109.927 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -163.54 173.12 39.61 Favored Glycine 0 N--CA 1.418 -2.51 0 N-CA-C 110.094 -1.202 . . . . 0.0 110.094 -177.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -19.53 99.45 0.01 OUTLIER 'Trans proline' 0 CA--C 1.545 1.067 1 C-N-CA 127.038 5.159 . . . . 0.0 118.515 -174.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 14.5 m 57.94 -178.08 0.07 Allowed 'General case' 0 CA--C 1.558 1.262 0 N-CA-C 115.49 1.663 . . . . 0.0 115.49 169.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -122.84 126.36 6.31 Favored Glycine 0 N--CA 1.423 -2.222 0 N-CA-C 106.706 -2.558 . . . . 0.0 106.706 172.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 25.5 mmt180 -124.01 110.45 14.79 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -176.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -108.24 92.64 4.15 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.455 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 68.4 p -114.73 163.44 15.46 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 179.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.572 ' O ' HG21 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -58.11 -39.85 79.69 Favored 'General case' 0 C--O 1.214 -0.775 0 CA-C-O 121.028 0.442 . . . . 0.0 109.885 -179.138 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.41 ' CG ' HH22 ' A' ' 73' ' ' ARG . 18.7 t-20 -60.78 -45.42 94.43 Favored 'General case' 0 C--N 1.31 -1.124 0 C-N-CA 124.967 1.307 . . . . 0.0 111.157 -175.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' MET . . . . . 0.473 ' SD ' ' HA ' ' A' ' 58' ' ' ALA . 35.6 tpp -67.48 -36.4 81.04 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.584 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.455 ' HG ' ' O ' ' A' ' 44' ' ' THR . 73.1 mt -69.75 -29.54 66.92 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.271 -178.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.572 HG21 ' O ' ' A' ' 45' ' ' MET . 44.2 t -67.07 -48.67 78.39 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.24 0 C-N-CA 123.679 0.792 . . . . 0.0 110.37 178.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -58.91 -41.16 86.6 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.955 177.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.706 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 49.9 mt -63.94 -46.05 95.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.629 176.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.512 ' CE2' ' HA3' ' A' ' 68' ' ' GLY . 49.0 t80 -63.0 -40.08 96.69 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 123.208 0.603 . . . . 0.0 111.361 -178.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.0 mp -75.78 -35.12 60.21 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 111.46 8.18 23.4 Favored Glycine 0 C--O 1.244 0.734 0 C-N-CA 119.822 -1.18 . . . . 0.0 112.184 -177.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 63.2 m -65.63 124.19 21.72 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 123.47 0.708 . . . . 0.0 109.872 177.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -82.88 20.26 1.21 Allowed 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 -178.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.1 m -77.55 -24.55 49.84 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 106.163 -1.791 . . . . 0.0 106.163 172.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.473 ' HA ' ' SD ' ' A' ' 47' ' ' MET . . . -52.85 151.06 4.8 Favored 'General case' 0 C--O 1.247 0.947 0 CA-C-N 113.529 -1.669 . . . . 0.0 112.042 178.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -93.92 -16.82 23.63 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.889 178.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 71.1 mt -132.03 143.5 39.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.392 -175.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.481 ' HG2' ' HB ' ' A' ' 34' ' ' ILE . 20.2 mm-40 -106.23 80.91 1.55 Allowed 'General case' 0 C--O 1.245 0.834 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 176.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 42.0 m -79.59 173.82 12.2 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 110.121 -0.325 . . . . 0.0 110.121 179.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.507 ' HA3' ' CE1' ' A' ' 21' ' ' PHE . . . -60.93 -31.15 75.2 Favored Glycine 0 N--CA 1.467 0.735 0 C-N-CA 121.096 -0.573 . . . . 0.0 112.513 -179.203 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.433 HG21 ' CD2' ' A' ' 21' ' ' PHE . 5.8 pt -73.74 2.77 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.73 0 N-CA-C 113.515 0.931 . . . . 0.0 113.515 177.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.706 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 6.4 t80 -65.56 106.54 1.46 Allowed 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -178.073 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 83.41 18.69 63.76 Favored Glycine 0 N--CA 1.429 -1.776 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.493 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.425 ' CG ' ' HA ' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -86.72 -35.27 19.34 Favored 'General case' 0 CA--C 1.51 -0.576 0 C-N-CA 119.022 -1.071 . . . . 0.0 109.956 177.197 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.512 ' HA3' ' CE2' ' A' ' 52' ' ' PHE . . . -105.25 44.37 1.49 Allowed Glycine 0 N--CA 1.426 -1.982 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 44.0 t -72.49 -0.21 12.07 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 123.402 0.681 . . . . 0.0 111.002 -177.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -97.74 1.94 49.03 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-O 121.207 0.527 . . . . 0.0 110.64 178.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -99.55 148.41 24.32 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 115.454 -0.794 . . . . 0.0 108.955 175.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 39.1 t -90.83 161.78 15.11 Favored 'General case' 0 C--N 1.281 -2.382 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 168.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.447 ' HB3' ' NH1' ' A' ' 73' ' ' ARG . 13.5 mtp-105 -60.29 -36.19 77.3 Favored 'General case' 0 C--O 1.219 -0.522 0 CA-C-O 121.053 0.454 . . . . 0.0 110.293 -177.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 19.4 t-160 -62.67 -41.64 99.19 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.113 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.65 ' ND2' ' H ' ' A' ' 127' ' ' GLU . 6.1 m120 -65.93 -52.58 48.59 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -176.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.7 -44.12 96.94 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.473 -0.785 . . . . 0.0 112.441 -177.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.436 ' CG ' HG23 ' A' ' 49' ' ' VAL . 42.9 mt-10 -64.33 -33.81 76.71 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 121.585 0.707 . . . . 0.0 111.009 178.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.417 ' HE ' ' CD ' ' A' ' 127' ' ' GLU . 17.7 mmm180 -78.04 -17.0 57.57 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.913 -179.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.3 tt -79.84 -42.69 23.8 Favored 'General case' 0 N--CA 1.426 -1.635 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 176.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -60.53 -19.98 58.86 Favored 'General case' 0 C--O 1.216 -0.705 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 172.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.404 ' HA ' HG13 ' A' ' 84' ' ' ILE . 73.0 mmtt -82.75 -28.58 30.31 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.463 176.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 29.1 tptp -70.43 -45.42 65.9 Favored 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 174.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.477 ' HB3' HD23 ' A' ' 89' ' ' LEU . 97.8 mt -58.83 -37.1 75.67 Favored 'General case' 0 N--CA 1.428 -1.563 0 CA-C-N 113.958 -1.474 . . . . 0.0 113.834 178.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.511 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 2.7 pp -74.02 -26.94 21.58 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.592 0 C-N-CA 119.884 -0.726 . . . . 0.0 111.627 178.392 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 49.0 mt -73.42 -47.65 40.12 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 123.49 0.494 . . . . 0.0 110.507 175.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -67.1 -25.31 66.15 Favored 'General case' 0 C--O 1.254 1.312 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.054 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? 85.51 23.52 0.08 Allowed 'General case' 0 CA--C 1.478 -1.797 0 C-N-CA 125.951 1.7 . . . . 0.0 113.475 175.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.421 HG21 HG23 ' A' ' 114' ' ' VAL . 2.0 mp -74.58 -41.47 48.67 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.224 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 169.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.511 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 3.7 mm? -103.68 140.39 37.65 Favored 'General case' 0 N--CA 1.424 -1.769 0 CA-C-N 114.153 -1.385 . . . . 0.0 109.748 175.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -131.35 109.75 10.57 Favored 'General case' 0 C--N 1.285 -2.216 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 176.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -94.96 149.21 21.5 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 121.051 0.453 . . . . 0.0 112.16 -172.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.456 ' O ' ' HA ' ' A' ' 103' ' ' ALA . 8.1 m-20 -97.78 108.37 21.07 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 94.5 mt -81.68 108.82 15.55 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.716 0.77 . . . . 0.0 109.661 176.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -120.69 125.57 48.01 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-N 114.802 -1.09 . . . . 0.0 108.402 -175.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.462 HG13 ' C ' ' A' ' 100' ' ' GLN . 16.9 tt -130.3 141.78 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.753 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 178.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -97.13 173.15 7.39 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 176.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -66.44 18.21 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 -173.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -118.61 10.24 12.46 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 177.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.407 ' HA ' HD13 ' A' ' 95' ' ' ILE . 6.1 m-20 60.13 29.32 18.9 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 122.644 1.212 . . . . 0.0 111.023 -174.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.462 ' C ' HG13 ' A' ' 95' ' ' ILE . 94.0 mt-30 -95.92 106.04 18.14 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 114.426 -1.261 . . . . 0.0 107.998 176.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -101.36 144.33 30.31 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.626 -0.715 . . . . 0.0 112.437 -175.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 9.6 tp -141.6 146.86 22.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 174.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.456 ' HA ' ' O ' ' A' ' 92' ' ' ASP . . . -112.0 129.04 56.33 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 110.156 -0.312 . . . . 0.0 110.156 -178.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -97.49 162.78 13.15 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 177.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.42 HG13 ' CD1' ' A' ' 89' ' ' LEU . 8.4 t -105.16 123.71 59.5 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.862 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 -177.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 26.2 mmt -137.83 162.68 33.32 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 113.178 -1.828 . . . . 0.0 106.743 173.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -127.71 123.29 35.06 Favored 'General case' 0 C--N 1.285 -2.226 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 177.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -125.49 -86.27 0.63 Allowed Glycine 0 N--CA 1.422 -2.237 0 C-N-CA 119.099 -1.524 . . . . 0.0 115.705 -171.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -57.32 -46.49 83.18 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 115.86 1.8 . . . . 0.0 115.86 -167.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.455 ' O ' HG21 ' A' ' 114' ' ' VAL . 41.9 mmtm -106.2 8.8 32.2 Favored 'General case' 0 C--N 1.308 -1.199 0 O-C-N 121.507 -0.746 . . . . 0.0 111.321 -179.095 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -54.64 -45.7 73.83 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -172.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -72.9 -24.28 60.82 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.213 0.53 . . . . 0.0 110.946 -176.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 7.2 m -75.51 -24.9 56.87 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 -178.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.455 HG21 ' O ' ' A' ' 110' ' ' LYS . 21.9 t -74.97 -37.52 41.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 176.004 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 81.4 mt -66.44 -38.59 87.73 Favored 'General case' 0 C--O 1.219 -0.507 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.621 177.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -72.57 -24.99 61.18 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 174.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 70.64 24.7 76.68 Favored Glycine 0 C--O 1.218 -0.852 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.402 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -95.98 32.64 1.86 Allowed 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 105.788 -1.93 . . . . 0.0 105.788 176.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.428 HD22 ' N ' ' A' ' 120' ' ' LYS . 0.3 OUTLIER -142.71 127.16 17.8 Favored 'General case' 0 N--CA 1.384 -3.772 0 CA-C-N 113.012 -1.904 . . . . 0.0 108.018 -174.531 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.46 ' HD3' ' O ' ' A' ' 120' ' ' LYS . 0.0 OUTLIER -130.25 137.99 50.3 Favored 'General case' 0 N--CA 1.414 -2.268 0 N-CA-C 107.896 -1.149 . . . . 0.0 107.896 172.362 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.547 HG21 ' O ' ' A' ' 11' ' ' VAL . 4.8 m -114.35 -174.79 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 C-N-CA 119.363 -0.935 . . . . 0.0 108.51 176.212 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -133.83 140.85 47.15 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -171.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . 0.529 ' O ' ' HB2' ' A' ' 9' ' ' ARG . 11.2 t80 -158.17 -175.5 5.38 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 175.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 26.1 ptt? -142.19 158.74 43.39 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 177.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -37.95 -54.01 1.32 Allowed 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 125.146 1.378 . . . . 0.0 113.176 -177.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 10.2 t -136.57 145.45 44.98 Favored 'General case' 0 N--CA 1.417 -2.088 0 CA-C-O 121.408 0.623 . . . . 0.0 110.924 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.65 ' H ' ' ND2' ' A' ' 75' ' ' ASN . 7.0 tm-20 . . . . . 0 C--N 1.283 -2.297 0 N-CA-C 101.284 -3.598 . . . . 0.0 101.284 175.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 39.8 m . . . . . 0 CA--C 1.507 -0.678 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -132.23 151.76 51.66 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 178.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.2 p -70.01 141.65 52.89 Favored 'General case' 0 N--CA 1.421 -1.917 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 174.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -78.17 126.5 30.89 Favored 'General case' 0 CA--C 1.483 -1.609 0 C-N-CA 119.232 -0.987 . . . . 0.0 109.203 -178.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -77.87 98.3 5.57 Favored 'General case' 0 C--N 1.274 -2.69 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.088 178.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -70.93 102.58 2.43 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 113.867 -1.515 . . . . 0.0 110.701 -177.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 33.8 mtmm -98.79 100.99 12.25 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 177.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.5 ' CG2' ' HA ' ' A' ' 124' ' ' MET . 9.1 m -128.88 179.47 5.7 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -174.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 72.1 mtm180 -96.49 143.16 27.75 Favored 'General case' 0 CA--C 1.499 -0.982 0 N-CA-C 114.621 1.341 . . . . 0.0 114.621 -175.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -98.16 90.26 4.79 Favored 'General case' 0 CA--C 1.48 -1.727 0 N-CA-C 102.146 -3.279 . . . . 0.0 102.146 170.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.448 ' O ' HG21 ' A' ' 11' ' ' VAL . 19.0 m -71.95 84.53 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.317 0 CA-C-O 122.85 1.31 . . . . 0.0 112.652 -172.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.486 HG21 ' HA ' ' A' ' 120' ' ' LYS . 37.8 p -100.88 -54.79 2.73 Favored 'General case' 0 C--N 1.26 -3.301 0 C-N-CA 117.869 -1.532 . . . . 0.0 112.831 174.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -86.96 -11.56 50.18 Favored 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 119.405 -0.918 . . . . 0.0 110.142 -178.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.429 ' OD1' ' HA ' ' A' ' 11' ' ' VAL . 1.6 m-20 -69.41 -41.77 75.96 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 104.864 -2.272 . . . . 0.0 104.864 173.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 51.5 t -70.07 -45.37 76.49 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.828 0 CA-C-N 112.946 -1.934 . . . . 0.0 109.847 176.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 30.9 ttmt -65.56 -35.54 81.13 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.6 p -62.72 -44.56 95.89 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 120.628 -0.429 . . . . 0.0 109.937 176.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 56.9 mt -53.9 -50.24 54.12 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 O-C-N 123.745 0.653 . . . . 0.0 109.725 172.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.418 ' O ' ' HG3' ' A' ' 23' ' ' GLN . 76.5 t -58.05 -46.36 88.08 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.867 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.27 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 58.7 mtm-85 -58.33 -32.43 68.49 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.666 ' CD2' HG23 ' A' ' 64' ' ' ILE . 70.7 m-85 -83.48 -37.75 22.71 Favored 'General case' 0 N--CA 1.427 -1.58 0 C-N-CA 119.514 -0.875 . . . . 0.0 112.747 179.067 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.403 HG21 ' HA ' ' A' ' 19' ' ' VAL . 27.7 m -69.01 -29.73 44.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 C-N-CA 117.629 -1.629 . . . . 0.0 109.668 176.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.418 ' HG3' ' O ' ' A' ' 19' ' ' VAL . 54.9 mt-30 -62.61 -38.35 89.82 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.471 170.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.632 ' HG3' ' O ' ' A' ' 21' ' ' PHE . 0.3 OUTLIER -64.71 -28.74 69.8 Favored 'General case' 0 CA--C 1.493 -1.245 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.466 -179.67 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 9.7 t-80 -71.77 0.65 8.43 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -175.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 16.7 m -69.84 -29.58 66.87 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 174.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 34.2 t -125.02 -16.84 5.95 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.073 178.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 16.8 m 70.4 89.92 0.1 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.277 1.431 . . . . 0.0 110.748 -177.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.418 ' C ' ' H ' ' A' ' 31' ' ' MET . 54.0 tt0 -81.67 -34.47 30.69 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 -179.434 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -82.23 41.24 2.76 Favored Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 110.699 -0.961 . . . . 0.0 110.699 174.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' MET . . . . . 0.418 ' H ' ' C ' ' A' ' 29' ' ' GLN . 25.8 ptt? -63.0 -13.53 36.36 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.958 1.303 . . . . 0.0 113.309 -176.048 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.41 -36.12 82.69 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 178.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 8.2 p30 49.07 -168.25 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 125.826 1.651 . . . . 0.0 113.574 176.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 65.7 mt -131.12 -60.2 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 177.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 35.8 mtmm -107.33 -34.98 6.92 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.871 179.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -174.51 152.55 1.71 Allowed 'General case' 0 CA--C 1.506 -0.735 0 C-N-CA 124.741 1.216 . . . . 0.0 107.859 179.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 30.0 m -72.23 -24.35 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-O 121.669 0.747 . . . . 0.0 109.235 174.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.474 ' CA ' HD12 ' A' ' 60' ' ' ILE . . . 171.69 158.75 16.4 Favored Glycine 0 N--CA 1.413 -2.878 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 177.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -84.77 -24.76 2.14 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.058 1.839 . . . . 0.0 111.595 176.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 23.0 t -176.62 -179.86 1.05 Allowed 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 -178.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -89.01 66.42 3.08 Favored Glycine 0 N--CA 1.443 -0.864 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 58.1 mtt180 -130.59 112.97 13.64 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -124.15 122.52 38.04 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.744 -177.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 41.6 p -116.63 155.98 27.84 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 106.306 -1.738 . . . . 0.0 106.306 172.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.468 ' O ' HG23 ' A' ' 49' ' ' VAL . 16.2 ptp -62.45 -36.08 81.3 Favored 'General case' 0 C--O 1.217 -0.637 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -175.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -66.13 -30.94 71.52 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.936 0.398 . . . . 0.0 110.133 -178.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 22.7 mmt -73.88 -41.32 62.35 Favored 'General case' 0 C--O 1.202 -1.409 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.845 177.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 80.4 mt -56.43 -37.21 69.91 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.979 0.418 . . . . 0.0 110.908 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 45' ' ' MET . 74.2 t -66.11 -44.51 91.77 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.317 0 C-N-CA 124.268 1.027 . . . . 0.0 110.601 177.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -59.72 -43.17 94.29 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.45 -178.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.414 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 1.9 mp -64.29 -47.93 87.61 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.959 174.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -54.81 -42.37 71.76 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.441 1.096 . . . . 0.0 111.16 -177.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.7 mp -83.04 -15.14 52.2 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 178.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.58 39.09 12.69 Favored Glycine 0 C--O 1.253 1.327 0 C-N-CA 120.417 -0.897 . . . . 0.0 111.079 -178.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 65.2 m -86.89 -172.52 4.03 Favored 'General case' 0 N--CA 1.418 -2.055 0 CA-C-N 115.294 -0.453 . . . . 0.0 111.886 -178.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -109.79 -4.72 15.88 Favored 'General case' 0 C--O 1.261 1.703 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 -170.213 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.3 m -78.07 -28.07 48.74 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 105.565 -2.013 . . . . 0.0 105.565 176.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -51.59 107.19 0.17 Allowed 'General case' 0 N--CA 1.419 -1.998 0 C-N-CA 126.56 1.944 . . . . 0.0 112.428 175.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.67 -7.27 28.18 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 174.212 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.474 HD12 ' CA ' ' A' ' 38' ' ' GLY . 28.1 mm -95.65 110.84 24.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 114.511 -1.222 . . . . 0.0 108.866 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -122.2 97.13 5.33 Favored 'General case' 0 C--N 1.293 -1.859 0 O-C-N 121.781 -0.575 . . . . 0.0 110.283 172.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.9 m -145.97 -80.13 0.16 Allowed 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 173.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -100.98 165.16 18.59 Favored Glycine 0 N--CA 1.433 -1.551 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.243 178.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.666 HG23 ' CD2' ' A' ' 21' ' ' PHE 0.26 16.6 pt 48.55 9.71 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.443 0 N-CA-C 117.573 2.434 . . . . 0.0 117.573 178.4 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.414 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 23.0 t80 -64.74 105.07 0.92 Allowed 'General case' 0 C--O 1.243 0.762 0 CA-C-N 118.442 0.565 . . . . 0.0 111.292 -177.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 74.56 29.63 61.34 Favored Glycine 0 C--N 1.312 -0.762 0 CA-C-N 115.628 -0.714 . . . . 0.0 112.241 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.433 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.7 OUTLIER -94.2 -19.31 20.86 Favored 'General case' 0 C--N 1.322 -0.611 0 O-C-N 122.409 -0.465 . . . . 0.0 111.565 176.83 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -126.53 39.09 2.05 Favored Glycine 0 N--CA 1.433 -1.538 0 C-N-CA 120.465 -0.874 . . . . 0.0 111.433 -178.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 15.5 m -71.3 1.76 5.72 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 123.944 0.898 . . . . 0.0 112.064 -177.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -98.99 4.27 47.18 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-O 121.422 0.629 . . . . 0.0 110.099 178.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -95.35 147.19 23.76 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 115.291 -0.868 . . . . 0.0 108.779 175.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.445 ' HB3' ' CG ' ' A' ' 75' ' ' ASN . 30.5 t -75.95 149.31 37.69 Favored 'General case' 0 N--CA 1.416 -2.171 0 N-CA-C 105.299 -2.112 . . . . 0.0 105.299 169.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.439 ' O ' ' HG3' ' A' ' 77' ' ' GLU . 0.2 OUTLIER -50.33 -44.92 54.54 Favored 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 123.946 0.898 . . . . 0.0 110.339 -173.356 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.419 ' HA ' ' OE1' ' A' ' 77' ' ' GLU . 17.5 t-80 -84.87 -12.55 53.25 Favored 'General case' 0 N--CA 1.428 -1.568 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.936 -173.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.662 ' ND2' ' HB3' ' A' ' 127' ' ' GLU . 6.5 m120 -71.58 -45.41 62.29 Favored 'General case' 0 CA--C 1.48 -1.718 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 179.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.412 ' HB1' HG11 ' A' ' 49' ' ' VAL . . . -63.88 -41.52 97.71 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 114.477 -1.238 . . . . 0.0 109.44 179.177 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.439 ' HG3' ' O ' ' A' ' 73' ' ' ARG . 47.9 mt-10 -61.26 -36.09 79.04 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-O 121.53 0.681 . . . . 0.0 110.508 176.136 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.607 ' NH1' ' HB2' ' A' ' 127' ' ' GLU . 62.7 ttp180 -72.75 -23.79 60.87 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.63 -177.007 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.3 tt -79.8 -44.36 20.76 Favored 'General case' 0 N--CA 1.419 -1.98 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.175 -178.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -63.13 -21.47 66.21 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 175.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.415 ' O ' HG13 ' A' ' 84' ' ' ILE . 22.6 mmtm -82.49 -28.19 31.32 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.814 176.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 45.8 tptt -70.29 -44.0 69.24 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 175.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.429 ' HB3' HD21 ' A' ' 89' ' ' LEU . 94.3 mt -62.24 -33.63 74.95 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 114.782 -1.099 . . . . 0.0 113.533 178.138 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.415 HG13 ' O ' ' A' ' 81' ' ' LYS . 2.5 pp -75.56 -25.77 17.85 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.643 0 C-N-CA 119.716 -0.794 . . . . 0.0 111.506 178.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 52.4 mt -72.12 -49.06 39.15 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 121.034 0.445 . . . . 0.0 110.693 176.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.52 -14.2 61.17 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.267 -179.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.407 ' HA ' ' HZ2' ' A' ' 87' ' ' LYS . 0.0 OUTLIER 83.96 13.45 0.32 Allowed 'General case' 0 CA--C 1.501 -0.915 0 C-N-CA 125.432 1.493 . . . . 0.0 112.153 167.761 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 1.8 mp -65.38 -41.65 91.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 169.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.429 HD21 ' HB3' ' A' ' 83' ' ' LEU . 3.3 mm? -103.88 148.01 26.65 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 114.107 -1.406 . . . . 0.0 110.466 174.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -132.76 127.84 35.53 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.386 177.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -94.53 137.16 33.98 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-O 121.264 0.554 . . . . 0.0 110.978 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -98.36 144.47 27.71 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 114.585 -1.189 . . . . 0.0 108.924 -179.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 91.1 mt -104.59 97.88 7.73 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 121.881 0.848 . . . . 0.0 110.528 -178.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -100.14 111.68 23.97 Favored 'General case' 0 C--N 1.282 -2.357 0 CA-C-N 114.443 -1.253 . . . . 0.0 108.09 -177.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.638 ' HA ' ' CB ' ' A' ' 101' ' ' ALA . 1.8 tt -132.3 141.88 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.844 0 O-C-N 123.597 0.56 . . . . 0.0 111.162 174.325 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.446 ' C ' ' H ' ' A' ' 98' ' ' ASN . 2.2 p-10 -99.32 171.38 8.01 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 177.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -67.8 26.4 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -172.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.446 ' H ' ' C ' ' A' ' 96' ' ' ASN . 15.3 m120 -119.0 -4.95 10.57 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 177.114 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 57.38 33.03 22.71 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 122.802 1.287 . . . . 0.0 110.718 -174.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.44 ' HG3' ' O ' ' A' ' 98' ' ' ASN . 27.3 mt-30 -128.53 87.19 2.55 Favored 'General case' 0 CA--C 1.495 -1.151 0 CA-C-N 114.023 -1.444 . . . . 0.0 108.744 -177.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.638 ' CB ' ' HA ' ' A' ' 95' ' ' ILE . . . -159.39 -177.86 6.73 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -175.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 10.6 tp -139.42 167.75 19.45 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.332 0 O-C-N 123.366 0.416 . . . . 0.0 110.436 -170.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -84.74 141.18 30.73 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 122.945 0.498 . . . . 0.0 110.556 179.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -111.8 167.72 10.14 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.21 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 14.7 t -98.27 129.65 48.21 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -177.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 26.3 mmt -136.33 163.45 30.41 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 113.774 -1.557 . . . . 0.0 107.943 176.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.475 ' HB3' ' CB ' ' A' ' 111' ' ' ALA . 7.7 mp -115.19 124.35 51.19 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 176.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -131.8 -102.86 0.89 Allowed Glycine 0 N--CA 1.434 -1.481 0 C-N-CA 118.592 -1.765 . . . . 0.0 116.316 -173.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 45.1 t-20 -58.24 -45.71 87.27 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.554 1.142 . . . . 0.0 113.693 -165.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.505 ' HD3' ' OG1' ' A' ' 113' ' ' THR . 19.8 mmtm -111.16 13.81 21.82 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -178.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.475 ' CB ' ' HB3' ' A' ' 107' ' ' LEU . . . -70.6 -38.5 74.01 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.693 0.758 . . . . 0.0 109.681 177.132 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.19 -30.64 71.69 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.882 0.848 . . . . 0.0 109.246 176.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' THR . . . . . 0.505 ' OG1' ' HD3' ' A' ' 110' ' ' LYS . 17.2 m -74.53 -25.65 59.47 Favored 'General case' 0 N--CA 1.424 -1.772 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.329 -178.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.48 ' HA ' ' HG ' ' A' ' 119' ' ' LEU . 63.4 t -66.15 -44.83 91.49 Favored 'Isoleucine or valine' 0 C--O 1.248 0.998 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 174.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 59.3 mt -63.74 -42.05 97.94 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.919 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -72.3 -14.3 61.71 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.618 177.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 83.43 11.6 79.98 Favored Glycine 0 C--O 1.213 -1.161 0 C-N-CA 120.685 -0.769 . . . . 0.0 113.65 176.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -95.92 23.27 6.5 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 122.562 1.172 . . . . 0.0 109.481 -176.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.573 HD11 ' O ' ' A' ' 119' ' ' LEU . 0.0 OUTLIER -103.39 101.33 11.23 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-O 122.926 1.346 . . . . 0.0 108.647 -178.474 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.486 ' HA ' HG21 ' A' ' 12' ' ' THR . 0.0 OUTLIER -128.94 96.55 4.38 Favored 'General case' 1 C--N 1.229 -4.668 0 CA-C-N 115.021 -0.99 . . . . 0.0 112.957 175.512 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 5.8 m -114.13 173.45 3.16 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.777 -178.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -104.94 160.62 14.88 Favored 'General case' 0 C--N 1.277 -2.545 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.967 -179.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . 0.472 ' O ' HG22 ' A' ' 8' ' ' THR . 70.8 t80 -158.06 135.12 10.0 Favored 'General case' 0 C--O 1.25 1.095 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.788 172.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.5 ' HA ' ' CG2' ' A' ' 8' ' ' THR . 17.6 tmm? -97.08 136.7 37.26 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 115.132 -0.94 . . . . 0.0 108.651 -179.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 -58.57 -68.3 0.27 Allowed 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 116.908 2.188 . . . . 0.0 116.908 -168.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 5.2 m -99.74 157.05 16.76 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -163.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.662 ' HB3' ' ND2' ' A' ' 75' ' ' ASN . 44.1 tt0 . . . . . 0 C--O 1.269 2.116 0 N-CA-C 104.719 -2.326 . . . . 0.0 104.719 176.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 49.3 t . . . . . 0 CA--C 1.507 -0.711 0 N-CA-C 104.471 -2.418 . . . . 0.0 104.471 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -78.77 80.23 5.14 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 170.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 11.7 p -144.82 -175.73 4.79 Favored 'General case' 0 N--CA 1.423 -1.81 0 CA-C-N 114.054 -1.43 . . . . 0.0 107.598 -172.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.576 ' HE2' ' O ' ' A' ' 5' ' ' ASP . 20.1 ptmt -78.57 170.59 16.4 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 175.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.576 ' O ' ' HE2' ' A' ' 4' ' ' LYS . 26.1 t70 -87.32 -178.44 6.19 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 176.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -83.66 -19.61 35.07 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 122.012 -0.43 . . . . 0.0 110.099 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -52.47 128.15 24.83 Favored 'General case' 0 C--O 1.25 1.09 0 C-N-CA 124.308 1.043 . . . . 0.0 113.264 -178.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.8 m -77.63 173.49 11.98 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 174.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 28.9 mmt180 -94.81 154.64 17.17 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 121.568 -0.708 . . . . 0.0 109.201 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -118.68 108.51 15.0 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 12.8 m -101.61 101.3 11.91 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.167 0 CA-C-O 122.271 1.034 . . . . 0.0 110.002 177.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.489 HG22 ' HA ' ' A' ' 120' ' ' LYS . 42.9 p -120.17 -40.2 2.73 Favored 'General case' 0 C--N 1.264 -3.134 0 C-N-CA 119.494 -0.882 . . . . 0.0 109.8 177.154 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -69.35 -40.62 77.41 Favored 'General case' 0 C--N 1.29 -1.982 0 C-N-CA 125.867 1.667 . . . . 0.0 109.643 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.403 ' CG ' ' HZ2' ' A' ' 67' ' ' LYS . 9.9 t0 -68.78 -45.29 71.72 Favored 'General case' 0 C--O 1.244 0.776 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 87.2 t -67.38 -40.83 85.48 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 CA-C-N 114.063 -1.426 . . . . 0.0 111.765 -177.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -65.31 -36.93 85.56 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 43.4 t -61.27 -46.76 89.02 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 175.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.404 ' O ' HG21 ' A' ' 22' ' ' VAL . 68.6 mt -56.0 -54.11 30.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 C-N-CA 123.072 0.549 . . . . 0.0 110.399 177.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 71.7 t -59.4 -44.03 91.68 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.789 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.859 -178.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 19.6 ttt180 -61.51 -45.86 92.44 Favored 'General case' 0 N--CA 1.436 -1.13 0 C-N-CA 120.0 -0.68 . . . . 0.0 110.847 179.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -63.15 -42.83 99.53 Favored 'General case' 0 CA--C 1.5 -0.943 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.441 ' O ' ' HB3' ' A' ' 25' ' ' HIS . 28.2 m -72.89 -33.47 43.62 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 C-N-CA 119.909 -0.716 . . . . 0.0 111.006 179.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -65.98 -54.86 20.72 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 121.164 -0.214 . . . . 0.0 110.796 173.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -77.28 1.53 18.42 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.365 0.602 . . . . 0.0 111.114 -177.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.441 ' HB3' ' O ' ' A' ' 22' ' ' VAL . 17.1 t-80 -58.31 -36.2 73.02 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 173.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.6 m -98.11 13.13 32.14 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.368 -177.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 14.8 m -112.37 11.43 20.0 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 177.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 25.8 t 74.42 130.77 0.04 OUTLIER 'General case' 0 C--O 1.246 0.919 0 C-N-CA 125.032 1.333 . . . . 0.0 112.506 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.488 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 78.4 mt-30 -127.94 -70.15 0.7 Allowed 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 114.987 -1.006 . . . . 0.0 108.813 177.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 33.42 -82.77 0.0 OUTLIER Glycine 0 N--CA 1.491 2.318 0 N-CA-C 117.349 1.699 . . . . 0.0 117.349 170.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.62 -28.39 68.49 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 123.685 0.794 . . . . 0.0 113.092 -176.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.488 ' HG2' ' O ' ' A' ' 29' ' ' GLN . 14.3 ptt180 -91.36 -10.77 40.01 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 179.057 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -113.72 -159.44 0.69 Allowed 'General case' 0 C--O 1.25 1.115 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 -178.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 67.0 mt -67.85 144.03 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 N-CA-C 104.479 -2.415 . . . . 0.0 104.479 167.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 41.2 mmtt -79.96 81.41 6.23 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 119.857 -0.737 . . . . 0.0 111.01 -169.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 11.0 t60 -164.43 130.45 2.93 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 115.063 -0.971 . . . . 0.0 108.71 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.48 ' HA ' ' OG ' ' A' ' 62' ' ' SER . 59.3 t -108.62 125.03 65.52 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 176.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -121.16 95.96 0.58 Allowed Glycine 0 CA--C 1.528 0.873 0 C-N-CA 120.375 -0.917 . . . . 0.0 113.668 -179.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -107.35 22.48 0.08 OUTLIER 'Trans proline' 0 CA--C 1.55 1.3 0 C-N-CA 123.597 2.865 . . . . 0.0 111.479 174.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 6.5 p -72.75 97.81 2.28 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -173.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.16 33.77 35.07 Favored Glycine 0 CA--C 1.509 -0.286 0 CA-C-N 115.781 -0.645 . . . . 0.0 113.593 173.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.421 ' NH1' ' HE1' ' A' ' 106' ' ' MET . 54.9 mtm180 62.06 -108.34 0.29 Allowed 'General case' 0 N--CA 1.426 -1.675 0 C-N-CA 123.445 0.698 . . . . 0.0 112.178 -177.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -157.87 128.08 6.2 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 -173.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.409 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 57.6 p -116.37 158.02 24.14 Favored 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 171.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.432 ' O ' HG21 ' A' ' 49' ' ' VAL . 21.2 ptm -54.91 -37.85 66.88 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 120.283 -0.567 . . . . 0.0 111.634 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -66.05 -36.02 82.12 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 46.0 mtt -66.94 -42.97 84.37 Favored 'General case' 0 CA--C 1.497 -1.09 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 44' ' ' THR . 80.8 mt -59.34 -45.58 90.98 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.111 -178.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.432 HG21 ' O ' ' A' ' 45' ' ' MET . 82.2 t -66.43 -52.78 42.95 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.137 0 C-N-CA 123.908 0.883 . . . . 0.0 111.311 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.16 -39.79 87.65 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.182 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.466 ' CD1' ' HA ' ' A' ' 58' ' ' ALA . 1.8 mp -71.6 -38.73 68.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 O-C-N 121.984 -0.447 . . . . 0.0 111.402 177.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.481 ' CE2' ' HA3' ' A' ' 68' ' ' GLY . 60.2 t80 -55.47 -37.71 68.16 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 124.111 0.964 . . . . 0.0 111.293 -178.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.5 mp -92.7 -25.85 18.04 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 177.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.33 50.23 4.61 Favored Glycine 0 C--O 1.22 -0.731 0 N-CA-C 108.694 -1.762 . . . . 0.0 108.694 -172.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 47.6 t -97.56 -170.24 1.97 Allowed 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 124.535 1.134 . . . . 0.0 112.92 -171.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.507 ' NZ ' ' HB2' ' A' ' 56' ' ' LYS . 6.2 mtmp? -43.55 -53.69 5.42 Favored 'General case' 0 C--O 1.247 0.925 0 C-N-CA 128.137 2.575 . . . . 0.0 112.282 -178.24 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.5 m -94.46 9.05 39.95 Favored 'General case' 0 N--CA 1.417 -2.087 0 CA-C-N 114.54 -1.209 . . . . 0.0 111.406 -171.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.466 ' HA ' ' CD1' ' A' ' 51' ' ' ILE . . . -82.41 91.12 6.78 Favored 'General case' 0 N--CA 1.399 -2.998 0 CA-C-O 121.918 0.866 . . . . 0.0 110.21 178.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.511 ' HA ' HE22 ' A' ' 61' ' ' GLN . 62.7 mttp -119.96 24.11 10.68 Favored 'General case' 0 C--N 1.287 -2.148 0 CA-C-N 114.622 -1.172 . . . . 0.0 109.519 179.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.407 ' HB ' HG12 ' A' ' 51' ' ' ILE . 1.9 mp -105.39 -55.4 5.66 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 CA-C-N 115.356 -0.838 . . . . 0.0 113.028 -178.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.52 ' HA ' ' CD2' ' A' ' 65' ' ' PHE . 26.2 mp0 67.22 -7.73 0.5 Allowed 'General case' 0 N--CA 1.507 2.376 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 175.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.48 ' OG ' ' HA ' ' A' ' 37' ' ' VAL . 12.6 m -94.59 84.71 4.33 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-O 120.765 0.317 . . . . 0.0 110.449 -179.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 101.67 138.74 10.29 Favored Glycine 0 N--CA 1.437 -1.246 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.024 178.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . 0.258 10.8 pt 49.45 14.92 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 N-CA-C 116.217 1.932 . . . . 0.0 116.217 177.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.52 ' CD2' ' HA ' ' A' ' 61' ' ' GLN . 27.9 t80 -75.5 104.88 6.25 Favored 'General case' 0 N--CA 1.419 -1.987 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -177.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 88.48 12.62 64.6 Favored Glycine 0 N--CA 1.437 -1.264 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.186 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.403 ' HZ2' ' CG ' ' A' ' 14' ' ' ASP . 0.1 OUTLIER -67.61 -34.53 77.19 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 -179.211 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.481 ' HA3' ' CE2' ' A' ' 52' ' ' PHE . . . -134.27 48.92 0.92 Allowed Glycine 0 N--CA 1.421 -2.324 0 C-N-CA 119.628 -1.272 . . . . 0.0 112.536 -175.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 19.9 m -71.36 4.27 3.06 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 120.975 0.417 . . . . 0.0 111.804 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -102.97 1.35 33.53 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-O 121.325 0.584 . . . . 0.0 109.99 177.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -95.26 160.11 14.69 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 174.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 41.2 t -88.75 169.98 11.17 Favored 'General case' 0 N--CA 1.411 -2.417 0 N-CA-C 103.901 -2.629 . . . . 0.0 103.901 165.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.528 ' O ' ' HG3' ' A' ' 77' ' ' GLU . 10.9 ptm180 -64.96 -27.37 68.79 Favored 'General case' 0 C--O 1.2 -1.536 0 C-N-CA 118.462 -1.295 . . . . 0.0 110.166 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.663 ' O ' ' HG2' ' A' ' 78' ' ' ARG . 34.2 m170 -57.34 -59.74 4.68 Favored 'General case' 0 C--O 1.209 -1.065 0 O-C-N 124.169 0.918 . . . . 0.0 112.439 -177.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.626 ' HA ' ' CG ' ' A' ' 78' ' ' ARG 0.398 12.9 m-80 -64.18 -28.0 69.46 Favored 'General case' 0 CA--C 1.485 -1.529 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 177.715 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.4 -50.59 72.24 Favored 'General case' 0 N--CA 1.439 -1.001 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 171.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.643 ' O ' ' HG2' ' A' ' 81' ' ' LYS . 42.9 mt-10 -56.83 -42.81 80.3 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.599 0.759 . . . . 0.0 111.078 177.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.663 ' HG2' ' O ' ' A' ' 74' ' ' HIS . 13.1 mmt85 -59.13 -36.41 75.18 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -175.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -77.57 -47.45 19.4 Favored 'General case' 0 CA--C 1.47 -2.125 0 CA-C-N 114.675 -1.148 . . . . 0.0 111.84 -172.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -62.91 -20.75 65.48 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 121.594 0.711 . . . . 0.0 109.207 178.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.643 ' HG2' ' O ' ' A' ' 77' ' ' GLU . 30.6 mmmt -88.87 -26.13 21.78 Favored 'General case' 0 N--CA 1.436 -1.133 0 C-N-CA 118.938 -1.105 . . . . 0.0 109.669 179.328 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 29.8 tptp -69.74 -45.69 67.58 Favored 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 177.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 95.8 mt -56.71 -40.77 76.23 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-N 114.086 -1.415 . . . . 0.0 113.581 177.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.598 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 2.5 pp -78.11 -18.12 13.77 Favored 'Isoleucine or valine' 0 C--O 1.254 1.342 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 179.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 46.9 mt -81.59 -48.66 11.48 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.49 175.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -66.49 -33.84 76.6 Favored 'General case' 0 C--O 1.249 1.042 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.525 ' HB3' ' HB2' ' A' ' 109' ' ' ASN 0.274 57.8 mttm 84.78 27.71 0.07 Allowed 'General case' 0 CA--C 1.454 -2.712 0 C-N-CA 126.524 1.93 . . . . 0.0 115.181 174.792 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.423 HG23 HG22 ' A' ' 114' ' ' VAL . 1.8 mp -67.75 -36.37 75.7 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.274 0 N-CA-C 105.111 -2.181 . . . . 0.0 105.111 164.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.598 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 4.4 mm? -110.94 151.68 27.64 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 114.005 -1.452 . . . . 0.0 108.318 171.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -141.43 111.95 7.01 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 177.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -92.46 143.23 26.57 Favored 'General case' 0 C--N 1.278 -2.518 0 CA-C-O 121.676 0.751 . . . . 0.0 111.439 -176.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -98.51 113.07 24.94 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 114.726 -1.125 . . . . 0.0 109.496 -178.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 72.1 mt -78.0 113.93 16.38 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 114.673 -1.149 . . . . 0.0 109.745 -178.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 92.0 t80 -119.46 100.04 7.05 Favored 'General case' 0 N--CA 1.417 -2.076 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 178.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.495 ' HA ' ' HB1' ' A' ' 101' ' ' ALA . 0.3 OUTLIER -130.89 144.05 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.388 -3.537 0 C-N-CA 119.409 -0.917 . . . . 0.0 109.467 -178.672 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 40.3 p30 -100.84 -178.92 3.91 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 120.306 -0.558 . . . . 0.0 111.453 -176.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -80.32 15.5 1.57 Allowed 'General case' 0 C--N 1.316 -0.874 0 C-N-CA 123.841 0.856 . . . . 0.0 111.275 -178.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.475 ' HB3' ' NE2' ' A' ' 100' ' ' GLN . 2.6 m-20 -117.54 -0.4 11.91 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 58.92 27.22 15.93 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 124.548 1.155 . . . . 0.0 110.17 -174.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.475 ' NE2' ' HB3' ' A' ' 98' ' ' ASN . 42.0 mt-30 -128.94 68.63 1.4 Allowed 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.756 -1.111 . . . . 0.0 111.933 -174.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.495 ' HB1' ' HA ' ' A' ' 95' ' ' ILE . . . -158.43 178.85 9.7 Favored 'General case' 0 C--N 1.273 -2.723 0 CA-C-N 114.577 -1.192 . . . . 0.0 108.42 178.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 14.7 tt -140.57 157.15 23.94 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.973 0 CA-C-N 118.708 0.685 . . . . 0.0 112.196 -170.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -85.64 135.02 33.96 Favored 'General case' 0 C--O 1.255 1.38 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.758 176.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -103.65 165.76 10.84 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 54.0 t -111.92 135.23 51.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -176.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.421 ' HE1' ' NH1' ' A' ' 42' ' ' ARG . 14.6 mmt -138.61 -173.59 3.59 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 113.463 -1.699 . . . . 0.0 107.775 176.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -137.26 138.21 39.84 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 177.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -145.52 -84.6 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.893 0 C-N-CA 118.313 -1.899 . . . . 0.0 116.456 -174.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.525 ' HB2' ' HB3' ' A' ' 87' ' ' LYS . 29.4 m-80 -56.57 -50.46 71.86 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 -166.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 40.0 mmtm -104.06 3.89 33.73 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.615 -0.678 . . . . 0.0 110.554 -176.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -58.31 -31.68 67.74 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 123.022 0.529 . . . . 0.0 112.29 -178.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -70.59 -26.22 63.42 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-O 121.57 0.7 . . . . 0.0 110.112 179.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 4.8 m -80.0 -23.88 41.23 Favored 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.423 HG22 HG23 ' A' ' 88' ' ' ILE . 54.5 t -67.9 -36.13 74.61 Favored 'Isoleucine or valine' 0 C--O 1.246 0.918 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 174.211 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 75.2 mt -73.22 -34.92 66.18 Favored 'General case' 0 C--O 1.216 -0.696 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.661 177.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -72.32 -14.51 61.76 Favored 'General case' 0 C--O 1.217 -0.629 0 CA-C-O 122.211 1.005 . . . . 0.0 108.709 175.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 94.18 -19.02 55.6 Favored Glycine 0 N--CA 1.44 -1.092 0 CA-C-N 115.186 -0.915 . . . . 0.0 113.163 176.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -87.63 66.57 8.97 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.738 0.78 . . . . 0.0 111.738 -173.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.464 ' O ' HD22 ' A' ' 119' ' ' LEU . 0.0 OUTLIER -126.75 79.44 1.87 Allowed 'General case' 0 C--N 1.288 -2.096 0 CA-C-O 123.636 1.684 . . . . 0.0 110.628 175.675 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.489 ' HA ' HG22 ' A' ' 12' ' ' THR . 0.0 OUTLIER -101.14 96.32 7.13 Favored 'General case' 0 C--N 1.264 -3.136 0 CA-C-N 114.587 -1.188 . . . . 0.0 112.136 174.877 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 5.9 m -93.25 172.34 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.138 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 177.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -110.98 163.87 13.38 Favored 'General case' 0 C--N 1.263 -3.161 0 CA-C-N 115.178 -0.919 . . . . 0.0 108.77 178.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -153.64 174.97 13.79 Favored 'General case' 0 N--CA 1.424 -1.769 0 CA-C-O 121.69 0.757 . . . . 0.0 111.287 -179.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 60.2 mtt -89.71 175.48 7.23 Favored 'General case' 0 N--CA 1.426 -1.632 0 C-N-CA 126.152 1.781 . . . . 0.0 108.137 -179.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -87.87 -150.17 0.17 Allowed 'General case' 0 C--N 1.283 -2.323 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.503 -179.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 9.5 t -99.16 135.45 40.56 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -169.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.485 ' HB3' ' ND2' ' A' ' 75' ' ' ASN . 1.3 tm-20 . . . . . 0 N--CA 1.445 -0.705 0 N-CA-C 101.148 -3.649 . . . . 0.0 101.148 176.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 50.3 m . . . . . 0 CA--C 1.507 -0.69 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -84.64 79.97 9.41 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 12.0 t -178.59 146.0 0.34 Allowed 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 178.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -148.24 127.75 13.2 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -97.11 131.25 44.07 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 120.963 0.411 . . . . 0.0 111.568 -178.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -145.81 24.34 1.35 Allowed 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 175.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.519 ' NZ ' ' HB2' ' A' ' 7' ' ' LYS . 6.9 mtmp? -110.87 -157.67 0.62 Allowed 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 -175.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 22.9 m -76.43 150.13 36.77 Favored 'General case' 0 N--CA 1.405 -2.684 0 N-CA-C 103.458 -2.793 . . . . 0.0 103.458 166.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 74.0 mtt180 -93.03 126.22 38.01 Favored 'General case' 0 C--N 1.278 -2.54 0 CA-C-O 121.237 0.542 . . . . 0.0 111.334 -167.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -78.26 89.62 4.32 Favored 'General case' 0 CA--C 1.491 -1.303 0 CA-C-O 122.408 1.099 . . . . 0.0 109.854 -178.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.511 ' O ' HG21 ' A' ' 121' ' ' VAL . 21.3 t -84.88 103.99 12.59 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.689 0 CA-C-N 113.395 -1.73 . . . . 0.0 109.772 -177.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.44 HG22 ' HA ' ' A' ' 120' ' ' LYS . 21.5 p -121.01 -50.41 2.16 Favored 'General case' 0 N--CA 1.413 -2.31 0 C-N-CA 117.758 -1.577 . . . . 0.0 112.482 175.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.409 ' HA ' ' CB ' ' A' ' 16' ' ' LYS . 0.3 OUTLIER -87.37 -11.91 47.92 Favored 'General case' 0 N--CA 1.426 -1.675 0 C-N-CA 119.126 -1.03 . . . . 0.0 112.304 -173.843 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.469 ' HB2' HG11 ' A' ' 11' ' ' VAL . 0.7 OUTLIER -65.85 -52.35 51.16 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 103.978 -2.601 . . . . 0.0 103.978 169.195 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.443 ' O ' ' HB ' ' A' ' 18' ' ' ILE . 31.3 t -56.77 -44.2 81.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 113.581 -1.645 . . . . 0.0 111.337 174.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.449 ' HE2' ' O ' ' A' ' 114' ' ' VAL . 2.0 tppp? -57.78 -45.28 86.21 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.788 177.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 53.4 m -61.78 -41.58 97.89 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.5 178.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.443 ' HB ' ' O ' ' A' ' 15' ' ' VAL . 66.2 mt -53.63 -52.64 31.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 O-C-N 123.748 0.655 . . . . 0.0 109.459 173.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 93.0 t -57.78 -45.05 87.13 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.576 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.74 179.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.441 ' HG3' ' O ' ' A' ' 16' ' ' LYS . 64.3 mtt85 -53.52 -45.72 69.87 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.151 0.501 . . . . 0.0 110.728 178.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.437 ' HA ' ' HG3' ' A' ' 24' ' ' GLU . 77.1 m-85 -83.18 -33.88 26.1 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 -174.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 18' ' ' ILE . 27.0 m -73.25 -31.77 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.521 0 C-N-CA 118.376 -1.329 . . . . 0.0 110.107 177.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -59.97 -48.73 80.5 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.194 174.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.437 ' HG3' ' HA ' ' A' ' 21' ' ' PHE . 1.5 pp20? -68.75 -27.86 66.29 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 120.292 -0.563 . . . . 0.0 112.111 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -68.06 -5.47 17.71 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -178.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 17.5 m -62.08 -28.27 69.5 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 170.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 11.8 m -94.24 81.13 4.02 Favored 'General case' 0 N--CA 1.419 -2.01 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 174.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.8 m -77.74 6.26 7.78 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 112.648 0.611 . . . . 0.0 112.648 -175.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -81.36 73.25 8.4 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-O 122.325 1.06 . . . . 0.0 111.571 -177.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -94.13 80.91 0.96 Allowed Glycine 0 N--CA 1.43 -1.716 0 N-CA-C 108.569 -1.812 . . . . 0.0 108.569 175.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 96.2 mmm -42.65 -79.18 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.565 1.146 . . . . 0.0 113.969 -174.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -91.72 -74.96 0.49 Allowed 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.226 178.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 51.3 t30 66.26 -176.5 0.19 Allowed 'General case' 0 CA--C 1.555 1.164 0 O-C-N 124.236 0.96 . . . . 0.0 109.51 -178.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 59.3 mt -60.71 -41.51 88.58 Favored 'Isoleucine or valine' 0 C--O 1.242 0.681 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 175.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.7 mtmm 176.71 159.17 0.33 Allowed 'General case' 0 C--O 1.243 0.743 0 C-N-CA 126.481 1.912 . . . . 0.0 109.459 177.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -166.45 128.59 1.84 Allowed 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 108.677 -0.861 . . . . 0.0 108.677 176.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 14.8 p -98.77 -20.02 5.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 175.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -86.71 125.16 7.3 Favored Glycine 0 N--CA 1.428 -1.877 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.332 177.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -80.71 -70.28 0.01 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 122.129 1.886 . . . . 0.0 111.254 175.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 57.3 m -166.27 172.95 10.57 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 140.46 -71.62 0.42 Allowed Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.091 -1.052 . . . . 0.0 112.377 176.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -174.6 162.57 3.42 Favored 'General case' 0 CA--C 1.502 -0.876 0 C-N-CA 124.282 1.033 . . . . 0.0 108.954 177.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -126.3 126.59 44.21 Favored 'General case' 0 CA--C 1.485 -1.532 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.575 ' HA ' ' HA ' ' A' ' 104' ' ' TYR . 55.4 p -82.13 155.55 24.96 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 175.328 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.547 ' O ' HG22 ' A' ' 49' ' ' VAL . 5.8 ptm -52.34 -35.67 51.59 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-O 121.427 0.632 . . . . 0.0 110.124 177.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.537 ' N ' ' HG3' ' A' ' 45' ' ' MET . 22.7 t-20 -63.22 -40.09 96.49 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.439 -1.255 . . . . 0.0 110.839 -175.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' MET . . . . . 0.539 ' HG3' ' OG1' ' A' ' 44' ' ' THR . 64.5 mtt -69.27 -36.44 77.1 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-O 121.554 0.692 . . . . 0.0 109.928 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 82.3 mt -67.91 -33.74 75.28 Favored 'General case' 0 C--O 1.206 -1.186 0 CA-C-N 114.992 -1.004 . . . . 0.0 111.227 -178.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.547 HG22 ' O ' ' A' ' 45' ' ' MET . 88.1 t -67.96 -38.88 80.69 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.016 0 C-N-CA 123.355 0.662 . . . . 0.0 110.303 178.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -53.69 -47.5 70.41 Favored 'General case' 0 CA--C 1.506 -0.732 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.128 175.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.438 HG13 ' O ' ' A' ' 47' ' ' MET . 4.9 mt -76.83 -38.58 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.524 0 CA-C-N 114.717 -1.129 . . . . 0.0 111.738 -176.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.45 ' CE2' ' HA3' ' A' ' 68' ' ' GLY . 60.5 t80 -53.1 -48.08 68.09 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 125.019 1.328 . . . . 0.0 110.733 179.142 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.9 mp -77.52 -12.12 59.93 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.085 -0.507 . . . . 0.0 112.302 178.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.95 26.97 54.68 Favored Glycine 0 C--O 1.249 1.066 0 C-N-CA 120.915 -0.659 . . . . 0.0 111.702 -179.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 40.2 t -67.29 176.4 2.27 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-O 121.797 0.808 . . . . 0.0 111.048 -176.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.474 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 0.7 OUTLIER -106.8 6.63 29.69 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 122.055 0.931 . . . . 0.0 110.117 176.592 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 27.8 p -90.89 1.21 57.17 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 169.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.74 117.41 8.85 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-N 113.69 -1.596 . . . . 0.0 108.893 178.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 43.0 mttp -81.52 -11.83 59.04 Favored 'General case' 0 C--N 1.29 -2.02 0 CA-C-N 114.801 -1.09 . . . . 0.0 111.862 -172.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.429 ' O ' HD11 ' A' ' 51' ' ' ILE . 66.7 mt -143.42 138.3 26.04 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.94 0 N-CA-C 105.953 -1.869 . . . . 0.0 105.953 175.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.583 ' HA ' ' CE2' ' A' ' 65' ' ' PHE . 25.6 mm-40 -93.6 44.78 1.14 Allowed 'General case' 0 C--N 1.3 -1.584 0 CA-C-O 120.993 0.425 . . . . 0.0 110.5 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 42.2 m -153.95 153.03 31.28 Favored 'General case' 0 C--O 1.245 0.844 0 O-C-N 122.026 -0.421 . . . . 0.0 110.203 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 80.92 109.29 0.31 Allowed Glycine 0 C--O 1.2 -2.014 0 CA-C-O 119.393 -0.671 . . . . 0.0 111.599 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . 0.275 3.7 pt 51.94 17.59 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 C-N-CA 125.007 1.323 . . . . 0.0 114.494 -176.255 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.583 ' CE2' ' HA ' ' A' ' 61' ' ' GLN . 18.3 t80 -62.68 107.53 0.98 Allowed 'General case' 0 C--O 1.252 1.222 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.515 -176.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 64.29 41.65 98.13 Favored Glycine 0 N--CA 1.434 -1.452 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.408 178.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 28.3 mmtm -114.86 -3.98 12.68 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.22 0.533 . . . . 0.0 111.017 177.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.45 ' HA3' ' CE2' ' A' ' 52' ' ' PHE . . . -133.51 30.32 3.02 Favored Glycine 0 N--CA 1.425 -2.055 0 N-CA-C 110.19 -1.164 . . . . 0.0 110.19 176.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 16.5 m -70.35 2.16 4.15 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 123.91 0.884 . . . . 0.0 112.417 -176.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -98.74 7.19 46.36 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-O 122.081 0.944 . . . . 0.0 109.199 176.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -108.28 146.65 32.59 Favored 'General case' 0 N--CA 1.418 -2.04 0 CA-C-N 114.675 -1.148 . . . . 0.0 108.825 177.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 44.6 t -86.15 169.21 13.3 Favored 'General case' 0 C--N 1.288 -2.081 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 171.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.425 HH21 ' ND2' ' A' ' 46' ' ' ASN . 11.3 tpt180 -58.77 -35.18 72.36 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 177.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 23.2 t-80 -61.61 -40.17 93.88 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 113.487 -1.688 . . . . 0.0 110.26 178.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -80.97 -49.89 10.39 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.522 -172.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.405 ' O ' ' HD2' ' A' ' 80' ' ' PHE . . . -59.31 -48.99 79.55 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.136 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.628 ' O ' ' HG3' ' A' ' 81' ' ' LYS . 18.3 mt-10 -65.16 -34.31 78.09 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 70.2 ttt180 -69.32 -28.61 66.39 Favored 'General case' 0 CA--C 1.521 -0.149 0 C-N-CA 119.432 -0.907 . . . . 0.0 109.476 -177.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.0 tt -78.77 -48.55 14.62 Favored 'General case' 0 N--CA 1.422 -1.832 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.569 -178.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.425 ' HA ' HD12 ' A' ' 83' ' ' LEU . 58.1 m-85 -59.54 -21.27 60.01 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-O 121.397 0.617 . . . . 0.0 110.235 177.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.628 ' HG3' ' O ' ' A' ' 77' ' ' GLU . 46.2 mttm -85.35 -26.29 26.59 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 119.208 -0.997 . . . . 0.0 109.097 179.116 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 58.9 tttp -73.34 -38.55 65.72 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 175.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.425 HD12 ' HA ' ' A' ' 80' ' ' PHE . 95.7 mt -58.05 -37.36 74.25 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 177.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.506 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 2.4 pp -75.86 -26.21 17.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 120.232 -0.587 . . . . 0.0 111.626 177.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 51.4 mt -74.97 -49.38 20.19 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.555 175.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -70.49 -24.11 62.79 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.578 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.4 ' HZ1' ' CG ' ' A' ' 90' ' ' ASP 0.288 50.6 mttm 83.23 24.07 0.14 Allowed 'General case' 0 CA--C 1.469 -2.171 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 172.545 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.0 mp -69.74 -39.95 78.6 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.273 0 N-CA-C 105.117 -2.179 . . . . 0.0 105.117 165.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.506 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 4.3 mm? -111.6 150.04 30.63 Favored 'General case' 0 CA--C 1.498 -1.041 0 CA-C-N 114.067 -1.424 . . . . 0.0 108.271 173.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.4 ' CG ' ' HZ1' ' A' ' 87' ' ' LYS . 0.7 OUTLIER -137.77 110.61 7.66 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.595 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.481 ' HA ' ' O ' ' A' ' 104' ' ' TYR . 38.8 mt-10 -95.35 147.52 23.42 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 177.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.548 ' O ' ' HA ' ' A' ' 103' ' ' ALA . 16.8 t70 -97.48 142.8 28.88 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.729 -1.123 . . . . 0.0 108.825 178.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 94.7 mt -103.75 101.72 11.55 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-O 121.971 0.891 . . . . 0.0 110.144 -178.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 72.0 t80 -107.74 115.65 30.54 Favored 'General case' 0 C--N 1.275 -2.658 0 CA-C-N 114.252 -1.34 . . . . 0.0 108.331 -175.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 17.1 tt -121.23 141.69 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.657 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.51 ' C ' ' H ' ' A' ' 98' ' ' ASN . 13.1 m-80 -97.44 -171.79 2.27 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -179.016 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -73.5 21.66 0.08 Allowed 'General case' 0 C--N 1.311 -1.094 0 C-N-CA 125.337 1.455 . . . . 0.0 111.203 178.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.51 ' H ' ' C ' ' A' ' 96' ' ' ASN . 14.8 m120 -119.29 -2.64 10.61 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 108.866 -0.791 . . . . 0.0 108.866 -178.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 59.42 25.45 14.2 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-O 122.832 1.301 . . . . 0.0 110.257 -172.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -100.05 108.65 20.88 Favored 'General case' 0 C--O 1.251 1.132 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 177.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -96.52 142.48 28.54 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 124.051 0.845 . . . . 0.0 111.567 -176.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 10.5 tp -131.44 145.21 35.56 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 174.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.548 ' HA ' ' O ' ' A' ' 92' ' ' ASP . . . -113.5 138.76 49.66 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.575 ' HA ' ' HA ' ' A' ' 44' ' ' THR . 24.8 p90 -134.74 163.47 29.71 Favored 'General case' 0 CA--C 1.496 -1.108 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 176.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 6.7 t -94.83 134.06 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.636 0 N-CA-C 115.112 1.523 . . . . 0.0 115.112 -163.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 68.9 mtm -140.69 168.92 18.65 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 111.422 -2.626 . . . . 0.0 105.14 173.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 7.0 mp -90.77 136.69 32.9 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 -179.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -91.57 -178.58 42.49 Favored Glycine 0 N--CA 1.438 -1.232 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.506 -176.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -70.23 -13.3 62.11 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -176.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.43 ' O ' HG21 ' A' ' 114' ' ' VAL . 46.9 mmtt -93.73 -3.65 51.85 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 178.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -62.01 -29.39 70.23 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.969 0.414 . . . . 0.0 111.223 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.431 ' HA ' ' HG ' ' A' ' 115' ' ' LEU . 0.0 OUTLIER -72.35 -31.96 66.07 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 120.218 -0.593 . . . . 0.0 110.247 179.673 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 9.9 m -72.87 -25.72 61.2 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -178.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.449 ' O ' ' HE2' ' A' ' 16' ' ' LYS . 22.0 t -72.1 -42.91 67.38 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.244 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.681 177.051 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.431 ' HG ' ' HA ' ' A' ' 112' ' ' GLN . 4.6 pp -67.87 -33.73 75.31 Favored 'General case' 0 CA--C 1.51 -0.57 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.969 178.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -71.41 -27.8 63.56 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 172.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 73.49 21.76 79.21 Favored Glycine 0 CA--C 1.495 -1.179 0 CA-C-N 115.333 -0.849 . . . . 0.0 112.36 177.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -97.33 35.51 1.61 Allowed 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 104.95 -2.241 . . . . 0.0 104.95 177.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.425 ' CD1' HG22 ' A' ' 114' ' ' VAL . 0.4 OUTLIER -142.42 124.91 15.7 Favored 'General case' 0 N--CA 1.381 -3.906 0 CA-C-N 113.037 -1.892 . . . . 0.0 107.165 -174.241 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.44 ' HA ' HG22 ' A' ' 12' ' ' THR . 0.2 OUTLIER -129.87 132.84 46.56 Favored 'General case' 0 N--CA 1.393 -3.295 0 N-CA-C 106.795 -1.558 . . . . 0.0 106.795 172.089 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.511 HG21 ' O ' ' A' ' 11' ' ' VAL . 14.0 m -106.51 -178.81 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 C-N-CA 118.528 -1.269 . . . . 0.0 107.924 174.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -129.28 134.07 47.77 Favored 'General case' 0 C--N 1.254 -3.573 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 178.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -107.32 113.54 26.99 Favored 'General case' 0 C--N 1.273 -2.719 0 C-N-CA 118.95 -1.1 . . . . 0.0 110.545 171.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 17.3 ptp -91.63 120.75 32.68 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 113.453 -1.703 . . . . 0.0 108.847 176.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -95.13 -73.29 0.59 Allowed 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.224 -174.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 25.8 m -120.34 70.19 0.88 Allowed 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 179.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 . . . . . 0 C--N 1.296 -1.753 0 N-CA-C 103.923 -2.621 . . . . 0.0 103.923 -172.43 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 48.6 t . . . . . 0 CA--C 1.505 -0.765 0 N-CA-C 106.352 -1.721 . . . . 0.0 106.352 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.6 pttp 54.53 -170.05 0.06 Allowed 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 125.887 1.675 . . . . 0.0 110.713 -175.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.406 ' HB ' ' O ' ' A' ' 5' ' ' ASP . 10.2 p -71.67 132.83 45.13 Favored 'General case' 0 N--CA 1.42 -1.952 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 174.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.0 -21.13 59.31 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.406 ' O ' ' HB ' ' A' ' 3' ' ' THR . 1.1 p-10 -151.43 149.72 29.6 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 114.581 -1.19 . . . . 0.0 109.487 -176.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 40.9 m-85 -97.6 -11.88 23.12 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 174.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . 0.388 64.4 mttm 97.96 172.32 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.68 0 N-CA-C 116.569 2.063 . . . . 0.0 116.569 169.158 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.4 m -102.02 143.53 31.75 Favored 'General case' 0 N--CA 1.41 -2.434 0 CA-C-N 113.949 -1.478 . . . . 0.0 112.676 -171.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 54.6 ttt180 -99.68 113.95 26.74 Favored 'General case' 0 N--CA 1.394 -3.253 0 N-CA-C 104.037 -2.579 . . . . 0.0 104.037 166.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -77.57 98.78 5.5 Favored 'General case' 0 CA--C 1.488 -1.434 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -174.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 30.4 m -99.94 65.58 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.275 -2.648 0 CA-C-O 122.417 1.103 . . . . 0.0 112.964 -173.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.479 ' O ' ' HB2' ' A' ' 16' ' ' LYS . 2.1 t -111.53 -37.74 5.13 Favored 'General case' 0 C--N 1.263 -3.188 0 C-N-CA 119.495 -0.882 . . . . 0.0 109.001 169.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -84.83 -20.64 30.6 Favored 'General case' 0 CA--C 1.496 -1.1 0 CA-C-O 120.989 0.423 . . . . 0.0 111.221 174.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.447 ' CG ' ' HZ2' ' A' ' 67' ' ' LYS . 8.0 t70 -76.24 -44.49 37.26 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 105.425 -2.065 . . . . 0.0 105.425 175.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.558 ' O ' ' HB ' ' A' ' 18' ' ' ILE . 4.9 t -64.35 -21.88 30.01 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.48 0 CA-C-N 112.938 -1.937 . . . . 0.0 111.167 174.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.614 ' HE2' ' O ' ' A' ' 114' ' ' VAL . 34.2 ttmt -75.09 -35.55 61.77 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 122.016 -0.427 . . . . 0.0 110.568 179.112 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 68.9 p -67.39 -31.25 71.34 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 119.358 -0.937 . . . . 0.0 108.883 173.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.558 ' HB ' ' O ' ' A' ' 15' ' ' VAL . 36.0 mt -63.62 -48.13 88.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.757 173.219 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.531 HG21 ' O ' ' A' ' 15' ' ' VAL . 97.2 t -56.96 -47.77 82.76 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.774 0 C-N-CA 123.289 0.636 . . . . 0.0 109.868 176.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.636 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 0.9 OUTLIER -52.61 -53.71 43.07 Favored 'General case' 0 C--O 1.22 -0.49 0 O-C-N 123.898 0.749 . . . . 0.0 109.332 176.838 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -52.94 -57.14 11.31 Favored 'General case' 0 N--CA 1.448 -0.545 0 O-C-N 124.424 1.078 . . . . 0.0 112.223 -178.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 27.1 m -67.78 -38.78 80.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.779 -177.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -60.33 -50.28 74.23 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 176.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.636 ' HG2' ' O ' ' A' ' 20' ' ' ARG . 10.3 pt-20 -79.6 -22.16 44.05 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.208 -0.597 . . . . 0.0 112.083 -178.095 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.535 ' CD2' ' HG3' ' A' ' 24' ' ' GLU . 98.3 m-70 -106.62 22.07 16.45 Favored 'General case' 0 CA--C 1.49 -1.345 0 C-N-CA 118.987 -1.085 . . . . 0.0 112.109 -176.357 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 34.0 t -62.39 -31.42 72.1 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 171.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 31.1 m -93.22 116.8 29.37 Favored 'General case' 0 N--CA 1.41 -2.439 0 N-CA-C 104.917 -2.253 . . . . 0.0 104.917 168.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 46.9 m -65.88 32.12 0.02 OUTLIER 'General case' 0 CA--C 1.564 1.511 0 N-CA-C 115.785 1.772 . . . . 0.0 115.785 -172.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -75.34 127.68 33.69 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 176.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 102.92 -26.95 22.27 Favored Glycine 0 N--CA 1.438 -1.23 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 -176.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 88.3 mtp -79.49 6.2 10.93 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.837 0.827 . . . . 0.0 111.085 -177.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 32.0 ptt85 -91.36 -14.67 30.29 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.61 175.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -92.76 79.22 4.75 Favored 'General case' 0 C--O 1.247 0.928 0 CA-C-O 121.727 0.775 . . . . 0.0 109.485 -177.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.506 HG12 ' H ' ' A' ' 36' ' ' HIS . 14.6 tt -177.61 156.85 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 CA-C-N 113.77 -1.559 . . . . 0.0 106.857 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.552 ' HA ' ' NZ ' ' A' ' 35' ' ' LYS . 2.8 tpmp? -94.77 -21.03 19.0 Favored 'General case' 0 N--CA 1.422 -1.83 0 C-N-CA 118.593 -1.243 . . . . 0.0 112.222 -178.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.506 ' H ' HG12 ' A' ' 34' ' ' ILE . 63.8 t-80 -56.28 130.66 45.42 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 123.888 0.743 . . . . 0.0 110.223 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 35.7 m -63.45 167.37 0.93 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.884 0 O-C-N 123.877 0.735 . . . . 0.0 112.876 -178.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 122.4 132.88 4.15 Favored Glycine 0 N--CA 1.429 -1.829 0 N-CA-C 110.351 -1.1 . . . . 0.0 110.351 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -79.88 7.76 4.42 Favored 'Trans proline' 0 CA--C 1.535 0.535 0 C-N-CA 122.667 2.245 . . . . 0.0 112.823 -177.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.3 m 65.02 -156.56 0.29 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.608 0.763 . . . . 0.0 109.221 -177.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.05 -38.99 2.21 Favored Glycine 0 CA--C 1.526 0.737 0 CA-C-N 118.508 0.594 . . . . 0.0 112.942 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.2 mtt180 -88.04 110.83 20.92 Favored 'General case' 0 N--CA 1.425 -1.691 0 O-C-N 122.412 -0.463 . . . . 0.0 110.115 178.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -107.58 107.48 18.33 Favored 'General case' 0 CA--C 1.481 -1.699 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 179.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 80.2 p -120.94 157.13 30.57 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -177.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.413 ' O ' HG23 ' A' ' 49' ' ' VAL . 22.0 ptm -50.13 -39.59 43.63 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.353 0.661 . . . . 0.0 112.63 -178.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -68.71 -39.29 80.52 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.156 -172.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 23.4 mmt -67.34 -38.6 85.11 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.467 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 78.7 mt -63.35 -41.95 98.89 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.247 -178.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 45' ' ' MET . 69.6 t -66.01 -45.16 91.55 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.058 0 C-N-CA 123.68 0.792 . . . . 0.0 110.679 179.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.598 ' OD2' ' HB3' ' A' ' 55' ' ' SER . 4.4 t70 -61.92 -36.78 82.39 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 114.678 -1.146 . . . . 0.0 109.626 -177.148 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.659 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 75.4 mt -69.54 -50.21 52.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.568 174.432 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.499 ' CE2' ' HA3' ' A' ' 68' ' ' GLY . 50.4 t80 -50.86 -41.21 57.74 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.446 1.098 . . . . 0.0 111.775 179.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.9 mp -80.17 -30.51 38.83 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 177.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 99.2 33.06 5.57 Favored Glycine 0 C--O 1.248 1.002 0 C-N-CA 120.166 -1.016 . . . . 0.0 112.725 -179.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.598 ' HB3' ' OD2' ' A' ' 50' ' ' ASP . 32.0 t -86.8 -176.45 5.78 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 123.291 0.636 . . . . 0.0 111.15 -176.06 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.14 9.17 17.12 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -176.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 16.9 m -89.44 -17.66 28.29 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 175.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.404 ' HB1' ' CG1' ' A' ' 51' ' ' ILE . . . -50.85 173.8 0.02 OUTLIER 'General case' 0 N--CA 1.432 -1.329 0 C-N-CA 128.861 2.865 . . . . 0.0 113.476 176.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.418 ' HZ2' ' HB3' ' A' ' 59' ' ' LYS . 4.0 mmmp? -116.87 11.02 14.31 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 -179.138 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.5 tt -158.65 164.82 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 N-CA-C 104.795 -2.298 . . . . 0.0 104.795 175.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -125.74 21.96 7.58 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 119.021 0.828 . . . . 0.0 110.42 177.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 43.8 m -152.24 146.95 25.83 Favored 'General case' 0 C--N 1.322 -0.63 0 O-C-N 122.002 -0.436 . . . . 0.0 110.037 -178.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.585 ' C ' ' H ' ' A' ' 65' ' ' PHE . . . 82.15 111.37 0.42 Allowed Glycine 0 C--O 1.212 -1.28 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.498 HD11 ' HG3' ' A' ' 67' ' ' LYS . 3.4 mm 70.25 -18.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 CA-C-O 121.971 0.891 . . . . 0.0 111.64 -176.269 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.659 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 3.5 t80 -65.46 104.45 0.99 Allowed 'General case' 0 N--CA 1.399 -2.986 0 C-N-CA 125.318 1.447 . . . . 0.0 109.202 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 102.93 0.36 48.52 Favored Glycine 0 N--CA 1.434 -1.46 0 C-N-CA 120.814 -0.707 . . . . 0.0 111.713 -178.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.498 ' HG3' HD11 ' A' ' 64' ' ' ILE . 2.9 mmmp? -67.35 -19.48 65.44 Favored 'General case' 0 C--O 1.252 1.189 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.499 ' HA3' ' CE2' ' A' ' 52' ' ' PHE . . . -148.81 49.76 0.58 Allowed Glycine 0 C--O 1.207 -1.544 0 C-N-CA 120.462 -0.875 . . . . 0.0 111.644 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 16.0 m -70.6 0.78 6.18 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -178.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -100.37 -5.34 27.44 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-O 121.094 0.473 . . . . 0.0 110.303 178.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.428 ' HA ' ' HB3' ' A' ' 127' ' ' GLU . 28.9 m-85 -80.41 144.11 32.92 Favored 'General case' 0 N--CA 1.428 -1.547 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.49 177.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 34.5 t -77.33 134.68 38.44 Favored 'General case' 0 N--CA 1.398 -3.029 0 N-CA-C 102.928 -2.989 . . . . 0.0 102.928 167.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.531 ' O ' ' HG3' ' A' ' 77' ' ' GLU . 10.6 ptm180 -52.12 -38.64 58.1 Favored 'General case' 0 C--O 1.202 -1.43 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -173.01 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.563 ' HA ' ' OE1' ' A' ' 77' ' ' GLU . 32.4 t-80 -70.86 -24.31 62.49 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 120.978 0.418 . . . . 0.0 111.475 -175.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -81.69 -38.2 26.21 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.29 -40.21 96.73 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 174.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.656 ' O ' ' HG2' ' A' ' 81' ' ' LYS . 80.0 mt-10 -58.15 -37.8 75.37 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.235 -0.439 . . . . 0.0 109.902 174.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 18.4 mmm180 -71.68 -23.13 61.6 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.372 -178.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.4 tt -76.38 -45.36 32.2 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 179.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -63.87 -19.53 65.13 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.432 0.634 . . . . 0.0 109.406 176.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.656 ' HG2' ' O ' ' A' ' 77' ' ' GLU . 31.3 mmmt -81.12 -28.43 35.14 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.379 176.154 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.428 ' HG2' ' OD2' ' A' ' 86' ' ' ASP . 58.3 tttm -74.48 -43.04 57.88 Favored 'General case' 0 C--O 1.193 -1.878 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 179.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.3 mt -58.64 -35.2 72.13 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 178.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.47 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 2.5 pp -74.67 -26.3 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.061 177.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.9 tt -76.85 -45.19 29.33 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 175.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.491 ' O ' ' HB2' ' A' ' 87' ' ' LYS . 70.9 m-20 -66.1 -29.62 69.98 Favored 'General case' 0 C--O 1.259 1.587 0 C-N-CA 123.491 0.716 . . . . 0.0 109.944 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.491 ' HB2' ' O ' ' A' ' 86' ' ' ASP . 4.4 mptp? 85.6 21.65 0.09 Allowed 'General case' 0 CA--C 1.478 -1.821 0 C-N-CA 125.252 1.421 . . . . 0.0 113.378 179.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 1.8 mp -68.62 -42.22 83.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 N-CA-C 104.8 -2.296 . . . . 0.0 104.8 164.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.47 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 90.7 mt -114.3 164.22 14.21 Favored 'General case' 0 N--CA 1.418 -2.068 0 CA-C-N 113.829 -1.532 . . . . 0.0 109.141 174.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.467 ' CG ' ' HZ2' ' A' ' 87' ' ' LYS . 0.2 OUTLIER -144.44 117.79 9.04 Favored 'General case' 0 C--N 1.283 -2.305 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 172.762 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -95.02 144.38 25.74 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-O 121.598 0.713 . . . . 0.0 112.463 -178.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.464 ' O ' ' HA ' ' A' ' 103' ' ' ALA . 16.6 t70 -100.0 133.24 44.68 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 114.195 -1.366 . . . . 0.0 109.055 178.422 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 98.3 mt -105.64 105.62 15.75 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 121.579 0.704 . . . . 0.0 109.429 -179.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -122.36 135.42 54.7 Favored 'General case' 0 C--N 1.28 -2.427 0 CA-C-N 114.561 -1.2 . . . . 0.0 109.06 -172.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.477 HG13 ' C ' ' A' ' 100' ' ' GLN . 16.6 tt -131.23 141.34 46.24 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.296 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 174.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.472 ' C ' ' H ' ' A' ' 98' ' ' ASN . 3.4 p-10 -96.11 172.81 7.75 Favored 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 176.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -66.67 17.97 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 -173.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.472 ' H ' ' C ' ' A' ' 96' ' ' ASN . 15.7 m120 -118.15 5.57 11.99 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.427 ' HA ' HD12 ' A' ' 95' ' ' ILE . 26.7 t70 65.97 26.47 10.93 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-O 123.531 1.634 . . . . 0.0 109.353 -177.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.477 ' C ' HG13 ' A' ' 95' ' ' ILE . 27.1 mt-30 -90.29 99.57 12.57 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.918 -1.037 . . . . 0.0 108.548 176.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -86.2 133.87 33.82 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.627 -178.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 16.4 tt -141.99 143.79 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.822 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 178.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.464 ' HA ' ' O ' ' A' ' 92' ' ' ASP . . . -112.08 119.96 40.22 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 -178.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -97.38 150.58 20.84 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 52.4 t -103.74 128.86 56.62 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 CA-C-O 121.759 0.79 . . . . 0.0 112.143 -178.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 58.3 mtt -128.28 178.82 5.99 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-N 113.908 -1.496 . . . . 0.0 107.792 177.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -99.52 137.49 37.94 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -178.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -98.21 -166.51 31.37 Favored Glycine 0 N--CA 1.439 -1.118 0 C-N-CA 120.799 -0.715 . . . . 0.0 113.158 -175.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 32.7 p30 -75.28 -2.85 30.06 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 114.147 1.165 . . . . 0.0 114.147 -175.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.502 ' O ' HG22 ' A' ' 114' ' ' VAL . 41.4 mmtm -101.98 -6.34 23.56 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 120.113 -0.635 . . . . 0.0 110.357 177.132 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -54.31 -43.77 71.42 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 113.623 0.972 . . . . 0.0 113.623 -172.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -73.44 -29.48 62.58 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.626 0.727 . . . . 0.0 109.701 -178.145 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 4.4 m -73.05 -26.19 61.2 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.585 -179.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.614 ' O ' ' HE2' ' A' ' 16' ' ' LYS . 24.9 t -68.41 -44.05 83.67 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.783 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 174.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 84.7 mt -62.39 -39.79 94.35 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.113 178.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -72.84 -19.37 61.33 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.059 175.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.456 ' C ' ' H ' ' A' ' 119' ' ' LEU . . . 60.87 30.42 72.98 Favored Glycine 0 C--O 1.212 -1.226 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.127 -177.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -95.99 22.58 7.3 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 105.862 -1.903 . . . . 0.0 105.862 174.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.456 ' H ' ' C ' ' A' ' 117' ' ' GLY . 0.8 OUTLIER -141.99 122.65 14.24 Favored 'General case' 0 N--CA 1.385 -3.676 0 CA-C-N 112.229 -2.26 . . . . 0.0 105.96 -175.869 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.533 ' HB2' ' HZ2' ' A' ' 120' ' ' LYS . 0.1 OUTLIER -131.08 127.6 38.5 Favored 'General case' 0 C--N 1.283 -2.308 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 171.549 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 5.1 m -119.07 173.28 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.261 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 177.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -123.31 161.36 24.79 Favored 'General case' 0 C--N 1.265 -3.076 0 CA-C-N 114.971 -1.013 . . . . 0.0 112.258 -171.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -141.51 130.83 23.61 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 104.93 -2.248 . . . . 0.0 104.93 164.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 25.3 mmt -107.9 143.84 35.96 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 116.229 1.937 . . . . 0.0 116.229 -163.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 72.21 -58.61 0.58 Allowed 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 116.64 2.089 . . . . 0.0 116.64 165.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 11.1 t -148.84 163.39 37.56 Favored 'General case' 0 C--N 1.289 -2.03 0 C-N-CA 120.536 -0.466 . . . . 0.0 110.091 -175.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.428 ' HB3' ' HA ' ' A' ' 71' ' ' TYR . 63.6 mt-10 . . . . . 0 N--CA 1.416 -2.165 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 175.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 41.4 m . . . . . 0 CA--C 1.514 -0.416 0 N-CA-C 107.599 -1.259 . . . . 0.0 107.599 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -62.26 -41.99 98.95 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 175.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.8 p -88.76 152.1 21.99 Favored 'General case' 0 N--CA 1.412 -2.344 0 CA-C-N 114.522 -1.217 . . . . 0.0 109.406 175.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -129.29 142.69 50.76 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 177.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -127.4 159.4 34.59 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 124.065 0.853 . . . . 0.0 108.9 -178.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -159.38 40.95 0.21 Allowed 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 105.128 -2.175 . . . . 0.0 105.128 -179.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 25.1 tptp -53.09 124.03 13.27 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 114.972 -1.013 . . . . 0.0 113.167 -174.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.57 178.37 7.32 Favored 'General case' 0 N--CA 1.422 -1.861 0 CA-C-N 114.862 -1.063 . . . . 0.0 113.037 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.535 ' HB2' ' O ' ' A' ' 123' ' ' PHE . 41.9 mtt85 -94.42 117.87 30.77 Favored 'General case' 0 N--CA 1.422 -1.86 0 N-CA-C 106.239 -1.764 . . . . 0.0 106.239 174.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -78.03 89.4 4.17 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 10.6 m -79.67 89.47 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 CA-C-O 122.69 1.233 . . . . 0.0 110.36 -178.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.435 ' CG2' ' HA ' ' A' ' 120' ' ' LYS . 34.3 p -115.3 -33.58 5.26 Favored 'General case' 0 C--N 1.261 -3.262 0 CA-C-O 122.092 0.949 . . . . 0.0 109.378 177.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -75.62 -40.64 56.0 Favored 'General case' 0 N--CA 1.413 -2.285 0 C-N-CA 125.967 1.707 . . . . 0.0 107.894 178.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.48 ' O ' ' HB3' ' A' ' 17' ' ' SER . 16.5 t70 -74.0 -39.78 63.39 Favored 'General case' 0 CA--C 1.495 -1.164 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 74.4 t -67.6 -32.99 59.32 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.691 177.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.557 ' HE2' ' O ' ' A' ' 114' ' ' VAL . 3.3 tppp? -66.85 -43.49 83.51 Favored 'General case' 0 C--O 1.245 0.833 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 174.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.48 ' HB3' ' O ' ' A' ' 14' ' ' ASP . 32.6 t -57.09 -47.95 79.78 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 114.092 -1.413 . . . . 0.0 108.718 174.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 28.2 mt -51.36 -42.86 28.47 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.736 0 C-N-CA 124.094 0.958 . . . . 0.0 111.746 177.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.425 ' HA ' HG21 ' A' ' 22' ' ' VAL . 72.9 t -59.62 -45.56 94.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 179.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 31.5 ttt180 -56.72 -45.33 81.98 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.788 0.804 . . . . 0.0 109.401 173.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.751 ' CG ' ' HB ' ' A' ' 64' ' ' ILE . 47.4 m-85 -68.63 -38.25 80.36 Favored 'General case' 0 N--CA 1.422 -1.835 0 N-CA-C 115.186 1.55 . . . . 0.0 115.186 -175.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.562 ' HA ' ' ND1' ' A' ' 25' ' ' HIS . 20.1 m -69.69 -36.62 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.859 0 C-N-CA 119.99 -0.684 . . . . 0.0 109.892 176.322 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.409 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 14.8 mm100 -60.63 -46.79 88.95 Favored 'General case' 0 CA--C 1.55 0.956 0 O-C-N 123.83 0.706 . . . . 0.0 111.318 172.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.476 ' OE2' ' HB3' ' A' ' 62' ' ' SER . 7.6 pt-20 -78.94 0.73 26.3 Favored 'General case' 0 C--O 1.247 0.955 0 O-C-N 121.707 -0.621 . . . . 0.0 112.473 178.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.562 ' ND1' ' HA ' ' A' ' 22' ' ' VAL . 28.3 m170 -72.21 -17.25 61.93 Favored 'General case' 0 C--O 1.215 -0.758 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 172.363 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 18.7 m -62.6 -26.85 68.82 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 123.951 0.782 . . . . 0.0 110.108 176.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 16.0 m -89.72 85.04 6.34 Favored 'General case' 0 C--O 1.258 1.551 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 172.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.46 ' OG ' HG12 ' A' ' 60' ' ' ILE . 33.1 t -104.55 -150.33 0.42 Allowed 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 114.108 -1.405 . . . . 0.0 109.708 -171.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 69.5 27.06 4.98 Favored 'General case' 0 C--O 1.244 0.812 0 C-N-CA 124.865 1.266 . . . . 0.0 109.893 179.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -89.14 58.58 3.92 Favored Glycine 0 N--CA 1.429 -1.828 0 CA-C-N 114.65 -1.159 . . . . 0.0 110.824 -178.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 65.9 mtt -83.9 -73.04 0.43 Allowed 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 120.762 0.315 . . . . 0.0 110.492 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 17.0 ptp180 -91.83 2.13 56.71 Favored 'General case' 0 C--O 1.213 -0.848 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -177.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -150.55 148.21 28.4 Favored 'General case' 0 CA--C 1.502 -0.896 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 -179.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.492 ' HA ' ' HG3' ' A' ' 61' ' ' GLN . 1.7 mp -74.69 92.68 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 CA-C-O 121.788 0.804 . . . . 0.0 111.442 179.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.432 ' HB2' ' O ' ' A' ' 61' ' ' GLN . 24.0 ttmm 65.75 176.68 0.21 Allowed 'General case' 0 CA--C 1.563 1.454 0 CA-C-N 113.898 -1.501 . . . . 0.0 111.315 176.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.41 ' H ' ' HG2' ' A' ' 35' ' ' LYS . 22.8 p-80 172.44 178.92 0.08 Allowed 'General case' 0 CA--C 1.501 -0.939 0 C-N-CA 127.177 2.191 . . . . 0.0 105.967 172.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 16.2 m -70.97 96.77 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 CA-C-O 121.667 0.746 . . . . 0.0 110.285 175.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -156.99 95.87 0.15 Allowed Glycine 0 N--CA 1.429 -1.789 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -75.54 107.3 2.44 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 122.456 2.104 . . . . 0.0 110.98 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 22.9 m -150.95 113.55 4.67 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -103.11 -143.92 13.47 Favored Glycine 0 N--CA 1.441 -1.008 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 179.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.408 ' HA ' ' NE ' ' A' ' 42' ' ' ARG . 1.9 mmp_? 69.09 69.33 0.27 Allowed 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 122.205 1.002 . . . . 0.0 111.462 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.483 ' CD1' HD23 ' A' ' 48' ' ' LEU . 2.9 p90 -109.21 128.56 55.14 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 114.526 -1.215 . . . . 0.0 111.03 -179.103 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 63.2 p -86.33 155.99 20.4 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 178.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.507 ' O ' HG21 ' A' ' 49' ' ' VAL . 19.2 ptt? -48.64 -41.81 32.37 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 123.483 0.49 . . . . 0.0 111.905 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.443 ' N ' ' HG3' ' A' ' 45' ' ' MET . 14.8 m120 -67.45 -31.96 72.49 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.584 -175.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' MET . . . . . 0.496 ' O ' HD11 ' A' ' 51' ' ' ILE . 26.3 mmt -74.88 -36.33 62.27 Favored 'General case' 0 C--O 1.203 -1.344 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.483 HD23 ' CD1' ' A' ' 43' ' ' PHE . 87.1 mt -60.75 -38.4 85.05 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.373 179.221 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.507 HG21 ' O ' ' A' ' 45' ' ' MET . 94.1 t -65.19 -41.59 92.03 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.203 0 C-N-CA 124.395 1.078 . . . . 0.0 110.861 178.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -55.38 -46.26 76.55 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.309 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.496 HD11 ' O ' ' A' ' 47' ' ' MET . 1.3 mp -70.07 -40.36 78.32 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.103 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.227 177.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -57.84 -42.29 84.13 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.735 0.814 . . . . 0.0 111.808 -175.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.9 mp -82.32 -20.17 37.9 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 178.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 96.14 32.63 6.65 Favored Glycine 0 C--N 1.313 -0.731 0 C-N-CA 120.126 -1.035 . . . . 0.0 112.257 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 31.1 t -76.55 137.41 39.55 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 177.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.509 ' HD3' ' O ' ' A' ' 56' ' ' LYS . 2.4 tmtm? -84.31 -0.87 54.14 Favored 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 119.264 -0.974 . . . . 0.0 109.537 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.0 m -77.86 -5.95 52.6 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 176.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.03 145.45 53.08 Favored 'General case' 0 N--CA 1.425 -1.721 0 C-N-CA 125.787 1.635 . . . . 0.0 111.173 175.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.515 ' N ' ' HD2' ' A' ' 59' ' ' LYS . 9.1 mptt -105.23 -1.57 25.17 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.447 -177.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.46 HG12 ' OG ' ' A' ' 28' ' ' SER . 60.6 mt -132.28 122.0 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.108 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -177.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.492 ' HG3' ' HA ' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -110.01 94.37 4.98 Favored 'General case' 0 C--N 1.277 -2.585 0 C-N-CA 118.313 -1.355 . . . . 0.0 108.707 176.901 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.476 ' HB3' ' OE2' ' A' ' 24' ' ' GLU . 73.5 m -104.25 177.79 4.74 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.843 176.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -75.32 7.63 22.89 Favored Glycine 0 N--CA 1.482 1.712 0 C-N-CA 121.068 -0.587 . . . . 0.0 113.979 -176.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.751 ' HB ' ' CG ' ' A' ' 21' ' ' PHE . 6.4 tt -100.74 3.1 10.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -69.52 95.97 0.88 Allowed 'General case' 0 N--CA 1.42 -1.945 0 CA-C-N 114.01 -1.45 . . . . 0.0 110.01 -173.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 102.35 17.22 20.54 Favored Glycine 0 N--CA 1.419 -2.438 0 CA-C-N 114.93 -1.032 . . . . 0.0 112.638 -179.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.493 ' HE2' HG13 ' A' ' 64' ' ' ILE . 33.5 mtmt -67.97 -58.1 5.1 Favored 'General case' 0 C--N 1.353 0.751 0 C-N-CA 117.891 -1.523 . . . . 0.0 110.51 175.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -95.41 47.82 1.92 Allowed Glycine 0 N--CA 1.436 -1.353 0 CA-C-N 115.154 -0.93 . . . . 0.0 113.356 -170.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 19.6 m -71.84 -4.31 27.26 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -178.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -100.91 2.93 41.33 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 121.682 0.753 . . . . 0.0 111.036 178.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.435 ' CD1' ' HG3' ' A' ' 125' ' ' GLU . 24.0 m-85 -88.44 142.57 27.61 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 174.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 42.5 t -71.08 148.5 47.44 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 105.331 -2.1 . . . . 0.0 105.331 168.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 35.1 ttt-85 -56.46 -42.92 79.0 Favored 'General case' 0 C--O 1.217 -0.637 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.945 -174.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.581 ' O ' ' HG2' ' A' ' 78' ' ' ARG . 90.8 m-70 -75.97 -20.3 58.02 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.476 -0.489 . . . . 0.0 111.274 -177.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -73.17 -44.14 60.37 Favored 'General case' 0 CA--C 1.501 -0.913 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 176.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.447 ' O ' ' HB3' ' A' ' 79' ' ' LEU . . . -61.69 -36.51 81.11 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 175.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -61.13 -32.93 72.62 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.639 174.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.581 ' HG2' ' O ' ' A' ' 74' ' ' HIS . 31.7 mmt180 -79.36 -25.93 42.13 Favored 'General case' 0 CA--C 1.496 -1.114 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -176.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.447 ' HB3' ' O ' ' A' ' 76' ' ' ALA . 14.5 tp -60.22 -61.24 2.74 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 124.154 0.909 . . . . 0.0 108.928 177.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -60.6 -27.72 67.95 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.452 -178.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.502 ' O ' HG13 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -69.18 -30.07 68.19 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.061 175.476 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 20.2 ttpp -80.88 -34.93 33.24 Favored 'General case' 0 C--O 1.203 -1.394 0 C-N-CA 117.294 -1.762 . . . . 0.0 107.713 -178.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.487 ' HB3' ' HG ' ' A' ' 89' ' ' LEU . 9.7 mp -60.11 -29.04 68.34 Favored 'General case' 0 C--O 1.211 -0.95 0 CA-C-N 116.24 -0.436 . . . . 0.0 112.015 176.235 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.502 HG13 ' O ' ' A' ' 81' ' ' LYS . 2.1 pp -82.93 -22.14 8.89 Favored 'Isoleucine or valine' 0 C--O 1.244 0.813 0 C-N-CA 120.028 -0.669 . . . . 0.0 111.278 178.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.5 tt -75.97 -49.83 16.58 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 174.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -65.38 -36.1 82.95 Favored 'General case' 0 C--O 1.253 1.281 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 178.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.481 ' HD3' HD22 ' A' ' 109' ' ' ASN 0.31 59.4 mttm 85.0 29.69 0.05 Allowed 'General case' 0 CA--C 1.464 -2.328 0 C-N-CA 125.954 1.702 . . . . 0.0 114.952 176.822 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 1.8 mp -69.04 -31.48 50.49 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 105.012 -2.218 . . . . 0.0 105.012 163.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.487 ' HG ' ' HB3' ' A' ' 83' ' ' LEU . 44.7 mt -116.01 154.4 29.94 Favored 'General case' 0 N--CA 1.425 -1.676 0 CA-C-N 113.966 -1.47 . . . . 0.0 108.896 173.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -139.81 117.68 11.71 Favored 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 174.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -94.54 145.32 24.89 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.471 0.653 . . . . 0.0 112.133 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -111.08 159.36 17.87 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-N 114.523 -1.217 . . . . 0.0 108.712 176.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 87.6 mt -117.92 145.37 44.71 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -170.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -141.51 163.06 33.94 Favored 'General case' 0 CA--C 1.479 -1.775 0 N-CA-C 105.412 -2.07 . . . . 0.0 105.412 173.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 19.0 tt -132.68 147.07 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.268 0 N-CA-C 106.811 -1.552 . . . . 0.0 106.811 171.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 47.0 p30 -92.41 -174.32 3.66 Favored 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 120.22 -0.592 . . . . 0.0 110.515 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -75.97 5.53 6.43 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 123.009 0.524 . . . . 0.0 111.973 -177.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -108.19 3.01 23.24 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 29.3 t70 66.84 26.73 9.27 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-O 123.547 1.641 . . . . 0.0 108.9 -176.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -101.13 110.62 22.66 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 114.8 -1.091 . . . . 0.0 108.507 177.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.7 140.78 51.53 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.513 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 10.5 tp -134.52 143.44 37.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -117.65 132.69 56.46 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.675 -178.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -108.47 153.0 23.96 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 55.5 t -97.6 137.87 24.02 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 CA-C-O 122.103 0.954 . . . . 0.0 112.964 -174.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 16.5 mmt -134.55 177.98 7.35 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 112.798 -2.001 . . . . 0.0 107.427 174.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 7.3 mp -92.03 142.32 27.66 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -94.97 -176.89 38.0 Favored Glycine 0 N--CA 1.414 -2.809 0 C-N-CA 119.991 -1.099 . . . . 0.0 114.778 -172.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.481 HD22 ' HD3' ' A' ' 87' ' ' LYS . 6.1 p30 -71.13 -11.37 60.91 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 114.075 -1.062 . . . . 0.0 112.404 -178.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.548 ' O ' HG22 ' A' ' 114' ' ' VAL . 40.2 mmtm -103.58 13.3 33.62 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 177.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.515 ' O ' ' HG ' ' A' ' 115' ' ' LEU . . . -75.94 -28.77 58.09 Favored 'General case' 0 CA--C 1.494 -1.201 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 -177.128 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 15.8 tp60 -66.16 -39.84 90.08 Favored 'General case' 0 N--CA 1.416 -2.141 0 CA-C-N 112.891 -1.959 . . . . 0.0 109.262 174.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 6.6 m -64.98 -32.7 74.56 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 177.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.557 ' O ' ' HE2' ' A' ' 16' ' ' LYS . 46.2 t -65.69 -46.41 89.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.103 177.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.515 ' HG ' ' O ' ' A' ' 111' ' ' ALA . 68.7 mt -62.59 -37.59 86.81 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.41 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -72.63 -21.35 61.12 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 86.54 12.21 70.02 Favored Glycine 0 C--O 1.215 -1.05 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.627 178.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -96.39 36.86 1.3 Allowed 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 122.299 1.047 . . . . 0.0 109.072 -176.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.704 ' O ' HD12 ' A' ' 119' ' ' LEU . 0.0 OUTLIER -124.7 121.0 33.43 Favored 'General case' 0 N--CA 1.422 -1.857 0 CA-C-O 122.264 1.031 . . . . 0.0 108.34 -176.42 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.435 ' HA ' ' CG2' ' A' ' 12' ' ' THR 0.265 7.7 ptmm? -131.1 85.5 2.27 Favored 'General case' 1 C--N 1.225 -4.805 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 172.676 . . . . . . . . 4 3 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 14.4 m -91.43 170.52 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.053 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 177.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -142.62 153.3 43.35 Favored 'General case' 0 C--N 1.266 -3.025 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 -176.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . 0.535 ' O ' ' HB2' ' A' ' 9' ' ' ARG . 56.2 t80 -158.3 143.21 16.35 Favored 'General case' 0 N--CA 1.432 -1.353 0 C-N-CA 120.869 -0.332 . . . . 0.0 111.118 175.059 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -92.97 98.38 11.32 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-O 121.368 0.604 . . . . 0.0 109.455 176.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.435 ' HG3' ' CD1' ' A' ' 71' ' ' TYR . 29.7 tt0 -45.1 -68.03 0.23 Allowed 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.094 1.358 . . . . 0.0 110.385 178.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 90.1 m -151.12 91.66 1.72 Allowed 'General case' 0 N--CA 1.414 -2.245 0 N-CA-C 103.334 -2.839 . . . . 0.0 103.334 173.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.463 ' C ' HH12 ' A' ' 9' ' ' ARG . 14.3 mm-40 . . . . . 0 C--O 1.252 1.189 0 O-C-N 125.158 1.536 . . . . 0.0 110.144 -171.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 36.8 m . . . . . 0 CA--C 1.505 -0.755 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -155.9 -72.19 0.11 Allowed 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 177.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 15.5 m -87.4 75.88 9.15 Favored 'General case' 0 N--CA 1.421 -1.922 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 175.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.464 ' HG2' ' H ' ' A' ' 5' ' ' ASP . 18.1 ttpp 68.22 -175.89 0.2 Allowed 'General case' 0 CA--C 1.571 1.785 0 CA-C-N 114.368 -1.287 . . . . 0.0 108.853 -177.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.464 ' H ' ' HG2' ' A' ' 4' ' ' LYS . 5.1 p-10 -75.34 167.68 21.45 Favored 'General case' 0 C--O 1.248 0.988 0 C-N-CA 123.723 0.809 . . . . 0.0 109.169 173.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 28.2 p90 -134.82 140.66 46.02 Favored 'General case' 0 N--CA 1.421 -1.892 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 171.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 35.8 mtmm -130.32 81.65 2.02 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 121.683 0.754 . . . . 0.0 110.413 177.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.1 m -124.54 173.4 8.5 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 105.001 -2.222 . . . . 0.0 105.001 178.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -94.75 113.53 25.31 Favored 'General case' 0 N--CA 1.429 -1.524 0 C-N-CA 118.974 -1.09 . . . . 0.0 108.764 178.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.472 ' OD2' ' HB2' ' A' ' 120' ' ' LYS . 0.2 OUTLIER -78.15 90.09 4.26 Favored 'General case' 0 CA--C 1.489 -1.371 0 O-C-N 124.016 0.823 . . . . 0.0 108.829 -179.725 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.6 m -74.58 85.58 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.216 0 CA-C-O 122.713 1.244 . . . . 0.0 109.759 178.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.597 ' O ' ' HE2' ' A' ' 16' ' ' LYS . 29.8 p -107.6 -30.33 8.66 Favored 'General case' 0 C--N 1.258 -3.409 0 C-N-CA 118.459 -1.297 . . . . 0.0 110.933 176.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -76.64 -38.95 53.79 Favored 'General case' 0 C--N 1.29 -1.992 0 C-N-CA 124.69 1.196 . . . . 0.0 108.81 -179.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.526 ' O ' ' HB3' ' A' ' 17' ' ' SER . 23.3 t70 -76.62 -36.92 57.15 Favored 'General case' 0 CA--C 1.491 -1.293 0 CA-C-O 122.178 0.989 . . . . 0.0 109.051 -179.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.503 ' O ' HG22 ' A' ' 19' ' ' VAL . 99.5 t -72.97 -21.46 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.803 0 CA-C-N 114.649 -1.16 . . . . 0.0 110.185 177.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.597 ' HE2' ' O ' ' A' ' 12' ' ' THR . 1.3 tppt? -72.25 -31.81 66.12 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 173.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.526 ' HB3' ' O ' ' A' ' 14' ' ' ASP . 29.0 t -63.84 -38.37 90.83 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 173.108 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.488 ' HB ' ' O ' ' A' ' 15' ' ' VAL . 41.4 mt -62.4 -42.89 97.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.005 173.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.503 HG22 ' O ' ' A' ' 15' ' ' VAL . 82.4 t -57.36 -42.8 81.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.137 177.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 43.7 ttt180 -54.05 -48.07 70.96 Favored 'General case' 0 C--N 1.332 -0.174 0 O-C-N 123.364 0.415 . . . . 0.0 109.892 174.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -65.4 -45.96 81.91 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 115.751 -0.658 . . . . 0.0 112.582 -177.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.436 HG21 ' HA ' ' A' ' 19' ' ' VAL . 29.4 m -65.63 -33.4 63.34 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 C-N-CA 119.907 -0.717 . . . . 0.0 111.045 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 14.7 mm-40 -60.22 -55.6 31.8 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 120.819 0.343 . . . . 0.0 110.806 170.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -75.8 -2.11 28.36 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -177.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -72.98 -8.57 56.28 Favored 'General case' 0 N--CA 1.478 0.94 0 O-C-N 121.92 -0.488 . . . . 0.0 110.72 -179.098 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 9.2 m -78.93 42.79 0.48 Allowed 'General case' 0 CA--C 1.562 1.429 0 C-N-CA 124.98 1.312 . . . . 0.0 111.358 -178.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 14.8 t 65.92 76.43 0.32 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.407 1.483 . . . . 0.0 113.086 179.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.1 p -103.25 100.33 10.22 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 106.568 -1.642 . . . . 0.0 106.568 170.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -92.27 151.27 20.41 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.564 -170.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -164.41 -162.71 15.9 Favored Glycine 0 N--CA 1.427 -1.95 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 177.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 17.5 tmm? -82.8 -62.97 1.46 Allowed 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 177.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.415 ' O ' ' HB3' ' A' ' 61' ' ' GLN . 6.8 tpp180 -80.37 -19.34 46.58 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.097 177.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -75.91 104.18 6.33 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -178.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.479 ' HB ' ' HG3' ' A' ' 61' ' ' GLN . 9.0 tt -46.73 -33.7 2.17 Favored 'Isoleucine or valine' 0 C--O 1.249 1.059 0 C-N-CA 127.203 2.201 . . . . 0.0 114.511 -175.421 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 26.2 mttp -66.44 117.38 8.58 Favored 'General case' 0 C--N 1.313 -0.978 0 C-N-CA 122.624 0.37 . . . . 0.0 110.421 -172.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -136.77 -88.61 0.29 Allowed 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.641 175.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 41.2 t -140.15 -88.52 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 121.185 0.517 . . . . 0.0 111.632 -176.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -106.7 -66.46 0.64 Allowed Glycine 0 C--N 1.309 -0.924 0 CA-C-N 115.748 -0.66 . . . . 0.0 114.33 -173.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -64.85 -57.41 0.29 Allowed 'Trans proline' 0 C--N 1.357 1.013 0 C-N-CA 122.009 1.806 . . . . 0.0 110.959 178.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.1 m -84.58 103.6 13.85 Favored 'General case' 0 N--CA 1.426 -1.643 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 158.67 -120.98 1.01 Allowed Glycine 0 N--CA 1.425 -2.099 0 N-CA-C 108.23 -1.948 . . . . 0.0 108.23 -178.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 14.9 mmt180 62.44 93.83 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.8 0.84 . . . . 0.0 111.448 177.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -107.57 90.57 3.34 Favored 'General case' 0 CA--C 1.481 -1.703 0 CA-C-O 121.64 0.733 . . . . 0.0 109.038 -175.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.545 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 47.1 p -109.98 144.63 38.25 Favored 'General case' 0 N--CA 1.414 -2.266 0 CA-C-N 114.347 -1.297 . . . . 0.0 107.852 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.523 ' O ' HG23 ' A' ' 49' ' ' VAL . 18.7 ptm -44.52 -44.34 8.59 Favored 'General case' 0 C--O 1.206 -1.19 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -176.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.469 ' N ' ' HG3' ' A' ' 45' ' ' MET . 16.7 t-20 -68.5 -37.97 80.56 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 121.049 -0.26 . . . . 0.0 111.595 -172.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 49.6 ttm -72.54 -36.56 68.32 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.597 ' O ' ' HB2' ' A' ' 52' ' ' PHE . 47.9 mt -67.88 -30.24 69.55 Favored 'General case' 0 C--O 1.192 -1.972 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.846 -178.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 45' ' ' MET . 43.0 t -74.19 -44.65 49.26 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.609 0 C-N-CA 123.327 0.651 . . . . 0.0 110.695 179.258 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -54.42 -51.41 65.0 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.728 HD13 ' CD1' ' A' ' 65' ' ' PHE . 6.2 tt -75.97 -24.79 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.28 0 N-CA-C 114.232 1.197 . . . . 0.0 114.232 -178.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.597 ' HB2' ' O ' ' A' ' 48' ' ' LEU . 59.8 t80 -55.44 -43.59 75.55 Favored 'General case' 0 C--N 1.277 -2.579 0 CA-C-N 114.842 -1.072 . . . . 0.0 108.754 175.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.485 ' HA ' ' O ' ' A' ' 68' ' ' GLY . 9.5 mp -77.73 -35.79 51.54 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.892 -1.049 . . . . 0.0 111.551 177.176 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 98.61 53.3 1.23 Allowed Glycine 0 C--N 1.305 -1.185 0 N-CA-C 108.496 -1.841 . . . . 0.0 108.496 -173.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 52.6 p -64.81 -178.89 0.46 Allowed 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 115.564 1.69 . . . . 0.0 115.564 -175.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -81.88 -27.75 33.3 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 113.117 -1.856 . . . . 0.0 110.811 176.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.8 m -88.72 -45.29 9.92 Favored 'General case' 0 C--O 1.252 1.219 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -175.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.623 ' HB3' ' CG1' ' A' ' 51' ' ' ILE . . . -97.91 90.58 4.98 Favored 'General case' 0 N--CA 1.403 -2.781 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 178.274 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 50.2 mttp -72.95 26.57 0.06 Allowed 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 126.285 1.834 . . . . 0.0 114.423 -174.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 81.3 mt 71.0 116.71 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 C-N-CA 125.391 1.476 . . . . 0.0 112.713 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.514 ' H ' ' CB ' ' A' ' 65' ' ' PHE . 17.4 mm-40 -113.34 17.52 18.46 Favored 'General case' 0 N--CA 1.439 -1.005 0 C-N-CA 119.782 -0.767 . . . . 0.0 112.372 -176.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 21.1 m 70.31 107.04 0.06 Allowed 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 124.111 0.964 . . . . 0.0 112.513 -178.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 153.6 -111.06 0.47 Allowed Glycine 0 CA--C 1.498 -0.973 0 N-CA-C 109.056 -1.618 . . . . 0.0 109.056 -179.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.555 ' O ' ' HG3' ' A' ' 67' ' ' LYS . 5.8 tt -91.12 -5.36 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 172.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.728 ' CD1' HD13 ' A' ' 51' ' ' ILE . 9.4 m-85 -70.85 102.04 2.27 Favored 'General case' 0 N--CA 1.41 -2.468 0 CA-C-N 113.353 -1.749 . . . . 0.0 108.959 -174.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.19 9.7 55.36 Favored Glycine 0 N--CA 1.42 -2.423 0 O-C-N 124.338 1.024 . . . . 0.0 112.829 -179.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.603 ' HD3' ' N ' ' A' ' 68' ' ' GLY . 0.1 OUTLIER -65.29 -31.81 73.15 Favored 'General case' 0 C--N 1.357 0.901 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 -178.439 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.603 ' N ' ' HD3' ' A' ' 67' ' ' LYS . . . -160.04 107.71 0.33 Allowed Glycine 0 CA--C 1.498 -1.018 0 C-N-CA 117.808 -2.139 . . . . 0.0 114.991 -175.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.45 ' HB3' ' O ' ' A' ' 53' ' ' LEU . 2.8 p -94.16 10.33 34.26 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 124.406 1.082 . . . . 0.0 110.29 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -91.56 6.31 46.15 Favored 'General case' 0 CA--C 1.506 -0.747 0 CA-C-O 121.965 0.888 . . . . 0.0 110.693 -178.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -99.45 143.12 30.06 Favored 'General case' 0 C--N 1.283 -2.31 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.269 175.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 30.0 t -78.24 139.73 38.9 Favored 'General case' 0 N--CA 1.414 -2.257 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 170.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.442 HH12 ' ND2' ' A' ' 46' ' ' ASN . 32.8 tpt85 -43.52 -56.46 3.64 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.385 1.074 . . . . 0.0 112.223 -175.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -81.32 -12.26 59.08 Favored 'General case' 0 C--N 1.309 -1.169 0 C-N-CA 120.132 -0.627 . . . . 0.0 112.407 -175.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.421 ' ND2' ' HA ' ' A' ' 126' ' ' THR . 19.5 m120 -86.57 -29.72 22.42 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.232 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.423 ' HB2' HG13 ' A' ' 49' ' ' VAL . . . -65.35 -40.04 93.09 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 171.154 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.492 ' HG3' HG12 ' A' ' 49' ' ' VAL . 38.7 mt-10 -60.44 -32.81 71.73 Favored 'General case' 0 C--O 1.246 0.874 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.43 173.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 15.3 tpp180 -68.9 -31.25 70.04 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 -176.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.661 ' HG ' ' CD1' ' A' ' 123' ' ' PHE . 0.4 OUTLIER -73.84 -47.99 34.48 Favored 'General case' 0 CA--C 1.469 -2.165 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.303 -178.571 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -59.2 -21.24 59.17 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-O 121.667 0.746 . . . . 0.0 109.125 176.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.406 ' NZ ' ' SD ' ' A' ' 45' ' ' MET . 30.7 mmtm -87.22 -31.61 20.22 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.78 178.107 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.644 ' HE2' ' O ' ' A' ' 122' ' ' ASP . 19.1 ttpp -71.91 -39.04 69.8 Favored 'General case' 0 C--O 1.194 -1.861 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 175.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.472 ' HB3' ' HG ' ' A' ' 89' ' ' LEU . 0.6 OUTLIER -57.19 -38.7 74.05 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 125.186 1.395 . . . . 0.0 112.16 178.484 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.5 pp -75.68 -23.23 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 119.76 -0.776 . . . . 0.0 111.525 177.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 50.2 mt -77.93 -41.83 35.06 Favored 'General case' 0 N--CA 1.45 -0.434 0 O-C-N 123.425 0.453 . . . . 0.0 110.597 173.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -65.2 -29.12 69.91 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? 84.9 15.71 0.18 Allowed 'General case' 0 CA--C 1.477 -1.859 0 C-N-CA 125.154 1.382 . . . . 0.0 112.77 175.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.431 HG23 HG21 ' A' ' 114' ' ' VAL . 1.8 mp -67.96 -38.44 79.98 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.794 0 N-CA-C 106.349 -1.722 . . . . 0.0 106.349 167.351 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.472 ' HG ' ' HB3' ' A' ' 83' ' ' LEU . 30.3 mt -109.03 151.01 26.93 Favored 'General case' 0 N--CA 1.414 -2.261 0 CA-C-N 114.4 -1.273 . . . . 0.0 111.003 177.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.409 ' O ' ' HB2' ' A' ' 106' ' ' MET . 15.6 m-20 -143.85 118.24 9.65 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 175.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -94.03 155.21 17.24 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 121.052 0.454 . . . . 0.0 112.187 -176.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.579 ' O ' ' HA ' ' A' ' 103' ' ' ALA . 13.4 m-20 -97.77 138.08 35.68 Favored 'General case' 0 CA--C 1.497 -1.059 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 91.5 mt -106.94 116.76 32.49 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 121.482 0.658 . . . . 0.0 111.168 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -125.83 108.9 11.92 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.415 HG13 ' C ' ' A' ' 100' ' ' GLN . 14.6 tt -112.04 148.94 14.83 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.381 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -177.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -103.69 -175.54 2.83 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -74.53 17.9 0.18 Allowed 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -177.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -118.45 6.01 11.77 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 177.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.408 ' HA ' HD12 ' A' ' 95' ' ' ILE . 6.1 m-20 62.18 28.28 16.98 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 122.299 1.047 . . . . 0.0 111.264 -176.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.415 ' C ' HG13 ' A' ' 95' ' ' ILE . 22.7 mt-30 -93.36 103.03 15.29 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 176.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -83.95 116.05 22.61 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.602 -177.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 4.3 mm -100.01 131.99 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.388 -3.535 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 176.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.579 ' HA ' ' O ' ' A' ' 92' ' ' ASP . . . -113.66 124.51 52.49 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.682 -178.261 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -97.06 155.65 16.71 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 42.2 t -100.55 120.89 50.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -175.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.409 ' HB2' ' O ' ' A' ' 90' ' ' ASP . 25.9 mmt -133.05 -173.04 3.09 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 113.369 -1.741 . . . . 0.0 108.307 177.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -143.67 134.24 24.92 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -138.01 -78.1 0.07 OUTLIER Glycine 0 N--CA 1.44 -1.098 0 C-N-CA 118.515 -1.802 . . . . 0.0 116.075 -174.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -63.78 -51.62 63.97 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 115.243 1.571 . . . . 0.0 115.243 -167.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.467 ' O ' HG22 ' A' ' 114' ' ' VAL . 65.1 mmtt -98.24 -1.64 41.49 Favored 'General case' 0 C--N 1.321 -0.645 0 O-C-N 121.474 -0.766 . . . . 0.0 109.802 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.598 ' O ' ' HG ' ' A' ' 115' ' ' LEU . . . -51.92 -33.18 36.04 Favored 'General case' 0 C--O 1.217 -0.608 0 CA-C-N 114.798 -1.092 . . . . 0.0 113.706 -174.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.406 HE21 ' N ' ' A' ' 113' ' ' THR . 0.0 OUTLIER -64.54 -37.42 87.5 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.474 -177.43 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' THR . . . . . 0.406 ' N ' HE21 ' A' ' 112' ' ' GLN . 5.4 m -78.19 -25.16 47.0 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 121.617 0.722 . . . . 0.0 109.238 -179.132 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.467 HG22 ' O ' ' A' ' 110' ' ' LYS . 62.0 t -67.64 -40.35 83.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-N 114.703 -1.135 . . . . 0.0 108.272 175.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.598 ' HG ' ' O ' ' A' ' 111' ' ' ALA . 73.1 mt -72.39 -29.09 63.43 Favored 'General case' 0 C--O 1.222 -0.388 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.92 177.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -73.19 -11.37 60.5 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-O 121.165 0.507 . . . . 0.0 110.111 173.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 86.47 -12.62 60.44 Favored Glycine 0 N--CA 1.438 -1.208 0 CA-C-N 115.621 -0.718 . . . . 0.0 113.05 177.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -91.33 62.85 4.78 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 122.253 1.025 . . . . 0.0 111.177 -173.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.555 ' O ' HD12 ' A' ' 119' ' ' LEU . 0.0 OUTLIER -132.04 131.53 42.54 Favored 'General case' 0 N--CA 1.409 -2.517 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 175.201 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.474 ' HA ' HG22 ' A' ' 12' ' ' THR . 0.0 OUTLIER -130.62 128.03 40.16 Favored 'General case' 1 C--N 1.241 -4.124 0 CA-C-N 113.311 -1.768 . . . . 0.0 109.66 179.486 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 14.3 m -133.71 170.66 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 176.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.644 ' O ' ' HE2' ' A' ' 82' ' ' LYS . 8.0 p-10 -108.68 161.01 15.48 Favored 'General case' 0 C--N 1.274 -2.7 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.756 -178.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . 0.661 ' CD1' ' HG ' ' A' ' 79' ' ' LEU . 37.8 t80 -159.08 156.53 29.35 Favored 'General case' 0 C--O 1.256 1.4 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 171.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.408 ' SD ' ' N ' ' A' ' 125' ' ' GLU . 0.0 OUTLIER -127.75 149.02 50.43 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 104.53 -2.396 . . . . 0.0 104.53 -179.735 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.419 ' C ' ' HG1' ' A' ' 126' ' ' THR . 37.6 mt-10 -66.09 -31.96 73.14 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 121.144 0.497 . . . . 0.0 111.857 -174.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.421 ' HA ' ' ND2' ' A' ' 75' ' ' ASN . 17.8 m -151.2 178.24 9.43 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 179.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 . . . . . 0 C--N 1.304 -1.4 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 175.648 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 37.2 m . . . . . 0 CA--C 1.507 -0.709 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 26.0 ttpp -164.01 160.19 21.53 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.7 p -66.77 141.41 57.73 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 123.575 0.547 . . . . 0.0 110.002 176.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.402 ' HE3' ' HB2' ' A' ' 5' ' ' ASP . 0.1 OUTLIER -156.71 -43.79 0.07 Allowed 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -178.654 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.402 ' HB2' ' HE3' ' A' ' 4' ' ' LYS . 3.5 t70 -124.45 157.5 35.05 Favored 'General case' 0 CA--C 1.476 -1.866 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -175.099 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -154.98 84.54 1.08 Allowed 'General case' 0 N--CA 1.407 -2.582 0 O-C-N 124.215 0.947 . . . . 0.0 109.698 -177.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 38.6 mtmm -126.68 80.79 1.96 Allowed 'General case' 0 C--N 1.285 -2.222 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.681 175.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.7 t -94.78 -172.51 2.74 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 47.0 mmt-85 -97.23 150.41 20.94 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 120.501 -0.48 . . . . 0.0 109.887 178.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -118.71 93.8 4.23 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 104.949 -2.241 . . . . 0.0 104.949 178.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.404 ' O ' HG22 ' A' ' 11' ' ' VAL . 11.8 m -82.07 87.59 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.272 -2.782 0 CA-C-O 122.64 1.209 . . . . 0.0 111.322 -175.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.497 HG22 ' HA ' ' A' ' 120' ' ' LYS . 44.7 p -98.47 -58.43 1.96 Allowed 'General case' 0 C--N 1.262 -3.208 0 C-N-CA 117.564 -1.654 . . . . 0.0 113.13 174.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.434 ' HA ' ' HB3' ' A' ' 16' ' ' LYS . 12.3 t70 -83.49 -10.9 58.05 Favored 'General case' 0 C--O 1.205 -1.281 0 C-N-CA 118.797 -1.161 . . . . 0.0 111.139 -176.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -66.59 -46.85 74.6 Favored 'General case' 0 CA--C 1.5 -0.977 0 N-CA-C 105.279 -2.119 . . . . 0.0 105.279 171.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 77.1 t -65.85 -43.28 93.21 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.404 0 CA-C-N 112.944 -1.935 . . . . 0.0 110.074 177.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.434 ' HB3' ' HA ' ' A' ' 13' ' ' ASP . 17.2 ttmt -64.95 -40.26 94.74 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.628 178.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.516 ' O ' ' HD2' ' A' ' 21' ' ' PHE . 72.2 m -55.13 -45.86 75.61 Favored 'General case' 0 CA--C 1.509 -0.608 0 O-C-N 123.33 0.394 . . . . 0.0 109.955 175.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.427 ' O ' HG21 ' A' ' 22' ' ' VAL . 88.1 mt -55.43 -56.62 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.486 177.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.406 HG23 HG11 ' A' ' 114' ' ' VAL . 97.9 t -60.19 -44.44 95.38 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.101 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.41 -179.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.488 ' O ' ' HG3' ' A' ' 24' ' ' GLU . 35.8 ttp180 -58.72 -36.32 74.09 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 124.036 0.934 . . . . 0.0 111.069 -178.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.516 ' HD2' ' O ' ' A' ' 17' ' ' SER . 64.8 m-85 -90.86 -25.36 19.9 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -178.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.427 HG21 ' O ' ' A' ' 18' ' ' ILE . 30.5 m -79.38 -30.8 14.0 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.377 0 C-N-CA 117.307 -1.757 . . . . 0.0 108.54 173.378 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -63.05 -52.4 62.95 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.251 174.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.488 ' HG3' ' O ' ' A' ' 20' ' ' ARG 0.322 0.0 OUTLIER -70.62 -20.16 62.77 Favored 'General case' 0 C--N 1.347 0.468 0 C-N-CA 119.366 -0.934 . . . . 0.0 112.849 -179.447 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 8.4 m80 -76.77 -37.36 55.99 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 119.619 -0.832 . . . . 0.0 110.127 172.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 29.7 t 54.34 44.87 28.31 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.664 0.786 . . . . 0.0 110.31 177.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 62.1 p 60.09 14.44 4.44 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 125.21 1.404 . . . . 0.0 112.997 -177.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.3 t -143.1 -150.92 0.33 Allowed 'General case' 0 N--CA 1.418 -2.039 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 -178.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 75.4 mm-40 74.91 147.82 0.09 Allowed 'General case' 0 C--O 1.213 -0.836 0 C-N-CA 125.401 1.48 . . . . 0.0 112.517 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.14 34.84 31.98 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 -176.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' MET . . . . . 0.482 ' SD ' ' HA2' ' A' ' 38' ' ' GLY . 24.1 mmt -45.35 -23.3 0.19 Allowed 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 126.656 1.983 . . . . 0.0 114.441 -175.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -72.16 -37.2 69.43 Favored 'General case' 0 C--N 1.314 -0.969 0 O-C-N 122.107 -0.371 . . . . 0.0 111.356 -178.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -126.44 -64.8 1.01 Allowed 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -170.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.4 tt -74.24 101.78 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 CA-C-O 122.819 1.295 . . . . 0.0 111.333 -176.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.491 ' C ' ' H ' ' A' ' 37' ' ' VAL . 9.5 mtmp? 60.96 77.3 0.33 Allowed 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 112.63 -2.077 . . . . 0.0 110.964 -176.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -75.59 37.49 0.14 Allowed 'General case' 0 CA--C 1.557 1.241 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.397 -178.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.491 ' H ' ' C ' ' A' ' 35' ' ' LYS . 10.7 p -133.14 10.36 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 C-N-CA 124.996 1.318 . . . . 0.0 107.695 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.482 ' HA2' ' SD ' ' A' ' 31' ' ' MET . . . 87.13 -139.18 15.96 Favored Glycine 0 N--CA 1.435 -1.399 0 CA-C-N 114.697 -1.138 . . . . 0.0 112.868 176.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -70.65 -23.08 27.14 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.443 2.095 . . . . 0.0 111.635 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.8 m -50.97 133.23 27.27 Favored 'General case' 0 C--O 1.249 1.073 0 C-N-CA 125.088 1.355 . . . . 0.0 110.966 -178.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 100.84 -175.9 26.77 Favored Glycine 0 N--CA 1.438 -1.174 0 N-CA-C 110.195 -1.162 . . . . 0.0 110.195 -178.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 73.7 mtt180 -151.67 -174.46 4.85 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 106.074 -1.825 . . . . 0.0 106.074 -178.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -110.1 161.2 15.78 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 177.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 51.2 p -122.56 156.34 34.4 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 176.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.442 ' HG3' ' N ' ' A' ' 46' ' ' ASN . 13.2 ptp -50.71 -42.27 56.91 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-O 121.221 0.534 . . . . 0.0 110.799 178.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.442 ' N ' ' HG3' ' A' ' 45' ' ' MET . 44.2 m-80 -64.1 -34.19 77.49 Favored 'General case' 0 CA--C 1.505 -0.77 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.348 -177.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' MET . . . . . 0.425 ' O ' ' HB ' ' A' ' 51' ' ' ILE . 49.2 ttm -71.2 -43.22 67.82 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.437 ' O ' HG23 ' A' ' 51' ' ' ILE . 82.9 mt -67.77 -42.8 81.16 Favored 'General case' 0 C--O 1.208 -1.101 0 CA-C-N 115.224 -0.898 . . . . 0.0 112.469 -176.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 45' ' ' MET . 69.2 t -64.57 -46.38 92.75 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.727 0 CA-C-O 121.622 0.725 . . . . 0.0 110.436 179.321 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -63.52 -37.85 88.88 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 114.712 -1.131 . . . . 0.0 108.927 -178.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.684 ' CG1' ' HB1' ' A' ' 58' ' ' ALA . 0.4 OUTLIER -76.33 -37.85 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.407 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 179.62 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.409 ' CZ ' ' HA3' ' A' ' 68' ' ' GLY . 37.8 t80 -55.81 -39.23 71.05 Favored 'General case' 0 C--N 1.296 -1.745 0 O-C-N 123.877 0.736 . . . . 0.0 110.036 176.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.5 mp -82.13 -28.77 32.01 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.137 -0.938 . . . . 0.0 112.116 177.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.15 35.43 15.1 Favored Glycine 0 C--O 1.251 1.159 0 N-CA-C 109.841 -1.303 . . . . 0.0 109.841 -176.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.525 ' OG ' ' HD3' ' A' ' 56' ' ' LYS . 34.9 t -70.47 -168.96 0.27 Allowed 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 126.619 1.968 . . . . 0.0 112.858 -172.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.535 ' HZ3' ' HB2' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -50.27 -66.75 0.34 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.205 1.402 . . . . 0.0 112.902 -174.236 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.05 -42.83 22.97 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 114.771 -1.104 . . . . 0.0 111.545 -170.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.684 ' HB1' ' CG1' ' A' ' 51' ' ' ILE . . . -91.78 81.1 5.23 Favored 'General case' 0 N--CA 1.398 -3.048 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 174.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.601 ' O ' ' HB ' ' A' ' 60' ' ' ILE . 0.1 OUTLIER -73.13 25.21 0.06 Allowed 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 114.612 -1.176 . . . . 0.0 111.99 -175.484 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.601 ' HB ' ' O ' ' A' ' 59' ' ' LYS . 88.3 mt 83.34 127.91 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 C-N-CA 126.831 2.053 . . . . 0.0 111.057 -175.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.457 ' HG3' ' O ' ' A' ' 60' ' ' ILE 0.297 14.8 mt-30 -135.82 58.86 1.73 Allowed 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 178.609 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 15.2 t 71.44 137.14 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 125.91 1.684 . . . . 0.0 112.729 177.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.422 ' C ' ' H ' ' A' ' 65' ' ' PHE . . . 97.28 -141.65 15.73 Favored Glycine 0 C--O 1.241 0.581 0 C-N-CA 121.288 -0.482 . . . . 0.0 112.728 177.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 6.3 pt -73.39 7.19 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 C-N-CA 123.331 0.652 . . . . 0.0 112.427 178.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.674 ' CD2' HG12 ' A' ' 51' ' ' ILE . 0.3 OUTLIER -70.96 113.32 7.88 Favored 'General case' 0 N--CA 1.389 -3.504 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 -178.784 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.68 33.67 46.34 Favored Glycine 0 N--CA 1.424 -2.116 0 CA-C-N 114.849 -1.068 . . . . 0.0 111.305 -174.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 32.9 mmtm -121.32 -15.08 8.19 Favored 'General case' 0 C--O 1.22 -0.452 0 CA-C-O 121.2 0.524 . . . . 0.0 109.72 174.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.409 ' HA3' ' CZ ' ' A' ' 52' ' ' PHE . . . -107.78 35.03 5.25 Favored Glycine 0 N--CA 1.432 -1.579 0 N-CA-C 109.771 -1.331 . . . . 0.0 109.771 178.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 9.2 m -72.62 6.23 2.58 Favored 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 124.932 1.293 . . . . 0.0 111.953 -176.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -93.52 -1.53 55.46 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-O 121.923 0.868 . . . . 0.0 109.337 176.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -103.41 153.62 20.28 Favored 'General case' 0 N--CA 1.422 -1.828 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 175.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 37.5 t -105.35 171.86 7.1 Favored 'General case' 0 C--N 1.28 -2.43 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 170.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.3 mmm180 -52.78 -37.95 60.37 Favored 'General case' 0 C--O 1.205 -1.277 0 CA-C-O 121.215 0.531 . . . . 0.0 110.869 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.453 ' O ' ' HG2' ' A' ' 78' ' ' ARG . 6.5 t-160 -67.6 -43.98 79.18 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.577 -172.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -68.78 -55.7 10.4 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.319 -178.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.433 ' O ' ' HD1' ' A' ' 80' ' ' PHE . . . -57.41 -44.82 84.88 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.929 -177.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -62.62 -33.92 75.99 Favored 'General case' 0 C--O 1.208 -1.096 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 178.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.453 ' HG2' ' O ' ' A' ' 74' ' ' HIS . 9.7 mmm180 -67.14 -30.31 70.26 Favored 'General case' 0 CA--C 1.495 -1.144 0 C-N-CA 119.08 -1.048 . . . . 0.0 110.296 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.527 ' O ' ' HG ' ' A' ' 83' ' ' LEU . 2.5 tt -79.46 -50.99 9.94 Favored 'General case' 0 N--CA 1.42 -1.926 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.261 -177.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.452 ' HA ' HD13 ' A' ' 83' ' ' LEU . 60.6 m-85 -58.45 -23.18 56.89 Favored 'General case' 0 CA--C 1.506 -0.747 0 CA-C-O 121.855 0.836 . . . . 0.0 110.326 179.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -89.2 -23.57 22.36 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 114.473 -1.239 . . . . 0.0 110.118 -179.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.406 ' HE2' ' O ' ' A' ' 122' ' ' ASP . 48.5 tttp -73.36 -40.27 64.51 Favored 'General case' 0 C--O 1.209 -1.053 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 174.127 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.527 ' HG ' ' O ' ' A' ' 79' ' ' LEU . 94.6 mt -53.62 -50.19 66.21 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 114.905 -1.043 . . . . 0.0 112.864 178.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.608 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 2.6 pp -73.82 -24.65 19.83 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -178.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 41.0 mt -79.83 -40.2 29.03 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 176.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.629 ' O ' ' HE2' ' A' ' 110' ' ' LYS . 35.1 t70 -82.96 -13.07 56.72 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.675 -177.268 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 86' ' ' ASP . 2.8 mptp? 85.61 16.77 0.13 Allowed 'General case' 0 CA--C 1.462 -2.418 0 N-CA-C 114.355 1.243 . . . . 0.0 114.355 171.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 11.6 mt -70.02 -45.32 76.87 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.092 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 168.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.608 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 4.3 mm? -114.95 158.57 21.83 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 113.953 -1.476 . . . . 0.0 108.416 174.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.45 ' O ' ' HB2' ' A' ' 106' ' ' MET . 0.3 OUTLIER -149.12 109.97 4.3 Favored 'General case' 0 CA--C 1.476 -1.902 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 176.452 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.434 ' HB2' ' O ' ' A' ' 104' ' ' TYR 0.28 11.8 pt-20 -95.53 159.11 15.15 Favored 'General case' 0 C--N 1.282 -2.36 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 178.56 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.438 ' O ' ' HA ' ' A' ' 103' ' ' ALA . 9.8 t70 -97.98 118.14 33.89 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 126.042 1.737 . . . . 0.0 109.287 -170.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -85.5 103.64 14.55 Favored 'General case' 0 N--CA 1.419 -1.997 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.993 179.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -100.54 113.48 26.32 Favored 'General case' 0 C--N 1.279 -2.479 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.438 HD12 HG23 ' A' ' 95' ' ' ILE . 16.3 tt -128.47 147.01 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.197 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -178.075 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 30.5 p-10 -98.16 -175.12 3.04 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -76.43 18.69 0.29 Allowed 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -177.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -117.89 3.92 12.18 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 178.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 62.91 28.41 16.33 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 122.29 1.043 . . . . 0.0 111.123 -175.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -97.92 106.09 18.34 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 176.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -104.64 146.88 28.29 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 -174.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 14.4 tt -135.19 143.24 37.65 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 N-CA-C 105.855 -1.906 . . . . 0.0 105.855 170.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.438 ' HA ' ' O ' ' A' ' 92' ' ' ASP . . . -112.11 131.5 55.41 Favored 'General case' 0 C--N 1.29 -2.005 0 C-N-CA 120.107 -0.637 . . . . 0.0 111.728 -176.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.434 ' O ' ' HB2' ' A' ' 91' ' ' GLU . 94.6 m-85 -105.21 143.61 33.15 Favored 'General case' 0 C--O 1.196 -1.73 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 177.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 49.8 t -95.3 131.18 42.79 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 CA-C-O 121.999 0.904 . . . . 0.0 113.177 -169.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.45 ' HB2' ' O ' ' A' ' 90' ' ' ASP . 84.8 mmm -130.51 -172.43 2.8 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 112.91 -1.95 . . . . 0.0 106.834 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -102.81 150.17 23.76 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -178.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.402 ' HA2' ' HB2' ' A' ' 90' ' ' ASP . . . -104.96 -175.42 24.56 Favored Glycine 0 N--CA 1.437 -1.248 0 C-N-CA 120.063 -1.065 . . . . 0.0 113.777 -176.044 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -58.67 -40.47 83.63 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 123.968 0.907 . . . . 0.0 112.256 -177.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.629 ' HE2' ' O ' ' A' ' 86' ' ' ASP . 37.5 mtmt -92.21 19.85 6.56 Favored 'General case' 0 C--N 1.314 -0.963 0 O-C-N 122.037 -0.415 . . . . 0.0 111.831 -176.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.449 ' O ' ' HB ' ' A' ' 114' ' ' VAL . . . -78.09 -30.25 49.48 Favored 'General case' 0 CA--C 1.497 -1.082 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 177.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 34.8 tp60 -63.76 -39.55 94.54 Favored 'General case' 0 N--CA 1.421 -1.921 0 CA-C-N 112.93 -1.941 . . . . 0.0 109.4 173.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 5.2 m -66.2 -30.14 70.55 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.522 ' HA ' ' HG ' ' A' ' 119' ' ' LEU . 94.5 t -64.64 -43.77 96.67 Favored 'Isoleucine or valine' 0 C--O 1.25 1.108 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.105 176.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 54.0 mt -69.05 -32.91 72.74 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.775 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -72.11 -24.43 61.48 Favored 'General case' 0 C--O 1.216 -0.659 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.213 177.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 103.18 -13.63 55.37 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.723 -0.751 . . . . 0.0 113.336 176.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -83.72 47.59 1.31 Allowed 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 121.531 0.682 . . . . 0.0 112.197 -175.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.522 ' HG ' ' HA ' ' A' ' 114' ' ' VAL . 0.0 OUTLIER -122.41 80.35 1.72 Allowed 'General case' 0 N--CA 1.434 -1.265 0 CA-C-O 123.263 1.506 . . . . 0.0 110.214 179.891 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.497 ' HA ' HG22 ' A' ' 12' ' ' THR . 5.8 ptmm? -114.31 93.13 4.21 Favored 'General case' 0 C--N 1.246 -3.902 0 C-N-CA 118.733 -1.187 . . . . 0.0 110.935 172.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 8.5 m -111.25 170.43 3.58 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.329 -176.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.406 ' O ' ' HE2' ' A' ' 82' ' ' LYS . 6.8 p-10 -95.52 168.43 10.7 Favored 'General case' 0 C--N 1.271 -2.816 0 CA-C-N 114.655 -1.157 . . . . 0.0 111.967 -178.117 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -158.36 142.34 15.59 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 114.627 -1.169 . . . . 0.0 108.028 172.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 26.5 ptt? -97.24 121.36 39.04 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 177.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -48.79 -55.29 11.96 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 115.316 1.599 . . . . 0.0 115.316 -168.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 8.1 t -150.81 157.29 42.75 Favored 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 119.089 -1.044 . . . . 0.0 111.784 -177.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.4 ' HG3' ' CE1' ' A' ' 74' ' ' HIS . 7.5 pt-20 . . . . . 0 N--CA 1.422 -1.856 0 N-CA-C 103.145 -2.909 . . . . 0.0 103.145 174.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.437 ' NH2' ' HB2' ' A' ' 14' ' ' ASP . 60.2 ttt180 . . . . . 0 N--CA 1.408 -2.54 0 CA-C-O 122.107 0.956 . . . . 0.0 112.446 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -81.09 111.68 17.76 Favored 'General case' 0 N--CA 1.394 -3.272 0 N-CA-C 104.633 -2.358 . . . . 0.0 104.633 170.03 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.4 m -84.58 76.15 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.279 -2.47 0 C-N-CA 118.281 -1.368 . . . . 0.0 109.721 178.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.654 HG22 ' HA ' ' A' ' 120' ' ' LYS . 26.1 p -110.07 -37.34 5.61 Favored 'General case' 0 C--N 1.259 -3.356 0 CA-C-N 114.849 -1.069 . . . . 0.0 109.391 178.467 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -69.67 -37.7 76.78 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 176.013 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.437 ' HB2' ' NH2' ' A' ' 9' ' ' ARG . 11.4 t70 -69.21 -54.93 12.26 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.73 -1.123 . . . . 0.0 108.176 -178.773 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.452 ' O ' HG23 ' A' ' 19' ' ' VAL . 77.2 t -63.27 -40.38 88.84 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.179 0 CA-C-N 113.76 -1.564 . . . . 0.0 112.966 -177.397 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 9.6 ttmm -67.08 -35.22 79.35 Favored 'General case' 0 C--N 1.323 -0.586 0 O-C-N 121.907 -0.496 . . . . 0.0 111.586 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 50.1 m -62.97 -45.42 92.52 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 174.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 66.6 mt -55.79 -53.3 39.04 Favored 'Isoleucine or valine' 0 C--O 1.243 0.723 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.134 175.601 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 15' ' ' VAL . 75.3 t -56.86 -43.99 81.2 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.011 0 CA-C-N 114.985 -1.007 . . . . 0.0 112.162 -178.585 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.461 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 32.9 ttt180 -53.04 -54.12 40.0 Favored 'General case' 0 N--CA 1.45 -0.453 0 O-C-N 123.765 0.666 . . . . 0.0 110.198 179.257 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.438 ' CD2' HG23 ' A' ' 64' ' ' ILE . 66.0 m-85 -64.91 -43.05 94.08 Favored 'General case' 0 CA--C 1.494 -1.193 0 N-CA-C 113.183 0.809 . . . . 0.0 113.183 -175.045 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 35.9 m -70.84 -35.96 62.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 C-N-CA 119.367 -0.933 . . . . 0.0 111.345 -178.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -65.13 -47.09 78.33 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 123.402 0.439 . . . . 0.0 110.782 177.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.461 ' HG2' ' O ' ' A' ' 20' ' ' ARG . 12.5 pt-20 . . . . . 0 C--O 1.238 0.457 0 C-N-CA 120.113 -0.635 . . . . 0.0 111.878 -179.405 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 . . . . . 0 CA--C 1.494 -1.182 0 CA-C-O 121.942 0.877 . . . . 0.0 110.226 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 70.1 p -118.79 162.27 18.75 Favored 'General case' 0 N--CA 1.413 -2.305 0 CA-C-N 114.193 -1.367 . . . . 0.0 107.762 178.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.524 ' O ' HG23 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -55.11 -44.27 74.81 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -176.5 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.436 ' O ' ' HB ' ' A' ' 49' ' ' VAL . 3.5 m-20 -71.22 -23.36 62.0 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -177.24 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 26.0 mmt -71.66 -39.7 70.14 Favored 'General case' 0 CA--C 1.508 -0.673 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 176.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 78.4 mt -66.95 -30.89 71.15 Favored 'General case' 0 C--O 1.216 -0.676 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.301 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 45' ' ' MET . 27.3 t -62.8 -52.7 56.28 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.944 0 C-N-CA 124.806 1.242 . . . . 0.0 110.98 178.465 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.451 ' CG ' ' HB3' ' A' ' 55' ' ' SER . 10.7 t70 -63.02 -38.2 90.24 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 114.848 -1.069 . . . . 0.0 109.287 -178.217 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.533 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 71.2 mt -63.91 -47.98 88.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.252 -0.885 . . . . 0.0 111.513 176.121 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.494 ' CE2' ' HA3' ' A' ' 68' ' ' GLY . 49.1 t80 -52.65 -43.34 65.43 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 124.778 1.231 . . . . 0.0 111.618 -177.221 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.473 HD11 ' HB2' ' A' ' 71' ' ' TYR . 8.9 mp -76.96 -22.54 53.09 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 179.361 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.77 31.48 18.04 Favored Glycine 0 C--O 1.267 2.2 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -174.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.451 ' HB3' ' CG ' ' A' ' 50' ' ' ASP . 22.8 t -75.69 -179.42 4.71 Favored 'General case' 0 N--CA 1.415 -2.187 0 CA-C-N 113.7 -1.25 . . . . 0.0 108.541 -178.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 43.7 mttm -123.51 17.36 9.67 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 118.76 -1.176 . . . . 0.0 113.297 -169.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.4 m -88.85 -38.31 14.68 Favored 'General case' 0 C--O 1.247 0.971 0 N-CA-C 105.06 -2.2 . . . . 0.0 105.06 173.491 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.446 ' HB1' HG12 ' A' ' 51' ' ' ILE . . . -45.85 137.37 5.61 Favored 'General case' 0 N--CA 1.429 -1.494 0 C-N-CA 128.213 2.605 . . . . 0.0 111.59 178.129 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -120.01 18.22 12.45 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.971 -178.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . 0.251 67.6 mt -104.03 -50.4 9.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 C-N-CA 117.496 -1.682 . . . . 0.0 114.19 -177.276 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.641 ' HA ' ' CD2' ' A' ' 65' ' ' PHE . 25.7 mp0 60.91 26.59 16.48 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 176.82 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.9 t -139.41 129.65 25.34 Favored 'General case' 0 N--CA 1.421 -1.898 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.249 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 106.38 -134.8 12.33 Favored Glycine 0 N--CA 1.435 -1.383 0 N-CA-C 111.61 -0.596 . . . . 0.0 111.61 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.438 HG23 ' CD2' ' A' ' 21' ' ' PHE . 1.4 pt -70.95 29.06 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 124.708 1.203 . . . . 0.0 113.694 179.204 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.641 ' CD2' ' HA ' ' A' ' 61' ' ' GLN . 9.0 t80 -71.69 112.31 7.7 Favored 'General case' 0 N--CA 1.425 -1.689 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -177.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.34 48.18 46.91 Favored Glycine 0 N--CA 1.441 -0.968 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.505 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 32.5 mmtm -119.25 -21.0 7.73 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 120.941 0.4 . . . . 0.0 111.34 177.061 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.494 ' HA3' ' CE2' ' A' ' 52' ' ' PHE . . . -121.58 45.13 1.25 Allowed Glycine 0 N--CA 1.437 -1.299 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 178.636 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.7 m -73.99 6.69 3.17 Favored 'General case' 0 C--N 1.306 -1.292 0 C-N-CA 124.614 1.166 . . . . 0.0 112.173 -175.455 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -101.71 3.87 40.06 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-O 121.527 0.679 . . . . 0.0 109.883 178.041 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.473 ' HB2' HD11 ' A' ' 53' ' ' LEU . 34.0 m-85 -101.36 168.8 9.3 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.884 176.561 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 36.1 t -104.07 155.77 18.42 Favored 'General case' 0 N--CA 1.417 -2.117 0 N-CA-C 104.548 -2.39 . . . . 0.0 104.548 168.62 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 69.7 mtm180 -57.7 -39.66 77.69 Favored 'General case' 0 C--O 1.209 -1.035 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -175.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 69.7 t60 -77.49 -17.0 58.41 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-O 121.519 0.676 . . . . 0.0 110.886 -176.633 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -80.53 -43.61 20.44 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 177.656 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.519 ' HB3' HG13 ' A' ' 49' ' ' VAL . . . -61.81 -41.55 97.91 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.009 -0.996 . . . . 0.0 108.842 175.682 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -54.16 -43.61 70.76 Favored 'General case' 0 CA--C 1.501 -0.929 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.327 174.056 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 20.2 ttm180 -64.93 -28.81 69.78 Favored 'General case' 0 C--O 1.217 -0.647 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.228 -172.273 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.3 tt -80.63 -47.25 14.37 Favored 'General case' 0 N--CA 1.429 -1.523 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.26 -177.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -62.09 -20.04 63.6 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 121.861 0.839 . . . . 0.0 109.471 177.424 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.524 ' HA ' HG13 ' A' ' 84' ' ' ILE . 94.4 mttt -91.26 -22.34 20.63 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 114.471 -1.241 . . . . 0.0 110.394 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 29.6 tptp -70.93 -47.08 61.03 Favored 'General case' 0 C--O 1.219 -0.531 0 N-CA-C 106.133 -1.802 . . . . 0.0 106.133 171.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 94.3 mt -56.8 -39.65 74.52 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 114.35 -1.295 . . . . 0.0 113.941 177.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.524 HG13 ' HA ' ' A' ' 81' ' ' LYS . 2.7 pp -69.61 -33.02 54.81 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.785 0 C-N-CA 120.261 -0.576 . . . . 0.0 110.908 178.453 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 53.4 mt -70.36 -44.1 68.81 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 121.087 0.47 . . . . 0.0 111.558 176.407 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -66.96 -27.28 67.33 Favored 'General case' 0 C--O 1.259 1.575 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.199 179.336 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.474 ' HD2' ' O ' ' A' ' 84' ' ' ILE . 2.2 mptp? 84.89 18.73 0.13 Allowed 'General case' 0 CA--C 1.476 -1.902 0 C-N-CA 125.781 1.632 . . . . 0.0 112.846 176.215 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.547 HG23 HG21 ' A' ' 114' ' ' VAL . 1.9 mp -69.77 -40.64 79.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 105.391 -2.077 . . . . 0.0 105.391 166.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.478 ' CD1' HG13 ' A' ' 105' ' ' VAL . 3.1 mm? -103.6 144.31 31.61 Favored 'General case' 0 N--CA 1.411 -2.405 0 CA-C-N 113.419 -1.719 . . . . 0.0 109.04 173.356 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -124.72 131.57 53.45 Favored 'General case' 0 N--CA 1.408 -2.538 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 176.407 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.47 ' H ' ' CD ' ' A' ' 91' ' ' GLU . 0.1 OUTLIER -95.27 129.67 42.31 Favored 'General case' 0 C--N 1.27 -2.86 0 CA-C-N 114.271 -1.331 . . . . 0.0 111.708 -173.838 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.519 ' HB2' ' HB2' ' A' ' 104' ' ' TYR . 7.9 m-20 -96.48 95.84 8.29 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 179.092 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 97.5 mt -76.28 114.54 15.08 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.461 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -130.86 130.86 44.12 Favored 'General case' 0 N--CA 1.42 -1.968 0 CA-C-N 115.344 -0.844 . . . . 0.0 108.837 -177.253 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.498 HG13 ' C ' ' A' ' 100' ' ' GLN . 16.8 tt -128.81 141.15 47.35 Favored 'Isoleucine or valine' 0 N--CA 1.399 -3.005 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 176.211 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.408 ' C ' ' H ' ' A' ' 98' ' ' ASN . 3.5 p-10 -95.72 170.85 9.04 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 176.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -67.9 21.72 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -173.461 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.408 ' H ' ' C ' ' A' ' 96' ' ' ASN . 16.8 m120 -119.32 7.49 11.26 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 177.429 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.488 ' HA ' HD11 ' A' ' 95' ' ' ILE . 8.4 m-20 62.14 30.76 17.82 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 124.787 1.305 . . . . 0.0 110.99 -177.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.498 ' C ' HG13 ' A' ' 95' ' ' ILE . 83.6 mm-40 -101.71 107.42 18.64 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 177.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -96.27 139.25 32.68 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 115.663 -0.699 . . . . 0.0 112.081 -175.049 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 18.4 tt -142.21 146.16 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.723 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 176.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.507 ' HA ' ' O ' ' A' ' 92' ' ' ASP . . . -114.19 132.86 55.95 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 -178.344 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.519 ' HB2' ' HB2' ' A' ' 92' ' ' ASP . 68.1 m-85 -97.23 175.4 6.29 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 177.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.478 HG13 ' CD1' ' A' ' 89' ' ' LEU . 14.6 t -116.4 121.01 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.803 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 -178.233 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 58.4 mtp -141.76 168.48 19.65 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 113.436 -1.711 . . . . 0.0 108.764 173.141 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.543 ' HB3' ' HB2' ' A' ' 111' ' ' ALA . 7.5 mp -116.86 130.27 56.61 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 177.11 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -131.8 -80.24 0.19 Allowed Glycine 0 N--CA 1.422 -2.257 0 C-N-CA 118.897 -1.62 . . . . 0.0 115.716 -175.072 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -65.96 -54.9 20.31 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 115.25 1.574 . . . . 0.0 115.25 -168.243 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.515 ' HB2' ' HA ' ' A' ' 88' ' ' ILE . 41.9 mmtm -97.55 6.15 48.51 Favored 'General case' 0 C--N 1.313 -0.979 0 O-C-N 121.455 -0.778 . . . . 0.0 109.995 -179.222 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.543 ' HB2' ' HB3' ' A' ' 107' ' ' LEU . . . -58.03 -32.82 68.34 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -175.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.5 -29.13 66.7 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.469 0.652 . . . . 0.0 110.029 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 13.1 m -75.95 -25.16 55.66 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.547 HG21 HG23 ' A' ' 88' ' ' ILE . 40.0 t -70.19 -39.69 77.23 Favored 'Isoleucine or valine' 0 C--O 1.25 1.083 0 CA-C-N 115.246 -0.888 . . . . 0.0 108.942 175.309 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.449 ' HG ' ' O ' ' A' ' 111' ' ' ALA . 76.1 mt -69.54 -39.2 77.6 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.981 178.47 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.41 ' OD1' ' HB2' ' A' ' 118' ' ' ASN . 28.0 t-20 -71.58 -20.07 62.05 Favored 'General case' 0 C--O 1.217 -0.635 0 CA-C-O 121.735 0.778 . . . . 0.0 109.529 176.632 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 85.04 6.52 84.78 Favored Glycine 0 CA--C 1.503 -0.718 0 CA-C-N 115.396 -0.82 . . . . 0.0 113.173 176.041 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.41 ' HB2' ' OD1' ' A' ' 116' ' ' ASN . 13.0 t-20 -93.81 18.9 9.54 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 121.584 0.707 . . . . 0.0 109.644 -175.64 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.545 HD13 ' O ' ' A' ' 119' ' ' LEU . 0.0 OUTLIER -90.06 112.53 24.01 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-O 123.277 1.513 . . . . 0.0 108.442 -176.898 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.654 ' HA ' HG22 ' A' ' 12' ' ' THR . 4.9 ptpp? -130.13 105.72 8.13 Favored 'General case' 1 C--N 1.228 -4.697 0 CA-C-N 113.309 -1.769 . . . . 0.0 112.229 179.551 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.4 m -119.07 171.01 7.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 177.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -105.56 158.39 16.71 Favored 'General case' 0 C--N 1.262 -3.223 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.291 -177.595 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -158.08 151.7 23.6 Favored 'General case' 0 N--CA 1.426 -1.636 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 172.214 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 49.8 ttm . . . . . 0 C--N 1.303 -1.415 0 C-N-CA 120.501 -0.48 . . . . 0.0 112.037 -173.384 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.509 ' O ' ' HA ' ' A' ' 122' ' ' ASP . 8.8 mpt_? . . . . . 0 N--CA 1.438 -1.027 0 N-CA-C 111.342 0.127 . . . . 0.0 111.342 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -84.97 90.86 7.92 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 177.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.2 m -85.72 64.96 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 CA-C-O 121.705 0.764 . . . . 0.0 110.498 -179.404 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.526 HG21 ' HB3' ' A' ' 120' ' ' LYS . 42.8 p -102.92 -16.84 15.74 Favored 'General case' 0 C--N 1.26 -3.3 0 C-N-CA 116.15 -2.22 . . . . 0.0 113.187 -176.283 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 17.9 p-10 -82.14 -35.88 28.01 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 174.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -68.65 -58.98 3.47 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.3 179.314 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 88.6 t -59.51 -35.72 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 CA-C-N 114.675 -1.148 . . . . 0.0 112.04 -179.028 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.468 ' HE3' HD11 ' A' ' 119' ' ' LEU . 3.6 tppp? -66.07 -40.01 90.52 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.294 178.5 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.463 ' O ' ' HD2' ' A' ' 21' ' ' PHE . 49.6 m -65.14 -42.03 94.19 Favored 'General case' 0 N--CA 1.442 -0.853 0 O-C-N 123.362 0.414 . . . . 0.0 110.246 178.782 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 59.0 mt -57.13 -51.89 63.35 Favored 'Isoleucine or valine' 0 C--O 1.244 0.807 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.266 176.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.51 HG11 HG11 ' A' ' 114' ' ' VAL . 70.6 t -65.6 -37.33 79.75 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.621 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.929 -178.001 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 16.2 ttp180 -55.11 -52.24 63.86 Favored 'General case' 0 C--O 1.222 -0.386 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.463 ' HD2' ' O ' ' A' ' 17' ' ' SER . 55.5 m-85 -63.16 -43.81 97.24 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-N 115.103 -0.953 . . . . 0.0 113.006 -177.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.444 HG22 ' HA ' ' A' ' 19' ' ' VAL . 27.3 m -72.87 -33.79 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.055 0 C-N-CA 119.365 -0.934 . . . . 0.0 111.742 -178.653 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 58.9 tp60 -65.59 -48.88 70.82 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 123.141 0.276 . . . . 0.0 110.737 176.172 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 . . . . . 0 N--CA 1.474 0.767 0 CA-C-O 121.69 0.757 . . . . 0.0 110.461 179.687 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 . . . . . 0 N--CA 1.433 -1.301 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.515 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 80.9 p -130.69 156.34 45.09 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 104.497 -2.409 . . . . 0.0 104.497 174.324 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.547 ' O ' HG23 ' A' ' 49' ' ' VAL . 11.9 ptp -59.91 -35.03 74.01 Favored 'General case' 0 C--O 1.215 -0.712 0 CA-C-N 119.701 1.137 . . . . 0.0 110.986 -179.382 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -72.72 -32.74 65.95 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.896 -175.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' MET . . . . . 0.687 ' SD ' ' HA ' ' A' ' 58' ' ' ALA . 48.2 tpp -67.17 -39.45 86.47 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 176.657 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.515 ' HG ' ' O ' ' A' ' 44' ' ' THR . 77.9 mt -64.26 -40.76 96.66 Favored 'General case' 0 C--O 1.207 -1.152 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.544 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.547 HG23 ' O ' ' A' ' 45' ' ' MET . 68.7 t -64.19 -46.3 93.87 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.687 0 C-N-CA 124.037 0.935 . . . . 0.0 110.245 177.363 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.579 ' OD1' ' HB3' ' A' ' 55' ' ' SER . 7.9 t70 -60.7 -44.32 96.7 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 114.731 -1.122 . . . . 0.0 109.507 -178.332 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.497 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 54.9 mt -65.18 -47.12 88.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.044 175.765 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.425 ' CZ ' ' HA3' ' A' ' 68' ' ' GLY . 25.7 t80 -57.18 -44.12 83.28 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 124.353 1.061 . . . . 0.0 110.757 -177.313 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.4 HD22 ' HD2' ' A' ' 73' ' ' ARG . 11.0 mp -77.21 -28.66 53.91 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 177.072 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 100.74 29.14 6.68 Favored Glycine 0 C--O 1.244 0.722 0 C-N-CA 120.525 -0.845 . . . . 0.0 113.162 177.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.579 ' HB3' ' OD1' ' A' ' 50' ' ' ASP . 23.1 t -80.28 -170.51 2.56 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 123.388 0.675 . . . . 0.0 110.836 -176.217 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.462 ' HD2' ' C ' ' A' ' 55' ' ' SER . 1.6 mptp? -121.14 7.84 10.31 Favored 'General case' 0 C--O 1.25 1.1 0 N-CA-C 114.271 1.212 . . . . 0.0 114.271 -177.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.5 m -78.36 -30.08 47.85 Favored 'General case' 0 C--O 1.245 0.823 0 N-CA-C 104.837 -2.283 . . . . 0.0 104.837 173.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.687 ' HA ' ' SD ' ' A' ' 47' ' ' MET . . . -50.2 120.97 4.93 Favored 'General case' 0 N--CA 1.417 -2.113 0 C-N-CA 127.34 2.256 . . . . 0.0 109.825 172.825 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.586 ' HA ' ' HE3' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -100.64 9.69 42.14 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-O 121.067 0.46 . . . . 0.0 111.297 -179.482 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 61.8 mt -128.23 120.88 54.4 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 176.253 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -105.39 32.43 4.27 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.192 0.52 . . . . 0.0 110.144 -177.117 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 24.5 m -141.65 126.76 18.43 Favored 'General case' 0 C--N 1.311 -1.077 0 O-C-N 122.057 -0.402 . . . . 0.0 110.84 -177.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 131.16 -132.57 6.87 Favored Glycine 0 N--CA 1.442 -0.91 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.452 HG23 ' CD2' ' A' ' 21' ' ' PHE . 1.7 pt -75.9 31.02 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 123.32 0.648 . . . . 0.0 112.054 177.244 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.497 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 11.5 t80 -66.87 112.8 4.47 Favored 'General case' 0 N--CA 1.42 -1.974 0 CA-C-O 120.992 0.425 . . . . 0.0 110.443 -174.262 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 63.79 36.8 93.78 Favored Glycine 0 N--CA 1.436 -1.303 0 CA-C-N 115.045 -0.98 . . . . 0.0 112.156 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.609 ' HA ' ' HE3' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -100.8 -25.04 14.25 Favored 'General case' 0 C--N 1.32 -0.701 0 O-C-N 122.153 -0.616 . . . . 0.0 110.247 177.672 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.425 ' HA3' ' CZ ' ' A' ' 52' ' ' PHE . . . -120.13 51.59 0.76 Allowed Glycine 0 N--CA 1.436 -1.351 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.7 t -82.84 9.3 10.16 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 122.017 0.913 . . . . 0.0 109.86 -174.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -102.0 6.8 41.33 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-O 121.709 0.766 . . . . 0.0 109.82 178.511 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -100.91 154.45 18.66 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 115.019 -0.991 . . . . 0.0 108.852 176.063 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.653 ' HB3' ' OD1' ' A' ' 75' ' ' ASN . 43.5 t -97.09 164.85 12.34 Favored 'General case' 0 N--CA 1.416 -2.141 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 171.419 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.4 ' HD2' HD22 ' A' ' 53' ' ' LEU . 10.6 mmm180 -54.16 -40.35 67.39 Favored 'General case' 0 CA--C 1.509 -0.624 0 C-N-CA 122.981 0.512 . . . . 0.0 112.289 -174.456 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 16.0 t-80 -86.87 -21.73 26.18 Favored 'General case' 0 C--O 1.2 -1.524 0 C-N-CA 119.015 -1.074 . . . . 0.0 111.372 -172.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.653 ' OD1' ' HB3' ' A' ' 72' ' ' SER . 13.4 m120 -79.78 -38.87 32.17 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 -178.403 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.41 ' HB3' HG13 ' A' ' 49' ' ' VAL . . . -64.09 -46.29 84.93 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.752 176.681 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.74 -20.56 61.18 Favored 'General case' 0 C--O 1.214 -0.808 0 C-N-CA 120.544 -0.463 . . . . 0.0 111.231 -178.802 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.413 ' HB3' ' O ' ' A' ' 75' ' ' ASN . 21.7 tpp180 -65.94 -35.63 81.14 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 176.728 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.2 tt -76.83 -45.27 29.22 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 114.761 -1.108 . . . . 0.0 110.175 -179.428 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -62.99 -17.19 61.87 Favored 'General case' 0 C--O 1.216 -0.693 0 C-N-CA 120.108 -0.637 . . . . 0.0 109.706 176.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.487 ' HA ' HG13 ' A' ' 84' ' ' ILE . 53.1 mttp -86.52 -26.18 24.71 Favored 'General case' 0 CA--C 1.496 -1.099 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.399 177.229 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.422 ' HG3' ' OD2' ' A' ' 86' ' ' ASP . 29.2 tptp -72.09 -47.24 52.82 Favored 'General case' 0 N--CA 1.427 -1.599 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 176.659 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.453 ' HB3' HD23 ' A' ' 89' ' ' LEU . 95.8 mt -58.7 -38.08 77.51 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 179.015 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.576 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 2.6 pp -77.7 -23.13 14.08 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 C-N-CA 120.048 -0.661 . . . . 0.0 111.747 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.9 tt -77.76 -47.24 19.49 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 176.127 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.422 ' OD2' ' HG3' ' A' ' 82' ' ' LYS . 68.3 m-20 -69.64 -20.95 63.59 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.567 -179.58 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.491 ' HB3' ' HB2' ' A' ' 109' ' ' ASN . 3.7 mptp? 84.75 15.61 0.19 Allowed 'General case' 0 CA--C 1.479 -1.765 0 C-N-CA 124.747 1.219 . . . . 0.0 113.679 173.643 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.541 HG22 HD22 ' A' ' 89' ' ' LEU . 1.8 mp -67.92 -39.92 82.53 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.847 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 169.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.576 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 4.4 mm? -112.08 147.74 35.41 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.682 170.315 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -133.32 100.53 4.87 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 120.838 0.351 . . . . 0.0 110.061 178.198 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.413 ' HG2' HG21 ' A' ' 84' ' ' ILE . 18.3 pt-20 -100.26 156.76 17.05 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.458 175.667 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -133.3 179.9 5.91 Favored 'General case' 0 C--O 1.248 0.987 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 179.025 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 99.1 mt -104.14 150.18 24.57 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 122.511 1.148 . . . . 0.0 113.727 -170.176 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -141.57 121.01 13.2 Favored 'General case' 0 N--CA 1.422 -1.85 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 176.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 14.7 tt -118.1 149.98 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.444 0 C-N-CA 119.687 -0.805 . . . . 0.0 108.94 -179.364 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 39.1 p30 -102.1 -176.7 3.19 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.201 178.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -74.05 11.51 0.9 Allowed 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 123.493 0.717 . . . . 0.0 112.315 -178.185 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -110.79 -2.89 15.99 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 -179.301 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 29.5 t70 69.11 24.48 6.1 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-O 123.462 1.601 . . . . 0.0 109.189 -176.358 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -97.52 107.12 19.56 Favored 'General case' 0 C--O 1.245 0.859 0 CA-C-N 114.998 -1.001 . . . . 0.0 108.749 176.021 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -88.68 129.53 35.5 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.833 -177.309 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 15.0 tt -124.5 150.14 29.14 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 175.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -108.92 134.54 51.46 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 122.315 -0.241 . . . . 0.0 110.681 -177.156 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -106.36 143.33 34.63 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.053 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 19.0 t -96.61 133.98 35.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 CA-C-O 122.094 0.949 . . . . 0.0 113.168 -171.422 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 62.6 mtt -134.62 175.95 9.08 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 113.365 -1.743 . . . . 0.0 106.876 176.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.479 ' H ' HD23 ' A' ' 107' ' ' LEU . 2.1 pt? -121.61 132.24 54.56 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -140.21 -104.99 0.6 Allowed Glycine 0 N--CA 1.429 -1.808 0 C-N-CA 118.484 -1.817 . . . . 0.0 115.525 -174.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.491 ' HB2' ' HB3' ' A' ' 87' ' ' LYS . 37.1 m-80 -49.99 -55.33 15.05 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 115.312 1.597 . . . . 0.0 115.312 -167.523 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.46 ' O ' HG23 ' A' ' 114' ' ' VAL . 74.8 mmtt -110.89 19.79 18.18 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.833 -0.542 . . . . 0.0 111.119 -176.652 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -76.3 -33.36 59.07 Favored 'General case' 0 CA--C 1.495 -1.167 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 35.5 tp60 -62.87 -36.48 83.44 Favored 'General case' 0 N--CA 1.423 -1.821 0 CA-C-N 113.025 -1.898 . . . . 0.0 110.023 173.349 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 19.8 m -69.31 -28.53 66.35 Favored 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 179.173 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.545 HG22 ' HG ' ' A' ' 119' ' ' LEU . 38.9 t -66.76 -43.81 89.71 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.758 176.765 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 65.3 mt -67.6 -33.05 74.22 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.314 -179.368 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -72.71 -23.5 60.87 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 177.21 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 98.12 -19.32 54.98 Favored Glycine 0 N--CA 1.44 -1.063 0 CA-C-N 115.597 -0.729 . . . . 0.0 113.075 177.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -79.17 24.22 0.34 Allowed 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.534 1.134 . . . . 0.0 113.56 -172.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.599 HD13 ' O ' ' A' ' 119' ' ' LEU . 0.0 OUTLIER -94.13 109.53 21.3 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 122.914 1.34 . . . . 0.0 109.73 -178.892 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.526 ' HB3' HG21 ' A' ' 12' ' ' THR 0.341 0.1 OUTLIER -129.54 114.65 16.35 Favored 'General case' 1 C--N 1.225 -4.831 0 N-CA-C 114.449 1.277 . . . . 0.0 114.449 172.651 . . . . . . . . 5 4 . 1 . 002 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 5.4 m -126.83 173.68 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.796 0 CA-C-N 114.758 -1.11 . . . . 0.0 108.147 177.635 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.509 ' HA ' ' O ' ' A' ' 9' ' ' ARG . 8.5 p-10 -107.77 173.07 6.48 Favored 'General case' 0 C--N 1.269 -2.919 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.702 -177.65 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' PHE . . . . . 0.401 ' O ' ' HD3' ' A' ' 9' ' ' ARG . 51.1 t80 -157.81 166.78 31.82 Favored 'General case' 0 C--O 1.251 1.166 0 C-N-CA 123.93 0.892 . . . . 0.0 108.95 178.708 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 42.8 tpp . . . . . 0 N--CA 1.442 -0.827 0 C-N-CA 125.827 1.651 . . . . 0.0 106.595 -178.737 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.486 ' HB2' ' O ' ' A' ' 123' ' ' PHE . 6.9 mpt_? . . . . . 0 N--CA 1.432 -1.355 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -90.76 94.18 9.56 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 -174.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.613 ' HB ' ' OD1' ' A' ' 14' ' ' ASP . 21.6 m -89.64 104.35 15.0 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 CA-C-O 122.658 1.218 . . . . 0.0 110.648 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -122.28 -42.61 2.35 Favored 'General case' 0 C--N 1.267 -3.018 0 C-N-CA 119.285 -0.966 . . . . 0.0 112.545 174.047 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.555 ' HA ' ' HB2' ' A' ' 16' ' ' LYS 0.367 7.3 m-20 -87.62 -9.84 53.13 Favored 'General case' 0 N--CA 1.419 -1.99 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 -171.639 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.613 ' OD1' ' HB ' ' A' ' 11' ' ' VAL . 20.2 p-10 -84.32 -39.92 18.55 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 105.545 -2.021 . . . . 0.0 105.545 171.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.431 ' O ' ' HB ' ' A' ' 18' ' ' ILE . 65.0 t -65.39 -37.32 79.79 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.378 0 CA-C-N 113.847 -1.524 . . . . 0.0 109.448 174.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.555 ' HB2' ' HA ' ' A' ' 13' ' ' ASP . 1.4 tppp? -61.6 -42.7 99.24 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 124.941 1.296 . . . . 0.0 109.776 178.67 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.9 t -61.66 -45.24 94.89 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.431 ' HB ' ' O ' ' A' ' 15' ' ' VAL . 87.6 mt -54.28 -54.28 22.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.168 175.79 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.417 HG21 HG11 ' A' ' 114' ' ' VAL . 77.2 t -56.5 -47.06 82.39 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.773 0 CA-C-N 115.144 -0.934 . . . . 0.0 111.562 -179.503 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 7.3 tpt180 -51.25 -51.6 52.57 Favored 'General case' 0 C--N 1.321 -0.644 0 O-C-N 123.421 0.451 . . . . 0.0 111.282 177.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.51 ' CE1' ' HA3' ' A' ' 63' ' ' GLY . 69.0 m-85 -72.58 -35.9 68.05 Favored 'General case' 0 CA--C 1.492 -1.287 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -174.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 27.0 m -73.96 -37.13 46.96 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.533 0 C-N-CA 118.963 -1.095 . . . . 0.0 110.222 178.442 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -61.02 -50.85 71.67 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 176.078 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 . . . . . 0 C--N 1.324 -0.511 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.922 -177.796 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 . . . . . 0 N--CA 1.432 -1.327 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.462 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 68.4 p -114.73 163.44 15.46 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 179.336 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.55 ' O ' HG23 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -58.11 -39.85 79.69 Favored 'General case' 0 C--O 1.214 -0.775 0 CA-C-O 121.028 0.442 . . . . 0.0 109.885 -179.138 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.428 ' CG ' HH22 ' A' ' 73' ' ' ARG . 18.7 t-20 -60.78 -45.42 94.43 Favored 'General case' 0 C--N 1.31 -1.124 0 C-N-CA 124.967 1.307 . . . . 0.0 111.157 -175.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' MET . . . . . 0.475 ' SD ' ' HA ' ' A' ' 58' ' ' ALA . 35.6 tpp -67.48 -36.4 81.04 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.584 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' A' ' 44' ' ' THR . 73.1 mt -69.75 -29.54 66.92 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.271 -178.569 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 45' ' ' MET . 44.2 t -67.07 -48.67 78.39 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.24 0 C-N-CA 123.679 0.792 . . . . 0.0 110.37 178.732 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -58.91 -41.16 86.6 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.955 177.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.716 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 49.9 mt -63.94 -46.05 95.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.629 176.584 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.528 ' CE2' ' HA3' ' A' ' 68' ' ' GLY . 49.0 t80 -63.0 -40.08 96.69 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 123.208 0.603 . . . . 0.0 111.361 -178.423 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.0 mp -75.78 -35.12 60.21 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 111.46 8.18 23.4 Favored Glycine 0 C--O 1.244 0.734 0 C-N-CA 119.822 -1.18 . . . . 0.0 112.184 -177.297 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 63.2 m -65.63 124.19 21.72 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 123.47 0.708 . . . . 0.0 109.872 177.503 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -82.88 20.26 1.21 Allowed 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 -178.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.1 m -77.55 -24.55 49.84 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 106.163 -1.791 . . . . 0.0 106.163 172.032 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.504 ' HB1' HG12 ' A' ' 51' ' ' ILE . . . -52.85 151.06 4.8 Favored 'General case' 0 C--O 1.247 0.947 0 CA-C-N 113.529 -1.669 . . . . 0.0 112.042 178.49 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -93.92 -16.82 23.63 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.889 178.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 71.1 mt -132.03 143.5 39.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.392 -175.017 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 20.2 mm-40 -106.23 80.91 1.55 Allowed 'General case' 0 C--O 1.245 0.834 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 176.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.4 ' O ' ' HB2' ' A' ' 65' ' ' PHE . 42.0 m -79.59 173.82 12.2 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 110.121 -0.325 . . . . 0.0 110.121 179.425 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.51 ' HA3' ' CE1' ' A' ' 21' ' ' PHE . . . -60.93 -31.15 75.2 Favored Glycine 0 N--CA 1.467 0.735 0 C-N-CA 121.096 -0.573 . . . . 0.0 112.513 -179.203 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.462 HG23 ' CD2' ' A' ' 21' ' ' PHE . 5.8 pt -73.74 2.77 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.73 0 N-CA-C 113.515 0.931 . . . . 0.0 113.515 177.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.716 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 6.4 t80 -65.56 106.54 1.46 Allowed 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -178.073 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 83.41 18.69 63.76 Favored Glycine 0 N--CA 1.429 -1.776 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.493 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.426 ' CG ' ' HA ' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -86.72 -35.27 19.34 Favored 'General case' 0 CA--C 1.51 -0.576 0 C-N-CA 119.022 -1.071 . . . . 0.0 109.956 177.197 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.528 ' HA3' ' CE2' ' A' ' 52' ' ' PHE . . . -105.25 44.37 1.49 Allowed Glycine 0 N--CA 1.426 -1.982 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 44.0 t -72.49 -0.21 12.07 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 123.402 0.681 . . . . 0.0 111.002 -177.042 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -97.74 1.94 49.03 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-O 121.207 0.527 . . . . 0.0 110.64 178.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -99.55 148.41 24.32 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 115.454 -0.794 . . . . 0.0 108.955 175.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 39.1 t -90.83 161.78 15.11 Favored 'General case' 0 C--N 1.281 -2.382 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 168.371 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.468 HH11 ' HB3' ' A' ' 73' ' ' ARG . 13.5 mtp-105 -60.29 -36.19 77.3 Favored 'General case' 0 C--O 1.219 -0.522 0 CA-C-O 121.053 0.454 . . . . 0.0 110.293 -177.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -62.67 -41.64 99.19 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.113 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -65.93 -52.58 48.59 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -176.422 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.445 ' HB3' HG13 ' A' ' 49' ' ' VAL . . . -60.7 -44.12 96.94 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.473 -0.785 . . . . 0.0 112.441 -177.102 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.468 ' CG ' HG21 ' A' ' 49' ' ' VAL . 42.9 mt-10 -64.33 -33.81 76.71 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 121.585 0.707 . . . . 0.0 111.009 178.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 17.7 mmm180 -78.04 -17.0 57.57 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.913 -179.524 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.3 tt -79.84 -42.69 23.8 Favored 'General case' 0 N--CA 1.426 -1.635 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 176.232 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -60.53 -19.98 58.86 Favored 'General case' 0 C--O 1.216 -0.705 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 172.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.45 ' HA ' HG13 ' A' ' 84' ' ' ILE . 73.0 mmtt -82.75 -28.58 30.31 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.463 176.78 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 29.1 tptp -70.43 -45.42 65.9 Favored 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 174.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.508 ' HB3' HD23 ' A' ' 89' ' ' LEU . 97.8 mt -58.83 -37.1 75.67 Favored 'General case' 0 N--CA 1.428 -1.563 0 CA-C-N 113.958 -1.474 . . . . 0.0 113.834 178.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.537 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 2.7 pp -74.02 -26.94 21.58 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.592 0 C-N-CA 119.884 -0.726 . . . . 0.0 111.627 178.392 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 49.0 mt -73.42 -47.65 40.12 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 123.49 0.494 . . . . 0.0 110.507 175.232 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.424 ' HB2' HD13 ' A' ' 88' ' ' ILE . 69.5 m-20 -67.1 -25.31 66.15 Favored 'General case' 0 C--O 1.254 1.312 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.054 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? 85.51 23.52 0.08 Allowed 'General case' 0 CA--C 1.478 -1.797 0 C-N-CA 125.951 1.7 . . . . 0.0 113.475 175.309 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.612 HD11 HD21 ' A' ' 119' ' ' LEU . 2.0 mp -74.58 -41.47 48.67 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.224 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 169.42 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.537 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 3.7 mm? -103.68 140.39 37.65 Favored 'General case' 0 N--CA 1.424 -1.769 0 CA-C-N 114.153 -1.385 . . . . 0.0 109.748 175.442 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -131.35 109.75 10.57 Favored 'General case' 0 C--N 1.285 -2.216 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 176.622 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -94.96 149.21 21.5 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 121.051 0.453 . . . . 0.0 112.16 -172.403 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.472 ' O ' ' HA ' ' A' ' 103' ' ' ALA . 8.1 m-20 -97.78 108.37 21.07 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 94.5 mt -81.68 108.82 15.55 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.716 0.77 . . . . 0.0 109.661 176.498 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -120.69 125.57 48.01 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-N 114.802 -1.09 . . . . 0.0 108.402 -175.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.52 HD11 ' HA ' ' A' ' 99' ' ' ASP . 16.9 tt -130.3 141.78 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.753 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 178.471 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -97.13 173.15 7.39 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 176.792 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -66.44 18.21 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 -173.406 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -118.61 10.24 12.46 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 177.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.52 ' HA ' HD11 ' A' ' 95' ' ' ILE . 6.1 m-20 60.13 29.32 18.9 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 122.644 1.212 . . . . 0.0 111.023 -174.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.479 ' C ' HG13 ' A' ' 95' ' ' ILE . 94.0 mt-30 -95.92 106.04 18.14 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 114.426 -1.261 . . . . 0.0 107.998 176.554 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -101.36 144.33 30.31 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.626 -0.715 . . . . 0.0 112.437 -175.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 9.6 tp -141.6 146.86 22.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 174.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.472 ' HA ' ' O ' ' A' ' 92' ' ' ASP . . . -112.0 129.04 56.33 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 110.156 -0.312 . . . . 0.0 110.156 -178.769 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -97.49 162.78 13.15 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 177.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.448 HG13 ' CD1' ' A' ' 89' ' ' LEU . 8.4 t -105.16 123.71 59.5 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.862 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 -177.318 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 26.2 mmt -137.83 162.68 33.32 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 113.178 -1.828 . . . . 0.0 106.743 173.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.421 ' H ' HD23 ' A' ' 107' ' ' LEU . 1.5 pt? -127.71 123.29 35.06 Favored 'General case' 0 C--N 1.285 -2.226 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 177.463 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -125.49 -86.27 0.63 Allowed Glycine 0 N--CA 1.422 -2.237 0 C-N-CA 119.099 -1.524 . . . . 0.0 115.705 -171.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -57.32 -46.49 83.18 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 115.86 1.8 . . . . 0.0 115.86 -167.096 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.466 ' O ' HG23 ' A' ' 114' ' ' VAL . 41.9 mmtm -106.2 8.8 32.2 Favored 'General case' 0 C--N 1.308 -1.199 0 O-C-N 121.507 -0.746 . . . . 0.0 111.321 -179.095 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -54.64 -45.7 73.83 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -172.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.9 -24.28 60.82 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.213 0.53 . . . . 0.0 110.946 -176.698 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 7.2 m -75.51 -24.9 56.87 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 -178.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.534 HG21 HG23 ' A' ' 88' ' ' ILE . 21.9 t -74.97 -37.52 41.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 176.004 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 81.4 mt -66.44 -38.59 87.73 Favored 'General case' 0 C--O 1.219 -0.507 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.621 177.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -72.57 -24.99 61.18 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 174.298 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 70.64 24.7 76.68 Favored Glycine 0 C--O 1.218 -0.852 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.402 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -95.98 32.64 1.86 Allowed 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 105.788 -1.93 . . . . 0.0 105.788 176.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.612 HD21 HD11 ' A' ' 88' ' ' ILE . 0.3 OUTLIER -142.71 127.16 17.8 Favored 'General case' 0 N--CA 1.384 -3.772 0 CA-C-N 113.012 -1.904 . . . . 0.0 108.018 -174.531 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.459 ' O ' ' HD3' ' A' ' 120' ' ' LYS . 0.0 OUTLIER -130.25 137.99 50.3 Favored 'General case' 0 N--CA 1.414 -2.268 0 N-CA-C 107.896 -1.149 . . . . 0.0 107.896 172.362 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.521 HG22 ' O ' ' A' ' 11' ' ' VAL . 4.8 m -114.35 -174.79 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 C-N-CA 119.363 -0.935 . . . . 0.0 108.51 176.212 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -133.83 140.85 47.15 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -171.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' PHE . . . . . 0.486 ' O ' ' HB2' ' A' ' 9' ' ' ARG . 11.2 t80 -158.17 -175.5 5.38 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 175.47 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 26.1 ptt? . . . . . 0 C--N 1.314 -0.97 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 177.679 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 72.1 mtm180 . . . . . 0 CA--C 1.499 -0.982 0 N-CA-C 114.621 1.341 . . . . 0.0 114.621 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -98.16 90.26 4.79 Favored 'General case' 0 CA--C 1.48 -1.727 0 N-CA-C 102.146 -3.279 . . . . 0.0 102.146 170.082 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.435 ' HA ' ' OD1' ' A' ' 14' ' ' ASP . 19.0 m -71.95 84.53 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.317 0 CA-C-O 122.85 1.31 . . . . 0.0 112.652 -172.517 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.802 HG22 ' HA ' ' A' ' 120' ' ' LYS . 37.8 p -100.88 -54.79 2.73 Favored 'General case' 0 C--N 1.26 -3.301 0 C-N-CA 117.869 -1.532 . . . . 0.0 112.831 174.687 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.472 ' HA ' ' HB3' ' A' ' 16' ' ' LYS . 8.2 t70 -86.96 -11.56 50.18 Favored 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 119.405 -0.918 . . . . 0.0 110.142 -178.707 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.435 ' OD1' ' HA ' ' A' ' 11' ' ' VAL . 1.6 m-20 -69.41 -41.77 75.96 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 104.864 -2.272 . . . . 0.0 104.864 173.412 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 51.5 t -70.07 -45.37 76.49 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.828 0 CA-C-N 112.946 -1.934 . . . . 0.0 109.847 176.089 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.472 ' HB3' ' HA ' ' A' ' 13' ' ' ASP . 30.9 ttmt -65.56 -35.54 81.13 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 -179.555 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.6 p -62.72 -44.56 95.89 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 120.628 -0.429 . . . . 0.0 109.937 176.059 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 56.9 mt -53.9 -50.24 54.12 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 O-C-N 123.745 0.653 . . . . 0.0 109.725 172.348 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.47 ' HA ' HG22 ' A' ' 22' ' ' VAL . 76.5 t -58.05 -46.36 88.08 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.867 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.27 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 58.7 mtm-85 -58.33 -32.43 68.49 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.672 ' CD2' HG23 ' A' ' 64' ' ' ILE . 70.7 m-85 -83.48 -37.75 22.71 Favored 'General case' 0 N--CA 1.427 -1.58 0 C-N-CA 119.514 -0.875 . . . . 0.0 112.747 179.067 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.47 HG22 ' HA ' ' A' ' 19' ' ' VAL . 27.7 m -69.01 -29.73 44.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 C-N-CA 117.629 -1.629 . . . . 0.0 109.668 176.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.411 ' HG3' ' O ' ' A' ' 19' ' ' VAL . 54.9 mt-30 -62.61 -38.35 89.82 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.471 170.645 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.635 ' HG3' ' O ' ' A' ' 21' ' ' PHE . 0.3 OUTLIER . . . . . 0 CA--C 1.493 -1.245 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.466 -179.67 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 . . . . . 0 N--CA 1.444 -0.727 0 CA-C-O 120.887 0.375 . . . . 0.0 110.744 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 41.6 p -116.63 155.98 27.84 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 106.306 -1.738 . . . . 0.0 106.306 172.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.454 ' O ' HG23 ' A' ' 49' ' ' VAL . 16.2 ptp -62.45 -36.08 81.3 Favored 'General case' 0 C--O 1.217 -0.637 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -175.382 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -66.13 -30.94 71.52 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.936 0.398 . . . . 0.0 110.133 -178.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 22.7 mmt -73.88 -41.32 62.35 Favored 'General case' 0 C--O 1.202 -1.409 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.845 177.307 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 80.4 mt -56.43 -37.21 69.91 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.979 0.418 . . . . 0.0 110.908 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.57 HG13 ' HB3' ' A' ' 76' ' ' ALA . 74.2 t -66.11 -44.51 91.77 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.317 0 C-N-CA 124.268 1.027 . . . . 0.0 110.601 177.042 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.434 ' CG ' ' HB2' ' A' ' 55' ' ' SER . 4.5 t70 -59.72 -43.17 94.29 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.45 -178.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.419 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 1.9 mp -64.29 -47.93 87.61 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.959 174.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -54.81 -42.37 71.76 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.441 1.096 . . . . 0.0 111.16 -177.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.444 HD11 ' HB2' ' A' ' 71' ' ' TYR . 9.7 mp -83.04 -15.14 52.2 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 178.635 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.58 39.09 12.69 Favored Glycine 0 C--O 1.253 1.327 0 C-N-CA 120.417 -0.897 . . . . 0.0 111.079 -178.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.434 ' HB2' ' CG ' ' A' ' 50' ' ' ASP . 65.2 m -86.89 -172.52 4.03 Favored 'General case' 0 N--CA 1.418 -2.055 0 CA-C-N 115.294 -0.453 . . . . 0.0 111.886 -178.159 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -109.79 -4.72 15.88 Favored 'General case' 0 C--O 1.261 1.703 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 -170.213 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.3 m -78.07 -28.07 48.74 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 105.565 -2.013 . . . . 0.0 105.565 176.467 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -51.59 107.19 0.17 Allowed 'General case' 0 N--CA 1.419 -1.998 0 C-N-CA 126.56 1.944 . . . . 0.0 112.428 175.373 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.67 -7.27 28.18 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 174.212 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 28.1 mm -95.65 110.84 24.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 114.511 -1.222 . . . . 0.0 108.866 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -122.2 97.13 5.33 Favored 'General case' 0 C--N 1.293 -1.859 0 O-C-N 121.781 -0.575 . . . . 0.0 110.283 172.144 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.9 m -145.97 -80.13 0.16 Allowed 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 173.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -100.98 165.16 18.59 Favored Glycine 0 N--CA 1.433 -1.551 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.243 178.096 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.672 HG23 ' CD2' ' A' ' 21' ' ' PHE 0.26 16.6 pt 48.55 9.71 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.443 0 N-CA-C 117.573 2.434 . . . . 0.0 117.573 178.4 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.419 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 23.0 t80 -64.74 105.07 0.92 Allowed 'General case' 0 C--O 1.243 0.762 0 CA-C-N 118.442 0.565 . . . . 0.0 111.292 -177.134 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 74.56 29.63 61.34 Favored Glycine 0 C--N 1.312 -0.762 0 CA-C-N 115.628 -0.714 . . . . 0.0 112.241 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.472 ' HA ' ' HE3' ' A' ' 67' ' ' LYS . 0.7 OUTLIER -94.2 -19.31 20.86 Favored 'General case' 0 C--N 1.322 -0.611 0 O-C-N 122.409 -0.465 . . . . 0.0 111.565 176.83 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -126.53 39.09 2.05 Favored Glycine 0 N--CA 1.433 -1.538 0 C-N-CA 120.465 -0.874 . . . . 0.0 111.433 -178.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 15.5 m -71.3 1.76 5.72 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 123.944 0.898 . . . . 0.0 112.064 -177.47 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -98.99 4.27 47.18 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-O 121.422 0.629 . . . . 0.0 110.099 178.299 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.444 ' HB2' HD11 ' A' ' 53' ' ' LEU . 9.9 m-85 -95.35 147.19 23.76 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 115.291 -0.868 . . . . 0.0 108.779 175.651 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.455 ' HB3' ' CG ' ' A' ' 75' ' ' ASN . 30.5 t -75.95 149.31 37.69 Favored 'General case' 0 N--CA 1.416 -2.171 0 N-CA-C 105.299 -2.112 . . . . 0.0 105.299 169.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.444 ' O ' ' HG3' ' A' ' 77' ' ' GLU . 0.2 OUTLIER -50.33 -44.92 54.54 Favored 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 123.946 0.898 . . . . 0.0 110.339 -173.356 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.423 ' HA ' ' OE1' ' A' ' 77' ' ' GLU . 17.5 t-80 -84.87 -12.55 53.25 Favored 'General case' 0 N--CA 1.428 -1.568 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.936 -173.119 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.455 ' CG ' ' HB3' ' A' ' 72' ' ' SER . 6.5 m120 -71.58 -45.41 62.29 Favored 'General case' 0 CA--C 1.48 -1.718 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 179.273 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.57 ' HB3' HG13 ' A' ' 49' ' ' VAL . . . -63.88 -41.52 97.71 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 114.477 -1.238 . . . . 0.0 109.44 179.177 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.444 ' HG3' ' O ' ' A' ' 73' ' ' ARG . 47.9 mt-10 -61.26 -36.09 79.04 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-O 121.53 0.681 . . . . 0.0 110.508 176.136 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 62.7 ttp180 -72.75 -23.79 60.87 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.63 -177.007 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.3 tt -79.8 -44.36 20.76 Favored 'General case' 0 N--CA 1.419 -1.98 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.175 -178.644 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.434 ' HB3' ' HE2' ' A' ' 45' ' ' MET . 76.3 m-85 -63.13 -21.47 66.21 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 175.784 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.416 ' O ' HG13 ' A' ' 84' ' ' ILE . 22.6 mmtm -82.49 -28.19 31.32 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.814 176.556 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 45.8 tptt -70.29 -44.0 69.24 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 175.429 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.448 ' HB3' HD23 ' A' ' 89' ' ' LEU . 94.3 mt -62.24 -33.63 74.95 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 114.782 -1.099 . . . . 0.0 113.533 178.138 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.543 HG21 ' HG3' ' A' ' 91' ' ' GLU . 2.5 pp -75.56 -25.77 17.85 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.643 0 C-N-CA 119.716 -0.794 . . . . 0.0 111.506 178.432 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 52.4 mt -72.12 -49.06 39.15 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 121.034 0.445 . . . . 0.0 110.693 176.09 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.52 -14.2 61.17 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.267 -179.201 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.437 ' HG2' ' HB3' ' A' ' 109' ' ' ASN . 0.0 OUTLIER 83.96 13.45 0.32 Allowed 'General case' 0 CA--C 1.501 -0.915 0 C-N-CA 125.432 1.493 . . . . 0.0 112.153 167.761 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 1.8 mp -65.38 -41.65 91.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 169.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.449 ' HB3' HG22 ' A' ' 84' ' ' ILE . 3.3 mm? -103.88 148.01 26.65 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 114.107 -1.406 . . . . 0.0 110.466 174.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -132.76 127.84 35.53 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.386 177.168 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.543 ' HG3' HG21 ' A' ' 84' ' ' ILE . 46.2 mt-10 -94.53 137.16 33.98 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-O 121.264 0.554 . . . . 0.0 110.978 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -98.36 144.47 27.71 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 114.585 -1.189 . . . . 0.0 108.924 -179.392 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 91.1 mt -104.59 97.88 7.73 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 121.881 0.848 . . . . 0.0 110.528 -178.102 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.405 ' O ' ' HB1' ' A' ' 101' ' ' ALA . 32.7 t80 -100.14 111.68 23.97 Favored 'General case' 0 C--N 1.282 -2.357 0 CA-C-N 114.443 -1.253 . . . . 0.0 108.09 -177.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.67 ' HA ' ' CB ' ' A' ' 101' ' ' ALA . 1.8 tt -132.3 141.88 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.844 0 O-C-N 123.597 0.56 . . . . 0.0 111.162 174.325 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -99.32 171.38 8.01 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 177.142 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -67.8 26.4 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -172.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.448 ' O ' ' HG3' ' A' ' 100' ' ' GLN . 15.3 m120 -119.0 -4.95 10.57 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 177.114 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 57.38 33.03 22.71 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 122.802 1.287 . . . . 0.0 110.718 -174.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.448 ' HG3' ' O ' ' A' ' 98' ' ' ASN . 78.0 mt-30 -128.53 87.19 2.55 Favored 'General case' 0 CA--C 1.495 -1.151 0 CA-C-N 114.023 -1.444 . . . . 0.0 108.744 -177.66 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.67 ' CB ' ' HA ' ' A' ' 95' ' ' ILE . . . -159.39 -177.86 6.73 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -175.682 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 10.6 tp -139.42 167.75 19.45 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.332 0 O-C-N 123.366 0.416 . . . . 0.0 110.436 -170.386 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -84.74 141.18 30.73 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 122.945 0.498 . . . . 0.0 110.556 179.173 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -111.8 167.72 10.14 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.21 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 14.7 t -98.27 129.65 48.21 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -177.434 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 26.3 mmt -136.33 163.45 30.41 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 113.774 -1.557 . . . . 0.0 107.943 176.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.486 ' HB3' ' CB ' ' A' ' 111' ' ' ALA . 7.7 mp -115.19 124.35 51.19 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 176.735 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -131.8 -102.86 0.89 Allowed Glycine 0 N--CA 1.434 -1.481 0 C-N-CA 118.592 -1.765 . . . . 0.0 116.316 -173.482 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.437 ' HB3' ' HG2' ' A' ' 87' ' ' LYS . 45.1 t-20 -58.24 -45.71 87.27 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.554 1.142 . . . . 0.0 113.693 -165.627 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.516 ' HD3' ' OG1' ' A' ' 113' ' ' THR . 19.8 mmtm -111.16 13.81 21.82 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -178.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.486 ' CB ' ' HB3' ' A' ' 107' ' ' LEU . . . -70.6 -38.5 74.01 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.693 0.758 . . . . 0.0 109.681 177.132 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -64.19 -30.64 71.69 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.882 0.848 . . . . 0.0 109.246 176.335 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.516 ' OG1' ' HD3' ' A' ' 110' ' ' LYS . 17.2 m -74.53 -25.65 59.47 Favored 'General case' 0 N--CA 1.424 -1.772 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.329 -178.431 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.508 ' HA ' ' HG ' ' A' ' 119' ' ' LEU . 63.4 t -66.15 -44.83 91.49 Favored 'Isoleucine or valine' 0 C--O 1.248 0.998 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 174.23 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 59.3 mt -63.74 -42.05 97.94 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.919 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -72.3 -14.3 61.71 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.618 177.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 83.43 11.6 79.98 Favored Glycine 0 C--O 1.213 -1.161 0 C-N-CA 120.685 -0.769 . . . . 0.0 113.65 176.272 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -95.92 23.27 6.5 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 122.562 1.172 . . . . 0.0 109.481 -176.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.538 HD13 ' O ' ' A' ' 119' ' ' LEU . 0.0 OUTLIER -103.39 101.33 11.23 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-O 122.926 1.346 . . . . 0.0 108.647 -178.474 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.802 ' HA ' HG22 ' A' ' 12' ' ' THR . 0.0 OUTLIER -128.94 96.55 4.38 Favored 'General case' 1 C--N 1.229 -4.668 0 CA-C-N 115.021 -0.99 . . . . 0.0 112.957 175.512 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 5.8 m -114.13 173.45 3.16 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.777 -178.317 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -104.94 160.62 14.88 Favored 'General case' 0 C--N 1.277 -2.545 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.967 -179.122 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -158.06 135.12 10.0 Favored 'General case' 0 C--O 1.25 1.095 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.788 172.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 17.6 tmm? . . . . . 0 N--CA 1.434 -1.26 0 CA-C-N 115.132 -0.94 . . . . 0.0 108.651 -179.285 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 28.9 mmt180 . . . . . 0 CA--C 1.501 -0.924 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -118.68 108.51 15.0 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.438 HG22 ' HB2' ' A' ' 123' ' ' PHE . 12.8 m -101.61 101.3 11.91 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.167 0 CA-C-O 122.271 1.034 . . . . 0.0 110.002 177.615 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.678 HG22 ' HA ' ' A' ' 120' ' ' LYS . 42.9 p -120.17 -40.2 2.73 Favored 'General case' 0 C--N 1.264 -3.134 0 C-N-CA 119.494 -0.882 . . . . 0.0 109.8 177.154 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -69.35 -40.62 77.41 Favored 'General case' 0 C--N 1.29 -1.982 0 C-N-CA 125.867 1.667 . . . . 0.0 109.643 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -68.78 -45.29 71.72 Favored 'General case' 0 C--O 1.244 0.776 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 87.2 t -67.38 -40.83 85.48 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 CA-C-N 114.063 -1.426 . . . . 0.0 111.765 -177.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -65.31 -36.93 85.56 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.039 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 43.4 t -61.27 -46.76 89.02 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 175.175 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 68.6 mt -56.0 -54.11 30.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 C-N-CA 123.072 0.549 . . . . 0.0 110.399 177.538 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 71.7 t -59.4 -44.03 91.68 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.789 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.859 -178.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 19.6 ttt180 -61.51 -45.86 92.44 Favored 'General case' 0 N--CA 1.436 -1.13 0 C-N-CA 120.0 -0.68 . . . . 0.0 110.847 179.095 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -63.15 -42.83 99.53 Favored 'General case' 0 CA--C 1.5 -0.943 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 28.2 m -72.89 -33.47 43.62 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 C-N-CA 119.909 -0.716 . . . . 0.0 111.006 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -65.98 -54.86 20.72 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 121.164 -0.214 . . . . 0.0 110.796 173.706 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 . . . . . 0 N--CA 1.467 0.392 0 CA-C-O 121.365 0.602 . . . . 0.0 111.114 -177.278 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 . . . . . 0 N--CA 1.436 -1.144 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.418 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 57.6 p -116.37 158.02 24.14 Favored 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 171.078 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.45 ' O ' HG23 ' A' ' 49' ' ' VAL . 21.2 ptm -54.91 -37.85 66.88 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 120.283 -0.567 . . . . 0.0 111.634 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -66.05 -36.02 82.12 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 46.0 mtt -66.94 -42.97 84.37 Favored 'General case' 0 CA--C 1.497 -1.09 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.168 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 44' ' ' THR . 80.8 mt -59.34 -45.58 90.98 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.111 -178.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 45' ' ' MET . 82.2 t -66.43 -52.78 42.95 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.137 0 C-N-CA 123.908 0.883 . . . . 0.0 111.311 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.16 -39.79 87.65 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.182 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.514 HD12 ' HA ' ' A' ' 58' ' ' ALA . 1.8 mp -71.6 -38.73 68.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 O-C-N 121.984 -0.447 . . . . 0.0 111.402 177.586 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.487 ' CE2' ' HA3' ' A' ' 68' ' ' GLY . 60.2 t80 -55.47 -37.71 68.16 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 124.111 0.964 . . . . 0.0 111.293 -178.191 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.5 mp -92.7 -25.85 18.04 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 177.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.33 50.23 4.61 Favored Glycine 0 C--O 1.22 -0.731 0 N-CA-C 108.694 -1.762 . . . . 0.0 108.694 -172.343 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 47.6 t -97.56 -170.24 1.97 Allowed 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 124.535 1.134 . . . . 0.0 112.92 -171.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.507 ' HB2' ' NZ ' ' A' ' 56' ' ' LYS . 6.2 mtmp? -43.55 -53.69 5.42 Favored 'General case' 0 C--O 1.247 0.925 0 C-N-CA 128.137 2.575 . . . . 0.0 112.282 -178.24 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.5 m -94.46 9.05 39.95 Favored 'General case' 0 N--CA 1.417 -2.087 0 CA-C-N 114.54 -1.209 . . . . 0.0 111.406 -171.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.532 ' HB1' ' HE2' ' A' ' 65' ' ' PHE . . . -82.41 91.12 6.78 Favored 'General case' 0 N--CA 1.399 -2.998 0 CA-C-O 121.918 0.866 . . . . 0.0 110.21 178.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.542 ' HA ' HE22 ' A' ' 61' ' ' GLN . 62.7 mttp -119.96 24.11 10.68 Favored 'General case' 0 C--N 1.287 -2.148 0 CA-C-N 114.622 -1.172 . . . . 0.0 109.519 179.259 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.458 ' HB ' HG12 ' A' ' 51' ' ' ILE . 1.9 mp -105.39 -55.4 5.66 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 CA-C-N 115.356 -0.838 . . . . 0.0 113.028 -178.618 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.542 HE22 ' HA ' ' A' ' 59' ' ' LYS . 26.2 mp0 67.22 -7.73 0.5 Allowed 'General case' 0 N--CA 1.507 2.376 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 175.242 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.423 ' H ' HG22 ' A' ' 60' ' ' ILE . 12.6 m -94.59 84.71 4.33 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-O 120.765 0.317 . . . . 0.0 110.449 -179.128 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 101.67 138.74 10.29 Favored Glycine 0 N--CA 1.437 -1.246 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.024 178.279 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . 0.258 10.8 pt 49.45 14.92 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 N-CA-C 116.217 1.932 . . . . 0.0 116.217 177.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.539 ' CD2' ' HA ' ' A' ' 61' ' ' GLN . 27.9 t80 -75.5 104.88 6.25 Favored 'General case' 0 N--CA 1.419 -1.987 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -177.331 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 88.48 12.62 64.6 Favored Glycine 0 N--CA 1.437 -1.264 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.186 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.61 -34.53 77.19 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 -179.211 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.487 ' HA3' ' CE2' ' A' ' 52' ' ' PHE . . . -134.27 48.92 0.92 Allowed Glycine 0 N--CA 1.421 -2.324 0 C-N-CA 119.628 -1.272 . . . . 0.0 112.536 -175.675 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 19.9 m -71.36 4.27 3.06 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 120.975 0.417 . . . . 0.0 111.804 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -102.97 1.35 33.53 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-O 121.325 0.584 . . . . 0.0 109.99 177.225 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -95.26 160.11 14.69 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 174.633 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 41.2 t -88.75 169.98 11.17 Favored 'General case' 0 N--CA 1.411 -2.417 0 N-CA-C 103.901 -2.629 . . . . 0.0 103.901 165.292 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.53 ' O ' ' HG3' ' A' ' 77' ' ' GLU . 10.9 ptm180 -64.96 -27.37 68.79 Favored 'General case' 0 C--O 1.2 -1.536 0 C-N-CA 118.462 -1.295 . . . . 0.0 110.166 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.668 ' O ' ' HG2' ' A' ' 78' ' ' ARG . 34.2 m170 -57.34 -59.74 4.68 Favored 'General case' 0 C--O 1.209 -1.065 0 O-C-N 124.169 0.918 . . . . 0.0 112.439 -177.749 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.642 ' HA ' ' CG ' ' A' ' 78' ' ' ARG 0.398 12.9 m-80 -64.18 -28.0 69.46 Favored 'General case' 0 CA--C 1.485 -1.529 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 177.715 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.4 -50.59 72.24 Favored 'General case' 0 N--CA 1.439 -1.001 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 171.444 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.65 ' O ' ' HG2' ' A' ' 81' ' ' LYS . 42.9 mt-10 -56.83 -42.81 80.3 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.599 0.759 . . . . 0.0 111.078 177.664 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.668 ' HG2' ' O ' ' A' ' 74' ' ' HIS . 13.1 mmt85 -59.13 -36.41 75.18 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -175.62 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -77.57 -47.45 19.4 Favored 'General case' 0 CA--C 1.47 -2.125 0 CA-C-N 114.675 -1.148 . . . . 0.0 111.84 -172.356 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -62.91 -20.75 65.48 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 121.594 0.711 . . . . 0.0 109.207 178.504 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.65 ' HG2' ' O ' ' A' ' 77' ' ' GLU . 30.6 mmmt -88.87 -26.13 21.78 Favored 'General case' 0 N--CA 1.436 -1.133 0 C-N-CA 118.938 -1.105 . . . . 0.0 109.669 179.328 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 29.8 tptp -69.74 -45.69 67.58 Favored 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 177.41 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.408 ' HB3' HD23 ' A' ' 89' ' ' LEU . 95.8 mt -56.71 -40.77 76.23 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-N 114.086 -1.415 . . . . 0.0 113.581 177.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.605 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 2.5 pp -78.11 -18.12 13.77 Favored 'Isoleucine or valine' 0 C--O 1.254 1.342 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 179.242 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 46.9 mt -81.59 -48.66 11.48 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.49 175.239 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -66.49 -33.84 76.6 Favored 'General case' 0 C--O 1.249 1.042 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.002 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.629 ' HB3' ' HB2' ' A' ' 109' ' ' ASN 0.274 57.8 mttm 84.78 27.71 0.07 Allowed 'General case' 0 CA--C 1.454 -2.712 0 C-N-CA 126.524 1.93 . . . . 0.0 115.181 174.792 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.535 HG23 HG21 ' A' ' 114' ' ' VAL . 1.8 mp -67.75 -36.37 75.7 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.274 0 N-CA-C 105.111 -2.181 . . . . 0.0 105.111 164.854 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.605 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 4.4 mm? -110.94 151.68 27.64 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 114.005 -1.452 . . . . 0.0 108.318 171.772 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -141.43 111.95 7.01 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 177.146 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -92.46 143.23 26.57 Favored 'General case' 0 C--N 1.278 -2.518 0 CA-C-O 121.676 0.751 . . . . 0.0 111.439 -176.542 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -98.51 113.07 24.94 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 114.726 -1.125 . . . . 0.0 109.496 -178.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 72.1 mt -78.0 113.93 16.38 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 114.673 -1.149 . . . . 0.0 109.745 -178.308 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 92.0 t80 -119.46 100.04 7.05 Favored 'General case' 0 N--CA 1.417 -2.076 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 178.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.867 ' HA ' ' HB3' ' A' ' 101' ' ' ALA . 0.3 OUTLIER -130.89 144.05 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.388 -3.537 0 C-N-CA 119.409 -0.917 . . . . 0.0 109.467 -178.672 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.441 ' H ' HD13 ' A' ' 95' ' ' ILE . 40.3 p30 -100.84 -178.92 3.91 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 120.306 -0.558 . . . . 0.0 111.453 -176.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -80.32 15.5 1.57 Allowed 'General case' 0 C--N 1.316 -0.874 0 C-N-CA 123.841 0.856 . . . . 0.0 111.275 -178.242 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.479 ' HB3' ' NE2' ' A' ' 100' ' ' GLN . 2.6 m-20 -117.54 -0.4 11.91 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 58.92 27.22 15.93 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 124.548 1.155 . . . . 0.0 110.17 -174.162 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.479 ' NE2' ' HB3' ' A' ' 98' ' ' ASN . 42.0 mt-30 -128.94 68.63 1.4 Allowed 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.756 -1.111 . . . . 0.0 111.933 -174.494 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.867 ' HB3' ' HA ' ' A' ' 95' ' ' ILE . . . -158.43 178.85 9.7 Favored 'General case' 0 C--N 1.273 -2.723 0 CA-C-N 114.577 -1.192 . . . . 0.0 108.42 178.364 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 14.7 tt -140.57 157.15 23.94 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.973 0 CA-C-N 118.708 0.685 . . . . 0.0 112.196 -170.553 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -85.64 135.02 33.96 Favored 'General case' 0 C--O 1.255 1.38 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.758 176.327 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -103.65 165.76 10.84 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 54.0 t -111.92 135.23 51.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -176.363 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 14.6 mmt -138.61 -173.59 3.59 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 113.463 -1.699 . . . . 0.0 107.775 176.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -137.26 138.21 39.84 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 177.309 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -145.52 -84.6 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.893 0 C-N-CA 118.313 -1.899 . . . . 0.0 116.456 -174.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.629 ' HB2' ' HB3' ' A' ' 87' ' ' LYS . 14.9 m120 -56.57 -50.46 71.86 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 -166.524 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 40.0 mmtm -104.06 3.89 33.73 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.615 -0.678 . . . . 0.0 110.554 -176.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -58.31 -31.68 67.74 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 123.022 0.529 . . . . 0.0 112.29 -178.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.59 -26.22 63.42 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-O 121.57 0.7 . . . . 0.0 110.112 179.347 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 4.8 m -80.0 -23.88 41.23 Favored 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.535 HG21 HG23 ' A' ' 88' ' ' ILE . 54.5 t -67.9 -36.13 74.61 Favored 'Isoleucine or valine' 0 C--O 1.246 0.918 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 174.211 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 75.2 mt -73.22 -34.92 66.18 Favored 'General case' 0 C--O 1.216 -0.696 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.661 177.479 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -72.32 -14.51 61.76 Favored 'General case' 0 C--O 1.217 -0.629 0 CA-C-O 122.211 1.005 . . . . 0.0 108.709 175.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 94.18 -19.02 55.6 Favored Glycine 0 N--CA 1.44 -1.092 0 CA-C-N 115.186 -0.915 . . . . 0.0 113.163 176.143 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -87.63 66.57 8.97 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.738 0.78 . . . . 0.0 111.738 -173.255 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.47 HD22 ' O ' ' A' ' 119' ' ' LEU . 0.0 OUTLIER -126.75 79.44 1.87 Allowed 'General case' 0 C--N 1.288 -2.096 0 CA-C-O 123.636 1.684 . . . . 0.0 110.628 175.675 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.678 ' HA ' HG22 ' A' ' 12' ' ' THR . 0.0 OUTLIER -101.14 96.32 7.13 Favored 'General case' 0 C--N 1.264 -3.136 0 CA-C-N 114.587 -1.188 . . . . 0.0 112.136 174.877 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 5.9 m -93.25 172.34 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.138 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 177.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -110.98 163.87 13.38 Favored 'General case' 0 C--N 1.263 -3.161 0 CA-C-N 115.178 -0.919 . . . . 0.0 108.77 178.242 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' PHE . . . . . 0.438 ' HB2' HG22 ' A' ' 11' ' ' VAL . 38.3 t80 -153.64 174.97 13.79 Favored 'General case' 0 N--CA 1.424 -1.769 0 CA-C-O 121.69 0.757 . . . . 0.0 111.287 -179.133 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 60.2 mtt . . . . . 0 N--CA 1.426 -1.632 0 C-N-CA 126.152 1.781 . . . . 0.0 108.137 -179.25 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 74.0 mtt180 . . . . . 0 N--CA 1.428 -1.555 0 CA-C-O 121.237 0.542 . . . . 0.0 111.334 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -78.26 89.62 4.32 Favored 'General case' 0 CA--C 1.491 -1.303 0 CA-C-O 122.408 1.099 . . . . 0.0 109.854 -178.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.512 HG13 ' HB2' ' A' ' 14' ' ' ASP . 21.3 t -84.88 103.99 12.59 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.689 0 CA-C-N 113.395 -1.73 . . . . 0.0 109.772 -177.507 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.618 HG22 ' HA ' ' A' ' 120' ' ' LYS . 21.5 p -121.01 -50.41 2.16 Favored 'General case' 0 N--CA 1.413 -2.31 0 C-N-CA 117.758 -1.577 . . . . 0.0 112.482 175.473 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.438 ' HA ' ' CB ' ' A' ' 16' ' ' LYS . 0.3 OUTLIER -87.37 -11.91 47.92 Favored 'General case' 0 N--CA 1.426 -1.675 0 C-N-CA 119.126 -1.03 . . . . 0.0 112.304 -173.843 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.512 ' HB2' HG13 ' A' ' 11' ' ' VAL . 0.7 OUTLIER -65.85 -52.35 51.16 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 103.978 -2.601 . . . . 0.0 103.978 169.195 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.51 HG23 HG12 ' A' ' 11' ' ' VAL . 31.3 t -56.77 -44.2 81.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 113.581 -1.645 . . . . 0.0 111.337 174.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.447 ' HE2' ' O ' ' A' ' 114' ' ' VAL . 2.0 tppp? -57.78 -45.28 86.21 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.788 177.383 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 53.4 m -61.78 -41.58 97.89 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.5 178.325 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.431 ' HB ' ' O ' ' A' ' 15' ' ' VAL . 66.2 mt -53.63 -52.64 31.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 O-C-N 123.748 0.655 . . . . 0.0 109.459 173.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.495 HG21 HG11 ' A' ' 114' ' ' VAL . 93.0 t -57.78 -45.05 87.13 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.576 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.74 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.436 ' HG3' ' O ' ' A' ' 16' ' ' LYS . 64.3 mtt85 -53.52 -45.72 69.87 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.151 0.501 . . . . 0.0 110.728 178.656 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.541 ' HA ' ' HG3' ' A' ' 24' ' ' GLU . 77.1 m-85 -83.18 -33.88 26.1 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 -174.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.42 HG22 ' O ' ' A' ' 18' ' ' ILE . 27.0 m -73.25 -31.77 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.521 0 C-N-CA 118.376 -1.329 . . . . 0.0 110.107 177.651 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -59.97 -48.73 80.5 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.194 174.445 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.541 ' HG3' ' HA ' ' A' ' 21' ' ' PHE . 1.5 pp20? . . . . . 0 C--O 1.238 0.453 0 C-N-CA 120.292 -0.563 . . . . 0.0 112.111 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 . . . . . 0 CA--C 1.485 -1.532 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.684 ' HA ' ' HA ' ' A' ' 104' ' ' TYR . 55.4 p -82.13 155.55 24.96 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 175.328 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.592 ' O ' HG23 ' A' ' 49' ' ' VAL . 5.8 ptm -52.34 -35.67 51.59 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-O 121.427 0.632 . . . . 0.0 110.124 177.295 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.539 ' N ' ' HG3' ' A' ' 45' ' ' MET . 8.3 t30 -63.22 -40.09 96.49 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.439 -1.255 . . . . 0.0 110.839 -175.434 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' MET . . . . . 0.538 ' HG3' ' OG1' ' A' ' 44' ' ' THR . 64.5 mtt -69.27 -36.44 77.1 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-O 121.554 0.692 . . . . 0.0 109.928 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 82.3 mt -67.91 -33.74 75.28 Favored 'General case' 0 C--O 1.206 -1.186 0 CA-C-N 114.992 -1.004 . . . . 0.0 111.227 -178.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.596 HG21 ' HG2' ' A' ' 77' ' ' GLU . 88.1 t -67.96 -38.88 80.69 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.016 0 C-N-CA 123.355 0.662 . . . . 0.0 110.303 178.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -53.69 -47.5 70.41 Favored 'General case' 0 CA--C 1.506 -0.732 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.128 175.102 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.46 HG23 ' HD2' ' A' ' 65' ' ' PHE . 4.9 mt -76.83 -38.58 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.524 0 CA-C-N 114.717 -1.129 . . . . 0.0 111.738 -176.31 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.464 ' CE2' ' HA3' ' A' ' 68' ' ' GLY . 60.5 t80 -53.1 -48.08 68.09 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 125.019 1.328 . . . . 0.0 110.733 179.142 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.9 mp -77.52 -12.12 59.93 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.085 -0.507 . . . . 0.0 112.302 178.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.95 26.97 54.68 Favored Glycine 0 C--O 1.249 1.066 0 C-N-CA 120.915 -0.659 . . . . 0.0 111.702 -179.323 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 40.2 t -67.29 176.4 2.27 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-O 121.797 0.808 . . . . 0.0 111.048 -176.426 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.474 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 0.7 OUTLIER -106.8 6.63 29.69 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 122.055 0.931 . . . . 0.0 110.117 176.592 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 27.8 p -90.89 1.21 57.17 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 169.28 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.74 117.41 8.85 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-N 113.69 -1.596 . . . . 0.0 108.893 178.451 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 43.0 mttp -81.52 -11.83 59.04 Favored 'General case' 0 C--N 1.29 -2.02 0 CA-C-N 114.801 -1.09 . . . . 0.0 111.862 -172.079 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 66.7 mt -143.42 138.3 26.04 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.94 0 N-CA-C 105.953 -1.869 . . . . 0.0 105.953 175.524 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.597 ' HA ' ' CE2' ' A' ' 65' ' ' PHE . 25.6 mm-40 -93.6 44.78 1.14 Allowed 'General case' 0 C--N 1.3 -1.584 0 CA-C-O 120.993 0.425 . . . . 0.0 110.5 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 42.2 m -153.95 153.03 31.28 Favored 'General case' 0 C--O 1.245 0.844 0 O-C-N 122.026 -0.421 . . . . 0.0 110.203 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 80.92 109.29 0.31 Allowed Glycine 0 C--O 1.2 -2.014 0 CA-C-O 119.393 -0.671 . . . . 0.0 111.599 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . 0.275 3.7 pt 51.94 17.59 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 C-N-CA 125.007 1.323 . . . . 0.0 114.494 -176.255 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.597 ' CE2' ' HA ' ' A' ' 61' ' ' GLN . 18.3 t80 -62.68 107.53 0.98 Allowed 'General case' 0 C--O 1.252 1.222 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.515 -176.477 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 64.29 41.65 98.13 Favored Glycine 0 N--CA 1.434 -1.452 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.408 178.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.421 ' HD3' ' HA ' ' A' ' 67' ' ' LYS . 28.3 mmtm -114.86 -3.98 12.68 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.22 0.533 . . . . 0.0 111.017 177.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.464 ' HA3' ' CE2' ' A' ' 52' ' ' PHE . . . -133.51 30.32 3.02 Favored Glycine 0 N--CA 1.425 -2.055 0 N-CA-C 110.19 -1.164 . . . . 0.0 110.19 176.782 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 16.5 m -70.35 2.16 4.15 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 123.91 0.884 . . . . 0.0 112.417 -176.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -98.74 7.19 46.36 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-O 122.081 0.944 . . . . 0.0 109.199 176.668 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -108.28 146.65 32.59 Favored 'General case' 0 N--CA 1.418 -2.04 0 CA-C-N 114.675 -1.148 . . . . 0.0 108.825 177.361 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 44.6 t -86.15 169.21 13.3 Favored 'General case' 0 C--N 1.288 -2.081 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 171.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 -58.77 -35.18 72.36 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 177.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 23.2 t-80 -61.61 -40.17 93.88 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 113.487 -1.688 . . . . 0.0 110.26 178.318 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -80.97 -49.89 10.39 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.522 -172.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.405 ' O ' ' HD2' ' A' ' 80' ' ' PHE . . . -59.31 -48.99 79.55 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.136 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.625 ' O ' ' HG3' ' A' ' 81' ' ' LYS . 18.3 mt-10 -65.16 -34.31 78.09 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 70.2 ttt180 -69.32 -28.61 66.39 Favored 'General case' 0 CA--C 1.521 -0.149 0 C-N-CA 119.432 -0.907 . . . . 0.0 109.476 -177.083 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.0 tt -78.77 -48.55 14.62 Favored 'General case' 0 N--CA 1.422 -1.832 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.569 -178.267 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.425 ' HA ' HD12 ' A' ' 83' ' ' LEU . 58.1 m-85 -59.54 -21.27 60.01 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-O 121.397 0.617 . . . . 0.0 110.235 177.369 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.625 ' HG3' ' O ' ' A' ' 77' ' ' GLU . 46.2 mttm -85.35 -26.29 26.59 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 119.208 -0.997 . . . . 0.0 109.097 179.116 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 58.9 tttp -73.34 -38.55 65.72 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 175.027 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.425 HD12 ' HA ' ' A' ' 80' ' ' PHE . 95.7 mt -58.05 -37.36 74.25 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 177.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.508 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 2.4 pp -75.86 -26.21 17.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 120.232 -0.587 . . . . 0.0 111.626 177.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 51.4 mt -74.97 -49.38 20.19 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.555 175.481 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -70.49 -24.11 62.79 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.578 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.288 50.6 mttm 83.23 24.07 0.14 Allowed 'General case' 0 CA--C 1.469 -2.171 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 172.545 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.418 HG23 HG21 ' A' ' 114' ' ' VAL . 2.0 mp -69.74 -39.95 78.6 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.273 0 N-CA-C 105.117 -2.179 . . . . 0.0 105.117 165.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.508 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 4.3 mm? -111.6 150.04 30.63 Favored 'General case' 0 CA--C 1.498 -1.041 0 CA-C-N 114.067 -1.424 . . . . 0.0 108.271 173.587 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -137.77 110.61 7.66 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.595 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.472 ' HA ' ' O ' ' A' ' 104' ' ' TYR . 38.8 mt-10 -95.35 147.52 23.42 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 177.809 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.565 ' O ' ' HA ' ' A' ' 103' ' ' ALA . 16.8 t70 -97.48 142.8 28.88 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.729 -1.123 . . . . 0.0 108.825 178.521 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 94.7 mt -103.75 101.72 11.55 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-O 121.971 0.891 . . . . 0.0 110.144 -178.059 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 72.0 t80 -107.74 115.65 30.54 Favored 'General case' 0 C--N 1.275 -2.658 0 CA-C-N 114.252 -1.34 . . . . 0.0 108.331 -175.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.411 HG13 ' C ' ' A' ' 100' ' ' GLN . 17.1 tt -121.23 141.69 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.657 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.459 ' C ' ' H ' ' A' ' 98' ' ' ASN . 13.1 m-80 -97.44 -171.79 2.27 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -179.016 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -73.5 21.66 0.08 Allowed 'General case' 0 C--N 1.311 -1.094 0 C-N-CA 125.337 1.455 . . . . 0.0 111.203 178.023 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.459 ' H ' ' C ' ' A' ' 96' ' ' ASN . 80.6 m-20 -119.29 -2.64 10.61 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 108.866 -0.791 . . . . 0.0 108.866 -178.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 59.42 25.45 14.2 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-O 122.832 1.301 . . . . 0.0 110.257 -172.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.411 ' C ' HG13 ' A' ' 95' ' ' ILE . 92.8 mt-30 -100.05 108.65 20.88 Favored 'General case' 0 C--O 1.251 1.132 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 177.047 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -96.52 142.48 28.54 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 124.051 0.845 . . . . 0.0 111.567 -176.148 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 10.5 tp -131.44 145.21 35.56 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 174.519 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.565 ' HA ' ' O ' ' A' ' 92' ' ' ASP . . . -113.5 138.76 49.66 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.488 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.684 ' HA ' ' HA ' ' A' ' 44' ' ' THR . 24.8 p90 -134.74 163.47 29.71 Favored 'General case' 0 CA--C 1.496 -1.108 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 176.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.491 HG13 HD12 ' A' ' 89' ' ' LEU . 6.7 t -94.83 134.06 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.636 0 N-CA-C 115.112 1.523 . . . . 0.0 115.112 -163.836 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 68.9 mtm -140.69 168.92 18.65 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 111.422 -2.626 . . . . 0.0 105.14 173.04 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 7.0 mp -90.77 136.69 32.9 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 -179.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -91.57 -178.58 42.49 Favored Glycine 0 N--CA 1.438 -1.232 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.506 -176.582 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -70.23 -13.3 62.11 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -176.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.434 ' O ' HG23 ' A' ' 114' ' ' VAL . 46.9 mmtt -93.73 -3.65 51.85 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 178.439 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -62.01 -29.39 70.23 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.969 0.414 . . . . 0.0 111.223 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.442 ' HA ' ' HG ' ' A' ' 115' ' ' LEU . 0.0 OUTLIER -72.35 -31.96 66.07 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 120.218 -0.593 . . . . 0.0 110.247 179.673 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 9.9 m -72.87 -25.72 61.2 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -178.312 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.495 HG11 HG21 ' A' ' 19' ' ' VAL . 22.0 t -72.1 -42.91 67.38 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.244 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.681 177.051 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.442 ' HG ' ' HA ' ' A' ' 112' ' ' GLN . 4.6 pp -67.87 -33.73 75.31 Favored 'General case' 0 CA--C 1.51 -0.57 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.969 178.722 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -71.41 -27.8 63.56 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 172.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 73.49 21.76 79.21 Favored Glycine 0 CA--C 1.495 -1.179 0 CA-C-N 115.333 -0.849 . . . . 0.0 112.36 177.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -97.33 35.51 1.61 Allowed 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 104.95 -2.241 . . . . 0.0 104.95 177.144 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.451 HD13 ' C ' ' A' ' 119' ' ' LEU . 0.4 OUTLIER -142.42 124.91 15.7 Favored 'General case' 0 N--CA 1.381 -3.906 0 CA-C-N 113.037 -1.892 . . . . 0.0 107.165 -174.241 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.618 ' HA ' HG22 ' A' ' 12' ' ' THR . 0.2 OUTLIER -129.87 132.84 46.56 Favored 'General case' 0 N--CA 1.393 -3.295 0 N-CA-C 106.795 -1.558 . . . . 0.0 106.795 172.089 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.508 HG22 ' O ' ' A' ' 11' ' ' VAL . 14.0 m -106.51 -178.81 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 C-N-CA 118.528 -1.269 . . . . 0.0 107.924 174.426 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -129.28 134.07 47.77 Favored 'General case' 0 C--N 1.254 -3.573 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 178.255 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -107.32 113.54 26.99 Favored 'General case' 0 C--N 1.273 -2.719 0 C-N-CA 118.95 -1.1 . . . . 0.0 110.545 171.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 17.3 ptp . . . . . 0 C--N 1.295 -1.795 0 CA-C-N 113.453 -1.703 . . . . 0.0 108.847 176.496 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 54.6 ttt180 . . . . . 0 N--CA 1.394 -3.253 0 N-CA-C 104.037 -2.579 . . . . 0.0 104.037 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.467 ' CG ' ' HZ1' ' A' ' 120' ' ' LYS . 1.9 t70 -77.57 98.78 5.5 Favored 'General case' 0 CA--C 1.488 -1.434 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -174.19 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.484 ' HB ' HG23 ' A' ' 15' ' ' VAL . 30.4 m -99.94 65.58 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.275 -2.648 0 CA-C-O 122.417 1.103 . . . . 0.0 112.964 -173.52 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.467 ' O ' ' HB2' ' A' ' 16' ' ' LYS . 2.1 t -111.53 -37.74 5.13 Favored 'General case' 0 C--N 1.263 -3.188 0 C-N-CA 119.495 -0.882 . . . . 0.0 109.001 169.083 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -84.83 -20.64 30.6 Favored 'General case' 0 CA--C 1.496 -1.1 0 CA-C-O 120.989 0.423 . . . . 0.0 111.221 174.593 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -76.24 -44.49 37.26 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 105.425 -2.065 . . . . 0.0 105.425 175.141 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.551 ' O ' ' HB ' ' A' ' 18' ' ' ILE . 4.9 t -64.35 -21.88 30.01 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.48 0 CA-C-N 112.938 -1.937 . . . . 0.0 111.167 174.623 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.636 ' HE2' ' O ' ' A' ' 114' ' ' VAL . 34.2 ttmt -75.09 -35.55 61.77 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 122.016 -0.427 . . . . 0.0 110.568 179.112 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 68.9 p -67.39 -31.25 71.34 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 119.358 -0.937 . . . . 0.0 108.883 173.12 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.551 ' HB ' ' O ' ' A' ' 15' ' ' VAL . 36.0 mt -63.62 -48.13 88.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.757 173.219 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 15' ' ' VAL . 97.2 t -56.96 -47.77 82.76 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.774 0 C-N-CA 123.289 0.636 . . . . 0.0 109.868 176.805 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.643 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 0.9 OUTLIER -52.61 -53.71 43.07 Favored 'General case' 0 C--O 1.22 -0.49 0 O-C-N 123.898 0.749 . . . . 0.0 109.332 176.838 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.423 ' HB2' HG13 ' A' ' 64' ' ' ILE . 83.2 t80 -52.94 -57.14 11.31 Favored 'General case' 0 N--CA 1.448 -0.545 0 O-C-N 124.424 1.078 . . . . 0.0 112.223 -178.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 27.1 m -67.78 -38.78 80.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.779 -177.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -60.33 -50.28 74.23 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 176.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.643 ' HG2' ' O ' ' A' ' 20' ' ' ARG . 10.3 pt-20 . . . . . 0 C--N 1.327 -0.41 0 C-N-CA 120.208 -0.597 . . . . 0.0 112.083 -178.095 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 . . . . . 0 CA--C 1.481 -1.699 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.41 HG21 HD11 ' A' ' 102' ' ' ILE . 80.2 p -120.94 157.13 30.57 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -177.563 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.419 ' O ' HG23 ' A' ' 49' ' ' VAL . 22.0 ptm -50.13 -39.59 43.63 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.353 0.661 . . . . 0.0 112.63 -178.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.4 ' N ' ' HG3' ' A' ' 45' ' ' MET . 18.9 t-20 -68.71 -39.29 80.52 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.156 -172.492 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 23.4 mmt -67.34 -38.6 85.11 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.467 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 78.7 mt -63.35 -41.95 98.89 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.247 -178.392 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.462 HG13 ' HB3' ' A' ' 76' ' ' ALA . 69.6 t -66.01 -45.16 91.55 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.058 0 C-N-CA 123.68 0.792 . . . . 0.0 110.679 179.435 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.566 ' OD2' ' HB3' ' A' ' 55' ' ' SER . 4.4 t70 -61.92 -36.78 82.39 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 114.678 -1.146 . . . . 0.0 109.626 -177.148 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.672 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 75.4 mt -69.54 -50.21 52.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.568 174.432 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.508 ' CE2' ' HA3' ' A' ' 68' ' ' GLY . 50.4 t80 -50.86 -41.21 57.74 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.446 1.098 . . . . 0.0 111.775 179.175 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.9 mp -80.17 -30.51 38.83 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 177.065 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 99.2 33.06 5.57 Favored Glycine 0 C--O 1.248 1.002 0 C-N-CA 120.166 -1.016 . . . . 0.0 112.725 -179.101 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.566 ' HB3' ' OD2' ' A' ' 50' ' ' ASP . 32.0 t -86.8 -176.45 5.78 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 123.291 0.636 . . . . 0.0 111.15 -176.06 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.14 9.17 17.12 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -176.72 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 16.9 m -89.44 -17.66 28.29 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 175.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.48 ' HB1' HG12 ' A' ' 51' ' ' ILE . . . -50.85 173.8 0.02 OUTLIER 'General case' 0 N--CA 1.432 -1.329 0 C-N-CA 128.861 2.865 . . . . 0.0 113.476 176.61 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.0 mmmp? -116.87 11.02 14.31 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 -179.138 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.429 HG22 HD13 ' A' ' 51' ' ' ILE . 15.5 tt -158.65 164.82 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 N-CA-C 104.795 -2.298 . . . . 0.0 104.795 175.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -125.74 21.96 7.58 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 119.021 0.828 . . . . 0.0 110.42 177.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 43.8 m -152.24 146.95 25.83 Favored 'General case' 0 C--N 1.322 -0.63 0 O-C-N 122.002 -0.436 . . . . 0.0 110.037 -178.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.554 ' C ' ' H ' ' A' ' 65' ' ' PHE . . . 82.15 111.37 0.42 Allowed Glycine 0 C--O 1.212 -1.28 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.632 HG22 HG22 ' A' ' 51' ' ' ILE . 3.4 mm 70.25 -18.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 CA-C-O 121.971 0.891 . . . . 0.0 111.64 -176.269 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.672 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 3.5 t80 -65.46 104.45 0.99 Allowed 'General case' 0 N--CA 1.399 -2.986 0 C-N-CA 125.318 1.447 . . . . 0.0 109.202 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 102.93 0.36 48.52 Favored Glycine 0 N--CA 1.434 -1.46 0 C-N-CA 120.814 -0.707 . . . . 0.0 111.713 -178.511 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.526 ' HG3' HD13 ' A' ' 64' ' ' ILE . 2.9 mmmp? -67.35 -19.48 65.44 Favored 'General case' 0 C--O 1.252 1.189 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.508 ' HA3' ' CE2' ' A' ' 52' ' ' PHE . . . -148.81 49.76 0.58 Allowed Glycine 0 C--O 1.207 -1.544 0 C-N-CA 120.462 -0.875 . . . . 0.0 111.644 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 16.0 m -70.6 0.78 6.18 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -178.061 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -100.37 -5.34 27.44 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-O 121.094 0.473 . . . . 0.0 110.303 178.589 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -80.41 144.11 32.92 Favored 'General case' 0 N--CA 1.428 -1.547 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.49 177.19 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 34.5 t -77.33 134.68 38.44 Favored 'General case' 0 N--CA 1.398 -3.029 0 N-CA-C 102.928 -2.989 . . . . 0.0 102.928 167.321 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.519 ' O ' ' HG3' ' A' ' 77' ' ' GLU . 10.6 ptm180 -52.12 -38.64 58.1 Favored 'General case' 0 C--O 1.202 -1.43 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -173.01 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.565 ' HA ' ' OE1' ' A' ' 77' ' ' GLU . 32.4 t-80 -70.86 -24.31 62.49 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 120.978 0.418 . . . . 0.0 111.475 -175.543 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -81.69 -38.2 26.21 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.462 ' HB3' HG13 ' A' ' 49' ' ' VAL . . . -63.29 -40.21 96.73 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 174.399 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.66 ' O ' ' HG2' ' A' ' 81' ' ' LYS . 80.0 mt-10 -58.15 -37.8 75.37 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.235 -0.439 . . . . 0.0 109.902 174.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 18.4 mmm180 -71.68 -23.13 61.6 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.372 -178.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.4 tt -76.38 -45.36 32.2 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 179.257 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -63.87 -19.53 65.13 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.432 0.634 . . . . 0.0 109.406 176.347 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.66 ' HG2' ' O ' ' A' ' 77' ' ' GLU . 31.3 mmmt -81.12 -28.43 35.14 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.379 176.154 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.43 ' HG2' ' OD2' ' A' ' 86' ' ' ASP . 58.3 tttm -74.48 -43.04 57.88 Favored 'General case' 0 C--O 1.193 -1.878 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 179.14 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.3 mt -58.64 -35.2 72.13 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 178.458 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.474 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 2.5 pp -74.67 -26.3 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.061 177.449 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.9 tt -76.85 -45.19 29.33 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 175.34 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.473 ' O ' ' HB2' ' A' ' 87' ' ' LYS . 70.9 m-20 -66.1 -29.62 69.98 Favored 'General case' 0 C--O 1.259 1.587 0 C-N-CA 123.491 0.716 . . . . 0.0 109.944 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.473 ' HB2' ' O ' ' A' ' 86' ' ' ASP . 4.4 mptp? 85.6 21.65 0.09 Allowed 'General case' 0 CA--C 1.478 -1.821 0 C-N-CA 125.252 1.421 . . . . 0.0 113.378 179.412 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 1.8 mp -68.62 -42.22 83.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 N-CA-C 104.8 -2.296 . . . . 0.0 104.8 164.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.474 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 90.7 mt -114.3 164.22 14.21 Favored 'General case' 0 N--CA 1.418 -2.068 0 CA-C-N 113.829 -1.532 . . . . 0.0 109.141 174.215 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.472 ' OD2' ' HG3' ' A' ' 87' ' ' LYS . 0.2 OUTLIER -144.44 117.79 9.04 Favored 'General case' 0 C--N 1.283 -2.305 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 172.762 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -95.02 144.38 25.74 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-O 121.598 0.713 . . . . 0.0 112.463 -178.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.477 ' O ' ' HA ' ' A' ' 103' ' ' ALA . 16.6 t70 -100.0 133.24 44.68 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 114.195 -1.366 . . . . 0.0 109.055 178.422 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 98.3 mt -105.64 105.62 15.75 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 121.579 0.704 . . . . 0.0 109.429 -179.31 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -122.36 135.42 54.7 Favored 'General case' 0 C--N 1.28 -2.427 0 CA-C-N 114.561 -1.2 . . . . 0.0 109.06 -172.402 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.56 HD11 ' HA ' ' A' ' 99' ' ' ASP . 16.6 tt -131.23 141.34 46.24 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.296 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 174.543 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.424 ' C ' ' H ' ' A' ' 98' ' ' ASN . 3.4 p-10 -96.11 172.81 7.75 Favored 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 176.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -66.67 17.97 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 -173.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.424 ' H ' ' C ' ' A' ' 96' ' ' ASN . 15.7 m120 -118.15 5.57 11.99 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.56 ' HA ' HD11 ' A' ' 95' ' ' ILE . 26.7 t70 65.97 26.47 10.93 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-O 123.531 1.634 . . . . 0.0 109.353 -177.714 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.492 ' C ' HG13 ' A' ' 95' ' ' ILE . 77.0 mt-30 -90.29 99.57 12.57 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.918 -1.037 . . . . 0.0 108.548 176.663 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -86.2 133.87 33.82 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.627 -178.65 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.41 HD11 HG21 ' A' ' 44' ' ' THR . 16.4 tt -141.99 143.79 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.822 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 178.565 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.477 ' HA ' ' O ' ' A' ' 92' ' ' ASP . . . -112.08 119.96 40.22 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 -178.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -97.38 150.58 20.84 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 52.4 t -103.74 128.86 56.62 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 CA-C-O 121.759 0.79 . . . . 0.0 112.143 -178.121 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 58.3 mtt -128.28 178.82 5.99 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-N 113.908 -1.496 . . . . 0.0 107.792 177.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.557 ' H ' HD23 ' A' ' 107' ' ' LEU . 1.7 pt? -99.52 137.49 37.94 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -178.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -98.21 -166.51 31.37 Favored Glycine 0 N--CA 1.439 -1.118 0 C-N-CA 120.799 -0.715 . . . . 0.0 113.158 -175.224 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 32.7 p30 -75.28 -2.85 30.06 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 114.147 1.165 . . . . 0.0 114.147 -175.161 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.512 ' O ' HG23 ' A' ' 114' ' ' VAL . 41.4 mmtm -101.98 -6.34 23.56 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 120.113 -0.635 . . . . 0.0 110.357 177.132 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -54.31 -43.77 71.42 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 113.623 0.972 . . . . 0.0 113.623 -172.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.44 -29.48 62.58 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.626 0.727 . . . . 0.0 109.701 -178.145 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 4.4 m -73.05 -26.19 61.2 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.585 -179.349 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.636 ' O ' ' HE2' ' A' ' 16' ' ' LYS . 24.9 t -68.41 -44.05 83.67 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.783 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 174.83 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 84.7 mt -62.39 -39.79 94.35 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.113 178.654 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -72.84 -19.37 61.33 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.059 175.717 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.458 ' C ' ' H ' ' A' ' 119' ' ' LEU . . . 60.87 30.42 72.98 Favored Glycine 0 C--O 1.212 -1.226 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.127 -177.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -95.99 22.58 7.3 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 105.862 -1.903 . . . . 0.0 105.862 174.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.468 HD13 ' C ' ' A' ' 119' ' ' LEU . 0.8 OUTLIER -141.99 122.65 14.24 Favored 'General case' 0 N--CA 1.385 -3.676 0 CA-C-N 112.229 -2.26 . . . . 0.0 105.96 -175.869 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.467 ' HZ1' ' CG ' ' A' ' 10' ' ' ASP . 0.1 OUTLIER -131.08 127.6 38.5 Favored 'General case' 0 C--N 1.283 -2.308 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 171.549 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.427 ' H ' ' HB ' ' A' ' 12' ' ' THR . 5.1 m -119.07 173.28 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.261 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 177.472 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -123.31 161.36 24.79 Favored 'General case' 0 C--N 1.265 -3.076 0 CA-C-N 114.971 -1.013 . . . . 0.0 112.258 -171.375 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -141.51 130.83 23.61 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 104.93 -2.248 . . . . 0.0 104.93 164.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 25.3 mmt . . . . . 0 C--N 1.298 -1.636 0 N-CA-C 116.229 1.937 . . . . 0.0 116.229 -163.207 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.633 ' HG3' HH11 ' A' ' 9' ' ' ARG . 41.9 mtt85 . . . . . 0 N--CA 1.422 -1.86 0 N-CA-C 106.239 -1.764 . . . . 0.0 106.239 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -78.03 89.4 4.17 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.101 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.417 HG23 HG23 ' A' ' 121' ' ' VAL . 10.6 m -79.67 89.47 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 CA-C-O 122.69 1.233 . . . . 0.0 110.36 -178.819 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.632 HG22 ' HA ' ' A' ' 120' ' ' LYS . 34.3 p -115.3 -33.58 5.26 Favored 'General case' 0 C--N 1.261 -3.262 0 CA-C-O 122.092 0.949 . . . . 0.0 109.378 177.584 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -75.62 -40.64 56.0 Favored 'General case' 0 N--CA 1.413 -2.285 0 C-N-CA 125.967 1.707 . . . . 0.0 107.894 178.299 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.483 ' O ' ' HB3' ' A' ' 17' ' ' SER . 16.5 t70 -74.0 -39.78 63.39 Favored 'General case' 0 CA--C 1.495 -1.164 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 74.4 t -67.6 -32.99 59.32 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.691 177.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.559 ' HE2' ' O ' ' A' ' 114' ' ' VAL . 3.3 tppp? -66.85 -43.49 83.51 Favored 'General case' 0 C--O 1.245 0.833 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 174.529 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.483 ' HB3' ' O ' ' A' ' 14' ' ' ASP . 32.6 t -57.09 -47.95 79.78 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 114.092 -1.413 . . . . 0.0 108.718 174.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 28.2 mt -51.36 -42.86 28.47 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.736 0 C-N-CA 124.094 0.958 . . . . 0.0 111.746 177.178 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.56 HG21 HG11 ' A' ' 114' ' ' VAL . 72.9 t -59.62 -45.56 94.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 179.324 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 31.5 ttt180 -56.72 -45.33 81.98 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.788 0.804 . . . . 0.0 109.401 173.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.775 ' CG ' ' HB ' ' A' ' 64' ' ' ILE . 47.4 m-85 -68.63 -38.25 80.36 Favored 'General case' 0 N--CA 1.422 -1.835 0 N-CA-C 115.186 1.55 . . . . 0.0 115.186 -175.24 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.467 HG22 ' HA ' ' A' ' 19' ' ' VAL . 20.1 m -69.69 -36.62 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.859 0 C-N-CA 119.99 -0.684 . . . . 0.0 109.892 176.322 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.42 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 14.8 mm100 -60.63 -46.79 88.95 Favored 'General case' 0 CA--C 1.55 0.956 0 O-C-N 123.83 0.706 . . . . 0.0 111.318 172.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.507 ' HG2' ' HA ' ' A' ' 21' ' ' PHE . 7.6 pt-20 . . . . . 0 C--O 1.247 0.955 0 O-C-N 121.707 -0.621 . . . . 0.0 112.473 178.438 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.486 ' CD1' HD21 ' A' ' 48' ' ' LEU . 2.9 p90 . . . . . 0 CA--C 1.493 -1.217 0 CA-C-O 120.501 0.191 . . . . 0.0 111.03 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 63.2 p -86.33 155.99 20.4 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 178.544 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.527 ' O ' HG23 ' A' ' 49' ' ' VAL . 19.2 ptt? -48.64 -41.81 32.37 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 123.483 0.49 . . . . 0.0 111.905 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.448 ' N ' ' HG3' ' A' ' 45' ' ' MET . 14.8 m120 -67.45 -31.96 72.49 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.584 -175.512 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' MET . . . . . 0.455 ' O ' HD13 ' A' ' 51' ' ' ILE . 26.3 mmt -74.88 -36.33 62.27 Favored 'General case' 0 C--O 1.203 -1.344 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.486 HD21 ' CD1' ' A' ' 43' ' ' PHE . 87.1 mt -60.75 -38.4 85.05 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.373 179.221 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.54 HG13 ' HB3' ' A' ' 76' ' ' ALA . 94.1 t -65.19 -41.59 92.03 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.203 0 C-N-CA 124.395 1.078 . . . . 0.0 110.861 178.674 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -55.38 -46.26 76.55 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.309 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.455 HD13 ' O ' ' A' ' 47' ' ' MET . 1.3 mp -70.07 -40.36 78.32 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.103 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.227 177.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -57.84 -42.29 84.13 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.735 0.814 . . . . 0.0 111.808 -175.552 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.408 HD11 ' HB2' ' A' ' 71' ' ' TYR . 7.9 mp -82.32 -20.17 37.9 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 178.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 96.14 32.63 6.65 Favored Glycine 0 C--N 1.313 -0.731 0 C-N-CA 120.126 -1.035 . . . . 0.0 112.257 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 31.1 t -76.55 137.41 39.55 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 177.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.496 ' O ' ' HD3' ' A' ' 56' ' ' LYS . 2.4 tmtm? -84.31 -0.87 54.14 Favored 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 119.264 -0.974 . . . . 0.0 109.537 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.0 m -77.86 -5.95 52.6 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 176.074 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.417 ' HB3' HE22 ' A' ' 61' ' ' GLN . . . -62.03 145.45 53.08 Favored 'General case' 0 N--CA 1.425 -1.721 0 C-N-CA 125.787 1.635 . . . . 0.0 111.173 175.182 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.528 ' HD2' ' N ' ' A' ' 59' ' ' LYS . 9.1 mptt -105.23 -1.57 25.17 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.447 -177.281 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.419 ' O ' HG13 ' A' ' 51' ' ' ILE . 60.6 mt -132.28 122.0 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.108 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -177.778 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.542 ' HA ' HE21 ' A' ' 61' ' ' GLN . 0.0 OUTLIER -110.01 94.37 4.98 Favored 'General case' 0 C--N 1.277 -2.585 0 C-N-CA 118.313 -1.355 . . . . 0.0 108.707 176.901 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.472 ' HB3' ' OE2' ' A' ' 24' ' ' GLU . 73.5 m -104.25 177.79 4.74 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.843 176.781 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -75.32 7.63 22.89 Favored Glycine 0 N--CA 1.482 1.712 0 C-N-CA 121.068 -0.587 . . . . 0.0 113.979 -176.569 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.775 ' HB ' ' CG ' ' A' ' 21' ' ' PHE . 6.4 tt -100.74 3.1 10.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.429 ' HB2' ' O ' ' A' ' 62' ' ' SER . 19.5 t80 -69.52 95.97 0.88 Allowed 'General case' 0 N--CA 1.42 -1.945 0 CA-C-N 114.01 -1.45 . . . . 0.0 110.01 -173.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 102.35 17.22 20.54 Favored Glycine 0 N--CA 1.419 -2.438 0 CA-C-N 114.93 -1.032 . . . . 0.0 112.638 -179.161 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.659 ' HE2' HG13 ' A' ' 64' ' ' ILE . 33.5 mtmt -67.97 -58.1 5.1 Favored 'General case' 0 C--N 1.353 0.751 0 C-N-CA 117.891 -1.523 . . . . 0.0 110.51 175.492 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -95.41 47.82 1.92 Allowed Glycine 0 N--CA 1.436 -1.353 0 CA-C-N 115.154 -0.93 . . . . 0.0 113.356 -170.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 19.6 m -71.84 -4.31 27.26 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -178.577 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -100.91 2.93 41.33 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 121.682 0.753 . . . . 0.0 111.036 178.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.408 ' HB2' HD11 ' A' ' 53' ' ' LEU . 24.0 m-85 -88.44 142.57 27.61 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 174.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 42.5 t -71.08 148.5 47.44 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 105.331 -2.1 . . . . 0.0 105.331 168.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 35.1 ttt-85 -56.46 -42.92 79.0 Favored 'General case' 0 C--O 1.217 -0.637 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.945 -174.544 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.594 ' O ' ' HG2' ' A' ' 78' ' ' ARG . 90.8 m-70 -75.97 -20.3 58.02 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.476 -0.489 . . . . 0.0 111.274 -177.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -73.17 -44.14 60.37 Favored 'General case' 0 CA--C 1.501 -0.913 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 176.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.54 ' HB3' HG13 ' A' ' 49' ' ' VAL . . . -61.69 -36.51 81.11 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 175.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -61.13 -32.93 72.62 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.639 174.474 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.594 ' HG2' ' O ' ' A' ' 74' ' ' HIS . 31.7 mmt180 -79.36 -25.93 42.13 Favored 'General case' 0 CA--C 1.496 -1.114 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -176.828 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.46 ' HB3' ' O ' ' A' ' 76' ' ' ALA . 14.5 tp -60.22 -61.24 2.74 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 124.154 0.909 . . . . 0.0 108.928 177.376 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -60.6 -27.72 67.95 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.452 -178.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.508 ' O ' HG13 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -69.18 -30.07 68.19 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.061 175.476 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 20.2 ttpp -80.88 -34.93 33.24 Favored 'General case' 0 C--O 1.203 -1.394 0 C-N-CA 117.294 -1.762 . . . . 0.0 107.713 -178.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.563 ' HB3' ' HG ' ' A' ' 89' ' ' LEU . 9.7 mp -60.11 -29.04 68.34 Favored 'General case' 0 C--O 1.211 -0.95 0 CA-C-N 116.24 -0.436 . . . . 0.0 112.015 176.235 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.508 HG13 ' O ' ' A' ' 81' ' ' LYS . 2.1 pp -82.93 -22.14 8.89 Favored 'Isoleucine or valine' 0 C--O 1.244 0.813 0 C-N-CA 120.028 -0.669 . . . . 0.0 111.278 178.519 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.5 tt -75.97 -49.83 16.58 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 174.241 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -65.38 -36.1 82.95 Favored 'General case' 0 C--O 1.253 1.281 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 178.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.576 ' HD3' HD21 ' A' ' 109' ' ' ASN 0.31 59.4 mttm 85.0 29.69 0.05 Allowed 'General case' 0 CA--C 1.464 -2.328 0 C-N-CA 125.954 1.702 . . . . 0.0 114.952 176.822 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.408 HG23 HG21 ' A' ' 114' ' ' VAL . 1.8 mp -69.04 -31.48 50.49 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 105.012 -2.218 . . . . 0.0 105.012 163.274 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.563 ' HG ' ' HB3' ' A' ' 83' ' ' LEU . 44.7 mt -116.01 154.4 29.94 Favored 'General case' 0 N--CA 1.425 -1.676 0 CA-C-N 113.966 -1.47 . . . . 0.0 108.896 173.229 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.416 ' HB2' ' HA2' ' A' ' 108' ' ' GLY . 1.8 m-20 -139.81 117.68 11.71 Favored 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 174.321 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.47 ' HG3' HG21 ' A' ' 84' ' ' ILE . 46.6 mt-10 -94.54 145.32 24.89 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.471 0.653 . . . . 0.0 112.133 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -111.08 159.36 17.87 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-N 114.523 -1.217 . . . . 0.0 108.712 176.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 87.6 mt -117.92 145.37 44.71 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -170.591 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -141.51 163.06 33.94 Favored 'General case' 0 CA--C 1.479 -1.775 0 N-CA-C 105.412 -2.07 . . . . 0.0 105.412 173.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 19.0 tt -132.68 147.07 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.268 0 N-CA-C 106.811 -1.552 . . . . 0.0 106.811 171.084 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 47.0 p30 -92.41 -174.32 3.66 Favored 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 120.22 -0.592 . . . . 0.0 110.515 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -75.97 5.53 6.43 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 123.009 0.524 . . . . 0.0 111.973 -177.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -108.19 3.01 23.24 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 29.3 t70 66.84 26.73 9.27 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-O 123.547 1.641 . . . . 0.0 108.9 -176.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -101.13 110.62 22.66 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 114.8 -1.091 . . . . 0.0 108.507 177.347 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.7 140.78 51.53 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.513 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 10.5 tp -134.52 143.44 37.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.4 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -117.65 132.69 56.46 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.675 -178.102 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -108.47 153.0 23.96 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 55.5 t -97.6 137.87 24.02 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 CA-C-O 122.103 0.954 . . . . 0.0 112.964 -174.12 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 16.5 mmt -134.55 177.98 7.35 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 112.798 -2.001 . . . . 0.0 107.427 174.428 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 7.3 mp -92.03 142.32 27.66 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.416 ' HA2' ' HB2' ' A' ' 90' ' ' ASP . . . -94.97 -176.89 38.0 Favored Glycine 0 N--CA 1.414 -2.809 0 C-N-CA 119.991 -1.099 . . . . 0.0 114.778 -172.81 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.576 HD21 ' HD3' ' A' ' 87' ' ' LYS . 6.1 p30 -71.13 -11.37 60.91 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 114.075 -1.062 . . . . 0.0 112.404 -178.631 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.559 ' O ' HG23 ' A' ' 114' ' ' VAL . 40.2 mmtm -103.58 13.3 33.62 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 177.672 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.521 ' O ' ' HG ' ' A' ' 115' ' ' LEU . . . -75.94 -28.77 58.09 Favored 'General case' 0 CA--C 1.494 -1.201 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 -177.128 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 15.8 tp60 -66.16 -39.84 90.08 Favored 'General case' 0 N--CA 1.416 -2.141 0 CA-C-N 112.891 -1.959 . . . . 0.0 109.262 174.592 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 6.6 m -64.98 -32.7 74.56 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 177.116 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.56 HG11 HG21 ' A' ' 19' ' ' VAL . 46.2 t -65.69 -46.41 89.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.103 177.643 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.521 ' HG ' ' O ' ' A' ' 111' ' ' ALA . 68.7 mt -62.59 -37.59 86.81 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.41 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -72.63 -21.35 61.12 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.049 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 86.54 12.21 70.02 Favored Glycine 0 C--O 1.215 -1.05 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.627 178.55 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -96.39 36.86 1.3 Allowed 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 122.299 1.047 . . . . 0.0 109.072 -176.283 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.634 HD13 ' O ' ' A' ' 119' ' ' LEU . 0.0 OUTLIER -124.7 121.0 33.43 Favored 'General case' 0 N--CA 1.422 -1.857 0 CA-C-O 122.264 1.031 . . . . 0.0 108.34 -176.42 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.632 ' HA ' HG22 ' A' ' 12' ' ' THR 0.265 7.7 ptmm? -131.1 85.5 2.27 Favored 'General case' 1 C--N 1.225 -4.805 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 172.676 . . . . . . . . 4 3 . 1 . 008 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.417 HG23 HG23 ' A' ' 11' ' ' VAL . 14.4 m -91.43 170.52 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.053 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 177.307 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -142.62 153.3 43.35 Favored 'General case' 0 C--N 1.266 -3.025 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 -176.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' PHE . . . . . 0.503 ' O ' ' HB2' ' A' ' 9' ' ' ARG . 56.2 t80 -158.3 143.21 16.35 Favored 'General case' 0 N--CA 1.432 -1.353 0 C-N-CA 120.869 -0.332 . . . . 0.0 111.118 175.059 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.439 -1.019 0 CA-C-O 121.368 0.604 . . . . 0.0 109.455 176.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 . . . . . 0 N--CA 1.429 -1.524 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.465 ' OD2' ' HB2' ' A' ' 120' ' ' LYS . 0.2 OUTLIER -78.15 90.09 4.26 Favored 'General case' 0 CA--C 1.489 -1.371 0 O-C-N 124.016 0.823 . . . . 0.0 108.829 -179.725 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.6 m -74.58 85.58 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.216 0 CA-C-O 122.713 1.244 . . . . 0.0 109.759 178.624 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.704 HG22 ' HA ' ' A' ' 120' ' ' LYS . 29.8 p -107.6 -30.33 8.66 Favored 'General case' 0 C--N 1.258 -3.409 0 C-N-CA 118.459 -1.297 . . . . 0.0 110.933 176.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -76.64 -38.95 53.79 Favored 'General case' 0 C--N 1.29 -1.992 0 C-N-CA 124.69 1.196 . . . . 0.0 108.81 -179.426 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.534 ' O ' ' HB3' ' A' ' 17' ' ' SER . 23.3 t70 -76.62 -36.92 57.15 Favored 'General case' 0 CA--C 1.491 -1.293 0 CA-C-O 122.178 0.989 . . . . 0.0 109.051 -179.609 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.511 ' O ' HG23 ' A' ' 19' ' ' VAL . 99.5 t -72.97 -21.46 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.803 0 CA-C-N 114.649 -1.16 . . . . 0.0 110.185 177.621 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.592 ' HE2' ' O ' ' A' ' 12' ' ' THR . 1.3 tppt? -72.25 -31.81 66.12 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 173.636 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.534 ' HB3' ' O ' ' A' ' 14' ' ' ASP . 29.0 t -63.84 -38.37 90.83 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 173.108 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.479 ' HB ' ' O ' ' A' ' 15' ' ' VAL . 41.4 mt -62.4 -42.89 97.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.005 173.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.511 HG23 ' O ' ' A' ' 15' ' ' VAL . 82.4 t -57.36 -42.8 81.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.137 177.652 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.405 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 43.7 ttt180 -54.05 -48.07 70.96 Favored 'General case' 0 C--N 1.332 -0.174 0 O-C-N 123.364 0.415 . . . . 0.0 109.892 174.758 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -65.4 -45.96 81.91 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 115.751 -0.658 . . . . 0.0 112.582 -177.114 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.493 HG22 ' HA ' ' A' ' 19' ' ' VAL . 29.4 m -65.63 -33.4 63.34 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 C-N-CA 119.907 -0.717 . . . . 0.0 111.045 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 14.7 mm-40 -60.22 -55.6 31.8 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 120.819 0.343 . . . . 0.0 110.806 170.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.405 ' HG2' ' O ' ' A' ' 20' ' ' ARG . 9.4 pt-20 . . . . . 0 CA--C 1.534 0.364 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -177.154 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 . . . . . 0 CA--C 1.481 -1.703 0 CA-C-O 121.64 0.733 . . . . 0.0 109.038 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.557 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 47.1 p -109.98 144.63 38.25 Favored 'General case' 0 N--CA 1.414 -2.266 0 CA-C-N 114.347 -1.297 . . . . 0.0 107.852 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.515 ' O ' HG23 ' A' ' 49' ' ' VAL . 18.7 ptm -44.52 -44.34 8.59 Favored 'General case' 0 C--O 1.206 -1.19 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -176.582 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.476 ' N ' ' HG3' ' A' ' 45' ' ' MET . 16.7 t-20 -68.5 -37.97 80.56 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 121.049 -0.26 . . . . 0.0 111.595 -172.316 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 49.6 ttm -72.54 -36.56 68.32 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.621 ' O ' ' HB2' ' A' ' 52' ' ' PHE . 47.9 mt -67.88 -30.24 69.55 Favored 'General case' 0 C--O 1.192 -1.972 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.846 -178.369 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.662 HG11 ' HG3' ' A' ' 77' ' ' GLU . 43.0 t -74.19 -44.65 49.26 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.609 0 C-N-CA 123.327 0.651 . . . . 0.0 110.695 179.258 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -54.42 -51.41 65.0 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.805 HD12 ' HB1' ' A' ' 58' ' ' ALA . 6.2 tt -75.97 -24.79 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.28 0 N-CA-C 114.232 1.197 . . . . 0.0 114.232 -178.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.621 ' HB2' ' O ' ' A' ' 48' ' ' LEU . 59.8 t80 -55.44 -43.59 75.55 Favored 'General case' 0 C--N 1.277 -2.579 0 CA-C-N 114.842 -1.072 . . . . 0.0 108.754 175.336 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.497 ' HA ' ' O ' ' A' ' 68' ' ' GLY . 9.5 mp -77.73 -35.79 51.54 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.892 -1.049 . . . . 0.0 111.551 177.176 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 98.61 53.3 1.23 Allowed Glycine 0 C--N 1.305 -1.185 0 N-CA-C 108.496 -1.841 . . . . 0.0 108.496 -173.163 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 52.6 p -64.81 -178.89 0.46 Allowed 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 115.564 1.69 . . . . 0.0 115.564 -175.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -81.88 -27.75 33.3 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 113.117 -1.856 . . . . 0.0 110.811 176.49 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.8 m -88.72 -45.29 9.92 Favored 'General case' 0 C--O 1.252 1.219 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -175.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.805 ' HB1' HD12 ' A' ' 51' ' ' ILE . . . -97.91 90.58 4.98 Favored 'General case' 0 N--CA 1.403 -2.781 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 178.274 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 50.2 mttp -72.95 26.57 0.06 Allowed 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 126.285 1.834 . . . . 0.0 114.423 -174.018 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.476 ' HA ' ' HB3' ' A' ' 65' ' ' PHE . 81.3 mt 71.0 116.71 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 C-N-CA 125.391 1.476 . . . . 0.0 112.713 179.328 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.571 ' HG2' HD11 ' A' ' 51' ' ' ILE . 17.4 mm-40 -113.34 17.52 18.46 Favored 'General case' 0 N--CA 1.439 -1.005 0 C-N-CA 119.782 -0.767 . . . . 0.0 112.372 -176.44 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 21.1 m 70.31 107.04 0.06 Allowed 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 124.111 0.964 . . . . 0.0 112.513 -178.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 153.6 -111.06 0.47 Allowed Glycine 0 CA--C 1.498 -0.973 0 N-CA-C 109.056 -1.618 . . . . 0.0 109.056 -179.099 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.558 ' O ' ' HG3' ' A' ' 67' ' ' LYS . 5.8 tt -91.12 -5.36 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 172.763 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.642 ' CD1' HD13 ' A' ' 51' ' ' ILE . 9.4 m-85 -70.85 102.04 2.27 Favored 'General case' 0 N--CA 1.41 -2.468 0 CA-C-N 113.353 -1.749 . . . . 0.0 108.959 -174.178 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.19 9.7 55.36 Favored Glycine 0 N--CA 1.42 -2.423 0 O-C-N 124.338 1.024 . . . . 0.0 112.829 -179.332 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.601 ' HD3' ' N ' ' A' ' 68' ' ' GLY . 0.1 OUTLIER -65.29 -31.81 73.15 Favored 'General case' 0 C--N 1.357 0.901 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 -178.439 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.601 ' N ' ' HD3' ' A' ' 67' ' ' LYS . . . -160.04 107.71 0.33 Allowed Glycine 0 CA--C 1.498 -1.018 0 C-N-CA 117.808 -2.139 . . . . 0.0 114.991 -175.243 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.454 ' HB3' ' O ' ' A' ' 53' ' ' LEU . 2.8 p -94.16 10.33 34.26 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 124.406 1.082 . . . . 0.0 110.29 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -91.56 6.31 46.15 Favored 'General case' 0 CA--C 1.506 -0.747 0 CA-C-O 121.965 0.888 . . . . 0.0 110.693 -178.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.408 ' HB2' HD11 ' A' ' 53' ' ' LEU . 43.1 m-85 -99.45 143.12 30.06 Favored 'General case' 0 C--N 1.283 -2.31 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.269 175.293 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 30.0 t -78.24 139.73 38.9 Favored 'General case' 0 N--CA 1.414 -2.257 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 170.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.468 HH12 ' ND2' ' A' ' 46' ' ' ASN . 32.8 tpt85 -43.52 -56.46 3.64 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.385 1.074 . . . . 0.0 112.223 -175.337 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -81.32 -12.26 59.08 Favored 'General case' 0 C--N 1.309 -1.169 0 C-N-CA 120.132 -0.627 . . . . 0.0 112.407 -175.29 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -86.57 -29.72 22.42 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.232 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.546 ' HB3' HG13 ' A' ' 49' ' ' VAL . . . -65.35 -40.04 93.09 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 171.154 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.662 ' HG3' HG11 ' A' ' 49' ' ' VAL . 38.7 mt-10 -60.44 -32.81 71.73 Favored 'General case' 0 C--O 1.246 0.874 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.43 173.66 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 15.3 tpp180 -68.9 -31.25 70.04 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 -176.606 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.707 ' HG ' ' CD1' ' A' ' 123' ' ' PHE . 0.4 OUTLIER -73.84 -47.99 34.48 Favored 'General case' 0 CA--C 1.469 -2.165 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.303 -178.571 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -59.2 -21.24 59.17 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-O 121.667 0.746 . . . . 0.0 109.125 176.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 30.7 mmtm -87.22 -31.61 20.22 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.78 178.107 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.664 ' HE2' ' O ' ' A' ' 122' ' ' ASP . 19.1 ttpp -71.91 -39.04 69.8 Favored 'General case' 0 C--O 1.194 -1.861 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 175.671 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.505 HD13 HD22 ' A' ' 79' ' ' LEU . 0.6 OUTLIER -57.19 -38.7 74.05 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 125.186 1.395 . . . . 0.0 112.16 178.484 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.409 HG21 ' HG3' ' A' ' 91' ' ' GLU . 2.5 pp -75.68 -23.23 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 119.76 -0.776 . . . . 0.0 111.525 177.482 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 50.2 mt -77.93 -41.83 35.06 Favored 'General case' 0 N--CA 1.45 -0.434 0 O-C-N 123.425 0.453 . . . . 0.0 110.597 173.54 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -65.2 -29.12 69.91 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.034 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.404 ' HB3' ' HG2' ' A' ' 110' ' ' LYS . 2.3 mptp? 84.9 15.71 0.18 Allowed 'General case' 0 CA--C 1.477 -1.859 0 C-N-CA 125.154 1.382 . . . . 0.0 112.77 175.291 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.58 HG23 HG21 ' A' ' 114' ' ' VAL . 1.8 mp -67.96 -38.44 79.98 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.794 0 N-CA-C 106.349 -1.722 . . . . 0.0 106.349 167.351 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.457 ' HG ' ' HB3' ' A' ' 83' ' ' LEU . 30.3 mt -109.03 151.01 26.93 Favored 'General case' 0 N--CA 1.414 -2.261 0 CA-C-N 114.4 -1.273 . . . . 0.0 111.003 177.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.419 ' O ' ' HB2' ' A' ' 106' ' ' MET . 15.6 m-20 -143.85 118.24 9.65 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 175.77 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.409 ' HG3' HG21 ' A' ' 84' ' ' ILE . 40.8 mt-10 -94.03 155.21 17.24 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 121.052 0.454 . . . . 0.0 112.187 -176.745 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.593 ' O ' ' HA ' ' A' ' 103' ' ' ALA . 13.4 m-20 -97.77 138.08 35.68 Favored 'General case' 0 CA--C 1.497 -1.059 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.207 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 91.5 mt -106.94 116.76 32.49 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 121.482 0.658 . . . . 0.0 111.168 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -125.83 108.9 11.92 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.5 HD11 ' HA ' ' A' ' 99' ' ' ASP . 14.6 tt -112.04 148.94 14.83 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.381 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -177.213 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -103.69 -175.54 2.83 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -74.53 17.9 0.18 Allowed 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -177.264 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -118.45 6.01 11.77 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 177.093 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.5 ' HA ' HD11 ' A' ' 95' ' ' ILE . 6.1 m-20 62.18 28.28 16.98 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 122.299 1.047 . . . . 0.0 111.264 -176.586 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.432 ' C ' HG13 ' A' ' 95' ' ' ILE . 96.3 mt-30 -93.36 103.03 15.29 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 176.502 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -83.95 116.05 22.61 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.602 -177.196 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 4.3 mm -100.01 131.99 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.388 -3.535 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 176.028 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.593 ' HA ' ' O ' ' A' ' 92' ' ' ASP . . . -113.66 124.51 52.49 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.682 -178.261 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -97.06 155.65 16.71 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.002 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 42.2 t -100.55 120.89 50.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -175.395 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.419 ' HB2' ' O ' ' A' ' 90' ' ' ASP . 25.9 mmt -133.05 -173.04 3.09 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 113.369 -1.741 . . . . 0.0 108.307 177.312 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -143.67 134.24 24.92 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -138.01 -78.1 0.07 OUTLIER Glycine 0 N--CA 1.44 -1.098 0 C-N-CA 118.515 -1.802 . . . . 0.0 116.075 -174.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -63.78 -51.62 63.97 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 115.243 1.571 . . . . 0.0 115.243 -167.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.495 ' O ' HG23 ' A' ' 114' ' ' VAL . 65.1 mmtt -98.24 -1.64 41.49 Favored 'General case' 0 C--N 1.321 -0.645 0 O-C-N 121.474 -0.766 . . . . 0.0 109.802 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.604 ' O ' ' HG ' ' A' ' 115' ' ' LEU . . . -51.92 -33.18 36.04 Favored 'General case' 0 C--O 1.217 -0.608 0 CA-C-N 114.798 -1.092 . . . . 0.0 113.706 -174.317 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.54 -37.42 87.5 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.474 -177.43 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 5.4 m -78.19 -25.16 47.0 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 121.617 0.722 . . . . 0.0 109.238 -179.132 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.58 HG21 HG23 ' A' ' 88' ' ' ILE . 62.0 t -67.64 -40.35 83.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-N 114.703 -1.135 . . . . 0.0 108.272 175.378 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.604 ' HG ' ' O ' ' A' ' 111' ' ' ALA . 73.1 mt -72.39 -29.09 63.43 Favored 'General case' 0 C--O 1.222 -0.388 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.92 177.495 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -73.19 -11.37 60.5 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-O 121.165 0.507 . . . . 0.0 110.111 173.13 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 86.47 -12.62 60.44 Favored Glycine 0 N--CA 1.438 -1.208 0 CA-C-N 115.621 -0.718 . . . . 0.0 113.05 177.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -91.33 62.85 4.78 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 122.253 1.025 . . . . 0.0 111.177 -173.767 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.514 HD13 ' O ' ' A' ' 119' ' ' LEU . 0.0 OUTLIER -132.04 131.53 42.54 Favored 'General case' 0 N--CA 1.409 -2.517 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 175.201 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.704 ' HA ' HG22 ' A' ' 12' ' ' THR . 0.0 OUTLIER -130.62 128.03 40.16 Favored 'General case' 1 C--N 1.241 -4.124 0 CA-C-N 113.311 -1.768 . . . . 0.0 109.66 179.486 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 14.3 m -133.71 170.66 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 176.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.664 ' O ' ' HE2' ' A' ' 82' ' ' LYS . 8.0 p-10 -108.68 161.01 15.48 Favored 'General case' 0 C--N 1.274 -2.7 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.756 -178.676 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' PHE . . . . . 0.707 ' CD1' ' HG ' ' A' ' 79' ' ' LEU . 37.8 t80 -159.08 156.53 29.35 Favored 'General case' 0 C--O 1.256 1.4 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 171.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.314 -0.974 0 N-CA-C 104.53 -2.396 . . . . 0.0 104.53 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 47.0 mmt-85 . . . . . 0 N--CA 1.438 -1.051 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -118.71 93.8 4.23 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 104.949 -2.241 . . . . 0.0 104.949 178.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.8 m -82.07 87.59 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.272 -2.782 0 CA-C-O 122.64 1.209 . . . . 0.0 111.322 -175.645 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.826 HG22 ' HA ' ' A' ' 120' ' ' LYS . 44.7 p -98.47 -58.43 1.96 Allowed 'General case' 0 C--N 1.262 -3.208 0 C-N-CA 117.564 -1.654 . . . . 0.0 113.13 174.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.533 ' HA ' ' HB3' ' A' ' 16' ' ' LYS . 12.3 t70 -83.49 -10.9 58.05 Favored 'General case' 0 C--O 1.205 -1.281 0 C-N-CA 118.797 -1.161 . . . . 0.0 111.139 -176.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -66.59 -46.85 74.6 Favored 'General case' 0 CA--C 1.5 -0.977 0 N-CA-C 105.279 -2.119 . . . . 0.0 105.279 171.535 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 77.1 t -65.85 -43.28 93.21 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.404 0 CA-C-N 112.944 -1.935 . . . . 0.0 110.074 177.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.533 ' HB3' ' HA ' ' A' ' 13' ' ' ASP . 17.2 ttmt -64.95 -40.26 94.74 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.628 178.339 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.507 ' O ' ' HD2' ' A' ' 21' ' ' PHE . 72.2 m -55.13 -45.86 75.61 Favored 'General case' 0 CA--C 1.509 -0.608 0 O-C-N 123.33 0.394 . . . . 0.0 109.955 175.432 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.415 ' O ' HG22 ' A' ' 22' ' ' VAL . 88.1 mt -55.43 -56.62 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.486 177.578 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.418 HG21 HG11 ' A' ' 114' ' ' VAL . 97.9 t -60.19 -44.44 95.38 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.101 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.41 -179.111 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.498 ' O ' ' HG3' ' A' ' 24' ' ' GLU . 35.8 ttp180 -58.72 -36.32 74.09 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 124.036 0.934 . . . . 0.0 111.069 -178.546 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.507 ' HD2' ' O ' ' A' ' 17' ' ' SER . 64.8 m-85 -90.86 -25.36 19.9 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -178.544 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.415 HG22 ' O ' ' A' ' 18' ' ' ILE . 30.5 m -79.38 -30.8 14.0 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.377 0 C-N-CA 117.307 -1.757 . . . . 0.0 108.54 173.378 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -63.05 -52.4 62.95 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.251 174.118 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.498 ' HG3' ' O ' ' A' ' 20' ' ' ARG 0.322 0.0 OUTLIER . . . . . 0 C--N 1.347 0.468 0 C-N-CA 119.366 -0.934 . . . . 0.0 112.849 -179.447 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 . . . . . 0 CA--C 1.488 -1.41 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 51.2 p -122.56 156.34 34.4 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 176.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.442 ' HG3' ' N ' ' A' ' 46' ' ' ASN . 13.2 ptp -50.71 -42.27 56.91 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-O 121.221 0.534 . . . . 0.0 110.799 178.154 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.442 ' N ' ' HG3' ' A' ' 45' ' ' MET . 44.2 m-80 -64.1 -34.19 77.49 Favored 'General case' 0 CA--C 1.505 -0.77 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.348 -177.717 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' MET . . . . . 0.446 ' O ' ' HB ' ' A' ' 51' ' ' ILE . 49.2 ttm -71.2 -43.22 67.82 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.444 ' O ' HG22 ' A' ' 51' ' ' ILE . 82.9 mt -67.77 -42.8 81.16 Favored 'General case' 0 C--O 1.208 -1.101 0 CA-C-N 115.224 -0.898 . . . . 0.0 112.469 -176.607 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.436 HG13 ' HB3' ' A' ' 76' ' ' ALA . 69.2 t -64.57 -46.38 92.75 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.727 0 CA-C-O 121.622 0.725 . . . . 0.0 110.436 179.321 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -63.52 -37.85 88.88 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 114.712 -1.131 . . . . 0.0 108.927 -178.09 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.702 ' CG1' ' HB1' ' A' ' 58' ' ' ALA . 0.4 OUTLIER -76.33 -37.85 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.407 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 179.62 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.428 ' CZ ' ' HA3' ' A' ' 68' ' ' GLY . 37.8 t80 -55.81 -39.23 71.05 Favored 'General case' 0 C--N 1.296 -1.745 0 O-C-N 123.877 0.736 . . . . 0.0 110.036 176.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.5 mp -82.13 -28.77 32.01 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.137 -0.938 . . . . 0.0 112.116 177.499 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.15 35.43 15.1 Favored Glycine 0 C--O 1.251 1.159 0 N-CA-C 109.841 -1.303 . . . . 0.0 109.841 -176.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.532 ' OG ' ' HD3' ' A' ' 56' ' ' LYS . 34.9 t -70.47 -168.96 0.27 Allowed 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 126.619 1.968 . . . . 0.0 112.858 -172.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.648 ' HD3' ' H ' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -50.27 -66.75 0.34 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.205 1.402 . . . . 0.0 112.902 -174.236 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.05 -42.83 22.97 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 114.771 -1.104 . . . . 0.0 111.545 -170.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.702 ' HB1' ' CG1' ' A' ' 51' ' ' ILE . . . -91.78 81.1 5.23 Favored 'General case' 0 N--CA 1.398 -3.048 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 174.653 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.509 ' O ' ' HB ' ' A' ' 60' ' ' ILE . 0.1 OUTLIER -73.13 25.21 0.06 Allowed 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 114.612 -1.176 . . . . 0.0 111.99 -175.484 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.509 ' HB ' ' O ' ' A' ' 59' ' ' LYS . 88.3 mt 83.34 127.91 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 C-N-CA 126.831 2.053 . . . . 0.0 111.057 -175.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.463 ' HG3' ' O ' ' A' ' 60' ' ' ILE 0.297 14.8 mt-30 -135.82 58.86 1.73 Allowed 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 178.609 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 15.2 t 71.44 137.14 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 125.91 1.684 . . . . 0.0 112.729 177.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.28 -141.65 15.73 Favored Glycine 0 C--O 1.241 0.581 0 C-N-CA 121.288 -0.482 . . . . 0.0 112.728 177.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.461 HG21 ' HB3' ' A' ' 17' ' ' SER . 6.3 pt -73.39 7.19 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 C-N-CA 123.331 0.652 . . . . 0.0 112.427 178.621 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.592 ' CD2' HG12 ' A' ' 51' ' ' ILE . 0.3 OUTLIER -70.96 113.32 7.88 Favored 'General case' 0 N--CA 1.389 -3.504 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 -178.784 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.68 33.67 46.34 Favored Glycine 0 N--CA 1.424 -2.116 0 CA-C-N 114.849 -1.068 . . . . 0.0 111.305 -174.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 32.9 mmtm -121.32 -15.08 8.19 Favored 'General case' 0 C--O 1.22 -0.452 0 CA-C-O 121.2 0.524 . . . . 0.0 109.72 174.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.428 ' HA3' ' CZ ' ' A' ' 52' ' ' PHE . . . -107.78 35.03 5.25 Favored Glycine 0 N--CA 1.432 -1.579 0 N-CA-C 109.771 -1.331 . . . . 0.0 109.771 178.826 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 9.2 m -72.62 6.23 2.58 Favored 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 124.932 1.293 . . . . 0.0 111.953 -176.513 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -93.52 -1.53 55.46 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-O 121.923 0.868 . . . . 0.0 109.337 176.507 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -103.41 153.62 20.28 Favored 'General case' 0 N--CA 1.422 -1.828 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 175.334 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.408 ' HB3' ' OD1' ' A' ' 75' ' ' ASN . 37.5 t -105.35 171.86 7.1 Favored 'General case' 0 C--N 1.28 -2.43 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 170.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.418 ' HD2' HG12 ' A' ' 49' ' ' VAL . 8.3 mmm180 -52.78 -37.95 60.37 Favored 'General case' 0 C--O 1.205 -1.277 0 CA-C-O 121.215 0.531 . . . . 0.0 110.869 179.615 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.463 ' O ' ' HG2' ' A' ' 78' ' ' ARG . 6.5 t-160 -67.6 -43.98 79.18 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.577 -172.793 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.408 ' OD1' ' HB3' ' A' ' 72' ' ' SER . 7.6 m120 -68.78 -55.7 10.4 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.319 -178.543 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.436 ' HB3' HG13 ' A' ' 49' ' ' VAL . . . -57.41 -44.82 84.88 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.929 -177.487 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.403 ' HG3' HG11 ' A' ' 49' ' ' VAL . 44.7 mt-10 -62.62 -33.92 75.99 Favored 'General case' 0 C--O 1.208 -1.096 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 178.538 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.463 ' HG2' ' O ' ' A' ' 74' ' ' HIS . 9.7 mmm180 -67.14 -30.31 70.26 Favored 'General case' 0 CA--C 1.495 -1.144 0 C-N-CA 119.08 -1.048 . . . . 0.0 110.296 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.536 ' O ' ' HG ' ' A' ' 83' ' ' LEU . 2.5 tt -79.46 -50.99 9.94 Favored 'General case' 0 N--CA 1.42 -1.926 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.261 -177.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.585 ' HA ' HD12 ' A' ' 83' ' ' LEU . 60.6 m-85 -58.45 -23.18 56.89 Favored 'General case' 0 CA--C 1.506 -0.747 0 CA-C-O 121.855 0.836 . . . . 0.0 110.326 179.119 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -89.2 -23.57 22.36 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 114.473 -1.239 . . . . 0.0 110.118 -179.147 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.401 ' HE2' ' O ' ' A' ' 122' ' ' ASP . 48.5 tttp -73.36 -40.27 64.51 Favored 'General case' 0 C--O 1.209 -1.053 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 174.127 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.585 HD12 ' HA ' ' A' ' 80' ' ' PHE . 94.6 mt -53.62 -50.19 66.21 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 114.905 -1.043 . . . . 0.0 112.864 178.453 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.616 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 2.6 pp -73.82 -24.65 19.83 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -178.706 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 41.0 mt -79.83 -40.2 29.03 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 176.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.629 ' O ' ' HE2' ' A' ' 110' ' ' LYS . 35.1 t70 -82.96 -13.07 56.72 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.675 -177.268 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.45 ' HG3' ' OD2' ' A' ' 90' ' ' ASP . 2.8 mptp? 85.61 16.77 0.13 Allowed 'General case' 0 CA--C 1.462 -2.418 0 N-CA-C 114.355 1.243 . . . . 0.0 114.355 171.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 11.6 mt -70.02 -45.32 76.87 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.092 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 168.556 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.616 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 4.3 mm? -114.95 158.57 21.83 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 113.953 -1.476 . . . . 0.0 108.416 174.609 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.466 ' HB2' ' HA2' ' A' ' 108' ' ' GLY . 0.3 OUTLIER -149.12 109.97 4.3 Favored 'General case' 0 CA--C 1.476 -1.902 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 176.452 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.449 ' HB2' ' O ' ' A' ' 104' ' ' TYR 0.28 11.8 pt-20 -95.53 159.11 15.15 Favored 'General case' 0 C--N 1.282 -2.36 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 178.56 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.462 ' O ' ' HA ' ' A' ' 103' ' ' ALA . 9.8 t70 -97.98 118.14 33.89 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 126.042 1.737 . . . . 0.0 109.287 -170.669 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -85.5 103.64 14.55 Favored 'General case' 0 N--CA 1.419 -1.997 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.993 179.514 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -100.54 113.48 26.32 Favored 'General case' 0 C--N 1.279 -2.479 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.503 HD11 ' HA ' ' A' ' 99' ' ' ASP . 16.3 tt -128.47 147.01 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.197 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -178.075 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 30.5 p-10 -98.16 -175.12 3.04 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -76.43 18.69 0.29 Allowed 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -177.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -117.89 3.92 12.18 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 178.738 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.503 ' HA ' HD11 ' A' ' 95' ' ' ILE . 5.7 m-20 62.91 28.41 16.33 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 122.29 1.043 . . . . 0.0 111.123 -175.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.406 ' C ' HG13 ' A' ' 95' ' ' ILE . 26.7 mt-30 -97.92 106.09 18.34 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 176.496 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -104.64 146.88 28.29 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 -174.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 14.4 tt -135.19 143.24 37.65 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 N-CA-C 105.855 -1.906 . . . . 0.0 105.855 170.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.462 ' HA ' ' O ' ' A' ' 92' ' ' ASP . . . -112.11 131.5 55.41 Favored 'General case' 0 C--N 1.29 -2.005 0 C-N-CA 120.107 -0.637 . . . . 0.0 111.728 -176.261 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.449 ' O ' ' HB2' ' A' ' 91' ' ' GLU . 94.6 m-85 -105.21 143.61 33.15 Favored 'General case' 0 C--O 1.196 -1.73 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 177.579 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.412 HG22 ' HB3' ' A' ' 91' ' ' GLU . 49.8 t -95.3 131.18 42.79 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 CA-C-O 121.999 0.904 . . . . 0.0 113.177 -169.673 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.449 ' HB2' ' O ' ' A' ' 90' ' ' ASP . 84.8 mmm -130.51 -172.43 2.8 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 112.91 -1.95 . . . . 0.0 106.834 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.525 ' H ' HD23 ' A' ' 107' ' ' LEU . 1.5 pt? -102.81 150.17 23.76 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -178.181 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.466 ' HA2' ' HB2' ' A' ' 90' ' ' ASP . . . -104.96 -175.42 24.56 Favored Glycine 0 N--CA 1.437 -1.248 0 C-N-CA 120.063 -1.065 . . . . 0.0 113.777 -176.044 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -58.67 -40.47 83.63 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 123.968 0.907 . . . . 0.0 112.256 -177.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.629 ' HE2' ' O ' ' A' ' 86' ' ' ASP . 37.5 mtmt -92.21 19.85 6.56 Favored 'General case' 0 C--N 1.314 -0.963 0 O-C-N 122.037 -0.415 . . . . 0.0 111.831 -176.525 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.453 ' O ' ' HB ' ' A' ' 114' ' ' VAL . . . -78.09 -30.25 49.48 Favored 'General case' 0 CA--C 1.497 -1.082 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 177.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 34.8 tp60 -63.76 -39.55 94.54 Favored 'General case' 0 N--CA 1.421 -1.921 0 CA-C-N 112.93 -1.941 . . . . 0.0 109.4 173.113 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 5.2 m -66.2 -30.14 70.55 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.536 ' HA ' ' HG ' ' A' ' 119' ' ' LEU . 94.5 t -64.64 -43.77 96.67 Favored 'Isoleucine or valine' 0 C--O 1.25 1.108 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.105 176.679 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 54.0 mt -69.05 -32.91 72.74 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.775 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -72.11 -24.43 61.48 Favored 'General case' 0 C--O 1.216 -0.659 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.213 177.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 103.18 -13.63 55.37 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.723 -0.751 . . . . 0.0 113.336 176.027 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -83.72 47.59 1.31 Allowed 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 121.531 0.682 . . . . 0.0 112.197 -175.243 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.536 ' HG ' ' HA ' ' A' ' 114' ' ' VAL . 0.0 OUTLIER -122.41 80.35 1.72 Allowed 'General case' 0 N--CA 1.434 -1.265 0 CA-C-O 123.263 1.506 . . . . 0.0 110.214 179.891 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.826 ' HA ' HG22 ' A' ' 12' ' ' THR . 5.8 ptmm? -114.31 93.13 4.21 Favored 'General case' 0 C--N 1.246 -3.902 0 C-N-CA 118.733 -1.187 . . . . 0.0 110.935 172.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 8.5 m -111.25 170.43 3.58 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.329 -176.247 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.401 ' O ' ' HE2' ' A' ' 82' ' ' LYS . 6.8 p-10 -95.52 168.43 10.7 Favored 'General case' 0 C--N 1.271 -2.816 0 CA-C-N 114.655 -1.157 . . . . 0.0 111.967 -178.117 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -158.36 142.34 15.59 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 114.627 -1.169 . . . . 0.0 108.028 172.14 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 26.5 ptt? . . . . . 0 C--N 1.295 -1.8 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 177.305 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 49.5 m . . . . . 0 N--CA 1.441 -0.91 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.56 ' HA ' ' O ' ' A' ' 5' ' ' ASP . 0.0 OUTLIER -62.46 95.1 0.07 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.8 -1.091 . . . . 0.0 112.197 -177.834 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.6 t 163.19 -27.72 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 -177.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 27.2 ttpp -121.2 -40.92 2.55 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 114.159 -1.382 . . . . 0.0 107.896 175.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.56 ' O ' ' HA ' ' A' ' 2' ' ' LYS . 7.4 m-20 -113.02 165.05 12.72 Favored 'General case' 0 CA--C 1.491 -1.317 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -178.22 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 47.5 p90 -97.35 3.93 50.92 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 121.979 0.895 . . . . 0.0 108.586 174.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.417 ' HE2' ' O ' ' A' ' 8' ' ' THR . 26.4 tttt -70.7 145.5 50.5 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 114.664 -1.153 . . . . 0.0 110.665 -177.251 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.532 ' HA ' ' NZ ' ' A' ' 2' ' ' LYS . 89.2 m -114.25 163.51 15.16 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 104.882 -2.266 . . . . 0.0 104.882 169.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.551 ' HB2' ' HB3' ' A' ' 127' ' ' GLU . 60.2 ttt180 -92.65 127.01 37.99 Favored 'General case' 0 N--CA 1.408 -2.54 0 C-N-CA 118.315 -1.354 . . . . 0.0 112.446 -165.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -81.09 111.68 17.76 Favored 'General case' 0 N--CA 1.394 -3.272 0 N-CA-C 104.633 -2.358 . . . . 0.0 104.633 170.03 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.4 m -84.58 76.15 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.279 -2.47 0 C-N-CA 118.281 -1.368 . . . . 0.0 109.721 178.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.654 HG22 ' HA ' ' A' ' 120' ' ' LYS . 26.1 p -110.07 -37.34 5.61 Favored 'General case' 0 C--N 1.259 -3.356 0 CA-C-N 114.849 -1.069 . . . . 0.0 109.391 178.467 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -69.67 -37.7 76.78 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 176.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.437 ' HB2' ' NH2' ' A' ' 9' ' ' ARG . 11.4 t70 -69.21 -54.93 12.26 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.73 -1.123 . . . . 0.0 108.176 -178.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.452 ' O ' HG23 ' A' ' 19' ' ' VAL . 77.2 t -63.27 -40.38 88.84 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.179 0 CA-C-N 113.76 -1.564 . . . . 0.0 112.966 -177.397 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 9.6 ttmm -67.08 -35.22 79.35 Favored 'General case' 0 C--N 1.323 -0.586 0 O-C-N 121.907 -0.496 . . . . 0.0 111.586 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 50.1 m -62.97 -45.42 92.52 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 174.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 66.6 mt -55.79 -53.3 39.04 Favored 'Isoleucine or valine' 0 C--O 1.243 0.723 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.134 175.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 15' ' ' VAL . 75.3 t -56.86 -43.99 81.2 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.011 0 CA-C-N 114.985 -1.007 . . . . 0.0 112.162 -178.585 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.461 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 32.9 ttt180 -53.04 -54.12 40.0 Favored 'General case' 0 N--CA 1.45 -0.453 0 O-C-N 123.765 0.666 . . . . 0.0 110.198 179.257 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.471 ' O ' ' HB2' ' A' ' 25' ' ' HIS . 66.0 m-85 -64.91 -43.05 94.08 Favored 'General case' 0 CA--C 1.494 -1.193 0 N-CA-C 113.183 0.809 . . . . 0.0 113.183 -175.045 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 35.9 m -70.84 -35.96 62.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 C-N-CA 119.367 -0.933 . . . . 0.0 111.345 -178.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -65.13 -47.09 78.33 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 123.402 0.439 . . . . 0.0 110.782 177.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.461 ' HG2' ' O ' ' A' ' 20' ' ' ARG . 12.5 pt-20 -79.98 -5.0 54.89 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 120.113 -0.635 . . . . 0.0 111.878 -179.405 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.471 ' HB2' ' O ' ' A' ' 21' ' ' PHE . 30.1 t-80 -78.73 34.91 0.23 Allowed 'General case' 0 CA--C 1.553 1.075 0 CA-C-O 121.673 0.749 . . . . 0.0 111.587 178.473 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 44.8 t -72.13 -16.97 62.0 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 171.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 24.9 t -134.21 -177.25 4.5 Favored 'General case' 0 N--CA 1.419 -1.995 0 N-CA-C 105.385 -2.08 . . . . 0.0 105.385 174.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 62.1 m -133.57 151.19 51.67 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 118.619 0.645 . . . . 0.0 110.995 -178.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -71.68 120.0 16.65 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.134 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -65.35 -22.95 69.77 Favored Glycine 0 C--O 1.223 -0.576 0 C-N-CA 121.345 -0.455 . . . . 0.0 112.508 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -76.57 6.02 6.51 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 123.196 0.598 . . . . 0.0 111.799 -178.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.8 ptm180 -57.54 -42.42 82.91 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 122.789 0.435 . . . . 0.0 110.657 178.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 40.7 t30 54.91 -70.05 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 115.861 1.8 . . . . 0.0 115.861 176.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 53.6 mt -31.77 -78.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 C-N-CA 126.843 2.057 . . . . 0.0 114.654 -167.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.478 ' HD2' ' HA ' ' A' ' 59' ' ' LYS . 99.2 mttt -90.27 76.59 6.79 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-O 122.449 1.119 . . . . 0.0 112.345 -176.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 30.6 p-80 -101.6 23.01 11.81 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 114.12 -1.4 . . . . 0.0 109.301 177.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 18.1 m -140.97 145.75 24.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 C-N-CA 124.261 1.024 . . . . 0.0 108.519 179.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 110.36 173.42 20.29 Favored Glycine 0 N--CA 1.438 -1.202 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.711 178.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -76.16 170.24 20.45 Favored 'Trans proline' 0 C--O 1.251 1.159 0 C-N-CA 122.214 1.943 . . . . 0.0 111.698 178.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.3 p -73.3 -173.84 1.46 Allowed 'General case' 0 C--O 1.256 1.424 0 C-N-CA 123.927 0.891 . . . . 0.0 112.579 -177.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -142.3 -174.64 15.0 Favored Glycine 0 N--CA 1.433 -1.503 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 -178.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 85.7 mtm180 -132.89 163.47 29.06 Favored 'General case' 0 N--CA 1.422 -1.836 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -107.82 92.15 3.95 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-O 121.942 0.877 . . . . 0.0 110.226 -174.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 70.1 p -118.79 162.27 18.75 Favored 'General case' 0 N--CA 1.413 -2.305 0 CA-C-N 114.193 -1.367 . . . . 0.0 107.762 178.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.524 ' O ' HG23 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -55.11 -44.27 74.81 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -176.5 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.436 ' O ' ' HB ' ' A' ' 49' ' ' VAL . 3.5 m-20 -71.22 -23.36 62.0 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -177.24 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 26.0 mmt -71.66 -39.7 70.14 Favored 'General case' 0 CA--C 1.508 -0.673 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 176.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 78.4 mt -66.95 -30.89 71.15 Favored 'General case' 0 C--O 1.216 -0.676 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.301 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 45' ' ' MET . 27.3 t -62.8 -52.7 56.28 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.944 0 C-N-CA 124.806 1.242 . . . . 0.0 110.98 178.465 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.451 ' CG ' ' HB3' ' A' ' 55' ' ' SER . 10.7 t70 -63.02 -38.2 90.24 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 114.848 -1.069 . . . . 0.0 109.287 -178.217 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.533 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 71.2 mt -63.91 -47.98 88.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.252 -0.885 . . . . 0.0 111.513 176.121 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.494 ' CE2' ' HA3' ' A' ' 68' ' ' GLY . 49.1 t80 -52.65 -43.34 65.43 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 124.778 1.231 . . . . 0.0 111.618 -177.221 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.473 HD11 ' HB2' ' A' ' 71' ' ' TYR . 8.9 mp -76.96 -22.54 53.09 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 179.361 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.77 31.48 18.04 Favored Glycine 0 C--O 1.267 2.2 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -174.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.451 ' HB3' ' CG ' ' A' ' 50' ' ' ASP . 22.8 t -75.69 -179.42 4.71 Favored 'General case' 0 N--CA 1.415 -2.187 0 CA-C-N 113.7 -1.25 . . . . 0.0 108.541 -178.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 43.7 mttm -123.51 17.36 9.67 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 118.76 -1.176 . . . . 0.0 113.297 -169.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.4 m -88.85 -38.31 14.68 Favored 'General case' 0 C--O 1.247 0.971 0 N-CA-C 105.06 -2.2 . . . . 0.0 105.06 173.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.446 ' HB1' HG12 ' A' ' 51' ' ' ILE . . . -45.85 137.37 5.61 Favored 'General case' 0 N--CA 1.429 -1.494 0 C-N-CA 128.213 2.605 . . . . 0.0 111.59 178.129 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.478 ' HA ' ' HD2' ' A' ' 35' ' ' LYS . 50.4 mtmt -120.01 18.22 12.45 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.971 -178.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . 0.251 67.6 mt -104.03 -50.4 9.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 C-N-CA 117.496 -1.682 . . . . 0.0 114.19 -177.276 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.641 ' HA ' ' CD2' ' A' ' 65' ' ' PHE . 25.7 mp0 60.91 26.59 16.48 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 176.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.9 t -139.41 129.65 25.34 Favored 'General case' 0 N--CA 1.421 -1.898 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.249 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 106.38 -134.8 12.33 Favored Glycine 0 N--CA 1.435 -1.383 0 N-CA-C 111.61 -0.596 . . . . 0.0 111.61 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.438 HG23 ' CD2' ' A' ' 21' ' ' PHE . 1.4 pt -70.95 29.06 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 124.708 1.203 . . . . 0.0 113.694 179.204 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.641 ' CD2' ' HA ' ' A' ' 61' ' ' GLN . 9.0 t80 -71.69 112.31 7.7 Favored 'General case' 0 N--CA 1.425 -1.689 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -177.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.34 48.18 46.91 Favored Glycine 0 N--CA 1.441 -0.968 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.505 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 32.5 mmtm -119.25 -21.0 7.73 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 120.941 0.4 . . . . 0.0 111.34 177.061 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.494 ' HA3' ' CE2' ' A' ' 52' ' ' PHE . . . -121.58 45.13 1.25 Allowed Glycine 0 N--CA 1.437 -1.299 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 178.636 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.7 m -73.99 6.69 3.17 Favored 'General case' 0 C--N 1.306 -1.292 0 C-N-CA 124.614 1.166 . . . . 0.0 112.173 -175.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -101.71 3.87 40.06 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-O 121.527 0.679 . . . . 0.0 109.883 178.041 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.473 ' HB2' HD11 ' A' ' 53' ' ' LEU . 34.0 m-85 -101.36 168.8 9.3 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.884 176.561 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 36.1 t -104.07 155.77 18.42 Favored 'General case' 0 N--CA 1.417 -2.117 0 N-CA-C 104.548 -2.39 . . . . 0.0 104.548 168.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 69.7 mtm180 -57.7 -39.66 77.69 Favored 'General case' 0 C--O 1.209 -1.035 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -175.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 69.7 t60 -77.49 -17.0 58.41 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-O 121.519 0.676 . . . . 0.0 110.886 -176.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -80.53 -43.61 20.44 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 177.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.519 ' HB3' HG13 ' A' ' 49' ' ' VAL . . . -61.81 -41.55 97.91 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.009 -0.996 . . . . 0.0 108.842 175.682 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -54.16 -43.61 70.76 Favored 'General case' 0 CA--C 1.501 -0.929 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.327 174.056 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 20.2 ttm180 -64.93 -28.81 69.78 Favored 'General case' 0 C--O 1.217 -0.647 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.228 -172.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.3 tt -80.63 -47.25 14.37 Favored 'General case' 0 N--CA 1.429 -1.523 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.26 -177.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -62.09 -20.04 63.6 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 121.861 0.839 . . . . 0.0 109.471 177.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.524 ' HA ' HG13 ' A' ' 84' ' ' ILE . 94.4 mttt -91.26 -22.34 20.63 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 114.471 -1.241 . . . . 0.0 110.394 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 29.6 tptp -70.93 -47.08 61.03 Favored 'General case' 0 C--O 1.219 -0.531 0 N-CA-C 106.133 -1.802 . . . . 0.0 106.133 171.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 94.3 mt -56.8 -39.65 74.52 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 114.35 -1.295 . . . . 0.0 113.941 177.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.524 HG13 ' HA ' ' A' ' 81' ' ' LYS . 2.7 pp -69.61 -33.02 54.81 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.785 0 C-N-CA 120.261 -0.576 . . . . 0.0 110.908 178.453 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 53.4 mt -70.36 -44.1 68.81 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 121.087 0.47 . . . . 0.0 111.558 176.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -66.96 -27.28 67.33 Favored 'General case' 0 C--O 1.259 1.575 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.199 179.336 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.474 ' HD2' ' O ' ' A' ' 84' ' ' ILE . 2.2 mptp? 84.89 18.73 0.13 Allowed 'General case' 0 CA--C 1.476 -1.902 0 C-N-CA 125.781 1.632 . . . . 0.0 112.846 176.215 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.547 HG23 HG21 ' A' ' 114' ' ' VAL . 1.9 mp -69.77 -40.64 79.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 105.391 -2.077 . . . . 0.0 105.391 166.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.478 ' CD1' HG13 ' A' ' 105' ' ' VAL . 3.1 mm? -103.6 144.31 31.61 Favored 'General case' 0 N--CA 1.411 -2.405 0 CA-C-N 113.419 -1.719 . . . . 0.0 109.04 173.356 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -124.72 131.57 53.45 Favored 'General case' 0 N--CA 1.408 -2.538 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 176.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.47 ' H ' ' CD ' ' A' ' 91' ' ' GLU . 0.1 OUTLIER -95.27 129.67 42.31 Favored 'General case' 0 C--N 1.27 -2.86 0 CA-C-N 114.271 -1.331 . . . . 0.0 111.708 -173.838 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.519 ' HB2' ' HB2' ' A' ' 104' ' ' TYR . 7.9 m-20 -96.48 95.84 8.29 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 179.092 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 97.5 mt -76.28 114.54 15.08 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.461 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -130.86 130.86 44.12 Favored 'General case' 0 N--CA 1.42 -1.968 0 CA-C-N 115.344 -0.844 . . . . 0.0 108.837 -177.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.498 HG13 ' C ' ' A' ' 100' ' ' GLN . 16.8 tt -128.81 141.15 47.35 Favored 'Isoleucine or valine' 0 N--CA 1.399 -3.005 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 176.211 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.408 ' C ' ' H ' ' A' ' 98' ' ' ASN . 3.5 p-10 -95.72 170.85 9.04 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 176.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -67.9 21.72 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -173.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.408 ' H ' ' C ' ' A' ' 96' ' ' ASN . 16.8 m120 -119.32 7.49 11.26 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 177.429 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.488 ' HA ' HD11 ' A' ' 95' ' ' ILE . 8.4 m-20 62.14 30.76 17.82 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 124.787 1.305 . . . . 0.0 110.99 -177.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.498 ' C ' HG13 ' A' ' 95' ' ' ILE . 83.6 mm-40 -101.71 107.42 18.64 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 177.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -96.27 139.25 32.68 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 115.663 -0.699 . . . . 0.0 112.081 -175.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 18.4 tt -142.21 146.16 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.723 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 176.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.507 ' HA ' ' O ' ' A' ' 92' ' ' ASP . . . -114.19 132.86 55.95 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 -178.344 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.519 ' HB2' ' HB2' ' A' ' 92' ' ' ASP . 68.1 m-85 -97.23 175.4 6.29 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 177.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.478 HG13 ' CD1' ' A' ' 89' ' ' LEU . 14.6 t -116.4 121.01 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.803 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 -178.233 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 58.4 mtp -141.76 168.48 19.65 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 113.436 -1.711 . . . . 0.0 108.764 173.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.543 ' HB3' ' HB2' ' A' ' 111' ' ' ALA . 7.5 mp -116.86 130.27 56.61 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 177.11 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -131.8 -80.24 0.19 Allowed Glycine 0 N--CA 1.422 -2.257 0 C-N-CA 118.897 -1.62 . . . . 0.0 115.716 -175.072 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -65.96 -54.9 20.31 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 115.25 1.574 . . . . 0.0 115.25 -168.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.515 ' HB2' ' HA ' ' A' ' 88' ' ' ILE . 41.9 mmtm -97.55 6.15 48.51 Favored 'General case' 0 C--N 1.313 -0.979 0 O-C-N 121.455 -0.778 . . . . 0.0 109.995 -179.222 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.543 ' HB2' ' HB3' ' A' ' 107' ' ' LEU . . . -58.03 -32.82 68.34 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -175.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.5 -29.13 66.7 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.469 0.652 . . . . 0.0 110.029 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 13.1 m -75.95 -25.16 55.66 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.547 HG21 HG23 ' A' ' 88' ' ' ILE . 40.0 t -70.19 -39.69 77.23 Favored 'Isoleucine or valine' 0 C--O 1.25 1.083 0 CA-C-N 115.246 -0.888 . . . . 0.0 108.942 175.309 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.449 ' HG ' ' O ' ' A' ' 111' ' ' ALA . 76.1 mt -69.54 -39.2 77.6 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.981 178.47 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.41 ' OD1' ' HB2' ' A' ' 118' ' ' ASN . 28.0 t-20 -71.58 -20.07 62.05 Favored 'General case' 0 C--O 1.217 -0.635 0 CA-C-O 121.735 0.778 . . . . 0.0 109.529 176.632 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 85.04 6.52 84.78 Favored Glycine 0 CA--C 1.503 -0.718 0 CA-C-N 115.396 -0.82 . . . . 0.0 113.173 176.041 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.41 ' HB2' ' OD1' ' A' ' 116' ' ' ASN . 13.0 t-20 -93.81 18.9 9.54 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 121.584 0.707 . . . . 0.0 109.644 -175.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.545 HD13 ' O ' ' A' ' 119' ' ' LEU . 0.0 OUTLIER -90.06 112.53 24.01 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-O 123.277 1.513 . . . . 0.0 108.442 -176.898 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.654 ' HA ' HG22 ' A' ' 12' ' ' THR . 4.9 ptpp? -130.13 105.72 8.13 Favored 'General case' 1 C--N 1.228 -4.697 0 CA-C-N 113.309 -1.769 . . . . 0.0 112.229 179.551 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.4 m -119.07 171.01 7.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 177.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -105.56 158.39 16.71 Favored 'General case' 0 C--N 1.262 -3.223 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.291 -177.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -158.08 151.7 23.6 Favored 'General case' 0 N--CA 1.426 -1.636 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 172.214 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 49.8 ttm -122.05 107.85 12.69 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 120.501 -0.48 . . . . 0.0 112.037 -173.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -133.91 -146.25 0.26 Allowed 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 174.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 18.8 m -97.89 71.9 2.21 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-O 122.6 1.191 . . . . 0.0 108.444 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.551 ' HB3' ' HB2' ' A' ' 9' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.428 -1.532 0 N-CA-C 102.401 -3.185 . . . . 0.0 102.401 177.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 74.1 m . . . . . 0 N--CA 1.464 0.236 0 N-CA-C 110.353 -0.24 . . . . 0.0 110.353 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 4.8 ttmp? -94.6 158.9 15.32 Favored 'General case' 0 C--O 1.225 -0.2 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 177.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 28.1 m 67.87 85.58 0.14 Allowed 'General case' 0 CA--C 1.535 0.366 0 O-C-N 124.298 0.999 . . . . 0.0 109.718 -178.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -135.04 -42.45 0.73 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.113 -173.554 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.402 ' HA ' HH12 ' A' ' 9' ' ' ARG . 22.9 t70 -93.48 97.75 10.74 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -173.284 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -75.29 -47.45 27.85 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 103.614 -2.736 . . . . 0.0 103.614 167.326 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.686 ' NZ ' ' HA ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -165.55 152.54 10.27 Favored 'General case' 0 N--CA 1.412 -2.362 0 N-CA-C 105.482 -2.044 . . . . 0.0 105.482 169.512 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.449 HG22 ' HB2' ' A' ' 122' ' ' ASP . 0.2 OUTLIER -77.96 155.95 30.51 Favored 'General case' 0 N--CA 1.419 -2.001 0 CA-C-O 121.133 0.492 . . . . 0.0 111.415 -171.575 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.509 ' O ' ' HA ' ' A' ' 122' ' ' ASP . 8.8 mpt_? -97.4 119.81 36.63 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.342 -170.215 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -84.97 90.86 7.92 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 177.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.2 m -85.72 64.96 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 CA-C-O 121.705 0.764 . . . . 0.0 110.498 -179.404 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.526 HG21 ' HB3' ' A' ' 120' ' ' LYS . 42.8 p -102.92 -16.84 15.74 Favored 'General case' 0 C--N 1.26 -3.3 0 C-N-CA 116.15 -2.22 . . . . 0.0 113.187 -176.283 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 17.9 p-10 -82.14 -35.88 28.01 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 174.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -68.65 -58.98 3.47 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.3 179.314 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 88.6 t -59.51 -35.72 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 CA-C-N 114.675 -1.148 . . . . 0.0 112.04 -179.028 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.468 ' HE3' HD11 ' A' ' 119' ' ' LEU . 3.6 tppp? -66.07 -40.01 90.52 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.294 178.5 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.463 ' O ' ' HD2' ' A' ' 21' ' ' PHE . 49.6 m -65.14 -42.03 94.19 Favored 'General case' 0 N--CA 1.442 -0.853 0 O-C-N 123.362 0.414 . . . . 0.0 110.246 178.782 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 59.0 mt -57.13 -51.89 63.35 Favored 'Isoleucine or valine' 0 C--O 1.244 0.807 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.266 176.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.51 HG11 HG11 ' A' ' 114' ' ' VAL . 70.6 t -65.6 -37.33 79.75 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.621 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.929 -178.001 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 16.2 ttp180 -55.11 -52.24 63.86 Favored 'General case' 0 C--O 1.222 -0.386 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.463 ' HD2' ' O ' ' A' ' 17' ' ' SER . 55.5 m-85 -63.16 -43.81 97.24 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-N 115.103 -0.953 . . . . 0.0 113.006 -177.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.444 HG22 ' HA ' ' A' ' 19' ' ' VAL . 27.3 m -72.87 -33.79 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.055 0 C-N-CA 119.365 -0.934 . . . . 0.0 111.742 -178.653 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 58.9 tp60 -65.59 -48.88 70.82 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 123.141 0.276 . . . . 0.0 110.737 176.172 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -69.03 -16.47 63.71 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 121.69 0.757 . . . . 0.0 110.461 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 46.7 t-80 -81.82 35.93 0.43 Allowed 'General case' 0 CA--C 1.551 0.984 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.514 177.366 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 20.0 m -60.54 -33.88 73.3 Favored 'General case' 0 CA--C 1.55 0.965 0 CA-C-O 122.008 0.909 . . . . 0.0 108.591 174.05 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 20.2 m -89.75 147.02 24.08 Favored 'General case' 0 N--CA 1.432 -1.368 0 CA-C-N 115.135 -0.939 . . . . 0.0 108.797 175.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 40.6 t -56.72 -49.05 76.32 Favored 'General case' 0 C--O 1.249 1.072 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 178.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 53.2 tp60 70.4 -43.23 0.54 Allowed 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 125.556 1.542 . . . . 0.0 113.185 174.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -78.3 56.86 4.07 Favored Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 112.181 -0.367 . . . . 0.0 112.181 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 90.1 mmm -83.33 5.52 23.02 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 123.68 0.792 . . . . 0.0 110.396 -178.166 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 18.8 mmm180 -78.15 -16.69 57.69 Favored 'General case' 0 C--O 1.214 -0.771 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.599 175.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 59.76 97.78 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 125.372 1.469 . . . . 0.0 113.213 176.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.61 HD12 ' CD ' ' A' ' 61' ' ' GLN . 2.2 tt -79.85 74.74 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 N-CA-C 109.055 -0.721 . . . . 0.0 109.055 174.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 97.9 mttt 40.66 80.1 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 126.726 2.01 . . . . 0.0 115.047 176.419 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 42.5 p-80 -165.28 146.21 7.28 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.809 177.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 16.5 m -94.08 110.29 23.33 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 CA-C-O 121.442 0.639 . . . . 0.0 109.422 175.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 136.48 171.27 12.21 Favored Glycine 0 N--CA 1.429 -1.816 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -72.56 145.74 42.65 Favored 'Trans proline' 0 C--O 1.248 0.986 0 C-N-CA 122.469 2.112 . . . . 0.0 112.354 -179.283 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 12.9 m -85.0 78.73 9.86 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -159.75 76.89 0.19 Allowed Glycine 0 N--CA 1.438 -1.224 0 C-N-CA 120.043 -1.075 . . . . 0.0 113.275 -178.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 63.0 mtt180 -135.2 115.94 13.91 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 174.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -109.09 109.79 20.88 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.15 -177.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.515 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 80.9 p -130.69 156.34 45.09 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 104.497 -2.409 . . . . 0.0 104.497 174.324 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.547 ' O ' HG23 ' A' ' 49' ' ' VAL . 11.9 ptp -59.91 -35.03 74.01 Favored 'General case' 0 C--O 1.215 -0.712 0 CA-C-N 119.701 1.137 . . . . 0.0 110.986 -179.382 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -72.72 -32.74 65.95 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.896 -175.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' MET . . . . . 0.687 ' SD ' ' HA ' ' A' ' 58' ' ' ALA . 48.2 tpp -67.17 -39.45 86.47 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 176.657 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.515 ' HG ' ' O ' ' A' ' 44' ' ' THR . 77.9 mt -64.26 -40.76 96.66 Favored 'General case' 0 C--O 1.207 -1.152 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.544 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.547 HG23 ' O ' ' A' ' 45' ' ' MET . 68.7 t -64.19 -46.3 93.87 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.687 0 C-N-CA 124.037 0.935 . . . . 0.0 110.245 177.363 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.579 ' OD1' ' HB3' ' A' ' 55' ' ' SER . 7.9 t70 -60.7 -44.32 96.7 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 114.731 -1.122 . . . . 0.0 109.507 -178.332 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.497 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 54.9 mt -65.18 -47.12 88.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.044 175.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.425 ' CZ ' ' HA3' ' A' ' 68' ' ' GLY . 25.7 t80 -57.18 -44.12 83.28 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 124.353 1.061 . . . . 0.0 110.757 -177.313 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.4 HD22 ' HD2' ' A' ' 73' ' ' ARG . 11.0 mp -77.21 -28.66 53.91 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 177.072 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 100.74 29.14 6.68 Favored Glycine 0 C--O 1.244 0.722 0 C-N-CA 120.525 -0.845 . . . . 0.0 113.162 177.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.579 ' HB3' ' OD1' ' A' ' 50' ' ' ASP . 23.1 t -80.28 -170.51 2.56 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 123.388 0.675 . . . . 0.0 110.836 -176.217 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.462 ' HD2' ' C ' ' A' ' 55' ' ' SER . 1.6 mptp? -121.14 7.84 10.31 Favored 'General case' 0 C--O 1.25 1.1 0 N-CA-C 114.271 1.212 . . . . 0.0 114.271 -177.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.5 m -78.36 -30.08 47.85 Favored 'General case' 0 C--O 1.245 0.823 0 N-CA-C 104.837 -2.283 . . . . 0.0 104.837 173.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.687 ' HA ' ' SD ' ' A' ' 47' ' ' MET . . . -50.2 120.97 4.93 Favored 'General case' 0 N--CA 1.417 -2.113 0 C-N-CA 127.34 2.256 . . . . 0.0 109.825 172.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.586 ' HA ' ' HE3' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -100.64 9.69 42.14 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-O 121.067 0.46 . . . . 0.0 111.297 -179.482 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 61.8 mt -128.23 120.88 54.4 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 176.253 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.61 ' CD ' HD12 ' A' ' 34' ' ' ILE . 29.9 mm-40 -105.39 32.43 4.27 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.192 0.52 . . . . 0.0 110.144 -177.117 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 24.5 m -141.65 126.76 18.43 Favored 'General case' 0 C--N 1.311 -1.077 0 O-C-N 122.057 -0.402 . . . . 0.0 110.84 -177.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 131.16 -132.57 6.87 Favored Glycine 0 N--CA 1.442 -0.91 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.452 HG23 ' CD2' ' A' ' 21' ' ' PHE . 1.7 pt -75.9 31.02 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 123.32 0.648 . . . . 0.0 112.054 177.244 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.497 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 11.5 t80 -66.87 112.8 4.47 Favored 'General case' 0 N--CA 1.42 -1.974 0 CA-C-O 120.992 0.425 . . . . 0.0 110.443 -174.262 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 63.79 36.8 93.78 Favored Glycine 0 N--CA 1.436 -1.303 0 CA-C-N 115.045 -0.98 . . . . 0.0 112.156 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.609 ' HA ' ' HE3' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -100.8 -25.04 14.25 Favored 'General case' 0 C--N 1.32 -0.701 0 O-C-N 122.153 -0.616 . . . . 0.0 110.247 177.672 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.425 ' HA3' ' CZ ' ' A' ' 52' ' ' PHE . . . -120.13 51.59 0.76 Allowed Glycine 0 N--CA 1.436 -1.351 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.7 t -82.84 9.3 10.16 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 122.017 0.913 . . . . 0.0 109.86 -174.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -102.0 6.8 41.33 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-O 121.709 0.766 . . . . 0.0 109.82 178.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -100.91 154.45 18.66 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 115.019 -0.991 . . . . 0.0 108.852 176.063 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.653 ' HB3' ' OD1' ' A' ' 75' ' ' ASN . 43.5 t -97.09 164.85 12.34 Favored 'General case' 0 N--CA 1.416 -2.141 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 171.419 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.4 ' HD2' HD22 ' A' ' 53' ' ' LEU . 10.6 mmm180 -54.16 -40.35 67.39 Favored 'General case' 0 CA--C 1.509 -0.624 0 C-N-CA 122.981 0.512 . . . . 0.0 112.289 -174.456 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 16.0 t-80 -86.87 -21.73 26.18 Favored 'General case' 0 C--O 1.2 -1.524 0 C-N-CA 119.015 -1.074 . . . . 0.0 111.372 -172.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.653 ' OD1' ' HB3' ' A' ' 72' ' ' SER . 13.4 m120 -79.78 -38.87 32.17 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 -178.403 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.41 ' HB3' HG13 ' A' ' 49' ' ' VAL . . . -64.09 -46.29 84.93 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.752 176.681 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.74 -20.56 61.18 Favored 'General case' 0 C--O 1.214 -0.808 0 C-N-CA 120.544 -0.463 . . . . 0.0 111.231 -178.802 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.413 ' HB3' ' O ' ' A' ' 75' ' ' ASN . 21.7 tpp180 -65.94 -35.63 81.14 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 176.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.2 tt -76.83 -45.27 29.22 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 114.761 -1.108 . . . . 0.0 110.175 -179.428 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -62.99 -17.19 61.87 Favored 'General case' 0 C--O 1.216 -0.693 0 C-N-CA 120.108 -0.637 . . . . 0.0 109.706 176.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.487 ' HA ' HG13 ' A' ' 84' ' ' ILE . 53.1 mttp -86.52 -26.18 24.71 Favored 'General case' 0 CA--C 1.496 -1.099 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.399 177.229 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.422 ' HG3' ' OD2' ' A' ' 86' ' ' ASP . 29.2 tptp -72.09 -47.24 52.82 Favored 'General case' 0 N--CA 1.427 -1.599 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 176.659 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.453 ' HB3' HD23 ' A' ' 89' ' ' LEU . 95.8 mt -58.7 -38.08 77.51 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 179.015 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.576 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 2.6 pp -77.7 -23.13 14.08 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 C-N-CA 120.048 -0.661 . . . . 0.0 111.747 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.9 tt -77.76 -47.24 19.49 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 176.127 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.422 ' OD2' ' HG3' ' A' ' 82' ' ' LYS . 68.3 m-20 -69.64 -20.95 63.59 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.567 -179.58 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.491 ' HB3' ' HB2' ' A' ' 109' ' ' ASN . 3.7 mptp? 84.75 15.61 0.19 Allowed 'General case' 0 CA--C 1.479 -1.765 0 C-N-CA 124.747 1.219 . . . . 0.0 113.679 173.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.541 HG22 HD22 ' A' ' 89' ' ' LEU . 1.8 mp -67.92 -39.92 82.53 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.847 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 169.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.576 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 4.4 mm? -112.08 147.74 35.41 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.682 170.315 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -133.32 100.53 4.87 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 120.838 0.351 . . . . 0.0 110.061 178.198 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.413 ' HG2' HG21 ' A' ' 84' ' ' ILE . 18.3 pt-20 -100.26 156.76 17.05 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.458 175.667 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -133.3 179.9 5.91 Favored 'General case' 0 C--O 1.248 0.987 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 179.025 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 99.1 mt -104.14 150.18 24.57 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 122.511 1.148 . . . . 0.0 113.727 -170.176 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -141.57 121.01 13.2 Favored 'General case' 0 N--CA 1.422 -1.85 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 176.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 14.7 tt -118.1 149.98 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.444 0 C-N-CA 119.687 -0.805 . . . . 0.0 108.94 -179.364 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 39.1 p30 -102.1 -176.7 3.19 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.201 178.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -74.05 11.51 0.9 Allowed 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 123.493 0.717 . . . . 0.0 112.315 -178.185 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -110.79 -2.89 15.99 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 -179.301 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 29.5 t70 69.11 24.48 6.1 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-O 123.462 1.601 . . . . 0.0 109.189 -176.358 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -97.52 107.12 19.56 Favored 'General case' 0 C--O 1.245 0.859 0 CA-C-N 114.998 -1.001 . . . . 0.0 108.749 176.021 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -88.68 129.53 35.5 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.833 -177.309 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 15.0 tt -124.5 150.14 29.14 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 175.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -108.92 134.54 51.46 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 122.315 -0.241 . . . . 0.0 110.681 -177.156 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -106.36 143.33 34.63 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.053 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 19.0 t -96.61 133.98 35.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 CA-C-O 122.094 0.949 . . . . 0.0 113.168 -171.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 62.6 mtt -134.62 175.95 9.08 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 113.365 -1.743 . . . . 0.0 106.876 176.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.479 ' H ' HD23 ' A' ' 107' ' ' LEU . 2.1 pt? -121.61 132.24 54.56 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -140.21 -104.99 0.6 Allowed Glycine 0 N--CA 1.429 -1.808 0 C-N-CA 118.484 -1.817 . . . . 0.0 115.525 -174.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.491 ' HB2' ' HB3' ' A' ' 87' ' ' LYS . 37.1 m-80 -49.99 -55.33 15.05 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 115.312 1.597 . . . . 0.0 115.312 -167.523 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.46 ' O ' HG23 ' A' ' 114' ' ' VAL . 74.8 mmtt -110.89 19.79 18.18 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.833 -0.542 . . . . 0.0 111.119 -176.652 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -76.3 -33.36 59.07 Favored 'General case' 0 CA--C 1.495 -1.167 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 35.5 tp60 -62.87 -36.48 83.44 Favored 'General case' 0 N--CA 1.423 -1.821 0 CA-C-N 113.025 -1.898 . . . . 0.0 110.023 173.349 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 19.8 m -69.31 -28.53 66.35 Favored 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 179.173 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.545 HG22 ' HG ' ' A' ' 119' ' ' LEU . 38.9 t -66.76 -43.81 89.71 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.758 176.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 65.3 mt -67.6 -33.05 74.22 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.314 -179.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -72.71 -23.5 60.87 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 177.21 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 98.12 -19.32 54.98 Favored Glycine 0 N--CA 1.44 -1.063 0 CA-C-N 115.597 -0.729 . . . . 0.0 113.075 177.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -79.17 24.22 0.34 Allowed 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.534 1.134 . . . . 0.0 113.56 -172.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.599 HD13 ' O ' ' A' ' 119' ' ' LEU . 0.0 OUTLIER -94.13 109.53 21.3 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 122.914 1.34 . . . . 0.0 109.73 -178.892 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.526 ' HB3' HG21 ' A' ' 12' ' ' THR 0.341 0.1 OUTLIER -129.54 114.65 16.35 Favored 'General case' 1 C--N 1.225 -4.831 0 N-CA-C 114.449 1.277 . . . . 0.0 114.449 172.651 . . . . . . . . 5 4 . 1 . 002 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 5.4 m -126.83 173.68 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.796 0 CA-C-N 114.758 -1.11 . . . . 0.0 108.147 177.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.509 ' HA ' ' O ' ' A' ' 9' ' ' ARG . 8.5 p-10 -107.77 173.07 6.48 Favored 'General case' 0 C--N 1.269 -2.919 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.702 -177.65 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' PHE . . . . . 0.401 ' O ' ' HD3' ' A' ' 9' ' ' ARG . 51.1 t80 -157.81 166.78 31.82 Favored 'General case' 0 C--O 1.251 1.166 0 C-N-CA 123.93 0.892 . . . . 0.0 108.95 178.708 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 42.8 tpp -141.19 118.85 11.64 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 125.827 1.651 . . . . 0.0 106.595 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.461 ' CD ' ' H ' ' A' ' 125' ' ' GLU . 1.9 mp0 -43.56 -72.8 0.05 Allowed 'General case' 0 N--CA 1.501 2.105 0 C-N-CA 124.477 1.111 . . . . 0.0 113.144 -176.372 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.467 ' HA ' ' ND2' ' A' ' 75' ' ' ASN . 14.9 t -114.32 -177.63 3.18 Favored 'General case' 0 N--CA 1.428 -1.568 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.739 -173.573 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.408 ' CD ' HH21 ' A' ' 78' ' ' ARG . 4.2 mm-40 . . . . . 0 C--N 1.305 -1.367 0 C-N-CA 125.304 1.442 . . . . 0.0 109.67 -174.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 7.3 p . . . . . 0 N--CA 1.441 -0.884 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.487 ' HG2' ' OD1' ' A' ' 5' ' ' ASP . 44.9 mmtm -163.26 -171.68 2.7 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 102.57 -3.122 . . . . 0.0 102.57 176.209 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 6.7 m -72.52 -30.68 64.7 Favored 'General case' 0 CA--C 1.552 1.043 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 169.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -141.76 104.29 4.5 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 175.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.487 ' OD1' ' HG2' ' A' ' 2' ' ' LYS . 26.9 t70 -118.92 102.47 8.8 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 -175.453 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 28.9 p90 -75.1 78.19 2.26 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 -174.401 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 6.3 ptmm? -175.43 -160.13 0.08 Allowed 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 126.658 1.983 . . . . 0.0 105.846 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.2 m -76.67 157.29 31.92 Favored 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 176.364 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.486 ' HB2' ' O ' ' A' ' 123' ' ' PHE . 6.9 mpt_? -93.83 130.14 39.97 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 -174.164 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -90.76 94.18 9.56 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 -174.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.613 ' HB ' ' OD1' ' A' ' 14' ' ' ASP . 21.6 m -89.64 104.35 15.0 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 CA-C-O 122.658 1.218 . . . . 0.0 110.648 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -122.28 -42.61 2.35 Favored 'General case' 0 C--N 1.267 -3.018 0 C-N-CA 119.285 -0.966 . . . . 0.0 112.545 174.047 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.555 ' HA ' ' HB2' ' A' ' 16' ' ' LYS 0.367 7.3 m-20 -87.62 -9.84 53.13 Favored 'General case' 0 N--CA 1.419 -1.99 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 -171.639 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.613 ' OD1' ' HB ' ' A' ' 11' ' ' VAL . 20.2 p-10 -84.32 -39.92 18.55 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 105.545 -2.021 . . . . 0.0 105.545 171.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.431 ' O ' ' HB ' ' A' ' 18' ' ' ILE . 65.0 t -65.39 -37.32 79.79 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.378 0 CA-C-N 113.847 -1.524 . . . . 0.0 109.448 174.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.555 ' HB2' ' HA ' ' A' ' 13' ' ' ASP . 1.4 tppp? -61.6 -42.7 99.24 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 124.941 1.296 . . . . 0.0 109.776 178.67 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.9 t -61.66 -45.24 94.89 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.431 ' HB ' ' O ' ' A' ' 15' ' ' VAL . 87.6 mt -54.28 -54.28 22.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.168 175.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.417 HG21 HG11 ' A' ' 114' ' ' VAL . 77.2 t -56.5 -47.06 82.39 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.773 0 CA-C-N 115.144 -0.934 . . . . 0.0 111.562 -179.503 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 7.3 tpt180 -51.25 -51.6 52.57 Favored 'General case' 0 C--N 1.321 -0.644 0 O-C-N 123.421 0.451 . . . . 0.0 111.282 177.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.51 ' CE1' ' HA3' ' A' ' 63' ' ' GLY . 69.0 m-85 -72.58 -35.9 68.05 Favored 'General case' 0 CA--C 1.492 -1.287 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -174.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 27.0 m -73.96 -37.13 46.96 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.533 0 C-N-CA 118.963 -1.095 . . . . 0.0 110.222 178.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -61.02 -50.85 71.67 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 176.078 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -71.46 -25.8 62.45 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.922 -177.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 14.6 t60 -69.68 -32.44 71.07 Favored 'General case' 0 C--O 1.211 -0.952 0 C-N-CA 120.156 -0.618 . . . . 0.0 109.764 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 20.3 m -82.29 6.26 17.43 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 121.184 0.516 . . . . 0.0 112.017 -175.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 33.1 t -95.51 7.67 45.56 Favored 'General case' 0 N--CA 1.44 -0.936 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 177.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 29.4 t -171.35 -166.76 0.48 Allowed 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 -178.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -83.8 -34.04 24.83 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 175.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 74.79 77.59 0.67 Allowed Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.106 179.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 66.7 mtt -61.72 18.47 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.425 0 C-N-CA 126.91 2.084 . . . . 0.0 115.281 -175.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 27.2 mmm180 -79.08 18.65 0.62 Allowed 'General case' 0 C--N 1.299 -1.587 0 C-N-CA 124.095 0.958 . . . . 0.0 112.315 -178.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -64.48 136.52 57.15 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 121.163 0.506 . . . . 0.0 112.325 -177.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.562 ' HB ' ' HG2' ' A' ' 61' ' ' GLN . 7.1 tt -101.7 -6.63 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-O 123.033 1.397 . . . . 0.0 107.639 176.621 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 48.7 mmtm -118.15 135.86 53.97 Favored 'General case' 0 N--CA 1.42 -1.95 0 N-CA-C 105.664 -1.976 . . . . 0.0 105.664 178.146 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 33.0 p80 -56.64 153.18 10.79 Favored 'General case' 0 C--O 1.244 0.797 0 O-C-N 123.749 0.656 . . . . 0.0 110.745 -179.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 56.2 t -50.34 123.47 2.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 O-C-N 124.413 1.07 . . . . 0.0 109.927 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -163.54 173.12 39.61 Favored Glycine 0 N--CA 1.418 -2.51 0 N-CA-C 110.094 -1.202 . . . . 0.0 110.094 -177.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -19.53 99.45 0.01 OUTLIER 'Trans proline' 0 CA--C 1.545 1.067 1 C-N-CA 127.038 5.159 . . . . 0.0 118.515 -174.573 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 14.5 m 57.94 -178.08 0.07 Allowed 'General case' 0 CA--C 1.558 1.262 0 N-CA-C 115.49 1.663 . . . . 0.0 115.49 169.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -122.84 126.36 6.31 Favored Glycine 0 N--CA 1.423 -2.222 0 N-CA-C 106.706 -2.558 . . . . 0.0 106.706 172.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 25.5 mmt180 -124.01 110.45 14.79 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -176.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -108.24 92.64 4.15 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.462 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 68.4 p -114.73 163.44 15.46 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 179.336 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.55 ' O ' HG23 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -58.11 -39.85 79.69 Favored 'General case' 0 C--O 1.214 -0.775 0 CA-C-O 121.028 0.442 . . . . 0.0 109.885 -179.138 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.428 ' CG ' HH22 ' A' ' 73' ' ' ARG . 18.7 t-20 -60.78 -45.42 94.43 Favored 'General case' 0 C--N 1.31 -1.124 0 C-N-CA 124.967 1.307 . . . . 0.0 111.157 -175.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' MET . . . . . 0.475 ' SD ' ' HA ' ' A' ' 58' ' ' ALA . 35.6 tpp -67.48 -36.4 81.04 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.584 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' A' ' 44' ' ' THR . 73.1 mt -69.75 -29.54 66.92 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.271 -178.569 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 45' ' ' MET . 44.2 t -67.07 -48.67 78.39 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.24 0 C-N-CA 123.679 0.792 . . . . 0.0 110.37 178.732 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -58.91 -41.16 86.6 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.955 177.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.716 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 49.9 mt -63.94 -46.05 95.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.629 176.584 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.528 ' CE2' ' HA3' ' A' ' 68' ' ' GLY . 49.0 t80 -63.0 -40.08 96.69 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 123.208 0.603 . . . . 0.0 111.361 -178.423 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.0 mp -75.78 -35.12 60.21 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 111.46 8.18 23.4 Favored Glycine 0 C--O 1.244 0.734 0 C-N-CA 119.822 -1.18 . . . . 0.0 112.184 -177.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 63.2 m -65.63 124.19 21.72 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 123.47 0.708 . . . . 0.0 109.872 177.503 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -82.88 20.26 1.21 Allowed 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 -178.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.1 m -77.55 -24.55 49.84 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 106.163 -1.791 . . . . 0.0 106.163 172.032 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.504 ' HB1' HG12 ' A' ' 51' ' ' ILE . . . -52.85 151.06 4.8 Favored 'General case' 0 C--O 1.247 0.947 0 CA-C-N 113.529 -1.669 . . . . 0.0 112.042 178.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -93.92 -16.82 23.63 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.889 178.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 71.1 mt -132.03 143.5 39.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.392 -175.017 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.562 ' HG2' ' HB ' ' A' ' 34' ' ' ILE . 20.2 mm-40 -106.23 80.91 1.55 Allowed 'General case' 0 C--O 1.245 0.834 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 176.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.4 ' O ' ' HB2' ' A' ' 65' ' ' PHE . 42.0 m -79.59 173.82 12.2 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 110.121 -0.325 . . . . 0.0 110.121 179.425 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.51 ' HA3' ' CE1' ' A' ' 21' ' ' PHE . . . -60.93 -31.15 75.2 Favored Glycine 0 N--CA 1.467 0.735 0 C-N-CA 121.096 -0.573 . . . . 0.0 112.513 -179.203 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.462 HG23 ' CD2' ' A' ' 21' ' ' PHE . 5.8 pt -73.74 2.77 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.73 0 N-CA-C 113.515 0.931 . . . . 0.0 113.515 177.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.716 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 6.4 t80 -65.56 106.54 1.46 Allowed 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -178.073 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 83.41 18.69 63.76 Favored Glycine 0 N--CA 1.429 -1.776 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.493 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.426 ' CG ' ' HA ' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -86.72 -35.27 19.34 Favored 'General case' 0 CA--C 1.51 -0.576 0 C-N-CA 119.022 -1.071 . . . . 0.0 109.956 177.197 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.528 ' HA3' ' CE2' ' A' ' 52' ' ' PHE . . . -105.25 44.37 1.49 Allowed Glycine 0 N--CA 1.426 -1.982 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 44.0 t -72.49 -0.21 12.07 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 123.402 0.681 . . . . 0.0 111.002 -177.042 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -97.74 1.94 49.03 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-O 121.207 0.527 . . . . 0.0 110.64 178.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -99.55 148.41 24.32 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 115.454 -0.794 . . . . 0.0 108.955 175.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 39.1 t -90.83 161.78 15.11 Favored 'General case' 0 C--N 1.281 -2.382 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 168.371 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.468 HH11 ' HB3' ' A' ' 73' ' ' ARG . 13.5 mtp-105 -60.29 -36.19 77.3 Favored 'General case' 0 C--O 1.219 -0.522 0 CA-C-O 121.053 0.454 . . . . 0.0 110.293 -177.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 19.4 t-160 -62.67 -41.64 99.19 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.113 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.674 ' ND2' ' H ' ' A' ' 127' ' ' GLU . 6.1 m120 -65.93 -52.58 48.59 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -176.422 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.445 ' HB3' HG13 ' A' ' 49' ' ' VAL . . . -60.7 -44.12 96.94 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.473 -0.785 . . . . 0.0 112.441 -177.102 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.468 ' CG ' HG21 ' A' ' 49' ' ' VAL . 42.9 mt-10 -64.33 -33.81 76.71 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 121.585 0.707 . . . . 0.0 111.009 178.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.464 ' HE ' ' CD ' ' A' ' 127' ' ' GLU . 17.7 mmm180 -78.04 -17.0 57.57 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.913 -179.524 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.3 tt -79.84 -42.69 23.8 Favored 'General case' 0 N--CA 1.426 -1.635 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 176.232 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -60.53 -19.98 58.86 Favored 'General case' 0 C--O 1.216 -0.705 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 172.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.45 ' HA ' HG13 ' A' ' 84' ' ' ILE . 73.0 mmtt -82.75 -28.58 30.31 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.463 176.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 29.1 tptp -70.43 -45.42 65.9 Favored 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 174.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.508 ' HB3' HD23 ' A' ' 89' ' ' LEU . 97.8 mt -58.83 -37.1 75.67 Favored 'General case' 0 N--CA 1.428 -1.563 0 CA-C-N 113.958 -1.474 . . . . 0.0 113.834 178.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.537 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 2.7 pp -74.02 -26.94 21.58 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.592 0 C-N-CA 119.884 -0.726 . . . . 0.0 111.627 178.392 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 49.0 mt -73.42 -47.65 40.12 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 123.49 0.494 . . . . 0.0 110.507 175.232 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.424 ' HB2' HD13 ' A' ' 88' ' ' ILE . 69.5 m-20 -67.1 -25.31 66.15 Favored 'General case' 0 C--O 1.254 1.312 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.054 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? 85.51 23.52 0.08 Allowed 'General case' 0 CA--C 1.478 -1.797 0 C-N-CA 125.951 1.7 . . . . 0.0 113.475 175.309 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.612 HD11 HD21 ' A' ' 119' ' ' LEU . 2.0 mp -74.58 -41.47 48.67 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.224 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 169.42 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.537 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 3.7 mm? -103.68 140.39 37.65 Favored 'General case' 0 N--CA 1.424 -1.769 0 CA-C-N 114.153 -1.385 . . . . 0.0 109.748 175.442 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -131.35 109.75 10.57 Favored 'General case' 0 C--N 1.285 -2.216 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 176.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -94.96 149.21 21.5 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 121.051 0.453 . . . . 0.0 112.16 -172.403 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.472 ' O ' ' HA ' ' A' ' 103' ' ' ALA . 8.1 m-20 -97.78 108.37 21.07 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 94.5 mt -81.68 108.82 15.55 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.716 0.77 . . . . 0.0 109.661 176.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -120.69 125.57 48.01 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-N 114.802 -1.09 . . . . 0.0 108.402 -175.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.52 HD11 ' HA ' ' A' ' 99' ' ' ASP . 16.9 tt -130.3 141.78 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.753 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 178.471 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -97.13 173.15 7.39 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 176.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -66.44 18.21 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 -173.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -118.61 10.24 12.46 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 177.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.52 ' HA ' HD11 ' A' ' 95' ' ' ILE . 6.1 m-20 60.13 29.32 18.9 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 122.644 1.212 . . . . 0.0 111.023 -174.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.479 ' C ' HG13 ' A' ' 95' ' ' ILE . 94.0 mt-30 -95.92 106.04 18.14 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 114.426 -1.261 . . . . 0.0 107.998 176.554 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -101.36 144.33 30.31 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.626 -0.715 . . . . 0.0 112.437 -175.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 9.6 tp -141.6 146.86 22.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 174.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.472 ' HA ' ' O ' ' A' ' 92' ' ' ASP . . . -112.0 129.04 56.33 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 110.156 -0.312 . . . . 0.0 110.156 -178.769 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -97.49 162.78 13.15 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 177.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.448 HG13 ' CD1' ' A' ' 89' ' ' LEU . 8.4 t -105.16 123.71 59.5 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.862 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 -177.318 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 26.2 mmt -137.83 162.68 33.32 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 113.178 -1.828 . . . . 0.0 106.743 173.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.421 ' H ' HD23 ' A' ' 107' ' ' LEU . 1.5 pt? -127.71 123.29 35.06 Favored 'General case' 0 C--N 1.285 -2.226 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 177.463 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -125.49 -86.27 0.63 Allowed Glycine 0 N--CA 1.422 -2.237 0 C-N-CA 119.099 -1.524 . . . . 0.0 115.705 -171.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -57.32 -46.49 83.18 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 115.86 1.8 . . . . 0.0 115.86 -167.096 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.466 ' O ' HG23 ' A' ' 114' ' ' VAL . 41.9 mmtm -106.2 8.8 32.2 Favored 'General case' 0 C--N 1.308 -1.199 0 O-C-N 121.507 -0.746 . . . . 0.0 111.321 -179.095 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -54.64 -45.7 73.83 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -172.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.9 -24.28 60.82 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.213 0.53 . . . . 0.0 110.946 -176.698 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 7.2 m -75.51 -24.9 56.87 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 -178.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.534 HG21 HG23 ' A' ' 88' ' ' ILE . 21.9 t -74.97 -37.52 41.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 176.004 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 81.4 mt -66.44 -38.59 87.73 Favored 'General case' 0 C--O 1.219 -0.507 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.621 177.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -72.57 -24.99 61.18 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 174.298 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 70.64 24.7 76.68 Favored Glycine 0 C--O 1.218 -0.852 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.402 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -95.98 32.64 1.86 Allowed 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 105.788 -1.93 . . . . 0.0 105.788 176.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.612 HD21 HD11 ' A' ' 88' ' ' ILE . 0.3 OUTLIER -142.71 127.16 17.8 Favored 'General case' 0 N--CA 1.384 -3.772 0 CA-C-N 113.012 -1.904 . . . . 0.0 108.018 -174.531 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.459 ' O ' ' HD3' ' A' ' 120' ' ' LYS . 0.0 OUTLIER -130.25 137.99 50.3 Favored 'General case' 0 N--CA 1.414 -2.268 0 N-CA-C 107.896 -1.149 . . . . 0.0 107.896 172.362 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.521 HG22 ' O ' ' A' ' 11' ' ' VAL . 4.8 m -114.35 -174.79 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 C-N-CA 119.363 -0.935 . . . . 0.0 108.51 176.212 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -133.83 140.85 47.15 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -171.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' PHE . . . . . 0.486 ' O ' ' HB2' ' A' ' 9' ' ' ARG . 11.2 t80 -158.17 -175.5 5.38 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 175.47 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 26.1 ptt? -142.19 158.74 43.39 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 177.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -37.95 -54.01 1.32 Allowed 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 125.146 1.378 . . . . 0.0 113.176 -177.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 10.2 t -136.57 145.45 44.98 Favored 'General case' 0 N--CA 1.417 -2.088 0 CA-C-O 121.408 0.623 . . . . 0.0 110.924 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.674 ' H ' ' ND2' ' A' ' 75' ' ' ASN . 7.0 tm-20 . . . . . 0 C--N 1.283 -2.297 0 N-CA-C 101.284 -3.598 . . . . 0.0 101.284 175.072 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 39.8 m . . . . . 0 CA--C 1.507 -0.678 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -132.23 151.76 51.66 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 178.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.2 p -70.01 141.65 52.89 Favored 'General case' 0 N--CA 1.421 -1.917 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 174.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -78.17 126.5 30.89 Favored 'General case' 0 CA--C 1.483 -1.609 0 C-N-CA 119.232 -0.987 . . . . 0.0 109.203 -178.3 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -77.87 98.3 5.57 Favored 'General case' 0 C--N 1.274 -2.69 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.088 178.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -70.93 102.58 2.43 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 113.867 -1.515 . . . . 0.0 110.701 -177.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 33.8 mtmm -98.79 100.99 12.25 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 177.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.508 ' CG2' ' HA ' ' A' ' 124' ' ' MET . 9.1 m -128.88 179.47 5.7 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -174.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.474 ' H ' HG22 ' A' ' 8' ' ' THR . 72.1 mtm180 -96.49 143.16 27.75 Favored 'General case' 0 CA--C 1.499 -0.982 0 N-CA-C 114.621 1.341 . . . . 0.0 114.621 -175.399 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -98.16 90.26 4.79 Favored 'General case' 0 CA--C 1.48 -1.727 0 N-CA-C 102.146 -3.279 . . . . 0.0 102.146 170.082 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.435 ' HA ' ' OD1' ' A' ' 14' ' ' ASP . 19.0 m -71.95 84.53 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.317 0 CA-C-O 122.85 1.31 . . . . 0.0 112.652 -172.517 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.802 HG22 ' HA ' ' A' ' 120' ' ' LYS . 37.8 p -100.88 -54.79 2.73 Favored 'General case' 0 C--N 1.26 -3.301 0 C-N-CA 117.869 -1.532 . . . . 0.0 112.831 174.687 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.472 ' HA ' ' HB3' ' A' ' 16' ' ' LYS . 8.2 t70 -86.96 -11.56 50.18 Favored 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 119.405 -0.918 . . . . 0.0 110.142 -178.707 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.435 ' OD1' ' HA ' ' A' ' 11' ' ' VAL . 1.6 m-20 -69.41 -41.77 75.96 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 104.864 -2.272 . . . . 0.0 104.864 173.412 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 51.5 t -70.07 -45.37 76.49 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.828 0 CA-C-N 112.946 -1.934 . . . . 0.0 109.847 176.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.472 ' HB3' ' HA ' ' A' ' 13' ' ' ASP . 30.9 ttmt -65.56 -35.54 81.13 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 -179.555 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.6 p -62.72 -44.56 95.89 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 120.628 -0.429 . . . . 0.0 109.937 176.059 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 56.9 mt -53.9 -50.24 54.12 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 O-C-N 123.745 0.653 . . . . 0.0 109.725 172.348 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.47 ' HA ' HG22 ' A' ' 22' ' ' VAL . 76.5 t -58.05 -46.36 88.08 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.867 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.27 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 58.7 mtm-85 -58.33 -32.43 68.49 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.672 ' CD2' HG23 ' A' ' 64' ' ' ILE . 70.7 m-85 -83.48 -37.75 22.71 Favored 'General case' 0 N--CA 1.427 -1.58 0 C-N-CA 119.514 -0.875 . . . . 0.0 112.747 179.067 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.47 HG22 ' HA ' ' A' ' 19' ' ' VAL . 27.7 m -69.01 -29.73 44.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 C-N-CA 117.629 -1.629 . . . . 0.0 109.668 176.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.411 ' HG3' ' O ' ' A' ' 19' ' ' VAL . 54.9 mt-30 -62.61 -38.35 89.82 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.471 170.645 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.635 ' HG3' ' O ' ' A' ' 21' ' ' PHE . 0.3 OUTLIER -64.71 -28.74 69.8 Favored 'General case' 0 CA--C 1.493 -1.245 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.466 -179.67 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 9.7 t-80 -71.77 0.65 8.43 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -175.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 16.7 m -69.84 -29.58 66.87 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 174.225 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 34.2 t -125.02 -16.84 5.95 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.073 178.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 16.8 m 70.4 89.92 0.1 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.277 1.431 . . . . 0.0 110.748 -177.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -81.67 -34.47 30.69 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 -179.434 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -82.23 41.24 2.76 Favored Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 110.699 -0.961 . . . . 0.0 110.699 174.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 25.8 ptt? -63.0 -13.53 36.36 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.958 1.303 . . . . 0.0 113.309 -176.048 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.41 -36.12 82.69 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 178.664 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 8.2 p30 49.07 -168.25 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 125.826 1.651 . . . . 0.0 113.574 176.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 65.7 mt -131.12 -60.2 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 177.159 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 35.8 mtmm -107.33 -34.98 6.92 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.871 179.021 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -174.51 152.55 1.71 Allowed 'General case' 0 CA--C 1.506 -0.735 0 C-N-CA 124.741 1.216 . . . . 0.0 107.859 179.022 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 30.0 m -72.23 -24.35 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-O 121.669 0.747 . . . . 0.0 109.235 174.07 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.489 ' CA ' HD13 ' A' ' 60' ' ' ILE . . . 171.69 158.75 16.4 Favored Glycine 0 N--CA 1.413 -2.878 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 177.735 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -84.77 -24.76 2.14 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.058 1.839 . . . . 0.0 111.595 176.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 23.0 t -176.62 -179.86 1.05 Allowed 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 -178.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -89.01 66.42 3.08 Favored Glycine 0 N--CA 1.443 -0.864 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 58.1 mtt180 -130.59 112.97 13.64 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -124.15 122.52 38.04 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.744 -177.18 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 41.6 p -116.63 155.98 27.84 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 106.306 -1.738 . . . . 0.0 106.306 172.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.454 ' O ' HG23 ' A' ' 49' ' ' VAL . 16.2 ptp -62.45 -36.08 81.3 Favored 'General case' 0 C--O 1.217 -0.637 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -175.382 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -66.13 -30.94 71.52 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.936 0.398 . . . . 0.0 110.133 -178.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 22.7 mmt -73.88 -41.32 62.35 Favored 'General case' 0 C--O 1.202 -1.409 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.845 177.307 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 80.4 mt -56.43 -37.21 69.91 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.979 0.418 . . . . 0.0 110.908 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.57 HG13 ' HB3' ' A' ' 76' ' ' ALA . 74.2 t -66.11 -44.51 91.77 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.317 0 C-N-CA 124.268 1.027 . . . . 0.0 110.601 177.042 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.434 ' CG ' ' HB2' ' A' ' 55' ' ' SER . 4.5 t70 -59.72 -43.17 94.29 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.45 -178.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.419 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 1.9 mp -64.29 -47.93 87.61 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.959 174.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -54.81 -42.37 71.76 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.441 1.096 . . . . 0.0 111.16 -177.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.444 HD11 ' HB2' ' A' ' 71' ' ' TYR . 9.7 mp -83.04 -15.14 52.2 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 178.635 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.58 39.09 12.69 Favored Glycine 0 C--O 1.253 1.327 0 C-N-CA 120.417 -0.897 . . . . 0.0 111.079 -178.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.434 ' HB2' ' CG ' ' A' ' 50' ' ' ASP . 65.2 m -86.89 -172.52 4.03 Favored 'General case' 0 N--CA 1.418 -2.055 0 CA-C-N 115.294 -0.453 . . . . 0.0 111.886 -178.159 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -109.79 -4.72 15.88 Favored 'General case' 0 C--O 1.261 1.703 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 -170.213 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.3 m -78.07 -28.07 48.74 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 105.565 -2.013 . . . . 0.0 105.565 176.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -51.59 107.19 0.17 Allowed 'General case' 0 N--CA 1.419 -1.998 0 C-N-CA 126.56 1.944 . . . . 0.0 112.428 175.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.67 -7.27 28.18 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 174.212 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.489 HD13 ' CA ' ' A' ' 38' ' ' GLY . 28.1 mm -95.65 110.84 24.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 114.511 -1.222 . . . . 0.0 108.866 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -122.2 97.13 5.33 Favored 'General case' 0 C--N 1.293 -1.859 0 O-C-N 121.781 -0.575 . . . . 0.0 110.283 172.144 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.9 m -145.97 -80.13 0.16 Allowed 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 173.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -100.98 165.16 18.59 Favored Glycine 0 N--CA 1.433 -1.551 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.243 178.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.672 HG23 ' CD2' ' A' ' 21' ' ' PHE 0.26 16.6 pt 48.55 9.71 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.443 0 N-CA-C 117.573 2.434 . . . . 0.0 117.573 178.4 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.419 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 23.0 t80 -64.74 105.07 0.92 Allowed 'General case' 0 C--O 1.243 0.762 0 CA-C-N 118.442 0.565 . . . . 0.0 111.292 -177.134 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 74.56 29.63 61.34 Favored Glycine 0 C--N 1.312 -0.762 0 CA-C-N 115.628 -0.714 . . . . 0.0 112.241 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.472 ' HA ' ' HE3' ' A' ' 67' ' ' LYS . 0.7 OUTLIER -94.2 -19.31 20.86 Favored 'General case' 0 C--N 1.322 -0.611 0 O-C-N 122.409 -0.465 . . . . 0.0 111.565 176.83 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -126.53 39.09 2.05 Favored Glycine 0 N--CA 1.433 -1.538 0 C-N-CA 120.465 -0.874 . . . . 0.0 111.433 -178.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 15.5 m -71.3 1.76 5.72 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 123.944 0.898 . . . . 0.0 112.064 -177.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -98.99 4.27 47.18 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-O 121.422 0.629 . . . . 0.0 110.099 178.299 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.444 ' HB2' HD11 ' A' ' 53' ' ' LEU . 9.9 m-85 -95.35 147.19 23.76 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 115.291 -0.868 . . . . 0.0 108.779 175.651 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.455 ' HB3' ' CG ' ' A' ' 75' ' ' ASN . 30.5 t -75.95 149.31 37.69 Favored 'General case' 0 N--CA 1.416 -2.171 0 N-CA-C 105.299 -2.112 . . . . 0.0 105.299 169.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.444 ' O ' ' HG3' ' A' ' 77' ' ' GLU . 0.2 OUTLIER -50.33 -44.92 54.54 Favored 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 123.946 0.898 . . . . 0.0 110.339 -173.356 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.423 ' HA ' ' OE1' ' A' ' 77' ' ' GLU . 17.5 t-80 -84.87 -12.55 53.25 Favored 'General case' 0 N--CA 1.428 -1.568 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.936 -173.119 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.668 ' ND2' ' HB3' ' A' ' 127' ' ' GLU . 6.5 m120 -71.58 -45.41 62.29 Favored 'General case' 0 CA--C 1.48 -1.718 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 179.273 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.57 ' HB3' HG13 ' A' ' 49' ' ' VAL . . . -63.88 -41.52 97.71 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 114.477 -1.238 . . . . 0.0 109.44 179.177 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.444 ' HG3' ' O ' ' A' ' 73' ' ' ARG . 47.9 mt-10 -61.26 -36.09 79.04 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-O 121.53 0.681 . . . . 0.0 110.508 176.136 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.612 ' NH1' ' HB2' ' A' ' 127' ' ' GLU . 62.7 ttp180 -72.75 -23.79 60.87 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.63 -177.007 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.3 tt -79.8 -44.36 20.76 Favored 'General case' 0 N--CA 1.419 -1.98 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.175 -178.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.434 ' HB3' ' HE2' ' A' ' 45' ' ' MET . 76.3 m-85 -63.13 -21.47 66.21 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 175.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.416 ' O ' HG13 ' A' ' 84' ' ' ILE . 22.6 mmtm -82.49 -28.19 31.32 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.814 176.556 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 45.8 tptt -70.29 -44.0 69.24 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 175.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.448 ' HB3' HD23 ' A' ' 89' ' ' LEU . 94.3 mt -62.24 -33.63 74.95 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 114.782 -1.099 . . . . 0.0 113.533 178.138 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.543 HG21 ' HG3' ' A' ' 91' ' ' GLU . 2.5 pp -75.56 -25.77 17.85 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.643 0 C-N-CA 119.716 -0.794 . . . . 0.0 111.506 178.432 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 52.4 mt -72.12 -49.06 39.15 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 121.034 0.445 . . . . 0.0 110.693 176.09 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.52 -14.2 61.17 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.267 -179.201 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.437 ' HG2' ' HB3' ' A' ' 109' ' ' ASN . 0.0 OUTLIER 83.96 13.45 0.32 Allowed 'General case' 0 CA--C 1.501 -0.915 0 C-N-CA 125.432 1.493 . . . . 0.0 112.153 167.761 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 1.8 mp -65.38 -41.65 91.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 169.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.449 ' HB3' HG22 ' A' ' 84' ' ' ILE . 3.3 mm? -103.88 148.01 26.65 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 114.107 -1.406 . . . . 0.0 110.466 174.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -132.76 127.84 35.53 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.386 177.168 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.543 ' HG3' HG21 ' A' ' 84' ' ' ILE . 46.2 mt-10 -94.53 137.16 33.98 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-O 121.264 0.554 . . . . 0.0 110.978 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -98.36 144.47 27.71 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 114.585 -1.189 . . . . 0.0 108.924 -179.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 91.1 mt -104.59 97.88 7.73 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 121.881 0.848 . . . . 0.0 110.528 -178.102 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.405 ' O ' ' HB1' ' A' ' 101' ' ' ALA . 32.7 t80 -100.14 111.68 23.97 Favored 'General case' 0 C--N 1.282 -2.357 0 CA-C-N 114.443 -1.253 . . . . 0.0 108.09 -177.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.67 ' HA ' ' CB ' ' A' ' 101' ' ' ALA . 1.8 tt -132.3 141.88 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.844 0 O-C-N 123.597 0.56 . . . . 0.0 111.162 174.325 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -99.32 171.38 8.01 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 177.142 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -67.8 26.4 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -172.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.448 ' O ' ' HG3' ' A' ' 100' ' ' GLN . 15.3 m120 -119.0 -4.95 10.57 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 177.114 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 57.38 33.03 22.71 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 122.802 1.287 . . . . 0.0 110.718 -174.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.448 ' HG3' ' O ' ' A' ' 98' ' ' ASN . 78.0 mt-30 -128.53 87.19 2.55 Favored 'General case' 0 CA--C 1.495 -1.151 0 CA-C-N 114.023 -1.444 . . . . 0.0 108.744 -177.66 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.67 ' CB ' ' HA ' ' A' ' 95' ' ' ILE . . . -159.39 -177.86 6.73 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -175.682 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 10.6 tp -139.42 167.75 19.45 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.332 0 O-C-N 123.366 0.416 . . . . 0.0 110.436 -170.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -84.74 141.18 30.73 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 122.945 0.498 . . . . 0.0 110.556 179.173 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -111.8 167.72 10.14 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.21 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 14.7 t -98.27 129.65 48.21 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -177.434 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 26.3 mmt -136.33 163.45 30.41 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 113.774 -1.557 . . . . 0.0 107.943 176.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.486 ' HB3' ' CB ' ' A' ' 111' ' ' ALA . 7.7 mp -115.19 124.35 51.19 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 176.735 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -131.8 -102.86 0.89 Allowed Glycine 0 N--CA 1.434 -1.481 0 C-N-CA 118.592 -1.765 . . . . 0.0 116.316 -173.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.437 ' HB3' ' HG2' ' A' ' 87' ' ' LYS . 45.1 t-20 -58.24 -45.71 87.27 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.554 1.142 . . . . 0.0 113.693 -165.627 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.516 ' HD3' ' OG1' ' A' ' 113' ' ' THR . 19.8 mmtm -111.16 13.81 21.82 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -178.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.486 ' CB ' ' HB3' ' A' ' 107' ' ' LEU . . . -70.6 -38.5 74.01 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.693 0.758 . . . . 0.0 109.681 177.132 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -64.19 -30.64 71.69 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.882 0.848 . . . . 0.0 109.246 176.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.516 ' OG1' ' HD3' ' A' ' 110' ' ' LYS . 17.2 m -74.53 -25.65 59.47 Favored 'General case' 0 N--CA 1.424 -1.772 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.329 -178.431 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.508 ' HA ' ' HG ' ' A' ' 119' ' ' LEU . 63.4 t -66.15 -44.83 91.49 Favored 'Isoleucine or valine' 0 C--O 1.248 0.998 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 174.23 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 59.3 mt -63.74 -42.05 97.94 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.919 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -72.3 -14.3 61.71 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.618 177.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 83.43 11.6 79.98 Favored Glycine 0 C--O 1.213 -1.161 0 C-N-CA 120.685 -0.769 . . . . 0.0 113.65 176.272 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -95.92 23.27 6.5 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 122.562 1.172 . . . . 0.0 109.481 -176.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.538 HD13 ' O ' ' A' ' 119' ' ' LEU . 0.0 OUTLIER -103.39 101.33 11.23 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-O 122.926 1.346 . . . . 0.0 108.647 -178.474 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.802 ' HA ' HG22 ' A' ' 12' ' ' THR . 0.0 OUTLIER -128.94 96.55 4.38 Favored 'General case' 1 C--N 1.229 -4.668 0 CA-C-N 115.021 -0.99 . . . . 0.0 112.957 175.512 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 5.8 m -114.13 173.45 3.16 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.777 -178.317 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -104.94 160.62 14.88 Favored 'General case' 0 C--N 1.277 -2.545 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.967 -179.122 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' PHE . . . . . 0.445 ' O ' HG22 ' A' ' 8' ' ' THR . 70.8 t80 -158.06 135.12 10.0 Favored 'General case' 0 C--O 1.25 1.095 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.788 172.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.508 ' HA ' ' CG2' ' A' ' 8' ' ' THR . 17.6 tmm? -97.08 136.7 37.26 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 115.132 -0.94 . . . . 0.0 108.651 -179.285 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 -58.57 -68.3 0.27 Allowed 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 116.908 2.188 . . . . 0.0 116.908 -168.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 5.2 m -99.74 157.05 16.76 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -163.491 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.668 ' HB3' ' ND2' ' A' ' 75' ' ' ASN . 44.1 tt0 . . . . . 0 C--O 1.269 2.116 0 N-CA-C 104.719 -2.326 . . . . 0.0 104.719 176.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 49.3 t . . . . . 0 CA--C 1.507 -0.711 0 N-CA-C 104.471 -2.418 . . . . 0.0 104.471 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -78.77 80.23 5.14 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 170.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 11.7 p -144.82 -175.73 4.79 Favored 'General case' 0 N--CA 1.423 -1.81 0 CA-C-N 114.054 -1.43 . . . . 0.0 107.598 -172.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.591 ' HE2' ' O ' ' A' ' 5' ' ' ASP . 20.1 ptmt -78.57 170.59 16.4 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 175.553 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.591 ' O ' ' HE2' ' A' ' 4' ' ' LYS . 26.1 t70 -87.32 -178.44 6.19 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 176.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -83.66 -19.61 35.07 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 122.012 -0.43 . . . . 0.0 110.099 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.407 ' HG3' ' O ' ' A' ' 8' ' ' THR . 27.8 tptp -52.47 128.15 24.83 Favored 'General case' 0 C--O 1.25 1.09 0 C-N-CA 124.308 1.043 . . . . 0.0 113.264 -178.098 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.407 ' O ' ' HG3' ' A' ' 7' ' ' LYS . 1.8 m -77.63 173.49 11.98 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 174.687 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 28.9 mmt180 -94.81 154.64 17.17 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 121.568 -0.708 . . . . 0.0 109.201 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -118.68 108.51 15.0 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.438 HG22 ' HB2' ' A' ' 123' ' ' PHE . 12.8 m -101.61 101.3 11.91 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.167 0 CA-C-O 122.271 1.034 . . . . 0.0 110.002 177.615 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.678 HG22 ' HA ' ' A' ' 120' ' ' LYS . 42.9 p -120.17 -40.2 2.73 Favored 'General case' 0 C--N 1.264 -3.134 0 C-N-CA 119.494 -0.882 . . . . 0.0 109.8 177.154 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -69.35 -40.62 77.41 Favored 'General case' 0 C--N 1.29 -1.982 0 C-N-CA 125.867 1.667 . . . . 0.0 109.643 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -68.78 -45.29 71.72 Favored 'General case' 0 C--O 1.244 0.776 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 87.2 t -67.38 -40.83 85.48 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 CA-C-N 114.063 -1.426 . . . . 0.0 111.765 -177.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -65.31 -36.93 85.56 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.039 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 43.4 t -61.27 -46.76 89.02 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 175.175 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 68.6 mt -56.0 -54.11 30.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 C-N-CA 123.072 0.549 . . . . 0.0 110.399 177.538 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 71.7 t -59.4 -44.03 91.68 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.789 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.859 -178.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 19.6 ttt180 -61.51 -45.86 92.44 Favored 'General case' 0 N--CA 1.436 -1.13 0 C-N-CA 120.0 -0.68 . . . . 0.0 110.847 179.095 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -63.15 -42.83 99.53 Favored 'General case' 0 CA--C 1.5 -0.943 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.452 ' O ' ' HB3' ' A' ' 25' ' ' HIS . 28.2 m -72.89 -33.47 43.62 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 C-N-CA 119.909 -0.716 . . . . 0.0 111.006 179.385 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -65.98 -54.86 20.72 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 121.164 -0.214 . . . . 0.0 110.796 173.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -77.28 1.53 18.42 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.365 0.602 . . . . 0.0 111.114 -177.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.452 ' HB3' ' O ' ' A' ' 22' ' ' VAL . 17.1 t-80 -58.31 -36.2 73.02 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 173.191 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.6 m -98.11 13.13 32.14 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.368 -177.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 14.8 m -112.37 11.43 20.0 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 177.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 25.8 t 74.42 130.77 0.04 OUTLIER 'General case' 0 C--O 1.246 0.919 0 C-N-CA 125.032 1.333 . . . . 0.0 112.506 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.512 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 78.4 mt-30 -127.94 -70.15 0.7 Allowed 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 114.987 -1.006 . . . . 0.0 108.813 177.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 33.42 -82.77 0.0 OUTLIER Glycine 0 N--CA 1.491 2.318 0 N-CA-C 117.349 1.699 . . . . 0.0 117.349 170.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.62 -28.39 68.49 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 123.685 0.794 . . . . 0.0 113.092 -176.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.512 ' HG2' ' O ' ' A' ' 29' ' ' GLN . 14.3 ptt180 -91.36 -10.77 40.01 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 179.057 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -113.72 -159.44 0.69 Allowed 'General case' 0 C--O 1.25 1.115 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 -178.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 67.0 mt -67.85 144.03 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 N-CA-C 104.479 -2.415 . . . . 0.0 104.479 167.146 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 41.2 mmtt -79.96 81.41 6.23 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 119.857 -0.737 . . . . 0.0 111.01 -169.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 11.0 t60 -164.43 130.45 2.93 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 115.063 -0.971 . . . . 0.0 108.71 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.469 ' HA ' ' OG ' ' A' ' 62' ' ' SER . 59.3 t -108.62 125.03 65.52 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 176.406 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -121.16 95.96 0.58 Allowed Glycine 0 CA--C 1.528 0.873 0 C-N-CA 120.375 -0.917 . . . . 0.0 113.668 -179.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -107.35 22.48 0.08 OUTLIER 'Trans proline' 0 CA--C 1.55 1.3 0 C-N-CA 123.597 2.865 . . . . 0.0 111.479 174.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 6.5 p -72.75 97.81 2.28 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -173.067 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.16 33.77 35.07 Favored Glycine 0 CA--C 1.509 -0.286 0 CA-C-N 115.781 -0.645 . . . . 0.0 113.593 173.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 54.9 mtm180 62.06 -108.34 0.29 Allowed 'General case' 0 N--CA 1.426 -1.675 0 C-N-CA 123.445 0.698 . . . . 0.0 112.178 -177.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -157.87 128.08 6.2 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 -173.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.418 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 57.6 p -116.37 158.02 24.14 Favored 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 171.078 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.45 ' O ' HG23 ' A' ' 49' ' ' VAL . 21.2 ptm -54.91 -37.85 66.88 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 120.283 -0.567 . . . . 0.0 111.634 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -66.05 -36.02 82.12 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 46.0 mtt -66.94 -42.97 84.37 Favored 'General case' 0 CA--C 1.497 -1.09 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.168 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 44' ' ' THR . 80.8 mt -59.34 -45.58 90.98 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.111 -178.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 45' ' ' MET . 82.2 t -66.43 -52.78 42.95 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.137 0 C-N-CA 123.908 0.883 . . . . 0.0 111.311 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.16 -39.79 87.65 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.182 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.514 HD12 ' HA ' ' A' ' 58' ' ' ALA . 1.8 mp -71.6 -38.73 68.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 O-C-N 121.984 -0.447 . . . . 0.0 111.402 177.586 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.487 ' CE2' ' HA3' ' A' ' 68' ' ' GLY . 60.2 t80 -55.47 -37.71 68.16 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 124.111 0.964 . . . . 0.0 111.293 -178.191 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.5 mp -92.7 -25.85 18.04 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 177.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.33 50.23 4.61 Favored Glycine 0 C--O 1.22 -0.731 0 N-CA-C 108.694 -1.762 . . . . 0.0 108.694 -172.343 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 47.6 t -97.56 -170.24 1.97 Allowed 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 124.535 1.134 . . . . 0.0 112.92 -171.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.507 ' HB2' ' NZ ' ' A' ' 56' ' ' LYS . 6.2 mtmp? -43.55 -53.69 5.42 Favored 'General case' 0 C--O 1.247 0.925 0 C-N-CA 128.137 2.575 . . . . 0.0 112.282 -178.24 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.5 m -94.46 9.05 39.95 Favored 'General case' 0 N--CA 1.417 -2.087 0 CA-C-N 114.54 -1.209 . . . . 0.0 111.406 -171.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.532 ' HB1' ' HE2' ' A' ' 65' ' ' PHE . . . -82.41 91.12 6.78 Favored 'General case' 0 N--CA 1.399 -2.998 0 CA-C-O 121.918 0.866 . . . . 0.0 110.21 178.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.542 ' HA ' HE22 ' A' ' 61' ' ' GLN . 62.7 mttp -119.96 24.11 10.68 Favored 'General case' 0 C--N 1.287 -2.148 0 CA-C-N 114.622 -1.172 . . . . 0.0 109.519 179.259 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.458 ' HB ' HG12 ' A' ' 51' ' ' ILE . 1.9 mp -105.39 -55.4 5.66 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 CA-C-N 115.356 -0.838 . . . . 0.0 113.028 -178.618 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.542 HE22 ' HA ' ' A' ' 59' ' ' LYS . 26.2 mp0 67.22 -7.73 0.5 Allowed 'General case' 0 N--CA 1.507 2.376 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 175.242 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.469 ' OG ' ' HA ' ' A' ' 37' ' ' VAL . 12.6 m -94.59 84.71 4.33 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-O 120.765 0.317 . . . . 0.0 110.449 -179.128 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 101.67 138.74 10.29 Favored Glycine 0 N--CA 1.437 -1.246 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.024 178.279 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . 0.258 10.8 pt 49.45 14.92 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 N-CA-C 116.217 1.932 . . . . 0.0 116.217 177.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.539 ' CD2' ' HA ' ' A' ' 61' ' ' GLN . 27.9 t80 -75.5 104.88 6.25 Favored 'General case' 0 N--CA 1.419 -1.987 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -177.331 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 88.48 12.62 64.6 Favored Glycine 0 N--CA 1.437 -1.264 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.186 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.61 -34.53 77.19 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 -179.211 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.487 ' HA3' ' CE2' ' A' ' 52' ' ' PHE . . . -134.27 48.92 0.92 Allowed Glycine 0 N--CA 1.421 -2.324 0 C-N-CA 119.628 -1.272 . . . . 0.0 112.536 -175.675 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 19.9 m -71.36 4.27 3.06 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 120.975 0.417 . . . . 0.0 111.804 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -102.97 1.35 33.53 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-O 121.325 0.584 . . . . 0.0 109.99 177.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -95.26 160.11 14.69 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 174.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 41.2 t -88.75 169.98 11.17 Favored 'General case' 0 N--CA 1.411 -2.417 0 N-CA-C 103.901 -2.629 . . . . 0.0 103.901 165.292 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.53 ' O ' ' HG3' ' A' ' 77' ' ' GLU . 10.9 ptm180 -64.96 -27.37 68.79 Favored 'General case' 0 C--O 1.2 -1.536 0 C-N-CA 118.462 -1.295 . . . . 0.0 110.166 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.668 ' O ' ' HG2' ' A' ' 78' ' ' ARG . 34.2 m170 -57.34 -59.74 4.68 Favored 'General case' 0 C--O 1.209 -1.065 0 O-C-N 124.169 0.918 . . . . 0.0 112.439 -177.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.642 ' HA ' ' CG ' ' A' ' 78' ' ' ARG 0.398 4.7 m120 -64.18 -28.0 69.46 Favored 'General case' 0 CA--C 1.485 -1.529 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 177.715 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.4 -50.59 72.24 Favored 'General case' 0 N--CA 1.439 -1.001 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 171.444 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.65 ' O ' ' HG2' ' A' ' 81' ' ' LYS . 42.9 mt-10 -56.83 -42.81 80.3 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.599 0.759 . . . . 0.0 111.078 177.664 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.668 ' HG2' ' O ' ' A' ' 74' ' ' HIS . 13.1 mmt85 -59.13 -36.41 75.18 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -175.62 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -77.57 -47.45 19.4 Favored 'General case' 0 CA--C 1.47 -2.125 0 CA-C-N 114.675 -1.148 . . . . 0.0 111.84 -172.356 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -62.91 -20.75 65.48 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 121.594 0.711 . . . . 0.0 109.207 178.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.65 ' HG2' ' O ' ' A' ' 77' ' ' GLU . 30.6 mmmt -88.87 -26.13 21.78 Favored 'General case' 0 N--CA 1.436 -1.133 0 C-N-CA 118.938 -1.105 . . . . 0.0 109.669 179.328 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 29.8 tptp -69.74 -45.69 67.58 Favored 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 177.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.408 ' HB3' HD23 ' A' ' 89' ' ' LEU . 95.8 mt -56.71 -40.77 76.23 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-N 114.086 -1.415 . . . . 0.0 113.581 177.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.605 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 2.5 pp -78.11 -18.12 13.77 Favored 'Isoleucine or valine' 0 C--O 1.254 1.342 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 179.242 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 46.9 mt -81.59 -48.66 11.48 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.49 175.239 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -66.49 -33.84 76.6 Favored 'General case' 0 C--O 1.249 1.042 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.002 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.629 ' HB3' ' HB2' ' A' ' 109' ' ' ASN 0.274 57.8 mttm 84.78 27.71 0.07 Allowed 'General case' 0 CA--C 1.454 -2.712 0 C-N-CA 126.524 1.93 . . . . 0.0 115.181 174.792 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.535 HG23 HG21 ' A' ' 114' ' ' VAL . 1.8 mp -67.75 -36.37 75.7 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.274 0 N-CA-C 105.111 -2.181 . . . . 0.0 105.111 164.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.605 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 4.4 mm? -110.94 151.68 27.64 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 114.005 -1.452 . . . . 0.0 108.318 171.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -141.43 111.95 7.01 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 177.146 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -92.46 143.23 26.57 Favored 'General case' 0 C--N 1.278 -2.518 0 CA-C-O 121.676 0.751 . . . . 0.0 111.439 -176.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -98.51 113.07 24.94 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 114.726 -1.125 . . . . 0.0 109.496 -178.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 72.1 mt -78.0 113.93 16.38 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 114.673 -1.149 . . . . 0.0 109.745 -178.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 92.0 t80 -119.46 100.04 7.05 Favored 'General case' 0 N--CA 1.417 -2.076 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 178.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.867 ' HA ' ' HB3' ' A' ' 101' ' ' ALA . 0.3 OUTLIER -130.89 144.05 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.388 -3.537 0 C-N-CA 119.409 -0.917 . . . . 0.0 109.467 -178.672 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.441 ' H ' HD13 ' A' ' 95' ' ' ILE . 40.3 p30 -100.84 -178.92 3.91 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 120.306 -0.558 . . . . 0.0 111.453 -176.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -80.32 15.5 1.57 Allowed 'General case' 0 C--N 1.316 -0.874 0 C-N-CA 123.841 0.856 . . . . 0.0 111.275 -178.242 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.479 ' HB3' ' NE2' ' A' ' 100' ' ' GLN . 2.6 m-20 -117.54 -0.4 11.91 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 58.92 27.22 15.93 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 124.548 1.155 . . . . 0.0 110.17 -174.162 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.479 ' NE2' ' HB3' ' A' ' 98' ' ' ASN . 42.0 mt-30 -128.94 68.63 1.4 Allowed 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.756 -1.111 . . . . 0.0 111.933 -174.494 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.867 ' HB3' ' HA ' ' A' ' 95' ' ' ILE . . . -158.43 178.85 9.7 Favored 'General case' 0 C--N 1.273 -2.723 0 CA-C-N 114.577 -1.192 . . . . 0.0 108.42 178.364 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 14.7 tt -140.57 157.15 23.94 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.973 0 CA-C-N 118.708 0.685 . . . . 0.0 112.196 -170.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -85.64 135.02 33.96 Favored 'General case' 0 C--O 1.255 1.38 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.758 176.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -103.65 165.76 10.84 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 54.0 t -111.92 135.23 51.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -176.363 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 14.6 mmt -138.61 -173.59 3.59 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 113.463 -1.699 . . . . 0.0 107.775 176.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -137.26 138.21 39.84 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 177.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -145.52 -84.6 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.893 0 C-N-CA 118.313 -1.899 . . . . 0.0 116.456 -174.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.629 ' HB2' ' HB3' ' A' ' 87' ' ' LYS . 14.9 m120 -56.57 -50.46 71.86 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 -166.524 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 40.0 mmtm -104.06 3.89 33.73 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.615 -0.678 . . . . 0.0 110.554 -176.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -58.31 -31.68 67.74 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 123.022 0.529 . . . . 0.0 112.29 -178.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.59 -26.22 63.42 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-O 121.57 0.7 . . . . 0.0 110.112 179.347 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 4.8 m -80.0 -23.88 41.23 Favored 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.535 HG21 HG23 ' A' ' 88' ' ' ILE . 54.5 t -67.9 -36.13 74.61 Favored 'Isoleucine or valine' 0 C--O 1.246 0.918 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 174.211 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 75.2 mt -73.22 -34.92 66.18 Favored 'General case' 0 C--O 1.216 -0.696 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.661 177.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -72.32 -14.51 61.76 Favored 'General case' 0 C--O 1.217 -0.629 0 CA-C-O 122.211 1.005 . . . . 0.0 108.709 175.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 94.18 -19.02 55.6 Favored Glycine 0 N--CA 1.44 -1.092 0 CA-C-N 115.186 -0.915 . . . . 0.0 113.163 176.143 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -87.63 66.57 8.97 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.738 0.78 . . . . 0.0 111.738 -173.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.47 HD22 ' O ' ' A' ' 119' ' ' LEU . 0.0 OUTLIER -126.75 79.44 1.87 Allowed 'General case' 0 C--N 1.288 -2.096 0 CA-C-O 123.636 1.684 . . . . 0.0 110.628 175.675 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.678 ' HA ' HG22 ' A' ' 12' ' ' THR . 0.0 OUTLIER -101.14 96.32 7.13 Favored 'General case' 0 C--N 1.264 -3.136 0 CA-C-N 114.587 -1.188 . . . . 0.0 112.136 174.877 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 5.9 m -93.25 172.34 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.138 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 177.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -110.98 163.87 13.38 Favored 'General case' 0 C--N 1.263 -3.161 0 CA-C-N 115.178 -0.919 . . . . 0.0 108.77 178.242 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' PHE . . . . . 0.438 ' HB2' HG22 ' A' ' 11' ' ' VAL . 38.3 t80 -153.64 174.97 13.79 Favored 'General case' 0 N--CA 1.424 -1.769 0 CA-C-O 121.69 0.757 . . . . 0.0 111.287 -179.133 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 60.2 mtt -89.71 175.48 7.23 Favored 'General case' 0 N--CA 1.426 -1.632 0 C-N-CA 126.152 1.781 . . . . 0.0 108.137 -179.25 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -87.87 -150.17 0.17 Allowed 'General case' 0 C--N 1.283 -2.323 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.503 -179.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 9.5 t -99.16 135.45 40.56 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -169.409 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 . . . . . 0 N--CA 1.445 -0.705 0 N-CA-C 101.148 -3.649 . . . . 0.0 101.148 176.73 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 50.3 m . . . . . 0 CA--C 1.507 -0.69 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -84.64 79.97 9.41 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 12.0 t -178.59 146.0 0.34 Allowed 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 178.365 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -148.24 127.75 13.2 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -97.11 131.25 44.07 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 120.963 0.411 . . . . 0.0 111.568 -178.045 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -145.81 24.34 1.35 Allowed 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 175.069 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.522 ' HB2' ' NZ ' ' A' ' 7' ' ' LYS . 6.9 mtmp? -110.87 -157.67 0.62 Allowed 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 -175.399 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 22.9 m -76.43 150.13 36.77 Favored 'General case' 0 N--CA 1.405 -2.684 0 N-CA-C 103.458 -2.793 . . . . 0.0 103.458 166.144 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 74.0 mtt180 -93.03 126.22 38.01 Favored 'General case' 0 C--N 1.278 -2.54 0 CA-C-O 121.237 0.542 . . . . 0.0 111.334 -167.281 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -78.26 89.62 4.32 Favored 'General case' 0 CA--C 1.491 -1.303 0 CA-C-O 122.408 1.099 . . . . 0.0 109.854 -178.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.512 HG13 ' HB2' ' A' ' 14' ' ' ASP . 21.3 t -84.88 103.99 12.59 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.689 0 CA-C-N 113.395 -1.73 . . . . 0.0 109.772 -177.507 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.618 HG22 ' HA ' ' A' ' 120' ' ' LYS . 21.5 p -121.01 -50.41 2.16 Favored 'General case' 0 N--CA 1.413 -2.31 0 C-N-CA 117.758 -1.577 . . . . 0.0 112.482 175.473 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.438 ' HA ' ' CB ' ' A' ' 16' ' ' LYS . 0.3 OUTLIER -87.37 -11.91 47.92 Favored 'General case' 0 N--CA 1.426 -1.675 0 C-N-CA 119.126 -1.03 . . . . 0.0 112.304 -173.843 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.512 ' HB2' HG13 ' A' ' 11' ' ' VAL . 0.7 OUTLIER -65.85 -52.35 51.16 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 103.978 -2.601 . . . . 0.0 103.978 169.195 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.51 HG23 HG12 ' A' ' 11' ' ' VAL . 31.3 t -56.77 -44.2 81.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 113.581 -1.645 . . . . 0.0 111.337 174.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.447 ' HE2' ' O ' ' A' ' 114' ' ' VAL . 2.0 tppp? -57.78 -45.28 86.21 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.788 177.383 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 53.4 m -61.78 -41.58 97.89 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.5 178.325 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.431 ' HB ' ' O ' ' A' ' 15' ' ' VAL . 66.2 mt -53.63 -52.64 31.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 O-C-N 123.748 0.655 . . . . 0.0 109.459 173.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.495 HG21 HG11 ' A' ' 114' ' ' VAL . 93.0 t -57.78 -45.05 87.13 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.576 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.74 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.436 ' HG3' ' O ' ' A' ' 16' ' ' LYS . 64.3 mtt85 -53.52 -45.72 69.87 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.151 0.501 . . . . 0.0 110.728 178.656 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.541 ' HA ' ' HG3' ' A' ' 24' ' ' GLU . 77.1 m-85 -83.18 -33.88 26.1 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 -174.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.42 HG22 ' O ' ' A' ' 18' ' ' ILE . 27.0 m -73.25 -31.77 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.521 0 C-N-CA 118.376 -1.329 . . . . 0.0 110.107 177.651 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -59.97 -48.73 80.5 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.194 174.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.541 ' HG3' ' HA ' ' A' ' 21' ' ' PHE . 1.5 pp20? -68.75 -27.86 66.29 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 120.292 -0.563 . . . . 0.0 112.111 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -68.06 -5.47 17.71 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -178.771 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 17.5 m -62.08 -28.27 69.5 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 170.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 11.8 m -94.24 81.13 4.02 Favored 'General case' 0 N--CA 1.419 -2.01 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 174.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.8 m -77.74 6.26 7.78 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 112.648 0.611 . . . . 0.0 112.648 -175.141 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -81.36 73.25 8.4 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-O 122.325 1.06 . . . . 0.0 111.571 -177.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -94.13 80.91 0.96 Allowed Glycine 0 N--CA 1.43 -1.716 0 N-CA-C 108.569 -1.812 . . . . 0.0 108.569 175.035 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 96.2 mmm -42.65 -79.18 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.565 1.146 . . . . 0.0 113.969 -174.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -91.72 -74.96 0.49 Allowed 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.226 178.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 51.3 t30 66.26 -176.5 0.19 Allowed 'General case' 0 CA--C 1.555 1.164 0 O-C-N 124.236 0.96 . . . . 0.0 109.51 -178.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 59.3 mt -60.71 -41.51 88.58 Favored 'Isoleucine or valine' 0 C--O 1.242 0.681 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 175.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.7 mtmm 176.71 159.17 0.33 Allowed 'General case' 0 C--O 1.243 0.743 0 C-N-CA 126.481 1.912 . . . . 0.0 109.459 177.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -166.45 128.59 1.84 Allowed 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 108.677 -0.861 . . . . 0.0 108.677 176.422 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 14.8 p -98.77 -20.02 5.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 175.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -86.71 125.16 7.3 Favored Glycine 0 N--CA 1.428 -1.877 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.332 177.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -80.71 -70.28 0.01 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 122.129 1.886 . . . . 0.0 111.254 175.487 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 57.3 m -166.27 172.95 10.57 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 140.46 -71.62 0.42 Allowed Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.091 -1.052 . . . . 0.0 112.377 176.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -174.6 162.57 3.42 Favored 'General case' 0 CA--C 1.502 -0.876 0 C-N-CA 124.282 1.033 . . . . 0.0 108.954 177.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -126.3 126.59 44.21 Favored 'General case' 0 CA--C 1.485 -1.532 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.684 ' HA ' ' HA ' ' A' ' 104' ' ' TYR . 55.4 p -82.13 155.55 24.96 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 175.328 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.592 ' O ' HG23 ' A' ' 49' ' ' VAL . 5.8 ptm -52.34 -35.67 51.59 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-O 121.427 0.632 . . . . 0.0 110.124 177.295 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.539 ' N ' ' HG3' ' A' ' 45' ' ' MET . 8.3 t30 -63.22 -40.09 96.49 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.439 -1.255 . . . . 0.0 110.839 -175.434 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' MET . . . . . 0.538 ' HG3' ' OG1' ' A' ' 44' ' ' THR . 64.5 mtt -69.27 -36.44 77.1 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-O 121.554 0.692 . . . . 0.0 109.928 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 82.3 mt -67.91 -33.74 75.28 Favored 'General case' 0 C--O 1.206 -1.186 0 CA-C-N 114.992 -1.004 . . . . 0.0 111.227 -178.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.596 HG21 ' HG2' ' A' ' 77' ' ' GLU . 88.1 t -67.96 -38.88 80.69 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.016 0 C-N-CA 123.355 0.662 . . . . 0.0 110.303 178.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -53.69 -47.5 70.41 Favored 'General case' 0 CA--C 1.506 -0.732 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.128 175.102 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.46 HG23 ' HD2' ' A' ' 65' ' ' PHE . 4.9 mt -76.83 -38.58 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.524 0 CA-C-N 114.717 -1.129 . . . . 0.0 111.738 -176.31 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.464 ' CE2' ' HA3' ' A' ' 68' ' ' GLY . 60.5 t80 -53.1 -48.08 68.09 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 125.019 1.328 . . . . 0.0 110.733 179.142 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.9 mp -77.52 -12.12 59.93 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.085 -0.507 . . . . 0.0 112.302 178.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.95 26.97 54.68 Favored Glycine 0 C--O 1.249 1.066 0 C-N-CA 120.915 -0.659 . . . . 0.0 111.702 -179.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 40.2 t -67.29 176.4 2.27 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-O 121.797 0.808 . . . . 0.0 111.048 -176.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.474 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 0.7 OUTLIER -106.8 6.63 29.69 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 122.055 0.931 . . . . 0.0 110.117 176.592 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 27.8 p -90.89 1.21 57.17 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 169.28 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.74 117.41 8.85 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-N 113.69 -1.596 . . . . 0.0 108.893 178.451 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 43.0 mttp -81.52 -11.83 59.04 Favored 'General case' 0 C--N 1.29 -2.02 0 CA-C-N 114.801 -1.09 . . . . 0.0 111.862 -172.079 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 66.7 mt -143.42 138.3 26.04 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.94 0 N-CA-C 105.953 -1.869 . . . . 0.0 105.953 175.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.597 ' HA ' ' CE2' ' A' ' 65' ' ' PHE . 25.6 mm-40 -93.6 44.78 1.14 Allowed 'General case' 0 C--N 1.3 -1.584 0 CA-C-O 120.993 0.425 . . . . 0.0 110.5 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 42.2 m -153.95 153.03 31.28 Favored 'General case' 0 C--O 1.245 0.844 0 O-C-N 122.026 -0.421 . . . . 0.0 110.203 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 80.92 109.29 0.31 Allowed Glycine 0 C--O 1.2 -2.014 0 CA-C-O 119.393 -0.671 . . . . 0.0 111.599 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . 0.275 3.7 pt 51.94 17.59 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 C-N-CA 125.007 1.323 . . . . 0.0 114.494 -176.255 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.597 ' CE2' ' HA ' ' A' ' 61' ' ' GLN . 18.3 t80 -62.68 107.53 0.98 Allowed 'General case' 0 C--O 1.252 1.222 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.515 -176.477 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 64.29 41.65 98.13 Favored Glycine 0 N--CA 1.434 -1.452 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.408 178.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.421 ' HD3' ' HA ' ' A' ' 67' ' ' LYS . 28.3 mmtm -114.86 -3.98 12.68 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.22 0.533 . . . . 0.0 111.017 177.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.464 ' HA3' ' CE2' ' A' ' 52' ' ' PHE . . . -133.51 30.32 3.02 Favored Glycine 0 N--CA 1.425 -2.055 0 N-CA-C 110.19 -1.164 . . . . 0.0 110.19 176.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 16.5 m -70.35 2.16 4.15 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 123.91 0.884 . . . . 0.0 112.417 -176.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -98.74 7.19 46.36 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-O 122.081 0.944 . . . . 0.0 109.199 176.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -108.28 146.65 32.59 Favored 'General case' 0 N--CA 1.418 -2.04 0 CA-C-N 114.675 -1.148 . . . . 0.0 108.825 177.361 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 44.6 t -86.15 169.21 13.3 Favored 'General case' 0 C--N 1.288 -2.081 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 171.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 -58.77 -35.18 72.36 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 177.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 23.2 t-80 -61.61 -40.17 93.88 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 113.487 -1.688 . . . . 0.0 110.26 178.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -80.97 -49.89 10.39 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.522 -172.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.405 ' O ' ' HD2' ' A' ' 80' ' ' PHE . . . -59.31 -48.99 79.55 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.136 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.625 ' O ' ' HG3' ' A' ' 81' ' ' LYS . 18.3 mt-10 -65.16 -34.31 78.09 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 70.2 ttt180 -69.32 -28.61 66.39 Favored 'General case' 0 CA--C 1.521 -0.149 0 C-N-CA 119.432 -0.907 . . . . 0.0 109.476 -177.083 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.0 tt -78.77 -48.55 14.62 Favored 'General case' 0 N--CA 1.422 -1.832 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.569 -178.267 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.425 ' HA ' HD12 ' A' ' 83' ' ' LEU . 58.1 m-85 -59.54 -21.27 60.01 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-O 121.397 0.617 . . . . 0.0 110.235 177.369 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.625 ' HG3' ' O ' ' A' ' 77' ' ' GLU . 46.2 mttm -85.35 -26.29 26.59 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 119.208 -0.997 . . . . 0.0 109.097 179.116 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 58.9 tttp -73.34 -38.55 65.72 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 175.027 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.425 HD12 ' HA ' ' A' ' 80' ' ' PHE . 95.7 mt -58.05 -37.36 74.25 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 177.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.508 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 2.4 pp -75.86 -26.21 17.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 120.232 -0.587 . . . . 0.0 111.626 177.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 51.4 mt -74.97 -49.38 20.19 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.555 175.481 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -70.49 -24.11 62.79 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.578 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.288 50.6 mttm 83.23 24.07 0.14 Allowed 'General case' 0 CA--C 1.469 -2.171 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 172.545 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.418 HG23 HG21 ' A' ' 114' ' ' VAL . 2.0 mp -69.74 -39.95 78.6 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.273 0 N-CA-C 105.117 -2.179 . . . . 0.0 105.117 165.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.508 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 4.3 mm? -111.6 150.04 30.63 Favored 'General case' 0 CA--C 1.498 -1.041 0 CA-C-N 114.067 -1.424 . . . . 0.0 108.271 173.587 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -137.77 110.61 7.66 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.595 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.472 ' HA ' ' O ' ' A' ' 104' ' ' TYR . 38.8 mt-10 -95.35 147.52 23.42 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 177.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.565 ' O ' ' HA ' ' A' ' 103' ' ' ALA . 16.8 t70 -97.48 142.8 28.88 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.729 -1.123 . . . . 0.0 108.825 178.521 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 94.7 mt -103.75 101.72 11.55 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-O 121.971 0.891 . . . . 0.0 110.144 -178.059 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 72.0 t80 -107.74 115.65 30.54 Favored 'General case' 0 C--N 1.275 -2.658 0 CA-C-N 114.252 -1.34 . . . . 0.0 108.331 -175.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.411 HG13 ' C ' ' A' ' 100' ' ' GLN . 17.1 tt -121.23 141.69 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.657 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.459 ' C ' ' H ' ' A' ' 98' ' ' ASN . 13.1 m-80 -97.44 -171.79 2.27 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -179.016 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -73.5 21.66 0.08 Allowed 'General case' 0 C--N 1.311 -1.094 0 C-N-CA 125.337 1.455 . . . . 0.0 111.203 178.023 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.459 ' H ' ' C ' ' A' ' 96' ' ' ASN . 80.6 m-20 -119.29 -2.64 10.61 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 108.866 -0.791 . . . . 0.0 108.866 -178.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 59.42 25.45 14.2 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-O 122.832 1.301 . . . . 0.0 110.257 -172.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.411 ' C ' HG13 ' A' ' 95' ' ' ILE . 92.8 mt-30 -100.05 108.65 20.88 Favored 'General case' 0 C--O 1.251 1.132 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 177.047 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -96.52 142.48 28.54 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 124.051 0.845 . . . . 0.0 111.567 -176.148 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 10.5 tp -131.44 145.21 35.56 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 174.519 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.565 ' HA ' ' O ' ' A' ' 92' ' ' ASP . . . -113.5 138.76 49.66 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.488 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.684 ' HA ' ' HA ' ' A' ' 44' ' ' THR . 24.8 p90 -134.74 163.47 29.71 Favored 'General case' 0 CA--C 1.496 -1.108 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 176.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.491 HG13 HD12 ' A' ' 89' ' ' LEU . 6.7 t -94.83 134.06 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.636 0 N-CA-C 115.112 1.523 . . . . 0.0 115.112 -163.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 68.9 mtm -140.69 168.92 18.65 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 111.422 -2.626 . . . . 0.0 105.14 173.04 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 7.0 mp -90.77 136.69 32.9 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 -179.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -91.57 -178.58 42.49 Favored Glycine 0 N--CA 1.438 -1.232 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.506 -176.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -70.23 -13.3 62.11 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -176.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.434 ' O ' HG23 ' A' ' 114' ' ' VAL . 46.9 mmtt -93.73 -3.65 51.85 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 178.439 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -62.01 -29.39 70.23 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.969 0.414 . . . . 0.0 111.223 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.442 ' HA ' ' HG ' ' A' ' 115' ' ' LEU . 0.0 OUTLIER -72.35 -31.96 66.07 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 120.218 -0.593 . . . . 0.0 110.247 179.673 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 9.9 m -72.87 -25.72 61.2 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -178.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.495 HG11 HG21 ' A' ' 19' ' ' VAL . 22.0 t -72.1 -42.91 67.38 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.244 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.681 177.051 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.442 ' HG ' ' HA ' ' A' ' 112' ' ' GLN . 4.6 pp -67.87 -33.73 75.31 Favored 'General case' 0 CA--C 1.51 -0.57 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.969 178.722 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -71.41 -27.8 63.56 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 172.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 73.49 21.76 79.21 Favored Glycine 0 CA--C 1.495 -1.179 0 CA-C-N 115.333 -0.849 . . . . 0.0 112.36 177.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -97.33 35.51 1.61 Allowed 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 104.95 -2.241 . . . . 0.0 104.95 177.144 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.451 HD13 ' C ' ' A' ' 119' ' ' LEU . 0.4 OUTLIER -142.42 124.91 15.7 Favored 'General case' 0 N--CA 1.381 -3.906 0 CA-C-N 113.037 -1.892 . . . . 0.0 107.165 -174.241 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.618 ' HA ' HG22 ' A' ' 12' ' ' THR . 0.2 OUTLIER -129.87 132.84 46.56 Favored 'General case' 0 N--CA 1.393 -3.295 0 N-CA-C 106.795 -1.558 . . . . 0.0 106.795 172.089 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.508 HG22 ' O ' ' A' ' 11' ' ' VAL . 14.0 m -106.51 -178.81 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 C-N-CA 118.528 -1.269 . . . . 0.0 107.924 174.426 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -129.28 134.07 47.77 Favored 'General case' 0 C--N 1.254 -3.573 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 178.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -107.32 113.54 26.99 Favored 'General case' 0 C--N 1.273 -2.719 0 C-N-CA 118.95 -1.1 . . . . 0.0 110.545 171.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.415 ' HB2' ' HB2' ' A' ' 127' ' ' GLU . 17.3 ptp -91.63 120.75 32.68 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 113.453 -1.703 . . . . 0.0 108.847 176.496 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -95.13 -73.29 0.59 Allowed 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.224 -174.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 25.8 m -120.34 70.19 0.88 Allowed 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 179.143 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.415 ' HB2' ' HB2' ' A' ' 124' ' ' MET . 15.8 mt-10 . . . . . 0 C--N 1.296 -1.753 0 N-CA-C 103.923 -2.621 . . . . 0.0 103.923 -172.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 48.6 t . . . . . 0 CA--C 1.505 -0.765 0 N-CA-C 106.352 -1.721 . . . . 0.0 106.352 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.6 pttp 54.53 -170.05 0.06 Allowed 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 125.887 1.675 . . . . 0.0 110.713 -175.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.411 ' HB ' ' O ' ' A' ' 5' ' ' ASP . 10.2 p -71.67 132.83 45.13 Favored 'General case' 0 N--CA 1.42 -1.952 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 174.441 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.0 -21.13 59.31 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.411 ' O ' ' HB ' ' A' ' 3' ' ' THR . 1.1 p-10 -151.43 149.72 29.6 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 114.581 -1.19 . . . . 0.0 109.487 -176.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.427 ' H ' ' CD ' ' A' ' 125' ' ' GLU . 40.9 m-85 -97.6 -11.88 23.12 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 174.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . 0.388 64.4 mttm 97.96 172.32 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.68 0 N-CA-C 116.569 2.063 . . . . 0.0 116.569 169.158 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.4 m -102.02 143.53 31.75 Favored 'General case' 0 N--CA 1.41 -2.434 0 CA-C-N 113.949 -1.478 . . . . 0.0 112.676 -171.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 54.6 ttt180 -99.68 113.95 26.74 Favored 'General case' 0 N--CA 1.394 -3.253 0 N-CA-C 104.037 -2.579 . . . . 0.0 104.037 166.375 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.467 ' CG ' ' HZ1' ' A' ' 120' ' ' LYS . 1.9 t70 -77.57 98.78 5.5 Favored 'General case' 0 CA--C 1.488 -1.434 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -174.19 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.484 ' HB ' HG23 ' A' ' 15' ' ' VAL . 30.4 m -99.94 65.58 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.275 -2.648 0 CA-C-O 122.417 1.103 . . . . 0.0 112.964 -173.52 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.467 ' O ' ' HB2' ' A' ' 16' ' ' LYS . 2.1 t -111.53 -37.74 5.13 Favored 'General case' 0 C--N 1.263 -3.188 0 C-N-CA 119.495 -0.882 . . . . 0.0 109.001 169.083 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -84.83 -20.64 30.6 Favored 'General case' 0 CA--C 1.496 -1.1 0 CA-C-O 120.989 0.423 . . . . 0.0 111.221 174.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -76.24 -44.49 37.26 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 105.425 -2.065 . . . . 0.0 105.425 175.141 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.551 ' O ' ' HB ' ' A' ' 18' ' ' ILE . 4.9 t -64.35 -21.88 30.01 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.48 0 CA-C-N 112.938 -1.937 . . . . 0.0 111.167 174.623 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.636 ' HE2' ' O ' ' A' ' 114' ' ' VAL . 34.2 ttmt -75.09 -35.55 61.77 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 122.016 -0.427 . . . . 0.0 110.568 179.112 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 68.9 p -67.39 -31.25 71.34 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 119.358 -0.937 . . . . 0.0 108.883 173.12 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.551 ' HB ' ' O ' ' A' ' 15' ' ' VAL . 36.0 mt -63.62 -48.13 88.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.757 173.219 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 15' ' ' VAL . 97.2 t -56.96 -47.77 82.76 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.774 0 C-N-CA 123.289 0.636 . . . . 0.0 109.868 176.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.643 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 0.9 OUTLIER -52.61 -53.71 43.07 Favored 'General case' 0 C--O 1.22 -0.49 0 O-C-N 123.898 0.749 . . . . 0.0 109.332 176.838 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.423 ' HB2' HG13 ' A' ' 64' ' ' ILE . 83.2 t80 -52.94 -57.14 11.31 Favored 'General case' 0 N--CA 1.448 -0.545 0 O-C-N 124.424 1.078 . . . . 0.0 112.223 -178.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 27.1 m -67.78 -38.78 80.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.779 -177.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -60.33 -50.28 74.23 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 176.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.643 ' HG2' ' O ' ' A' ' 20' ' ' ARG . 10.3 pt-20 -79.6 -22.16 44.05 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.208 -0.597 . . . . 0.0 112.083 -178.095 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.546 ' CD2' ' HG3' ' A' ' 24' ' ' GLU . 98.3 m-70 -106.62 22.07 16.45 Favored 'General case' 0 CA--C 1.49 -1.345 0 C-N-CA 118.987 -1.085 . . . . 0.0 112.109 -176.357 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 34.0 t -62.39 -31.42 72.1 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 171.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 31.1 m -93.22 116.8 29.37 Favored 'General case' 0 N--CA 1.41 -2.439 0 N-CA-C 104.917 -2.253 . . . . 0.0 104.917 168.05 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 46.9 m -65.88 32.12 0.02 OUTLIER 'General case' 0 CA--C 1.564 1.511 0 N-CA-C 115.785 1.772 . . . . 0.0 115.785 -172.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -75.34 127.68 33.69 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 176.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 102.92 -26.95 22.27 Favored Glycine 0 N--CA 1.438 -1.23 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 -176.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 88.3 mtp -79.49 6.2 10.93 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.837 0.827 . . . . 0.0 111.085 -177.277 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 32.0 ptt85 -91.36 -14.67 30.29 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.61 175.076 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -92.76 79.22 4.75 Favored 'General case' 0 C--O 1.247 0.928 0 CA-C-O 121.727 0.775 . . . . 0.0 109.485 -177.182 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.549 HG12 ' H ' ' A' ' 36' ' ' HIS . 14.6 tt -177.61 156.85 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 CA-C-N 113.77 -1.559 . . . . 0.0 106.857 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.566 ' HA ' ' NZ ' ' A' ' 35' ' ' LYS . 2.8 tpmp? -94.77 -21.03 19.0 Favored 'General case' 0 N--CA 1.422 -1.83 0 C-N-CA 118.593 -1.243 . . . . 0.0 112.222 -178.627 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.549 ' H ' HG12 ' A' ' 34' ' ' ILE . 63.8 t-80 -56.28 130.66 45.42 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 123.888 0.743 . . . . 0.0 110.223 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 35.7 m -63.45 167.37 0.93 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.884 0 O-C-N 123.877 0.735 . . . . 0.0 112.876 -178.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 122.4 132.88 4.15 Favored Glycine 0 N--CA 1.429 -1.829 0 N-CA-C 110.351 -1.1 . . . . 0.0 110.351 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -79.88 7.76 4.42 Favored 'Trans proline' 0 CA--C 1.535 0.535 0 C-N-CA 122.667 2.245 . . . . 0.0 112.823 -177.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.3 m 65.02 -156.56 0.29 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.608 0.763 . . . . 0.0 109.221 -177.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.05 -38.99 2.21 Favored Glycine 0 CA--C 1.526 0.737 0 CA-C-N 118.508 0.594 . . . . 0.0 112.942 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.2 mtt180 -88.04 110.83 20.92 Favored 'General case' 0 N--CA 1.425 -1.691 0 O-C-N 122.412 -0.463 . . . . 0.0 110.115 178.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -107.58 107.48 18.33 Favored 'General case' 0 CA--C 1.481 -1.699 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 179.077 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.41 HG21 HD11 ' A' ' 102' ' ' ILE . 80.2 p -120.94 157.13 30.57 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -177.563 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.419 ' O ' HG23 ' A' ' 49' ' ' VAL . 22.0 ptm -50.13 -39.59 43.63 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.353 0.661 . . . . 0.0 112.63 -178.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.4 ' N ' ' HG3' ' A' ' 45' ' ' MET . 18.9 t-20 -68.71 -39.29 80.52 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.156 -172.492 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 23.4 mmt -67.34 -38.6 85.11 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.467 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 78.7 mt -63.35 -41.95 98.89 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.247 -178.392 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.462 HG13 ' HB3' ' A' ' 76' ' ' ALA . 69.6 t -66.01 -45.16 91.55 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.058 0 C-N-CA 123.68 0.792 . . . . 0.0 110.679 179.435 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.566 ' OD2' ' HB3' ' A' ' 55' ' ' SER . 4.4 t70 -61.92 -36.78 82.39 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 114.678 -1.146 . . . . 0.0 109.626 -177.148 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.672 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 75.4 mt -69.54 -50.21 52.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.568 174.432 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.508 ' CE2' ' HA3' ' A' ' 68' ' ' GLY . 50.4 t80 -50.86 -41.21 57.74 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.446 1.098 . . . . 0.0 111.775 179.175 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.9 mp -80.17 -30.51 38.83 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 177.065 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 99.2 33.06 5.57 Favored Glycine 0 C--O 1.248 1.002 0 C-N-CA 120.166 -1.016 . . . . 0.0 112.725 -179.101 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.566 ' HB3' ' OD2' ' A' ' 50' ' ' ASP . 32.0 t -86.8 -176.45 5.78 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 123.291 0.636 . . . . 0.0 111.15 -176.06 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.14 9.17 17.12 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -176.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 16.9 m -89.44 -17.66 28.29 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 175.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.48 ' HB1' HG12 ' A' ' 51' ' ' ILE . . . -50.85 173.8 0.02 OUTLIER 'General case' 0 N--CA 1.432 -1.329 0 C-N-CA 128.861 2.865 . . . . 0.0 113.476 176.61 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.0 mmmp? -116.87 11.02 14.31 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 -179.138 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.429 HG22 HD13 ' A' ' 51' ' ' ILE . 15.5 tt -158.65 164.82 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 N-CA-C 104.795 -2.298 . . . . 0.0 104.795 175.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.401 HE21 HD12 ' A' ' 34' ' ' ILE . 30.1 mm-40 -125.74 21.96 7.58 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 119.021 0.828 . . . . 0.0 110.42 177.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 43.8 m -152.24 146.95 25.83 Favored 'General case' 0 C--N 1.322 -0.63 0 O-C-N 122.002 -0.436 . . . . 0.0 110.037 -178.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.554 ' C ' ' H ' ' A' ' 65' ' ' PHE . . . 82.15 111.37 0.42 Allowed Glycine 0 C--O 1.212 -1.28 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.632 HG22 HG22 ' A' ' 51' ' ' ILE . 3.4 mm 70.25 -18.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 CA-C-O 121.971 0.891 . . . . 0.0 111.64 -176.269 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.672 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 3.5 t80 -65.46 104.45 0.99 Allowed 'General case' 0 N--CA 1.399 -2.986 0 C-N-CA 125.318 1.447 . . . . 0.0 109.202 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 102.93 0.36 48.52 Favored Glycine 0 N--CA 1.434 -1.46 0 C-N-CA 120.814 -0.707 . . . . 0.0 111.713 -178.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.526 ' HG3' HD13 ' A' ' 64' ' ' ILE . 2.9 mmmp? -67.35 -19.48 65.44 Favored 'General case' 0 C--O 1.252 1.189 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.508 ' HA3' ' CE2' ' A' ' 52' ' ' PHE . . . -148.81 49.76 0.58 Allowed Glycine 0 C--O 1.207 -1.544 0 C-N-CA 120.462 -0.875 . . . . 0.0 111.644 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 16.0 m -70.6 0.78 6.18 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -178.061 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -100.37 -5.34 27.44 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-O 121.094 0.473 . . . . 0.0 110.303 178.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.503 ' HA ' ' HB3' ' A' ' 127' ' ' GLU . 28.9 m-85 -80.41 144.11 32.92 Favored 'General case' 0 N--CA 1.428 -1.547 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.49 177.19 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 34.5 t -77.33 134.68 38.44 Favored 'General case' 0 N--CA 1.398 -3.029 0 N-CA-C 102.928 -2.989 . . . . 0.0 102.928 167.321 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.519 ' O ' ' HG3' ' A' ' 77' ' ' GLU . 10.6 ptm180 -52.12 -38.64 58.1 Favored 'General case' 0 C--O 1.202 -1.43 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -173.01 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.565 ' HA ' ' OE1' ' A' ' 77' ' ' GLU . 32.4 t-80 -70.86 -24.31 62.49 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 120.978 0.418 . . . . 0.0 111.475 -175.543 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -81.69 -38.2 26.21 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.462 ' HB3' HG13 ' A' ' 49' ' ' VAL . . . -63.29 -40.21 96.73 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 174.399 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.66 ' O ' ' HG2' ' A' ' 81' ' ' LYS . 80.0 mt-10 -58.15 -37.8 75.37 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.235 -0.439 . . . . 0.0 109.902 174.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 18.4 mmm180 -71.68 -23.13 61.6 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.372 -178.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.4 tt -76.38 -45.36 32.2 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 179.257 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -63.87 -19.53 65.13 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.432 0.634 . . . . 0.0 109.406 176.347 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.66 ' HG2' ' O ' ' A' ' 77' ' ' GLU . 31.3 mmmt -81.12 -28.43 35.14 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.379 176.154 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.43 ' HG2' ' OD2' ' A' ' 86' ' ' ASP . 58.3 tttm -74.48 -43.04 57.88 Favored 'General case' 0 C--O 1.193 -1.878 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 179.14 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.3 mt -58.64 -35.2 72.13 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 178.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.474 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 2.5 pp -74.67 -26.3 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.061 177.449 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.9 tt -76.85 -45.19 29.33 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 175.34 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.473 ' O ' ' HB2' ' A' ' 87' ' ' LYS . 70.9 m-20 -66.1 -29.62 69.98 Favored 'General case' 0 C--O 1.259 1.587 0 C-N-CA 123.491 0.716 . . . . 0.0 109.944 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.473 ' HB2' ' O ' ' A' ' 86' ' ' ASP . 4.4 mptp? 85.6 21.65 0.09 Allowed 'General case' 0 CA--C 1.478 -1.821 0 C-N-CA 125.252 1.421 . . . . 0.0 113.378 179.412 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 1.8 mp -68.62 -42.22 83.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 N-CA-C 104.8 -2.296 . . . . 0.0 104.8 164.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.474 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 90.7 mt -114.3 164.22 14.21 Favored 'General case' 0 N--CA 1.418 -2.068 0 CA-C-N 113.829 -1.532 . . . . 0.0 109.141 174.215 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.472 ' OD2' ' HG3' ' A' ' 87' ' ' LYS . 0.2 OUTLIER -144.44 117.79 9.04 Favored 'General case' 0 C--N 1.283 -2.305 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 172.762 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -95.02 144.38 25.74 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-O 121.598 0.713 . . . . 0.0 112.463 -178.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.477 ' O ' ' HA ' ' A' ' 103' ' ' ALA . 16.6 t70 -100.0 133.24 44.68 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 114.195 -1.366 . . . . 0.0 109.055 178.422 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 98.3 mt -105.64 105.62 15.75 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 121.579 0.704 . . . . 0.0 109.429 -179.31 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -122.36 135.42 54.7 Favored 'General case' 0 C--N 1.28 -2.427 0 CA-C-N 114.561 -1.2 . . . . 0.0 109.06 -172.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.56 HD11 ' HA ' ' A' ' 99' ' ' ASP . 16.6 tt -131.23 141.34 46.24 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.296 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 174.543 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.424 ' C ' ' H ' ' A' ' 98' ' ' ASN . 3.4 p-10 -96.11 172.81 7.75 Favored 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 176.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -66.67 17.97 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 -173.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.424 ' H ' ' C ' ' A' ' 96' ' ' ASN . 15.7 m120 -118.15 5.57 11.99 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.56 ' HA ' HD11 ' A' ' 95' ' ' ILE . 26.7 t70 65.97 26.47 10.93 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-O 123.531 1.634 . . . . 0.0 109.353 -177.714 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.492 ' C ' HG13 ' A' ' 95' ' ' ILE . 77.0 mt-30 -90.29 99.57 12.57 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.918 -1.037 . . . . 0.0 108.548 176.663 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -86.2 133.87 33.82 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.627 -178.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.41 HD11 HG21 ' A' ' 44' ' ' THR . 16.4 tt -141.99 143.79 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.822 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 178.565 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.477 ' HA ' ' O ' ' A' ' 92' ' ' ASP . . . -112.08 119.96 40.22 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 -178.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -97.38 150.58 20.84 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 52.4 t -103.74 128.86 56.62 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 CA-C-O 121.759 0.79 . . . . 0.0 112.143 -178.121 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 58.3 mtt -128.28 178.82 5.99 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-N 113.908 -1.496 . . . . 0.0 107.792 177.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.557 ' H ' HD23 ' A' ' 107' ' ' LEU . 1.7 pt? -99.52 137.49 37.94 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -178.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -98.21 -166.51 31.37 Favored Glycine 0 N--CA 1.439 -1.118 0 C-N-CA 120.799 -0.715 . . . . 0.0 113.158 -175.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 32.7 p30 -75.28 -2.85 30.06 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 114.147 1.165 . . . . 0.0 114.147 -175.161 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.512 ' O ' HG23 ' A' ' 114' ' ' VAL . 41.4 mmtm -101.98 -6.34 23.56 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 120.113 -0.635 . . . . 0.0 110.357 177.132 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -54.31 -43.77 71.42 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 113.623 0.972 . . . . 0.0 113.623 -172.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.44 -29.48 62.58 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.626 0.727 . . . . 0.0 109.701 -178.145 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 4.4 m -73.05 -26.19 61.2 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.585 -179.349 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.636 ' O ' ' HE2' ' A' ' 16' ' ' LYS . 24.9 t -68.41 -44.05 83.67 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.783 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 174.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 84.7 mt -62.39 -39.79 94.35 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.113 178.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -72.84 -19.37 61.33 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.059 175.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.458 ' C ' ' H ' ' A' ' 119' ' ' LEU . . . 60.87 30.42 72.98 Favored Glycine 0 C--O 1.212 -1.226 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.127 -177.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -95.99 22.58 7.3 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 105.862 -1.903 . . . . 0.0 105.862 174.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.468 HD13 ' C ' ' A' ' 119' ' ' LEU . 0.8 OUTLIER -141.99 122.65 14.24 Favored 'General case' 0 N--CA 1.385 -3.676 0 CA-C-N 112.229 -2.26 . . . . 0.0 105.96 -175.869 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.467 ' HZ1' ' CG ' ' A' ' 10' ' ' ASP . 0.1 OUTLIER -131.08 127.6 38.5 Favored 'General case' 0 C--N 1.283 -2.308 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 171.549 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.427 ' H ' ' HB ' ' A' ' 12' ' ' THR . 5.1 m -119.07 173.28 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.261 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 177.472 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -123.31 161.36 24.79 Favored 'General case' 0 C--N 1.265 -3.076 0 CA-C-N 114.971 -1.013 . . . . 0.0 112.258 -171.375 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -141.51 130.83 23.61 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 104.93 -2.248 . . . . 0.0 104.93 164.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 25.3 mmt -107.9 143.84 35.96 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 116.229 1.937 . . . . 0.0 116.229 -163.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.427 ' CD ' ' H ' ' A' ' 6' ' ' TYR . 7.5 mm-40 72.21 -58.61 0.58 Allowed 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 116.64 2.089 . . . . 0.0 116.64 165.428 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 11.1 t -148.84 163.39 37.56 Favored 'General case' 0 C--N 1.289 -2.03 0 C-N-CA 120.536 -0.466 . . . . 0.0 110.091 -175.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.503 ' HB3' ' HA ' ' A' ' 71' ' ' TYR . 63.6 mt-10 . . . . . 0 N--CA 1.416 -2.165 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 175.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 41.4 m . . . . . 0 CA--C 1.514 -0.416 0 N-CA-C 107.599 -1.259 . . . . 0.0 107.599 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -62.26 -41.99 98.95 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 175.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.8 p -88.76 152.1 21.99 Favored 'General case' 0 N--CA 1.412 -2.344 0 CA-C-N 114.522 -1.217 . . . . 0.0 109.406 175.148 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -129.29 142.69 50.76 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 177.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -127.4 159.4 34.59 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 124.065 0.853 . . . . 0.0 108.9 -178.489 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -159.38 40.95 0.21 Allowed 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 105.128 -2.175 . . . . 0.0 105.128 -179.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 25.1 tptp -53.09 124.03 13.27 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 114.972 -1.013 . . . . 0.0 113.167 -174.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.57 178.37 7.32 Favored 'General case' 0 N--CA 1.422 -1.861 0 CA-C-N 114.862 -1.063 . . . . 0.0 113.037 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.633 ' HG3' HH11 ' A' ' 9' ' ' ARG . 41.9 mtt85 -94.42 117.87 30.77 Favored 'General case' 0 N--CA 1.422 -1.86 0 N-CA-C 106.239 -1.764 . . . . 0.0 106.239 174.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -78.03 89.4 4.17 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.101 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.417 HG23 HG23 ' A' ' 121' ' ' VAL . 10.6 m -79.67 89.47 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 CA-C-O 122.69 1.233 . . . . 0.0 110.36 -178.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.632 HG22 ' HA ' ' A' ' 120' ' ' LYS . 34.3 p -115.3 -33.58 5.26 Favored 'General case' 0 C--N 1.261 -3.262 0 CA-C-O 122.092 0.949 . . . . 0.0 109.378 177.584 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -75.62 -40.64 56.0 Favored 'General case' 0 N--CA 1.413 -2.285 0 C-N-CA 125.967 1.707 . . . . 0.0 107.894 178.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.483 ' O ' ' HB3' ' A' ' 17' ' ' SER . 16.5 t70 -74.0 -39.78 63.39 Favored 'General case' 0 CA--C 1.495 -1.164 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 74.4 t -67.6 -32.99 59.32 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.691 177.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.559 ' HE2' ' O ' ' A' ' 114' ' ' VAL . 3.3 tppp? -66.85 -43.49 83.51 Favored 'General case' 0 C--O 1.245 0.833 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 174.529 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.483 ' HB3' ' O ' ' A' ' 14' ' ' ASP . 32.6 t -57.09 -47.95 79.78 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 114.092 -1.413 . . . . 0.0 108.718 174.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 28.2 mt -51.36 -42.86 28.47 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.736 0 C-N-CA 124.094 0.958 . . . . 0.0 111.746 177.178 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.56 HG21 HG11 ' A' ' 114' ' ' VAL . 72.9 t -59.62 -45.56 94.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 179.324 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 31.5 ttt180 -56.72 -45.33 81.98 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.788 0.804 . . . . 0.0 109.401 173.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.775 ' CG ' ' HB ' ' A' ' 64' ' ' ILE . 47.4 m-85 -68.63 -38.25 80.36 Favored 'General case' 0 N--CA 1.422 -1.835 0 N-CA-C 115.186 1.55 . . . . 0.0 115.186 -175.24 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.573 ' HA ' ' ND1' ' A' ' 25' ' ' HIS . 20.1 m -69.69 -36.62 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.859 0 C-N-CA 119.99 -0.684 . . . . 0.0 109.892 176.322 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.42 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 14.8 mm100 -60.63 -46.79 88.95 Favored 'General case' 0 CA--C 1.55 0.956 0 O-C-N 123.83 0.706 . . . . 0.0 111.318 172.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.507 ' HG2' ' HA ' ' A' ' 21' ' ' PHE . 7.6 pt-20 -78.94 0.73 26.3 Favored 'General case' 0 C--O 1.247 0.955 0 O-C-N 121.707 -0.621 . . . . 0.0 112.473 178.438 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.573 ' ND1' ' HA ' ' A' ' 22' ' ' VAL . 28.3 m170 -72.21 -17.25 61.93 Favored 'General case' 0 C--O 1.215 -0.758 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 172.363 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 18.7 m -62.6 -26.85 68.82 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 123.951 0.782 . . . . 0.0 110.108 176.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 16.0 m -89.72 85.04 6.34 Favored 'General case' 0 C--O 1.258 1.551 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 172.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.475 ' OG ' HG12 ' A' ' 60' ' ' ILE . 33.1 t -104.55 -150.33 0.42 Allowed 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 114.108 -1.405 . . . . 0.0 109.708 -171.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 69.5 27.06 4.98 Favored 'General case' 0 C--O 1.244 0.812 0 C-N-CA 124.865 1.266 . . . . 0.0 109.893 179.333 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -89.14 58.58 3.92 Favored Glycine 0 N--CA 1.429 -1.828 0 CA-C-N 114.65 -1.159 . . . . 0.0 110.824 -178.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 65.9 mtt -83.9 -73.04 0.43 Allowed 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 120.762 0.315 . . . . 0.0 110.492 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 17.0 ptp180 -91.83 2.13 56.71 Favored 'General case' 0 C--O 1.213 -0.848 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -177.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -150.55 148.21 28.4 Favored 'General case' 0 CA--C 1.502 -0.896 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 -179.106 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.535 ' HA ' ' HG3' ' A' ' 61' ' ' GLN . 1.7 mp -74.69 92.68 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 CA-C-O 121.788 0.804 . . . . 0.0 111.442 179.142 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.462 ' HG2' ' H ' ' A' ' 36' ' ' HIS . 24.0 ttmm 65.75 176.68 0.21 Allowed 'General case' 0 CA--C 1.563 1.454 0 CA-C-N 113.898 -1.501 . . . . 0.0 111.315 176.487 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.462 ' H ' ' HG2' ' A' ' 35' ' ' LYS . 22.8 p-80 172.44 178.92 0.08 Allowed 'General case' 0 CA--C 1.501 -0.939 0 C-N-CA 127.177 2.191 . . . . 0.0 105.967 172.732 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 16.2 m -70.97 96.77 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 CA-C-O 121.667 0.746 . . . . 0.0 110.285 175.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -156.99 95.87 0.15 Allowed Glycine 0 N--CA 1.429 -1.789 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -75.54 107.3 2.44 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 122.456 2.104 . . . . 0.0 110.98 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.422 ' HB2' ' HB3' ' A' ' 28' ' ' SER . 22.9 m -150.95 113.55 4.67 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.124 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -103.11 -143.92 13.47 Favored Glycine 0 N--CA 1.441 -1.008 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 179.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.448 ' NE ' ' HA ' ' A' ' 42' ' ' ARG . 1.9 mmp_? 69.09 69.33 0.27 Allowed 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 122.205 1.002 . . . . 0.0 111.462 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.486 ' CD1' HD21 ' A' ' 48' ' ' LEU . 2.9 p90 -109.21 128.56 55.14 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 114.526 -1.215 . . . . 0.0 111.03 -179.103 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 63.2 p -86.33 155.99 20.4 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 178.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.527 ' O ' HG23 ' A' ' 49' ' ' VAL . 19.2 ptt? -48.64 -41.81 32.37 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 123.483 0.49 . . . . 0.0 111.905 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.448 ' N ' ' HG3' ' A' ' 45' ' ' MET . 14.8 m120 -67.45 -31.96 72.49 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.584 -175.512 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' MET . . . . . 0.455 ' O ' HD13 ' A' ' 51' ' ' ILE . 26.3 mmt -74.88 -36.33 62.27 Favored 'General case' 0 C--O 1.203 -1.344 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.486 HD21 ' CD1' ' A' ' 43' ' ' PHE . 87.1 mt -60.75 -38.4 85.05 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.373 179.221 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.54 HG13 ' HB3' ' A' ' 76' ' ' ALA . 94.1 t -65.19 -41.59 92.03 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.203 0 C-N-CA 124.395 1.078 . . . . 0.0 110.861 178.674 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -55.38 -46.26 76.55 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.309 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.455 HD13 ' O ' ' A' ' 47' ' ' MET . 1.3 mp -70.07 -40.36 78.32 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.103 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.227 177.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -57.84 -42.29 84.13 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.735 0.814 . . . . 0.0 111.808 -175.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.408 HD11 ' HB2' ' A' ' 71' ' ' TYR . 7.9 mp -82.32 -20.17 37.9 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 178.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 96.14 32.63 6.65 Favored Glycine 0 C--N 1.313 -0.731 0 C-N-CA 120.126 -1.035 . . . . 0.0 112.257 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 31.1 t -76.55 137.41 39.55 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 177.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.496 ' O ' ' HD3' ' A' ' 56' ' ' LYS . 2.4 tmtm? -84.31 -0.87 54.14 Favored 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 119.264 -0.974 . . . . 0.0 109.537 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.0 m -77.86 -5.95 52.6 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 176.074 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.417 ' HB3' HE22 ' A' ' 61' ' ' GLN . . . -62.03 145.45 53.08 Favored 'General case' 0 N--CA 1.425 -1.721 0 C-N-CA 125.787 1.635 . . . . 0.0 111.173 175.182 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.528 ' HD2' ' N ' ' A' ' 59' ' ' LYS . 9.1 mptt -105.23 -1.57 25.17 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.447 -177.281 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.475 HG12 ' OG ' ' A' ' 28' ' ' SER . 60.6 mt -132.28 122.0 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.108 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -177.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.542 ' HA ' HE21 ' A' ' 61' ' ' GLN . 0.0 OUTLIER -110.01 94.37 4.98 Favored 'General case' 0 C--N 1.277 -2.585 0 C-N-CA 118.313 -1.355 . . . . 0.0 108.707 176.901 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.472 ' HB3' ' OE2' ' A' ' 24' ' ' GLU . 73.5 m -104.25 177.79 4.74 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.843 176.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -75.32 7.63 22.89 Favored Glycine 0 N--CA 1.482 1.712 0 C-N-CA 121.068 -0.587 . . . . 0.0 113.979 -176.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.775 ' HB ' ' CG ' ' A' ' 21' ' ' PHE . 6.4 tt -100.74 3.1 10.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.429 ' HB2' ' O ' ' A' ' 62' ' ' SER . 19.5 t80 -69.52 95.97 0.88 Allowed 'General case' 0 N--CA 1.42 -1.945 0 CA-C-N 114.01 -1.45 . . . . 0.0 110.01 -173.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 102.35 17.22 20.54 Favored Glycine 0 N--CA 1.419 -2.438 0 CA-C-N 114.93 -1.032 . . . . 0.0 112.638 -179.161 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.659 ' HE2' HG13 ' A' ' 64' ' ' ILE . 33.5 mtmt -67.97 -58.1 5.1 Favored 'General case' 0 C--N 1.353 0.751 0 C-N-CA 117.891 -1.523 . . . . 0.0 110.51 175.492 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -95.41 47.82 1.92 Allowed Glycine 0 N--CA 1.436 -1.353 0 CA-C-N 115.154 -0.93 . . . . 0.0 113.356 -170.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 19.6 m -71.84 -4.31 27.26 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -178.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -100.91 2.93 41.33 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 121.682 0.753 . . . . 0.0 111.036 178.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.435 ' CD1' ' HG3' ' A' ' 125' ' ' GLU . 24.0 m-85 -88.44 142.57 27.61 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 174.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 42.5 t -71.08 148.5 47.44 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 105.331 -2.1 . . . . 0.0 105.331 168.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 35.1 ttt-85 -56.46 -42.92 79.0 Favored 'General case' 0 C--O 1.217 -0.637 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.945 -174.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.594 ' O ' ' HG2' ' A' ' 78' ' ' ARG . 90.8 m-70 -75.97 -20.3 58.02 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.476 -0.489 . . . . 0.0 111.274 -177.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -73.17 -44.14 60.37 Favored 'General case' 0 CA--C 1.501 -0.913 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 176.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.54 ' HB3' HG13 ' A' ' 49' ' ' VAL . . . -61.69 -36.51 81.11 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 175.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -61.13 -32.93 72.62 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.639 174.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.594 ' HG2' ' O ' ' A' ' 74' ' ' HIS . 31.7 mmt180 -79.36 -25.93 42.13 Favored 'General case' 0 CA--C 1.496 -1.114 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -176.828 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.46 ' HB3' ' O ' ' A' ' 76' ' ' ALA . 14.5 tp -60.22 -61.24 2.74 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 124.154 0.909 . . . . 0.0 108.928 177.376 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -60.6 -27.72 67.95 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.452 -178.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.508 ' O ' HG13 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -69.18 -30.07 68.19 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.061 175.476 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 20.2 ttpp -80.88 -34.93 33.24 Favored 'General case' 0 C--O 1.203 -1.394 0 C-N-CA 117.294 -1.762 . . . . 0.0 107.713 -178.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.563 ' HB3' ' HG ' ' A' ' 89' ' ' LEU . 9.7 mp -60.11 -29.04 68.34 Favored 'General case' 0 C--O 1.211 -0.95 0 CA-C-N 116.24 -0.436 . . . . 0.0 112.015 176.235 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.508 HG13 ' O ' ' A' ' 81' ' ' LYS . 2.1 pp -82.93 -22.14 8.89 Favored 'Isoleucine or valine' 0 C--O 1.244 0.813 0 C-N-CA 120.028 -0.669 . . . . 0.0 111.278 178.519 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.5 tt -75.97 -49.83 16.58 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 174.241 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -65.38 -36.1 82.95 Favored 'General case' 0 C--O 1.253 1.281 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 178.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.576 ' HD3' HD21 ' A' ' 109' ' ' ASN 0.31 59.4 mttm 85.0 29.69 0.05 Allowed 'General case' 0 CA--C 1.464 -2.328 0 C-N-CA 125.954 1.702 . . . . 0.0 114.952 176.822 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.408 HG23 HG21 ' A' ' 114' ' ' VAL . 1.8 mp -69.04 -31.48 50.49 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 105.012 -2.218 . . . . 0.0 105.012 163.274 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.563 ' HG ' ' HB3' ' A' ' 83' ' ' LEU . 44.7 mt -116.01 154.4 29.94 Favored 'General case' 0 N--CA 1.425 -1.676 0 CA-C-N 113.966 -1.47 . . . . 0.0 108.896 173.229 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.416 ' HB2' ' HA2' ' A' ' 108' ' ' GLY . 1.8 m-20 -139.81 117.68 11.71 Favored 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 174.321 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.47 ' HG3' HG21 ' A' ' 84' ' ' ILE . 46.6 mt-10 -94.54 145.32 24.89 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.471 0.653 . . . . 0.0 112.133 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -111.08 159.36 17.87 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-N 114.523 -1.217 . . . . 0.0 108.712 176.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 87.6 mt -117.92 145.37 44.71 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -170.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -141.51 163.06 33.94 Favored 'General case' 0 CA--C 1.479 -1.775 0 N-CA-C 105.412 -2.07 . . . . 0.0 105.412 173.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 19.0 tt -132.68 147.07 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.268 0 N-CA-C 106.811 -1.552 . . . . 0.0 106.811 171.084 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 47.0 p30 -92.41 -174.32 3.66 Favored 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 120.22 -0.592 . . . . 0.0 110.515 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -75.97 5.53 6.43 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 123.009 0.524 . . . . 0.0 111.973 -177.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -108.19 3.01 23.24 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 29.3 t70 66.84 26.73 9.27 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-O 123.547 1.641 . . . . 0.0 108.9 -176.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -101.13 110.62 22.66 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 114.8 -1.091 . . . . 0.0 108.507 177.347 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.7 140.78 51.53 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.513 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 10.5 tp -134.52 143.44 37.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.4 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -117.65 132.69 56.46 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.675 -178.102 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -108.47 153.0 23.96 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 55.5 t -97.6 137.87 24.02 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 CA-C-O 122.103 0.954 . . . . 0.0 112.964 -174.12 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 16.5 mmt -134.55 177.98 7.35 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 112.798 -2.001 . . . . 0.0 107.427 174.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 7.3 mp -92.03 142.32 27.66 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.416 ' HA2' ' HB2' ' A' ' 90' ' ' ASP . . . -94.97 -176.89 38.0 Favored Glycine 0 N--CA 1.414 -2.809 0 C-N-CA 119.991 -1.099 . . . . 0.0 114.778 -172.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.576 HD21 ' HD3' ' A' ' 87' ' ' LYS . 6.1 p30 -71.13 -11.37 60.91 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 114.075 -1.062 . . . . 0.0 112.404 -178.631 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.559 ' O ' HG23 ' A' ' 114' ' ' VAL . 40.2 mmtm -103.58 13.3 33.62 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 177.672 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.521 ' O ' ' HG ' ' A' ' 115' ' ' LEU . . . -75.94 -28.77 58.09 Favored 'General case' 0 CA--C 1.494 -1.201 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 -177.128 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 15.8 tp60 -66.16 -39.84 90.08 Favored 'General case' 0 N--CA 1.416 -2.141 0 CA-C-N 112.891 -1.959 . . . . 0.0 109.262 174.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 6.6 m -64.98 -32.7 74.56 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 177.116 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.56 HG11 HG21 ' A' ' 19' ' ' VAL . 46.2 t -65.69 -46.41 89.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.103 177.643 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.521 ' HG ' ' O ' ' A' ' 111' ' ' ALA . 68.7 mt -62.59 -37.59 86.81 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.41 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -72.63 -21.35 61.12 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.049 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 86.54 12.21 70.02 Favored Glycine 0 C--O 1.215 -1.05 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.627 178.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -96.39 36.86 1.3 Allowed 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 122.299 1.047 . . . . 0.0 109.072 -176.283 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.634 HD13 ' O ' ' A' ' 119' ' ' LEU . 0.0 OUTLIER -124.7 121.0 33.43 Favored 'General case' 0 N--CA 1.422 -1.857 0 CA-C-O 122.264 1.031 . . . . 0.0 108.34 -176.42 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.632 ' HA ' HG22 ' A' ' 12' ' ' THR 0.265 7.7 ptmm? -131.1 85.5 2.27 Favored 'General case' 1 C--N 1.225 -4.805 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 172.676 . . . . . . . . 4 3 . 1 . 008 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.417 HG23 HG23 ' A' ' 11' ' ' VAL . 14.4 m -91.43 170.52 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.053 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 177.307 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -142.62 153.3 43.35 Favored 'General case' 0 C--N 1.266 -3.025 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 -176.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' PHE . . . . . 0.503 ' O ' ' HB2' ' A' ' 9' ' ' ARG . 56.2 t80 -158.3 143.21 16.35 Favored 'General case' 0 N--CA 1.432 -1.353 0 C-N-CA 120.869 -0.332 . . . . 0.0 111.118 175.059 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -92.97 98.38 11.32 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-O 121.368 0.604 . . . . 0.0 109.455 176.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.435 ' HG3' ' CD1' ' A' ' 71' ' ' TYR . 29.7 tt0 -45.1 -68.03 0.23 Allowed 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.094 1.358 . . . . 0.0 110.385 178.53 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 90.1 m -151.12 91.66 1.72 Allowed 'General case' 0 N--CA 1.414 -2.245 0 N-CA-C 103.334 -2.839 . . . . 0.0 103.334 173.368 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.424 ' C ' HH12 ' A' ' 9' ' ' ARG . 14.3 mm-40 . . . . . 0 C--O 1.252 1.189 0 O-C-N 125.158 1.536 . . . . 0.0 110.144 -171.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 36.8 m . . . . . 0 CA--C 1.505 -0.755 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -155.9 -72.19 0.11 Allowed 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 177.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 15.5 m -87.4 75.88 9.15 Favored 'General case' 0 N--CA 1.421 -1.922 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 175.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.573 ' HG2' ' H ' ' A' ' 5' ' ' ASP . 18.1 ttpp 68.22 -175.89 0.2 Allowed 'General case' 0 CA--C 1.571 1.785 0 CA-C-N 114.368 -1.287 . . . . 0.0 108.853 -177.536 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.573 ' H ' ' HG2' ' A' ' 4' ' ' LYS . 5.1 p-10 -75.34 167.68 21.45 Favored 'General case' 0 C--O 1.248 0.988 0 C-N-CA 123.723 0.809 . . . . 0.0 109.169 173.538 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 28.2 p90 -134.82 140.66 46.02 Favored 'General case' 0 N--CA 1.421 -1.892 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 171.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 35.8 mtmm -130.32 81.65 2.02 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 121.683 0.754 . . . . 0.0 110.413 177.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.1 m -124.54 173.4 8.5 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 105.001 -2.222 . . . . 0.0 105.001 178.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -94.75 113.53 25.31 Favored 'General case' 0 N--CA 1.429 -1.524 0 C-N-CA 118.974 -1.09 . . . . 0.0 108.764 178.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.465 ' OD2' ' HB2' ' A' ' 120' ' ' LYS . 0.2 OUTLIER -78.15 90.09 4.26 Favored 'General case' 0 CA--C 1.489 -1.371 0 O-C-N 124.016 0.823 . . . . 0.0 108.829 -179.725 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.6 m -74.58 85.58 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.216 0 CA-C-O 122.713 1.244 . . . . 0.0 109.759 178.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.704 HG22 ' HA ' ' A' ' 120' ' ' LYS . 29.8 p -107.6 -30.33 8.66 Favored 'General case' 0 C--N 1.258 -3.409 0 C-N-CA 118.459 -1.297 . . . . 0.0 110.933 176.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -76.64 -38.95 53.79 Favored 'General case' 0 C--N 1.29 -1.992 0 C-N-CA 124.69 1.196 . . . . 0.0 108.81 -179.426 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.534 ' O ' ' HB3' ' A' ' 17' ' ' SER . 23.3 t70 -76.62 -36.92 57.15 Favored 'General case' 0 CA--C 1.491 -1.293 0 CA-C-O 122.178 0.989 . . . . 0.0 109.051 -179.609 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.511 ' O ' HG23 ' A' ' 19' ' ' VAL . 99.5 t -72.97 -21.46 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.803 0 CA-C-N 114.649 -1.16 . . . . 0.0 110.185 177.621 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.592 ' HE2' ' O ' ' A' ' 12' ' ' THR . 1.3 tppt? -72.25 -31.81 66.12 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 173.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.534 ' HB3' ' O ' ' A' ' 14' ' ' ASP . 29.0 t -63.84 -38.37 90.83 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 173.108 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.479 ' HB ' ' O ' ' A' ' 15' ' ' VAL . 41.4 mt -62.4 -42.89 97.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.005 173.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.511 HG23 ' O ' ' A' ' 15' ' ' VAL . 82.4 t -57.36 -42.8 81.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.137 177.652 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.405 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 43.7 ttt180 -54.05 -48.07 70.96 Favored 'General case' 0 C--N 1.332 -0.174 0 O-C-N 123.364 0.415 . . . . 0.0 109.892 174.758 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -65.4 -45.96 81.91 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 115.751 -0.658 . . . . 0.0 112.582 -177.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.493 HG22 ' HA ' ' A' ' 19' ' ' VAL . 29.4 m -65.63 -33.4 63.34 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 C-N-CA 119.907 -0.717 . . . . 0.0 111.045 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 14.7 mm-40 -60.22 -55.6 31.8 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 120.819 0.343 . . . . 0.0 110.806 170.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.405 ' HG2' ' O ' ' A' ' 20' ' ' ARG . 9.4 pt-20 -75.8 -2.11 28.36 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -177.154 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -72.98 -8.57 56.28 Favored 'General case' 0 N--CA 1.478 0.94 0 O-C-N 121.92 -0.488 . . . . 0.0 110.72 -179.098 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 9.2 m -78.93 42.79 0.48 Allowed 'General case' 0 CA--C 1.562 1.429 0 C-N-CA 124.98 1.312 . . . . 0.0 111.358 -178.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 14.8 t 65.92 76.43 0.32 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.407 1.483 . . . . 0.0 113.086 179.221 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.1 p -103.25 100.33 10.22 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 106.568 -1.642 . . . . 0.0 106.568 170.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -92.27 151.27 20.41 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.564 -170.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -164.41 -162.71 15.9 Favored Glycine 0 N--CA 1.427 -1.95 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 177.204 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 17.5 tmm? -82.8 -62.97 1.46 Allowed 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 177.392 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.422 ' O ' ' HB3' ' A' ' 61' ' ' GLN . 6.8 tpp180 -80.37 -19.34 46.58 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.097 177.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -75.91 104.18 6.33 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -178.04 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.514 ' HB ' ' HG3' ' A' ' 61' ' ' GLN . 9.0 tt -46.73 -33.7 2.17 Favored 'Isoleucine or valine' 0 C--O 1.249 1.059 0 C-N-CA 127.203 2.201 . . . . 0.0 114.511 -175.421 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 26.2 mttp -66.44 117.38 8.58 Favored 'General case' 0 C--N 1.313 -0.978 0 C-N-CA 122.624 0.37 . . . . 0.0 110.421 -172.108 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -136.77 -88.61 0.29 Allowed 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.641 175.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 41.2 t -140.15 -88.52 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 121.185 0.517 . . . . 0.0 111.632 -176.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -106.7 -66.46 0.64 Allowed Glycine 0 C--N 1.309 -0.924 0 CA-C-N 115.748 -0.66 . . . . 0.0 114.33 -173.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -64.85 -57.41 0.29 Allowed 'Trans proline' 0 C--N 1.357 1.013 0 C-N-CA 122.009 1.806 . . . . 0.0 110.959 178.128 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.1 m -84.58 103.6 13.85 Favored 'General case' 0 N--CA 1.426 -1.643 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.06 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 158.67 -120.98 1.01 Allowed Glycine 0 N--CA 1.425 -2.099 0 N-CA-C 108.23 -1.948 . . . . 0.0 108.23 -178.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 14.9 mmt180 62.44 93.83 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.8 0.84 . . . . 0.0 111.448 177.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -107.57 90.57 3.34 Favored 'General case' 0 CA--C 1.481 -1.703 0 CA-C-O 121.64 0.733 . . . . 0.0 109.038 -175.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.557 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 47.1 p -109.98 144.63 38.25 Favored 'General case' 0 N--CA 1.414 -2.266 0 CA-C-N 114.347 -1.297 . . . . 0.0 107.852 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.515 ' O ' HG23 ' A' ' 49' ' ' VAL . 18.7 ptm -44.52 -44.34 8.59 Favored 'General case' 0 C--O 1.206 -1.19 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -176.582 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.476 ' N ' ' HG3' ' A' ' 45' ' ' MET . 16.7 t-20 -68.5 -37.97 80.56 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 121.049 -0.26 . . . . 0.0 111.595 -172.316 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 49.6 ttm -72.54 -36.56 68.32 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.621 ' O ' ' HB2' ' A' ' 52' ' ' PHE . 47.9 mt -67.88 -30.24 69.55 Favored 'General case' 0 C--O 1.192 -1.972 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.846 -178.369 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.662 HG11 ' HG3' ' A' ' 77' ' ' GLU . 43.0 t -74.19 -44.65 49.26 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.609 0 C-N-CA 123.327 0.651 . . . . 0.0 110.695 179.258 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -54.42 -51.41 65.0 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.805 HD12 ' HB1' ' A' ' 58' ' ' ALA . 6.2 tt -75.97 -24.79 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.28 0 N-CA-C 114.232 1.197 . . . . 0.0 114.232 -178.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.621 ' HB2' ' O ' ' A' ' 48' ' ' LEU . 59.8 t80 -55.44 -43.59 75.55 Favored 'General case' 0 C--N 1.277 -2.579 0 CA-C-N 114.842 -1.072 . . . . 0.0 108.754 175.336 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.497 ' HA ' ' O ' ' A' ' 68' ' ' GLY . 9.5 mp -77.73 -35.79 51.54 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.892 -1.049 . . . . 0.0 111.551 177.176 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 98.61 53.3 1.23 Allowed Glycine 0 C--N 1.305 -1.185 0 N-CA-C 108.496 -1.841 . . . . 0.0 108.496 -173.163 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 52.6 p -64.81 -178.89 0.46 Allowed 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 115.564 1.69 . . . . 0.0 115.564 -175.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -81.88 -27.75 33.3 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 113.117 -1.856 . . . . 0.0 110.811 176.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.8 m -88.72 -45.29 9.92 Favored 'General case' 0 C--O 1.252 1.219 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -175.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.805 ' HB1' HD12 ' A' ' 51' ' ' ILE . . . -97.91 90.58 4.98 Favored 'General case' 0 N--CA 1.403 -2.781 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 178.274 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 50.2 mttp -72.95 26.57 0.06 Allowed 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 126.285 1.834 . . . . 0.0 114.423 -174.018 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.476 ' HA ' ' HB3' ' A' ' 65' ' ' PHE . 81.3 mt 71.0 116.71 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 C-N-CA 125.391 1.476 . . . . 0.0 112.713 179.328 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.571 ' HG2' HD11 ' A' ' 51' ' ' ILE . 17.4 mm-40 -113.34 17.52 18.46 Favored 'General case' 0 N--CA 1.439 -1.005 0 C-N-CA 119.782 -0.767 . . . . 0.0 112.372 -176.44 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 21.1 m 70.31 107.04 0.06 Allowed 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 124.111 0.964 . . . . 0.0 112.513 -178.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 153.6 -111.06 0.47 Allowed Glycine 0 CA--C 1.498 -0.973 0 N-CA-C 109.056 -1.618 . . . . 0.0 109.056 -179.099 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.558 ' O ' ' HG3' ' A' ' 67' ' ' LYS . 5.8 tt -91.12 -5.36 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 172.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.642 ' CD1' HD13 ' A' ' 51' ' ' ILE . 9.4 m-85 -70.85 102.04 2.27 Favored 'General case' 0 N--CA 1.41 -2.468 0 CA-C-N 113.353 -1.749 . . . . 0.0 108.959 -174.178 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.19 9.7 55.36 Favored Glycine 0 N--CA 1.42 -2.423 0 O-C-N 124.338 1.024 . . . . 0.0 112.829 -179.332 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.601 ' HD3' ' N ' ' A' ' 68' ' ' GLY . 0.1 OUTLIER -65.29 -31.81 73.15 Favored 'General case' 0 C--N 1.357 0.901 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 -178.439 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.601 ' N ' ' HD3' ' A' ' 67' ' ' LYS . . . -160.04 107.71 0.33 Allowed Glycine 0 CA--C 1.498 -1.018 0 C-N-CA 117.808 -2.139 . . . . 0.0 114.991 -175.243 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.454 ' HB3' ' O ' ' A' ' 53' ' ' LEU . 2.8 p -94.16 10.33 34.26 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 124.406 1.082 . . . . 0.0 110.29 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -91.56 6.31 46.15 Favored 'General case' 0 CA--C 1.506 -0.747 0 CA-C-O 121.965 0.888 . . . . 0.0 110.693 -178.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.408 ' HB2' HD11 ' A' ' 53' ' ' LEU . 43.1 m-85 -99.45 143.12 30.06 Favored 'General case' 0 C--N 1.283 -2.31 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.269 175.293 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 30.0 t -78.24 139.73 38.9 Favored 'General case' 0 N--CA 1.414 -2.257 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 170.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.468 HH12 ' ND2' ' A' ' 46' ' ' ASN . 32.8 tpt85 -43.52 -56.46 3.64 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.385 1.074 . . . . 0.0 112.223 -175.337 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -81.32 -12.26 59.08 Favored 'General case' 0 C--N 1.309 -1.169 0 C-N-CA 120.132 -0.627 . . . . 0.0 112.407 -175.29 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.437 ' ND2' ' HA ' ' A' ' 126' ' ' THR . 19.5 m120 -86.57 -29.72 22.42 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.232 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.546 ' HB3' HG13 ' A' ' 49' ' ' VAL . . . -65.35 -40.04 93.09 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 171.154 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.662 ' HG3' HG11 ' A' ' 49' ' ' VAL . 38.7 mt-10 -60.44 -32.81 71.73 Favored 'General case' 0 C--O 1.246 0.874 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.43 173.66 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 15.3 tpp180 -68.9 -31.25 70.04 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 -176.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.707 ' HG ' ' CD1' ' A' ' 123' ' ' PHE . 0.4 OUTLIER -73.84 -47.99 34.48 Favored 'General case' 0 CA--C 1.469 -2.165 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.303 -178.571 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -59.2 -21.24 59.17 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-O 121.667 0.746 . . . . 0.0 109.125 176.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 30.7 mmtm -87.22 -31.61 20.22 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.78 178.107 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.664 ' HE2' ' O ' ' A' ' 122' ' ' ASP . 19.1 ttpp -71.91 -39.04 69.8 Favored 'General case' 0 C--O 1.194 -1.861 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 175.671 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.505 HD13 HD22 ' A' ' 79' ' ' LEU . 0.6 OUTLIER -57.19 -38.7 74.05 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 125.186 1.395 . . . . 0.0 112.16 178.484 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.409 HG21 ' HG3' ' A' ' 91' ' ' GLU . 2.5 pp -75.68 -23.23 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 119.76 -0.776 . . . . 0.0 111.525 177.482 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 50.2 mt -77.93 -41.83 35.06 Favored 'General case' 0 N--CA 1.45 -0.434 0 O-C-N 123.425 0.453 . . . . 0.0 110.597 173.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -65.2 -29.12 69.91 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.034 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.404 ' HB3' ' HG2' ' A' ' 110' ' ' LYS . 2.3 mptp? 84.9 15.71 0.18 Allowed 'General case' 0 CA--C 1.477 -1.859 0 C-N-CA 125.154 1.382 . . . . 0.0 112.77 175.291 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.58 HG23 HG21 ' A' ' 114' ' ' VAL . 1.8 mp -67.96 -38.44 79.98 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.794 0 N-CA-C 106.349 -1.722 . . . . 0.0 106.349 167.351 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.457 ' HG ' ' HB3' ' A' ' 83' ' ' LEU . 30.3 mt -109.03 151.01 26.93 Favored 'General case' 0 N--CA 1.414 -2.261 0 CA-C-N 114.4 -1.273 . . . . 0.0 111.003 177.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.419 ' O ' ' HB2' ' A' ' 106' ' ' MET . 15.6 m-20 -143.85 118.24 9.65 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 175.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.409 ' HG3' HG21 ' A' ' 84' ' ' ILE . 40.8 mt-10 -94.03 155.21 17.24 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 121.052 0.454 . . . . 0.0 112.187 -176.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.593 ' O ' ' HA ' ' A' ' 103' ' ' ALA . 13.4 m-20 -97.77 138.08 35.68 Favored 'General case' 0 CA--C 1.497 -1.059 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.207 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 91.5 mt -106.94 116.76 32.49 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 121.482 0.658 . . . . 0.0 111.168 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -125.83 108.9 11.92 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.5 HD11 ' HA ' ' A' ' 99' ' ' ASP . 14.6 tt -112.04 148.94 14.83 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.381 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -177.213 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -103.69 -175.54 2.83 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -74.53 17.9 0.18 Allowed 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -177.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -118.45 6.01 11.77 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 177.093 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.5 ' HA ' HD11 ' A' ' 95' ' ' ILE . 6.1 m-20 62.18 28.28 16.98 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 122.299 1.047 . . . . 0.0 111.264 -176.586 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.432 ' C ' HG13 ' A' ' 95' ' ' ILE . 96.3 mt-30 -93.36 103.03 15.29 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 176.502 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -83.95 116.05 22.61 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.602 -177.196 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 4.3 mm -100.01 131.99 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.388 -3.535 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 176.028 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.593 ' HA ' ' O ' ' A' ' 92' ' ' ASP . . . -113.66 124.51 52.49 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.682 -178.261 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -97.06 155.65 16.71 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.002 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 42.2 t -100.55 120.89 50.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -175.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.419 ' HB2' ' O ' ' A' ' 90' ' ' ASP . 25.9 mmt -133.05 -173.04 3.09 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 113.369 -1.741 . . . . 0.0 108.307 177.312 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -143.67 134.24 24.92 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -138.01 -78.1 0.07 OUTLIER Glycine 0 N--CA 1.44 -1.098 0 C-N-CA 118.515 -1.802 . . . . 0.0 116.075 -174.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -63.78 -51.62 63.97 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 115.243 1.571 . . . . 0.0 115.243 -167.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.495 ' O ' HG23 ' A' ' 114' ' ' VAL . 65.1 mmtt -98.24 -1.64 41.49 Favored 'General case' 0 C--N 1.321 -0.645 0 O-C-N 121.474 -0.766 . . . . 0.0 109.802 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.604 ' O ' ' HG ' ' A' ' 115' ' ' LEU . . . -51.92 -33.18 36.04 Favored 'General case' 0 C--O 1.217 -0.608 0 CA-C-N 114.798 -1.092 . . . . 0.0 113.706 -174.317 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.54 -37.42 87.5 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.474 -177.43 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 5.4 m -78.19 -25.16 47.0 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 121.617 0.722 . . . . 0.0 109.238 -179.132 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.58 HG21 HG23 ' A' ' 88' ' ' ILE . 62.0 t -67.64 -40.35 83.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-N 114.703 -1.135 . . . . 0.0 108.272 175.378 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.604 ' HG ' ' O ' ' A' ' 111' ' ' ALA . 73.1 mt -72.39 -29.09 63.43 Favored 'General case' 0 C--O 1.222 -0.388 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.92 177.495 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -73.19 -11.37 60.5 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-O 121.165 0.507 . . . . 0.0 110.111 173.13 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 86.47 -12.62 60.44 Favored Glycine 0 N--CA 1.438 -1.208 0 CA-C-N 115.621 -0.718 . . . . 0.0 113.05 177.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -91.33 62.85 4.78 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 122.253 1.025 . . . . 0.0 111.177 -173.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.514 HD13 ' O ' ' A' ' 119' ' ' LEU . 0.0 OUTLIER -132.04 131.53 42.54 Favored 'General case' 0 N--CA 1.409 -2.517 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 175.201 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.704 ' HA ' HG22 ' A' ' 12' ' ' THR . 0.0 OUTLIER -130.62 128.03 40.16 Favored 'General case' 1 C--N 1.241 -4.124 0 CA-C-N 113.311 -1.768 . . . . 0.0 109.66 179.486 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 14.3 m -133.71 170.66 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 176.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.664 ' O ' ' HE2' ' A' ' 82' ' ' LYS . 8.0 p-10 -108.68 161.01 15.48 Favored 'General case' 0 C--N 1.274 -2.7 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.756 -178.676 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' PHE . . . . . 0.707 ' CD1' ' HG ' ' A' ' 79' ' ' LEU . 37.8 t80 -159.08 156.53 29.35 Favored 'General case' 0 C--O 1.256 1.4 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 171.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.408 ' SD ' ' N ' ' A' ' 125' ' ' GLU . 0.0 OUTLIER -127.75 149.02 50.43 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 104.53 -2.396 . . . . 0.0 104.53 -179.735 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.408 ' N ' ' SD ' ' A' ' 124' ' ' MET . 37.6 mt-10 -66.09 -31.96 73.14 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 121.144 0.497 . . . . 0.0 111.857 -174.293 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.448 HG22 ' H ' ' A' ' 127' ' ' GLU . 17.8 m -151.2 178.24 9.43 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 179.485 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.448 ' H ' HG22 ' A' ' 126' ' ' THR . 4.8 mp0 . . . . . 0 C--N 1.304 -1.4 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 175.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 37.2 m . . . . . 0 CA--C 1.507 -0.709 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 26.0 ttpp -164.01 160.19 21.53 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.7 p -66.77 141.41 57.73 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 123.575 0.547 . . . . 0.0 110.002 176.321 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.436 ' HE3' ' HB2' ' A' ' 5' ' ' ASP . 0.1 OUTLIER -156.71 -43.79 0.07 Allowed 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -178.654 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.436 ' HB2' ' HE3' ' A' ' 4' ' ' LYS . 3.5 t70 -124.45 157.5 35.05 Favored 'General case' 0 CA--C 1.476 -1.866 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -175.099 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -154.98 84.54 1.08 Allowed 'General case' 0 N--CA 1.407 -2.582 0 O-C-N 124.215 0.947 . . . . 0.0 109.698 -177.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 38.6 mtmm -126.68 80.79 1.96 Allowed 'General case' 0 C--N 1.285 -2.222 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.681 175.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.7 t -94.78 -172.51 2.74 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 47.0 mmt-85 -97.23 150.41 20.94 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 120.501 -0.48 . . . . 0.0 109.887 178.276 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -118.71 93.8 4.23 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 104.949 -2.241 . . . . 0.0 104.949 178.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.8 m -82.07 87.59 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.272 -2.782 0 CA-C-O 122.64 1.209 . . . . 0.0 111.322 -175.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.826 HG22 ' HA ' ' A' ' 120' ' ' LYS . 44.7 p -98.47 -58.43 1.96 Allowed 'General case' 0 C--N 1.262 -3.208 0 C-N-CA 117.564 -1.654 . . . . 0.0 113.13 174.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.533 ' HA ' ' HB3' ' A' ' 16' ' ' LYS . 12.3 t70 -83.49 -10.9 58.05 Favored 'General case' 0 C--O 1.205 -1.281 0 C-N-CA 118.797 -1.161 . . . . 0.0 111.139 -176.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -66.59 -46.85 74.6 Favored 'General case' 0 CA--C 1.5 -0.977 0 N-CA-C 105.279 -2.119 . . . . 0.0 105.279 171.535 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 77.1 t -65.85 -43.28 93.21 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.404 0 CA-C-N 112.944 -1.935 . . . . 0.0 110.074 177.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.533 ' HB3' ' HA ' ' A' ' 13' ' ' ASP . 17.2 ttmt -64.95 -40.26 94.74 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.628 178.339 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.507 ' O ' ' HD2' ' A' ' 21' ' ' PHE . 72.2 m -55.13 -45.86 75.61 Favored 'General case' 0 CA--C 1.509 -0.608 0 O-C-N 123.33 0.394 . . . . 0.0 109.955 175.432 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.415 ' O ' HG22 ' A' ' 22' ' ' VAL . 88.1 mt -55.43 -56.62 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.486 177.578 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.418 HG21 HG11 ' A' ' 114' ' ' VAL . 97.9 t -60.19 -44.44 95.38 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.101 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.41 -179.111 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.498 ' O ' ' HG3' ' A' ' 24' ' ' GLU . 35.8 ttp180 -58.72 -36.32 74.09 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 124.036 0.934 . . . . 0.0 111.069 -178.546 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.507 ' HD2' ' O ' ' A' ' 17' ' ' SER . 64.8 m-85 -90.86 -25.36 19.9 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -178.544 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.415 HG22 ' O ' ' A' ' 18' ' ' ILE . 30.5 m -79.38 -30.8 14.0 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.377 0 C-N-CA 117.307 -1.757 . . . . 0.0 108.54 173.378 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -63.05 -52.4 62.95 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.251 174.118 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.498 ' HG3' ' O ' ' A' ' 20' ' ' ARG 0.322 0.0 OUTLIER -70.62 -20.16 62.77 Favored 'General case' 0 C--N 1.347 0.468 0 C-N-CA 119.366 -0.934 . . . . 0.0 112.849 -179.447 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 8.4 m80 -76.77 -37.36 55.99 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 119.619 -0.832 . . . . 0.0 110.127 172.158 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 29.7 t 54.34 44.87 28.31 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.664 0.786 . . . . 0.0 110.31 177.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 62.1 p 60.09 14.44 4.44 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 125.21 1.404 . . . . 0.0 112.997 -177.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.3 t -143.1 -150.92 0.33 Allowed 'General case' 0 N--CA 1.418 -2.039 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 -178.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 75.4 mm-40 74.91 147.82 0.09 Allowed 'General case' 0 C--O 1.213 -0.836 0 C-N-CA 125.401 1.48 . . . . 0.0 112.517 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.14 34.84 31.98 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 -176.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.488 ' SD ' ' HA2' ' A' ' 38' ' ' GLY . 24.1 mmt -45.35 -23.3 0.19 Allowed 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 126.656 1.983 . . . . 0.0 114.441 -175.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -72.16 -37.2 69.43 Favored 'General case' 0 C--N 1.314 -0.969 0 O-C-N 122.107 -0.371 . . . . 0.0 111.356 -178.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -126.44 -64.8 1.01 Allowed 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -170.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.4 tt -74.24 101.78 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 CA-C-O 122.819 1.295 . . . . 0.0 111.333 -176.211 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.459 ' C ' ' H ' ' A' ' 37' ' ' VAL . 9.5 mtmp? 60.96 77.3 0.33 Allowed 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 112.63 -2.077 . . . . 0.0 110.964 -176.41 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -75.59 37.49 0.14 Allowed 'General case' 0 CA--C 1.557 1.241 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.397 -178.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.459 ' H ' ' C ' ' A' ' 35' ' ' LYS . 10.7 p -133.14 10.36 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 C-N-CA 124.996 1.318 . . . . 0.0 107.695 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.488 ' HA2' ' SD ' ' A' ' 31' ' ' MET . . . 87.13 -139.18 15.96 Favored Glycine 0 N--CA 1.435 -1.399 0 CA-C-N 114.697 -1.138 . . . . 0.0 112.868 176.633 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -70.65 -23.08 27.14 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.443 2.095 . . . . 0.0 111.635 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.458 ' HB2' HG13 ' A' ' 37' ' ' VAL . 1.8 m -50.97 133.23 27.27 Favored 'General case' 0 C--O 1.249 1.073 0 C-N-CA 125.088 1.355 . . . . 0.0 110.966 -178.61 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 100.84 -175.9 26.77 Favored Glycine 0 N--CA 1.438 -1.174 0 N-CA-C 110.195 -1.162 . . . . 0.0 110.195 -178.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.41 ' HD3' ' SD ' ' A' ' 106' ' ' MET . 73.7 mtt180 -151.67 -174.46 4.85 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 106.074 -1.825 . . . . 0.0 106.074 -178.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -110.1 161.2 15.78 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 177.083 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 51.2 p -122.56 156.34 34.4 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 176.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.442 ' HG3' ' N ' ' A' ' 46' ' ' ASN . 13.2 ptp -50.71 -42.27 56.91 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-O 121.221 0.534 . . . . 0.0 110.799 178.154 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.442 ' N ' ' HG3' ' A' ' 45' ' ' MET . 44.2 m-80 -64.1 -34.19 77.49 Favored 'General case' 0 CA--C 1.505 -0.77 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.348 -177.717 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' MET . . . . . 0.446 ' O ' ' HB ' ' A' ' 51' ' ' ILE . 49.2 ttm -71.2 -43.22 67.82 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.444 ' O ' HG22 ' A' ' 51' ' ' ILE . 82.9 mt -67.77 -42.8 81.16 Favored 'General case' 0 C--O 1.208 -1.101 0 CA-C-N 115.224 -0.898 . . . . 0.0 112.469 -176.607 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.436 HG13 ' HB3' ' A' ' 76' ' ' ALA . 69.2 t -64.57 -46.38 92.75 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.727 0 CA-C-O 121.622 0.725 . . . . 0.0 110.436 179.321 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -63.52 -37.85 88.88 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 114.712 -1.131 . . . . 0.0 108.927 -178.09 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.702 ' CG1' ' HB1' ' A' ' 58' ' ' ALA . 0.4 OUTLIER -76.33 -37.85 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.407 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 179.62 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.428 ' CZ ' ' HA3' ' A' ' 68' ' ' GLY . 37.8 t80 -55.81 -39.23 71.05 Favored 'General case' 0 C--N 1.296 -1.745 0 O-C-N 123.877 0.736 . . . . 0.0 110.036 176.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.5 mp -82.13 -28.77 32.01 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.137 -0.938 . . . . 0.0 112.116 177.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.15 35.43 15.1 Favored Glycine 0 C--O 1.251 1.159 0 N-CA-C 109.841 -1.303 . . . . 0.0 109.841 -176.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.532 ' OG ' ' HD3' ' A' ' 56' ' ' LYS . 34.9 t -70.47 -168.96 0.27 Allowed 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 126.619 1.968 . . . . 0.0 112.858 -172.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.648 ' HD3' ' H ' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -50.27 -66.75 0.34 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.205 1.402 . . . . 0.0 112.902 -174.236 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.05 -42.83 22.97 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 114.771 -1.104 . . . . 0.0 111.545 -170.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.702 ' HB1' ' CG1' ' A' ' 51' ' ' ILE . . . -91.78 81.1 5.23 Favored 'General case' 0 N--CA 1.398 -3.048 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 174.653 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.509 ' O ' ' HB ' ' A' ' 60' ' ' ILE . 0.1 OUTLIER -73.13 25.21 0.06 Allowed 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 114.612 -1.176 . . . . 0.0 111.99 -175.484 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.509 ' HB ' ' O ' ' A' ' 59' ' ' LYS . 88.3 mt 83.34 127.91 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 C-N-CA 126.831 2.053 . . . . 0.0 111.057 -175.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.463 ' HG3' ' O ' ' A' ' 60' ' ' ILE 0.297 14.8 mt-30 -135.82 58.86 1.73 Allowed 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 178.609 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 15.2 t 71.44 137.14 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 125.91 1.684 . . . . 0.0 112.729 177.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.28 -141.65 15.73 Favored Glycine 0 C--O 1.241 0.581 0 C-N-CA 121.288 -0.482 . . . . 0.0 112.728 177.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.461 HG21 ' HB3' ' A' ' 17' ' ' SER . 6.3 pt -73.39 7.19 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 C-N-CA 123.331 0.652 . . . . 0.0 112.427 178.621 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.592 ' CD2' HG12 ' A' ' 51' ' ' ILE . 0.3 OUTLIER -70.96 113.32 7.88 Favored 'General case' 0 N--CA 1.389 -3.504 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 -178.784 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.68 33.67 46.34 Favored Glycine 0 N--CA 1.424 -2.116 0 CA-C-N 114.849 -1.068 . . . . 0.0 111.305 -174.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 32.9 mmtm -121.32 -15.08 8.19 Favored 'General case' 0 C--O 1.22 -0.452 0 CA-C-O 121.2 0.524 . . . . 0.0 109.72 174.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.428 ' HA3' ' CZ ' ' A' ' 52' ' ' PHE . . . -107.78 35.03 5.25 Favored Glycine 0 N--CA 1.432 -1.579 0 N-CA-C 109.771 -1.331 . . . . 0.0 109.771 178.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 9.2 m -72.62 6.23 2.58 Favored 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 124.932 1.293 . . . . 0.0 111.953 -176.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -93.52 -1.53 55.46 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-O 121.923 0.868 . . . . 0.0 109.337 176.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -103.41 153.62 20.28 Favored 'General case' 0 N--CA 1.422 -1.828 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 175.334 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.408 ' HB3' ' OD1' ' A' ' 75' ' ' ASN . 37.5 t -105.35 171.86 7.1 Favored 'General case' 0 C--N 1.28 -2.43 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 170.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.418 ' HD2' HG12 ' A' ' 49' ' ' VAL . 8.3 mmm180 -52.78 -37.95 60.37 Favored 'General case' 0 C--O 1.205 -1.277 0 CA-C-O 121.215 0.531 . . . . 0.0 110.869 179.615 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.463 ' O ' ' HG2' ' A' ' 78' ' ' ARG . 6.5 t-160 -67.6 -43.98 79.18 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.577 -172.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.408 ' OD1' ' HB3' ' A' ' 72' ' ' SER . 7.6 m120 -68.78 -55.7 10.4 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.319 -178.543 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.436 ' HB3' HG13 ' A' ' 49' ' ' VAL . . . -57.41 -44.82 84.88 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.929 -177.487 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.403 ' HG3' HG11 ' A' ' 49' ' ' VAL . 44.7 mt-10 -62.62 -33.92 75.99 Favored 'General case' 0 C--O 1.208 -1.096 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 178.538 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.463 ' HG2' ' O ' ' A' ' 74' ' ' HIS . 9.7 mmm180 -67.14 -30.31 70.26 Favored 'General case' 0 CA--C 1.495 -1.144 0 C-N-CA 119.08 -1.048 . . . . 0.0 110.296 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.536 ' O ' ' HG ' ' A' ' 83' ' ' LEU . 2.5 tt -79.46 -50.99 9.94 Favored 'General case' 0 N--CA 1.42 -1.926 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.261 -177.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.585 ' HA ' HD12 ' A' ' 83' ' ' LEU . 60.6 m-85 -58.45 -23.18 56.89 Favored 'General case' 0 CA--C 1.506 -0.747 0 CA-C-O 121.855 0.836 . . . . 0.0 110.326 179.119 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -89.2 -23.57 22.36 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 114.473 -1.239 . . . . 0.0 110.118 -179.147 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.401 ' HE2' ' O ' ' A' ' 122' ' ' ASP . 48.5 tttp -73.36 -40.27 64.51 Favored 'General case' 0 C--O 1.209 -1.053 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 174.127 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.585 HD12 ' HA ' ' A' ' 80' ' ' PHE . 94.6 mt -53.62 -50.19 66.21 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 114.905 -1.043 . . . . 0.0 112.864 178.453 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.616 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 2.6 pp -73.82 -24.65 19.83 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -178.706 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 41.0 mt -79.83 -40.2 29.03 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 176.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.629 ' O ' ' HE2' ' A' ' 110' ' ' LYS . 35.1 t70 -82.96 -13.07 56.72 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.675 -177.268 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.45 ' HG3' ' OD2' ' A' ' 90' ' ' ASP . 2.8 mptp? 85.61 16.77 0.13 Allowed 'General case' 0 CA--C 1.462 -2.418 0 N-CA-C 114.355 1.243 . . . . 0.0 114.355 171.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 11.6 mt -70.02 -45.32 76.87 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.092 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 168.556 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.616 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 4.3 mm? -114.95 158.57 21.83 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 113.953 -1.476 . . . . 0.0 108.416 174.609 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.466 ' HB2' ' HA2' ' A' ' 108' ' ' GLY . 0.3 OUTLIER -149.12 109.97 4.3 Favored 'General case' 0 CA--C 1.476 -1.902 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 176.452 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.449 ' HB2' ' O ' ' A' ' 104' ' ' TYR 0.28 11.8 pt-20 -95.53 159.11 15.15 Favored 'General case' 0 C--N 1.282 -2.36 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 178.56 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.462 ' O ' ' HA ' ' A' ' 103' ' ' ALA . 9.8 t70 -97.98 118.14 33.89 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 126.042 1.737 . . . . 0.0 109.287 -170.669 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -85.5 103.64 14.55 Favored 'General case' 0 N--CA 1.419 -1.997 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.993 179.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -100.54 113.48 26.32 Favored 'General case' 0 C--N 1.279 -2.479 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.503 HD11 ' HA ' ' A' ' 99' ' ' ASP . 16.3 tt -128.47 147.01 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.197 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -178.075 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 30.5 p-10 -98.16 -175.12 3.04 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -76.43 18.69 0.29 Allowed 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -177.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -117.89 3.92 12.18 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 178.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.503 ' HA ' HD11 ' A' ' 95' ' ' ILE . 5.7 m-20 62.91 28.41 16.33 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 122.29 1.043 . . . . 0.0 111.123 -175.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.406 ' C ' HG13 ' A' ' 95' ' ' ILE . 26.7 mt-30 -97.92 106.09 18.34 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 176.496 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -104.64 146.88 28.29 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 -174.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 14.4 tt -135.19 143.24 37.65 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 N-CA-C 105.855 -1.906 . . . . 0.0 105.855 170.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.462 ' HA ' ' O ' ' A' ' 92' ' ' ASP . . . -112.11 131.5 55.41 Favored 'General case' 0 C--N 1.29 -2.005 0 C-N-CA 120.107 -0.637 . . . . 0.0 111.728 -176.261 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.449 ' O ' ' HB2' ' A' ' 91' ' ' GLU . 94.6 m-85 -105.21 143.61 33.15 Favored 'General case' 0 C--O 1.196 -1.73 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 177.579 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.412 HG22 ' HB3' ' A' ' 91' ' ' GLU . 49.8 t -95.3 131.18 42.79 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 CA-C-O 121.999 0.904 . . . . 0.0 113.177 -169.673 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.449 ' HB2' ' O ' ' A' ' 90' ' ' ASP . 84.8 mmm -130.51 -172.43 2.8 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 112.91 -1.95 . . . . 0.0 106.834 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.525 ' H ' HD23 ' A' ' 107' ' ' LEU . 1.5 pt? -102.81 150.17 23.76 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -178.181 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.466 ' HA2' ' HB2' ' A' ' 90' ' ' ASP . . . -104.96 -175.42 24.56 Favored Glycine 0 N--CA 1.437 -1.248 0 C-N-CA 120.063 -1.065 . . . . 0.0 113.777 -176.044 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -58.67 -40.47 83.63 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 123.968 0.907 . . . . 0.0 112.256 -177.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.629 ' HE2' ' O ' ' A' ' 86' ' ' ASP . 37.5 mtmt -92.21 19.85 6.56 Favored 'General case' 0 C--N 1.314 -0.963 0 O-C-N 122.037 -0.415 . . . . 0.0 111.831 -176.525 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.453 ' O ' ' HB ' ' A' ' 114' ' ' VAL . . . -78.09 -30.25 49.48 Favored 'General case' 0 CA--C 1.497 -1.082 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 177.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 34.8 tp60 -63.76 -39.55 94.54 Favored 'General case' 0 N--CA 1.421 -1.921 0 CA-C-N 112.93 -1.941 . . . . 0.0 109.4 173.113 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 5.2 m -66.2 -30.14 70.55 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.536 ' HA ' ' HG ' ' A' ' 119' ' ' LEU . 94.5 t -64.64 -43.77 96.67 Favored 'Isoleucine or valine' 0 C--O 1.25 1.108 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.105 176.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 54.0 mt -69.05 -32.91 72.74 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.775 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -72.11 -24.43 61.48 Favored 'General case' 0 C--O 1.216 -0.659 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.213 177.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 103.18 -13.63 55.37 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.723 -0.751 . . . . 0.0 113.336 176.027 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -83.72 47.59 1.31 Allowed 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 121.531 0.682 . . . . 0.0 112.197 -175.243 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.536 ' HG ' ' HA ' ' A' ' 114' ' ' VAL . 0.0 OUTLIER -122.41 80.35 1.72 Allowed 'General case' 0 N--CA 1.434 -1.265 0 CA-C-O 123.263 1.506 . . . . 0.0 110.214 179.891 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.826 ' HA ' HG22 ' A' ' 12' ' ' THR . 5.8 ptmm? -114.31 93.13 4.21 Favored 'General case' 0 C--N 1.246 -3.902 0 C-N-CA 118.733 -1.187 . . . . 0.0 110.935 172.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 8.5 m -111.25 170.43 3.58 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.329 -176.247 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.401 ' O ' ' HE2' ' A' ' 82' ' ' LYS . 6.8 p-10 -95.52 168.43 10.7 Favored 'General case' 0 C--N 1.271 -2.816 0 CA-C-N 114.655 -1.157 . . . . 0.0 111.967 -178.117 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -158.36 142.34 15.59 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 114.627 -1.169 . . . . 0.0 108.028 172.14 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 26.5 ptt? -97.24 121.36 39.04 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 177.305 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -48.79 -55.29 11.96 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 115.316 1.599 . . . . 0.0 115.316 -168.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 8.1 t -150.81 157.29 42.75 Favored 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 119.089 -1.044 . . . . 0.0 111.784 -177.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 . . . . . 0 N--CA 1.422 -1.856 0 N-CA-C 103.145 -2.909 . . . . 0.0 103.145 174.739 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.437 ' NH2' ' HB2' ' A' ' 14' ' ' ASP . 60.2 ttt180 . . . . . 0 N--CA 1.408 -2.54 0 CA-C-O 122.107 0.956 . . . . 0.0 112.446 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -81.09 111.68 17.76 Favored 'General case' 0 N--CA 1.394 -3.272 0 N-CA-C 104.633 -2.358 . . . . 0.0 104.633 170.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.4 m -84.58 76.15 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.279 -2.47 0 C-N-CA 118.281 -1.368 . . . . 0.0 109.721 178.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.654 HG22 ' HA ' ' A' ' 120' ' ' LYS . 26.1 p -110.07 -37.34 5.61 Favored 'General case' 0 C--N 1.259 -3.356 0 CA-C-N 114.849 -1.069 . . . . 0.0 109.391 178.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -69.67 -37.7 76.78 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 176.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.437 ' HB2' ' NH2' ' A' ' 9' ' ' ARG . 11.4 t70 -69.21 -54.93 12.26 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.73 -1.123 . . . . 0.0 108.176 -178.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.452 ' O ' HG23 ' A' ' 19' ' ' VAL . 77.2 t -63.27 -40.38 88.84 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.179 0 CA-C-N 113.76 -1.564 . . . . 0.0 112.966 -177.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 9.6 ttmm -67.08 -35.22 79.35 Favored 'General case' 0 C--N 1.323 -0.586 0 O-C-N 121.907 -0.496 . . . . 0.0 111.586 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 50.1 m -62.97 -45.42 92.52 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 174.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 66.6 mt -55.79 -53.3 39.04 Favored 'Isoleucine or valine' 0 C--O 1.243 0.723 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.134 175.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 15' ' ' VAL . 75.3 t -56.86 -43.99 81.2 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.011 0 CA-C-N 114.985 -1.007 . . . . 0.0 112.162 -178.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.461 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 32.9 ttt180 -53.04 -54.12 40.0 Favored 'General case' 0 N--CA 1.45 -0.453 0 O-C-N 123.765 0.666 . . . . 0.0 110.198 179.257 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.438 ' CD2' HG23 ' A' ' 64' ' ' ILE . 66.0 m-85 -64.91 -43.05 94.08 Favored 'General case' 0 CA--C 1.494 -1.193 0 N-CA-C 113.183 0.809 . . . . 0.0 113.183 -175.045 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 35.9 m -70.84 -35.96 62.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 C-N-CA 119.367 -0.933 . . . . 0.0 111.345 -178.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -65.13 -47.09 78.33 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 123.402 0.439 . . . . 0.0 110.782 177.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.461 ' HG2' ' O ' ' A' ' 20' ' ' ARG . 12.5 pt-20 . . . . . 0 C--O 1.238 0.457 0 C-N-CA 120.113 -0.635 . . . . 0.0 111.878 -179.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 . . . . . 0 CA--C 1.494 -1.182 0 CA-C-O 121.942 0.877 . . . . 0.0 110.226 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 70.1 p -118.79 162.27 18.75 Favored 'General case' 0 N--CA 1.413 -2.305 0 CA-C-N 114.193 -1.367 . . . . 0.0 107.762 178.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.524 ' O ' HG23 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -55.11 -44.27 74.81 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -176.5 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.436 ' O ' ' HB ' ' A' ' 49' ' ' VAL . 3.5 m-20 -71.22 -23.36 62.0 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -177.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 26.0 mmt -71.66 -39.7 70.14 Favored 'General case' 0 CA--C 1.508 -0.673 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 176.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 78.4 mt -66.95 -30.89 71.15 Favored 'General case' 0 C--O 1.216 -0.676 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.301 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 45' ' ' MET . 27.3 t -62.8 -52.7 56.28 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.944 0 C-N-CA 124.806 1.242 . . . . 0.0 110.98 178.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.451 ' CG ' ' HB3' ' A' ' 55' ' ' SER . 10.7 t70 -63.02 -38.2 90.24 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 114.848 -1.069 . . . . 0.0 109.287 -178.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.533 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 71.2 mt -63.91 -47.98 88.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.252 -0.885 . . . . 0.0 111.513 176.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.494 ' CE2' ' HA3' ' A' ' 68' ' ' GLY . 49.1 t80 -52.65 -43.34 65.43 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 124.778 1.231 . . . . 0.0 111.618 -177.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.473 HD11 ' HB2' ' A' ' 71' ' ' TYR . 8.9 mp -76.96 -22.54 53.09 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 179.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.77 31.48 18.04 Favored Glycine 0 C--O 1.267 2.2 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -174.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.451 ' HB3' ' CG ' ' A' ' 50' ' ' ASP . 22.8 t -75.69 -179.42 4.71 Favored 'General case' 0 N--CA 1.415 -2.187 0 CA-C-N 113.7 -1.25 . . . . 0.0 108.541 -178.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 43.7 mttm -123.51 17.36 9.67 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 118.76 -1.176 . . . . 0.0 113.297 -169.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.4 m -88.85 -38.31 14.68 Favored 'General case' 0 C--O 1.247 0.971 0 N-CA-C 105.06 -2.2 . . . . 0.0 105.06 173.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.446 ' HB1' HG12 ' A' ' 51' ' ' ILE . . . -45.85 137.37 5.61 Favored 'General case' 0 N--CA 1.429 -1.494 0 C-N-CA 128.213 2.605 . . . . 0.0 111.59 178.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -120.01 18.22 12.45 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.971 -178.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . 0.251 67.6 mt -104.03 -50.4 9.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 C-N-CA 117.496 -1.682 . . . . 0.0 114.19 -177.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.641 ' HA ' ' CD2' ' A' ' 65' ' ' PHE . 25.7 mp0 60.91 26.59 16.48 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 176.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.9 t -139.41 129.65 25.34 Favored 'General case' 0 N--CA 1.421 -1.898 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 106.38 -134.8 12.33 Favored Glycine 0 N--CA 1.435 -1.383 0 N-CA-C 111.61 -0.596 . . . . 0.0 111.61 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.438 HG23 ' CD2' ' A' ' 21' ' ' PHE . 1.4 pt -70.95 29.06 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 124.708 1.203 . . . . 0.0 113.694 179.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.641 ' CD2' ' HA ' ' A' ' 61' ' ' GLN . 9.0 t80 -71.69 112.31 7.7 Favored 'General case' 0 N--CA 1.425 -1.689 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -177.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.34 48.18 46.91 Favored Glycine 0 N--CA 1.441 -0.968 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.505 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 32.5 mmtm -119.25 -21.0 7.73 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 120.941 0.4 . . . . 0.0 111.34 177.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.494 ' HA3' ' CE2' ' A' ' 52' ' ' PHE . . . -121.58 45.13 1.25 Allowed Glycine 0 N--CA 1.437 -1.299 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 178.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.7 m -73.99 6.69 3.17 Favored 'General case' 0 C--N 1.306 -1.292 0 C-N-CA 124.614 1.166 . . . . 0.0 112.173 -175.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -101.71 3.87 40.06 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-O 121.527 0.679 . . . . 0.0 109.883 178.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.473 ' HB2' HD11 ' A' ' 53' ' ' LEU . 34.0 m-85 -101.36 168.8 9.3 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.884 176.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 36.1 t -104.07 155.77 18.42 Favored 'General case' 0 N--CA 1.417 -2.117 0 N-CA-C 104.548 -2.39 . . . . 0.0 104.548 168.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 69.7 mtm180 -57.7 -39.66 77.69 Favored 'General case' 0 C--O 1.209 -1.035 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -175.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 69.7 t60 -77.49 -17.0 58.41 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-O 121.519 0.676 . . . . 0.0 110.886 -176.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -80.53 -43.61 20.44 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 177.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.519 ' HB3' HG13 ' A' ' 49' ' ' VAL . . . -61.81 -41.55 97.91 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.009 -0.996 . . . . 0.0 108.842 175.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -54.16 -43.61 70.76 Favored 'General case' 0 CA--C 1.501 -0.929 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.327 174.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 20.2 ttm180 -64.93 -28.81 69.78 Favored 'General case' 0 C--O 1.217 -0.647 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.228 -172.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.3 tt -80.63 -47.25 14.37 Favored 'General case' 0 N--CA 1.429 -1.523 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.26 -177.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -62.09 -20.04 63.6 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 121.861 0.839 . . . . 0.0 109.471 177.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.524 ' HA ' HG13 ' A' ' 84' ' ' ILE . 94.4 mttt -91.26 -22.34 20.63 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 114.471 -1.241 . . . . 0.0 110.394 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 29.6 tptp -70.93 -47.08 61.03 Favored 'General case' 0 C--O 1.219 -0.531 0 N-CA-C 106.133 -1.802 . . . . 0.0 106.133 171.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 94.3 mt -56.8 -39.65 74.52 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 114.35 -1.295 . . . . 0.0 113.941 177.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.524 HG13 ' HA ' ' A' ' 81' ' ' LYS . 2.7 pp -69.61 -33.02 54.81 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.785 0 C-N-CA 120.261 -0.576 . . . . 0.0 110.908 178.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 53.4 mt -70.36 -44.1 68.81 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 121.087 0.47 . . . . 0.0 111.558 176.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -66.96 -27.28 67.33 Favored 'General case' 0 C--O 1.259 1.575 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.199 179.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.474 ' HD2' ' O ' ' A' ' 84' ' ' ILE . 2.2 mptp? 84.89 18.73 0.13 Allowed 'General case' 0 CA--C 1.476 -1.902 0 C-N-CA 125.781 1.632 . . . . 0.0 112.846 176.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.547 HG23 HG21 ' A' ' 114' ' ' VAL . 1.9 mp -69.77 -40.64 79.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 105.391 -2.077 . . . . 0.0 105.391 166.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.478 ' CD1' HG13 ' A' ' 105' ' ' VAL . 3.1 mm? -103.6 144.31 31.61 Favored 'General case' 0 N--CA 1.411 -2.405 0 CA-C-N 113.419 -1.719 . . . . 0.0 109.04 173.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -124.72 131.57 53.45 Favored 'General case' 0 N--CA 1.408 -2.538 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 176.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.47 ' H ' ' CD ' ' A' ' 91' ' ' GLU . 0.1 OUTLIER -95.27 129.67 42.31 Favored 'General case' 0 C--N 1.27 -2.86 0 CA-C-N 114.271 -1.331 . . . . 0.0 111.708 -173.838 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.519 ' HB2' ' HB2' ' A' ' 104' ' ' TYR . 7.9 m-20 -96.48 95.84 8.29 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 179.092 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 97.5 mt -76.28 114.54 15.08 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.461 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -130.86 130.86 44.12 Favored 'General case' 0 N--CA 1.42 -1.968 0 CA-C-N 115.344 -0.844 . . . . 0.0 108.837 -177.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.498 HG13 ' C ' ' A' ' 100' ' ' GLN . 16.8 tt -128.81 141.15 47.35 Favored 'Isoleucine or valine' 0 N--CA 1.399 -3.005 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 176.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.408 ' C ' ' H ' ' A' ' 98' ' ' ASN . 3.5 p-10 -95.72 170.85 9.04 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 176.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -67.9 21.72 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -173.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.408 ' H ' ' C ' ' A' ' 96' ' ' ASN . 16.8 m120 -119.32 7.49 11.26 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 177.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.488 ' HA ' HD11 ' A' ' 95' ' ' ILE . 8.4 m-20 62.14 30.76 17.82 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 124.787 1.305 . . . . 0.0 110.99 -177.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.498 ' C ' HG13 ' A' ' 95' ' ' ILE . 83.6 mm-40 -101.71 107.42 18.64 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 177.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -96.27 139.25 32.68 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 115.663 -0.699 . . . . 0.0 112.081 -175.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 18.4 tt -142.21 146.16 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.723 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 176.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.507 ' HA ' ' O ' ' A' ' 92' ' ' ASP . . . -114.19 132.86 55.95 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 -178.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.519 ' HB2' ' HB2' ' A' ' 92' ' ' ASP . 68.1 m-85 -97.23 175.4 6.29 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 177.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.478 HG13 ' CD1' ' A' ' 89' ' ' LEU . 14.6 t -116.4 121.01 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.803 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 -178.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 58.4 mtp -141.76 168.48 19.65 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 113.436 -1.711 . . . . 0.0 108.764 173.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.543 ' HB3' ' HB2' ' A' ' 111' ' ' ALA . 7.5 mp -116.86 130.27 56.61 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 177.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -131.8 -80.24 0.19 Allowed Glycine 0 N--CA 1.422 -2.257 0 C-N-CA 118.897 -1.62 . . . . 0.0 115.716 -175.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -65.96 -54.9 20.31 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 115.25 1.574 . . . . 0.0 115.25 -168.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.515 ' HB2' ' HA ' ' A' ' 88' ' ' ILE . 41.9 mmtm -97.55 6.15 48.51 Favored 'General case' 0 C--N 1.313 -0.979 0 O-C-N 121.455 -0.778 . . . . 0.0 109.995 -179.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.543 ' HB2' ' HB3' ' A' ' 107' ' ' LEU . . . -58.03 -32.82 68.34 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -175.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.404 HE21 ' N ' ' A' ' 113' ' ' THR . 0.2 OUTLIER -69.5 -29.13 66.7 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.469 0.652 . . . . 0.0 110.029 -179.898 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.404 ' N ' HE21 ' A' ' 112' ' ' GLN . 13.1 m -75.95 -25.16 55.66 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.547 HG21 HG23 ' A' ' 88' ' ' ILE . 40.0 t -70.19 -39.69 77.23 Favored 'Isoleucine or valine' 0 C--O 1.25 1.083 0 CA-C-N 115.246 -0.888 . . . . 0.0 108.942 175.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.449 ' HG ' ' O ' ' A' ' 111' ' ' ALA . 76.1 mt -69.54 -39.2 77.6 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.981 178.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.41 ' OD1' ' HB2' ' A' ' 118' ' ' ASN . 28.0 t-20 -71.58 -20.07 62.05 Favored 'General case' 0 C--O 1.217 -0.635 0 CA-C-O 121.735 0.778 . . . . 0.0 109.529 176.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 85.04 6.52 84.78 Favored Glycine 0 CA--C 1.503 -0.718 0 CA-C-N 115.396 -0.82 . . . . 0.0 113.173 176.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.41 ' HB2' ' OD1' ' A' ' 116' ' ' ASN . 13.0 t-20 -93.81 18.9 9.54 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 121.584 0.707 . . . . 0.0 109.644 -175.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.545 ' O ' HD13 ' A' ' 119' ' ' LEU . 0.0 OUTLIER -90.06 112.53 24.01 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-O 123.277 1.513 . . . . 0.0 108.442 -176.898 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.654 ' HA ' HG22 ' A' ' 12' ' ' THR . 4.9 ptpp? -130.13 105.72 8.13 Favored 'General case' 1 C--N 1.228 -4.697 0 CA-C-N 113.309 -1.769 . . . . 0.0 112.229 179.551 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.4 m -119.07 171.01 7.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 177.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -105.56 158.39 16.71 Favored 'General case' 0 C--N 1.262 -3.223 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.291 -177.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -158.08 151.7 23.6 Favored 'General case' 0 N--CA 1.426 -1.636 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 172.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 49.8 ttm . . . . . 0 C--N 1.303 -1.415 0 C-N-CA 120.501 -0.48 . . . . 0.0 112.037 -173.384 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.509 ' O ' ' HA ' ' A' ' 122' ' ' ASP . 8.8 mpt_? . . . . . 0 N--CA 1.438 -1.027 0 N-CA-C 111.342 0.127 . . . . 0.0 111.342 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -84.97 90.86 7.92 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 177.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.2 m -85.72 64.96 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 CA-C-O 121.705 0.764 . . . . 0.0 110.498 -179.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.526 HG21 ' HB3' ' A' ' 120' ' ' LYS . 42.8 p -102.92 -16.84 15.74 Favored 'General case' 0 C--N 1.26 -3.3 0 C-N-CA 116.15 -2.22 . . . . 0.0 113.187 -176.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 17.9 p-10 -82.14 -35.88 28.01 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 174.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -68.65 -58.98 3.47 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.3 179.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 88.6 t -59.51 -35.72 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 CA-C-N 114.675 -1.148 . . . . 0.0 112.04 -179.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.468 ' HE3' HD11 ' A' ' 119' ' ' LEU . 3.6 tppp? -66.07 -40.01 90.52 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.294 178.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.463 ' O ' ' HD2' ' A' ' 21' ' ' PHE . 49.6 m -65.14 -42.03 94.19 Favored 'General case' 0 N--CA 1.442 -0.853 0 O-C-N 123.362 0.414 . . . . 0.0 110.246 178.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 59.0 mt -57.13 -51.89 63.35 Favored 'Isoleucine or valine' 0 C--O 1.244 0.807 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.266 176.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.51 HG11 HG11 ' A' ' 114' ' ' VAL . 70.6 t -65.6 -37.33 79.75 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.621 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.929 -178.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 16.2 ttp180 -55.11 -52.24 63.86 Favored 'General case' 0 C--O 1.222 -0.386 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.463 ' HD2' ' O ' ' A' ' 17' ' ' SER . 55.5 m-85 -63.16 -43.81 97.24 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-N 115.103 -0.953 . . . . 0.0 113.006 -177.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.444 HG22 ' HA ' ' A' ' 19' ' ' VAL . 27.3 m -72.87 -33.79 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.055 0 C-N-CA 119.365 -0.934 . . . . 0.0 111.742 -178.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 58.9 tp60 -65.59 -48.88 70.82 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 123.141 0.276 . . . . 0.0 110.737 176.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 . . . . . 0 N--CA 1.474 0.767 0 CA-C-O 121.69 0.757 . . . . 0.0 110.461 179.687 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 . . . . . 0 N--CA 1.433 -1.301 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.515 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 80.9 p -130.69 156.34 45.09 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 104.497 -2.409 . . . . 0.0 104.497 174.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.547 ' O ' HG23 ' A' ' 49' ' ' VAL . 11.9 ptp -59.91 -35.03 74.01 Favored 'General case' 0 C--O 1.215 -0.712 0 CA-C-N 119.701 1.137 . . . . 0.0 110.986 -179.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -72.72 -32.74 65.95 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.896 -175.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . 0.687 ' SD ' ' HA ' ' A' ' 58' ' ' ALA . 48.2 tpp -67.17 -39.45 86.47 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 176.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.515 ' HG ' ' O ' ' A' ' 44' ' ' THR . 77.9 mt -64.26 -40.76 96.66 Favored 'General case' 0 C--O 1.207 -1.152 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.544 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.547 HG23 ' O ' ' A' ' 45' ' ' MET . 68.7 t -64.19 -46.3 93.87 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.687 0 C-N-CA 124.037 0.935 . . . . 0.0 110.245 177.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.579 ' OD1' ' HB3' ' A' ' 55' ' ' SER . 7.9 t70 -60.7 -44.32 96.7 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 114.731 -1.122 . . . . 0.0 109.507 -178.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.497 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 54.9 mt -65.18 -47.12 88.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.044 175.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.425 ' CZ ' ' HA3' ' A' ' 68' ' ' GLY . 25.7 t80 -57.18 -44.12 83.28 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 124.353 1.061 . . . . 0.0 110.757 -177.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.4 HD22 ' HD2' ' A' ' 73' ' ' ARG . 11.0 mp -77.21 -28.66 53.91 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 177.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 100.74 29.14 6.68 Favored Glycine 0 C--O 1.244 0.722 0 C-N-CA 120.525 -0.845 . . . . 0.0 113.162 177.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.579 ' HB3' ' OD1' ' A' ' 50' ' ' ASP . 23.1 t -80.28 -170.51 2.56 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 123.388 0.675 . . . . 0.0 110.836 -176.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.462 ' HD2' ' C ' ' A' ' 55' ' ' SER . 1.6 mptp? -121.14 7.84 10.31 Favored 'General case' 0 C--O 1.25 1.1 0 N-CA-C 114.271 1.212 . . . . 0.0 114.271 -177.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.5 m -78.36 -30.08 47.85 Favored 'General case' 0 C--O 1.245 0.823 0 N-CA-C 104.837 -2.283 . . . . 0.0 104.837 173.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.687 ' HA ' ' SD ' ' A' ' 47' ' ' MET . . . -50.2 120.97 4.93 Favored 'General case' 0 N--CA 1.417 -2.113 0 C-N-CA 127.34 2.256 . . . . 0.0 109.825 172.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.586 ' HA ' ' HE3' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -100.64 9.69 42.14 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-O 121.067 0.46 . . . . 0.0 111.297 -179.482 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 61.8 mt -128.23 120.88 54.4 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 176.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -105.39 32.43 4.27 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.192 0.52 . . . . 0.0 110.144 -177.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 24.5 m -141.65 126.76 18.43 Favored 'General case' 0 C--N 1.311 -1.077 0 O-C-N 122.057 -0.402 . . . . 0.0 110.84 -177.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 131.16 -132.57 6.87 Favored Glycine 0 N--CA 1.442 -0.91 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.452 HG23 ' CD2' ' A' ' 21' ' ' PHE . 1.7 pt -75.9 31.02 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 123.32 0.648 . . . . 0.0 112.054 177.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.497 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 11.5 t80 -66.87 112.8 4.47 Favored 'General case' 0 N--CA 1.42 -1.974 0 CA-C-O 120.992 0.425 . . . . 0.0 110.443 -174.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 63.79 36.8 93.78 Favored Glycine 0 N--CA 1.436 -1.303 0 CA-C-N 115.045 -0.98 . . . . 0.0 112.156 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.609 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -100.8 -25.04 14.25 Favored 'General case' 0 C--N 1.32 -0.701 0 O-C-N 122.153 -0.616 . . . . 0.0 110.247 177.672 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.425 ' HA3' ' CZ ' ' A' ' 52' ' ' PHE . . . -120.13 51.59 0.76 Allowed Glycine 0 N--CA 1.436 -1.351 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.7 t -82.84 9.3 10.16 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 122.017 0.913 . . . . 0.0 109.86 -174.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -102.0 6.8 41.33 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-O 121.709 0.766 . . . . 0.0 109.82 178.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -100.91 154.45 18.66 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 115.019 -0.991 . . . . 0.0 108.852 176.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.653 ' HB3' ' OD1' ' A' ' 75' ' ' ASN . 43.5 t -97.09 164.85 12.34 Favored 'General case' 0 N--CA 1.416 -2.141 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 171.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.4 ' HD2' HD22 ' A' ' 53' ' ' LEU . 10.6 mmm180 -54.16 -40.35 67.39 Favored 'General case' 0 CA--C 1.509 -0.624 0 C-N-CA 122.981 0.512 . . . . 0.0 112.289 -174.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 16.0 t-80 -86.87 -21.73 26.18 Favored 'General case' 0 C--O 1.2 -1.524 0 C-N-CA 119.015 -1.074 . . . . 0.0 111.372 -172.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.653 ' OD1' ' HB3' ' A' ' 72' ' ' SER . 13.4 m120 -79.78 -38.87 32.17 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 -178.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.41 ' HB3' HG13 ' A' ' 49' ' ' VAL . . . -64.09 -46.29 84.93 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.752 176.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.74 -20.56 61.18 Favored 'General case' 0 C--O 1.214 -0.808 0 C-N-CA 120.544 -0.463 . . . . 0.0 111.231 -178.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.413 ' HB3' ' O ' ' A' ' 75' ' ' ASN . 21.7 tpp180 -65.94 -35.63 81.14 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 176.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.2 tt -76.83 -45.27 29.22 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 114.761 -1.108 . . . . 0.0 110.175 -179.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -62.99 -17.19 61.87 Favored 'General case' 0 C--O 1.216 -0.693 0 C-N-CA 120.108 -0.637 . . . . 0.0 109.706 176.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.487 ' HA ' HG13 ' A' ' 84' ' ' ILE . 53.1 mttp -86.52 -26.18 24.71 Favored 'General case' 0 CA--C 1.496 -1.099 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.399 177.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.422 ' HG3' ' OD2' ' A' ' 86' ' ' ASP . 29.2 tptp -72.09 -47.24 52.82 Favored 'General case' 0 N--CA 1.427 -1.599 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 176.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.453 ' HB3' HD23 ' A' ' 89' ' ' LEU . 95.8 mt -58.7 -38.08 77.51 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 179.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.576 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 2.6 pp -77.7 -23.13 14.08 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 C-N-CA 120.048 -0.661 . . . . 0.0 111.747 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.9 tt -77.76 -47.24 19.49 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 176.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.422 ' OD2' ' HG3' ' A' ' 82' ' ' LYS . 68.3 m-20 -69.64 -20.95 63.59 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.567 -179.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.491 ' HB3' ' HB2' ' A' ' 109' ' ' ASN . 3.7 mptp? 84.75 15.61 0.19 Allowed 'General case' 0 CA--C 1.479 -1.765 0 C-N-CA 124.747 1.219 . . . . 0.0 113.679 173.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.541 HG22 HD22 ' A' ' 89' ' ' LEU . 1.8 mp -67.92 -39.92 82.53 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.847 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 169.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.576 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 4.4 mm? -112.08 147.74 35.41 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.682 170.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -133.32 100.53 4.87 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 120.838 0.351 . . . . 0.0 110.061 178.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.413 ' HG2' HG21 ' A' ' 84' ' ' ILE . 18.3 pt-20 -100.26 156.76 17.05 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.458 175.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -133.3 179.9 5.91 Favored 'General case' 0 C--O 1.248 0.987 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 179.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 99.1 mt -104.14 150.18 24.57 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 122.511 1.148 . . . . 0.0 113.727 -170.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -141.57 121.01 13.2 Favored 'General case' 0 N--CA 1.422 -1.85 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 176.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 14.7 tt -118.1 149.98 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.444 0 C-N-CA 119.687 -0.805 . . . . 0.0 108.94 -179.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 39.1 p30 -102.1 -176.7 3.19 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.201 178.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -74.05 11.51 0.9 Allowed 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 123.493 0.717 . . . . 0.0 112.315 -178.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -110.79 -2.89 15.99 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 -179.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 29.5 t70 69.11 24.48 6.1 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-O 123.462 1.601 . . . . 0.0 109.189 -176.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -97.52 107.12 19.56 Favored 'General case' 0 C--O 1.245 0.859 0 CA-C-N 114.998 -1.001 . . . . 0.0 108.749 176.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -88.68 129.53 35.5 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.833 -177.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 15.0 tt -124.5 150.14 29.14 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 175.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -108.92 134.54 51.46 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 122.315 -0.241 . . . . 0.0 110.681 -177.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -106.36 143.33 34.63 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 19.0 t -96.61 133.98 35.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 CA-C-O 122.094 0.949 . . . . 0.0 113.168 -171.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 62.6 mtt -134.62 175.95 9.08 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 113.365 -1.743 . . . . 0.0 106.876 176.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.479 HD23 ' H ' ' A' ' 107' ' ' LEU . 2.1 pt? -121.61 132.24 54.56 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -140.21 -104.99 0.6 Allowed Glycine 0 N--CA 1.429 -1.808 0 C-N-CA 118.484 -1.817 . . . . 0.0 115.525 -174.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.491 ' HB2' ' HB3' ' A' ' 87' ' ' LYS . 37.1 m-80 -49.99 -55.33 15.05 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 115.312 1.597 . . . . 0.0 115.312 -167.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.46 ' O ' HG23 ' A' ' 114' ' ' VAL . 74.8 mmtt -110.89 19.79 18.18 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.833 -0.542 . . . . 0.0 111.119 -176.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -76.3 -33.36 59.07 Favored 'General case' 0 CA--C 1.495 -1.167 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 35.5 tp60 -62.87 -36.48 83.44 Favored 'General case' 0 N--CA 1.423 -1.821 0 CA-C-N 113.025 -1.898 . . . . 0.0 110.023 173.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 19.8 m -69.31 -28.53 66.35 Favored 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 179.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.545 HG22 ' HG ' ' A' ' 119' ' ' LEU . 38.9 t -66.76 -43.81 89.71 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.758 176.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 65.3 mt -67.6 -33.05 74.22 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.314 -179.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -72.71 -23.5 60.87 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 177.21 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 98.12 -19.32 54.98 Favored Glycine 0 N--CA 1.44 -1.063 0 CA-C-N 115.597 -0.729 . . . . 0.0 113.075 177.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -79.17 24.22 0.34 Allowed 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.534 1.134 . . . . 0.0 113.56 -172.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.599 ' O ' HD13 ' A' ' 119' ' ' LEU . 0.0 OUTLIER -94.13 109.53 21.3 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 122.914 1.34 . . . . 0.0 109.73 -178.892 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.526 ' HB3' HG21 ' A' ' 12' ' ' THR 0.341 0.1 OUTLIER -129.54 114.65 16.35 Favored 'General case' 1 C--N 1.225 -4.831 0 N-CA-C 114.449 1.277 . . . . 0.0 114.449 172.651 . . . . . . . . 5 4 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 5.4 m -126.83 173.68 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.796 0 CA-C-N 114.758 -1.11 . . . . 0.0 108.147 177.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.509 ' HA ' ' O ' ' A' ' 9' ' ' ARG . 8.5 p-10 -107.77 173.07 6.48 Favored 'General case' 0 C--N 1.269 -2.919 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.702 -177.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . 0.401 ' O ' ' HD3' ' A' ' 9' ' ' ARG . 51.1 t80 -157.81 166.78 31.82 Favored 'General case' 0 C--O 1.251 1.166 0 C-N-CA 123.93 0.892 . . . . 0.0 108.95 178.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 42.8 tpp . . . . . 0 N--CA 1.442 -0.827 0 C-N-CA 125.827 1.651 . . . . 0.0 106.595 -178.737 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.486 ' HB2' ' O ' ' A' ' 123' ' ' PHE . 6.9 mpt_? . . . . . 0 N--CA 1.432 -1.355 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -90.76 94.18 9.56 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 -174.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.613 ' HB ' ' OD1' ' A' ' 14' ' ' ASP . 21.6 m -89.64 104.35 15.0 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 CA-C-O 122.658 1.218 . . . . 0.0 110.648 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -122.28 -42.61 2.35 Favored 'General case' 0 C--N 1.267 -3.018 0 C-N-CA 119.285 -0.966 . . . . 0.0 112.545 174.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.555 ' HA ' ' HB2' ' A' ' 16' ' ' LYS 0.367 7.3 m-20 -87.62 -9.84 53.13 Favored 'General case' 0 N--CA 1.419 -1.99 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 -171.639 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.613 ' OD1' ' HB ' ' A' ' 11' ' ' VAL . 20.2 p-10 -84.32 -39.92 18.55 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 105.545 -2.021 . . . . 0.0 105.545 171.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.431 ' O ' ' HB ' ' A' ' 18' ' ' ILE . 65.0 t -65.39 -37.32 79.79 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.378 0 CA-C-N 113.847 -1.524 . . . . 0.0 109.448 174.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.555 ' HB2' ' HA ' ' A' ' 13' ' ' ASP . 1.4 tppp? -61.6 -42.7 99.24 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 124.941 1.296 . . . . 0.0 109.776 178.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.9 t -61.66 -45.24 94.89 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.431 ' HB ' ' O ' ' A' ' 15' ' ' VAL . 87.6 mt -54.28 -54.28 22.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.168 175.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.417 HG21 HG11 ' A' ' 114' ' ' VAL . 77.2 t -56.5 -47.06 82.39 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.773 0 CA-C-N 115.144 -0.934 . . . . 0.0 111.562 -179.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 7.3 tpt180 -51.25 -51.6 52.57 Favored 'General case' 0 C--N 1.321 -0.644 0 O-C-N 123.421 0.451 . . . . 0.0 111.282 177.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.51 ' CE1' ' HA3' ' A' ' 63' ' ' GLY . 69.0 m-85 -72.58 -35.9 68.05 Favored 'General case' 0 CA--C 1.492 -1.287 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -174.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 27.0 m -73.96 -37.13 46.96 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.533 0 C-N-CA 118.963 -1.095 . . . . 0.0 110.222 178.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -61.02 -50.85 71.67 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 176.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 . . . . . 0 C--N 1.324 -0.511 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.922 -177.796 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 . . . . . 0 N--CA 1.432 -1.327 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.462 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 68.4 p -114.73 163.44 15.46 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 179.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.55 ' O ' HG23 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -58.11 -39.85 79.69 Favored 'General case' 0 C--O 1.214 -0.775 0 CA-C-O 121.028 0.442 . . . . 0.0 109.885 -179.138 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.428 ' CG ' HH22 ' A' ' 73' ' ' ARG . 18.7 t-20 -60.78 -45.42 94.43 Favored 'General case' 0 C--N 1.31 -1.124 0 C-N-CA 124.967 1.307 . . . . 0.0 111.157 -175.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . 0.475 ' SD ' ' HA ' ' A' ' 58' ' ' ALA . 35.6 tpp -67.48 -36.4 81.04 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.584 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' A' ' 44' ' ' THR . 73.1 mt -69.75 -29.54 66.92 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.271 -178.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 45' ' ' MET . 44.2 t -67.07 -48.67 78.39 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.24 0 C-N-CA 123.679 0.792 . . . . 0.0 110.37 178.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -58.91 -41.16 86.6 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.955 177.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.716 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 49.9 mt -63.94 -46.05 95.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.629 176.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.528 ' CE2' ' HA3' ' A' ' 68' ' ' GLY . 49.0 t80 -63.0 -40.08 96.69 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 123.208 0.603 . . . . 0.0 111.361 -178.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.0 mp -75.78 -35.12 60.21 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 111.46 8.18 23.4 Favored Glycine 0 C--O 1.244 0.734 0 C-N-CA 119.822 -1.18 . . . . 0.0 112.184 -177.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 63.2 m -65.63 124.19 21.72 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 123.47 0.708 . . . . 0.0 109.872 177.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -82.88 20.26 1.21 Allowed 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 -178.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.1 m -77.55 -24.55 49.84 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 106.163 -1.791 . . . . 0.0 106.163 172.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.504 ' HB1' HG12 ' A' ' 51' ' ' ILE . . . -52.85 151.06 4.8 Favored 'General case' 0 C--O 1.247 0.947 0 CA-C-N 113.529 -1.669 . . . . 0.0 112.042 178.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -93.92 -16.82 23.63 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.889 178.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 71.1 mt -132.03 143.5 39.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.392 -175.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 20.2 mm-40 -106.23 80.91 1.55 Allowed 'General case' 0 C--O 1.245 0.834 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 176.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.4 ' O ' ' HB2' ' A' ' 65' ' ' PHE . 42.0 m -79.59 173.82 12.2 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 110.121 -0.325 . . . . 0.0 110.121 179.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.51 ' HA3' ' CE1' ' A' ' 21' ' ' PHE . . . -60.93 -31.15 75.2 Favored Glycine 0 N--CA 1.467 0.735 0 C-N-CA 121.096 -0.573 . . . . 0.0 112.513 -179.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.462 HG23 ' CD2' ' A' ' 21' ' ' PHE . 5.8 pt -73.74 2.77 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.73 0 N-CA-C 113.515 0.931 . . . . 0.0 113.515 177.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.716 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 6.4 t80 -65.56 106.54 1.46 Allowed 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -178.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 83.41 18.69 63.76 Favored Glycine 0 N--CA 1.429 -1.776 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.493 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.426 ' CG ' ' HA ' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -86.72 -35.27 19.34 Favored 'General case' 0 CA--C 1.51 -0.576 0 C-N-CA 119.022 -1.071 . . . . 0.0 109.956 177.197 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.528 ' HA3' ' CE2' ' A' ' 52' ' ' PHE . . . -105.25 44.37 1.49 Allowed Glycine 0 N--CA 1.426 -1.982 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 44.0 t -72.49 -0.21 12.07 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 123.402 0.681 . . . . 0.0 111.002 -177.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -97.74 1.94 49.03 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-O 121.207 0.527 . . . . 0.0 110.64 178.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -99.55 148.41 24.32 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 115.454 -0.794 . . . . 0.0 108.955 175.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 39.1 t -90.83 161.78 15.11 Favored 'General case' 0 C--N 1.281 -2.382 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 168.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.468 ' HB3' HH11 ' A' ' 73' ' ' ARG . 13.5 mtp-105 -60.29 -36.19 77.3 Favored 'General case' 0 C--O 1.219 -0.522 0 CA-C-O 121.053 0.454 . . . . 0.0 110.293 -177.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 19.4 t-160 -62.67 -41.64 99.19 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.113 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -65.93 -52.58 48.59 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -176.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.445 ' HB3' HG13 ' A' ' 49' ' ' VAL . . . -60.7 -44.12 96.94 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.473 -0.785 . . . . 0.0 112.441 -177.102 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.468 ' CG ' HG21 ' A' ' 49' ' ' VAL . 42.9 mt-10 -64.33 -33.81 76.71 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 121.585 0.707 . . . . 0.0 111.009 178.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 17.7 mmm180 -78.04 -17.0 57.57 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.913 -179.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.3 tt -79.84 -42.69 23.8 Favored 'General case' 0 N--CA 1.426 -1.635 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 176.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -60.53 -19.98 58.86 Favored 'General case' 0 C--O 1.216 -0.705 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 172.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.45 ' HA ' HG13 ' A' ' 84' ' ' ILE . 73.0 mmtt -82.75 -28.58 30.31 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.463 176.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 29.1 tptp -70.43 -45.42 65.9 Favored 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 174.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.508 ' HB3' HD23 ' A' ' 89' ' ' LEU . 97.8 mt -58.83 -37.1 75.67 Favored 'General case' 0 N--CA 1.428 -1.563 0 CA-C-N 113.958 -1.474 . . . . 0.0 113.834 178.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.537 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 2.7 pp -74.02 -26.94 21.58 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.592 0 C-N-CA 119.884 -0.726 . . . . 0.0 111.627 178.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 49.0 mt -73.42 -47.65 40.12 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 123.49 0.494 . . . . 0.0 110.507 175.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.424 ' HB2' HD13 ' A' ' 88' ' ' ILE . 69.5 m-20 -67.1 -25.31 66.15 Favored 'General case' 0 C--O 1.254 1.312 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.054 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? 85.51 23.52 0.08 Allowed 'General case' 0 CA--C 1.478 -1.797 0 C-N-CA 125.951 1.7 . . . . 0.0 113.475 175.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.612 HD11 HD21 ' A' ' 119' ' ' LEU . 2.0 mp -74.58 -41.47 48.67 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.224 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 169.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.537 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 3.7 mm? -103.68 140.39 37.65 Favored 'General case' 0 N--CA 1.424 -1.769 0 CA-C-N 114.153 -1.385 . . . . 0.0 109.748 175.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -131.35 109.75 10.57 Favored 'General case' 0 C--N 1.285 -2.216 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 176.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -94.96 149.21 21.5 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 121.051 0.453 . . . . 0.0 112.16 -172.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.472 ' O ' ' HA ' ' A' ' 103' ' ' ALA . 8.1 m-20 -97.78 108.37 21.07 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 94.5 mt -81.68 108.82 15.55 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.716 0.77 . . . . 0.0 109.661 176.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -120.69 125.57 48.01 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-N 114.802 -1.09 . . . . 0.0 108.402 -175.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.52 HD11 ' HA ' ' A' ' 99' ' ' ASP . 16.9 tt -130.3 141.78 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.753 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 178.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -97.13 173.15 7.39 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 176.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -66.44 18.21 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 -173.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -118.61 10.24 12.46 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 177.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.52 ' HA ' HD11 ' A' ' 95' ' ' ILE . 6.1 m-20 60.13 29.32 18.9 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 122.644 1.212 . . . . 0.0 111.023 -174.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.479 ' C ' HG13 ' A' ' 95' ' ' ILE . 94.0 mt-30 -95.92 106.04 18.14 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 114.426 -1.261 . . . . 0.0 107.998 176.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -101.36 144.33 30.31 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.626 -0.715 . . . . 0.0 112.437 -175.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 9.6 tp -141.6 146.86 22.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 174.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.472 ' HA ' ' O ' ' A' ' 92' ' ' ASP . . . -112.0 129.04 56.33 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 110.156 -0.312 . . . . 0.0 110.156 -178.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -97.49 162.78 13.15 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 177.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.448 HG13 ' CD1' ' A' ' 89' ' ' LEU . 8.4 t -105.16 123.71 59.5 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.862 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 -177.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 26.2 mmt -137.83 162.68 33.32 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 113.178 -1.828 . . . . 0.0 106.743 173.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.421 HD23 ' H ' ' A' ' 107' ' ' LEU . 1.5 pt? -127.71 123.29 35.06 Favored 'General case' 0 C--N 1.285 -2.226 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 177.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -125.49 -86.27 0.63 Allowed Glycine 0 N--CA 1.422 -2.237 0 C-N-CA 119.099 -1.524 . . . . 0.0 115.705 -171.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -57.32 -46.49 83.18 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 115.86 1.8 . . . . 0.0 115.86 -167.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.466 ' O ' HG23 ' A' ' 114' ' ' VAL . 41.9 mmtm -106.2 8.8 32.2 Favored 'General case' 0 C--N 1.308 -1.199 0 O-C-N 121.507 -0.746 . . . . 0.0 111.321 -179.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -54.64 -45.7 73.83 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -172.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -72.9 -24.28 60.82 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.213 0.53 . . . . 0.0 110.946 -176.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 7.2 m -75.51 -24.9 56.87 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 -178.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.534 HG21 HG23 ' A' ' 88' ' ' ILE . 21.9 t -74.97 -37.52 41.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 176.004 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 81.4 mt -66.44 -38.59 87.73 Favored 'General case' 0 C--O 1.219 -0.507 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.621 177.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -72.57 -24.99 61.18 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 174.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 70.64 24.7 76.68 Favored Glycine 0 C--O 1.218 -0.852 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.402 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -95.98 32.64 1.86 Allowed 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 105.788 -1.93 . . . . 0.0 105.788 176.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.612 HD21 HD11 ' A' ' 88' ' ' ILE . 0.3 OUTLIER -142.71 127.16 17.8 Favored 'General case' 0 N--CA 1.384 -3.772 0 CA-C-N 113.012 -1.904 . . . . 0.0 108.018 -174.531 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.459 ' HD3' ' O ' ' A' ' 120' ' ' LYS . 0.0 OUTLIER -130.25 137.99 50.3 Favored 'General case' 0 N--CA 1.414 -2.268 0 N-CA-C 107.896 -1.149 . . . . 0.0 107.896 172.362 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.521 HG22 ' O ' ' A' ' 11' ' ' VAL . 4.8 m -114.35 -174.79 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 C-N-CA 119.363 -0.935 . . . . 0.0 108.51 176.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -133.83 140.85 47.15 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -171.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . 0.486 ' O ' ' HB2' ' A' ' 9' ' ' ARG . 11.2 t80 -158.17 -175.5 5.38 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 175.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 26.1 ptt? . . . . . 0 C--N 1.314 -0.97 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 177.679 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 72.1 mtm180 . . . . . 0 CA--C 1.499 -0.982 0 N-CA-C 114.621 1.341 . . . . 0.0 114.621 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -98.16 90.26 4.79 Favored 'General case' 0 CA--C 1.48 -1.727 0 N-CA-C 102.146 -3.279 . . . . 0.0 102.146 170.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.435 ' HA ' ' OD1' ' A' ' 14' ' ' ASP . 19.0 m -71.95 84.53 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.317 0 CA-C-O 122.85 1.31 . . . . 0.0 112.652 -172.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.802 HG22 ' HA ' ' A' ' 120' ' ' LYS . 37.8 p -100.88 -54.79 2.73 Favored 'General case' 0 C--N 1.26 -3.301 0 C-N-CA 117.869 -1.532 . . . . 0.0 112.831 174.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.472 ' HA ' ' HB3' ' A' ' 16' ' ' LYS . 8.2 t70 -86.96 -11.56 50.18 Favored 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 119.405 -0.918 . . . . 0.0 110.142 -178.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.435 ' OD1' ' HA ' ' A' ' 11' ' ' VAL . 1.6 m-20 -69.41 -41.77 75.96 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 104.864 -2.272 . . . . 0.0 104.864 173.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 51.5 t -70.07 -45.37 76.49 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.828 0 CA-C-N 112.946 -1.934 . . . . 0.0 109.847 176.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.472 ' HB3' ' HA ' ' A' ' 13' ' ' ASP . 30.9 ttmt -65.56 -35.54 81.13 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 -179.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.6 p -62.72 -44.56 95.89 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 120.628 -0.429 . . . . 0.0 109.937 176.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 56.9 mt -53.9 -50.24 54.12 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 O-C-N 123.745 0.653 . . . . 0.0 109.725 172.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.47 ' HA ' HG22 ' A' ' 22' ' ' VAL . 76.5 t -58.05 -46.36 88.08 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.867 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.27 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 58.7 mtm-85 -58.33 -32.43 68.49 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.672 ' CD2' HG23 ' A' ' 64' ' ' ILE . 70.7 m-85 -83.48 -37.75 22.71 Favored 'General case' 0 N--CA 1.427 -1.58 0 C-N-CA 119.514 -0.875 . . . . 0.0 112.747 179.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.47 HG22 ' HA ' ' A' ' 19' ' ' VAL . 27.7 m -69.01 -29.73 44.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 C-N-CA 117.629 -1.629 . . . . 0.0 109.668 176.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.411 ' HG3' ' O ' ' A' ' 19' ' ' VAL . 54.9 mt-30 -62.61 -38.35 89.82 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.471 170.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.635 ' HG3' ' O ' ' A' ' 21' ' ' PHE . 0.3 OUTLIER . . . . . 0 CA--C 1.493 -1.245 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.466 -179.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 . . . . . 0 N--CA 1.444 -0.727 0 CA-C-O 120.887 0.375 . . . . 0.0 110.744 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 41.6 p -116.63 155.98 27.84 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 106.306 -1.738 . . . . 0.0 106.306 172.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.454 ' O ' HG23 ' A' ' 49' ' ' VAL . 16.2 ptp -62.45 -36.08 81.3 Favored 'General case' 0 C--O 1.217 -0.637 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -175.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -66.13 -30.94 71.52 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.936 0.398 . . . . 0.0 110.133 -178.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 22.7 mmt -73.88 -41.32 62.35 Favored 'General case' 0 C--O 1.202 -1.409 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.845 177.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 80.4 mt -56.43 -37.21 69.91 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.979 0.418 . . . . 0.0 110.908 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.57 HG13 ' HB3' ' A' ' 76' ' ' ALA . 74.2 t -66.11 -44.51 91.77 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.317 0 C-N-CA 124.268 1.027 . . . . 0.0 110.601 177.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.434 ' CG ' ' HB2' ' A' ' 55' ' ' SER . 4.5 t70 -59.72 -43.17 94.29 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.45 -178.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.419 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 1.9 mp -64.29 -47.93 87.61 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.959 174.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -54.81 -42.37 71.76 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.441 1.096 . . . . 0.0 111.16 -177.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.444 HD11 ' HB2' ' A' ' 71' ' ' TYR . 9.7 mp -83.04 -15.14 52.2 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 178.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.58 39.09 12.69 Favored Glycine 0 C--O 1.253 1.327 0 C-N-CA 120.417 -0.897 . . . . 0.0 111.079 -178.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.434 ' HB2' ' CG ' ' A' ' 50' ' ' ASP . 65.2 m -86.89 -172.52 4.03 Favored 'General case' 0 N--CA 1.418 -2.055 0 CA-C-N 115.294 -0.453 . . . . 0.0 111.886 -178.159 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -109.79 -4.72 15.88 Favored 'General case' 0 C--O 1.261 1.703 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 -170.213 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.3 m -78.07 -28.07 48.74 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 105.565 -2.013 . . . . 0.0 105.565 176.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -51.59 107.19 0.17 Allowed 'General case' 0 N--CA 1.419 -1.998 0 C-N-CA 126.56 1.944 . . . . 0.0 112.428 175.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.67 -7.27 28.18 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 174.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 28.1 mm -95.65 110.84 24.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 114.511 -1.222 . . . . 0.0 108.866 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -122.2 97.13 5.33 Favored 'General case' 0 C--N 1.293 -1.859 0 O-C-N 121.781 -0.575 . . . . 0.0 110.283 172.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.9 m -145.97 -80.13 0.16 Allowed 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 173.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -100.98 165.16 18.59 Favored Glycine 0 N--CA 1.433 -1.551 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.243 178.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.672 HG23 ' CD2' ' A' ' 21' ' ' PHE 0.26 16.6 pt 48.55 9.71 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.443 0 N-CA-C 117.573 2.434 . . . . 0.0 117.573 178.4 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.419 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 23.0 t80 -64.74 105.07 0.92 Allowed 'General case' 0 C--O 1.243 0.762 0 CA-C-N 118.442 0.565 . . . . 0.0 111.292 -177.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 74.56 29.63 61.34 Favored Glycine 0 C--N 1.312 -0.762 0 CA-C-N 115.628 -0.714 . . . . 0.0 112.241 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.472 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.7 OUTLIER -94.2 -19.31 20.86 Favored 'General case' 0 C--N 1.322 -0.611 0 O-C-N 122.409 -0.465 . . . . 0.0 111.565 176.83 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -126.53 39.09 2.05 Favored Glycine 0 N--CA 1.433 -1.538 0 C-N-CA 120.465 -0.874 . . . . 0.0 111.433 -178.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 15.5 m -71.3 1.76 5.72 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 123.944 0.898 . . . . 0.0 112.064 -177.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -98.99 4.27 47.18 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-O 121.422 0.629 . . . . 0.0 110.099 178.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.444 ' HB2' HD11 ' A' ' 53' ' ' LEU . 9.9 m-85 -95.35 147.19 23.76 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 115.291 -0.868 . . . . 0.0 108.779 175.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.455 ' HB3' ' CG ' ' A' ' 75' ' ' ASN . 30.5 t -75.95 149.31 37.69 Favored 'General case' 0 N--CA 1.416 -2.171 0 N-CA-C 105.299 -2.112 . . . . 0.0 105.299 169.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.444 ' O ' ' HG3' ' A' ' 77' ' ' GLU . 0.2 OUTLIER -50.33 -44.92 54.54 Favored 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 123.946 0.898 . . . . 0.0 110.339 -173.356 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.423 ' HA ' ' OE1' ' A' ' 77' ' ' GLU . 17.5 t-80 -84.87 -12.55 53.25 Favored 'General case' 0 N--CA 1.428 -1.568 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.936 -173.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.455 ' CG ' ' HB3' ' A' ' 72' ' ' SER . 6.5 m120 -71.58 -45.41 62.29 Favored 'General case' 0 CA--C 1.48 -1.718 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 179.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.57 ' HB3' HG13 ' A' ' 49' ' ' VAL . . . -63.88 -41.52 97.71 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 114.477 -1.238 . . . . 0.0 109.44 179.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.444 ' HG3' ' O ' ' A' ' 73' ' ' ARG . 47.9 mt-10 -61.26 -36.09 79.04 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-O 121.53 0.681 . . . . 0.0 110.508 176.136 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 62.7 ttp180 -72.75 -23.79 60.87 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.63 -177.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.3 tt -79.8 -44.36 20.76 Favored 'General case' 0 N--CA 1.419 -1.98 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.175 -178.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.434 ' HB3' ' HE2' ' A' ' 45' ' ' MET . 76.3 m-85 -63.13 -21.47 66.21 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 175.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.416 ' O ' HG13 ' A' ' 84' ' ' ILE . 22.6 mmtm -82.49 -28.19 31.32 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.814 176.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 45.8 tptt -70.29 -44.0 69.24 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 175.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.448 ' HB3' HD23 ' A' ' 89' ' ' LEU . 94.3 mt -62.24 -33.63 74.95 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 114.782 -1.099 . . . . 0.0 113.533 178.138 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.543 HG21 ' HG3' ' A' ' 91' ' ' GLU . 2.5 pp -75.56 -25.77 17.85 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.643 0 C-N-CA 119.716 -0.794 . . . . 0.0 111.506 178.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 52.4 mt -72.12 -49.06 39.15 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 121.034 0.445 . . . . 0.0 110.693 176.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.52 -14.2 61.17 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.267 -179.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.437 ' HG2' ' HB3' ' A' ' 109' ' ' ASN . 0.0 OUTLIER 83.96 13.45 0.32 Allowed 'General case' 0 CA--C 1.501 -0.915 0 C-N-CA 125.432 1.493 . . . . 0.0 112.153 167.761 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 1.8 mp -65.38 -41.65 91.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 169.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.449 ' HB3' HG22 ' A' ' 84' ' ' ILE . 3.3 mm? -103.88 148.01 26.65 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 114.107 -1.406 . . . . 0.0 110.466 174.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -132.76 127.84 35.53 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.386 177.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.543 ' HG3' HG21 ' A' ' 84' ' ' ILE . 46.2 mt-10 -94.53 137.16 33.98 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-O 121.264 0.554 . . . . 0.0 110.978 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -98.36 144.47 27.71 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 114.585 -1.189 . . . . 0.0 108.924 -179.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 91.1 mt -104.59 97.88 7.73 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 121.881 0.848 . . . . 0.0 110.528 -178.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.405 ' O ' ' HB1' ' A' ' 101' ' ' ALA . 32.7 t80 -100.14 111.68 23.97 Favored 'General case' 0 C--N 1.282 -2.357 0 CA-C-N 114.443 -1.253 . . . . 0.0 108.09 -177.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.67 ' HA ' ' CB ' ' A' ' 101' ' ' ALA . 1.8 tt -132.3 141.88 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.844 0 O-C-N 123.597 0.56 . . . . 0.0 111.162 174.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -99.32 171.38 8.01 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 177.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -67.8 26.4 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -172.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.448 ' O ' ' HG3' ' A' ' 100' ' ' GLN . 15.3 m120 -119.0 -4.95 10.57 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 177.114 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 57.38 33.03 22.71 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 122.802 1.287 . . . . 0.0 110.718 -174.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.448 ' HG3' ' O ' ' A' ' 98' ' ' ASN . 27.3 mt-30 -128.53 87.19 2.55 Favored 'General case' 0 CA--C 1.495 -1.151 0 CA-C-N 114.023 -1.444 . . . . 0.0 108.744 -177.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.67 ' CB ' ' HA ' ' A' ' 95' ' ' ILE . . . -159.39 -177.86 6.73 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -175.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 10.6 tp -139.42 167.75 19.45 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.332 0 O-C-N 123.366 0.416 . . . . 0.0 110.436 -170.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -84.74 141.18 30.73 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 122.945 0.498 . . . . 0.0 110.556 179.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -111.8 167.72 10.14 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.21 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 14.7 t -98.27 129.65 48.21 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -177.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 26.3 mmt -136.33 163.45 30.41 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 113.774 -1.557 . . . . 0.0 107.943 176.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.486 ' HB3' ' CB ' ' A' ' 111' ' ' ALA . 7.7 mp -115.19 124.35 51.19 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 176.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -131.8 -102.86 0.89 Allowed Glycine 0 N--CA 1.434 -1.481 0 C-N-CA 118.592 -1.765 . . . . 0.0 116.316 -173.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.437 ' HB3' ' HG2' ' A' ' 87' ' ' LYS . 45.1 t-20 -58.24 -45.71 87.27 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.554 1.142 . . . . 0.0 113.693 -165.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.516 ' HD3' ' OG1' ' A' ' 113' ' ' THR . 19.8 mmtm -111.16 13.81 21.82 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -178.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.486 ' CB ' ' HB3' ' A' ' 107' ' ' LEU . . . -70.6 -38.5 74.01 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.693 0.758 . . . . 0.0 109.681 177.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.409 HE21 ' C ' ' A' ' 112' ' ' GLN . 0.0 OUTLIER -64.19 -30.64 71.69 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.882 0.848 . . . . 0.0 109.246 176.335 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.516 ' OG1' ' HD3' ' A' ' 110' ' ' LYS . 17.2 m -74.53 -25.65 59.47 Favored 'General case' 0 N--CA 1.424 -1.772 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.329 -178.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.508 ' HA ' ' HG ' ' A' ' 119' ' ' LEU . 63.4 t -66.15 -44.83 91.49 Favored 'Isoleucine or valine' 0 C--O 1.248 0.998 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 174.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 59.3 mt -63.74 -42.05 97.94 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.919 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -72.3 -14.3 61.71 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.618 177.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 83.43 11.6 79.98 Favored Glycine 0 C--O 1.213 -1.161 0 C-N-CA 120.685 -0.769 . . . . 0.0 113.65 176.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -95.92 23.27 6.5 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 122.562 1.172 . . . . 0.0 109.481 -176.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.538 ' O ' HD13 ' A' ' 119' ' ' LEU . 0.0 OUTLIER -103.39 101.33 11.23 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-O 122.926 1.346 . . . . 0.0 108.647 -178.474 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.802 ' HA ' HG22 ' A' ' 12' ' ' THR . 0.0 OUTLIER -128.94 96.55 4.38 Favored 'General case' 1 C--N 1.229 -4.668 0 CA-C-N 115.021 -0.99 . . . . 0.0 112.957 175.512 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 5.8 m -114.13 173.45 3.16 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.777 -178.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -104.94 160.62 14.88 Favored 'General case' 0 C--N 1.277 -2.545 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.967 -179.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -158.06 135.12 10.0 Favored 'General case' 0 C--O 1.25 1.095 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.788 172.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 17.6 tmm? . . . . . 0 N--CA 1.434 -1.26 0 CA-C-N 115.132 -0.94 . . . . 0.0 108.651 -179.285 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 28.9 mmt180 . . . . . 0 CA--C 1.501 -0.924 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -118.68 108.51 15.0 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.438 HG22 ' HB2' ' A' ' 123' ' ' PHE . 12.8 m -101.61 101.3 11.91 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.167 0 CA-C-O 122.271 1.034 . . . . 0.0 110.002 177.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.678 HG22 ' HA ' ' A' ' 120' ' ' LYS . 42.9 p -120.17 -40.2 2.73 Favored 'General case' 0 C--N 1.264 -3.134 0 C-N-CA 119.494 -0.882 . . . . 0.0 109.8 177.154 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -69.35 -40.62 77.41 Favored 'General case' 0 C--N 1.29 -1.982 0 C-N-CA 125.867 1.667 . . . . 0.0 109.643 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -68.78 -45.29 71.72 Favored 'General case' 0 C--O 1.244 0.776 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 87.2 t -67.38 -40.83 85.48 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 CA-C-N 114.063 -1.426 . . . . 0.0 111.765 -177.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -65.31 -36.93 85.56 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 43.4 t -61.27 -46.76 89.02 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 175.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 68.6 mt -56.0 -54.11 30.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 C-N-CA 123.072 0.549 . . . . 0.0 110.399 177.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 71.7 t -59.4 -44.03 91.68 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.789 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.859 -178.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 19.6 ttt180 -61.51 -45.86 92.44 Favored 'General case' 0 N--CA 1.436 -1.13 0 C-N-CA 120.0 -0.68 . . . . 0.0 110.847 179.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -63.15 -42.83 99.53 Favored 'General case' 0 CA--C 1.5 -0.943 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 28.2 m -72.89 -33.47 43.62 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 C-N-CA 119.909 -0.716 . . . . 0.0 111.006 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -65.98 -54.86 20.72 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 121.164 -0.214 . . . . 0.0 110.796 173.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 . . . . . 0 N--CA 1.467 0.392 0 CA-C-O 121.365 0.602 . . . . 0.0 111.114 -177.278 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 . . . . . 0 N--CA 1.436 -1.144 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.418 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 57.6 p -116.37 158.02 24.14 Favored 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 171.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.45 ' O ' HG23 ' A' ' 49' ' ' VAL . 21.2 ptm -54.91 -37.85 66.88 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 120.283 -0.567 . . . . 0.0 111.634 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -66.05 -36.02 82.12 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 46.0 mtt -66.94 -42.97 84.37 Favored 'General case' 0 CA--C 1.497 -1.09 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 44' ' ' THR . 80.8 mt -59.34 -45.58 90.98 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.111 -178.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 45' ' ' MET . 82.2 t -66.43 -52.78 42.95 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.137 0 C-N-CA 123.908 0.883 . . . . 0.0 111.311 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.16 -39.79 87.65 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.182 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.514 HD12 ' HA ' ' A' ' 58' ' ' ALA . 1.8 mp -71.6 -38.73 68.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 O-C-N 121.984 -0.447 . . . . 0.0 111.402 177.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.487 ' CE2' ' HA3' ' A' ' 68' ' ' GLY . 60.2 t80 -55.47 -37.71 68.16 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 124.111 0.964 . . . . 0.0 111.293 -178.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.5 mp -92.7 -25.85 18.04 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 177.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.33 50.23 4.61 Favored Glycine 0 C--O 1.22 -0.731 0 N-CA-C 108.694 -1.762 . . . . 0.0 108.694 -172.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 47.6 t -97.56 -170.24 1.97 Allowed 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 124.535 1.134 . . . . 0.0 112.92 -171.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.507 ' NZ ' ' HB2' ' A' ' 56' ' ' LYS . 6.2 mtmp? -43.55 -53.69 5.42 Favored 'General case' 0 C--O 1.247 0.925 0 C-N-CA 128.137 2.575 . . . . 0.0 112.282 -178.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.5 m -94.46 9.05 39.95 Favored 'General case' 0 N--CA 1.417 -2.087 0 CA-C-N 114.54 -1.209 . . . . 0.0 111.406 -171.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.532 ' HB1' ' HE2' ' A' ' 65' ' ' PHE . . . -82.41 91.12 6.78 Favored 'General case' 0 N--CA 1.399 -2.998 0 CA-C-O 121.918 0.866 . . . . 0.0 110.21 178.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.542 ' HA ' HE22 ' A' ' 61' ' ' GLN . 62.7 mttp -119.96 24.11 10.68 Favored 'General case' 0 C--N 1.287 -2.148 0 CA-C-N 114.622 -1.172 . . . . 0.0 109.519 179.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.458 ' HB ' HG12 ' A' ' 51' ' ' ILE . 1.9 mp -105.39 -55.4 5.66 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 CA-C-N 115.356 -0.838 . . . . 0.0 113.028 -178.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.542 HE22 ' HA ' ' A' ' 59' ' ' LYS . 26.2 mp0 67.22 -7.73 0.5 Allowed 'General case' 0 N--CA 1.507 2.376 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 175.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.423 ' H ' HG22 ' A' ' 60' ' ' ILE . 12.6 m -94.59 84.71 4.33 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-O 120.765 0.317 . . . . 0.0 110.449 -179.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 101.67 138.74 10.29 Favored Glycine 0 N--CA 1.437 -1.246 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.024 178.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . 0.258 10.8 pt 49.45 14.92 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 N-CA-C 116.217 1.932 . . . . 0.0 116.217 177.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.539 ' CD2' ' HA ' ' A' ' 61' ' ' GLN . 27.9 t80 -75.5 104.88 6.25 Favored 'General case' 0 N--CA 1.419 -1.987 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -177.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 88.48 12.62 64.6 Favored Glycine 0 N--CA 1.437 -1.264 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.186 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.61 -34.53 77.19 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 -179.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.487 ' HA3' ' CE2' ' A' ' 52' ' ' PHE . . . -134.27 48.92 0.92 Allowed Glycine 0 N--CA 1.421 -2.324 0 C-N-CA 119.628 -1.272 . . . . 0.0 112.536 -175.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 19.9 m -71.36 4.27 3.06 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 120.975 0.417 . . . . 0.0 111.804 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -102.97 1.35 33.53 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-O 121.325 0.584 . . . . 0.0 109.99 177.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -95.26 160.11 14.69 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 174.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 41.2 t -88.75 169.98 11.17 Favored 'General case' 0 N--CA 1.411 -2.417 0 N-CA-C 103.901 -2.629 . . . . 0.0 103.901 165.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.53 ' O ' ' HG3' ' A' ' 77' ' ' GLU . 10.9 ptm180 -64.96 -27.37 68.79 Favored 'General case' 0 C--O 1.2 -1.536 0 C-N-CA 118.462 -1.295 . . . . 0.0 110.166 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.668 ' O ' ' HG2' ' A' ' 78' ' ' ARG . 34.2 m170 -57.34 -59.74 4.68 Favored 'General case' 0 C--O 1.209 -1.065 0 O-C-N 124.169 0.918 . . . . 0.0 112.439 -177.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.642 ' HA ' ' CG ' ' A' ' 78' ' ' ARG 0.398 12.9 m-80 -64.18 -28.0 69.46 Favored 'General case' 0 CA--C 1.485 -1.529 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 177.715 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.4 -50.59 72.24 Favored 'General case' 0 N--CA 1.439 -1.001 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 171.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.65 ' O ' ' HG2' ' A' ' 81' ' ' LYS . 42.9 mt-10 -56.83 -42.81 80.3 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.599 0.759 . . . . 0.0 111.078 177.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.668 ' HG2' ' O ' ' A' ' 74' ' ' HIS . 13.1 mmt85 -59.13 -36.41 75.18 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -175.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -77.57 -47.45 19.4 Favored 'General case' 0 CA--C 1.47 -2.125 0 CA-C-N 114.675 -1.148 . . . . 0.0 111.84 -172.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -62.91 -20.75 65.48 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 121.594 0.711 . . . . 0.0 109.207 178.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.65 ' HG2' ' O ' ' A' ' 77' ' ' GLU . 30.6 mmmt -88.87 -26.13 21.78 Favored 'General case' 0 N--CA 1.436 -1.133 0 C-N-CA 118.938 -1.105 . . . . 0.0 109.669 179.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 29.8 tptp -69.74 -45.69 67.58 Favored 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 177.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.408 ' HB3' HD23 ' A' ' 89' ' ' LEU . 95.8 mt -56.71 -40.77 76.23 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-N 114.086 -1.415 . . . . 0.0 113.581 177.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.605 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 2.5 pp -78.11 -18.12 13.77 Favored 'Isoleucine or valine' 0 C--O 1.254 1.342 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 179.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 46.9 mt -81.59 -48.66 11.48 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.49 175.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -66.49 -33.84 76.6 Favored 'General case' 0 C--O 1.249 1.042 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.629 ' HB3' ' HB2' ' A' ' 109' ' ' ASN 0.274 57.8 mttm 84.78 27.71 0.07 Allowed 'General case' 0 CA--C 1.454 -2.712 0 C-N-CA 126.524 1.93 . . . . 0.0 115.181 174.792 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.535 HG23 HG21 ' A' ' 114' ' ' VAL . 1.8 mp -67.75 -36.37 75.7 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.274 0 N-CA-C 105.111 -2.181 . . . . 0.0 105.111 164.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.605 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 4.4 mm? -110.94 151.68 27.64 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 114.005 -1.452 . . . . 0.0 108.318 171.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -141.43 111.95 7.01 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 177.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -92.46 143.23 26.57 Favored 'General case' 0 C--N 1.278 -2.518 0 CA-C-O 121.676 0.751 . . . . 0.0 111.439 -176.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -98.51 113.07 24.94 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 114.726 -1.125 . . . . 0.0 109.496 -178.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 72.1 mt -78.0 113.93 16.38 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 114.673 -1.149 . . . . 0.0 109.745 -178.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 92.0 t80 -119.46 100.04 7.05 Favored 'General case' 0 N--CA 1.417 -2.076 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 178.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.867 ' HA ' ' HB3' ' A' ' 101' ' ' ALA . 0.3 OUTLIER -130.89 144.05 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.388 -3.537 0 C-N-CA 119.409 -0.917 . . . . 0.0 109.467 -178.672 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.441 ' H ' HD13 ' A' ' 95' ' ' ILE . 40.3 p30 -100.84 -178.92 3.91 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 120.306 -0.558 . . . . 0.0 111.453 -176.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -80.32 15.5 1.57 Allowed 'General case' 0 C--N 1.316 -0.874 0 C-N-CA 123.841 0.856 . . . . 0.0 111.275 -178.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.479 ' HB3' ' NE2' ' A' ' 100' ' ' GLN . 2.6 m-20 -117.54 -0.4 11.91 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 58.92 27.22 15.93 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 124.548 1.155 . . . . 0.0 110.17 -174.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.479 ' NE2' ' HB3' ' A' ' 98' ' ' ASN . 42.0 mt-30 -128.94 68.63 1.4 Allowed 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.756 -1.111 . . . . 0.0 111.933 -174.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.867 ' HB3' ' HA ' ' A' ' 95' ' ' ILE . . . -158.43 178.85 9.7 Favored 'General case' 0 C--N 1.273 -2.723 0 CA-C-N 114.577 -1.192 . . . . 0.0 108.42 178.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 14.7 tt -140.57 157.15 23.94 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.973 0 CA-C-N 118.708 0.685 . . . . 0.0 112.196 -170.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -85.64 135.02 33.96 Favored 'General case' 0 C--O 1.255 1.38 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.758 176.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -103.65 165.76 10.84 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 54.0 t -111.92 135.23 51.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -176.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 14.6 mmt -138.61 -173.59 3.59 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 113.463 -1.699 . . . . 0.0 107.775 176.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -137.26 138.21 39.84 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 177.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -145.52 -84.6 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.893 0 C-N-CA 118.313 -1.899 . . . . 0.0 116.456 -174.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.629 ' HB2' ' HB3' ' A' ' 87' ' ' LYS . 29.4 m-80 -56.57 -50.46 71.86 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 -166.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 40.0 mmtm -104.06 3.89 33.73 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.615 -0.678 . . . . 0.0 110.554 -176.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -58.31 -31.68 67.74 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 123.022 0.529 . . . . 0.0 112.29 -178.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -70.59 -26.22 63.42 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-O 121.57 0.7 . . . . 0.0 110.112 179.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 4.8 m -80.0 -23.88 41.23 Favored 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.535 HG21 HG23 ' A' ' 88' ' ' ILE . 54.5 t -67.9 -36.13 74.61 Favored 'Isoleucine or valine' 0 C--O 1.246 0.918 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 174.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 75.2 mt -73.22 -34.92 66.18 Favored 'General case' 0 C--O 1.216 -0.696 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.661 177.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -72.32 -14.51 61.76 Favored 'General case' 0 C--O 1.217 -0.629 0 CA-C-O 122.211 1.005 . . . . 0.0 108.709 175.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 94.18 -19.02 55.6 Favored Glycine 0 N--CA 1.44 -1.092 0 CA-C-N 115.186 -0.915 . . . . 0.0 113.163 176.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -87.63 66.57 8.97 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.738 0.78 . . . . 0.0 111.738 -173.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.47 ' O ' HD22 ' A' ' 119' ' ' LEU . 0.0 OUTLIER -126.75 79.44 1.87 Allowed 'General case' 0 C--N 1.288 -2.096 0 CA-C-O 123.636 1.684 . . . . 0.0 110.628 175.675 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.678 ' HA ' HG22 ' A' ' 12' ' ' THR . 0.0 OUTLIER -101.14 96.32 7.13 Favored 'General case' 0 C--N 1.264 -3.136 0 CA-C-N 114.587 -1.188 . . . . 0.0 112.136 174.877 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 5.9 m -93.25 172.34 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.138 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 177.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -110.98 163.87 13.38 Favored 'General case' 0 C--N 1.263 -3.161 0 CA-C-N 115.178 -0.919 . . . . 0.0 108.77 178.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . 0.438 ' HB2' HG22 ' A' ' 11' ' ' VAL . 38.3 t80 -153.64 174.97 13.79 Favored 'General case' 0 N--CA 1.424 -1.769 0 CA-C-O 121.69 0.757 . . . . 0.0 111.287 -179.133 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 60.2 mtt . . . . . 0 N--CA 1.426 -1.632 0 C-N-CA 126.152 1.781 . . . . 0.0 108.137 -179.25 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 74.0 mtt180 . . . . . 0 N--CA 1.428 -1.555 0 CA-C-O 121.237 0.542 . . . . 0.0 111.334 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -78.26 89.62 4.32 Favored 'General case' 0 CA--C 1.491 -1.303 0 CA-C-O 122.408 1.099 . . . . 0.0 109.854 -178.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.512 HG13 ' HB2' ' A' ' 14' ' ' ASP . 21.3 t -84.88 103.99 12.59 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.689 0 CA-C-N 113.395 -1.73 . . . . 0.0 109.772 -177.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.618 HG22 ' HA ' ' A' ' 120' ' ' LYS . 21.5 p -121.01 -50.41 2.16 Favored 'General case' 0 N--CA 1.413 -2.31 0 C-N-CA 117.758 -1.577 . . . . 0.0 112.482 175.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.438 ' HA ' ' CB ' ' A' ' 16' ' ' LYS . 0.3 OUTLIER -87.37 -11.91 47.92 Favored 'General case' 0 N--CA 1.426 -1.675 0 C-N-CA 119.126 -1.03 . . . . 0.0 112.304 -173.843 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.512 ' HB2' HG13 ' A' ' 11' ' ' VAL . 0.7 OUTLIER -65.85 -52.35 51.16 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 103.978 -2.601 . . . . 0.0 103.978 169.195 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.51 HG23 HG12 ' A' ' 11' ' ' VAL . 31.3 t -56.77 -44.2 81.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 113.581 -1.645 . . . . 0.0 111.337 174.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.447 ' HE2' ' O ' ' A' ' 114' ' ' VAL . 2.0 tppp? -57.78 -45.28 86.21 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.788 177.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 53.4 m -61.78 -41.58 97.89 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.5 178.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.431 ' HB ' ' O ' ' A' ' 15' ' ' VAL . 66.2 mt -53.63 -52.64 31.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 O-C-N 123.748 0.655 . . . . 0.0 109.459 173.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.495 HG21 HG11 ' A' ' 114' ' ' VAL . 93.0 t -57.78 -45.05 87.13 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.576 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.74 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.436 ' HG3' ' O ' ' A' ' 16' ' ' LYS . 64.3 mtt85 -53.52 -45.72 69.87 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.151 0.501 . . . . 0.0 110.728 178.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.541 ' HA ' ' HG3' ' A' ' 24' ' ' GLU . 77.1 m-85 -83.18 -33.88 26.1 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 -174.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.42 HG22 ' O ' ' A' ' 18' ' ' ILE . 27.0 m -73.25 -31.77 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.521 0 C-N-CA 118.376 -1.329 . . . . 0.0 110.107 177.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -59.97 -48.73 80.5 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.194 174.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.541 ' HG3' ' HA ' ' A' ' 21' ' ' PHE . 1.5 pp20? . . . . . 0 C--O 1.238 0.453 0 C-N-CA 120.292 -0.563 . . . . 0.0 112.111 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 . . . . . 0 CA--C 1.485 -1.532 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.684 ' HA ' ' HA ' ' A' ' 104' ' ' TYR . 55.4 p -82.13 155.55 24.96 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 175.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.592 ' O ' HG23 ' A' ' 49' ' ' VAL . 5.8 ptm -52.34 -35.67 51.59 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-O 121.427 0.632 . . . . 0.0 110.124 177.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.539 ' N ' ' HG3' ' A' ' 45' ' ' MET . 22.7 t-20 -63.22 -40.09 96.49 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.439 -1.255 . . . . 0.0 110.839 -175.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . 0.538 ' HG3' ' OG1' ' A' ' 44' ' ' THR . 64.5 mtt -69.27 -36.44 77.1 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-O 121.554 0.692 . . . . 0.0 109.928 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 82.3 mt -67.91 -33.74 75.28 Favored 'General case' 0 C--O 1.206 -1.186 0 CA-C-N 114.992 -1.004 . . . . 0.0 111.227 -178.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.596 HG21 ' HG2' ' A' ' 77' ' ' GLU . 88.1 t -67.96 -38.88 80.69 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.016 0 C-N-CA 123.355 0.662 . . . . 0.0 110.303 178.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -53.69 -47.5 70.41 Favored 'General case' 0 CA--C 1.506 -0.732 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.128 175.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.46 HG23 ' HD2' ' A' ' 65' ' ' PHE . 4.9 mt -76.83 -38.58 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.524 0 CA-C-N 114.717 -1.129 . . . . 0.0 111.738 -176.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.464 ' CE2' ' HA3' ' A' ' 68' ' ' GLY . 60.5 t80 -53.1 -48.08 68.09 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 125.019 1.328 . . . . 0.0 110.733 179.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.9 mp -77.52 -12.12 59.93 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.085 -0.507 . . . . 0.0 112.302 178.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.95 26.97 54.68 Favored Glycine 0 C--O 1.249 1.066 0 C-N-CA 120.915 -0.659 . . . . 0.0 111.702 -179.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 40.2 t -67.29 176.4 2.27 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-O 121.797 0.808 . . . . 0.0 111.048 -176.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.474 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 0.7 OUTLIER -106.8 6.63 29.69 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 122.055 0.931 . . . . 0.0 110.117 176.592 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 27.8 p -90.89 1.21 57.17 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 169.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.74 117.41 8.85 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-N 113.69 -1.596 . . . . 0.0 108.893 178.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 43.0 mttp -81.52 -11.83 59.04 Favored 'General case' 0 C--N 1.29 -2.02 0 CA-C-N 114.801 -1.09 . . . . 0.0 111.862 -172.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 66.7 mt -143.42 138.3 26.04 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.94 0 N-CA-C 105.953 -1.869 . . . . 0.0 105.953 175.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.597 ' HA ' ' CE2' ' A' ' 65' ' ' PHE . 25.6 mm-40 -93.6 44.78 1.14 Allowed 'General case' 0 C--N 1.3 -1.584 0 CA-C-O 120.993 0.425 . . . . 0.0 110.5 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 42.2 m -153.95 153.03 31.28 Favored 'General case' 0 C--O 1.245 0.844 0 O-C-N 122.026 -0.421 . . . . 0.0 110.203 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 80.92 109.29 0.31 Allowed Glycine 0 C--O 1.2 -2.014 0 CA-C-O 119.393 -0.671 . . . . 0.0 111.599 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . 0.275 3.7 pt 51.94 17.59 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 C-N-CA 125.007 1.323 . . . . 0.0 114.494 -176.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.597 ' CE2' ' HA ' ' A' ' 61' ' ' GLN . 18.3 t80 -62.68 107.53 0.98 Allowed 'General case' 0 C--O 1.252 1.222 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.515 -176.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 64.29 41.65 98.13 Favored Glycine 0 N--CA 1.434 -1.452 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.408 178.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.421 ' HD3' ' HA ' ' A' ' 67' ' ' LYS . 28.3 mmtm -114.86 -3.98 12.68 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.22 0.533 . . . . 0.0 111.017 177.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.464 ' HA3' ' CE2' ' A' ' 52' ' ' PHE . . . -133.51 30.32 3.02 Favored Glycine 0 N--CA 1.425 -2.055 0 N-CA-C 110.19 -1.164 . . . . 0.0 110.19 176.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 16.5 m -70.35 2.16 4.15 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 123.91 0.884 . . . . 0.0 112.417 -176.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -98.74 7.19 46.36 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-O 122.081 0.944 . . . . 0.0 109.199 176.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -108.28 146.65 32.59 Favored 'General case' 0 N--CA 1.418 -2.04 0 CA-C-N 114.675 -1.148 . . . . 0.0 108.825 177.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 44.6 t -86.15 169.21 13.3 Favored 'General case' 0 C--N 1.288 -2.081 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 171.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.429 HH21 ' ND2' ' A' ' 46' ' ' ASN . 11.3 tpt180 -58.77 -35.18 72.36 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 177.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 23.2 t-80 -61.61 -40.17 93.88 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 113.487 -1.688 . . . . 0.0 110.26 178.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -80.97 -49.89 10.39 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.522 -172.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.405 ' O ' ' HD2' ' A' ' 80' ' ' PHE . . . -59.31 -48.99 79.55 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.136 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.625 ' O ' ' HG3' ' A' ' 81' ' ' LYS . 18.3 mt-10 -65.16 -34.31 78.09 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 70.2 ttt180 -69.32 -28.61 66.39 Favored 'General case' 0 CA--C 1.521 -0.149 0 C-N-CA 119.432 -0.907 . . . . 0.0 109.476 -177.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.0 tt -78.77 -48.55 14.62 Favored 'General case' 0 N--CA 1.422 -1.832 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.569 -178.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.425 ' HA ' HD12 ' A' ' 83' ' ' LEU . 58.1 m-85 -59.54 -21.27 60.01 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-O 121.397 0.617 . . . . 0.0 110.235 177.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.625 ' HG3' ' O ' ' A' ' 77' ' ' GLU . 46.2 mttm -85.35 -26.29 26.59 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 119.208 -0.997 . . . . 0.0 109.097 179.116 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 58.9 tttp -73.34 -38.55 65.72 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 175.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.425 HD12 ' HA ' ' A' ' 80' ' ' PHE . 95.7 mt -58.05 -37.36 74.25 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 177.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.508 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 2.4 pp -75.86 -26.21 17.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 120.232 -0.587 . . . . 0.0 111.626 177.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 51.4 mt -74.97 -49.38 20.19 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.555 175.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -70.49 -24.11 62.79 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.578 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.288 50.6 mttm 83.23 24.07 0.14 Allowed 'General case' 0 CA--C 1.469 -2.171 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 172.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.418 HG23 HG21 ' A' ' 114' ' ' VAL . 2.0 mp -69.74 -39.95 78.6 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.273 0 N-CA-C 105.117 -2.179 . . . . 0.0 105.117 165.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.508 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 4.3 mm? -111.6 150.04 30.63 Favored 'General case' 0 CA--C 1.498 -1.041 0 CA-C-N 114.067 -1.424 . . . . 0.0 108.271 173.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -137.77 110.61 7.66 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.472 ' HA ' ' O ' ' A' ' 104' ' ' TYR . 38.8 mt-10 -95.35 147.52 23.42 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 177.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.565 ' O ' ' HA ' ' A' ' 103' ' ' ALA . 16.8 t70 -97.48 142.8 28.88 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.729 -1.123 . . . . 0.0 108.825 178.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 94.7 mt -103.75 101.72 11.55 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-O 121.971 0.891 . . . . 0.0 110.144 -178.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 72.0 t80 -107.74 115.65 30.54 Favored 'General case' 0 C--N 1.275 -2.658 0 CA-C-N 114.252 -1.34 . . . . 0.0 108.331 -175.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.411 HG13 ' C ' ' A' ' 100' ' ' GLN . 17.1 tt -121.23 141.69 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.657 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.459 ' C ' ' H ' ' A' ' 98' ' ' ASN . 13.1 m-80 -97.44 -171.79 2.27 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -179.016 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -73.5 21.66 0.08 Allowed 'General case' 0 C--N 1.311 -1.094 0 C-N-CA 125.337 1.455 . . . . 0.0 111.203 178.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.459 ' H ' ' C ' ' A' ' 96' ' ' ASN . 14.8 m120 -119.29 -2.64 10.61 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 108.866 -0.791 . . . . 0.0 108.866 -178.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 59.42 25.45 14.2 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-O 122.832 1.301 . . . . 0.0 110.257 -172.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.411 ' C ' HG13 ' A' ' 95' ' ' ILE . 26.0 mt-30 -100.05 108.65 20.88 Favored 'General case' 0 C--O 1.251 1.132 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 177.047 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -96.52 142.48 28.54 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 124.051 0.845 . . . . 0.0 111.567 -176.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 10.5 tp -131.44 145.21 35.56 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 174.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.565 ' HA ' ' O ' ' A' ' 92' ' ' ASP . . . -113.5 138.76 49.66 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.684 ' HA ' ' HA ' ' A' ' 44' ' ' THR . 24.8 p90 -134.74 163.47 29.71 Favored 'General case' 0 CA--C 1.496 -1.108 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 176.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.491 HG13 HD12 ' A' ' 89' ' ' LEU . 6.7 t -94.83 134.06 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.636 0 N-CA-C 115.112 1.523 . . . . 0.0 115.112 -163.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 68.9 mtm -140.69 168.92 18.65 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 111.422 -2.626 . . . . 0.0 105.14 173.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 7.0 mp -90.77 136.69 32.9 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 -179.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -91.57 -178.58 42.49 Favored Glycine 0 N--CA 1.438 -1.232 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.506 -176.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -70.23 -13.3 62.11 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -176.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.434 ' O ' HG23 ' A' ' 114' ' ' VAL . 46.9 mmtt -93.73 -3.65 51.85 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 178.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -62.01 -29.39 70.23 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.969 0.414 . . . . 0.0 111.223 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.442 ' HA ' ' HG ' ' A' ' 115' ' ' LEU . 0.0 OUTLIER -72.35 -31.96 66.07 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 120.218 -0.593 . . . . 0.0 110.247 179.673 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 9.9 m -72.87 -25.72 61.2 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -178.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.495 HG11 HG21 ' A' ' 19' ' ' VAL . 22.0 t -72.1 -42.91 67.38 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.244 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.681 177.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.442 ' HG ' ' HA ' ' A' ' 112' ' ' GLN . 4.6 pp -67.87 -33.73 75.31 Favored 'General case' 0 CA--C 1.51 -0.57 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.969 178.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -71.41 -27.8 63.56 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 172.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 73.49 21.76 79.21 Favored Glycine 0 CA--C 1.495 -1.179 0 CA-C-N 115.333 -0.849 . . . . 0.0 112.36 177.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -97.33 35.51 1.61 Allowed 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 104.95 -2.241 . . . . 0.0 104.95 177.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.451 HD13 ' C ' ' A' ' 119' ' ' LEU . 0.4 OUTLIER -142.42 124.91 15.7 Favored 'General case' 0 N--CA 1.381 -3.906 0 CA-C-N 113.037 -1.892 . . . . 0.0 107.165 -174.241 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.618 ' HA ' HG22 ' A' ' 12' ' ' THR . 0.2 OUTLIER -129.87 132.84 46.56 Favored 'General case' 0 N--CA 1.393 -3.295 0 N-CA-C 106.795 -1.558 . . . . 0.0 106.795 172.089 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.508 HG22 ' O ' ' A' ' 11' ' ' VAL . 14.0 m -106.51 -178.81 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 C-N-CA 118.528 -1.269 . . . . 0.0 107.924 174.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -129.28 134.07 47.77 Favored 'General case' 0 C--N 1.254 -3.573 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 178.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -107.32 113.54 26.99 Favored 'General case' 0 C--N 1.273 -2.719 0 C-N-CA 118.95 -1.1 . . . . 0.0 110.545 171.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 17.3 ptp . . . . . 0 C--N 1.295 -1.795 0 CA-C-N 113.453 -1.703 . . . . 0.0 108.847 176.496 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 54.6 ttt180 . . . . . 0 N--CA 1.394 -3.253 0 N-CA-C 104.037 -2.579 . . . . 0.0 104.037 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.467 ' CG ' ' HZ1' ' A' ' 120' ' ' LYS . 1.9 t70 -77.57 98.78 5.5 Favored 'General case' 0 CA--C 1.488 -1.434 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -174.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.484 ' HB ' HG23 ' A' ' 15' ' ' VAL . 30.4 m -99.94 65.58 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.275 -2.648 0 CA-C-O 122.417 1.103 . . . . 0.0 112.964 -173.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.467 ' O ' ' HB2' ' A' ' 16' ' ' LYS . 2.1 t -111.53 -37.74 5.13 Favored 'General case' 0 C--N 1.263 -3.188 0 C-N-CA 119.495 -0.882 . . . . 0.0 109.001 169.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -84.83 -20.64 30.6 Favored 'General case' 0 CA--C 1.496 -1.1 0 CA-C-O 120.989 0.423 . . . . 0.0 111.221 174.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -76.24 -44.49 37.26 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 105.425 -2.065 . . . . 0.0 105.425 175.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.551 ' O ' ' HB ' ' A' ' 18' ' ' ILE . 4.9 t -64.35 -21.88 30.01 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.48 0 CA-C-N 112.938 -1.937 . . . . 0.0 111.167 174.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.636 ' HE2' ' O ' ' A' ' 114' ' ' VAL . 34.2 ttmt -75.09 -35.55 61.77 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 122.016 -0.427 . . . . 0.0 110.568 179.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 68.9 p -67.39 -31.25 71.34 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 119.358 -0.937 . . . . 0.0 108.883 173.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.551 ' HB ' ' O ' ' A' ' 15' ' ' VAL . 36.0 mt -63.62 -48.13 88.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.757 173.219 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 15' ' ' VAL . 97.2 t -56.96 -47.77 82.76 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.774 0 C-N-CA 123.289 0.636 . . . . 0.0 109.868 176.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.643 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 0.9 OUTLIER -52.61 -53.71 43.07 Favored 'General case' 0 C--O 1.22 -0.49 0 O-C-N 123.898 0.749 . . . . 0.0 109.332 176.838 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.423 ' HB2' HG13 ' A' ' 64' ' ' ILE . 83.2 t80 -52.94 -57.14 11.31 Favored 'General case' 0 N--CA 1.448 -0.545 0 O-C-N 124.424 1.078 . . . . 0.0 112.223 -178.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 27.1 m -67.78 -38.78 80.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.779 -177.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -60.33 -50.28 74.23 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 176.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.643 ' HG2' ' O ' ' A' ' 20' ' ' ARG . 10.3 pt-20 . . . . . 0 C--N 1.327 -0.41 0 C-N-CA 120.208 -0.597 . . . . 0.0 112.083 -178.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 . . . . . 0 CA--C 1.481 -1.699 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.41 HG21 HD11 ' A' ' 102' ' ' ILE . 80.2 p -120.94 157.13 30.57 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -177.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.419 ' O ' HG23 ' A' ' 49' ' ' VAL . 22.0 ptm -50.13 -39.59 43.63 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.353 0.661 . . . . 0.0 112.63 -178.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.4 ' N ' ' HG3' ' A' ' 45' ' ' MET . 18.9 t-20 -68.71 -39.29 80.52 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.156 -172.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 23.4 mmt -67.34 -38.6 85.11 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.467 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 78.7 mt -63.35 -41.95 98.89 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.247 -178.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.462 HG13 ' HB3' ' A' ' 76' ' ' ALA . 69.6 t -66.01 -45.16 91.55 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.058 0 C-N-CA 123.68 0.792 . . . . 0.0 110.679 179.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.566 ' OD2' ' HB3' ' A' ' 55' ' ' SER . 4.4 t70 -61.92 -36.78 82.39 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 114.678 -1.146 . . . . 0.0 109.626 -177.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.672 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 75.4 mt -69.54 -50.21 52.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.568 174.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.508 ' CE2' ' HA3' ' A' ' 68' ' ' GLY . 50.4 t80 -50.86 -41.21 57.74 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.446 1.098 . . . . 0.0 111.775 179.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.9 mp -80.17 -30.51 38.83 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 177.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 99.2 33.06 5.57 Favored Glycine 0 C--O 1.248 1.002 0 C-N-CA 120.166 -1.016 . . . . 0.0 112.725 -179.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.566 ' HB3' ' OD2' ' A' ' 50' ' ' ASP . 32.0 t -86.8 -176.45 5.78 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 123.291 0.636 . . . . 0.0 111.15 -176.06 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.14 9.17 17.12 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -176.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 16.9 m -89.44 -17.66 28.29 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 175.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.48 ' HB1' HG12 ' A' ' 51' ' ' ILE . . . -50.85 173.8 0.02 OUTLIER 'General case' 0 N--CA 1.432 -1.329 0 C-N-CA 128.861 2.865 . . . . 0.0 113.476 176.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.0 mmmp? -116.87 11.02 14.31 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 -179.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.429 HG22 HD13 ' A' ' 51' ' ' ILE . 15.5 tt -158.65 164.82 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 N-CA-C 104.795 -2.298 . . . . 0.0 104.795 175.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -125.74 21.96 7.58 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 119.021 0.828 . . . . 0.0 110.42 177.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 43.8 m -152.24 146.95 25.83 Favored 'General case' 0 C--N 1.322 -0.63 0 O-C-N 122.002 -0.436 . . . . 0.0 110.037 -178.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.554 ' C ' ' H ' ' A' ' 65' ' ' PHE . . . 82.15 111.37 0.42 Allowed Glycine 0 C--O 1.212 -1.28 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.632 HG22 HG22 ' A' ' 51' ' ' ILE . 3.4 mm 70.25 -18.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 CA-C-O 121.971 0.891 . . . . 0.0 111.64 -176.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.672 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 3.5 t80 -65.46 104.45 0.99 Allowed 'General case' 0 N--CA 1.399 -2.986 0 C-N-CA 125.318 1.447 . . . . 0.0 109.202 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 102.93 0.36 48.52 Favored Glycine 0 N--CA 1.434 -1.46 0 C-N-CA 120.814 -0.707 . . . . 0.0 111.713 -178.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.526 ' HG3' HD13 ' A' ' 64' ' ' ILE . 2.9 mmmp? -67.35 -19.48 65.44 Favored 'General case' 0 C--O 1.252 1.189 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.508 ' HA3' ' CE2' ' A' ' 52' ' ' PHE . . . -148.81 49.76 0.58 Allowed Glycine 0 C--O 1.207 -1.544 0 C-N-CA 120.462 -0.875 . . . . 0.0 111.644 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 16.0 m -70.6 0.78 6.18 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -178.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -100.37 -5.34 27.44 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-O 121.094 0.473 . . . . 0.0 110.303 178.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -80.41 144.11 32.92 Favored 'General case' 0 N--CA 1.428 -1.547 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.49 177.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 34.5 t -77.33 134.68 38.44 Favored 'General case' 0 N--CA 1.398 -3.029 0 N-CA-C 102.928 -2.989 . . . . 0.0 102.928 167.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.519 ' O ' ' HG3' ' A' ' 77' ' ' GLU . 10.6 ptm180 -52.12 -38.64 58.1 Favored 'General case' 0 C--O 1.202 -1.43 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -173.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.565 ' HA ' ' OE1' ' A' ' 77' ' ' GLU . 32.4 t-80 -70.86 -24.31 62.49 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 120.978 0.418 . . . . 0.0 111.475 -175.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -81.69 -38.2 26.21 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.462 ' HB3' HG13 ' A' ' 49' ' ' VAL . . . -63.29 -40.21 96.73 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 174.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.66 ' O ' ' HG2' ' A' ' 81' ' ' LYS . 80.0 mt-10 -58.15 -37.8 75.37 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.235 -0.439 . . . . 0.0 109.902 174.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 18.4 mmm180 -71.68 -23.13 61.6 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.372 -178.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.4 tt -76.38 -45.36 32.2 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 179.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -63.87 -19.53 65.13 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.432 0.634 . . . . 0.0 109.406 176.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.66 ' HG2' ' O ' ' A' ' 77' ' ' GLU . 31.3 mmmt -81.12 -28.43 35.14 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.379 176.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.43 ' HG2' ' OD2' ' A' ' 86' ' ' ASP . 58.3 tttm -74.48 -43.04 57.88 Favored 'General case' 0 C--O 1.193 -1.878 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 179.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.3 mt -58.64 -35.2 72.13 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 178.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.474 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 2.5 pp -74.67 -26.3 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.061 177.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.9 tt -76.85 -45.19 29.33 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 175.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.473 ' O ' ' HB2' ' A' ' 87' ' ' LYS . 70.9 m-20 -66.1 -29.62 69.98 Favored 'General case' 0 C--O 1.259 1.587 0 C-N-CA 123.491 0.716 . . . . 0.0 109.944 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.473 ' HB2' ' O ' ' A' ' 86' ' ' ASP . 4.4 mptp? 85.6 21.65 0.09 Allowed 'General case' 0 CA--C 1.478 -1.821 0 C-N-CA 125.252 1.421 . . . . 0.0 113.378 179.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 1.8 mp -68.62 -42.22 83.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 N-CA-C 104.8 -2.296 . . . . 0.0 104.8 164.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.474 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 90.7 mt -114.3 164.22 14.21 Favored 'General case' 0 N--CA 1.418 -2.068 0 CA-C-N 113.829 -1.532 . . . . 0.0 109.141 174.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.472 ' OD2' ' HG3' ' A' ' 87' ' ' LYS . 0.2 OUTLIER -144.44 117.79 9.04 Favored 'General case' 0 C--N 1.283 -2.305 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 172.762 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -95.02 144.38 25.74 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-O 121.598 0.713 . . . . 0.0 112.463 -178.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.477 ' O ' ' HA ' ' A' ' 103' ' ' ALA . 16.6 t70 -100.0 133.24 44.68 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 114.195 -1.366 . . . . 0.0 109.055 178.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 98.3 mt -105.64 105.62 15.75 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 121.579 0.704 . . . . 0.0 109.429 -179.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -122.36 135.42 54.7 Favored 'General case' 0 C--N 1.28 -2.427 0 CA-C-N 114.561 -1.2 . . . . 0.0 109.06 -172.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.56 HD11 ' HA ' ' A' ' 99' ' ' ASP . 16.6 tt -131.23 141.34 46.24 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.296 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 174.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.424 ' C ' ' H ' ' A' ' 98' ' ' ASN . 3.4 p-10 -96.11 172.81 7.75 Favored 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 176.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -66.67 17.97 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 -173.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.424 ' H ' ' C ' ' A' ' 96' ' ' ASN . 15.7 m120 -118.15 5.57 11.99 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.56 ' HA ' HD11 ' A' ' 95' ' ' ILE . 26.7 t70 65.97 26.47 10.93 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-O 123.531 1.634 . . . . 0.0 109.353 -177.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.492 ' C ' HG13 ' A' ' 95' ' ' ILE . 27.1 mt-30 -90.29 99.57 12.57 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.918 -1.037 . . . . 0.0 108.548 176.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -86.2 133.87 33.82 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.627 -178.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.41 HD11 HG21 ' A' ' 44' ' ' THR . 16.4 tt -141.99 143.79 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.822 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 178.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.477 ' HA ' ' O ' ' A' ' 92' ' ' ASP . . . -112.08 119.96 40.22 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 -178.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -97.38 150.58 20.84 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 52.4 t -103.74 128.86 56.62 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 CA-C-O 121.759 0.79 . . . . 0.0 112.143 -178.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 58.3 mtt -128.28 178.82 5.99 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-N 113.908 -1.496 . . . . 0.0 107.792 177.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.557 HD23 ' H ' ' A' ' 107' ' ' LEU . 1.7 pt? -99.52 137.49 37.94 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -178.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -98.21 -166.51 31.37 Favored Glycine 0 N--CA 1.439 -1.118 0 C-N-CA 120.799 -0.715 . . . . 0.0 113.158 -175.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 32.7 p30 -75.28 -2.85 30.06 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 114.147 1.165 . . . . 0.0 114.147 -175.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.512 ' O ' HG23 ' A' ' 114' ' ' VAL . 41.4 mmtm -101.98 -6.34 23.56 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 120.113 -0.635 . . . . 0.0 110.357 177.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -54.31 -43.77 71.42 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 113.623 0.972 . . . . 0.0 113.623 -172.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -73.44 -29.48 62.58 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.626 0.727 . . . . 0.0 109.701 -178.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 4.4 m -73.05 -26.19 61.2 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.585 -179.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.636 ' O ' ' HE2' ' A' ' 16' ' ' LYS . 24.9 t -68.41 -44.05 83.67 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.783 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 174.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 84.7 mt -62.39 -39.79 94.35 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.113 178.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -72.84 -19.37 61.33 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.059 175.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.458 ' C ' ' H ' ' A' ' 119' ' ' LEU . . . 60.87 30.42 72.98 Favored Glycine 0 C--O 1.212 -1.226 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.127 -177.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -95.99 22.58 7.3 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 105.862 -1.903 . . . . 0.0 105.862 174.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.468 HD13 ' C ' ' A' ' 119' ' ' LEU . 0.8 OUTLIER -141.99 122.65 14.24 Favored 'General case' 0 N--CA 1.385 -3.676 0 CA-C-N 112.229 -2.26 . . . . 0.0 105.96 -175.869 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.467 ' HZ1' ' CG ' ' A' ' 10' ' ' ASP . 0.1 OUTLIER -131.08 127.6 38.5 Favored 'General case' 0 C--N 1.283 -2.308 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 171.549 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.427 ' H ' ' HB ' ' A' ' 12' ' ' THR . 5.1 m -119.07 173.28 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.261 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 177.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -123.31 161.36 24.79 Favored 'General case' 0 C--N 1.265 -3.076 0 CA-C-N 114.971 -1.013 . . . . 0.0 112.258 -171.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -141.51 130.83 23.61 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 104.93 -2.248 . . . . 0.0 104.93 164.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 25.3 mmt . . . . . 0 C--N 1.298 -1.636 0 N-CA-C 116.229 1.937 . . . . 0.0 116.229 -163.207 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.633 HH11 ' HG3' ' A' ' 9' ' ' ARG . 41.9 mtt85 . . . . . 0 N--CA 1.422 -1.86 0 N-CA-C 106.239 -1.764 . . . . 0.0 106.239 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -78.03 89.4 4.17 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.417 HG23 HG23 ' A' ' 121' ' ' VAL . 10.6 m -79.67 89.47 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 CA-C-O 122.69 1.233 . . . . 0.0 110.36 -178.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.632 HG22 ' HA ' ' A' ' 120' ' ' LYS . 34.3 p -115.3 -33.58 5.26 Favored 'General case' 0 C--N 1.261 -3.262 0 CA-C-O 122.092 0.949 . . . . 0.0 109.378 177.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -75.62 -40.64 56.0 Favored 'General case' 0 N--CA 1.413 -2.285 0 C-N-CA 125.967 1.707 . . . . 0.0 107.894 178.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.483 ' O ' ' HB3' ' A' ' 17' ' ' SER . 16.5 t70 -74.0 -39.78 63.39 Favored 'General case' 0 CA--C 1.495 -1.164 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 74.4 t -67.6 -32.99 59.32 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.691 177.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.559 ' HE2' ' O ' ' A' ' 114' ' ' VAL . 3.3 tppp? -66.85 -43.49 83.51 Favored 'General case' 0 C--O 1.245 0.833 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 174.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.483 ' HB3' ' O ' ' A' ' 14' ' ' ASP . 32.6 t -57.09 -47.95 79.78 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 114.092 -1.413 . . . . 0.0 108.718 174.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 28.2 mt -51.36 -42.86 28.47 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.736 0 C-N-CA 124.094 0.958 . . . . 0.0 111.746 177.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.56 HG21 HG11 ' A' ' 114' ' ' VAL . 72.9 t -59.62 -45.56 94.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 179.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 31.5 ttt180 -56.72 -45.33 81.98 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.788 0.804 . . . . 0.0 109.401 173.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.775 ' CG ' ' HB ' ' A' ' 64' ' ' ILE . 47.4 m-85 -68.63 -38.25 80.36 Favored 'General case' 0 N--CA 1.422 -1.835 0 N-CA-C 115.186 1.55 . . . . 0.0 115.186 -175.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.467 HG22 ' HA ' ' A' ' 19' ' ' VAL . 20.1 m -69.69 -36.62 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.859 0 C-N-CA 119.99 -0.684 . . . . 0.0 109.892 176.322 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.42 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 14.8 mm100 -60.63 -46.79 88.95 Favored 'General case' 0 CA--C 1.55 0.956 0 O-C-N 123.83 0.706 . . . . 0.0 111.318 172.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.507 ' HG2' ' HA ' ' A' ' 21' ' ' PHE . 7.6 pt-20 . . . . . 0 C--O 1.247 0.955 0 O-C-N 121.707 -0.621 . . . . 0.0 112.473 178.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.486 ' CD1' HD21 ' A' ' 48' ' ' LEU . 2.9 p90 . . . . . 0 CA--C 1.493 -1.217 0 CA-C-O 120.501 0.191 . . . . 0.0 111.03 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 63.2 p -86.33 155.99 20.4 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 178.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.527 ' O ' HG23 ' A' ' 49' ' ' VAL . 19.2 ptt? -48.64 -41.81 32.37 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 123.483 0.49 . . . . 0.0 111.905 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.448 ' N ' ' HG3' ' A' ' 45' ' ' MET . 14.8 m120 -67.45 -31.96 72.49 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.584 -175.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . 0.455 ' O ' HD13 ' A' ' 51' ' ' ILE . 26.3 mmt -74.88 -36.33 62.27 Favored 'General case' 0 C--O 1.203 -1.344 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.486 HD21 ' CD1' ' A' ' 43' ' ' PHE . 87.1 mt -60.75 -38.4 85.05 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.373 179.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.54 HG13 ' HB3' ' A' ' 76' ' ' ALA . 94.1 t -65.19 -41.59 92.03 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.203 0 C-N-CA 124.395 1.078 . . . . 0.0 110.861 178.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -55.38 -46.26 76.55 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.309 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.455 HD13 ' O ' ' A' ' 47' ' ' MET . 1.3 mp -70.07 -40.36 78.32 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.103 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.227 177.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -57.84 -42.29 84.13 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.735 0.814 . . . . 0.0 111.808 -175.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.408 HD11 ' HB2' ' A' ' 71' ' ' TYR . 7.9 mp -82.32 -20.17 37.9 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 178.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 96.14 32.63 6.65 Favored Glycine 0 C--N 1.313 -0.731 0 C-N-CA 120.126 -1.035 . . . . 0.0 112.257 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 31.1 t -76.55 137.41 39.55 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 177.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.496 ' HD3' ' O ' ' A' ' 56' ' ' LYS . 2.4 tmtm? -84.31 -0.87 54.14 Favored 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 119.264 -0.974 . . . . 0.0 109.537 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.0 m -77.86 -5.95 52.6 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 176.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.417 ' HB3' HE22 ' A' ' 61' ' ' GLN . . . -62.03 145.45 53.08 Favored 'General case' 0 N--CA 1.425 -1.721 0 C-N-CA 125.787 1.635 . . . . 0.0 111.173 175.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.528 ' N ' ' HD2' ' A' ' 59' ' ' LYS . 9.1 mptt -105.23 -1.57 25.17 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.447 -177.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.419 ' O ' HG13 ' A' ' 51' ' ' ILE . 60.6 mt -132.28 122.0 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.108 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -177.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.542 HE21 ' HA ' ' A' ' 61' ' ' GLN . 0.0 OUTLIER -110.01 94.37 4.98 Favored 'General case' 0 C--N 1.277 -2.585 0 C-N-CA 118.313 -1.355 . . . . 0.0 108.707 176.901 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.472 ' HB3' ' OE2' ' A' ' 24' ' ' GLU . 73.5 m -104.25 177.79 4.74 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.843 176.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -75.32 7.63 22.89 Favored Glycine 0 N--CA 1.482 1.712 0 C-N-CA 121.068 -0.587 . . . . 0.0 113.979 -176.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.775 ' HB ' ' CG ' ' A' ' 21' ' ' PHE . 6.4 tt -100.74 3.1 10.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.429 ' HB2' ' O ' ' A' ' 62' ' ' SER . 19.5 t80 -69.52 95.97 0.88 Allowed 'General case' 0 N--CA 1.42 -1.945 0 CA-C-N 114.01 -1.45 . . . . 0.0 110.01 -173.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 102.35 17.22 20.54 Favored Glycine 0 N--CA 1.419 -2.438 0 CA-C-N 114.93 -1.032 . . . . 0.0 112.638 -179.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.659 ' HE2' HG13 ' A' ' 64' ' ' ILE . 33.5 mtmt -67.97 -58.1 5.1 Favored 'General case' 0 C--N 1.353 0.751 0 C-N-CA 117.891 -1.523 . . . . 0.0 110.51 175.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -95.41 47.82 1.92 Allowed Glycine 0 N--CA 1.436 -1.353 0 CA-C-N 115.154 -0.93 . . . . 0.0 113.356 -170.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 19.6 m -71.84 -4.31 27.26 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -178.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -100.91 2.93 41.33 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 121.682 0.753 . . . . 0.0 111.036 178.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.408 ' HB2' HD11 ' A' ' 53' ' ' LEU . 24.0 m-85 -88.44 142.57 27.61 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 174.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 42.5 t -71.08 148.5 47.44 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 105.331 -2.1 . . . . 0.0 105.331 168.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 35.1 ttt-85 -56.46 -42.92 79.0 Favored 'General case' 0 C--O 1.217 -0.637 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.945 -174.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.594 ' O ' ' HG2' ' A' ' 78' ' ' ARG . 90.8 m-70 -75.97 -20.3 58.02 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.476 -0.489 . . . . 0.0 111.274 -177.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -73.17 -44.14 60.37 Favored 'General case' 0 CA--C 1.501 -0.913 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 176.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.54 ' HB3' HG13 ' A' ' 49' ' ' VAL . . . -61.69 -36.51 81.11 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 175.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -61.13 -32.93 72.62 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.639 174.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.594 ' HG2' ' O ' ' A' ' 74' ' ' HIS . 31.7 mmt180 -79.36 -25.93 42.13 Favored 'General case' 0 CA--C 1.496 -1.114 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -176.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.46 ' HB3' ' O ' ' A' ' 76' ' ' ALA . 14.5 tp -60.22 -61.24 2.74 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 124.154 0.909 . . . . 0.0 108.928 177.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -60.6 -27.72 67.95 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.452 -178.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.508 ' O ' HG13 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -69.18 -30.07 68.19 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.061 175.476 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 20.2 ttpp -80.88 -34.93 33.24 Favored 'General case' 0 C--O 1.203 -1.394 0 C-N-CA 117.294 -1.762 . . . . 0.0 107.713 -178.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.563 ' HB3' ' HG ' ' A' ' 89' ' ' LEU . 9.7 mp -60.11 -29.04 68.34 Favored 'General case' 0 C--O 1.211 -0.95 0 CA-C-N 116.24 -0.436 . . . . 0.0 112.015 176.235 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.508 HG13 ' O ' ' A' ' 81' ' ' LYS . 2.1 pp -82.93 -22.14 8.89 Favored 'Isoleucine or valine' 0 C--O 1.244 0.813 0 C-N-CA 120.028 -0.669 . . . . 0.0 111.278 178.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.5 tt -75.97 -49.83 16.58 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 174.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -65.38 -36.1 82.95 Favored 'General case' 0 C--O 1.253 1.281 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 178.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.576 ' HD3' HD21 ' A' ' 109' ' ' ASN 0.31 59.4 mttm 85.0 29.69 0.05 Allowed 'General case' 0 CA--C 1.464 -2.328 0 C-N-CA 125.954 1.702 . . . . 0.0 114.952 176.822 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.408 HG23 HG21 ' A' ' 114' ' ' VAL . 1.8 mp -69.04 -31.48 50.49 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 105.012 -2.218 . . . . 0.0 105.012 163.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.563 ' HG ' ' HB3' ' A' ' 83' ' ' LEU . 44.7 mt -116.01 154.4 29.94 Favored 'General case' 0 N--CA 1.425 -1.676 0 CA-C-N 113.966 -1.47 . . . . 0.0 108.896 173.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.416 ' HB2' ' HA2' ' A' ' 108' ' ' GLY . 1.8 m-20 -139.81 117.68 11.71 Favored 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 174.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.47 ' HG3' HG21 ' A' ' 84' ' ' ILE . 46.6 mt-10 -94.54 145.32 24.89 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.471 0.653 . . . . 0.0 112.133 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -111.08 159.36 17.87 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-N 114.523 -1.217 . . . . 0.0 108.712 176.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 87.6 mt -117.92 145.37 44.71 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -170.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -141.51 163.06 33.94 Favored 'General case' 0 CA--C 1.479 -1.775 0 N-CA-C 105.412 -2.07 . . . . 0.0 105.412 173.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 19.0 tt -132.68 147.07 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.268 0 N-CA-C 106.811 -1.552 . . . . 0.0 106.811 171.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 47.0 p30 -92.41 -174.32 3.66 Favored 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 120.22 -0.592 . . . . 0.0 110.515 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -75.97 5.53 6.43 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 123.009 0.524 . . . . 0.0 111.973 -177.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -108.19 3.01 23.24 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 29.3 t70 66.84 26.73 9.27 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-O 123.547 1.641 . . . . 0.0 108.9 -176.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -101.13 110.62 22.66 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 114.8 -1.091 . . . . 0.0 108.507 177.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.7 140.78 51.53 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.513 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 10.5 tp -134.52 143.44 37.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -117.65 132.69 56.46 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.675 -178.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -108.47 153.0 23.96 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 55.5 t -97.6 137.87 24.02 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 CA-C-O 122.103 0.954 . . . . 0.0 112.964 -174.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 16.5 mmt -134.55 177.98 7.35 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 112.798 -2.001 . . . . 0.0 107.427 174.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 7.3 mp -92.03 142.32 27.66 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.416 ' HA2' ' HB2' ' A' ' 90' ' ' ASP . . . -94.97 -176.89 38.0 Favored Glycine 0 N--CA 1.414 -2.809 0 C-N-CA 119.991 -1.099 . . . . 0.0 114.778 -172.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.576 HD21 ' HD3' ' A' ' 87' ' ' LYS . 6.1 p30 -71.13 -11.37 60.91 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 114.075 -1.062 . . . . 0.0 112.404 -178.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.559 ' O ' HG23 ' A' ' 114' ' ' VAL . 40.2 mmtm -103.58 13.3 33.62 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 177.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.521 ' O ' ' HG ' ' A' ' 115' ' ' LEU . . . -75.94 -28.77 58.09 Favored 'General case' 0 CA--C 1.494 -1.201 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 -177.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 15.8 tp60 -66.16 -39.84 90.08 Favored 'General case' 0 N--CA 1.416 -2.141 0 CA-C-N 112.891 -1.959 . . . . 0.0 109.262 174.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 6.6 m -64.98 -32.7 74.56 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 177.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.56 HG11 HG21 ' A' ' 19' ' ' VAL . 46.2 t -65.69 -46.41 89.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.103 177.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.521 ' HG ' ' O ' ' A' ' 111' ' ' ALA . 68.7 mt -62.59 -37.59 86.81 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.41 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -72.63 -21.35 61.12 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 86.54 12.21 70.02 Favored Glycine 0 C--O 1.215 -1.05 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.627 178.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -96.39 36.86 1.3 Allowed 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 122.299 1.047 . . . . 0.0 109.072 -176.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.634 ' O ' HD13 ' A' ' 119' ' ' LEU . 0.0 OUTLIER -124.7 121.0 33.43 Favored 'General case' 0 N--CA 1.422 -1.857 0 CA-C-O 122.264 1.031 . . . . 0.0 108.34 -176.42 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.632 ' HA ' HG22 ' A' ' 12' ' ' THR 0.265 7.7 ptmm? -131.1 85.5 2.27 Favored 'General case' 1 C--N 1.225 -4.805 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 172.676 . . . . . . . . 4 3 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.417 HG23 HG23 ' A' ' 11' ' ' VAL . 14.4 m -91.43 170.52 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.053 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 177.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -142.62 153.3 43.35 Favored 'General case' 0 C--N 1.266 -3.025 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 -176.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . 0.503 ' O ' ' HB2' ' A' ' 9' ' ' ARG . 56.2 t80 -158.3 143.21 16.35 Favored 'General case' 0 N--CA 1.432 -1.353 0 C-N-CA 120.869 -0.332 . . . . 0.0 111.118 175.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.439 -1.019 0 CA-C-O 121.368 0.604 . . . . 0.0 109.455 176.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 . . . . . 0 N--CA 1.429 -1.524 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.465 ' OD2' ' HB2' ' A' ' 120' ' ' LYS . 0.2 OUTLIER -78.15 90.09 4.26 Favored 'General case' 0 CA--C 1.489 -1.371 0 O-C-N 124.016 0.823 . . . . 0.0 108.829 -179.725 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.6 m -74.58 85.58 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.216 0 CA-C-O 122.713 1.244 . . . . 0.0 109.759 178.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.704 HG22 ' HA ' ' A' ' 120' ' ' LYS . 29.8 p -107.6 -30.33 8.66 Favored 'General case' 0 C--N 1.258 -3.409 0 C-N-CA 118.459 -1.297 . . . . 0.0 110.933 176.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -76.64 -38.95 53.79 Favored 'General case' 0 C--N 1.29 -1.992 0 C-N-CA 124.69 1.196 . . . . 0.0 108.81 -179.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.534 ' O ' ' HB3' ' A' ' 17' ' ' SER . 23.3 t70 -76.62 -36.92 57.15 Favored 'General case' 0 CA--C 1.491 -1.293 0 CA-C-O 122.178 0.989 . . . . 0.0 109.051 -179.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.511 ' O ' HG23 ' A' ' 19' ' ' VAL . 99.5 t -72.97 -21.46 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.803 0 CA-C-N 114.649 -1.16 . . . . 0.0 110.185 177.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.592 ' HE2' ' O ' ' A' ' 12' ' ' THR . 1.3 tppt? -72.25 -31.81 66.12 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 173.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.534 ' HB3' ' O ' ' A' ' 14' ' ' ASP . 29.0 t -63.84 -38.37 90.83 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 173.108 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.479 ' HB ' ' O ' ' A' ' 15' ' ' VAL . 41.4 mt -62.4 -42.89 97.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.005 173.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.511 HG23 ' O ' ' A' ' 15' ' ' VAL . 82.4 t -57.36 -42.8 81.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.137 177.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.405 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 43.7 ttt180 -54.05 -48.07 70.96 Favored 'General case' 0 C--N 1.332 -0.174 0 O-C-N 123.364 0.415 . . . . 0.0 109.892 174.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -65.4 -45.96 81.91 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 115.751 -0.658 . . . . 0.0 112.582 -177.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.493 HG22 ' HA ' ' A' ' 19' ' ' VAL . 29.4 m -65.63 -33.4 63.34 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 C-N-CA 119.907 -0.717 . . . . 0.0 111.045 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 14.7 mm-40 -60.22 -55.6 31.8 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 120.819 0.343 . . . . 0.0 110.806 170.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.405 ' HG2' ' O ' ' A' ' 20' ' ' ARG . 9.4 pt-20 . . . . . 0 CA--C 1.534 0.364 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -177.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 . . . . . 0 CA--C 1.481 -1.703 0 CA-C-O 121.64 0.733 . . . . 0.0 109.038 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.557 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 47.1 p -109.98 144.63 38.25 Favored 'General case' 0 N--CA 1.414 -2.266 0 CA-C-N 114.347 -1.297 . . . . 0.0 107.852 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.515 ' O ' HG23 ' A' ' 49' ' ' VAL . 18.7 ptm -44.52 -44.34 8.59 Favored 'General case' 0 C--O 1.206 -1.19 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -176.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.476 ' N ' ' HG3' ' A' ' 45' ' ' MET . 16.7 t-20 -68.5 -37.97 80.56 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 121.049 -0.26 . . . . 0.0 111.595 -172.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 49.6 ttm -72.54 -36.56 68.32 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.621 ' O ' ' HB2' ' A' ' 52' ' ' PHE . 47.9 mt -67.88 -30.24 69.55 Favored 'General case' 0 C--O 1.192 -1.972 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.846 -178.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.662 HG11 ' HG3' ' A' ' 77' ' ' GLU . 43.0 t -74.19 -44.65 49.26 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.609 0 C-N-CA 123.327 0.651 . . . . 0.0 110.695 179.258 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -54.42 -51.41 65.0 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.805 HD12 ' HB1' ' A' ' 58' ' ' ALA . 6.2 tt -75.97 -24.79 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.28 0 N-CA-C 114.232 1.197 . . . . 0.0 114.232 -178.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.621 ' HB2' ' O ' ' A' ' 48' ' ' LEU . 59.8 t80 -55.44 -43.59 75.55 Favored 'General case' 0 C--N 1.277 -2.579 0 CA-C-N 114.842 -1.072 . . . . 0.0 108.754 175.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.497 ' HA ' ' O ' ' A' ' 68' ' ' GLY . 9.5 mp -77.73 -35.79 51.54 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.892 -1.049 . . . . 0.0 111.551 177.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 98.61 53.3 1.23 Allowed Glycine 0 C--N 1.305 -1.185 0 N-CA-C 108.496 -1.841 . . . . 0.0 108.496 -173.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 52.6 p -64.81 -178.89 0.46 Allowed 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 115.564 1.69 . . . . 0.0 115.564 -175.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -81.88 -27.75 33.3 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 113.117 -1.856 . . . . 0.0 110.811 176.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.8 m -88.72 -45.29 9.92 Favored 'General case' 0 C--O 1.252 1.219 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -175.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.805 ' HB1' HD12 ' A' ' 51' ' ' ILE . . . -97.91 90.58 4.98 Favored 'General case' 0 N--CA 1.403 -2.781 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 178.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 50.2 mttp -72.95 26.57 0.06 Allowed 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 126.285 1.834 . . . . 0.0 114.423 -174.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.476 ' HA ' ' HB3' ' A' ' 65' ' ' PHE . 81.3 mt 71.0 116.71 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 C-N-CA 125.391 1.476 . . . . 0.0 112.713 179.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.571 ' HG2' HD11 ' A' ' 51' ' ' ILE . 17.4 mm-40 -113.34 17.52 18.46 Favored 'General case' 0 N--CA 1.439 -1.005 0 C-N-CA 119.782 -0.767 . . . . 0.0 112.372 -176.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 21.1 m 70.31 107.04 0.06 Allowed 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 124.111 0.964 . . . . 0.0 112.513 -178.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 153.6 -111.06 0.47 Allowed Glycine 0 CA--C 1.498 -0.973 0 N-CA-C 109.056 -1.618 . . . . 0.0 109.056 -179.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.558 ' O ' ' HG3' ' A' ' 67' ' ' LYS . 5.8 tt -91.12 -5.36 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 172.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.642 ' CD1' HD13 ' A' ' 51' ' ' ILE . 9.4 m-85 -70.85 102.04 2.27 Favored 'General case' 0 N--CA 1.41 -2.468 0 CA-C-N 113.353 -1.749 . . . . 0.0 108.959 -174.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.19 9.7 55.36 Favored Glycine 0 N--CA 1.42 -2.423 0 O-C-N 124.338 1.024 . . . . 0.0 112.829 -179.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.601 ' HD3' ' N ' ' A' ' 68' ' ' GLY . 0.1 OUTLIER -65.29 -31.81 73.15 Favored 'General case' 0 C--N 1.357 0.901 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 -178.439 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.601 ' N ' ' HD3' ' A' ' 67' ' ' LYS . . . -160.04 107.71 0.33 Allowed Glycine 0 CA--C 1.498 -1.018 0 C-N-CA 117.808 -2.139 . . . . 0.0 114.991 -175.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.454 ' HB3' ' O ' ' A' ' 53' ' ' LEU . 2.8 p -94.16 10.33 34.26 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 124.406 1.082 . . . . 0.0 110.29 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -91.56 6.31 46.15 Favored 'General case' 0 CA--C 1.506 -0.747 0 CA-C-O 121.965 0.888 . . . . 0.0 110.693 -178.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.408 ' HB2' HD11 ' A' ' 53' ' ' LEU . 43.1 m-85 -99.45 143.12 30.06 Favored 'General case' 0 C--N 1.283 -2.31 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.269 175.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 30.0 t -78.24 139.73 38.9 Favored 'General case' 0 N--CA 1.414 -2.257 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 170.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.468 HH12 ' ND2' ' A' ' 46' ' ' ASN . 32.8 tpt85 -43.52 -56.46 3.64 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.385 1.074 . . . . 0.0 112.223 -175.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -81.32 -12.26 59.08 Favored 'General case' 0 C--N 1.309 -1.169 0 C-N-CA 120.132 -0.627 . . . . 0.0 112.407 -175.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -86.57 -29.72 22.42 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.546 ' HB3' HG13 ' A' ' 49' ' ' VAL . . . -65.35 -40.04 93.09 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 171.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.662 ' HG3' HG11 ' A' ' 49' ' ' VAL . 38.7 mt-10 -60.44 -32.81 71.73 Favored 'General case' 0 C--O 1.246 0.874 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.43 173.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 15.3 tpp180 -68.9 -31.25 70.04 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 -176.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.707 ' HG ' ' CD1' ' A' ' 123' ' ' PHE . 0.4 OUTLIER -73.84 -47.99 34.48 Favored 'General case' 0 CA--C 1.469 -2.165 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.303 -178.571 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -59.2 -21.24 59.17 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-O 121.667 0.746 . . . . 0.0 109.125 176.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 30.7 mmtm -87.22 -31.61 20.22 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.78 178.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.664 ' HE2' ' O ' ' A' ' 122' ' ' ASP . 19.1 ttpp -71.91 -39.04 69.8 Favored 'General case' 0 C--O 1.194 -1.861 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 175.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.505 HD13 HD22 ' A' ' 79' ' ' LEU . 0.6 OUTLIER -57.19 -38.7 74.05 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 125.186 1.395 . . . . 0.0 112.16 178.484 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.409 HG21 ' HG3' ' A' ' 91' ' ' GLU . 2.5 pp -75.68 -23.23 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 119.76 -0.776 . . . . 0.0 111.525 177.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 50.2 mt -77.93 -41.83 35.06 Favored 'General case' 0 N--CA 1.45 -0.434 0 O-C-N 123.425 0.453 . . . . 0.0 110.597 173.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -65.2 -29.12 69.91 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.404 ' HB3' ' HG2' ' A' ' 110' ' ' LYS . 2.3 mptp? 84.9 15.71 0.18 Allowed 'General case' 0 CA--C 1.477 -1.859 0 C-N-CA 125.154 1.382 . . . . 0.0 112.77 175.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.58 HG23 HG21 ' A' ' 114' ' ' VAL . 1.8 mp -67.96 -38.44 79.98 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.794 0 N-CA-C 106.349 -1.722 . . . . 0.0 106.349 167.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.457 ' HG ' ' HB3' ' A' ' 83' ' ' LEU . 30.3 mt -109.03 151.01 26.93 Favored 'General case' 0 N--CA 1.414 -2.261 0 CA-C-N 114.4 -1.273 . . . . 0.0 111.003 177.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.419 ' O ' ' HB2' ' A' ' 106' ' ' MET . 15.6 m-20 -143.85 118.24 9.65 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 175.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.409 ' HG3' HG21 ' A' ' 84' ' ' ILE . 40.8 mt-10 -94.03 155.21 17.24 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 121.052 0.454 . . . . 0.0 112.187 -176.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.593 ' O ' ' HA ' ' A' ' 103' ' ' ALA . 13.4 m-20 -97.77 138.08 35.68 Favored 'General case' 0 CA--C 1.497 -1.059 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 91.5 mt -106.94 116.76 32.49 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 121.482 0.658 . . . . 0.0 111.168 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -125.83 108.9 11.92 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.5 HD11 ' HA ' ' A' ' 99' ' ' ASP . 14.6 tt -112.04 148.94 14.83 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.381 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -177.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -103.69 -175.54 2.83 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -74.53 17.9 0.18 Allowed 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -177.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -118.45 6.01 11.77 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 177.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.5 ' HA ' HD11 ' A' ' 95' ' ' ILE . 6.1 m-20 62.18 28.28 16.98 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 122.299 1.047 . . . . 0.0 111.264 -176.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.432 ' C ' HG13 ' A' ' 95' ' ' ILE . 22.7 mt-30 -93.36 103.03 15.29 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 176.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -83.95 116.05 22.61 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.602 -177.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 4.3 mm -100.01 131.99 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.388 -3.535 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 176.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.593 ' HA ' ' O ' ' A' ' 92' ' ' ASP . . . -113.66 124.51 52.49 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.682 -178.261 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -97.06 155.65 16.71 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 42.2 t -100.55 120.89 50.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -175.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.419 ' HB2' ' O ' ' A' ' 90' ' ' ASP . 25.9 mmt -133.05 -173.04 3.09 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 113.369 -1.741 . . . . 0.0 108.307 177.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -143.67 134.24 24.92 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -138.01 -78.1 0.07 OUTLIER Glycine 0 N--CA 1.44 -1.098 0 C-N-CA 118.515 -1.802 . . . . 0.0 116.075 -174.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -63.78 -51.62 63.97 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 115.243 1.571 . . . . 0.0 115.243 -167.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.495 ' O ' HG23 ' A' ' 114' ' ' VAL . 65.1 mmtt -98.24 -1.64 41.49 Favored 'General case' 0 C--N 1.321 -0.645 0 O-C-N 121.474 -0.766 . . . . 0.0 109.802 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.604 ' O ' ' HG ' ' A' ' 115' ' ' LEU . . . -51.92 -33.18 36.04 Favored 'General case' 0 C--O 1.217 -0.608 0 CA-C-N 114.798 -1.092 . . . . 0.0 113.706 -174.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.46 HE21 ' N ' ' A' ' 113' ' ' THR . 0.0 OUTLIER -64.54 -37.42 87.5 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.474 -177.43 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.46 ' N ' HE21 ' A' ' 112' ' ' GLN . 5.4 m -78.19 -25.16 47.0 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 121.617 0.722 . . . . 0.0 109.238 -179.132 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.58 HG21 HG23 ' A' ' 88' ' ' ILE . 62.0 t -67.64 -40.35 83.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-N 114.703 -1.135 . . . . 0.0 108.272 175.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.604 ' HG ' ' O ' ' A' ' 111' ' ' ALA . 73.1 mt -72.39 -29.09 63.43 Favored 'General case' 0 C--O 1.222 -0.388 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.92 177.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -73.19 -11.37 60.5 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-O 121.165 0.507 . . . . 0.0 110.111 173.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 86.47 -12.62 60.44 Favored Glycine 0 N--CA 1.438 -1.208 0 CA-C-N 115.621 -0.718 . . . . 0.0 113.05 177.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -91.33 62.85 4.78 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 122.253 1.025 . . . . 0.0 111.177 -173.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.514 ' O ' HD13 ' A' ' 119' ' ' LEU . 0.0 OUTLIER -132.04 131.53 42.54 Favored 'General case' 0 N--CA 1.409 -2.517 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 175.201 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.704 ' HA ' HG22 ' A' ' 12' ' ' THR . 0.0 OUTLIER -130.62 128.03 40.16 Favored 'General case' 1 C--N 1.241 -4.124 0 CA-C-N 113.311 -1.768 . . . . 0.0 109.66 179.486 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 14.3 m -133.71 170.66 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 176.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.664 ' O ' ' HE2' ' A' ' 82' ' ' LYS . 8.0 p-10 -108.68 161.01 15.48 Favored 'General case' 0 C--N 1.274 -2.7 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.756 -178.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . 0.707 ' CD1' ' HG ' ' A' ' 79' ' ' LEU . 37.8 t80 -159.08 156.53 29.35 Favored 'General case' 0 C--O 1.256 1.4 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 171.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.314 -0.974 0 N-CA-C 104.53 -2.396 . . . . 0.0 104.53 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 47.0 mmt-85 . . . . . 0 N--CA 1.438 -1.051 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -118.71 93.8 4.23 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 104.949 -2.241 . . . . 0.0 104.949 178.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.8 m -82.07 87.59 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.272 -2.782 0 CA-C-O 122.64 1.209 . . . . 0.0 111.322 -175.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.826 HG22 ' HA ' ' A' ' 120' ' ' LYS . 44.7 p -98.47 -58.43 1.96 Allowed 'General case' 0 C--N 1.262 -3.208 0 C-N-CA 117.564 -1.654 . . . . 0.0 113.13 174.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.533 ' HA ' ' HB3' ' A' ' 16' ' ' LYS . 12.3 t70 -83.49 -10.9 58.05 Favored 'General case' 0 C--O 1.205 -1.281 0 C-N-CA 118.797 -1.161 . . . . 0.0 111.139 -176.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -66.59 -46.85 74.6 Favored 'General case' 0 CA--C 1.5 -0.977 0 N-CA-C 105.279 -2.119 . . . . 0.0 105.279 171.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 77.1 t -65.85 -43.28 93.21 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.404 0 CA-C-N 112.944 -1.935 . . . . 0.0 110.074 177.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.533 ' HB3' ' HA ' ' A' ' 13' ' ' ASP . 17.2 ttmt -64.95 -40.26 94.74 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.628 178.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.507 ' O ' ' HD2' ' A' ' 21' ' ' PHE . 72.2 m -55.13 -45.86 75.61 Favored 'General case' 0 CA--C 1.509 -0.608 0 O-C-N 123.33 0.394 . . . . 0.0 109.955 175.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.415 ' O ' HG22 ' A' ' 22' ' ' VAL . 88.1 mt -55.43 -56.62 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.486 177.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.418 HG21 HG11 ' A' ' 114' ' ' VAL . 97.9 t -60.19 -44.44 95.38 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.101 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.41 -179.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.498 ' O ' ' HG3' ' A' ' 24' ' ' GLU . 35.8 ttp180 -58.72 -36.32 74.09 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 124.036 0.934 . . . . 0.0 111.069 -178.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.507 ' HD2' ' O ' ' A' ' 17' ' ' SER . 64.8 m-85 -90.86 -25.36 19.9 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -178.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.415 HG22 ' O ' ' A' ' 18' ' ' ILE . 30.5 m -79.38 -30.8 14.0 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.377 0 C-N-CA 117.307 -1.757 . . . . 0.0 108.54 173.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -63.05 -52.4 62.95 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.251 174.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.498 ' HG3' ' O ' ' A' ' 20' ' ' ARG 0.322 0.0 OUTLIER . . . . . 0 C--N 1.347 0.468 0 C-N-CA 119.366 -0.934 . . . . 0.0 112.849 -179.447 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 . . . . . 0 CA--C 1.488 -1.41 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 51.2 p -122.56 156.34 34.4 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 176.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.442 ' HG3' ' N ' ' A' ' 46' ' ' ASN . 13.2 ptp -50.71 -42.27 56.91 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-O 121.221 0.534 . . . . 0.0 110.799 178.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.442 ' N ' ' HG3' ' A' ' 45' ' ' MET . 44.2 m-80 -64.1 -34.19 77.49 Favored 'General case' 0 CA--C 1.505 -0.77 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.348 -177.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . 0.446 ' O ' ' HB ' ' A' ' 51' ' ' ILE . 49.2 ttm -71.2 -43.22 67.82 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.444 ' O ' HG22 ' A' ' 51' ' ' ILE . 82.9 mt -67.77 -42.8 81.16 Favored 'General case' 0 C--O 1.208 -1.101 0 CA-C-N 115.224 -0.898 . . . . 0.0 112.469 -176.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.436 HG13 ' HB3' ' A' ' 76' ' ' ALA . 69.2 t -64.57 -46.38 92.75 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.727 0 CA-C-O 121.622 0.725 . . . . 0.0 110.436 179.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -63.52 -37.85 88.88 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 114.712 -1.131 . . . . 0.0 108.927 -178.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.702 ' CG1' ' HB1' ' A' ' 58' ' ' ALA . 0.4 OUTLIER -76.33 -37.85 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.407 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 179.62 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.428 ' CZ ' ' HA3' ' A' ' 68' ' ' GLY . 37.8 t80 -55.81 -39.23 71.05 Favored 'General case' 0 C--N 1.296 -1.745 0 O-C-N 123.877 0.736 . . . . 0.0 110.036 176.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.5 mp -82.13 -28.77 32.01 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.137 -0.938 . . . . 0.0 112.116 177.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.15 35.43 15.1 Favored Glycine 0 C--O 1.251 1.159 0 N-CA-C 109.841 -1.303 . . . . 0.0 109.841 -176.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.532 ' OG ' ' HD3' ' A' ' 56' ' ' LYS . 34.9 t -70.47 -168.96 0.27 Allowed 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 126.619 1.968 . . . . 0.0 112.858 -172.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.648 ' HD3' ' H ' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -50.27 -66.75 0.34 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.205 1.402 . . . . 0.0 112.902 -174.236 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.05 -42.83 22.97 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 114.771 -1.104 . . . . 0.0 111.545 -170.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.702 ' HB1' ' CG1' ' A' ' 51' ' ' ILE . . . -91.78 81.1 5.23 Favored 'General case' 0 N--CA 1.398 -3.048 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 174.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.509 ' O ' ' HB ' ' A' ' 60' ' ' ILE . 0.1 OUTLIER -73.13 25.21 0.06 Allowed 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 114.612 -1.176 . . . . 0.0 111.99 -175.484 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.509 ' HB ' ' O ' ' A' ' 59' ' ' LYS . 88.3 mt 83.34 127.91 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 C-N-CA 126.831 2.053 . . . . 0.0 111.057 -175.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.463 ' HG3' ' O ' ' A' ' 60' ' ' ILE 0.297 14.8 mt-30 -135.82 58.86 1.73 Allowed 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 178.609 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 15.2 t 71.44 137.14 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 125.91 1.684 . . . . 0.0 112.729 177.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.28 -141.65 15.73 Favored Glycine 0 C--O 1.241 0.581 0 C-N-CA 121.288 -0.482 . . . . 0.0 112.728 177.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.461 HG21 ' HB3' ' A' ' 17' ' ' SER . 6.3 pt -73.39 7.19 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 C-N-CA 123.331 0.652 . . . . 0.0 112.427 178.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.592 ' CD2' HG12 ' A' ' 51' ' ' ILE . 0.3 OUTLIER -70.96 113.32 7.88 Favored 'General case' 0 N--CA 1.389 -3.504 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 -178.784 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.68 33.67 46.34 Favored Glycine 0 N--CA 1.424 -2.116 0 CA-C-N 114.849 -1.068 . . . . 0.0 111.305 -174.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 32.9 mmtm -121.32 -15.08 8.19 Favored 'General case' 0 C--O 1.22 -0.452 0 CA-C-O 121.2 0.524 . . . . 0.0 109.72 174.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.428 ' HA3' ' CZ ' ' A' ' 52' ' ' PHE . . . -107.78 35.03 5.25 Favored Glycine 0 N--CA 1.432 -1.579 0 N-CA-C 109.771 -1.331 . . . . 0.0 109.771 178.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 9.2 m -72.62 6.23 2.58 Favored 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 124.932 1.293 . . . . 0.0 111.953 -176.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -93.52 -1.53 55.46 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-O 121.923 0.868 . . . . 0.0 109.337 176.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -103.41 153.62 20.28 Favored 'General case' 0 N--CA 1.422 -1.828 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 175.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.408 ' HB3' ' OD1' ' A' ' 75' ' ' ASN . 37.5 t -105.35 171.86 7.1 Favored 'General case' 0 C--N 1.28 -2.43 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 170.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.418 ' HD2' HG12 ' A' ' 49' ' ' VAL . 8.3 mmm180 -52.78 -37.95 60.37 Favored 'General case' 0 C--O 1.205 -1.277 0 CA-C-O 121.215 0.531 . . . . 0.0 110.869 179.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.463 ' O ' ' HG2' ' A' ' 78' ' ' ARG . 6.5 t-160 -67.6 -43.98 79.18 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.577 -172.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.408 ' OD1' ' HB3' ' A' ' 72' ' ' SER . 7.6 m120 -68.78 -55.7 10.4 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.319 -178.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.436 ' HB3' HG13 ' A' ' 49' ' ' VAL . . . -57.41 -44.82 84.88 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.929 -177.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.403 ' HG3' HG11 ' A' ' 49' ' ' VAL . 44.7 mt-10 -62.62 -33.92 75.99 Favored 'General case' 0 C--O 1.208 -1.096 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 178.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.463 ' HG2' ' O ' ' A' ' 74' ' ' HIS . 9.7 mmm180 -67.14 -30.31 70.26 Favored 'General case' 0 CA--C 1.495 -1.144 0 C-N-CA 119.08 -1.048 . . . . 0.0 110.296 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.536 ' O ' ' HG ' ' A' ' 83' ' ' LEU . 2.5 tt -79.46 -50.99 9.94 Favored 'General case' 0 N--CA 1.42 -1.926 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.261 -177.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.585 ' HA ' HD12 ' A' ' 83' ' ' LEU . 60.6 m-85 -58.45 -23.18 56.89 Favored 'General case' 0 CA--C 1.506 -0.747 0 CA-C-O 121.855 0.836 . . . . 0.0 110.326 179.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -89.2 -23.57 22.36 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 114.473 -1.239 . . . . 0.0 110.118 -179.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.401 ' HE2' ' O ' ' A' ' 122' ' ' ASP . 48.5 tttp -73.36 -40.27 64.51 Favored 'General case' 0 C--O 1.209 -1.053 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 174.127 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.585 HD12 ' HA ' ' A' ' 80' ' ' PHE . 94.6 mt -53.62 -50.19 66.21 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 114.905 -1.043 . . . . 0.0 112.864 178.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.616 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 2.6 pp -73.82 -24.65 19.83 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -178.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 41.0 mt -79.83 -40.2 29.03 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 176.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.629 ' O ' ' HE2' ' A' ' 110' ' ' LYS . 35.1 t70 -82.96 -13.07 56.72 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.675 -177.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.45 ' HG3' ' OD2' ' A' ' 90' ' ' ASP . 2.8 mptp? 85.61 16.77 0.13 Allowed 'General case' 0 CA--C 1.462 -2.418 0 N-CA-C 114.355 1.243 . . . . 0.0 114.355 171.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 11.6 mt -70.02 -45.32 76.87 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.092 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 168.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.616 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 4.3 mm? -114.95 158.57 21.83 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 113.953 -1.476 . . . . 0.0 108.416 174.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.466 ' HB2' ' HA2' ' A' ' 108' ' ' GLY . 0.3 OUTLIER -149.12 109.97 4.3 Favored 'General case' 0 CA--C 1.476 -1.902 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 176.452 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.449 ' HB2' ' O ' ' A' ' 104' ' ' TYR 0.28 11.8 pt-20 -95.53 159.11 15.15 Favored 'General case' 0 C--N 1.282 -2.36 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 178.56 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.462 ' O ' ' HA ' ' A' ' 103' ' ' ALA . 9.8 t70 -97.98 118.14 33.89 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 126.042 1.737 . . . . 0.0 109.287 -170.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -85.5 103.64 14.55 Favored 'General case' 0 N--CA 1.419 -1.997 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.993 179.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -100.54 113.48 26.32 Favored 'General case' 0 C--N 1.279 -2.479 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.503 HD11 ' HA ' ' A' ' 99' ' ' ASP . 16.3 tt -128.47 147.01 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.197 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -178.075 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 30.5 p-10 -98.16 -175.12 3.04 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -76.43 18.69 0.29 Allowed 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -177.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -117.89 3.92 12.18 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 178.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.503 ' HA ' HD11 ' A' ' 95' ' ' ILE . 5.7 m-20 62.91 28.41 16.33 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 122.29 1.043 . . . . 0.0 111.123 -175.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.406 ' C ' HG13 ' A' ' 95' ' ' ILE . 26.7 mt-30 -97.92 106.09 18.34 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 176.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -104.64 146.88 28.29 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 -174.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 14.4 tt -135.19 143.24 37.65 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 N-CA-C 105.855 -1.906 . . . . 0.0 105.855 170.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.462 ' HA ' ' O ' ' A' ' 92' ' ' ASP . . . -112.11 131.5 55.41 Favored 'General case' 0 C--N 1.29 -2.005 0 C-N-CA 120.107 -0.637 . . . . 0.0 111.728 -176.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.449 ' O ' ' HB2' ' A' ' 91' ' ' GLU . 94.6 m-85 -105.21 143.61 33.15 Favored 'General case' 0 C--O 1.196 -1.73 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 177.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.412 HG22 ' HB3' ' A' ' 91' ' ' GLU . 49.8 t -95.3 131.18 42.79 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 CA-C-O 121.999 0.904 . . . . 0.0 113.177 -169.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.449 ' HB2' ' O ' ' A' ' 90' ' ' ASP . 84.8 mmm -130.51 -172.43 2.8 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 112.91 -1.95 . . . . 0.0 106.834 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.525 HD23 ' H ' ' A' ' 107' ' ' LEU . 1.5 pt? -102.81 150.17 23.76 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -178.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.466 ' HA2' ' HB2' ' A' ' 90' ' ' ASP . . . -104.96 -175.42 24.56 Favored Glycine 0 N--CA 1.437 -1.248 0 C-N-CA 120.063 -1.065 . . . . 0.0 113.777 -176.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -58.67 -40.47 83.63 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 123.968 0.907 . . . . 0.0 112.256 -177.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.629 ' HE2' ' O ' ' A' ' 86' ' ' ASP . 37.5 mtmt -92.21 19.85 6.56 Favored 'General case' 0 C--N 1.314 -0.963 0 O-C-N 122.037 -0.415 . . . . 0.0 111.831 -176.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.453 ' O ' ' HB ' ' A' ' 114' ' ' VAL . . . -78.09 -30.25 49.48 Favored 'General case' 0 CA--C 1.497 -1.082 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 177.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 34.8 tp60 -63.76 -39.55 94.54 Favored 'General case' 0 N--CA 1.421 -1.921 0 CA-C-N 112.93 -1.941 . . . . 0.0 109.4 173.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 5.2 m -66.2 -30.14 70.55 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.536 ' HA ' ' HG ' ' A' ' 119' ' ' LEU . 94.5 t -64.64 -43.77 96.67 Favored 'Isoleucine or valine' 0 C--O 1.25 1.108 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.105 176.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 54.0 mt -69.05 -32.91 72.74 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.775 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -72.11 -24.43 61.48 Favored 'General case' 0 C--O 1.216 -0.659 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.213 177.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 103.18 -13.63 55.37 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.723 -0.751 . . . . 0.0 113.336 176.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -83.72 47.59 1.31 Allowed 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 121.531 0.682 . . . . 0.0 112.197 -175.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.536 ' HG ' ' HA ' ' A' ' 114' ' ' VAL . 0.0 OUTLIER -122.41 80.35 1.72 Allowed 'General case' 0 N--CA 1.434 -1.265 0 CA-C-O 123.263 1.506 . . . . 0.0 110.214 179.891 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.826 ' HA ' HG22 ' A' ' 12' ' ' THR . 5.8 ptmm? -114.31 93.13 4.21 Favored 'General case' 0 C--N 1.246 -3.902 0 C-N-CA 118.733 -1.187 . . . . 0.0 110.935 172.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 8.5 m -111.25 170.43 3.58 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.329 -176.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.401 ' O ' ' HE2' ' A' ' 82' ' ' LYS . 6.8 p-10 -95.52 168.43 10.7 Favored 'General case' 0 C--N 1.271 -2.816 0 CA-C-N 114.655 -1.157 . . . . 0.0 111.967 -178.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -158.36 142.34 15.59 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 114.627 -1.169 . . . . 0.0 108.028 172.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 26.5 ptt? . . . . . 0 C--N 1.295 -1.8 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 177.305 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 49.5 m . . . . . 0 N--CA 1.441 -0.91 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.56 ' HA ' ' O ' ' A' ' 5' ' ' ASP . 0.0 OUTLIER -62.46 95.1 0.07 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.8 -1.091 . . . . 0.0 112.197 -177.834 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.6 t 163.19 -27.72 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 -177.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 27.2 ttpp -121.2 -40.92 2.55 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 114.159 -1.382 . . . . 0.0 107.896 175.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.56 ' O ' ' HA ' ' A' ' 2' ' ' LYS . 7.4 m-20 -113.02 165.05 12.72 Favored 'General case' 0 CA--C 1.491 -1.317 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -178.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 47.5 p90 -97.35 3.93 50.92 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 121.979 0.895 . . . . 0.0 108.586 174.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.417 ' HE2' ' O ' ' A' ' 8' ' ' THR . 26.4 tttt -70.7 145.5 50.5 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 114.664 -1.153 . . . . 0.0 110.665 -177.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.532 ' HA ' ' NZ ' ' A' ' 2' ' ' LYS . 89.2 m -114.25 163.51 15.16 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 104.882 -2.266 . . . . 0.0 104.882 169.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.551 ' HB2' ' HB3' ' A' ' 127' ' ' GLU . 60.2 ttt180 -92.65 127.01 37.99 Favored 'General case' 0 N--CA 1.408 -2.54 0 C-N-CA 118.315 -1.354 . . . . 0.0 112.446 -165.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -81.09 111.68 17.76 Favored 'General case' 0 N--CA 1.394 -3.272 0 N-CA-C 104.633 -2.358 . . . . 0.0 104.633 170.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.4 m -84.58 76.15 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.279 -2.47 0 C-N-CA 118.281 -1.368 . . . . 0.0 109.721 178.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.654 HG22 ' HA ' ' A' ' 120' ' ' LYS . 26.1 p -110.07 -37.34 5.61 Favored 'General case' 0 C--N 1.259 -3.356 0 CA-C-N 114.849 -1.069 . . . . 0.0 109.391 178.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -69.67 -37.7 76.78 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 176.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.437 ' HB2' ' NH2' ' A' ' 9' ' ' ARG . 11.4 t70 -69.21 -54.93 12.26 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.73 -1.123 . . . . 0.0 108.176 -178.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.452 ' O ' HG23 ' A' ' 19' ' ' VAL . 77.2 t -63.27 -40.38 88.84 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.179 0 CA-C-N 113.76 -1.564 . . . . 0.0 112.966 -177.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 9.6 ttmm -67.08 -35.22 79.35 Favored 'General case' 0 C--N 1.323 -0.586 0 O-C-N 121.907 -0.496 . . . . 0.0 111.586 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 50.1 m -62.97 -45.42 92.52 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 174.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 66.6 mt -55.79 -53.3 39.04 Favored 'Isoleucine or valine' 0 C--O 1.243 0.723 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.134 175.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 15' ' ' VAL . 75.3 t -56.86 -43.99 81.2 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.011 0 CA-C-N 114.985 -1.007 . . . . 0.0 112.162 -178.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.461 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 32.9 ttt180 -53.04 -54.12 40.0 Favored 'General case' 0 N--CA 1.45 -0.453 0 O-C-N 123.765 0.666 . . . . 0.0 110.198 179.257 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.471 ' O ' ' HB2' ' A' ' 25' ' ' HIS . 66.0 m-85 -64.91 -43.05 94.08 Favored 'General case' 0 CA--C 1.494 -1.193 0 N-CA-C 113.183 0.809 . . . . 0.0 113.183 -175.045 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 35.9 m -70.84 -35.96 62.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 C-N-CA 119.367 -0.933 . . . . 0.0 111.345 -178.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -65.13 -47.09 78.33 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 123.402 0.439 . . . . 0.0 110.782 177.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.461 ' HG2' ' O ' ' A' ' 20' ' ' ARG . 12.5 pt-20 -79.98 -5.0 54.89 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 120.113 -0.635 . . . . 0.0 111.878 -179.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.471 ' HB2' ' O ' ' A' ' 21' ' ' PHE . 30.1 t-80 -78.73 34.91 0.23 Allowed 'General case' 0 CA--C 1.553 1.075 0 CA-C-O 121.673 0.749 . . . . 0.0 111.587 178.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 44.8 t -72.13 -16.97 62.0 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 171.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 24.9 t -134.21 -177.25 4.5 Favored 'General case' 0 N--CA 1.419 -1.995 0 N-CA-C 105.385 -2.08 . . . . 0.0 105.385 174.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 62.1 m -133.57 151.19 51.67 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 118.619 0.645 . . . . 0.0 110.995 -178.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -71.68 120.0 16.65 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.134 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -65.35 -22.95 69.77 Favored Glycine 0 C--O 1.223 -0.576 0 C-N-CA 121.345 -0.455 . . . . 0.0 112.508 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -76.57 6.02 6.51 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 123.196 0.598 . . . . 0.0 111.799 -178.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.8 ptm180 -57.54 -42.42 82.91 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 122.789 0.435 . . . . 0.0 110.657 178.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 40.7 t30 54.91 -70.05 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 115.861 1.8 . . . . 0.0 115.861 176.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 53.6 mt -31.77 -78.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 C-N-CA 126.843 2.057 . . . . 0.0 114.654 -167.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.478 ' HD2' ' HA ' ' A' ' 59' ' ' LYS . 99.2 mttt -90.27 76.59 6.79 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-O 122.449 1.119 . . . . 0.0 112.345 -176.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 32.9 p80 -101.6 23.01 11.81 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 114.12 -1.4 . . . . 0.0 109.301 177.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 18.1 m -140.97 145.75 24.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 C-N-CA 124.261 1.024 . . . . 0.0 108.519 179.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 110.36 173.42 20.29 Favored Glycine 0 N--CA 1.438 -1.202 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.711 178.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -76.16 170.24 20.45 Favored 'Trans proline' 0 C--O 1.251 1.159 0 C-N-CA 122.214 1.943 . . . . 0.0 111.698 178.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.3 p -73.3 -173.84 1.46 Allowed 'General case' 0 C--O 1.256 1.424 0 C-N-CA 123.927 0.891 . . . . 0.0 112.579 -177.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -142.3 -174.64 15.0 Favored Glycine 0 N--CA 1.433 -1.503 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 -178.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 85.7 mtm180 -132.89 163.47 29.06 Favored 'General case' 0 N--CA 1.422 -1.836 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -107.82 92.15 3.95 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-O 121.942 0.877 . . . . 0.0 110.226 -174.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 70.1 p -118.79 162.27 18.75 Favored 'General case' 0 N--CA 1.413 -2.305 0 CA-C-N 114.193 -1.367 . . . . 0.0 107.762 178.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.524 ' O ' HG23 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -55.11 -44.27 74.81 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -176.5 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.436 ' O ' ' HB ' ' A' ' 49' ' ' VAL . 3.5 m-20 -71.22 -23.36 62.0 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -177.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 26.0 mmt -71.66 -39.7 70.14 Favored 'General case' 0 CA--C 1.508 -0.673 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 176.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 78.4 mt -66.95 -30.89 71.15 Favored 'General case' 0 C--O 1.216 -0.676 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.301 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 45' ' ' MET . 27.3 t -62.8 -52.7 56.28 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.944 0 C-N-CA 124.806 1.242 . . . . 0.0 110.98 178.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.451 ' CG ' ' HB3' ' A' ' 55' ' ' SER . 10.7 t70 -63.02 -38.2 90.24 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 114.848 -1.069 . . . . 0.0 109.287 -178.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.533 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 71.2 mt -63.91 -47.98 88.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.252 -0.885 . . . . 0.0 111.513 176.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.494 ' CE2' ' HA3' ' A' ' 68' ' ' GLY . 49.1 t80 -52.65 -43.34 65.43 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 124.778 1.231 . . . . 0.0 111.618 -177.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.473 HD11 ' HB2' ' A' ' 71' ' ' TYR . 8.9 mp -76.96 -22.54 53.09 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 179.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.77 31.48 18.04 Favored Glycine 0 C--O 1.267 2.2 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -174.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.451 ' HB3' ' CG ' ' A' ' 50' ' ' ASP . 22.8 t -75.69 -179.42 4.71 Favored 'General case' 0 N--CA 1.415 -2.187 0 CA-C-N 113.7 -1.25 . . . . 0.0 108.541 -178.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 43.7 mttm -123.51 17.36 9.67 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 118.76 -1.176 . . . . 0.0 113.297 -169.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.4 m -88.85 -38.31 14.68 Favored 'General case' 0 C--O 1.247 0.971 0 N-CA-C 105.06 -2.2 . . . . 0.0 105.06 173.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.446 ' HB1' HG12 ' A' ' 51' ' ' ILE . . . -45.85 137.37 5.61 Favored 'General case' 0 N--CA 1.429 -1.494 0 C-N-CA 128.213 2.605 . . . . 0.0 111.59 178.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.478 ' HA ' ' HD2' ' A' ' 35' ' ' LYS . 50.4 mtmt -120.01 18.22 12.45 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.971 -178.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . 0.251 67.6 mt -104.03 -50.4 9.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 C-N-CA 117.496 -1.682 . . . . 0.0 114.19 -177.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.641 ' HA ' ' CD2' ' A' ' 65' ' ' PHE . 25.7 mp0 60.91 26.59 16.48 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 176.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.9 t -139.41 129.65 25.34 Favored 'General case' 0 N--CA 1.421 -1.898 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 106.38 -134.8 12.33 Favored Glycine 0 N--CA 1.435 -1.383 0 N-CA-C 111.61 -0.596 . . . . 0.0 111.61 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.438 HG23 ' CD2' ' A' ' 21' ' ' PHE . 1.4 pt -70.95 29.06 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 124.708 1.203 . . . . 0.0 113.694 179.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.641 ' CD2' ' HA ' ' A' ' 61' ' ' GLN . 9.0 t80 -71.69 112.31 7.7 Favored 'General case' 0 N--CA 1.425 -1.689 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -177.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.34 48.18 46.91 Favored Glycine 0 N--CA 1.441 -0.968 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.505 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 32.5 mmtm -119.25 -21.0 7.73 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 120.941 0.4 . . . . 0.0 111.34 177.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.494 ' HA3' ' CE2' ' A' ' 52' ' ' PHE . . . -121.58 45.13 1.25 Allowed Glycine 0 N--CA 1.437 -1.299 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 178.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.7 m -73.99 6.69 3.17 Favored 'General case' 0 C--N 1.306 -1.292 0 C-N-CA 124.614 1.166 . . . . 0.0 112.173 -175.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -101.71 3.87 40.06 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-O 121.527 0.679 . . . . 0.0 109.883 178.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.473 ' HB2' HD11 ' A' ' 53' ' ' LEU . 34.0 m-85 -101.36 168.8 9.3 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.884 176.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 36.1 t -104.07 155.77 18.42 Favored 'General case' 0 N--CA 1.417 -2.117 0 N-CA-C 104.548 -2.39 . . . . 0.0 104.548 168.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 69.7 mtm180 -57.7 -39.66 77.69 Favored 'General case' 0 C--O 1.209 -1.035 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -175.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 69.7 t60 -77.49 -17.0 58.41 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-O 121.519 0.676 . . . . 0.0 110.886 -176.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -80.53 -43.61 20.44 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 177.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.519 ' HB3' HG13 ' A' ' 49' ' ' VAL . . . -61.81 -41.55 97.91 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.009 -0.996 . . . . 0.0 108.842 175.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -54.16 -43.61 70.76 Favored 'General case' 0 CA--C 1.501 -0.929 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.327 174.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 20.2 ttm180 -64.93 -28.81 69.78 Favored 'General case' 0 C--O 1.217 -0.647 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.228 -172.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.3 tt -80.63 -47.25 14.37 Favored 'General case' 0 N--CA 1.429 -1.523 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.26 -177.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -62.09 -20.04 63.6 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 121.861 0.839 . . . . 0.0 109.471 177.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.524 ' HA ' HG13 ' A' ' 84' ' ' ILE . 94.4 mttt -91.26 -22.34 20.63 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 114.471 -1.241 . . . . 0.0 110.394 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 29.6 tptp -70.93 -47.08 61.03 Favored 'General case' 0 C--O 1.219 -0.531 0 N-CA-C 106.133 -1.802 . . . . 0.0 106.133 171.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 94.3 mt -56.8 -39.65 74.52 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 114.35 -1.295 . . . . 0.0 113.941 177.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.524 HG13 ' HA ' ' A' ' 81' ' ' LYS . 2.7 pp -69.61 -33.02 54.81 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.785 0 C-N-CA 120.261 -0.576 . . . . 0.0 110.908 178.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 53.4 mt -70.36 -44.1 68.81 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 121.087 0.47 . . . . 0.0 111.558 176.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -66.96 -27.28 67.33 Favored 'General case' 0 C--O 1.259 1.575 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.199 179.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.474 ' HD2' ' O ' ' A' ' 84' ' ' ILE . 2.2 mptp? 84.89 18.73 0.13 Allowed 'General case' 0 CA--C 1.476 -1.902 0 C-N-CA 125.781 1.632 . . . . 0.0 112.846 176.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.547 HG23 HG21 ' A' ' 114' ' ' VAL . 1.9 mp -69.77 -40.64 79.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 105.391 -2.077 . . . . 0.0 105.391 166.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.478 ' CD1' HG13 ' A' ' 105' ' ' VAL . 3.1 mm? -103.6 144.31 31.61 Favored 'General case' 0 N--CA 1.411 -2.405 0 CA-C-N 113.419 -1.719 . . . . 0.0 109.04 173.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -124.72 131.57 53.45 Favored 'General case' 0 N--CA 1.408 -2.538 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 176.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.47 ' H ' ' CD ' ' A' ' 91' ' ' GLU . 0.1 OUTLIER -95.27 129.67 42.31 Favored 'General case' 0 C--N 1.27 -2.86 0 CA-C-N 114.271 -1.331 . . . . 0.0 111.708 -173.838 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.519 ' HB2' ' HB2' ' A' ' 104' ' ' TYR . 7.9 m-20 -96.48 95.84 8.29 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 179.092 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 97.5 mt -76.28 114.54 15.08 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.461 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -130.86 130.86 44.12 Favored 'General case' 0 N--CA 1.42 -1.968 0 CA-C-N 115.344 -0.844 . . . . 0.0 108.837 -177.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.498 HG13 ' C ' ' A' ' 100' ' ' GLN . 16.8 tt -128.81 141.15 47.35 Favored 'Isoleucine or valine' 0 N--CA 1.399 -3.005 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 176.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.408 ' C ' ' H ' ' A' ' 98' ' ' ASN . 3.5 p-10 -95.72 170.85 9.04 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 176.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -67.9 21.72 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -173.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.408 ' H ' ' C ' ' A' ' 96' ' ' ASN . 16.8 m120 -119.32 7.49 11.26 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 177.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.488 ' HA ' HD11 ' A' ' 95' ' ' ILE . 8.4 m-20 62.14 30.76 17.82 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 124.787 1.305 . . . . 0.0 110.99 -177.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.498 ' C ' HG13 ' A' ' 95' ' ' ILE . 83.6 mm-40 -101.71 107.42 18.64 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 177.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -96.27 139.25 32.68 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 115.663 -0.699 . . . . 0.0 112.081 -175.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 18.4 tt -142.21 146.16 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.723 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 176.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.507 ' HA ' ' O ' ' A' ' 92' ' ' ASP . . . -114.19 132.86 55.95 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 -178.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.519 ' HB2' ' HB2' ' A' ' 92' ' ' ASP . 68.1 m-85 -97.23 175.4 6.29 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 177.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.478 HG13 ' CD1' ' A' ' 89' ' ' LEU . 14.6 t -116.4 121.01 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.803 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 -178.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 58.4 mtp -141.76 168.48 19.65 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 113.436 -1.711 . . . . 0.0 108.764 173.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.543 ' HB3' ' HB2' ' A' ' 111' ' ' ALA . 7.5 mp -116.86 130.27 56.61 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 177.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -131.8 -80.24 0.19 Allowed Glycine 0 N--CA 1.422 -2.257 0 C-N-CA 118.897 -1.62 . . . . 0.0 115.716 -175.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -65.96 -54.9 20.31 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 115.25 1.574 . . . . 0.0 115.25 -168.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.515 ' HB2' ' HA ' ' A' ' 88' ' ' ILE . 41.9 mmtm -97.55 6.15 48.51 Favored 'General case' 0 C--N 1.313 -0.979 0 O-C-N 121.455 -0.778 . . . . 0.0 109.995 -179.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.543 ' HB2' ' HB3' ' A' ' 107' ' ' LEU . . . -58.03 -32.82 68.34 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -175.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.404 HE21 ' N ' ' A' ' 113' ' ' THR . 0.2 OUTLIER -69.5 -29.13 66.7 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.469 0.652 . . . . 0.0 110.029 -179.898 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.404 ' N ' HE21 ' A' ' 112' ' ' GLN . 13.1 m -75.95 -25.16 55.66 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.547 HG21 HG23 ' A' ' 88' ' ' ILE . 40.0 t -70.19 -39.69 77.23 Favored 'Isoleucine or valine' 0 C--O 1.25 1.083 0 CA-C-N 115.246 -0.888 . . . . 0.0 108.942 175.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.449 ' HG ' ' O ' ' A' ' 111' ' ' ALA . 76.1 mt -69.54 -39.2 77.6 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.981 178.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.41 ' OD1' ' HB2' ' A' ' 118' ' ' ASN . 28.0 t-20 -71.58 -20.07 62.05 Favored 'General case' 0 C--O 1.217 -0.635 0 CA-C-O 121.735 0.778 . . . . 0.0 109.529 176.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 85.04 6.52 84.78 Favored Glycine 0 CA--C 1.503 -0.718 0 CA-C-N 115.396 -0.82 . . . . 0.0 113.173 176.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.41 ' HB2' ' OD1' ' A' ' 116' ' ' ASN . 13.0 t-20 -93.81 18.9 9.54 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 121.584 0.707 . . . . 0.0 109.644 -175.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.545 ' O ' HD13 ' A' ' 119' ' ' LEU . 0.0 OUTLIER -90.06 112.53 24.01 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-O 123.277 1.513 . . . . 0.0 108.442 -176.898 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.654 ' HA ' HG22 ' A' ' 12' ' ' THR . 4.9 ptpp? -130.13 105.72 8.13 Favored 'General case' 1 C--N 1.228 -4.697 0 CA-C-N 113.309 -1.769 . . . . 0.0 112.229 179.551 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.4 m -119.07 171.01 7.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 177.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -105.56 158.39 16.71 Favored 'General case' 0 C--N 1.262 -3.223 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.291 -177.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -158.08 151.7 23.6 Favored 'General case' 0 N--CA 1.426 -1.636 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 172.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 49.8 ttm -122.05 107.85 12.69 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 120.501 -0.48 . . . . 0.0 112.037 -173.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -133.91 -146.25 0.26 Allowed 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 174.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 18.8 m -97.89 71.9 2.21 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-O 122.6 1.191 . . . . 0.0 108.444 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.551 ' HB3' ' HB2' ' A' ' 9' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.428 -1.532 0 N-CA-C 102.401 -3.185 . . . . 0.0 102.401 177.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 74.1 m . . . . . 0 N--CA 1.464 0.236 0 N-CA-C 110.353 -0.24 . . . . 0.0 110.353 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 4.8 ttmp? -94.6 158.9 15.32 Favored 'General case' 0 C--O 1.225 -0.2 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 177.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 28.1 m 67.87 85.58 0.14 Allowed 'General case' 0 CA--C 1.535 0.366 0 O-C-N 124.298 0.999 . . . . 0.0 109.718 -178.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -135.04 -42.45 0.73 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.113 -173.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.402 ' HA ' HH12 ' A' ' 9' ' ' ARG . 22.9 t70 -93.48 97.75 10.74 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -173.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -75.29 -47.45 27.85 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 103.614 -2.736 . . . . 0.0 103.614 167.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.686 ' NZ ' ' HA ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -165.55 152.54 10.27 Favored 'General case' 0 N--CA 1.412 -2.362 0 N-CA-C 105.482 -2.044 . . . . 0.0 105.482 169.512 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.449 HG22 ' HB2' ' A' ' 122' ' ' ASP . 0.2 OUTLIER -77.96 155.95 30.51 Favored 'General case' 0 N--CA 1.419 -2.001 0 CA-C-O 121.133 0.492 . . . . 0.0 111.415 -171.575 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.509 ' O ' ' HA ' ' A' ' 122' ' ' ASP . 8.8 mpt_? -97.4 119.81 36.63 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.342 -170.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -84.97 90.86 7.92 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 177.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.2 m -85.72 64.96 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 CA-C-O 121.705 0.764 . . . . 0.0 110.498 -179.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.526 HG21 ' HB3' ' A' ' 120' ' ' LYS . 42.8 p -102.92 -16.84 15.74 Favored 'General case' 0 C--N 1.26 -3.3 0 C-N-CA 116.15 -2.22 . . . . 0.0 113.187 -176.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 17.9 p-10 -82.14 -35.88 28.01 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 174.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -68.65 -58.98 3.47 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.3 179.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 88.6 t -59.51 -35.72 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 CA-C-N 114.675 -1.148 . . . . 0.0 112.04 -179.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.468 ' HE3' HD11 ' A' ' 119' ' ' LEU . 3.6 tppp? -66.07 -40.01 90.52 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.294 178.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.463 ' O ' ' HD2' ' A' ' 21' ' ' PHE . 49.6 m -65.14 -42.03 94.19 Favored 'General case' 0 N--CA 1.442 -0.853 0 O-C-N 123.362 0.414 . . . . 0.0 110.246 178.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 59.0 mt -57.13 -51.89 63.35 Favored 'Isoleucine or valine' 0 C--O 1.244 0.807 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.266 176.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.51 HG11 HG11 ' A' ' 114' ' ' VAL . 70.6 t -65.6 -37.33 79.75 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.621 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.929 -178.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 16.2 ttp180 -55.11 -52.24 63.86 Favored 'General case' 0 C--O 1.222 -0.386 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.463 ' HD2' ' O ' ' A' ' 17' ' ' SER . 55.5 m-85 -63.16 -43.81 97.24 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-N 115.103 -0.953 . . . . 0.0 113.006 -177.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.444 HG22 ' HA ' ' A' ' 19' ' ' VAL . 27.3 m -72.87 -33.79 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.055 0 C-N-CA 119.365 -0.934 . . . . 0.0 111.742 -178.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 58.9 tp60 -65.59 -48.88 70.82 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 123.141 0.276 . . . . 0.0 110.737 176.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -69.03 -16.47 63.71 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 121.69 0.757 . . . . 0.0 110.461 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 46.7 t-80 -81.82 35.93 0.43 Allowed 'General case' 0 CA--C 1.551 0.984 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.514 177.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 20.0 m -60.54 -33.88 73.3 Favored 'General case' 0 CA--C 1.55 0.965 0 CA-C-O 122.008 0.909 . . . . 0.0 108.591 174.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 20.2 m -89.75 147.02 24.08 Favored 'General case' 0 N--CA 1.432 -1.368 0 CA-C-N 115.135 -0.939 . . . . 0.0 108.797 175.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 40.6 t -56.72 -49.05 76.32 Favored 'General case' 0 C--O 1.249 1.072 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 178.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 53.2 tp60 70.4 -43.23 0.54 Allowed 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 125.556 1.542 . . . . 0.0 113.185 174.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -78.3 56.86 4.07 Favored Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 112.181 -0.367 . . . . 0.0 112.181 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 90.1 mmm -83.33 5.52 23.02 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 123.68 0.792 . . . . 0.0 110.396 -178.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 18.8 mmm180 -78.15 -16.69 57.69 Favored 'General case' 0 C--O 1.214 -0.771 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.599 175.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 59.76 97.78 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 125.372 1.469 . . . . 0.0 113.213 176.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.61 HD12 ' CD ' ' A' ' 61' ' ' GLN . 2.2 tt -79.85 74.74 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 N-CA-C 109.055 -0.721 . . . . 0.0 109.055 174.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 97.9 mttt 40.66 80.1 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 126.726 2.01 . . . . 0.0 115.047 176.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 42.5 p-80 -165.28 146.21 7.28 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.809 177.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 16.5 m -94.08 110.29 23.33 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 CA-C-O 121.442 0.639 . . . . 0.0 109.422 175.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 136.48 171.27 12.21 Favored Glycine 0 N--CA 1.429 -1.816 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -72.56 145.74 42.65 Favored 'Trans proline' 0 C--O 1.248 0.986 0 C-N-CA 122.469 2.112 . . . . 0.0 112.354 -179.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 12.9 m -85.0 78.73 9.86 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -159.75 76.89 0.19 Allowed Glycine 0 N--CA 1.438 -1.224 0 C-N-CA 120.043 -1.075 . . . . 0.0 113.275 -178.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 63.0 mtt180 -135.2 115.94 13.91 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 174.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -109.09 109.79 20.88 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.15 -177.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.515 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 80.9 p -130.69 156.34 45.09 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 104.497 -2.409 . . . . 0.0 104.497 174.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.547 ' O ' HG23 ' A' ' 49' ' ' VAL . 11.9 ptp -59.91 -35.03 74.01 Favored 'General case' 0 C--O 1.215 -0.712 0 CA-C-N 119.701 1.137 . . . . 0.0 110.986 -179.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -72.72 -32.74 65.95 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.896 -175.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . 0.687 ' SD ' ' HA ' ' A' ' 58' ' ' ALA . 48.2 tpp -67.17 -39.45 86.47 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 176.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.515 ' HG ' ' O ' ' A' ' 44' ' ' THR . 77.9 mt -64.26 -40.76 96.66 Favored 'General case' 0 C--O 1.207 -1.152 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.544 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.547 HG23 ' O ' ' A' ' 45' ' ' MET . 68.7 t -64.19 -46.3 93.87 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.687 0 C-N-CA 124.037 0.935 . . . . 0.0 110.245 177.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.579 ' OD1' ' HB3' ' A' ' 55' ' ' SER . 7.9 t70 -60.7 -44.32 96.7 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 114.731 -1.122 . . . . 0.0 109.507 -178.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.497 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 54.9 mt -65.18 -47.12 88.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.044 175.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.425 ' CZ ' ' HA3' ' A' ' 68' ' ' GLY . 25.7 t80 -57.18 -44.12 83.28 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 124.353 1.061 . . . . 0.0 110.757 -177.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.4 HD22 ' HD2' ' A' ' 73' ' ' ARG . 11.0 mp -77.21 -28.66 53.91 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 177.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 100.74 29.14 6.68 Favored Glycine 0 C--O 1.244 0.722 0 C-N-CA 120.525 -0.845 . . . . 0.0 113.162 177.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.579 ' HB3' ' OD1' ' A' ' 50' ' ' ASP . 23.1 t -80.28 -170.51 2.56 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 123.388 0.675 . . . . 0.0 110.836 -176.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.462 ' HD2' ' C ' ' A' ' 55' ' ' SER . 1.6 mptp? -121.14 7.84 10.31 Favored 'General case' 0 C--O 1.25 1.1 0 N-CA-C 114.271 1.212 . . . . 0.0 114.271 -177.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.5 m -78.36 -30.08 47.85 Favored 'General case' 0 C--O 1.245 0.823 0 N-CA-C 104.837 -2.283 . . . . 0.0 104.837 173.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.687 ' HA ' ' SD ' ' A' ' 47' ' ' MET . . . -50.2 120.97 4.93 Favored 'General case' 0 N--CA 1.417 -2.113 0 C-N-CA 127.34 2.256 . . . . 0.0 109.825 172.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.586 ' HA ' ' HE3' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -100.64 9.69 42.14 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-O 121.067 0.46 . . . . 0.0 111.297 -179.482 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 61.8 mt -128.23 120.88 54.4 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 176.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.61 ' CD ' HD12 ' A' ' 34' ' ' ILE . 29.9 mm-40 -105.39 32.43 4.27 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.192 0.52 . . . . 0.0 110.144 -177.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 24.5 m -141.65 126.76 18.43 Favored 'General case' 0 C--N 1.311 -1.077 0 O-C-N 122.057 -0.402 . . . . 0.0 110.84 -177.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 131.16 -132.57 6.87 Favored Glycine 0 N--CA 1.442 -0.91 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.452 HG23 ' CD2' ' A' ' 21' ' ' PHE . 1.7 pt -75.9 31.02 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 123.32 0.648 . . . . 0.0 112.054 177.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.497 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 11.5 t80 -66.87 112.8 4.47 Favored 'General case' 0 N--CA 1.42 -1.974 0 CA-C-O 120.992 0.425 . . . . 0.0 110.443 -174.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 63.79 36.8 93.78 Favored Glycine 0 N--CA 1.436 -1.303 0 CA-C-N 115.045 -0.98 . . . . 0.0 112.156 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.609 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -100.8 -25.04 14.25 Favored 'General case' 0 C--N 1.32 -0.701 0 O-C-N 122.153 -0.616 . . . . 0.0 110.247 177.672 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.425 ' HA3' ' CZ ' ' A' ' 52' ' ' PHE . . . -120.13 51.59 0.76 Allowed Glycine 0 N--CA 1.436 -1.351 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.7 t -82.84 9.3 10.16 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 122.017 0.913 . . . . 0.0 109.86 -174.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -102.0 6.8 41.33 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-O 121.709 0.766 . . . . 0.0 109.82 178.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -100.91 154.45 18.66 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 115.019 -0.991 . . . . 0.0 108.852 176.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.653 ' HB3' ' OD1' ' A' ' 75' ' ' ASN . 43.5 t -97.09 164.85 12.34 Favored 'General case' 0 N--CA 1.416 -2.141 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 171.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.4 ' HD2' HD22 ' A' ' 53' ' ' LEU . 10.6 mmm180 -54.16 -40.35 67.39 Favored 'General case' 0 CA--C 1.509 -0.624 0 C-N-CA 122.981 0.512 . . . . 0.0 112.289 -174.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 16.0 t-80 -86.87 -21.73 26.18 Favored 'General case' 0 C--O 1.2 -1.524 0 C-N-CA 119.015 -1.074 . . . . 0.0 111.372 -172.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.653 ' OD1' ' HB3' ' A' ' 72' ' ' SER . 13.4 m120 -79.78 -38.87 32.17 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 -178.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.41 ' HB3' HG13 ' A' ' 49' ' ' VAL . . . -64.09 -46.29 84.93 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.752 176.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.74 -20.56 61.18 Favored 'General case' 0 C--O 1.214 -0.808 0 C-N-CA 120.544 -0.463 . . . . 0.0 111.231 -178.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.413 ' HB3' ' O ' ' A' ' 75' ' ' ASN . 21.7 tpp180 -65.94 -35.63 81.14 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 176.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.2 tt -76.83 -45.27 29.22 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 114.761 -1.108 . . . . 0.0 110.175 -179.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -62.99 -17.19 61.87 Favored 'General case' 0 C--O 1.216 -0.693 0 C-N-CA 120.108 -0.637 . . . . 0.0 109.706 176.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.487 ' HA ' HG13 ' A' ' 84' ' ' ILE . 53.1 mttp -86.52 -26.18 24.71 Favored 'General case' 0 CA--C 1.496 -1.099 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.399 177.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.422 ' HG3' ' OD2' ' A' ' 86' ' ' ASP . 29.2 tptp -72.09 -47.24 52.82 Favored 'General case' 0 N--CA 1.427 -1.599 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 176.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.453 ' HB3' HD23 ' A' ' 89' ' ' LEU . 95.8 mt -58.7 -38.08 77.51 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 179.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.576 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 2.6 pp -77.7 -23.13 14.08 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 C-N-CA 120.048 -0.661 . . . . 0.0 111.747 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.9 tt -77.76 -47.24 19.49 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 176.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.422 ' OD2' ' HG3' ' A' ' 82' ' ' LYS . 68.3 m-20 -69.64 -20.95 63.59 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.567 -179.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.491 ' HB3' ' HB2' ' A' ' 109' ' ' ASN . 3.7 mptp? 84.75 15.61 0.19 Allowed 'General case' 0 CA--C 1.479 -1.765 0 C-N-CA 124.747 1.219 . . . . 0.0 113.679 173.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.541 HG22 HD22 ' A' ' 89' ' ' LEU . 1.8 mp -67.92 -39.92 82.53 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.847 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 169.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.576 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 4.4 mm? -112.08 147.74 35.41 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.682 170.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -133.32 100.53 4.87 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 120.838 0.351 . . . . 0.0 110.061 178.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.413 ' HG2' HG21 ' A' ' 84' ' ' ILE . 18.3 pt-20 -100.26 156.76 17.05 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.458 175.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -133.3 179.9 5.91 Favored 'General case' 0 C--O 1.248 0.987 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 179.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 99.1 mt -104.14 150.18 24.57 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 122.511 1.148 . . . . 0.0 113.727 -170.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -141.57 121.01 13.2 Favored 'General case' 0 N--CA 1.422 -1.85 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 176.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 14.7 tt -118.1 149.98 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.444 0 C-N-CA 119.687 -0.805 . . . . 0.0 108.94 -179.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 39.1 p30 -102.1 -176.7 3.19 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.201 178.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -74.05 11.51 0.9 Allowed 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 123.493 0.717 . . . . 0.0 112.315 -178.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -110.79 -2.89 15.99 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 -179.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 29.5 t70 69.11 24.48 6.1 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-O 123.462 1.601 . . . . 0.0 109.189 -176.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -97.52 107.12 19.56 Favored 'General case' 0 C--O 1.245 0.859 0 CA-C-N 114.998 -1.001 . . . . 0.0 108.749 176.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -88.68 129.53 35.5 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.833 -177.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 15.0 tt -124.5 150.14 29.14 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 175.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -108.92 134.54 51.46 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 122.315 -0.241 . . . . 0.0 110.681 -177.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -106.36 143.33 34.63 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 19.0 t -96.61 133.98 35.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 CA-C-O 122.094 0.949 . . . . 0.0 113.168 -171.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 62.6 mtt -134.62 175.95 9.08 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 113.365 -1.743 . . . . 0.0 106.876 176.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.479 HD23 ' H ' ' A' ' 107' ' ' LEU . 2.1 pt? -121.61 132.24 54.56 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -140.21 -104.99 0.6 Allowed Glycine 0 N--CA 1.429 -1.808 0 C-N-CA 118.484 -1.817 . . . . 0.0 115.525 -174.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.491 ' HB2' ' HB3' ' A' ' 87' ' ' LYS . 37.1 m-80 -49.99 -55.33 15.05 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 115.312 1.597 . . . . 0.0 115.312 -167.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.46 ' O ' HG23 ' A' ' 114' ' ' VAL . 74.8 mmtt -110.89 19.79 18.18 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.833 -0.542 . . . . 0.0 111.119 -176.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -76.3 -33.36 59.07 Favored 'General case' 0 CA--C 1.495 -1.167 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 35.5 tp60 -62.87 -36.48 83.44 Favored 'General case' 0 N--CA 1.423 -1.821 0 CA-C-N 113.025 -1.898 . . . . 0.0 110.023 173.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 19.8 m -69.31 -28.53 66.35 Favored 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 179.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.545 HG22 ' HG ' ' A' ' 119' ' ' LEU . 38.9 t -66.76 -43.81 89.71 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.758 176.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 65.3 mt -67.6 -33.05 74.22 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.314 -179.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -72.71 -23.5 60.87 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 177.21 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 98.12 -19.32 54.98 Favored Glycine 0 N--CA 1.44 -1.063 0 CA-C-N 115.597 -0.729 . . . . 0.0 113.075 177.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -79.17 24.22 0.34 Allowed 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.534 1.134 . . . . 0.0 113.56 -172.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.599 ' O ' HD13 ' A' ' 119' ' ' LEU . 0.0 OUTLIER -94.13 109.53 21.3 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 122.914 1.34 . . . . 0.0 109.73 -178.892 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.526 ' HB3' HG21 ' A' ' 12' ' ' THR 0.341 0.1 OUTLIER -129.54 114.65 16.35 Favored 'General case' 1 C--N 1.225 -4.831 0 N-CA-C 114.449 1.277 . . . . 0.0 114.449 172.651 . . . . . . . . 5 4 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 5.4 m -126.83 173.68 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.796 0 CA-C-N 114.758 -1.11 . . . . 0.0 108.147 177.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.509 ' HA ' ' O ' ' A' ' 9' ' ' ARG . 8.5 p-10 -107.77 173.07 6.48 Favored 'General case' 0 C--N 1.269 -2.919 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.702 -177.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . 0.401 ' O ' ' HD3' ' A' ' 9' ' ' ARG . 51.1 t80 -157.81 166.78 31.82 Favored 'General case' 0 C--O 1.251 1.166 0 C-N-CA 123.93 0.892 . . . . 0.0 108.95 178.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 42.8 tpp -141.19 118.85 11.64 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 125.827 1.651 . . . . 0.0 106.595 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.461 ' H ' ' CD ' ' A' ' 125' ' ' GLU . 1.9 mp0 -43.56 -72.8 0.05 Allowed 'General case' 0 N--CA 1.501 2.105 0 C-N-CA 124.477 1.111 . . . . 0.0 113.144 -176.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.467 ' HA ' ' ND2' ' A' ' 75' ' ' ASN . 14.9 t -114.32 -177.63 3.18 Favored 'General case' 0 N--CA 1.428 -1.568 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.739 -173.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.408 ' CD ' HH21 ' A' ' 78' ' ' ARG . 4.2 mm-40 . . . . . 0 C--N 1.305 -1.367 0 C-N-CA 125.304 1.442 . . . . 0.0 109.67 -174.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 7.3 p . . . . . 0 N--CA 1.441 -0.884 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.487 ' HG2' ' OD1' ' A' ' 5' ' ' ASP . 44.9 mmtm -163.26 -171.68 2.7 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 102.57 -3.122 . . . . 0.0 102.57 176.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 6.7 m -72.52 -30.68 64.7 Favored 'General case' 0 CA--C 1.552 1.043 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 169.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -141.76 104.29 4.5 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 175.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.487 ' OD1' ' HG2' ' A' ' 2' ' ' LYS . 26.9 t70 -118.92 102.47 8.8 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 -175.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 28.9 p90 -75.1 78.19 2.26 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 -174.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 6.3 ptmm? -175.43 -160.13 0.08 Allowed 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 126.658 1.983 . . . . 0.0 105.846 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.2 m -76.67 157.29 31.92 Favored 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 176.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.486 ' HB2' ' O ' ' A' ' 123' ' ' PHE . 6.9 mpt_? -93.83 130.14 39.97 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 -174.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -90.76 94.18 9.56 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 -174.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.613 ' HB ' ' OD1' ' A' ' 14' ' ' ASP . 21.6 m -89.64 104.35 15.0 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 CA-C-O 122.658 1.218 . . . . 0.0 110.648 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -122.28 -42.61 2.35 Favored 'General case' 0 C--N 1.267 -3.018 0 C-N-CA 119.285 -0.966 . . . . 0.0 112.545 174.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.555 ' HA ' ' HB2' ' A' ' 16' ' ' LYS 0.367 7.3 m-20 -87.62 -9.84 53.13 Favored 'General case' 0 N--CA 1.419 -1.99 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 -171.639 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.613 ' OD1' ' HB ' ' A' ' 11' ' ' VAL . 20.2 p-10 -84.32 -39.92 18.55 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 105.545 -2.021 . . . . 0.0 105.545 171.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.431 ' O ' ' HB ' ' A' ' 18' ' ' ILE . 65.0 t -65.39 -37.32 79.79 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.378 0 CA-C-N 113.847 -1.524 . . . . 0.0 109.448 174.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.555 ' HB2' ' HA ' ' A' ' 13' ' ' ASP . 1.4 tppp? -61.6 -42.7 99.24 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 124.941 1.296 . . . . 0.0 109.776 178.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.9 t -61.66 -45.24 94.89 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.431 ' HB ' ' O ' ' A' ' 15' ' ' VAL . 87.6 mt -54.28 -54.28 22.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.168 175.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.417 HG21 HG11 ' A' ' 114' ' ' VAL . 77.2 t -56.5 -47.06 82.39 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.773 0 CA-C-N 115.144 -0.934 . . . . 0.0 111.562 -179.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 7.3 tpt180 -51.25 -51.6 52.57 Favored 'General case' 0 C--N 1.321 -0.644 0 O-C-N 123.421 0.451 . . . . 0.0 111.282 177.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.51 ' CE1' ' HA3' ' A' ' 63' ' ' GLY . 69.0 m-85 -72.58 -35.9 68.05 Favored 'General case' 0 CA--C 1.492 -1.287 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -174.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 27.0 m -73.96 -37.13 46.96 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.533 0 C-N-CA 118.963 -1.095 . . . . 0.0 110.222 178.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -61.02 -50.85 71.67 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 176.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -71.46 -25.8 62.45 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.922 -177.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 14.6 t60 -69.68 -32.44 71.07 Favored 'General case' 0 C--O 1.211 -0.952 0 C-N-CA 120.156 -0.618 . . . . 0.0 109.764 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 20.3 m -82.29 6.26 17.43 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 121.184 0.516 . . . . 0.0 112.017 -175.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 33.1 t -95.51 7.67 45.56 Favored 'General case' 0 N--CA 1.44 -0.936 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 177.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 29.4 t -171.35 -166.76 0.48 Allowed 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 -178.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -83.8 -34.04 24.83 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 175.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 74.79 77.59 0.67 Allowed Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.106 179.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 66.7 mtt -61.72 18.47 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.425 0 C-N-CA 126.91 2.084 . . . . 0.0 115.281 -175.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 27.2 mmm180 -79.08 18.65 0.62 Allowed 'General case' 0 C--N 1.299 -1.587 0 C-N-CA 124.095 0.958 . . . . 0.0 112.315 -178.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -64.48 136.52 57.15 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 121.163 0.506 . . . . 0.0 112.325 -177.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.562 ' HB ' ' HG2' ' A' ' 61' ' ' GLN . 7.1 tt -101.7 -6.63 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-O 123.033 1.397 . . . . 0.0 107.639 176.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 48.7 mmtm -118.15 135.86 53.97 Favored 'General case' 0 N--CA 1.42 -1.95 0 N-CA-C 105.664 -1.976 . . . . 0.0 105.664 178.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 14.7 p-80 -56.64 153.18 10.79 Favored 'General case' 0 C--O 1.244 0.797 0 O-C-N 123.749 0.656 . . . . 0.0 110.745 -179.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 56.2 t -50.34 123.47 2.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 O-C-N 124.413 1.07 . . . . 0.0 109.927 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -163.54 173.12 39.61 Favored Glycine 0 N--CA 1.418 -2.51 0 N-CA-C 110.094 -1.202 . . . . 0.0 110.094 -177.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -19.53 99.45 0.01 OUTLIER 'Trans proline' 0 CA--C 1.545 1.067 1 C-N-CA 127.038 5.159 . . . . 0.0 118.515 -174.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 14.5 m 57.94 -178.08 0.07 Allowed 'General case' 0 CA--C 1.558 1.262 0 N-CA-C 115.49 1.663 . . . . 0.0 115.49 169.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -122.84 126.36 6.31 Favored Glycine 0 N--CA 1.423 -2.222 0 N-CA-C 106.706 -2.558 . . . . 0.0 106.706 172.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 25.5 mmt180 -124.01 110.45 14.79 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -176.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -108.24 92.64 4.15 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.462 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 68.4 p -114.73 163.44 15.46 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 179.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.55 ' O ' HG23 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -58.11 -39.85 79.69 Favored 'General case' 0 C--O 1.214 -0.775 0 CA-C-O 121.028 0.442 . . . . 0.0 109.885 -179.138 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.428 ' CG ' HH22 ' A' ' 73' ' ' ARG . 18.7 t-20 -60.78 -45.42 94.43 Favored 'General case' 0 C--N 1.31 -1.124 0 C-N-CA 124.967 1.307 . . . . 0.0 111.157 -175.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . 0.475 ' SD ' ' HA ' ' A' ' 58' ' ' ALA . 35.6 tpp -67.48 -36.4 81.04 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.584 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' A' ' 44' ' ' THR . 73.1 mt -69.75 -29.54 66.92 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.271 -178.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 45' ' ' MET . 44.2 t -67.07 -48.67 78.39 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.24 0 C-N-CA 123.679 0.792 . . . . 0.0 110.37 178.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -58.91 -41.16 86.6 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.955 177.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.716 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 49.9 mt -63.94 -46.05 95.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.629 176.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.528 ' CE2' ' HA3' ' A' ' 68' ' ' GLY . 49.0 t80 -63.0 -40.08 96.69 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 123.208 0.603 . . . . 0.0 111.361 -178.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.0 mp -75.78 -35.12 60.21 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 111.46 8.18 23.4 Favored Glycine 0 C--O 1.244 0.734 0 C-N-CA 119.822 -1.18 . . . . 0.0 112.184 -177.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 63.2 m -65.63 124.19 21.72 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 123.47 0.708 . . . . 0.0 109.872 177.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -82.88 20.26 1.21 Allowed 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 -178.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.1 m -77.55 -24.55 49.84 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 106.163 -1.791 . . . . 0.0 106.163 172.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.504 ' HB1' HG12 ' A' ' 51' ' ' ILE . . . -52.85 151.06 4.8 Favored 'General case' 0 C--O 1.247 0.947 0 CA-C-N 113.529 -1.669 . . . . 0.0 112.042 178.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -93.92 -16.82 23.63 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.889 178.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 71.1 mt -132.03 143.5 39.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.392 -175.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.562 ' HG2' ' HB ' ' A' ' 34' ' ' ILE . 20.2 mm-40 -106.23 80.91 1.55 Allowed 'General case' 0 C--O 1.245 0.834 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 176.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.4 ' O ' ' HB2' ' A' ' 65' ' ' PHE . 42.0 m -79.59 173.82 12.2 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 110.121 -0.325 . . . . 0.0 110.121 179.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.51 ' HA3' ' CE1' ' A' ' 21' ' ' PHE . . . -60.93 -31.15 75.2 Favored Glycine 0 N--CA 1.467 0.735 0 C-N-CA 121.096 -0.573 . . . . 0.0 112.513 -179.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.462 HG23 ' CD2' ' A' ' 21' ' ' PHE . 5.8 pt -73.74 2.77 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.73 0 N-CA-C 113.515 0.931 . . . . 0.0 113.515 177.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.716 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 6.4 t80 -65.56 106.54 1.46 Allowed 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -178.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 83.41 18.69 63.76 Favored Glycine 0 N--CA 1.429 -1.776 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.493 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.426 ' CG ' ' HA ' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -86.72 -35.27 19.34 Favored 'General case' 0 CA--C 1.51 -0.576 0 C-N-CA 119.022 -1.071 . . . . 0.0 109.956 177.197 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.528 ' HA3' ' CE2' ' A' ' 52' ' ' PHE . . . -105.25 44.37 1.49 Allowed Glycine 0 N--CA 1.426 -1.982 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 44.0 t -72.49 -0.21 12.07 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 123.402 0.681 . . . . 0.0 111.002 -177.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -97.74 1.94 49.03 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-O 121.207 0.527 . . . . 0.0 110.64 178.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -99.55 148.41 24.32 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 115.454 -0.794 . . . . 0.0 108.955 175.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 39.1 t -90.83 161.78 15.11 Favored 'General case' 0 C--N 1.281 -2.382 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 168.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.468 ' HB3' HH11 ' A' ' 73' ' ' ARG . 13.5 mtp-105 -60.29 -36.19 77.3 Favored 'General case' 0 C--O 1.219 -0.522 0 CA-C-O 121.053 0.454 . . . . 0.0 110.293 -177.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 19.4 t-160 -62.67 -41.64 99.19 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.113 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.674 ' ND2' ' H ' ' A' ' 127' ' ' GLU . 6.1 m120 -65.93 -52.58 48.59 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -176.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.445 ' HB3' HG13 ' A' ' 49' ' ' VAL . . . -60.7 -44.12 96.94 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.473 -0.785 . . . . 0.0 112.441 -177.102 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.468 ' CG ' HG21 ' A' ' 49' ' ' VAL . 42.9 mt-10 -64.33 -33.81 76.71 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 121.585 0.707 . . . . 0.0 111.009 178.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.464 ' HE ' ' CD ' ' A' ' 127' ' ' GLU . 17.7 mmm180 -78.04 -17.0 57.57 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.913 -179.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.3 tt -79.84 -42.69 23.8 Favored 'General case' 0 N--CA 1.426 -1.635 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 176.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -60.53 -19.98 58.86 Favored 'General case' 0 C--O 1.216 -0.705 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 172.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.45 ' HA ' HG13 ' A' ' 84' ' ' ILE . 73.0 mmtt -82.75 -28.58 30.31 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.463 176.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 29.1 tptp -70.43 -45.42 65.9 Favored 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 174.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.508 ' HB3' HD23 ' A' ' 89' ' ' LEU . 97.8 mt -58.83 -37.1 75.67 Favored 'General case' 0 N--CA 1.428 -1.563 0 CA-C-N 113.958 -1.474 . . . . 0.0 113.834 178.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.537 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 2.7 pp -74.02 -26.94 21.58 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.592 0 C-N-CA 119.884 -0.726 . . . . 0.0 111.627 178.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 49.0 mt -73.42 -47.65 40.12 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 123.49 0.494 . . . . 0.0 110.507 175.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.424 ' HB2' HD13 ' A' ' 88' ' ' ILE . 69.5 m-20 -67.1 -25.31 66.15 Favored 'General case' 0 C--O 1.254 1.312 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.054 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? 85.51 23.52 0.08 Allowed 'General case' 0 CA--C 1.478 -1.797 0 C-N-CA 125.951 1.7 . . . . 0.0 113.475 175.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.612 HD11 HD21 ' A' ' 119' ' ' LEU . 2.0 mp -74.58 -41.47 48.67 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.224 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 169.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.537 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 3.7 mm? -103.68 140.39 37.65 Favored 'General case' 0 N--CA 1.424 -1.769 0 CA-C-N 114.153 -1.385 . . . . 0.0 109.748 175.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -131.35 109.75 10.57 Favored 'General case' 0 C--N 1.285 -2.216 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 176.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -94.96 149.21 21.5 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 121.051 0.453 . . . . 0.0 112.16 -172.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.472 ' O ' ' HA ' ' A' ' 103' ' ' ALA . 8.1 m-20 -97.78 108.37 21.07 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 94.5 mt -81.68 108.82 15.55 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.716 0.77 . . . . 0.0 109.661 176.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -120.69 125.57 48.01 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-N 114.802 -1.09 . . . . 0.0 108.402 -175.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.52 HD11 ' HA ' ' A' ' 99' ' ' ASP . 16.9 tt -130.3 141.78 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.753 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 178.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -97.13 173.15 7.39 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 176.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -66.44 18.21 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 -173.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -118.61 10.24 12.46 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 177.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.52 ' HA ' HD11 ' A' ' 95' ' ' ILE . 6.1 m-20 60.13 29.32 18.9 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 122.644 1.212 . . . . 0.0 111.023 -174.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.479 ' C ' HG13 ' A' ' 95' ' ' ILE . 94.0 mt-30 -95.92 106.04 18.14 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 114.426 -1.261 . . . . 0.0 107.998 176.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -101.36 144.33 30.31 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.626 -0.715 . . . . 0.0 112.437 -175.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 9.6 tp -141.6 146.86 22.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 174.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.472 ' HA ' ' O ' ' A' ' 92' ' ' ASP . . . -112.0 129.04 56.33 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 110.156 -0.312 . . . . 0.0 110.156 -178.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -97.49 162.78 13.15 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 177.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.448 HG13 ' CD1' ' A' ' 89' ' ' LEU . 8.4 t -105.16 123.71 59.5 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.862 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 -177.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 26.2 mmt -137.83 162.68 33.32 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 113.178 -1.828 . . . . 0.0 106.743 173.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.421 HD23 ' H ' ' A' ' 107' ' ' LEU . 1.5 pt? -127.71 123.29 35.06 Favored 'General case' 0 C--N 1.285 -2.226 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 177.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -125.49 -86.27 0.63 Allowed Glycine 0 N--CA 1.422 -2.237 0 C-N-CA 119.099 -1.524 . . . . 0.0 115.705 -171.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -57.32 -46.49 83.18 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 115.86 1.8 . . . . 0.0 115.86 -167.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.466 ' O ' HG23 ' A' ' 114' ' ' VAL . 41.9 mmtm -106.2 8.8 32.2 Favored 'General case' 0 C--N 1.308 -1.199 0 O-C-N 121.507 -0.746 . . . . 0.0 111.321 -179.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -54.64 -45.7 73.83 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -172.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -72.9 -24.28 60.82 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.213 0.53 . . . . 0.0 110.946 -176.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 7.2 m -75.51 -24.9 56.87 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 -178.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.534 HG21 HG23 ' A' ' 88' ' ' ILE . 21.9 t -74.97 -37.52 41.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 176.004 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 81.4 mt -66.44 -38.59 87.73 Favored 'General case' 0 C--O 1.219 -0.507 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.621 177.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -72.57 -24.99 61.18 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 174.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 70.64 24.7 76.68 Favored Glycine 0 C--O 1.218 -0.852 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.402 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -95.98 32.64 1.86 Allowed 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 105.788 -1.93 . . . . 0.0 105.788 176.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.612 HD21 HD11 ' A' ' 88' ' ' ILE . 0.3 OUTLIER -142.71 127.16 17.8 Favored 'General case' 0 N--CA 1.384 -3.772 0 CA-C-N 113.012 -1.904 . . . . 0.0 108.018 -174.531 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.459 ' HD3' ' O ' ' A' ' 120' ' ' LYS . 0.0 OUTLIER -130.25 137.99 50.3 Favored 'General case' 0 N--CA 1.414 -2.268 0 N-CA-C 107.896 -1.149 . . . . 0.0 107.896 172.362 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.521 HG22 ' O ' ' A' ' 11' ' ' VAL . 4.8 m -114.35 -174.79 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 C-N-CA 119.363 -0.935 . . . . 0.0 108.51 176.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -133.83 140.85 47.15 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -171.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . 0.486 ' O ' ' HB2' ' A' ' 9' ' ' ARG . 11.2 t80 -158.17 -175.5 5.38 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 175.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 26.1 ptt? -142.19 158.74 43.39 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 177.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -37.95 -54.01 1.32 Allowed 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 125.146 1.378 . . . . 0.0 113.176 -177.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 10.2 t -136.57 145.45 44.98 Favored 'General case' 0 N--CA 1.417 -2.088 0 CA-C-O 121.408 0.623 . . . . 0.0 110.924 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.674 ' H ' ' ND2' ' A' ' 75' ' ' ASN . 7.0 tm-20 . . . . . 0 C--N 1.283 -2.297 0 N-CA-C 101.284 -3.598 . . . . 0.0 101.284 175.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 39.8 m . . . . . 0 CA--C 1.507 -0.678 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -132.23 151.76 51.66 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 178.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.2 p -70.01 141.65 52.89 Favored 'General case' 0 N--CA 1.421 -1.917 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 174.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -78.17 126.5 30.89 Favored 'General case' 0 CA--C 1.483 -1.609 0 C-N-CA 119.232 -0.987 . . . . 0.0 109.203 -178.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -77.87 98.3 5.57 Favored 'General case' 0 C--N 1.274 -2.69 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.088 178.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -70.93 102.58 2.43 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 113.867 -1.515 . . . . 0.0 110.701 -177.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 33.8 mtmm -98.79 100.99 12.25 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 177.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.508 ' CG2' ' HA ' ' A' ' 124' ' ' MET . 9.1 m -128.88 179.47 5.7 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -174.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.474 ' H ' HG22 ' A' ' 8' ' ' THR . 72.1 mtm180 -96.49 143.16 27.75 Favored 'General case' 0 CA--C 1.499 -0.982 0 N-CA-C 114.621 1.341 . . . . 0.0 114.621 -175.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -98.16 90.26 4.79 Favored 'General case' 0 CA--C 1.48 -1.727 0 N-CA-C 102.146 -3.279 . . . . 0.0 102.146 170.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.435 ' HA ' ' OD1' ' A' ' 14' ' ' ASP . 19.0 m -71.95 84.53 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.317 0 CA-C-O 122.85 1.31 . . . . 0.0 112.652 -172.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.802 HG22 ' HA ' ' A' ' 120' ' ' LYS . 37.8 p -100.88 -54.79 2.73 Favored 'General case' 0 C--N 1.26 -3.301 0 C-N-CA 117.869 -1.532 . . . . 0.0 112.831 174.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.472 ' HA ' ' HB3' ' A' ' 16' ' ' LYS . 8.2 t70 -86.96 -11.56 50.18 Favored 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 119.405 -0.918 . . . . 0.0 110.142 -178.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.435 ' OD1' ' HA ' ' A' ' 11' ' ' VAL . 1.6 m-20 -69.41 -41.77 75.96 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 104.864 -2.272 . . . . 0.0 104.864 173.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 51.5 t -70.07 -45.37 76.49 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.828 0 CA-C-N 112.946 -1.934 . . . . 0.0 109.847 176.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.472 ' HB3' ' HA ' ' A' ' 13' ' ' ASP . 30.9 ttmt -65.56 -35.54 81.13 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 -179.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.6 p -62.72 -44.56 95.89 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 120.628 -0.429 . . . . 0.0 109.937 176.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 56.9 mt -53.9 -50.24 54.12 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 O-C-N 123.745 0.653 . . . . 0.0 109.725 172.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.47 ' HA ' HG22 ' A' ' 22' ' ' VAL . 76.5 t -58.05 -46.36 88.08 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.867 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.27 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 58.7 mtm-85 -58.33 -32.43 68.49 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.672 ' CD2' HG23 ' A' ' 64' ' ' ILE . 70.7 m-85 -83.48 -37.75 22.71 Favored 'General case' 0 N--CA 1.427 -1.58 0 C-N-CA 119.514 -0.875 . . . . 0.0 112.747 179.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.47 HG22 ' HA ' ' A' ' 19' ' ' VAL . 27.7 m -69.01 -29.73 44.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 C-N-CA 117.629 -1.629 . . . . 0.0 109.668 176.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.411 ' HG3' ' O ' ' A' ' 19' ' ' VAL . 54.9 mt-30 -62.61 -38.35 89.82 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.471 170.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.635 ' HG3' ' O ' ' A' ' 21' ' ' PHE . 0.3 OUTLIER -64.71 -28.74 69.8 Favored 'General case' 0 CA--C 1.493 -1.245 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.466 -179.67 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 9.7 t-80 -71.77 0.65 8.43 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -175.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 16.7 m -69.84 -29.58 66.87 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 174.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 34.2 t -125.02 -16.84 5.95 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.073 178.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 16.8 m 70.4 89.92 0.1 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.277 1.431 . . . . 0.0 110.748 -177.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -81.67 -34.47 30.69 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 -179.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -82.23 41.24 2.76 Favored Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 110.699 -0.961 . . . . 0.0 110.699 174.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 25.8 ptt? -63.0 -13.53 36.36 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.958 1.303 . . . . 0.0 113.309 -176.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.41 -36.12 82.69 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 178.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 8.2 p30 49.07 -168.25 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 125.826 1.651 . . . . 0.0 113.574 176.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 65.7 mt -131.12 -60.2 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 177.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 35.8 mtmm -107.33 -34.98 6.92 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.871 179.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -174.51 152.55 1.71 Allowed 'General case' 0 CA--C 1.506 -0.735 0 C-N-CA 124.741 1.216 . . . . 0.0 107.859 179.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 30.0 m -72.23 -24.35 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-O 121.669 0.747 . . . . 0.0 109.235 174.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.489 ' CA ' HD13 ' A' ' 60' ' ' ILE . . . 171.69 158.75 16.4 Favored Glycine 0 N--CA 1.413 -2.878 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 177.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -84.77 -24.76 2.14 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.058 1.839 . . . . 0.0 111.595 176.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 23.0 t -176.62 -179.86 1.05 Allowed 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 -178.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -89.01 66.42 3.08 Favored Glycine 0 N--CA 1.443 -0.864 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 58.1 mtt180 -130.59 112.97 13.64 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -124.15 122.52 38.04 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.744 -177.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 41.6 p -116.63 155.98 27.84 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 106.306 -1.738 . . . . 0.0 106.306 172.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.454 ' O ' HG23 ' A' ' 49' ' ' VAL . 16.2 ptp -62.45 -36.08 81.3 Favored 'General case' 0 C--O 1.217 -0.637 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -175.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -66.13 -30.94 71.52 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.936 0.398 . . . . 0.0 110.133 -178.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 22.7 mmt -73.88 -41.32 62.35 Favored 'General case' 0 C--O 1.202 -1.409 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.845 177.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 80.4 mt -56.43 -37.21 69.91 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.979 0.418 . . . . 0.0 110.908 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.57 HG13 ' HB3' ' A' ' 76' ' ' ALA . 74.2 t -66.11 -44.51 91.77 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.317 0 C-N-CA 124.268 1.027 . . . . 0.0 110.601 177.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.434 ' CG ' ' HB2' ' A' ' 55' ' ' SER . 4.5 t70 -59.72 -43.17 94.29 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.45 -178.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.419 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 1.9 mp -64.29 -47.93 87.61 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.959 174.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -54.81 -42.37 71.76 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.441 1.096 . . . . 0.0 111.16 -177.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.444 HD11 ' HB2' ' A' ' 71' ' ' TYR . 9.7 mp -83.04 -15.14 52.2 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 178.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.58 39.09 12.69 Favored Glycine 0 C--O 1.253 1.327 0 C-N-CA 120.417 -0.897 . . . . 0.0 111.079 -178.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.434 ' HB2' ' CG ' ' A' ' 50' ' ' ASP . 65.2 m -86.89 -172.52 4.03 Favored 'General case' 0 N--CA 1.418 -2.055 0 CA-C-N 115.294 -0.453 . . . . 0.0 111.886 -178.159 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -109.79 -4.72 15.88 Favored 'General case' 0 C--O 1.261 1.703 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 -170.213 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.3 m -78.07 -28.07 48.74 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 105.565 -2.013 . . . . 0.0 105.565 176.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -51.59 107.19 0.17 Allowed 'General case' 0 N--CA 1.419 -1.998 0 C-N-CA 126.56 1.944 . . . . 0.0 112.428 175.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.67 -7.27 28.18 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 174.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.489 HD13 ' CA ' ' A' ' 38' ' ' GLY . 28.1 mm -95.65 110.84 24.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 114.511 -1.222 . . . . 0.0 108.866 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -122.2 97.13 5.33 Favored 'General case' 0 C--N 1.293 -1.859 0 O-C-N 121.781 -0.575 . . . . 0.0 110.283 172.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.9 m -145.97 -80.13 0.16 Allowed 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 173.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -100.98 165.16 18.59 Favored Glycine 0 N--CA 1.433 -1.551 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.243 178.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.672 HG23 ' CD2' ' A' ' 21' ' ' PHE 0.26 16.6 pt 48.55 9.71 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.443 0 N-CA-C 117.573 2.434 . . . . 0.0 117.573 178.4 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.419 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 23.0 t80 -64.74 105.07 0.92 Allowed 'General case' 0 C--O 1.243 0.762 0 CA-C-N 118.442 0.565 . . . . 0.0 111.292 -177.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 74.56 29.63 61.34 Favored Glycine 0 C--N 1.312 -0.762 0 CA-C-N 115.628 -0.714 . . . . 0.0 112.241 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.472 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.7 OUTLIER -94.2 -19.31 20.86 Favored 'General case' 0 C--N 1.322 -0.611 0 O-C-N 122.409 -0.465 . . . . 0.0 111.565 176.83 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -126.53 39.09 2.05 Favored Glycine 0 N--CA 1.433 -1.538 0 C-N-CA 120.465 -0.874 . . . . 0.0 111.433 -178.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 15.5 m -71.3 1.76 5.72 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 123.944 0.898 . . . . 0.0 112.064 -177.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -98.99 4.27 47.18 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-O 121.422 0.629 . . . . 0.0 110.099 178.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.444 ' HB2' HD11 ' A' ' 53' ' ' LEU . 9.9 m-85 -95.35 147.19 23.76 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 115.291 -0.868 . . . . 0.0 108.779 175.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.455 ' HB3' ' CG ' ' A' ' 75' ' ' ASN . 30.5 t -75.95 149.31 37.69 Favored 'General case' 0 N--CA 1.416 -2.171 0 N-CA-C 105.299 -2.112 . . . . 0.0 105.299 169.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.444 ' O ' ' HG3' ' A' ' 77' ' ' GLU . 0.2 OUTLIER -50.33 -44.92 54.54 Favored 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 123.946 0.898 . . . . 0.0 110.339 -173.356 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.423 ' HA ' ' OE1' ' A' ' 77' ' ' GLU . 17.5 t-80 -84.87 -12.55 53.25 Favored 'General case' 0 N--CA 1.428 -1.568 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.936 -173.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.668 ' ND2' ' HB3' ' A' ' 127' ' ' GLU . 6.5 m120 -71.58 -45.41 62.29 Favored 'General case' 0 CA--C 1.48 -1.718 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 179.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.57 ' HB3' HG13 ' A' ' 49' ' ' VAL . . . -63.88 -41.52 97.71 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 114.477 -1.238 . . . . 0.0 109.44 179.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.444 ' HG3' ' O ' ' A' ' 73' ' ' ARG . 47.9 mt-10 -61.26 -36.09 79.04 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-O 121.53 0.681 . . . . 0.0 110.508 176.136 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.612 ' NH1' ' HB2' ' A' ' 127' ' ' GLU . 62.7 ttp180 -72.75 -23.79 60.87 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.63 -177.007 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.3 tt -79.8 -44.36 20.76 Favored 'General case' 0 N--CA 1.419 -1.98 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.175 -178.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.434 ' HB3' ' HE2' ' A' ' 45' ' ' MET . 76.3 m-85 -63.13 -21.47 66.21 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 175.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.416 ' O ' HG13 ' A' ' 84' ' ' ILE . 22.6 mmtm -82.49 -28.19 31.32 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.814 176.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 45.8 tptt -70.29 -44.0 69.24 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 175.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.448 ' HB3' HD23 ' A' ' 89' ' ' LEU . 94.3 mt -62.24 -33.63 74.95 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 114.782 -1.099 . . . . 0.0 113.533 178.138 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.543 HG21 ' HG3' ' A' ' 91' ' ' GLU . 2.5 pp -75.56 -25.77 17.85 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.643 0 C-N-CA 119.716 -0.794 . . . . 0.0 111.506 178.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 52.4 mt -72.12 -49.06 39.15 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 121.034 0.445 . . . . 0.0 110.693 176.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.52 -14.2 61.17 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.267 -179.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.437 ' HG2' ' HB3' ' A' ' 109' ' ' ASN . 0.0 OUTLIER 83.96 13.45 0.32 Allowed 'General case' 0 CA--C 1.501 -0.915 0 C-N-CA 125.432 1.493 . . . . 0.0 112.153 167.761 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 1.8 mp -65.38 -41.65 91.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 169.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.449 ' HB3' HG22 ' A' ' 84' ' ' ILE . 3.3 mm? -103.88 148.01 26.65 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 114.107 -1.406 . . . . 0.0 110.466 174.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -132.76 127.84 35.53 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.386 177.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.543 ' HG3' HG21 ' A' ' 84' ' ' ILE . 46.2 mt-10 -94.53 137.16 33.98 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-O 121.264 0.554 . . . . 0.0 110.978 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -98.36 144.47 27.71 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 114.585 -1.189 . . . . 0.0 108.924 -179.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 91.1 mt -104.59 97.88 7.73 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 121.881 0.848 . . . . 0.0 110.528 -178.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.405 ' O ' ' HB1' ' A' ' 101' ' ' ALA . 32.7 t80 -100.14 111.68 23.97 Favored 'General case' 0 C--N 1.282 -2.357 0 CA-C-N 114.443 -1.253 . . . . 0.0 108.09 -177.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.67 ' HA ' ' CB ' ' A' ' 101' ' ' ALA . 1.8 tt -132.3 141.88 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.844 0 O-C-N 123.597 0.56 . . . . 0.0 111.162 174.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -99.32 171.38 8.01 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 177.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -67.8 26.4 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -172.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.448 ' O ' ' HG3' ' A' ' 100' ' ' GLN . 15.3 m120 -119.0 -4.95 10.57 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 177.114 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 57.38 33.03 22.71 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 122.802 1.287 . . . . 0.0 110.718 -174.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.448 ' HG3' ' O ' ' A' ' 98' ' ' ASN . 27.3 mt-30 -128.53 87.19 2.55 Favored 'General case' 0 CA--C 1.495 -1.151 0 CA-C-N 114.023 -1.444 . . . . 0.0 108.744 -177.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.67 ' CB ' ' HA ' ' A' ' 95' ' ' ILE . . . -159.39 -177.86 6.73 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -175.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 10.6 tp -139.42 167.75 19.45 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.332 0 O-C-N 123.366 0.416 . . . . 0.0 110.436 -170.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -84.74 141.18 30.73 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 122.945 0.498 . . . . 0.0 110.556 179.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -111.8 167.72 10.14 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.21 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 14.7 t -98.27 129.65 48.21 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -177.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 26.3 mmt -136.33 163.45 30.41 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 113.774 -1.557 . . . . 0.0 107.943 176.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.486 ' HB3' ' CB ' ' A' ' 111' ' ' ALA . 7.7 mp -115.19 124.35 51.19 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 176.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -131.8 -102.86 0.89 Allowed Glycine 0 N--CA 1.434 -1.481 0 C-N-CA 118.592 -1.765 . . . . 0.0 116.316 -173.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.437 ' HB3' ' HG2' ' A' ' 87' ' ' LYS . 45.1 t-20 -58.24 -45.71 87.27 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.554 1.142 . . . . 0.0 113.693 -165.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.516 ' HD3' ' OG1' ' A' ' 113' ' ' THR . 19.8 mmtm -111.16 13.81 21.82 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -178.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.486 ' CB ' ' HB3' ' A' ' 107' ' ' LEU . . . -70.6 -38.5 74.01 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.693 0.758 . . . . 0.0 109.681 177.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.409 HE21 ' C ' ' A' ' 112' ' ' GLN . 0.0 OUTLIER -64.19 -30.64 71.69 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.882 0.848 . . . . 0.0 109.246 176.335 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.516 ' OG1' ' HD3' ' A' ' 110' ' ' LYS . 17.2 m -74.53 -25.65 59.47 Favored 'General case' 0 N--CA 1.424 -1.772 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.329 -178.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.508 ' HA ' ' HG ' ' A' ' 119' ' ' LEU . 63.4 t -66.15 -44.83 91.49 Favored 'Isoleucine or valine' 0 C--O 1.248 0.998 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 174.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 59.3 mt -63.74 -42.05 97.94 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.919 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -72.3 -14.3 61.71 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.618 177.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 83.43 11.6 79.98 Favored Glycine 0 C--O 1.213 -1.161 0 C-N-CA 120.685 -0.769 . . . . 0.0 113.65 176.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -95.92 23.27 6.5 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 122.562 1.172 . . . . 0.0 109.481 -176.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.538 ' O ' HD13 ' A' ' 119' ' ' LEU . 0.0 OUTLIER -103.39 101.33 11.23 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-O 122.926 1.346 . . . . 0.0 108.647 -178.474 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.802 ' HA ' HG22 ' A' ' 12' ' ' THR . 0.0 OUTLIER -128.94 96.55 4.38 Favored 'General case' 1 C--N 1.229 -4.668 0 CA-C-N 115.021 -0.99 . . . . 0.0 112.957 175.512 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 5.8 m -114.13 173.45 3.16 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.777 -178.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -104.94 160.62 14.88 Favored 'General case' 0 C--N 1.277 -2.545 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.967 -179.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . 0.445 ' O ' HG22 ' A' ' 8' ' ' THR . 70.8 t80 -158.06 135.12 10.0 Favored 'General case' 0 C--O 1.25 1.095 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.788 172.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.508 ' HA ' ' CG2' ' A' ' 8' ' ' THR . 17.6 tmm? -97.08 136.7 37.26 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 115.132 -0.94 . . . . 0.0 108.651 -179.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 -58.57 -68.3 0.27 Allowed 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 116.908 2.188 . . . . 0.0 116.908 -168.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 5.2 m -99.74 157.05 16.76 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -163.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.668 ' HB3' ' ND2' ' A' ' 75' ' ' ASN . 44.1 tt0 . . . . . 0 C--O 1.269 2.116 0 N-CA-C 104.719 -2.326 . . . . 0.0 104.719 176.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 49.3 t . . . . . 0 CA--C 1.507 -0.711 0 N-CA-C 104.471 -2.418 . . . . 0.0 104.471 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -78.77 80.23 5.14 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 170.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 11.7 p -144.82 -175.73 4.79 Favored 'General case' 0 N--CA 1.423 -1.81 0 CA-C-N 114.054 -1.43 . . . . 0.0 107.598 -172.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.591 ' HE2' ' O ' ' A' ' 5' ' ' ASP . 20.1 ptmt -78.57 170.59 16.4 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 175.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.591 ' O ' ' HE2' ' A' ' 4' ' ' LYS . 26.1 t70 -87.32 -178.44 6.19 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 176.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -83.66 -19.61 35.07 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 122.012 -0.43 . . . . 0.0 110.099 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.407 ' HG3' ' O ' ' A' ' 8' ' ' THR . 27.8 tptp -52.47 128.15 24.83 Favored 'General case' 0 C--O 1.25 1.09 0 C-N-CA 124.308 1.043 . . . . 0.0 113.264 -178.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.407 ' O ' ' HG3' ' A' ' 7' ' ' LYS . 1.8 m -77.63 173.49 11.98 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 174.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 28.9 mmt180 -94.81 154.64 17.17 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 121.568 -0.708 . . . . 0.0 109.201 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -118.68 108.51 15.0 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.438 HG22 ' HB2' ' A' ' 123' ' ' PHE . 12.8 m -101.61 101.3 11.91 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.167 0 CA-C-O 122.271 1.034 . . . . 0.0 110.002 177.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.678 HG22 ' HA ' ' A' ' 120' ' ' LYS . 42.9 p -120.17 -40.2 2.73 Favored 'General case' 0 C--N 1.264 -3.134 0 C-N-CA 119.494 -0.882 . . . . 0.0 109.8 177.154 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -69.35 -40.62 77.41 Favored 'General case' 0 C--N 1.29 -1.982 0 C-N-CA 125.867 1.667 . . . . 0.0 109.643 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -68.78 -45.29 71.72 Favored 'General case' 0 C--O 1.244 0.776 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 87.2 t -67.38 -40.83 85.48 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 CA-C-N 114.063 -1.426 . . . . 0.0 111.765 -177.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -65.31 -36.93 85.56 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 43.4 t -61.27 -46.76 89.02 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 175.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 68.6 mt -56.0 -54.11 30.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 C-N-CA 123.072 0.549 . . . . 0.0 110.399 177.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 71.7 t -59.4 -44.03 91.68 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.789 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.859 -178.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 19.6 ttt180 -61.51 -45.86 92.44 Favored 'General case' 0 N--CA 1.436 -1.13 0 C-N-CA 120.0 -0.68 . . . . 0.0 110.847 179.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -63.15 -42.83 99.53 Favored 'General case' 0 CA--C 1.5 -0.943 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.452 ' O ' ' HB3' ' A' ' 25' ' ' HIS . 28.2 m -72.89 -33.47 43.62 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 C-N-CA 119.909 -0.716 . . . . 0.0 111.006 179.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -65.98 -54.86 20.72 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 121.164 -0.214 . . . . 0.0 110.796 173.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -77.28 1.53 18.42 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.365 0.602 . . . . 0.0 111.114 -177.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.452 ' HB3' ' O ' ' A' ' 22' ' ' VAL . 17.1 t-80 -58.31 -36.2 73.02 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 173.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.6 m -98.11 13.13 32.14 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.368 -177.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 14.8 m -112.37 11.43 20.0 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 177.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 25.8 t 74.42 130.77 0.04 OUTLIER 'General case' 0 C--O 1.246 0.919 0 C-N-CA 125.032 1.333 . . . . 0.0 112.506 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.512 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 78.4 mt-30 -127.94 -70.15 0.7 Allowed 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 114.987 -1.006 . . . . 0.0 108.813 177.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 33.42 -82.77 0.0 OUTLIER Glycine 0 N--CA 1.491 2.318 0 N-CA-C 117.349 1.699 . . . . 0.0 117.349 170.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.62 -28.39 68.49 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 123.685 0.794 . . . . 0.0 113.092 -176.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.512 ' HG2' ' O ' ' A' ' 29' ' ' GLN . 14.3 ptt180 -91.36 -10.77 40.01 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 179.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -113.72 -159.44 0.69 Allowed 'General case' 0 C--O 1.25 1.115 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 -178.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 67.0 mt -67.85 144.03 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 N-CA-C 104.479 -2.415 . . . . 0.0 104.479 167.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 41.2 mmtt -79.96 81.41 6.23 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 119.857 -0.737 . . . . 0.0 111.01 -169.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 11.0 t60 -164.43 130.45 2.93 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 115.063 -0.971 . . . . 0.0 108.71 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.469 ' HA ' ' OG ' ' A' ' 62' ' ' SER . 59.3 t -108.62 125.03 65.52 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 176.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -121.16 95.96 0.58 Allowed Glycine 0 CA--C 1.528 0.873 0 C-N-CA 120.375 -0.917 . . . . 0.0 113.668 -179.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -107.35 22.48 0.08 OUTLIER 'Trans proline' 0 CA--C 1.55 1.3 0 C-N-CA 123.597 2.865 . . . . 0.0 111.479 174.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 6.5 p -72.75 97.81 2.28 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -173.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.16 33.77 35.07 Favored Glycine 0 CA--C 1.509 -0.286 0 CA-C-N 115.781 -0.645 . . . . 0.0 113.593 173.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 54.9 mtm180 62.06 -108.34 0.29 Allowed 'General case' 0 N--CA 1.426 -1.675 0 C-N-CA 123.445 0.698 . . . . 0.0 112.178 -177.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -157.87 128.08 6.2 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 -173.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.418 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 57.6 p -116.37 158.02 24.14 Favored 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 171.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.45 ' O ' HG23 ' A' ' 49' ' ' VAL . 21.2 ptm -54.91 -37.85 66.88 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 120.283 -0.567 . . . . 0.0 111.634 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -66.05 -36.02 82.12 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 46.0 mtt -66.94 -42.97 84.37 Favored 'General case' 0 CA--C 1.497 -1.09 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 44' ' ' THR . 80.8 mt -59.34 -45.58 90.98 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.111 -178.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 45' ' ' MET . 82.2 t -66.43 -52.78 42.95 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.137 0 C-N-CA 123.908 0.883 . . . . 0.0 111.311 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.16 -39.79 87.65 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.182 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.514 HD12 ' HA ' ' A' ' 58' ' ' ALA . 1.8 mp -71.6 -38.73 68.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 O-C-N 121.984 -0.447 . . . . 0.0 111.402 177.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.487 ' CE2' ' HA3' ' A' ' 68' ' ' GLY . 60.2 t80 -55.47 -37.71 68.16 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 124.111 0.964 . . . . 0.0 111.293 -178.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.5 mp -92.7 -25.85 18.04 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 177.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.33 50.23 4.61 Favored Glycine 0 C--O 1.22 -0.731 0 N-CA-C 108.694 -1.762 . . . . 0.0 108.694 -172.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 47.6 t -97.56 -170.24 1.97 Allowed 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 124.535 1.134 . . . . 0.0 112.92 -171.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.507 ' NZ ' ' HB2' ' A' ' 56' ' ' LYS . 6.2 mtmp? -43.55 -53.69 5.42 Favored 'General case' 0 C--O 1.247 0.925 0 C-N-CA 128.137 2.575 . . . . 0.0 112.282 -178.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.5 m -94.46 9.05 39.95 Favored 'General case' 0 N--CA 1.417 -2.087 0 CA-C-N 114.54 -1.209 . . . . 0.0 111.406 -171.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.532 ' HB1' ' HE2' ' A' ' 65' ' ' PHE . . . -82.41 91.12 6.78 Favored 'General case' 0 N--CA 1.399 -2.998 0 CA-C-O 121.918 0.866 . . . . 0.0 110.21 178.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.542 ' HA ' HE22 ' A' ' 61' ' ' GLN . 62.7 mttp -119.96 24.11 10.68 Favored 'General case' 0 C--N 1.287 -2.148 0 CA-C-N 114.622 -1.172 . . . . 0.0 109.519 179.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.458 ' HB ' HG12 ' A' ' 51' ' ' ILE . 1.9 mp -105.39 -55.4 5.66 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 CA-C-N 115.356 -0.838 . . . . 0.0 113.028 -178.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.542 HE22 ' HA ' ' A' ' 59' ' ' LYS . 26.2 mp0 67.22 -7.73 0.5 Allowed 'General case' 0 N--CA 1.507 2.376 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 175.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.469 ' OG ' ' HA ' ' A' ' 37' ' ' VAL . 12.6 m -94.59 84.71 4.33 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-O 120.765 0.317 . . . . 0.0 110.449 -179.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 101.67 138.74 10.29 Favored Glycine 0 N--CA 1.437 -1.246 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.024 178.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . 0.258 10.8 pt 49.45 14.92 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 N-CA-C 116.217 1.932 . . . . 0.0 116.217 177.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.539 ' CD2' ' HA ' ' A' ' 61' ' ' GLN . 27.9 t80 -75.5 104.88 6.25 Favored 'General case' 0 N--CA 1.419 -1.987 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -177.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 88.48 12.62 64.6 Favored Glycine 0 N--CA 1.437 -1.264 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.186 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.61 -34.53 77.19 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 -179.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.487 ' HA3' ' CE2' ' A' ' 52' ' ' PHE . . . -134.27 48.92 0.92 Allowed Glycine 0 N--CA 1.421 -2.324 0 C-N-CA 119.628 -1.272 . . . . 0.0 112.536 -175.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 19.9 m -71.36 4.27 3.06 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 120.975 0.417 . . . . 0.0 111.804 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -102.97 1.35 33.53 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-O 121.325 0.584 . . . . 0.0 109.99 177.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -95.26 160.11 14.69 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 174.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 41.2 t -88.75 169.98 11.17 Favored 'General case' 0 N--CA 1.411 -2.417 0 N-CA-C 103.901 -2.629 . . . . 0.0 103.901 165.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.53 ' O ' ' HG3' ' A' ' 77' ' ' GLU . 10.9 ptm180 -64.96 -27.37 68.79 Favored 'General case' 0 C--O 1.2 -1.536 0 C-N-CA 118.462 -1.295 . . . . 0.0 110.166 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.668 ' O ' ' HG2' ' A' ' 78' ' ' ARG . 34.2 m170 -57.34 -59.74 4.68 Favored 'General case' 0 C--O 1.209 -1.065 0 O-C-N 124.169 0.918 . . . . 0.0 112.439 -177.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.642 ' HA ' ' CG ' ' A' ' 78' ' ' ARG 0.398 12.9 m-80 -64.18 -28.0 69.46 Favored 'General case' 0 CA--C 1.485 -1.529 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 177.715 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.4 -50.59 72.24 Favored 'General case' 0 N--CA 1.439 -1.001 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 171.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.65 ' O ' ' HG2' ' A' ' 81' ' ' LYS . 42.9 mt-10 -56.83 -42.81 80.3 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.599 0.759 . . . . 0.0 111.078 177.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.668 ' HG2' ' O ' ' A' ' 74' ' ' HIS . 13.1 mmt85 -59.13 -36.41 75.18 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -175.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -77.57 -47.45 19.4 Favored 'General case' 0 CA--C 1.47 -2.125 0 CA-C-N 114.675 -1.148 . . . . 0.0 111.84 -172.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -62.91 -20.75 65.48 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 121.594 0.711 . . . . 0.0 109.207 178.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.65 ' HG2' ' O ' ' A' ' 77' ' ' GLU . 30.6 mmmt -88.87 -26.13 21.78 Favored 'General case' 0 N--CA 1.436 -1.133 0 C-N-CA 118.938 -1.105 . . . . 0.0 109.669 179.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 29.8 tptp -69.74 -45.69 67.58 Favored 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 177.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.408 ' HB3' HD23 ' A' ' 89' ' ' LEU . 95.8 mt -56.71 -40.77 76.23 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-N 114.086 -1.415 . . . . 0.0 113.581 177.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.605 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 2.5 pp -78.11 -18.12 13.77 Favored 'Isoleucine or valine' 0 C--O 1.254 1.342 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 179.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 46.9 mt -81.59 -48.66 11.48 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.49 175.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -66.49 -33.84 76.6 Favored 'General case' 0 C--O 1.249 1.042 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.629 ' HB3' ' HB2' ' A' ' 109' ' ' ASN 0.274 57.8 mttm 84.78 27.71 0.07 Allowed 'General case' 0 CA--C 1.454 -2.712 0 C-N-CA 126.524 1.93 . . . . 0.0 115.181 174.792 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.535 HG23 HG21 ' A' ' 114' ' ' VAL . 1.8 mp -67.75 -36.37 75.7 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.274 0 N-CA-C 105.111 -2.181 . . . . 0.0 105.111 164.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.605 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 4.4 mm? -110.94 151.68 27.64 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 114.005 -1.452 . . . . 0.0 108.318 171.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -141.43 111.95 7.01 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 177.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -92.46 143.23 26.57 Favored 'General case' 0 C--N 1.278 -2.518 0 CA-C-O 121.676 0.751 . . . . 0.0 111.439 -176.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -98.51 113.07 24.94 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 114.726 -1.125 . . . . 0.0 109.496 -178.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 72.1 mt -78.0 113.93 16.38 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 114.673 -1.149 . . . . 0.0 109.745 -178.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 92.0 t80 -119.46 100.04 7.05 Favored 'General case' 0 N--CA 1.417 -2.076 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 178.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.867 ' HA ' ' HB3' ' A' ' 101' ' ' ALA . 0.3 OUTLIER -130.89 144.05 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.388 -3.537 0 C-N-CA 119.409 -0.917 . . . . 0.0 109.467 -178.672 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.441 ' H ' HD13 ' A' ' 95' ' ' ILE . 40.3 p30 -100.84 -178.92 3.91 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 120.306 -0.558 . . . . 0.0 111.453 -176.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -80.32 15.5 1.57 Allowed 'General case' 0 C--N 1.316 -0.874 0 C-N-CA 123.841 0.856 . . . . 0.0 111.275 -178.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.479 ' HB3' ' NE2' ' A' ' 100' ' ' GLN . 2.6 m-20 -117.54 -0.4 11.91 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 58.92 27.22 15.93 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 124.548 1.155 . . . . 0.0 110.17 -174.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.479 ' NE2' ' HB3' ' A' ' 98' ' ' ASN . 42.0 mt-30 -128.94 68.63 1.4 Allowed 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.756 -1.111 . . . . 0.0 111.933 -174.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.867 ' HB3' ' HA ' ' A' ' 95' ' ' ILE . . . -158.43 178.85 9.7 Favored 'General case' 0 C--N 1.273 -2.723 0 CA-C-N 114.577 -1.192 . . . . 0.0 108.42 178.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 14.7 tt -140.57 157.15 23.94 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.973 0 CA-C-N 118.708 0.685 . . . . 0.0 112.196 -170.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -85.64 135.02 33.96 Favored 'General case' 0 C--O 1.255 1.38 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.758 176.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -103.65 165.76 10.84 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 54.0 t -111.92 135.23 51.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -176.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 14.6 mmt -138.61 -173.59 3.59 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 113.463 -1.699 . . . . 0.0 107.775 176.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -137.26 138.21 39.84 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 177.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -145.52 -84.6 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.893 0 C-N-CA 118.313 -1.899 . . . . 0.0 116.456 -174.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.629 ' HB2' ' HB3' ' A' ' 87' ' ' LYS . 29.4 m-80 -56.57 -50.46 71.86 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 -166.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 40.0 mmtm -104.06 3.89 33.73 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.615 -0.678 . . . . 0.0 110.554 -176.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -58.31 -31.68 67.74 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 123.022 0.529 . . . . 0.0 112.29 -178.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -70.59 -26.22 63.42 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-O 121.57 0.7 . . . . 0.0 110.112 179.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 4.8 m -80.0 -23.88 41.23 Favored 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.535 HG21 HG23 ' A' ' 88' ' ' ILE . 54.5 t -67.9 -36.13 74.61 Favored 'Isoleucine or valine' 0 C--O 1.246 0.918 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 174.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 75.2 mt -73.22 -34.92 66.18 Favored 'General case' 0 C--O 1.216 -0.696 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.661 177.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -72.32 -14.51 61.76 Favored 'General case' 0 C--O 1.217 -0.629 0 CA-C-O 122.211 1.005 . . . . 0.0 108.709 175.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 94.18 -19.02 55.6 Favored Glycine 0 N--CA 1.44 -1.092 0 CA-C-N 115.186 -0.915 . . . . 0.0 113.163 176.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -87.63 66.57 8.97 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.738 0.78 . . . . 0.0 111.738 -173.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.47 ' O ' HD22 ' A' ' 119' ' ' LEU . 0.0 OUTLIER -126.75 79.44 1.87 Allowed 'General case' 0 C--N 1.288 -2.096 0 CA-C-O 123.636 1.684 . . . . 0.0 110.628 175.675 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.678 ' HA ' HG22 ' A' ' 12' ' ' THR . 0.0 OUTLIER -101.14 96.32 7.13 Favored 'General case' 0 C--N 1.264 -3.136 0 CA-C-N 114.587 -1.188 . . . . 0.0 112.136 174.877 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 5.9 m -93.25 172.34 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.138 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 177.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -110.98 163.87 13.38 Favored 'General case' 0 C--N 1.263 -3.161 0 CA-C-N 115.178 -0.919 . . . . 0.0 108.77 178.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . 0.438 ' HB2' HG22 ' A' ' 11' ' ' VAL . 38.3 t80 -153.64 174.97 13.79 Favored 'General case' 0 N--CA 1.424 -1.769 0 CA-C-O 121.69 0.757 . . . . 0.0 111.287 -179.133 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 60.2 mtt -89.71 175.48 7.23 Favored 'General case' 0 N--CA 1.426 -1.632 0 C-N-CA 126.152 1.781 . . . . 0.0 108.137 -179.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -87.87 -150.17 0.17 Allowed 'General case' 0 C--N 1.283 -2.323 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.503 -179.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 9.5 t -99.16 135.45 40.56 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -169.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.491 ' HB3' ' ND2' ' A' ' 75' ' ' ASN . 1.3 tm-20 . . . . . 0 N--CA 1.445 -0.705 0 N-CA-C 101.148 -3.649 . . . . 0.0 101.148 176.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 50.3 m . . . . . 0 CA--C 1.507 -0.69 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -84.64 79.97 9.41 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 12.0 t -178.59 146.0 0.34 Allowed 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 178.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -148.24 127.75 13.2 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -97.11 131.25 44.07 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 120.963 0.411 . . . . 0.0 111.568 -178.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -145.81 24.34 1.35 Allowed 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 175.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.522 ' NZ ' ' HB2' ' A' ' 7' ' ' LYS . 6.9 mtmp? -110.87 -157.67 0.62 Allowed 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 -175.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 22.9 m -76.43 150.13 36.77 Favored 'General case' 0 N--CA 1.405 -2.684 0 N-CA-C 103.458 -2.793 . . . . 0.0 103.458 166.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 74.0 mtt180 -93.03 126.22 38.01 Favored 'General case' 0 C--N 1.278 -2.54 0 CA-C-O 121.237 0.542 . . . . 0.0 111.334 -167.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -78.26 89.62 4.32 Favored 'General case' 0 CA--C 1.491 -1.303 0 CA-C-O 122.408 1.099 . . . . 0.0 109.854 -178.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.512 HG13 ' HB2' ' A' ' 14' ' ' ASP . 21.3 t -84.88 103.99 12.59 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.689 0 CA-C-N 113.395 -1.73 . . . . 0.0 109.772 -177.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.618 HG22 ' HA ' ' A' ' 120' ' ' LYS . 21.5 p -121.01 -50.41 2.16 Favored 'General case' 0 N--CA 1.413 -2.31 0 C-N-CA 117.758 -1.577 . . . . 0.0 112.482 175.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.438 ' HA ' ' CB ' ' A' ' 16' ' ' LYS . 0.3 OUTLIER -87.37 -11.91 47.92 Favored 'General case' 0 N--CA 1.426 -1.675 0 C-N-CA 119.126 -1.03 . . . . 0.0 112.304 -173.843 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.512 ' HB2' HG13 ' A' ' 11' ' ' VAL . 0.7 OUTLIER -65.85 -52.35 51.16 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 103.978 -2.601 . . . . 0.0 103.978 169.195 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.51 HG23 HG12 ' A' ' 11' ' ' VAL . 31.3 t -56.77 -44.2 81.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 113.581 -1.645 . . . . 0.0 111.337 174.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.447 ' HE2' ' O ' ' A' ' 114' ' ' VAL . 2.0 tppp? -57.78 -45.28 86.21 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.788 177.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 53.4 m -61.78 -41.58 97.89 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.5 178.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.431 ' HB ' ' O ' ' A' ' 15' ' ' VAL . 66.2 mt -53.63 -52.64 31.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 O-C-N 123.748 0.655 . . . . 0.0 109.459 173.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.495 HG21 HG11 ' A' ' 114' ' ' VAL . 93.0 t -57.78 -45.05 87.13 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.576 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.74 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.436 ' HG3' ' O ' ' A' ' 16' ' ' LYS . 64.3 mtt85 -53.52 -45.72 69.87 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.151 0.501 . . . . 0.0 110.728 178.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.541 ' HA ' ' HG3' ' A' ' 24' ' ' GLU . 77.1 m-85 -83.18 -33.88 26.1 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 -174.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.42 HG22 ' O ' ' A' ' 18' ' ' ILE . 27.0 m -73.25 -31.77 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.521 0 C-N-CA 118.376 -1.329 . . . . 0.0 110.107 177.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -59.97 -48.73 80.5 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.194 174.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.541 ' HG3' ' HA ' ' A' ' 21' ' ' PHE . 1.5 pp20? -68.75 -27.86 66.29 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 120.292 -0.563 . . . . 0.0 112.111 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -68.06 -5.47 17.71 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -178.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 17.5 m -62.08 -28.27 69.5 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 170.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 11.8 m -94.24 81.13 4.02 Favored 'General case' 0 N--CA 1.419 -2.01 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 174.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.8 m -77.74 6.26 7.78 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 112.648 0.611 . . . . 0.0 112.648 -175.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -81.36 73.25 8.4 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-O 122.325 1.06 . . . . 0.0 111.571 -177.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -94.13 80.91 0.96 Allowed Glycine 0 N--CA 1.43 -1.716 0 N-CA-C 108.569 -1.812 . . . . 0.0 108.569 175.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 96.2 mmm -42.65 -79.18 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.565 1.146 . . . . 0.0 113.969 -174.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -91.72 -74.96 0.49 Allowed 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.226 178.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 51.3 t30 66.26 -176.5 0.19 Allowed 'General case' 0 CA--C 1.555 1.164 0 O-C-N 124.236 0.96 . . . . 0.0 109.51 -178.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 59.3 mt -60.71 -41.51 88.58 Favored 'Isoleucine or valine' 0 C--O 1.242 0.681 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 175.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.7 mtmm 176.71 159.17 0.33 Allowed 'General case' 0 C--O 1.243 0.743 0 C-N-CA 126.481 1.912 . . . . 0.0 109.459 177.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -166.45 128.59 1.84 Allowed 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 108.677 -0.861 . . . . 0.0 108.677 176.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 14.8 p -98.77 -20.02 5.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 175.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -86.71 125.16 7.3 Favored Glycine 0 N--CA 1.428 -1.877 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.332 177.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -80.71 -70.28 0.01 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 122.129 1.886 . . . . 0.0 111.254 175.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 57.3 m -166.27 172.95 10.57 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 140.46 -71.62 0.42 Allowed Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.091 -1.052 . . . . 0.0 112.377 176.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -174.6 162.57 3.42 Favored 'General case' 0 CA--C 1.502 -0.876 0 C-N-CA 124.282 1.033 . . . . 0.0 108.954 177.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -126.3 126.59 44.21 Favored 'General case' 0 CA--C 1.485 -1.532 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.684 ' HA ' ' HA ' ' A' ' 104' ' ' TYR . 55.4 p -82.13 155.55 24.96 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 175.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.592 ' O ' HG23 ' A' ' 49' ' ' VAL . 5.8 ptm -52.34 -35.67 51.59 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-O 121.427 0.632 . . . . 0.0 110.124 177.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.539 ' N ' ' HG3' ' A' ' 45' ' ' MET . 22.7 t-20 -63.22 -40.09 96.49 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.439 -1.255 . . . . 0.0 110.839 -175.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . 0.538 ' HG3' ' OG1' ' A' ' 44' ' ' THR . 64.5 mtt -69.27 -36.44 77.1 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-O 121.554 0.692 . . . . 0.0 109.928 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 82.3 mt -67.91 -33.74 75.28 Favored 'General case' 0 C--O 1.206 -1.186 0 CA-C-N 114.992 -1.004 . . . . 0.0 111.227 -178.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.596 HG21 ' HG2' ' A' ' 77' ' ' GLU . 88.1 t -67.96 -38.88 80.69 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.016 0 C-N-CA 123.355 0.662 . . . . 0.0 110.303 178.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -53.69 -47.5 70.41 Favored 'General case' 0 CA--C 1.506 -0.732 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.128 175.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.46 HG23 ' HD2' ' A' ' 65' ' ' PHE . 4.9 mt -76.83 -38.58 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.524 0 CA-C-N 114.717 -1.129 . . . . 0.0 111.738 -176.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.464 ' CE2' ' HA3' ' A' ' 68' ' ' GLY . 60.5 t80 -53.1 -48.08 68.09 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 125.019 1.328 . . . . 0.0 110.733 179.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.9 mp -77.52 -12.12 59.93 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.085 -0.507 . . . . 0.0 112.302 178.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.95 26.97 54.68 Favored Glycine 0 C--O 1.249 1.066 0 C-N-CA 120.915 -0.659 . . . . 0.0 111.702 -179.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 40.2 t -67.29 176.4 2.27 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-O 121.797 0.808 . . . . 0.0 111.048 -176.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.474 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 0.7 OUTLIER -106.8 6.63 29.69 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 122.055 0.931 . . . . 0.0 110.117 176.592 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 27.8 p -90.89 1.21 57.17 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 169.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.74 117.41 8.85 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-N 113.69 -1.596 . . . . 0.0 108.893 178.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 43.0 mttp -81.52 -11.83 59.04 Favored 'General case' 0 C--N 1.29 -2.02 0 CA-C-N 114.801 -1.09 . . . . 0.0 111.862 -172.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 66.7 mt -143.42 138.3 26.04 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.94 0 N-CA-C 105.953 -1.869 . . . . 0.0 105.953 175.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.597 ' HA ' ' CE2' ' A' ' 65' ' ' PHE . 25.6 mm-40 -93.6 44.78 1.14 Allowed 'General case' 0 C--N 1.3 -1.584 0 CA-C-O 120.993 0.425 . . . . 0.0 110.5 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 42.2 m -153.95 153.03 31.28 Favored 'General case' 0 C--O 1.245 0.844 0 O-C-N 122.026 -0.421 . . . . 0.0 110.203 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 80.92 109.29 0.31 Allowed Glycine 0 C--O 1.2 -2.014 0 CA-C-O 119.393 -0.671 . . . . 0.0 111.599 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . 0.275 3.7 pt 51.94 17.59 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 C-N-CA 125.007 1.323 . . . . 0.0 114.494 -176.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.597 ' CE2' ' HA ' ' A' ' 61' ' ' GLN . 18.3 t80 -62.68 107.53 0.98 Allowed 'General case' 0 C--O 1.252 1.222 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.515 -176.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 64.29 41.65 98.13 Favored Glycine 0 N--CA 1.434 -1.452 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.408 178.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.421 ' HD3' ' HA ' ' A' ' 67' ' ' LYS . 28.3 mmtm -114.86 -3.98 12.68 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.22 0.533 . . . . 0.0 111.017 177.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.464 ' HA3' ' CE2' ' A' ' 52' ' ' PHE . . . -133.51 30.32 3.02 Favored Glycine 0 N--CA 1.425 -2.055 0 N-CA-C 110.19 -1.164 . . . . 0.0 110.19 176.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 16.5 m -70.35 2.16 4.15 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 123.91 0.884 . . . . 0.0 112.417 -176.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -98.74 7.19 46.36 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-O 122.081 0.944 . . . . 0.0 109.199 176.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -108.28 146.65 32.59 Favored 'General case' 0 N--CA 1.418 -2.04 0 CA-C-N 114.675 -1.148 . . . . 0.0 108.825 177.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 44.6 t -86.15 169.21 13.3 Favored 'General case' 0 C--N 1.288 -2.081 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 171.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.429 HH21 ' ND2' ' A' ' 46' ' ' ASN . 11.3 tpt180 -58.77 -35.18 72.36 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 177.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 23.2 t-80 -61.61 -40.17 93.88 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 113.487 -1.688 . . . . 0.0 110.26 178.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -80.97 -49.89 10.39 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.522 -172.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.405 ' O ' ' HD2' ' A' ' 80' ' ' PHE . . . -59.31 -48.99 79.55 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.136 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.625 ' O ' ' HG3' ' A' ' 81' ' ' LYS . 18.3 mt-10 -65.16 -34.31 78.09 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 70.2 ttt180 -69.32 -28.61 66.39 Favored 'General case' 0 CA--C 1.521 -0.149 0 C-N-CA 119.432 -0.907 . . . . 0.0 109.476 -177.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.0 tt -78.77 -48.55 14.62 Favored 'General case' 0 N--CA 1.422 -1.832 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.569 -178.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.425 ' HA ' HD12 ' A' ' 83' ' ' LEU . 58.1 m-85 -59.54 -21.27 60.01 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-O 121.397 0.617 . . . . 0.0 110.235 177.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.625 ' HG3' ' O ' ' A' ' 77' ' ' GLU . 46.2 mttm -85.35 -26.29 26.59 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 119.208 -0.997 . . . . 0.0 109.097 179.116 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 58.9 tttp -73.34 -38.55 65.72 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 175.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.425 HD12 ' HA ' ' A' ' 80' ' ' PHE . 95.7 mt -58.05 -37.36 74.25 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 177.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.508 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 2.4 pp -75.86 -26.21 17.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 120.232 -0.587 . . . . 0.0 111.626 177.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 51.4 mt -74.97 -49.38 20.19 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.555 175.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -70.49 -24.11 62.79 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.578 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.288 50.6 mttm 83.23 24.07 0.14 Allowed 'General case' 0 CA--C 1.469 -2.171 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 172.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.418 HG23 HG21 ' A' ' 114' ' ' VAL . 2.0 mp -69.74 -39.95 78.6 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.273 0 N-CA-C 105.117 -2.179 . . . . 0.0 105.117 165.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.508 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 4.3 mm? -111.6 150.04 30.63 Favored 'General case' 0 CA--C 1.498 -1.041 0 CA-C-N 114.067 -1.424 . . . . 0.0 108.271 173.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -137.77 110.61 7.66 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.472 ' HA ' ' O ' ' A' ' 104' ' ' TYR . 38.8 mt-10 -95.35 147.52 23.42 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 177.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.565 ' O ' ' HA ' ' A' ' 103' ' ' ALA . 16.8 t70 -97.48 142.8 28.88 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.729 -1.123 . . . . 0.0 108.825 178.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 94.7 mt -103.75 101.72 11.55 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-O 121.971 0.891 . . . . 0.0 110.144 -178.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 72.0 t80 -107.74 115.65 30.54 Favored 'General case' 0 C--N 1.275 -2.658 0 CA-C-N 114.252 -1.34 . . . . 0.0 108.331 -175.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.411 HG13 ' C ' ' A' ' 100' ' ' GLN . 17.1 tt -121.23 141.69 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.657 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.459 ' C ' ' H ' ' A' ' 98' ' ' ASN . 13.1 m-80 -97.44 -171.79 2.27 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -179.016 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -73.5 21.66 0.08 Allowed 'General case' 0 C--N 1.311 -1.094 0 C-N-CA 125.337 1.455 . . . . 0.0 111.203 178.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.459 ' H ' ' C ' ' A' ' 96' ' ' ASN . 14.8 m120 -119.29 -2.64 10.61 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 108.866 -0.791 . . . . 0.0 108.866 -178.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 59.42 25.45 14.2 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-O 122.832 1.301 . . . . 0.0 110.257 -172.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.411 ' C ' HG13 ' A' ' 95' ' ' ILE . 26.0 mt-30 -100.05 108.65 20.88 Favored 'General case' 0 C--O 1.251 1.132 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 177.047 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -96.52 142.48 28.54 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 124.051 0.845 . . . . 0.0 111.567 -176.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 10.5 tp -131.44 145.21 35.56 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 174.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.565 ' HA ' ' O ' ' A' ' 92' ' ' ASP . . . -113.5 138.76 49.66 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.684 ' HA ' ' HA ' ' A' ' 44' ' ' THR . 24.8 p90 -134.74 163.47 29.71 Favored 'General case' 0 CA--C 1.496 -1.108 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 176.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.491 HG13 HD12 ' A' ' 89' ' ' LEU . 6.7 t -94.83 134.06 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.636 0 N-CA-C 115.112 1.523 . . . . 0.0 115.112 -163.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 68.9 mtm -140.69 168.92 18.65 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 111.422 -2.626 . . . . 0.0 105.14 173.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 7.0 mp -90.77 136.69 32.9 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 -179.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -91.57 -178.58 42.49 Favored Glycine 0 N--CA 1.438 -1.232 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.506 -176.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -70.23 -13.3 62.11 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -176.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.434 ' O ' HG23 ' A' ' 114' ' ' VAL . 46.9 mmtt -93.73 -3.65 51.85 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 178.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -62.01 -29.39 70.23 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.969 0.414 . . . . 0.0 111.223 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.442 ' HA ' ' HG ' ' A' ' 115' ' ' LEU . 0.0 OUTLIER -72.35 -31.96 66.07 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 120.218 -0.593 . . . . 0.0 110.247 179.673 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 9.9 m -72.87 -25.72 61.2 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -178.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.495 HG11 HG21 ' A' ' 19' ' ' VAL . 22.0 t -72.1 -42.91 67.38 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.244 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.681 177.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.442 ' HG ' ' HA ' ' A' ' 112' ' ' GLN . 4.6 pp -67.87 -33.73 75.31 Favored 'General case' 0 CA--C 1.51 -0.57 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.969 178.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -71.41 -27.8 63.56 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 172.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 73.49 21.76 79.21 Favored Glycine 0 CA--C 1.495 -1.179 0 CA-C-N 115.333 -0.849 . . . . 0.0 112.36 177.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -97.33 35.51 1.61 Allowed 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 104.95 -2.241 . . . . 0.0 104.95 177.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.451 HD13 ' C ' ' A' ' 119' ' ' LEU . 0.4 OUTLIER -142.42 124.91 15.7 Favored 'General case' 0 N--CA 1.381 -3.906 0 CA-C-N 113.037 -1.892 . . . . 0.0 107.165 -174.241 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.618 ' HA ' HG22 ' A' ' 12' ' ' THR . 0.2 OUTLIER -129.87 132.84 46.56 Favored 'General case' 0 N--CA 1.393 -3.295 0 N-CA-C 106.795 -1.558 . . . . 0.0 106.795 172.089 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.508 HG22 ' O ' ' A' ' 11' ' ' VAL . 14.0 m -106.51 -178.81 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 C-N-CA 118.528 -1.269 . . . . 0.0 107.924 174.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -129.28 134.07 47.77 Favored 'General case' 0 C--N 1.254 -3.573 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 178.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -107.32 113.54 26.99 Favored 'General case' 0 C--N 1.273 -2.719 0 C-N-CA 118.95 -1.1 . . . . 0.0 110.545 171.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.415 ' HB2' ' HB2' ' A' ' 127' ' ' GLU . 17.3 ptp -91.63 120.75 32.68 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 113.453 -1.703 . . . . 0.0 108.847 176.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -95.13 -73.29 0.59 Allowed 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.224 -174.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 25.8 m -120.34 70.19 0.88 Allowed 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 179.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.415 ' HB2' ' HB2' ' A' ' 124' ' ' MET . 15.8 mt-10 . . . . . 0 C--N 1.296 -1.753 0 N-CA-C 103.923 -2.621 . . . . 0.0 103.923 -172.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 48.6 t . . . . . 0 CA--C 1.505 -0.765 0 N-CA-C 106.352 -1.721 . . . . 0.0 106.352 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.6 pttp 54.53 -170.05 0.06 Allowed 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 125.887 1.675 . . . . 0.0 110.713 -175.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.411 ' HB ' ' O ' ' A' ' 5' ' ' ASP . 10.2 p -71.67 132.83 45.13 Favored 'General case' 0 N--CA 1.42 -1.952 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 174.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.0 -21.13 59.31 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.411 ' O ' ' HB ' ' A' ' 3' ' ' THR . 1.1 p-10 -151.43 149.72 29.6 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 114.581 -1.19 . . . . 0.0 109.487 -176.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.427 ' H ' ' CD ' ' A' ' 125' ' ' GLU . 40.9 m-85 -97.6 -11.88 23.12 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 174.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . 0.388 64.4 mttm 97.96 172.32 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.68 0 N-CA-C 116.569 2.063 . . . . 0.0 116.569 169.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.4 m -102.02 143.53 31.75 Favored 'General case' 0 N--CA 1.41 -2.434 0 CA-C-N 113.949 -1.478 . . . . 0.0 112.676 -171.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 54.6 ttt180 -99.68 113.95 26.74 Favored 'General case' 0 N--CA 1.394 -3.253 0 N-CA-C 104.037 -2.579 . . . . 0.0 104.037 166.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.467 ' CG ' ' HZ1' ' A' ' 120' ' ' LYS . 1.9 t70 -77.57 98.78 5.5 Favored 'General case' 0 CA--C 1.488 -1.434 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -174.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.484 ' HB ' HG23 ' A' ' 15' ' ' VAL . 30.4 m -99.94 65.58 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.275 -2.648 0 CA-C-O 122.417 1.103 . . . . 0.0 112.964 -173.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.467 ' O ' ' HB2' ' A' ' 16' ' ' LYS . 2.1 t -111.53 -37.74 5.13 Favored 'General case' 0 C--N 1.263 -3.188 0 C-N-CA 119.495 -0.882 . . . . 0.0 109.001 169.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -84.83 -20.64 30.6 Favored 'General case' 0 CA--C 1.496 -1.1 0 CA-C-O 120.989 0.423 . . . . 0.0 111.221 174.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -76.24 -44.49 37.26 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 105.425 -2.065 . . . . 0.0 105.425 175.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.551 ' O ' ' HB ' ' A' ' 18' ' ' ILE . 4.9 t -64.35 -21.88 30.01 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.48 0 CA-C-N 112.938 -1.937 . . . . 0.0 111.167 174.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.636 ' HE2' ' O ' ' A' ' 114' ' ' VAL . 34.2 ttmt -75.09 -35.55 61.77 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 122.016 -0.427 . . . . 0.0 110.568 179.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 68.9 p -67.39 -31.25 71.34 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 119.358 -0.937 . . . . 0.0 108.883 173.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.551 ' HB ' ' O ' ' A' ' 15' ' ' VAL . 36.0 mt -63.62 -48.13 88.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.757 173.219 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 15' ' ' VAL . 97.2 t -56.96 -47.77 82.76 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.774 0 C-N-CA 123.289 0.636 . . . . 0.0 109.868 176.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.643 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 0.9 OUTLIER -52.61 -53.71 43.07 Favored 'General case' 0 C--O 1.22 -0.49 0 O-C-N 123.898 0.749 . . . . 0.0 109.332 176.838 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.423 ' HB2' HG13 ' A' ' 64' ' ' ILE . 83.2 t80 -52.94 -57.14 11.31 Favored 'General case' 0 N--CA 1.448 -0.545 0 O-C-N 124.424 1.078 . . . . 0.0 112.223 -178.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 27.1 m -67.78 -38.78 80.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.779 -177.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -60.33 -50.28 74.23 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 176.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.643 ' HG2' ' O ' ' A' ' 20' ' ' ARG . 10.3 pt-20 -79.6 -22.16 44.05 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.208 -0.597 . . . . 0.0 112.083 -178.095 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.546 ' CD2' ' HG3' ' A' ' 24' ' ' GLU . 98.3 m-70 -106.62 22.07 16.45 Favored 'General case' 0 CA--C 1.49 -1.345 0 C-N-CA 118.987 -1.085 . . . . 0.0 112.109 -176.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 34.0 t -62.39 -31.42 72.1 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 171.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 31.1 m -93.22 116.8 29.37 Favored 'General case' 0 N--CA 1.41 -2.439 0 N-CA-C 104.917 -2.253 . . . . 0.0 104.917 168.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 46.9 m -65.88 32.12 0.02 OUTLIER 'General case' 0 CA--C 1.564 1.511 0 N-CA-C 115.785 1.772 . . . . 0.0 115.785 -172.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -75.34 127.68 33.69 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 176.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 102.92 -26.95 22.27 Favored Glycine 0 N--CA 1.438 -1.23 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 -176.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 88.3 mtp -79.49 6.2 10.93 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.837 0.827 . . . . 0.0 111.085 -177.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 32.0 ptt85 -91.36 -14.67 30.29 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.61 175.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -92.76 79.22 4.75 Favored 'General case' 0 C--O 1.247 0.928 0 CA-C-O 121.727 0.775 . . . . 0.0 109.485 -177.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.549 HG12 ' H ' ' A' ' 36' ' ' HIS . 14.6 tt -177.61 156.85 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 CA-C-N 113.77 -1.559 . . . . 0.0 106.857 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.566 ' HA ' ' NZ ' ' A' ' 35' ' ' LYS . 2.8 tpmp? -94.77 -21.03 19.0 Favored 'General case' 0 N--CA 1.422 -1.83 0 C-N-CA 118.593 -1.243 . . . . 0.0 112.222 -178.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.549 ' H ' HG12 ' A' ' 34' ' ' ILE . 63.8 t-80 -56.28 130.66 45.42 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 123.888 0.743 . . . . 0.0 110.223 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 35.7 m -63.45 167.37 0.93 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.884 0 O-C-N 123.877 0.735 . . . . 0.0 112.876 -178.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 122.4 132.88 4.15 Favored Glycine 0 N--CA 1.429 -1.829 0 N-CA-C 110.351 -1.1 . . . . 0.0 110.351 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -79.88 7.76 4.42 Favored 'Trans proline' 0 CA--C 1.535 0.535 0 C-N-CA 122.667 2.245 . . . . 0.0 112.823 -177.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.3 m 65.02 -156.56 0.29 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.608 0.763 . . . . 0.0 109.221 -177.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.05 -38.99 2.21 Favored Glycine 0 CA--C 1.526 0.737 0 CA-C-N 118.508 0.594 . . . . 0.0 112.942 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.2 mtt180 -88.04 110.83 20.92 Favored 'General case' 0 N--CA 1.425 -1.691 0 O-C-N 122.412 -0.463 . . . . 0.0 110.115 178.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -107.58 107.48 18.33 Favored 'General case' 0 CA--C 1.481 -1.699 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 179.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.41 HG21 HD11 ' A' ' 102' ' ' ILE . 80.2 p -120.94 157.13 30.57 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -177.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.419 ' O ' HG23 ' A' ' 49' ' ' VAL . 22.0 ptm -50.13 -39.59 43.63 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.353 0.661 . . . . 0.0 112.63 -178.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.4 ' N ' ' HG3' ' A' ' 45' ' ' MET . 18.9 t-20 -68.71 -39.29 80.52 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.156 -172.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 23.4 mmt -67.34 -38.6 85.11 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.467 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 78.7 mt -63.35 -41.95 98.89 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.247 -178.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.462 HG13 ' HB3' ' A' ' 76' ' ' ALA . 69.6 t -66.01 -45.16 91.55 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.058 0 C-N-CA 123.68 0.792 . . . . 0.0 110.679 179.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.566 ' OD2' ' HB3' ' A' ' 55' ' ' SER . 4.4 t70 -61.92 -36.78 82.39 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 114.678 -1.146 . . . . 0.0 109.626 -177.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.672 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 75.4 mt -69.54 -50.21 52.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.568 174.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.508 ' CE2' ' HA3' ' A' ' 68' ' ' GLY . 50.4 t80 -50.86 -41.21 57.74 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.446 1.098 . . . . 0.0 111.775 179.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.9 mp -80.17 -30.51 38.83 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 177.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 99.2 33.06 5.57 Favored Glycine 0 C--O 1.248 1.002 0 C-N-CA 120.166 -1.016 . . . . 0.0 112.725 -179.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.566 ' HB3' ' OD2' ' A' ' 50' ' ' ASP . 32.0 t -86.8 -176.45 5.78 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 123.291 0.636 . . . . 0.0 111.15 -176.06 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.14 9.17 17.12 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -176.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 16.9 m -89.44 -17.66 28.29 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 175.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.48 ' HB1' HG12 ' A' ' 51' ' ' ILE . . . -50.85 173.8 0.02 OUTLIER 'General case' 0 N--CA 1.432 -1.329 0 C-N-CA 128.861 2.865 . . . . 0.0 113.476 176.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.0 mmmp? -116.87 11.02 14.31 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 -179.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.429 HG22 HD13 ' A' ' 51' ' ' ILE . 15.5 tt -158.65 164.82 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 N-CA-C 104.795 -2.298 . . . . 0.0 104.795 175.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.401 HE21 HD12 ' A' ' 34' ' ' ILE . 30.1 mm-40 -125.74 21.96 7.58 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 119.021 0.828 . . . . 0.0 110.42 177.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 43.8 m -152.24 146.95 25.83 Favored 'General case' 0 C--N 1.322 -0.63 0 O-C-N 122.002 -0.436 . . . . 0.0 110.037 -178.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.554 ' C ' ' H ' ' A' ' 65' ' ' PHE . . . 82.15 111.37 0.42 Allowed Glycine 0 C--O 1.212 -1.28 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.632 HG22 HG22 ' A' ' 51' ' ' ILE . 3.4 mm 70.25 -18.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 CA-C-O 121.971 0.891 . . . . 0.0 111.64 -176.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.672 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 3.5 t80 -65.46 104.45 0.99 Allowed 'General case' 0 N--CA 1.399 -2.986 0 C-N-CA 125.318 1.447 . . . . 0.0 109.202 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 102.93 0.36 48.52 Favored Glycine 0 N--CA 1.434 -1.46 0 C-N-CA 120.814 -0.707 . . . . 0.0 111.713 -178.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.526 ' HG3' HD13 ' A' ' 64' ' ' ILE . 2.9 mmmp? -67.35 -19.48 65.44 Favored 'General case' 0 C--O 1.252 1.189 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.508 ' HA3' ' CE2' ' A' ' 52' ' ' PHE . . . -148.81 49.76 0.58 Allowed Glycine 0 C--O 1.207 -1.544 0 C-N-CA 120.462 -0.875 . . . . 0.0 111.644 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 16.0 m -70.6 0.78 6.18 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -178.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -100.37 -5.34 27.44 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-O 121.094 0.473 . . . . 0.0 110.303 178.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.503 ' HA ' ' HB3' ' A' ' 127' ' ' GLU . 28.9 m-85 -80.41 144.11 32.92 Favored 'General case' 0 N--CA 1.428 -1.547 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.49 177.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 34.5 t -77.33 134.68 38.44 Favored 'General case' 0 N--CA 1.398 -3.029 0 N-CA-C 102.928 -2.989 . . . . 0.0 102.928 167.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.519 ' O ' ' HG3' ' A' ' 77' ' ' GLU . 10.6 ptm180 -52.12 -38.64 58.1 Favored 'General case' 0 C--O 1.202 -1.43 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -173.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.565 ' HA ' ' OE1' ' A' ' 77' ' ' GLU . 32.4 t-80 -70.86 -24.31 62.49 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 120.978 0.418 . . . . 0.0 111.475 -175.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -81.69 -38.2 26.21 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.462 ' HB3' HG13 ' A' ' 49' ' ' VAL . . . -63.29 -40.21 96.73 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 174.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.66 ' O ' ' HG2' ' A' ' 81' ' ' LYS . 80.0 mt-10 -58.15 -37.8 75.37 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.235 -0.439 . . . . 0.0 109.902 174.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 18.4 mmm180 -71.68 -23.13 61.6 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.372 -178.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.4 tt -76.38 -45.36 32.2 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 179.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -63.87 -19.53 65.13 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.432 0.634 . . . . 0.0 109.406 176.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.66 ' HG2' ' O ' ' A' ' 77' ' ' GLU . 31.3 mmmt -81.12 -28.43 35.14 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.379 176.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.43 ' HG2' ' OD2' ' A' ' 86' ' ' ASP . 58.3 tttm -74.48 -43.04 57.88 Favored 'General case' 0 C--O 1.193 -1.878 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 179.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.3 mt -58.64 -35.2 72.13 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 178.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.474 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 2.5 pp -74.67 -26.3 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.061 177.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.9 tt -76.85 -45.19 29.33 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 175.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.473 ' O ' ' HB2' ' A' ' 87' ' ' LYS . 70.9 m-20 -66.1 -29.62 69.98 Favored 'General case' 0 C--O 1.259 1.587 0 C-N-CA 123.491 0.716 . . . . 0.0 109.944 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.473 ' HB2' ' O ' ' A' ' 86' ' ' ASP . 4.4 mptp? 85.6 21.65 0.09 Allowed 'General case' 0 CA--C 1.478 -1.821 0 C-N-CA 125.252 1.421 . . . . 0.0 113.378 179.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 1.8 mp -68.62 -42.22 83.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 N-CA-C 104.8 -2.296 . . . . 0.0 104.8 164.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.474 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 90.7 mt -114.3 164.22 14.21 Favored 'General case' 0 N--CA 1.418 -2.068 0 CA-C-N 113.829 -1.532 . . . . 0.0 109.141 174.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.472 ' OD2' ' HG3' ' A' ' 87' ' ' LYS . 0.2 OUTLIER -144.44 117.79 9.04 Favored 'General case' 0 C--N 1.283 -2.305 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 172.762 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -95.02 144.38 25.74 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-O 121.598 0.713 . . . . 0.0 112.463 -178.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.477 ' O ' ' HA ' ' A' ' 103' ' ' ALA . 16.6 t70 -100.0 133.24 44.68 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 114.195 -1.366 . . . . 0.0 109.055 178.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 98.3 mt -105.64 105.62 15.75 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 121.579 0.704 . . . . 0.0 109.429 -179.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -122.36 135.42 54.7 Favored 'General case' 0 C--N 1.28 -2.427 0 CA-C-N 114.561 -1.2 . . . . 0.0 109.06 -172.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.56 HD11 ' HA ' ' A' ' 99' ' ' ASP . 16.6 tt -131.23 141.34 46.24 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.296 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 174.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.424 ' C ' ' H ' ' A' ' 98' ' ' ASN . 3.4 p-10 -96.11 172.81 7.75 Favored 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 176.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -66.67 17.97 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 -173.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.424 ' H ' ' C ' ' A' ' 96' ' ' ASN . 15.7 m120 -118.15 5.57 11.99 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.56 ' HA ' HD11 ' A' ' 95' ' ' ILE . 26.7 t70 65.97 26.47 10.93 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-O 123.531 1.634 . . . . 0.0 109.353 -177.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.492 ' C ' HG13 ' A' ' 95' ' ' ILE . 27.1 mt-30 -90.29 99.57 12.57 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.918 -1.037 . . . . 0.0 108.548 176.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -86.2 133.87 33.82 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.627 -178.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.41 HD11 HG21 ' A' ' 44' ' ' THR . 16.4 tt -141.99 143.79 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.822 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 178.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.477 ' HA ' ' O ' ' A' ' 92' ' ' ASP . . . -112.08 119.96 40.22 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 -178.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -97.38 150.58 20.84 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 52.4 t -103.74 128.86 56.62 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 CA-C-O 121.759 0.79 . . . . 0.0 112.143 -178.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 58.3 mtt -128.28 178.82 5.99 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-N 113.908 -1.496 . . . . 0.0 107.792 177.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.557 HD23 ' H ' ' A' ' 107' ' ' LEU . 1.7 pt? -99.52 137.49 37.94 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -178.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -98.21 -166.51 31.37 Favored Glycine 0 N--CA 1.439 -1.118 0 C-N-CA 120.799 -0.715 . . . . 0.0 113.158 -175.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 32.7 p30 -75.28 -2.85 30.06 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 114.147 1.165 . . . . 0.0 114.147 -175.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.512 ' O ' HG23 ' A' ' 114' ' ' VAL . 41.4 mmtm -101.98 -6.34 23.56 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 120.113 -0.635 . . . . 0.0 110.357 177.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -54.31 -43.77 71.42 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 113.623 0.972 . . . . 0.0 113.623 -172.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -73.44 -29.48 62.58 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.626 0.727 . . . . 0.0 109.701 -178.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 4.4 m -73.05 -26.19 61.2 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.585 -179.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.636 ' O ' ' HE2' ' A' ' 16' ' ' LYS . 24.9 t -68.41 -44.05 83.67 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.783 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 174.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 84.7 mt -62.39 -39.79 94.35 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.113 178.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -72.84 -19.37 61.33 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.059 175.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.458 ' C ' ' H ' ' A' ' 119' ' ' LEU . . . 60.87 30.42 72.98 Favored Glycine 0 C--O 1.212 -1.226 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.127 -177.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -95.99 22.58 7.3 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 105.862 -1.903 . . . . 0.0 105.862 174.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.468 HD13 ' C ' ' A' ' 119' ' ' LEU . 0.8 OUTLIER -141.99 122.65 14.24 Favored 'General case' 0 N--CA 1.385 -3.676 0 CA-C-N 112.229 -2.26 . . . . 0.0 105.96 -175.869 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.467 ' HZ1' ' CG ' ' A' ' 10' ' ' ASP . 0.1 OUTLIER -131.08 127.6 38.5 Favored 'General case' 0 C--N 1.283 -2.308 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 171.549 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.427 ' H ' ' HB ' ' A' ' 12' ' ' THR . 5.1 m -119.07 173.28 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.261 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 177.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -123.31 161.36 24.79 Favored 'General case' 0 C--N 1.265 -3.076 0 CA-C-N 114.971 -1.013 . . . . 0.0 112.258 -171.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -141.51 130.83 23.61 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 104.93 -2.248 . . . . 0.0 104.93 164.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 25.3 mmt -107.9 143.84 35.96 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 116.229 1.937 . . . . 0.0 116.229 -163.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.427 ' CD ' ' H ' ' A' ' 6' ' ' TYR . 7.5 mm-40 72.21 -58.61 0.58 Allowed 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 116.64 2.089 . . . . 0.0 116.64 165.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 11.1 t -148.84 163.39 37.56 Favored 'General case' 0 C--N 1.289 -2.03 0 C-N-CA 120.536 -0.466 . . . . 0.0 110.091 -175.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.503 ' HB3' ' HA ' ' A' ' 71' ' ' TYR . 63.6 mt-10 . . . . . 0 N--CA 1.416 -2.165 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 175.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 41.4 m . . . . . 0 CA--C 1.514 -0.416 0 N-CA-C 107.599 -1.259 . . . . 0.0 107.599 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -62.26 -41.99 98.95 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 175.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.8 p -88.76 152.1 21.99 Favored 'General case' 0 N--CA 1.412 -2.344 0 CA-C-N 114.522 -1.217 . . . . 0.0 109.406 175.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -129.29 142.69 50.76 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 177.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -127.4 159.4 34.59 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 124.065 0.853 . . . . 0.0 108.9 -178.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -159.38 40.95 0.21 Allowed 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 105.128 -2.175 . . . . 0.0 105.128 -179.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 25.1 tptp -53.09 124.03 13.27 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 114.972 -1.013 . . . . 0.0 113.167 -174.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.57 178.37 7.32 Favored 'General case' 0 N--CA 1.422 -1.861 0 CA-C-N 114.862 -1.063 . . . . 0.0 113.037 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.633 HH11 ' HG3' ' A' ' 9' ' ' ARG . 41.9 mtt85 -94.42 117.87 30.77 Favored 'General case' 0 N--CA 1.422 -1.86 0 N-CA-C 106.239 -1.764 . . . . 0.0 106.239 174.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -78.03 89.4 4.17 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.417 HG23 HG23 ' A' ' 121' ' ' VAL . 10.6 m -79.67 89.47 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 CA-C-O 122.69 1.233 . . . . 0.0 110.36 -178.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.632 HG22 ' HA ' ' A' ' 120' ' ' LYS . 34.3 p -115.3 -33.58 5.26 Favored 'General case' 0 C--N 1.261 -3.262 0 CA-C-O 122.092 0.949 . . . . 0.0 109.378 177.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -75.62 -40.64 56.0 Favored 'General case' 0 N--CA 1.413 -2.285 0 C-N-CA 125.967 1.707 . . . . 0.0 107.894 178.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.483 ' O ' ' HB3' ' A' ' 17' ' ' SER . 16.5 t70 -74.0 -39.78 63.39 Favored 'General case' 0 CA--C 1.495 -1.164 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 74.4 t -67.6 -32.99 59.32 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.691 177.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.559 ' HE2' ' O ' ' A' ' 114' ' ' VAL . 3.3 tppp? -66.85 -43.49 83.51 Favored 'General case' 0 C--O 1.245 0.833 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 174.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.483 ' HB3' ' O ' ' A' ' 14' ' ' ASP . 32.6 t -57.09 -47.95 79.78 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 114.092 -1.413 . . . . 0.0 108.718 174.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 28.2 mt -51.36 -42.86 28.47 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.736 0 C-N-CA 124.094 0.958 . . . . 0.0 111.746 177.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.56 HG21 HG11 ' A' ' 114' ' ' VAL . 72.9 t -59.62 -45.56 94.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 179.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 31.5 ttt180 -56.72 -45.33 81.98 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.788 0.804 . . . . 0.0 109.401 173.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.775 ' CG ' ' HB ' ' A' ' 64' ' ' ILE . 47.4 m-85 -68.63 -38.25 80.36 Favored 'General case' 0 N--CA 1.422 -1.835 0 N-CA-C 115.186 1.55 . . . . 0.0 115.186 -175.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.573 ' HA ' ' ND1' ' A' ' 25' ' ' HIS . 20.1 m -69.69 -36.62 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.859 0 C-N-CA 119.99 -0.684 . . . . 0.0 109.892 176.322 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.42 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 14.8 mm100 -60.63 -46.79 88.95 Favored 'General case' 0 CA--C 1.55 0.956 0 O-C-N 123.83 0.706 . . . . 0.0 111.318 172.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.507 ' HG2' ' HA ' ' A' ' 21' ' ' PHE . 7.6 pt-20 -78.94 0.73 26.3 Favored 'General case' 0 C--O 1.247 0.955 0 O-C-N 121.707 -0.621 . . . . 0.0 112.473 178.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.573 ' ND1' ' HA ' ' A' ' 22' ' ' VAL . 28.3 m170 -72.21 -17.25 61.93 Favored 'General case' 0 C--O 1.215 -0.758 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 172.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 18.7 m -62.6 -26.85 68.82 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 123.951 0.782 . . . . 0.0 110.108 176.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 16.0 m -89.72 85.04 6.34 Favored 'General case' 0 C--O 1.258 1.551 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 172.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.475 ' OG ' HG12 ' A' ' 60' ' ' ILE . 33.1 t -104.55 -150.33 0.42 Allowed 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 114.108 -1.405 . . . . 0.0 109.708 -171.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 69.5 27.06 4.98 Favored 'General case' 0 C--O 1.244 0.812 0 C-N-CA 124.865 1.266 . . . . 0.0 109.893 179.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -89.14 58.58 3.92 Favored Glycine 0 N--CA 1.429 -1.828 0 CA-C-N 114.65 -1.159 . . . . 0.0 110.824 -178.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 65.9 mtt -83.9 -73.04 0.43 Allowed 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 120.762 0.315 . . . . 0.0 110.492 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 17.0 ptp180 -91.83 2.13 56.71 Favored 'General case' 0 C--O 1.213 -0.848 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -177.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -150.55 148.21 28.4 Favored 'General case' 0 CA--C 1.502 -0.896 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 -179.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.535 ' HA ' ' HG3' ' A' ' 61' ' ' GLN . 1.7 mp -74.69 92.68 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 CA-C-O 121.788 0.804 . . . . 0.0 111.442 179.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.462 ' HG2' ' H ' ' A' ' 36' ' ' HIS . 24.0 ttmm 65.75 176.68 0.21 Allowed 'General case' 0 CA--C 1.563 1.454 0 CA-C-N 113.898 -1.501 . . . . 0.0 111.315 176.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.462 ' H ' ' HG2' ' A' ' 35' ' ' LYS . 22.8 p-80 172.44 178.92 0.08 Allowed 'General case' 0 CA--C 1.501 -0.939 0 C-N-CA 127.177 2.191 . . . . 0.0 105.967 172.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 16.2 m -70.97 96.77 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 CA-C-O 121.667 0.746 . . . . 0.0 110.285 175.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -156.99 95.87 0.15 Allowed Glycine 0 N--CA 1.429 -1.789 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -75.54 107.3 2.44 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 122.456 2.104 . . . . 0.0 110.98 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.422 ' HB2' ' HB3' ' A' ' 28' ' ' SER . 22.9 m -150.95 113.55 4.67 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -103.11 -143.92 13.47 Favored Glycine 0 N--CA 1.441 -1.008 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 179.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.448 ' HA ' ' NE ' ' A' ' 42' ' ' ARG . 1.9 mmp_? 69.09 69.33 0.27 Allowed 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 122.205 1.002 . . . . 0.0 111.462 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.486 ' CD1' HD21 ' A' ' 48' ' ' LEU . 2.9 p90 -109.21 128.56 55.14 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 114.526 -1.215 . . . . 0.0 111.03 -179.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 63.2 p -86.33 155.99 20.4 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 178.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.527 ' O ' HG23 ' A' ' 49' ' ' VAL . 19.2 ptt? -48.64 -41.81 32.37 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 123.483 0.49 . . . . 0.0 111.905 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.448 ' N ' ' HG3' ' A' ' 45' ' ' MET . 14.8 m120 -67.45 -31.96 72.49 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.584 -175.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . 0.455 ' O ' HD13 ' A' ' 51' ' ' ILE . 26.3 mmt -74.88 -36.33 62.27 Favored 'General case' 0 C--O 1.203 -1.344 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.486 HD21 ' CD1' ' A' ' 43' ' ' PHE . 87.1 mt -60.75 -38.4 85.05 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.373 179.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.54 HG13 ' HB3' ' A' ' 76' ' ' ALA . 94.1 t -65.19 -41.59 92.03 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.203 0 C-N-CA 124.395 1.078 . . . . 0.0 110.861 178.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -55.38 -46.26 76.55 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.309 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.455 HD13 ' O ' ' A' ' 47' ' ' MET . 1.3 mp -70.07 -40.36 78.32 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.103 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.227 177.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -57.84 -42.29 84.13 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.735 0.814 . . . . 0.0 111.808 -175.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.408 HD11 ' HB2' ' A' ' 71' ' ' TYR . 7.9 mp -82.32 -20.17 37.9 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 178.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 96.14 32.63 6.65 Favored Glycine 0 C--N 1.313 -0.731 0 C-N-CA 120.126 -1.035 . . . . 0.0 112.257 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 31.1 t -76.55 137.41 39.55 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 177.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.496 ' HD3' ' O ' ' A' ' 56' ' ' LYS . 2.4 tmtm? -84.31 -0.87 54.14 Favored 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 119.264 -0.974 . . . . 0.0 109.537 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.0 m -77.86 -5.95 52.6 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 176.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.417 ' HB3' HE22 ' A' ' 61' ' ' GLN . . . -62.03 145.45 53.08 Favored 'General case' 0 N--CA 1.425 -1.721 0 C-N-CA 125.787 1.635 . . . . 0.0 111.173 175.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.528 ' N ' ' HD2' ' A' ' 59' ' ' LYS . 9.1 mptt -105.23 -1.57 25.17 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.447 -177.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.475 HG12 ' OG ' ' A' ' 28' ' ' SER . 60.6 mt -132.28 122.0 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.108 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -177.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.542 HE21 ' HA ' ' A' ' 61' ' ' GLN . 0.0 OUTLIER -110.01 94.37 4.98 Favored 'General case' 0 C--N 1.277 -2.585 0 C-N-CA 118.313 -1.355 . . . . 0.0 108.707 176.901 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.472 ' HB3' ' OE2' ' A' ' 24' ' ' GLU . 73.5 m -104.25 177.79 4.74 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.843 176.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -75.32 7.63 22.89 Favored Glycine 0 N--CA 1.482 1.712 0 C-N-CA 121.068 -0.587 . . . . 0.0 113.979 -176.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.775 ' HB ' ' CG ' ' A' ' 21' ' ' PHE . 6.4 tt -100.74 3.1 10.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.429 ' HB2' ' O ' ' A' ' 62' ' ' SER . 19.5 t80 -69.52 95.97 0.88 Allowed 'General case' 0 N--CA 1.42 -1.945 0 CA-C-N 114.01 -1.45 . . . . 0.0 110.01 -173.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 102.35 17.22 20.54 Favored Glycine 0 N--CA 1.419 -2.438 0 CA-C-N 114.93 -1.032 . . . . 0.0 112.638 -179.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.659 ' HE2' HG13 ' A' ' 64' ' ' ILE . 33.5 mtmt -67.97 -58.1 5.1 Favored 'General case' 0 C--N 1.353 0.751 0 C-N-CA 117.891 -1.523 . . . . 0.0 110.51 175.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -95.41 47.82 1.92 Allowed Glycine 0 N--CA 1.436 -1.353 0 CA-C-N 115.154 -0.93 . . . . 0.0 113.356 -170.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 19.6 m -71.84 -4.31 27.26 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -178.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -100.91 2.93 41.33 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 121.682 0.753 . . . . 0.0 111.036 178.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.435 ' CD1' ' HG3' ' A' ' 125' ' ' GLU . 24.0 m-85 -88.44 142.57 27.61 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 174.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 42.5 t -71.08 148.5 47.44 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 105.331 -2.1 . . . . 0.0 105.331 168.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 35.1 ttt-85 -56.46 -42.92 79.0 Favored 'General case' 0 C--O 1.217 -0.637 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.945 -174.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.594 ' O ' ' HG2' ' A' ' 78' ' ' ARG . 90.8 m-70 -75.97 -20.3 58.02 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.476 -0.489 . . . . 0.0 111.274 -177.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -73.17 -44.14 60.37 Favored 'General case' 0 CA--C 1.501 -0.913 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 176.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.54 ' HB3' HG13 ' A' ' 49' ' ' VAL . . . -61.69 -36.51 81.11 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 175.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -61.13 -32.93 72.62 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.639 174.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.594 ' HG2' ' O ' ' A' ' 74' ' ' HIS . 31.7 mmt180 -79.36 -25.93 42.13 Favored 'General case' 0 CA--C 1.496 -1.114 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -176.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.46 ' HB3' ' O ' ' A' ' 76' ' ' ALA . 14.5 tp -60.22 -61.24 2.74 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 124.154 0.909 . . . . 0.0 108.928 177.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -60.6 -27.72 67.95 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.452 -178.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.508 ' O ' HG13 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -69.18 -30.07 68.19 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.061 175.476 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 20.2 ttpp -80.88 -34.93 33.24 Favored 'General case' 0 C--O 1.203 -1.394 0 C-N-CA 117.294 -1.762 . . . . 0.0 107.713 -178.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.563 ' HB3' ' HG ' ' A' ' 89' ' ' LEU . 9.7 mp -60.11 -29.04 68.34 Favored 'General case' 0 C--O 1.211 -0.95 0 CA-C-N 116.24 -0.436 . . . . 0.0 112.015 176.235 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.508 HG13 ' O ' ' A' ' 81' ' ' LYS . 2.1 pp -82.93 -22.14 8.89 Favored 'Isoleucine or valine' 0 C--O 1.244 0.813 0 C-N-CA 120.028 -0.669 . . . . 0.0 111.278 178.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.5 tt -75.97 -49.83 16.58 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 174.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -65.38 -36.1 82.95 Favored 'General case' 0 C--O 1.253 1.281 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 178.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.576 ' HD3' HD21 ' A' ' 109' ' ' ASN 0.31 59.4 mttm 85.0 29.69 0.05 Allowed 'General case' 0 CA--C 1.464 -2.328 0 C-N-CA 125.954 1.702 . . . . 0.0 114.952 176.822 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.408 HG23 HG21 ' A' ' 114' ' ' VAL . 1.8 mp -69.04 -31.48 50.49 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 105.012 -2.218 . . . . 0.0 105.012 163.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.563 ' HG ' ' HB3' ' A' ' 83' ' ' LEU . 44.7 mt -116.01 154.4 29.94 Favored 'General case' 0 N--CA 1.425 -1.676 0 CA-C-N 113.966 -1.47 . . . . 0.0 108.896 173.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.416 ' HB2' ' HA2' ' A' ' 108' ' ' GLY . 1.8 m-20 -139.81 117.68 11.71 Favored 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 174.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.47 ' HG3' HG21 ' A' ' 84' ' ' ILE . 46.6 mt-10 -94.54 145.32 24.89 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.471 0.653 . . . . 0.0 112.133 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -111.08 159.36 17.87 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-N 114.523 -1.217 . . . . 0.0 108.712 176.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 87.6 mt -117.92 145.37 44.71 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -170.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -141.51 163.06 33.94 Favored 'General case' 0 CA--C 1.479 -1.775 0 N-CA-C 105.412 -2.07 . . . . 0.0 105.412 173.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 19.0 tt -132.68 147.07 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.268 0 N-CA-C 106.811 -1.552 . . . . 0.0 106.811 171.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 47.0 p30 -92.41 -174.32 3.66 Favored 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 120.22 -0.592 . . . . 0.0 110.515 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -75.97 5.53 6.43 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 123.009 0.524 . . . . 0.0 111.973 -177.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -108.19 3.01 23.24 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 29.3 t70 66.84 26.73 9.27 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-O 123.547 1.641 . . . . 0.0 108.9 -176.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -101.13 110.62 22.66 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 114.8 -1.091 . . . . 0.0 108.507 177.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.7 140.78 51.53 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.513 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 10.5 tp -134.52 143.44 37.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -117.65 132.69 56.46 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.675 -178.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -108.47 153.0 23.96 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 55.5 t -97.6 137.87 24.02 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 CA-C-O 122.103 0.954 . . . . 0.0 112.964 -174.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 16.5 mmt -134.55 177.98 7.35 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 112.798 -2.001 . . . . 0.0 107.427 174.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 7.3 mp -92.03 142.32 27.66 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.416 ' HA2' ' HB2' ' A' ' 90' ' ' ASP . . . -94.97 -176.89 38.0 Favored Glycine 0 N--CA 1.414 -2.809 0 C-N-CA 119.991 -1.099 . . . . 0.0 114.778 -172.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.576 HD21 ' HD3' ' A' ' 87' ' ' LYS . 6.1 p30 -71.13 -11.37 60.91 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 114.075 -1.062 . . . . 0.0 112.404 -178.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.559 ' O ' HG23 ' A' ' 114' ' ' VAL . 40.2 mmtm -103.58 13.3 33.62 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 177.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.521 ' O ' ' HG ' ' A' ' 115' ' ' LEU . . . -75.94 -28.77 58.09 Favored 'General case' 0 CA--C 1.494 -1.201 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 -177.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 15.8 tp60 -66.16 -39.84 90.08 Favored 'General case' 0 N--CA 1.416 -2.141 0 CA-C-N 112.891 -1.959 . . . . 0.0 109.262 174.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 6.6 m -64.98 -32.7 74.56 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 177.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.56 HG11 HG21 ' A' ' 19' ' ' VAL . 46.2 t -65.69 -46.41 89.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.103 177.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.521 ' HG ' ' O ' ' A' ' 111' ' ' ALA . 68.7 mt -62.59 -37.59 86.81 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.41 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -72.63 -21.35 61.12 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 86.54 12.21 70.02 Favored Glycine 0 C--O 1.215 -1.05 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.627 178.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -96.39 36.86 1.3 Allowed 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 122.299 1.047 . . . . 0.0 109.072 -176.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.634 ' O ' HD13 ' A' ' 119' ' ' LEU . 0.0 OUTLIER -124.7 121.0 33.43 Favored 'General case' 0 N--CA 1.422 -1.857 0 CA-C-O 122.264 1.031 . . . . 0.0 108.34 -176.42 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.632 ' HA ' HG22 ' A' ' 12' ' ' THR 0.265 7.7 ptmm? -131.1 85.5 2.27 Favored 'General case' 1 C--N 1.225 -4.805 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 172.676 . . . . . . . . 4 3 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.417 HG23 HG23 ' A' ' 11' ' ' VAL . 14.4 m -91.43 170.52 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.053 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 177.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -142.62 153.3 43.35 Favored 'General case' 0 C--N 1.266 -3.025 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 -176.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . 0.503 ' O ' ' HB2' ' A' ' 9' ' ' ARG . 56.2 t80 -158.3 143.21 16.35 Favored 'General case' 0 N--CA 1.432 -1.353 0 C-N-CA 120.869 -0.332 . . . . 0.0 111.118 175.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -92.97 98.38 11.32 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-O 121.368 0.604 . . . . 0.0 109.455 176.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.435 ' HG3' ' CD1' ' A' ' 71' ' ' TYR . 29.7 tt0 -45.1 -68.03 0.23 Allowed 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.094 1.358 . . . . 0.0 110.385 178.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 90.1 m -151.12 91.66 1.72 Allowed 'General case' 0 N--CA 1.414 -2.245 0 N-CA-C 103.334 -2.839 . . . . 0.0 103.334 173.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.424 ' C ' HH12 ' A' ' 9' ' ' ARG . 14.3 mm-40 . . . . . 0 C--O 1.252 1.189 0 O-C-N 125.158 1.536 . . . . 0.0 110.144 -171.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 36.8 m . . . . . 0 CA--C 1.505 -0.755 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -155.9 -72.19 0.11 Allowed 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 177.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 15.5 m -87.4 75.88 9.15 Favored 'General case' 0 N--CA 1.421 -1.922 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 175.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.573 ' HG2' ' H ' ' A' ' 5' ' ' ASP . 18.1 ttpp 68.22 -175.89 0.2 Allowed 'General case' 0 CA--C 1.571 1.785 0 CA-C-N 114.368 -1.287 . . . . 0.0 108.853 -177.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.573 ' H ' ' HG2' ' A' ' 4' ' ' LYS . 5.1 p-10 -75.34 167.68 21.45 Favored 'General case' 0 C--O 1.248 0.988 0 C-N-CA 123.723 0.809 . . . . 0.0 109.169 173.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 28.2 p90 -134.82 140.66 46.02 Favored 'General case' 0 N--CA 1.421 -1.892 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 171.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 35.8 mtmm -130.32 81.65 2.02 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 121.683 0.754 . . . . 0.0 110.413 177.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.1 m -124.54 173.4 8.5 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 105.001 -2.222 . . . . 0.0 105.001 178.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -94.75 113.53 25.31 Favored 'General case' 0 N--CA 1.429 -1.524 0 C-N-CA 118.974 -1.09 . . . . 0.0 108.764 178.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.465 ' OD2' ' HB2' ' A' ' 120' ' ' LYS . 0.2 OUTLIER -78.15 90.09 4.26 Favored 'General case' 0 CA--C 1.489 -1.371 0 O-C-N 124.016 0.823 . . . . 0.0 108.829 -179.725 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.6 m -74.58 85.58 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.216 0 CA-C-O 122.713 1.244 . . . . 0.0 109.759 178.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.704 HG22 ' HA ' ' A' ' 120' ' ' LYS . 29.8 p -107.6 -30.33 8.66 Favored 'General case' 0 C--N 1.258 -3.409 0 C-N-CA 118.459 -1.297 . . . . 0.0 110.933 176.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -76.64 -38.95 53.79 Favored 'General case' 0 C--N 1.29 -1.992 0 C-N-CA 124.69 1.196 . . . . 0.0 108.81 -179.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.534 ' O ' ' HB3' ' A' ' 17' ' ' SER . 23.3 t70 -76.62 -36.92 57.15 Favored 'General case' 0 CA--C 1.491 -1.293 0 CA-C-O 122.178 0.989 . . . . 0.0 109.051 -179.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.511 ' O ' HG23 ' A' ' 19' ' ' VAL . 99.5 t -72.97 -21.46 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.803 0 CA-C-N 114.649 -1.16 . . . . 0.0 110.185 177.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.592 ' HE2' ' O ' ' A' ' 12' ' ' THR . 1.3 tppt? -72.25 -31.81 66.12 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 173.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.534 ' HB3' ' O ' ' A' ' 14' ' ' ASP . 29.0 t -63.84 -38.37 90.83 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 173.108 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.479 ' HB ' ' O ' ' A' ' 15' ' ' VAL . 41.4 mt -62.4 -42.89 97.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.005 173.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.511 HG23 ' O ' ' A' ' 15' ' ' VAL . 82.4 t -57.36 -42.8 81.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.137 177.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.405 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 43.7 ttt180 -54.05 -48.07 70.96 Favored 'General case' 0 C--N 1.332 -0.174 0 O-C-N 123.364 0.415 . . . . 0.0 109.892 174.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -65.4 -45.96 81.91 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 115.751 -0.658 . . . . 0.0 112.582 -177.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.493 HG22 ' HA ' ' A' ' 19' ' ' VAL . 29.4 m -65.63 -33.4 63.34 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 C-N-CA 119.907 -0.717 . . . . 0.0 111.045 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 14.7 mm-40 -60.22 -55.6 31.8 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 120.819 0.343 . . . . 0.0 110.806 170.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.405 ' HG2' ' O ' ' A' ' 20' ' ' ARG . 9.4 pt-20 -75.8 -2.11 28.36 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -177.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -72.98 -8.57 56.28 Favored 'General case' 0 N--CA 1.478 0.94 0 O-C-N 121.92 -0.488 . . . . 0.0 110.72 -179.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 9.2 m -78.93 42.79 0.48 Allowed 'General case' 0 CA--C 1.562 1.429 0 C-N-CA 124.98 1.312 . . . . 0.0 111.358 -178.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 14.8 t 65.92 76.43 0.32 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.407 1.483 . . . . 0.0 113.086 179.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.1 p -103.25 100.33 10.22 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 106.568 -1.642 . . . . 0.0 106.568 170.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -92.27 151.27 20.41 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.564 -170.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -164.41 -162.71 15.9 Favored Glycine 0 N--CA 1.427 -1.95 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 177.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 17.5 tmm? -82.8 -62.97 1.46 Allowed 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 177.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.422 ' O ' ' HB3' ' A' ' 61' ' ' GLN . 6.8 tpp180 -80.37 -19.34 46.58 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.097 177.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -75.91 104.18 6.33 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -178.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.514 ' HB ' ' HG3' ' A' ' 61' ' ' GLN . 9.0 tt -46.73 -33.7 2.17 Favored 'Isoleucine or valine' 0 C--O 1.249 1.059 0 C-N-CA 127.203 2.201 . . . . 0.0 114.511 -175.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 26.2 mttp -66.44 117.38 8.58 Favored 'General case' 0 C--N 1.313 -0.978 0 C-N-CA 122.624 0.37 . . . . 0.0 110.421 -172.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -136.77 -88.61 0.29 Allowed 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.641 175.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 41.2 t -140.15 -88.52 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 121.185 0.517 . . . . 0.0 111.632 -176.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -106.7 -66.46 0.64 Allowed Glycine 0 C--N 1.309 -0.924 0 CA-C-N 115.748 -0.66 . . . . 0.0 114.33 -173.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -64.85 -57.41 0.29 Allowed 'Trans proline' 0 C--N 1.357 1.013 0 C-N-CA 122.009 1.806 . . . . 0.0 110.959 178.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.1 m -84.58 103.6 13.85 Favored 'General case' 0 N--CA 1.426 -1.643 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 158.67 -120.98 1.01 Allowed Glycine 0 N--CA 1.425 -2.099 0 N-CA-C 108.23 -1.948 . . . . 0.0 108.23 -178.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 14.9 mmt180 62.44 93.83 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.8 0.84 . . . . 0.0 111.448 177.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -107.57 90.57 3.34 Favored 'General case' 0 CA--C 1.481 -1.703 0 CA-C-O 121.64 0.733 . . . . 0.0 109.038 -175.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.557 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 47.1 p -109.98 144.63 38.25 Favored 'General case' 0 N--CA 1.414 -2.266 0 CA-C-N 114.347 -1.297 . . . . 0.0 107.852 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.515 ' O ' HG23 ' A' ' 49' ' ' VAL . 18.7 ptm -44.52 -44.34 8.59 Favored 'General case' 0 C--O 1.206 -1.19 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -176.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.476 ' N ' ' HG3' ' A' ' 45' ' ' MET . 16.7 t-20 -68.5 -37.97 80.56 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 121.049 -0.26 . . . . 0.0 111.595 -172.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 49.6 ttm -72.54 -36.56 68.32 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.621 ' O ' ' HB2' ' A' ' 52' ' ' PHE . 47.9 mt -67.88 -30.24 69.55 Favored 'General case' 0 C--O 1.192 -1.972 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.846 -178.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.662 HG11 ' HG3' ' A' ' 77' ' ' GLU . 43.0 t -74.19 -44.65 49.26 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.609 0 C-N-CA 123.327 0.651 . . . . 0.0 110.695 179.258 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -54.42 -51.41 65.0 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.805 HD12 ' HB1' ' A' ' 58' ' ' ALA . 6.2 tt -75.97 -24.79 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.28 0 N-CA-C 114.232 1.197 . . . . 0.0 114.232 -178.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.621 ' HB2' ' O ' ' A' ' 48' ' ' LEU . 59.8 t80 -55.44 -43.59 75.55 Favored 'General case' 0 C--N 1.277 -2.579 0 CA-C-N 114.842 -1.072 . . . . 0.0 108.754 175.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.497 ' HA ' ' O ' ' A' ' 68' ' ' GLY . 9.5 mp -77.73 -35.79 51.54 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.892 -1.049 . . . . 0.0 111.551 177.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 98.61 53.3 1.23 Allowed Glycine 0 C--N 1.305 -1.185 0 N-CA-C 108.496 -1.841 . . . . 0.0 108.496 -173.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 52.6 p -64.81 -178.89 0.46 Allowed 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 115.564 1.69 . . . . 0.0 115.564 -175.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -81.88 -27.75 33.3 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 113.117 -1.856 . . . . 0.0 110.811 176.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.8 m -88.72 -45.29 9.92 Favored 'General case' 0 C--O 1.252 1.219 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -175.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.805 ' HB1' HD12 ' A' ' 51' ' ' ILE . . . -97.91 90.58 4.98 Favored 'General case' 0 N--CA 1.403 -2.781 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 178.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 50.2 mttp -72.95 26.57 0.06 Allowed 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 126.285 1.834 . . . . 0.0 114.423 -174.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.476 ' HA ' ' HB3' ' A' ' 65' ' ' PHE . 81.3 mt 71.0 116.71 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 C-N-CA 125.391 1.476 . . . . 0.0 112.713 179.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.571 ' HG2' HD11 ' A' ' 51' ' ' ILE . 17.4 mm-40 -113.34 17.52 18.46 Favored 'General case' 0 N--CA 1.439 -1.005 0 C-N-CA 119.782 -0.767 . . . . 0.0 112.372 -176.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 21.1 m 70.31 107.04 0.06 Allowed 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 124.111 0.964 . . . . 0.0 112.513 -178.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 153.6 -111.06 0.47 Allowed Glycine 0 CA--C 1.498 -0.973 0 N-CA-C 109.056 -1.618 . . . . 0.0 109.056 -179.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.558 ' O ' ' HG3' ' A' ' 67' ' ' LYS . 5.8 tt -91.12 -5.36 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 172.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.642 ' CD1' HD13 ' A' ' 51' ' ' ILE . 9.4 m-85 -70.85 102.04 2.27 Favored 'General case' 0 N--CA 1.41 -2.468 0 CA-C-N 113.353 -1.749 . . . . 0.0 108.959 -174.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.19 9.7 55.36 Favored Glycine 0 N--CA 1.42 -2.423 0 O-C-N 124.338 1.024 . . . . 0.0 112.829 -179.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.601 ' HD3' ' N ' ' A' ' 68' ' ' GLY . 0.1 OUTLIER -65.29 -31.81 73.15 Favored 'General case' 0 C--N 1.357 0.901 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 -178.439 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.601 ' N ' ' HD3' ' A' ' 67' ' ' LYS . . . -160.04 107.71 0.33 Allowed Glycine 0 CA--C 1.498 -1.018 0 C-N-CA 117.808 -2.139 . . . . 0.0 114.991 -175.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.454 ' HB3' ' O ' ' A' ' 53' ' ' LEU . 2.8 p -94.16 10.33 34.26 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 124.406 1.082 . . . . 0.0 110.29 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -91.56 6.31 46.15 Favored 'General case' 0 CA--C 1.506 -0.747 0 CA-C-O 121.965 0.888 . . . . 0.0 110.693 -178.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.408 ' HB2' HD11 ' A' ' 53' ' ' LEU . 43.1 m-85 -99.45 143.12 30.06 Favored 'General case' 0 C--N 1.283 -2.31 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.269 175.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 30.0 t -78.24 139.73 38.9 Favored 'General case' 0 N--CA 1.414 -2.257 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 170.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.468 HH12 ' ND2' ' A' ' 46' ' ' ASN . 32.8 tpt85 -43.52 -56.46 3.64 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.385 1.074 . . . . 0.0 112.223 -175.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -81.32 -12.26 59.08 Favored 'General case' 0 C--N 1.309 -1.169 0 C-N-CA 120.132 -0.627 . . . . 0.0 112.407 -175.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.437 ' ND2' ' HA ' ' A' ' 126' ' ' THR . 19.5 m120 -86.57 -29.72 22.42 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.546 ' HB3' HG13 ' A' ' 49' ' ' VAL . . . -65.35 -40.04 93.09 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 171.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.662 ' HG3' HG11 ' A' ' 49' ' ' VAL . 38.7 mt-10 -60.44 -32.81 71.73 Favored 'General case' 0 C--O 1.246 0.874 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.43 173.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 15.3 tpp180 -68.9 -31.25 70.04 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 -176.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.707 ' HG ' ' CD1' ' A' ' 123' ' ' PHE . 0.4 OUTLIER -73.84 -47.99 34.48 Favored 'General case' 0 CA--C 1.469 -2.165 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.303 -178.571 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -59.2 -21.24 59.17 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-O 121.667 0.746 . . . . 0.0 109.125 176.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 30.7 mmtm -87.22 -31.61 20.22 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.78 178.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.664 ' HE2' ' O ' ' A' ' 122' ' ' ASP . 19.1 ttpp -71.91 -39.04 69.8 Favored 'General case' 0 C--O 1.194 -1.861 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 175.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.505 HD13 HD22 ' A' ' 79' ' ' LEU . 0.6 OUTLIER -57.19 -38.7 74.05 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 125.186 1.395 . . . . 0.0 112.16 178.484 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.409 HG21 ' HG3' ' A' ' 91' ' ' GLU . 2.5 pp -75.68 -23.23 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 119.76 -0.776 . . . . 0.0 111.525 177.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 50.2 mt -77.93 -41.83 35.06 Favored 'General case' 0 N--CA 1.45 -0.434 0 O-C-N 123.425 0.453 . . . . 0.0 110.597 173.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -65.2 -29.12 69.91 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.404 ' HB3' ' HG2' ' A' ' 110' ' ' LYS . 2.3 mptp? 84.9 15.71 0.18 Allowed 'General case' 0 CA--C 1.477 -1.859 0 C-N-CA 125.154 1.382 . . . . 0.0 112.77 175.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.58 HG23 HG21 ' A' ' 114' ' ' VAL . 1.8 mp -67.96 -38.44 79.98 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.794 0 N-CA-C 106.349 -1.722 . . . . 0.0 106.349 167.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.457 ' HG ' ' HB3' ' A' ' 83' ' ' LEU . 30.3 mt -109.03 151.01 26.93 Favored 'General case' 0 N--CA 1.414 -2.261 0 CA-C-N 114.4 -1.273 . . . . 0.0 111.003 177.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.419 ' O ' ' HB2' ' A' ' 106' ' ' MET . 15.6 m-20 -143.85 118.24 9.65 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 175.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.409 ' HG3' HG21 ' A' ' 84' ' ' ILE . 40.8 mt-10 -94.03 155.21 17.24 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 121.052 0.454 . . . . 0.0 112.187 -176.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.593 ' O ' ' HA ' ' A' ' 103' ' ' ALA . 13.4 m-20 -97.77 138.08 35.68 Favored 'General case' 0 CA--C 1.497 -1.059 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 91.5 mt -106.94 116.76 32.49 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 121.482 0.658 . . . . 0.0 111.168 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -125.83 108.9 11.92 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.5 HD11 ' HA ' ' A' ' 99' ' ' ASP . 14.6 tt -112.04 148.94 14.83 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.381 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -177.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -103.69 -175.54 2.83 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -74.53 17.9 0.18 Allowed 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -177.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -118.45 6.01 11.77 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 177.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.5 ' HA ' HD11 ' A' ' 95' ' ' ILE . 6.1 m-20 62.18 28.28 16.98 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 122.299 1.047 . . . . 0.0 111.264 -176.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.432 ' C ' HG13 ' A' ' 95' ' ' ILE . 22.7 mt-30 -93.36 103.03 15.29 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 176.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -83.95 116.05 22.61 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.602 -177.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 4.3 mm -100.01 131.99 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.388 -3.535 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 176.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.593 ' HA ' ' O ' ' A' ' 92' ' ' ASP . . . -113.66 124.51 52.49 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.682 -178.261 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -97.06 155.65 16.71 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 42.2 t -100.55 120.89 50.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -175.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.419 ' HB2' ' O ' ' A' ' 90' ' ' ASP . 25.9 mmt -133.05 -173.04 3.09 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 113.369 -1.741 . . . . 0.0 108.307 177.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -143.67 134.24 24.92 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -138.01 -78.1 0.07 OUTLIER Glycine 0 N--CA 1.44 -1.098 0 C-N-CA 118.515 -1.802 . . . . 0.0 116.075 -174.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -63.78 -51.62 63.97 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 115.243 1.571 . . . . 0.0 115.243 -167.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.495 ' O ' HG23 ' A' ' 114' ' ' VAL . 65.1 mmtt -98.24 -1.64 41.49 Favored 'General case' 0 C--N 1.321 -0.645 0 O-C-N 121.474 -0.766 . . . . 0.0 109.802 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.604 ' O ' ' HG ' ' A' ' 115' ' ' LEU . . . -51.92 -33.18 36.04 Favored 'General case' 0 C--O 1.217 -0.608 0 CA-C-N 114.798 -1.092 . . . . 0.0 113.706 -174.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.46 HE21 ' N ' ' A' ' 113' ' ' THR . 0.0 OUTLIER -64.54 -37.42 87.5 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.474 -177.43 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.46 ' N ' HE21 ' A' ' 112' ' ' GLN . 5.4 m -78.19 -25.16 47.0 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 121.617 0.722 . . . . 0.0 109.238 -179.132 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.58 HG21 HG23 ' A' ' 88' ' ' ILE . 62.0 t -67.64 -40.35 83.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-N 114.703 -1.135 . . . . 0.0 108.272 175.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.604 ' HG ' ' O ' ' A' ' 111' ' ' ALA . 73.1 mt -72.39 -29.09 63.43 Favored 'General case' 0 C--O 1.222 -0.388 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.92 177.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -73.19 -11.37 60.5 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-O 121.165 0.507 . . . . 0.0 110.111 173.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 86.47 -12.62 60.44 Favored Glycine 0 N--CA 1.438 -1.208 0 CA-C-N 115.621 -0.718 . . . . 0.0 113.05 177.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -91.33 62.85 4.78 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 122.253 1.025 . . . . 0.0 111.177 -173.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.514 ' O ' HD13 ' A' ' 119' ' ' LEU . 0.0 OUTLIER -132.04 131.53 42.54 Favored 'General case' 0 N--CA 1.409 -2.517 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 175.201 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.704 ' HA ' HG22 ' A' ' 12' ' ' THR . 0.0 OUTLIER -130.62 128.03 40.16 Favored 'General case' 1 C--N 1.241 -4.124 0 CA-C-N 113.311 -1.768 . . . . 0.0 109.66 179.486 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 14.3 m -133.71 170.66 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 176.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.664 ' O ' ' HE2' ' A' ' 82' ' ' LYS . 8.0 p-10 -108.68 161.01 15.48 Favored 'General case' 0 C--N 1.274 -2.7 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.756 -178.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . 0.707 ' CD1' ' HG ' ' A' ' 79' ' ' LEU . 37.8 t80 -159.08 156.53 29.35 Favored 'General case' 0 C--O 1.256 1.4 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 171.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.408 ' SD ' ' N ' ' A' ' 125' ' ' GLU . 0.0 OUTLIER -127.75 149.02 50.43 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 104.53 -2.396 . . . . 0.0 104.53 -179.735 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.408 ' N ' ' SD ' ' A' ' 124' ' ' MET . 37.6 mt-10 -66.09 -31.96 73.14 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 121.144 0.497 . . . . 0.0 111.857 -174.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.448 HG22 ' H ' ' A' ' 127' ' ' GLU . 17.8 m -151.2 178.24 9.43 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 179.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.448 ' H ' HG22 ' A' ' 126' ' ' THR . 4.8 mp0 . . . . . 0 C--N 1.304 -1.4 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 175.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 37.2 m . . . . . 0 CA--C 1.507 -0.709 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 26.0 ttpp -164.01 160.19 21.53 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.7 p -66.77 141.41 57.73 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 123.575 0.547 . . . . 0.0 110.002 176.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.436 ' HE3' ' HB2' ' A' ' 5' ' ' ASP . 0.1 OUTLIER -156.71 -43.79 0.07 Allowed 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -178.654 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.436 ' HB2' ' HE3' ' A' ' 4' ' ' LYS . 3.5 t70 -124.45 157.5 35.05 Favored 'General case' 0 CA--C 1.476 -1.866 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -175.099 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -154.98 84.54 1.08 Allowed 'General case' 0 N--CA 1.407 -2.582 0 O-C-N 124.215 0.947 . . . . 0.0 109.698 -177.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 38.6 mtmm -126.68 80.79 1.96 Allowed 'General case' 0 C--N 1.285 -2.222 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.681 175.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.7 t -94.78 -172.51 2.74 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 47.0 mmt-85 -97.23 150.41 20.94 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 120.501 -0.48 . . . . 0.0 109.887 178.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -118.71 93.8 4.23 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 104.949 -2.241 . . . . 0.0 104.949 178.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.8 m -82.07 87.59 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.272 -2.782 0 CA-C-O 122.64 1.209 . . . . 0.0 111.322 -175.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.826 HG22 ' HA ' ' A' ' 120' ' ' LYS . 44.7 p -98.47 -58.43 1.96 Allowed 'General case' 0 C--N 1.262 -3.208 0 C-N-CA 117.564 -1.654 . . . . 0.0 113.13 174.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.533 ' HA ' ' HB3' ' A' ' 16' ' ' LYS . 12.3 t70 -83.49 -10.9 58.05 Favored 'General case' 0 C--O 1.205 -1.281 0 C-N-CA 118.797 -1.161 . . . . 0.0 111.139 -176.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -66.59 -46.85 74.6 Favored 'General case' 0 CA--C 1.5 -0.977 0 N-CA-C 105.279 -2.119 . . . . 0.0 105.279 171.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 77.1 t -65.85 -43.28 93.21 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.404 0 CA-C-N 112.944 -1.935 . . . . 0.0 110.074 177.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.533 ' HB3' ' HA ' ' A' ' 13' ' ' ASP . 17.2 ttmt -64.95 -40.26 94.74 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.628 178.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.507 ' O ' ' HD2' ' A' ' 21' ' ' PHE . 72.2 m -55.13 -45.86 75.61 Favored 'General case' 0 CA--C 1.509 -0.608 0 O-C-N 123.33 0.394 . . . . 0.0 109.955 175.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.415 ' O ' HG22 ' A' ' 22' ' ' VAL . 88.1 mt -55.43 -56.62 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.486 177.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.418 HG21 HG11 ' A' ' 114' ' ' VAL . 97.9 t -60.19 -44.44 95.38 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.101 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.41 -179.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.498 ' O ' ' HG3' ' A' ' 24' ' ' GLU . 35.8 ttp180 -58.72 -36.32 74.09 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 124.036 0.934 . . . . 0.0 111.069 -178.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.507 ' HD2' ' O ' ' A' ' 17' ' ' SER . 64.8 m-85 -90.86 -25.36 19.9 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -178.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.415 HG22 ' O ' ' A' ' 18' ' ' ILE . 30.5 m -79.38 -30.8 14.0 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.377 0 C-N-CA 117.307 -1.757 . . . . 0.0 108.54 173.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -63.05 -52.4 62.95 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.251 174.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.498 ' HG3' ' O ' ' A' ' 20' ' ' ARG 0.322 0.0 OUTLIER -70.62 -20.16 62.77 Favored 'General case' 0 C--N 1.347 0.468 0 C-N-CA 119.366 -0.934 . . . . 0.0 112.849 -179.447 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 8.4 m80 -76.77 -37.36 55.99 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 119.619 -0.832 . . . . 0.0 110.127 172.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 29.7 t 54.34 44.87 28.31 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.664 0.786 . . . . 0.0 110.31 177.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 62.1 p 60.09 14.44 4.44 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 125.21 1.404 . . . . 0.0 112.997 -177.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.3 t -143.1 -150.92 0.33 Allowed 'General case' 0 N--CA 1.418 -2.039 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 -178.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 75.4 mm-40 74.91 147.82 0.09 Allowed 'General case' 0 C--O 1.213 -0.836 0 C-N-CA 125.401 1.48 . . . . 0.0 112.517 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.14 34.84 31.98 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 -176.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.488 ' SD ' ' HA2' ' A' ' 38' ' ' GLY . 24.1 mmt -45.35 -23.3 0.19 Allowed 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 126.656 1.983 . . . . 0.0 114.441 -175.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -72.16 -37.2 69.43 Favored 'General case' 0 C--N 1.314 -0.969 0 O-C-N 122.107 -0.371 . . . . 0.0 111.356 -178.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -126.44 -64.8 1.01 Allowed 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -170.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.4 tt -74.24 101.78 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 CA-C-O 122.819 1.295 . . . . 0.0 111.333 -176.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.459 ' C ' ' H ' ' A' ' 37' ' ' VAL . 9.5 mtmp? 60.96 77.3 0.33 Allowed 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 112.63 -2.077 . . . . 0.0 110.964 -176.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -75.59 37.49 0.14 Allowed 'General case' 0 CA--C 1.557 1.241 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.397 -178.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.459 ' H ' ' C ' ' A' ' 35' ' ' LYS . 10.7 p -133.14 10.36 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 C-N-CA 124.996 1.318 . . . . 0.0 107.695 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.488 ' HA2' ' SD ' ' A' ' 31' ' ' MET . . . 87.13 -139.18 15.96 Favored Glycine 0 N--CA 1.435 -1.399 0 CA-C-N 114.697 -1.138 . . . . 0.0 112.868 176.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -70.65 -23.08 27.14 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.443 2.095 . . . . 0.0 111.635 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.458 ' HB2' HG13 ' A' ' 37' ' ' VAL . 1.8 m -50.97 133.23 27.27 Favored 'General case' 0 C--O 1.249 1.073 0 C-N-CA 125.088 1.355 . . . . 0.0 110.966 -178.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 100.84 -175.9 26.77 Favored Glycine 0 N--CA 1.438 -1.174 0 N-CA-C 110.195 -1.162 . . . . 0.0 110.195 -178.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.41 ' HD3' ' SD ' ' A' ' 106' ' ' MET . 73.7 mtt180 -151.67 -174.46 4.85 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 106.074 -1.825 . . . . 0.0 106.074 -178.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -110.1 161.2 15.78 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 177.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 51.2 p -122.56 156.34 34.4 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 176.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.442 ' HG3' ' N ' ' A' ' 46' ' ' ASN . 13.2 ptp -50.71 -42.27 56.91 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-O 121.221 0.534 . . . . 0.0 110.799 178.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.442 ' N ' ' HG3' ' A' ' 45' ' ' MET . 44.2 m-80 -64.1 -34.19 77.49 Favored 'General case' 0 CA--C 1.505 -0.77 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.348 -177.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . 0.446 ' O ' ' HB ' ' A' ' 51' ' ' ILE . 49.2 ttm -71.2 -43.22 67.82 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.444 ' O ' HG22 ' A' ' 51' ' ' ILE . 82.9 mt -67.77 -42.8 81.16 Favored 'General case' 0 C--O 1.208 -1.101 0 CA-C-N 115.224 -0.898 . . . . 0.0 112.469 -176.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.436 HG13 ' HB3' ' A' ' 76' ' ' ALA . 69.2 t -64.57 -46.38 92.75 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.727 0 CA-C-O 121.622 0.725 . . . . 0.0 110.436 179.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -63.52 -37.85 88.88 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 114.712 -1.131 . . . . 0.0 108.927 -178.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.702 ' CG1' ' HB1' ' A' ' 58' ' ' ALA . 0.4 OUTLIER -76.33 -37.85 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.407 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 179.62 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.428 ' CZ ' ' HA3' ' A' ' 68' ' ' GLY . 37.8 t80 -55.81 -39.23 71.05 Favored 'General case' 0 C--N 1.296 -1.745 0 O-C-N 123.877 0.736 . . . . 0.0 110.036 176.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.5 mp -82.13 -28.77 32.01 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.137 -0.938 . . . . 0.0 112.116 177.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.15 35.43 15.1 Favored Glycine 0 C--O 1.251 1.159 0 N-CA-C 109.841 -1.303 . . . . 0.0 109.841 -176.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.532 ' OG ' ' HD3' ' A' ' 56' ' ' LYS . 34.9 t -70.47 -168.96 0.27 Allowed 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 126.619 1.968 . . . . 0.0 112.858 -172.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.648 ' HD3' ' H ' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -50.27 -66.75 0.34 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.205 1.402 . . . . 0.0 112.902 -174.236 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.05 -42.83 22.97 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 114.771 -1.104 . . . . 0.0 111.545 -170.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.702 ' HB1' ' CG1' ' A' ' 51' ' ' ILE . . . -91.78 81.1 5.23 Favored 'General case' 0 N--CA 1.398 -3.048 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 174.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.509 ' O ' ' HB ' ' A' ' 60' ' ' ILE . 0.1 OUTLIER -73.13 25.21 0.06 Allowed 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 114.612 -1.176 . . . . 0.0 111.99 -175.484 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.509 ' HB ' ' O ' ' A' ' 59' ' ' LYS . 88.3 mt 83.34 127.91 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 C-N-CA 126.831 2.053 . . . . 0.0 111.057 -175.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.463 ' HG3' ' O ' ' A' ' 60' ' ' ILE 0.297 14.8 mt-30 -135.82 58.86 1.73 Allowed 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 178.609 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 15.2 t 71.44 137.14 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 125.91 1.684 . . . . 0.0 112.729 177.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.28 -141.65 15.73 Favored Glycine 0 C--O 1.241 0.581 0 C-N-CA 121.288 -0.482 . . . . 0.0 112.728 177.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.461 HG21 ' HB3' ' A' ' 17' ' ' SER . 6.3 pt -73.39 7.19 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 C-N-CA 123.331 0.652 . . . . 0.0 112.427 178.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.592 ' CD2' HG12 ' A' ' 51' ' ' ILE . 0.3 OUTLIER -70.96 113.32 7.88 Favored 'General case' 0 N--CA 1.389 -3.504 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 -178.784 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.68 33.67 46.34 Favored Glycine 0 N--CA 1.424 -2.116 0 CA-C-N 114.849 -1.068 . . . . 0.0 111.305 -174.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 32.9 mmtm -121.32 -15.08 8.19 Favored 'General case' 0 C--O 1.22 -0.452 0 CA-C-O 121.2 0.524 . . . . 0.0 109.72 174.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.428 ' HA3' ' CZ ' ' A' ' 52' ' ' PHE . . . -107.78 35.03 5.25 Favored Glycine 0 N--CA 1.432 -1.579 0 N-CA-C 109.771 -1.331 . . . . 0.0 109.771 178.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 9.2 m -72.62 6.23 2.58 Favored 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 124.932 1.293 . . . . 0.0 111.953 -176.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -93.52 -1.53 55.46 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-O 121.923 0.868 . . . . 0.0 109.337 176.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -103.41 153.62 20.28 Favored 'General case' 0 N--CA 1.422 -1.828 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 175.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.408 ' HB3' ' OD1' ' A' ' 75' ' ' ASN . 37.5 t -105.35 171.86 7.1 Favored 'General case' 0 C--N 1.28 -2.43 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 170.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.418 ' HD2' HG12 ' A' ' 49' ' ' VAL . 8.3 mmm180 -52.78 -37.95 60.37 Favored 'General case' 0 C--O 1.205 -1.277 0 CA-C-O 121.215 0.531 . . . . 0.0 110.869 179.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.463 ' O ' ' HG2' ' A' ' 78' ' ' ARG . 6.5 t-160 -67.6 -43.98 79.18 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.577 -172.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.408 ' OD1' ' HB3' ' A' ' 72' ' ' SER . 7.6 m120 -68.78 -55.7 10.4 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.319 -178.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.436 ' HB3' HG13 ' A' ' 49' ' ' VAL . . . -57.41 -44.82 84.88 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.929 -177.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.403 ' HG3' HG11 ' A' ' 49' ' ' VAL . 44.7 mt-10 -62.62 -33.92 75.99 Favored 'General case' 0 C--O 1.208 -1.096 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 178.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.463 ' HG2' ' O ' ' A' ' 74' ' ' HIS . 9.7 mmm180 -67.14 -30.31 70.26 Favored 'General case' 0 CA--C 1.495 -1.144 0 C-N-CA 119.08 -1.048 . . . . 0.0 110.296 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.536 ' O ' ' HG ' ' A' ' 83' ' ' LEU . 2.5 tt -79.46 -50.99 9.94 Favored 'General case' 0 N--CA 1.42 -1.926 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.261 -177.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.585 ' HA ' HD12 ' A' ' 83' ' ' LEU . 60.6 m-85 -58.45 -23.18 56.89 Favored 'General case' 0 CA--C 1.506 -0.747 0 CA-C-O 121.855 0.836 . . . . 0.0 110.326 179.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -89.2 -23.57 22.36 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 114.473 -1.239 . . . . 0.0 110.118 -179.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.401 ' HE2' ' O ' ' A' ' 122' ' ' ASP . 48.5 tttp -73.36 -40.27 64.51 Favored 'General case' 0 C--O 1.209 -1.053 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 174.127 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.585 HD12 ' HA ' ' A' ' 80' ' ' PHE . 94.6 mt -53.62 -50.19 66.21 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 114.905 -1.043 . . . . 0.0 112.864 178.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.616 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 2.6 pp -73.82 -24.65 19.83 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -178.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 41.0 mt -79.83 -40.2 29.03 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 176.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.629 ' O ' ' HE2' ' A' ' 110' ' ' LYS . 35.1 t70 -82.96 -13.07 56.72 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.675 -177.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.45 ' HG3' ' OD2' ' A' ' 90' ' ' ASP . 2.8 mptp? 85.61 16.77 0.13 Allowed 'General case' 0 CA--C 1.462 -2.418 0 N-CA-C 114.355 1.243 . . . . 0.0 114.355 171.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 11.6 mt -70.02 -45.32 76.87 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.092 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 168.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.616 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 4.3 mm? -114.95 158.57 21.83 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 113.953 -1.476 . . . . 0.0 108.416 174.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.466 ' HB2' ' HA2' ' A' ' 108' ' ' GLY . 0.3 OUTLIER -149.12 109.97 4.3 Favored 'General case' 0 CA--C 1.476 -1.902 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 176.452 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.449 ' HB2' ' O ' ' A' ' 104' ' ' TYR 0.28 11.8 pt-20 -95.53 159.11 15.15 Favored 'General case' 0 C--N 1.282 -2.36 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 178.56 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.462 ' O ' ' HA ' ' A' ' 103' ' ' ALA . 9.8 t70 -97.98 118.14 33.89 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 126.042 1.737 . . . . 0.0 109.287 -170.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -85.5 103.64 14.55 Favored 'General case' 0 N--CA 1.419 -1.997 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.993 179.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -100.54 113.48 26.32 Favored 'General case' 0 C--N 1.279 -2.479 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.503 HD11 ' HA ' ' A' ' 99' ' ' ASP . 16.3 tt -128.47 147.01 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.197 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -178.075 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 30.5 p-10 -98.16 -175.12 3.04 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -76.43 18.69 0.29 Allowed 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -177.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -117.89 3.92 12.18 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 178.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.503 ' HA ' HD11 ' A' ' 95' ' ' ILE . 5.7 m-20 62.91 28.41 16.33 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 122.29 1.043 . . . . 0.0 111.123 -175.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.406 ' C ' HG13 ' A' ' 95' ' ' ILE . 26.7 mt-30 -97.92 106.09 18.34 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 176.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -104.64 146.88 28.29 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 -174.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 14.4 tt -135.19 143.24 37.65 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 N-CA-C 105.855 -1.906 . . . . 0.0 105.855 170.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.462 ' HA ' ' O ' ' A' ' 92' ' ' ASP . . . -112.11 131.5 55.41 Favored 'General case' 0 C--N 1.29 -2.005 0 C-N-CA 120.107 -0.637 . . . . 0.0 111.728 -176.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.449 ' O ' ' HB2' ' A' ' 91' ' ' GLU . 94.6 m-85 -105.21 143.61 33.15 Favored 'General case' 0 C--O 1.196 -1.73 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 177.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.412 HG22 ' HB3' ' A' ' 91' ' ' GLU . 49.8 t -95.3 131.18 42.79 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 CA-C-O 121.999 0.904 . . . . 0.0 113.177 -169.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.449 ' HB2' ' O ' ' A' ' 90' ' ' ASP . 84.8 mmm -130.51 -172.43 2.8 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 112.91 -1.95 . . . . 0.0 106.834 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.525 HD23 ' H ' ' A' ' 107' ' ' LEU . 1.5 pt? -102.81 150.17 23.76 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -178.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.466 ' HA2' ' HB2' ' A' ' 90' ' ' ASP . . . -104.96 -175.42 24.56 Favored Glycine 0 N--CA 1.437 -1.248 0 C-N-CA 120.063 -1.065 . . . . 0.0 113.777 -176.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -58.67 -40.47 83.63 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 123.968 0.907 . . . . 0.0 112.256 -177.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.629 ' HE2' ' O ' ' A' ' 86' ' ' ASP . 37.5 mtmt -92.21 19.85 6.56 Favored 'General case' 0 C--N 1.314 -0.963 0 O-C-N 122.037 -0.415 . . . . 0.0 111.831 -176.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.453 ' O ' ' HB ' ' A' ' 114' ' ' VAL . . . -78.09 -30.25 49.48 Favored 'General case' 0 CA--C 1.497 -1.082 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 177.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 34.8 tp60 -63.76 -39.55 94.54 Favored 'General case' 0 N--CA 1.421 -1.921 0 CA-C-N 112.93 -1.941 . . . . 0.0 109.4 173.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 5.2 m -66.2 -30.14 70.55 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.536 ' HA ' ' HG ' ' A' ' 119' ' ' LEU . 94.5 t -64.64 -43.77 96.67 Favored 'Isoleucine or valine' 0 C--O 1.25 1.108 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.105 176.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 54.0 mt -69.05 -32.91 72.74 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.775 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -72.11 -24.43 61.48 Favored 'General case' 0 C--O 1.216 -0.659 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.213 177.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 103.18 -13.63 55.37 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.723 -0.751 . . . . 0.0 113.336 176.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -83.72 47.59 1.31 Allowed 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 121.531 0.682 . . . . 0.0 112.197 -175.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.536 ' HG ' ' HA ' ' A' ' 114' ' ' VAL . 0.0 OUTLIER -122.41 80.35 1.72 Allowed 'General case' 0 N--CA 1.434 -1.265 0 CA-C-O 123.263 1.506 . . . . 0.0 110.214 179.891 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.826 ' HA ' HG22 ' A' ' 12' ' ' THR . 5.8 ptmm? -114.31 93.13 4.21 Favored 'General case' 0 C--N 1.246 -3.902 0 C-N-CA 118.733 -1.187 . . . . 0.0 110.935 172.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 8.5 m -111.25 170.43 3.58 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.329 -176.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.401 ' O ' ' HE2' ' A' ' 82' ' ' LYS . 6.8 p-10 -95.52 168.43 10.7 Favored 'General case' 0 C--N 1.271 -2.816 0 CA-C-N 114.655 -1.157 . . . . 0.0 111.967 -178.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -158.36 142.34 15.59 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 114.627 -1.169 . . . . 0.0 108.028 172.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 26.5 ptt? -97.24 121.36 39.04 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 177.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -48.79 -55.29 11.96 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 115.316 1.599 . . . . 0.0 115.316 -168.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 8.1 t -150.81 157.29 42.75 Favored 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 119.089 -1.044 . . . . 0.0 111.784 -177.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 . . . . . 0 N--CA 1.422 -1.856 0 N-CA-C 103.145 -2.909 . . . . 0.0 103.145 174.739 . . . . . . . . 0 0 . 1 stop_ save_